data_1zc1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zc1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.876 0.282 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 117' ' ' THR . 92.3 mm-40 -100.09 123.6 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -119.59 128.08 53.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.181 0.515 . . . . 0.0 111.927 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.756 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 50.5 t80 -133.7 138.49 45.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.96 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -116.75 136.71 52.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.979 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.2 mt-10 -140.05 148.96 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.461 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -121.84 126.81 49.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.537 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 89.6 m-85 -149.94 161.72 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HG2' HD23 ' A' ' 111' ' ' LEU . 90.0 mtt180 -92.85 130.82 38.33 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.898 ' HB2' HD13 ' A' ' 96' ' ' LEU . 17.5 p -101.19 147.81 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.95 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -130.11 148.74 70.94 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.69 ' O ' ' HG2' ' A' ' 32' ' ' MET . 55.4 Cg_endo -70.68 109.81 2.58 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.25 1.967 . . . . 0.0 112.44 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.623 HG12 ' HB3' ' A' ' 95' ' ' TYR . 84.1 mt -60.01 -26.7 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.476 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' HH12 ' A' ' 38' ' ' ARG . . . -58.24 -38.62 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.123 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.69 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.1 ptm -68.99 -23.64 64.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.742 0.306 . . . . 0.0 111.07 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.435 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 98.9 mtp -61.9 139.81 58.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 111.235 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.694 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.08 141.58 55.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.645 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.544 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.95 -39.91 87.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -60.0 -39.7 86.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.527 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.694 HG12 ' HB2' ' A' ' 34' ' ' ASN . 49.4 pt -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 22.0 ptt180 -128.29 160.1 33.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 88.1 tttt -100.46 134.56 43.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.07 -40.02 88.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.588 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 96.0 m-20 -61.5 -39.97 92.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.14 92.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.09 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.08 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.84 5.4 41.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.83 179.08 35.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.327 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -109.97 25.57 16.18 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.305 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 61.0 mttm -101.24 135.25 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.272 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.3 pt -120.24 156.54 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.256 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.561 ' C ' HD23 ' A' ' 50' ' ' LEU . 90.4 m-85 -100.25 130.48 46.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.569 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 49' ' ' PHE . 4.0 mm? -129.8 163.31 47.91 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.831 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.685 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 60.4 Cg_endo -77.1 149.45 28.52 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.244 1.963 . . . . 0.0 112.82 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.82 -23.8 62.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -59.97 -39.99 87.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.075 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.488 ' HB3' ' CD ' ' A' ' 23' ' ' GLU . . . -68.07 -41.28 82.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.996 0.426 . . . . 0.0 110.998 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 58.8 tp -60.95 -43.25 98.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.5 m -60.2 -40.27 89.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.54 -40.01 94.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.2 0.524 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' CD2' ' A' ' 21' ' ' PHE . 88.2 mt -60.05 -39.98 87.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.046 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.2 m -59.83 -40.01 87.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.123 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -59.97 -36.27 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.254 0.549 . . . . 0.0 110.092 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' HG ' HD12 ' A' ' 63' ' ' ILE . 12.4 tp -79.98 1.11 28.75 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.51 47.99 8.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.6 HD12 ' HG ' ' A' ' 61' ' ' LEU . 49.2 mm -86.46 121.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -70.21 140.0 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.717 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 40.3 t80 -88.25 147.14 39.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.716 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.717 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 15.0 Cg_exo -71.09 158.91 94.52 Favored 'Cis proline' 0 C--N 1.352 0.752 0 C-N-CA 124.567 -1.014 . . . . 0.0 113.138 0.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.541 ' HG2' HG23 ' A' ' 63' ' ' ILE . 68.0 mtt -95.52 139.45 31.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.476 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 117' ' ' THR . 82.4 mt -107.16 138.33 43.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.716 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.757 ' HB3' HG22 ' A' ' 114' ' ' ILE . 12.3 m-30 -120.09 140.02 51.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.044 0.449 . . . . 0.0 112.027 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HB3' ' OG ' ' A' ' 115' ' ' SER . 62.6 tttp -119.02 130.18 55.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.744 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -94.25 133.21 38.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 94.2 m -120.01 129.94 54.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.318 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.13 110.82 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.193 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -67.65 -40.0 84.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.531 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -39.92 87.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 104' ' ' LEU . 67.1 p -101.29 -13.48 18.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.487 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 0.25 26.11 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.795 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -100.4 139.95 35.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 72' ' ' THR . 13.1 m -121.7 117.42 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.021 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.414 HG23 ' OD1' ' A' ' 158' ' ' ASP . 72.0 p -100.97 155.87 17.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.434 ' CE1' ' NZ ' ' A' ' 70' ' ' LYS . 63.3 m80 -100.4 114.84 28.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 110.621 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.74 160.01 15.66 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.923 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.713 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.99 164.3 22.56 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.027 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -127.83 133.52 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 117.26 0.53 . . . . 0.0 112.266 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.5 tp -92.03 -78.83 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.911 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -150.78 160.02 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 76.1 m-85 -94.93 116.63 28.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 49' ' ' PHE . 47.7 pt -125.89 -8.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -99.55 103.68 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.379 . . . . 0.0 111.786 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.56 -39.98 92.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.293 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.65 -30.33 69.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.179 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.66 74.38 0.79 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.522 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -119.9 140.72 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.323 . . . . 0.0 110.775 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 25' ' ' PHE . 57.3 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.623 ' HB3' HG12 ' A' ' 30' ' ' ILE . 87.1 m-85 -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.545 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.898 HD13 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -137.6 156.85 74.58 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.917 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.672 ' HG2' ' HB2' ' A' ' 100' ' ' MET . 37.8 Cg_endo -68.8 158.54 57.43 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.045 1.83 . . . . 0.0 111.459 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.25 -41.13 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 48.1 p-90 -65.76 -38.55 89.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.672 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . 58.2 ttm -60.04 -40.12 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.358 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.597 ' CG ' HD22 ' A' ' 96' ' ' LEU . 97.8 mtp -59.89 -40.01 87.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.92 -40.06 94.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -66.89 -40.23 87.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.357 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.513 ' O ' HG22 ' A' ' 76' ' ' THR . 85.2 mt -70.58 -24.31 62.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.329 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.5 pt -117.75 142.87 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.409 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -96.39 159.96 30.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.746 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.7 138.42 8.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.564 2.176 . . . . 0.0 112.537 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.03 -9.98 75.53 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.765 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.5 m -71.58 150.04 45.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 26' ' ' ARG . 87.3 mt -75.68 144.65 41.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.0 tp -127.05 130.98 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.079 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 97.4 mt-30 -104.3 128.95 52.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 69' ' ' PHE . 91.9 mt -119.4 122.69 69.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 74.7 p -121.6 139.28 53.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.53 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.756 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 32.4 m -85.29 122.39 29.39 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 10.0 t -130.02 138.44 50.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.47 128.8 54.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.385 . . . . 0.0 110.344 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.52 152.25 46.92 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.731 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HB2' ' OE1' ' A' ' 179' ' ' GLU . 67.4 Cg_endo -73.84 16.46 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.187 1.925 . . . . 0.0 112.537 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 191' ' ' ASP . 10.8 mp 64.57 108.32 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.369 . . . . 0.0 111.454 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.93 167.94 1.6 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.55 -28.2 9.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.675 0.238 . . . . 0.0 111.585 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -142.46 132.1 23.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.369 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.588 HG13 HG23 ' A' ' 194' ' ' THR . 2.7 p -131.33 130.17 62.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 111.327 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HE2' HD11 ' A' ' 174' ' ' LEU . 88.3 tttt -99.7 120.09 39.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.66 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.707 HD22 HG13 ' A' ' 173' ' ' ILE . 85.5 mt -111.44 140.49 45.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 111.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' OE1' ' HE2' ' A' ' 172' ' ' LYS . 45.0 tt0 -91.71 117.2 67.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.03 159.79 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.516 2.144 . . . . 0.0 112.167 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -136.19 121.51 19.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.2 m 66.79 135.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.29 -21.13 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.87 -40.06 87.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.414 ' HE1' ' CE1' ' A' ' 196' ' ' PHE . 60.9 t80 -60.03 -40.06 88.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.756 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.419 ' N ' HD13 ' A' ' 135' ' ' LEU . 9.8 mp -80.72 -10.53 59.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.5 -10.22 59.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.281 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 138' ' ' SER . 84.0 mt -64.18 139.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.745 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.436 ' N ' HG21 ' A' ' 137' ' ' ILE . 83.1 p -59.96 -40.05 87.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.349 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -127.12 71.92 76.29 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.788 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.92 -32.99 93.12 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.631 2.221 . . . . 0.0 111.879 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.19 -40.2 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.12 97.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.3 t -60.06 -41.15 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 127' ' ' LEU . 3.1 tm? -60.3 -44.01 95.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.194 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.1 -39.93 87.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.6 -40.03 95.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 162' ' ' ILE . 75.7 t -61.78 -42.95 96.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.01 -40.05 87.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.821 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -65.04 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.86 -40.02 96.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.518 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.434 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 96.9 m-85 -105.56 119.69 39.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.768 0.318 . . . . 0.0 111.179 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.442 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 42.7 p -69.83 -35.79 75.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.627 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 34.3 p -124.56 140.32 53.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 111.607 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 185' ' ' ILE . 90.5 mt -122.1 130.17 53.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.6 m -119.78 140.12 51.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.015 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.533 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 98.3 t -60.05 -40.47 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.175 0.512 . . . . 0.0 110.652 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.74 -29.43 61.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.875 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.458 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 93.9 m-20 -78.45 140.14 38.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.93 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.68 120.07 55.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.921 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.482 HD13 ' CG1' ' A' ' 147' ' ' VAL . 46.7 pt -103.38 137.93 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.927 0.394 . . . . 0.0 111.379 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 170' ' ' LYS . 99.0 mt-10 -119.98 140.05 51.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.205 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 147' ' ' VAL . 6.0 tt -116.21 135.61 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.729 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.0 t -109.76 115.19 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -123.56 127.35 48.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.5 t30 51.73 40.05 26.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.687 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.56 9.8 86.51 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.975 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 163' ' ' SER . 59.5 mttm -111.1 144.1 40.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.8 m -114.75 130.79 56.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.79 140.07 51.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.67 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 62.4 mttp -100.32 121.62 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.552 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.432 ' HB ' HG13 ' A' ' 160' ' ' ILE . 85.3 mt -120.02 120.01 61.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.711 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.872 ' HE3' HD22 ' A' ' 174' ' ' LEU . 38.5 ttpt -116.2 125.55 52.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.707 HG13 HD22 ' A' ' 127' ' ' LEU . 4.9 mp -78.45 83.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.429 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.872 HD22 ' HE3' ' A' ' 172' ' ' LYS . 76.3 mt -59.99 -49.97 75.6 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 126' ' ' LYS . 98.9 mt-10 -152.39 138.99 18.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.024 0.44 . . . . 0.0 111.735 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.561 HG12 ' CG2' ' A' ' 125' ' ' VAL . 16.7 m -140.33 151.57 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.686 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -96.18 104.77 18.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 65.0 Cg_endo -100.3 167.42 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.286 2.657 . . . . 0.0 112.706 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.422 ' OE1' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.92 -0.08 40.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.4 p -139.83 159.79 41.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.007 0.432 . . . . 0.0 111.376 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.2 m -70.08 -10.3 58.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 t -57.76 -25.75 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.286 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 181' ' ' SER . 34.2 mmtp 60.02 39.97 19.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.756 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -128.29 139.69 52.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.64 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 154' ' ' LEU . 39.9 pt -127.32 131.53 70.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.534 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 23.3 m -139.97 119.95 13.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.08 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 187' ' ' VAL . 9.1 p -118.15 112.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.749 0.785 . . . . 0.0 111.171 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.593 HD13 ' HD2' ' A' ' 66' ' ' PRO . 55.5 mt -71.59 -60.72 2.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.547 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.08 -79.94 0.33 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.1 t -168.05 41.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.56 ' HB2' HD21 ' A' ' 121' ' ' LEU . 94.7 m-20 -88.76 2.09 54.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.548 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.584 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.1 tp -111.6 130.32 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.35 129.07 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.588 HG23 HG13 ' A' ' 125' ' ' VAL . 69.7 p -112.95 139.82 48.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.36 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.03 140.88 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.414 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 98.3 m-85 -100.02 121.11 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.48 110.48 28.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo . . . . . 0 C--N 1.347 0.488 0 C-N-CA 122.256 1.97 . . . . 0.0 112.26 -179.63 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 65.0 Cg_exo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.825 0.26 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.501 ' OE1' HD12 ' A' ' 63' ' ' ILE . 78.1 mt-30 -112.11 127.15 55.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.0 m -120.02 131.12 55.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.024 0.44 . . . . 0.0 111.755 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 27.7 t80 -124.11 141.06 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.301 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.04 130.58 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.16 0.505 . . . . 0.0 112.045 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -141.83 156.54 45.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.438 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -116.06 124.36 50.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.747 0.308 . . . . 0.0 110.692 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CB ' HG12 ' A' ' 94' ' ' VAL . 90.8 m-85 -136.03 150.92 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.681 ' HD2' ' HG2' ' A' ' 93' ' ' ARG . 7.4 ptp180 -82.24 143.76 31.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.842 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.746 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 46.5 t -98.99 123.14 43.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 112.175 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CB ' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m-85 -117.85 146.24 38.47 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 32' ' ' MET . 71.8 Cg_endo -77.72 105.27 2.0 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.717 2.278 . . . . 0.0 112.953 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.824 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.4 mt -61.39 -40.02 84.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.847 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.02 75.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.814 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.407 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . 97.7 mmm -68.34 -30.98 70.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.453 ' CE ' HG21 ' A' ' 37' ' ' ILE . 99.7 mmm -60.34 148.54 36.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -59.94 150.24 29.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.98 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.6 m-20 -59.93 -40.05 87.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -64.4 -40.19 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG21 ' CE ' ' A' ' 33' ' ' MET . 85.6 mt -70.77 -40.91 77.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.592 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.452 ' NH1' HG23 ' A' ' 37' ' ' ILE . 84.5 mmt-85 -122.58 140.08 53.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.798 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 9.8 mtpm? -80.58 149.35 29.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.1 -40.03 88.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.04 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.99 87.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.88 80.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.071 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.645 ' OD1' HG22 ' A' ' 30' ' ' ILE . 98.5 m-20 -60.03 -39.89 87.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.964 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.65 16.76 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.98 168.6 26.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.329 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.15 16.36 58.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.118 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.1 mttt -100.72 135.57 41.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 111.129 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.698 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.5 pt -118.75 150.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.201 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 90.1 m-85 -100.51 131.91 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.986 0.422 . . . . 0.0 111.018 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD21 HG21 ' A' ' 114' ' ' ILE . 5.4 mp -132.67 162.0 59.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 80.3 Cg_endo -77.28 153.05 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.166 1.91 . . . . 0.0 112.904 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.27 -18.31 55.47 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.145 2.563 . . . . 0.0 112.545 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.8 t -60.01 -40.0 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.18 82.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.16 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD23 ' CE1' ' A' ' 87' ' ' PHE . 81.5 mt -60.09 -41.37 92.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.695 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.1 m -60.02 -40.12 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.417 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -68.23 -39.99 82.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD2' HG13 ' A' ' 63' ' ' ILE . 95.7 mt -60.1 -39.88 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.158 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -59.97 -40.05 87.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 110.261 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -60.01 -39.96 87.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.508 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD11 ' CD1' ' A' ' 21' ' ' PHE . 88.6 mt -81.24 -0.07 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.821 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 39.96 19.29 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.48 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.501 HD12 ' OE1' ' A' ' 19' ' ' GLN . 41.4 mm -68.13 136.79 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.682 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -92.42 140.2 29.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.421 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.469 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 43.7 p90 -87.29 155.74 54.4 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 18.0 Cg_exo -66.88 162.49 74.09 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.758 0.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -95.0 130.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.821 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 117' ' ' THR . 65.0 mt -114.67 140.1 49.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.618 ' HB3' HG22 ' A' ' 114' ' ' ILE . 35.7 m-85 -120.01 140.08 51.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.734 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HG2' HG13 ' A' ' 79' ' ' VAL . 86.6 tttt -117.03 130.38 56.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.978 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD12 HD23 ' A' ' 96' ' ' LEU . 50.9 mt -96.0 120.98 37.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 113' ' ' GLN . 97.3 m -104.03 120.06 40.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.28 115.38 30.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.605 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -67.83 -39.96 83.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.957 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 m -97.16 -14.96 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.34 -6.08 4.69 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.682 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.597 HH21 ' HB3' ' A' ' 157' ' ' ASP . 78.8 ttt180 -100.68 139.97 35.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 70' ' ' LYS . 47.3 t -118.08 119.99 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.3 p -99.93 159.62 14.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.621 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 74.5 m80 -101.74 115.14 29.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 110.655 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.21 158.26 18.93 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.939 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -91.68 157.07 24.28 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.593 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 8.4 p -127.97 134.07 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 117.294 0.547 . . . . 0.0 112.341 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.658 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 44.4 tp -91.84 -79.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.558 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -142.65 159.71 41.7 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.719 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.621 ' CE1' HD23 ' A' ' 55' ' ' LEU . 72.5 m-85 -97.72 116.39 29.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' A' ' 49' ' ' PHE . 47.9 pt -127.61 -4.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -84.58 98.17 10.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.417 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.87 -39.88 76.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 0.0 110.519 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.51 -30.67 71.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.363 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.0 42.97 1.14 Allowed Glycine 0 C--N 1.32 -0.323 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.684 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.681 ' HG2' ' HD2' ' A' ' 26' ' ' ARG . 29.4 mtm105 -117.15 150.9 37.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 112.151 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.771 HG13 HD22 ' A' ' 112' ' ' LEU . 14.8 p -128.78 145.03 36.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.219 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.824 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.1 m-85 -120.54 141.93 49.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.44 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.529 HD23 HD12 ' A' ' 71' ' ' LEU . 69.8 mt -120.21 142.49 33.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.925 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 101' ' ' MET . 51.3 Cg_exo -57.95 156.97 26.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.511 2.141 . . . . 0.0 111.836 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.03 -41.97 93.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.789 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.621 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 49.3 p-90 -70.0 -40.11 75.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.281 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.621 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 97.4 mtp -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.647 0.26 . . . . 0.0 111.037 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.2 mtp -60.06 -40.03 88.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.052 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 -40.01 94.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 110.496 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.966 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.09 -24.25 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.29 29.96 65.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.589 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.575 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 45.6 pt -116.29 144.8 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.333 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.478 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -97.4 160.2 29.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.605 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 7.8 Cg_endo -49.2 135.22 31.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.591 2.194 . . . . 0.0 112.136 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 -6.51 82.64 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.699 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.575 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 93.1 p -74.61 157.39 35.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 110.659 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.85 140.03 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.981 0.42 . . . . 0.0 111.02 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.771 HD22 HG13 ' A' ' 94' ' ' VAL . 61.6 tp -127.05 130.13 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.417 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.63 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 64.0 tt0 -107.7 120.24 41.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.618 HG22 ' HB3' ' A' ' 69' ' ' PHE . 86.1 mt -111.37 129.98 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.442 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.619 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 80.6 p -126.38 139.85 52.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 20' ' ' THR . 20.7 t -77.52 120.61 22.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.2 m -119.99 130.0 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.039 0.447 . . . . 0.0 111.899 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 96.5 m-20 -121.41 119.96 33.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.453 HG13 ' OG ' ' A' ' 184' ' ' SER . 16.7 m -120.93 150.02 52.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.78 142.92 16.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.907 2.405 . . . . 0.0 109.917 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 186' ' ' CYS . 9.8 mt -60.91 120.3 9.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.211 0.529 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.42 160.36 54.02 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 96.6 mt-30 -99.98 -19.94 16.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.154 -0.219 . . . . 0.0 111.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.13 134.96 23.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 111.729 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 194' ' ' THR . 2.4 p -136.4 129.74 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 84.7 tttt -97.06 119.97 36.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.022 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.565 HD12 HD22 ' A' ' 144' ' ' LEU . 88.0 mt -113.55 130.44 56.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.223 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 10.2 tt0 -104.28 110.03 63.54 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.45 170.29 16.13 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.596 2.197 . . . . 0.0 112.437 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.471 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 94.1 mt-30 -132.67 122.86 25.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.981 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.0 m 67.87 137.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.755 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.27 -18.26 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.685 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.01 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.527 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 66.4 t80 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.68 -2.0 58.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.7 mt -58.08 138.99 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.2 p -59.96 -37.65 80.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.555 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.4 m-20 -118.75 80.45 17.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.8 -32.01 30.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.623 2.216 . . . . 0.0 112.271 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -60.06 -40.84 90.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.09 98.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 147' ' ' VAL . 94.1 t -64.0 -42.55 96.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.565 HD22 HD12 ' A' ' 127' ' ' LEU . 3.1 tm? -59.91 -42.33 93.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.04 -42.11 93.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -59.97 -40.06 87.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.088 0.47 . . . . 0.0 110.59 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.673 HG23 HG23 ' A' ' 162' ' ' ILE . 57.7 t -61.46 -43.78 97.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.249 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.96 -40.24 92.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.803 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -63.32 -40.01 96.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.655 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -59.98 -39.97 87.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.313 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 88.5 m-85 -102.34 122.07 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.046 0.45 . . . . 0.0 111.676 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.426 ' C ' HD21 ' A' ' 68' ' ' LEU . 66.2 m -61.1 -39.98 91.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.218 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.586 ' HB ' HD21 ' A' ' 68' ' ' LEU . 8.2 t -128.05 140.76 51.77 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.983 0.421 . . . . 0.0 111.187 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.479 ' HB3' HG13 ' A' ' 185' ' ' ILE . 49.8 tp -114.8 121.5 43.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.449 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 53.4 m -119.38 140.29 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.744 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 90.0 t -59.98 -41.51 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.48 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.597 ' HB3' HH21 ' A' ' 78' ' ' ARG . 95.9 m-20 -70.05 -34.92 73.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 95.7 m-20 -73.58 139.34 45.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.252 0.549 . . . . 0.0 112.412 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.31 120.0 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.57 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.582 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 45.2 pt -106.96 138.42 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.043 0.449 . . . . 0.0 112.109 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.673 HG23 HG23 ' A' ' 147' ' ' VAL . 44.6 pt -127.34 141.37 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.2 t -110.73 117.86 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.179 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.459 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 54.0 t80 -120.45 120.28 35.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 56.21 40.05 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.577 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.96 9.89 86.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.089 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.9 mttt -112.74 137.42 51.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.785 0.293 . . . . 0.0 110.381 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.7 p -109.99 129.08 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 111.486 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CD1' ' HD1' ' A' ' 134' ' ' PHE . 89.2 m-85 -120.06 140.0 51.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.592 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 97.7 mttt -101.12 124.57 47.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.247 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -119.27 128.95 54.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.006 0.432 . . . . 0.0 110.684 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.3 mp -83.63 109.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 128' ' ' GLU . 84.4 mt -67.89 -54.07 21.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 49.8 mt-10 -157.65 140.36 14.86 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.349 . . . . 0.0 111.212 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 125' ' ' VAL . 4.5 m -140.05 154.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -110.18 102.59 51.59 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.494 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.494 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 63.6 Cg_endo -104.04 -2.69 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.144 3.229 . . . . 0.0 113.201 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 61.67 27.87 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.4 p -140.16 147.37 40.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.985 0.422 . . . . 0.0 111.186 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.7 m -61.66 -40.03 93.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.0 p -60.01 -20.18 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 50.5 mttt 57.23 39.8 28.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.0 111.432 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.453 ' OG ' HG13 ' A' ' 119' ' ' VAL . 41.4 t -121.62 140.81 51.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.153 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 17.7 pt -125.24 148.5 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.414 . . . . 0.0 111.475 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.664 ' O ' HD22 ' A' ' 121' ' ' LEU . 53.0 t -139.27 99.38 3.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.574 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 187' ' ' VAL . 11.7 p -117.45 113.27 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.783 0.801 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mt -77.26 -62.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.29 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.02 -79.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.4 t -161.18 42.87 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.739 0.304 . . . . 0.0 111.662 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.455 ' HB2' HD21 ' A' ' 121' ' ' LEU . 92.7 m-20 -89.74 6.13 42.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' A' ' 125' ' ' VAL . 31.8 tp -120.45 130.09 54.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.869 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 123' ' ' GLN . 33.0 t -90.45 121.89 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.864 ' HA ' HG11 ' A' ' 125' ' ' VAL . 52.6 p -100.99 151.98 21.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.463 0.649 . . . . 0.0 112.411 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -129.65 139.1 51.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.541 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.84 137.02 46.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.756 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 198' ' ' PRO . . . -121.18 165.88 17.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.365 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 197' ' ' ALA . 13.7 Cg_endo . . . . . 0 C--N 1.344 0.318 0 C-N-CA 122.143 1.895 . . . . 0.0 111.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 46.3 Cg_exo . . . . . 0 C--O 1.23 0.101 0 CA-C-O 120.855 0.273 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 96.5 mt-30 -105.45 120.44 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 116' ' ' SER . 72.6 p -121.17 129.79 53.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 111.689 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 78.6 t80 -119.85 139.43 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -106.26 134.86 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.137 0.494 . . . . 0.0 111.976 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.0 mt-10 -141.1 151.37 43.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.92 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -120.53 136.78 54.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.992 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -152.57 159.97 43.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.848 0.356 . . . . 0.0 111.082 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 94' ' ' VAL . 89.2 mtt180 -84.35 140.31 31.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 17.3 t -97.66 125.75 42.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.571 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.45 149.79 44.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.298 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.93 100.47 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.923 2.416 . . . . 0.0 112.326 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.573 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 83.6 mt -60.5 -40.1 83.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 110.406 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 98' ' ' GLN . . . -60.01 -32.54 70.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.294 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.2 ttm -66.98 -39.02 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.407 ' HE2' HG23 ' A' ' 37' ' ' ILE . 94.8 mtp -60.9 151.72 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.45 143.8 48.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.184 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.8 m-20 -60.03 -40.05 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.072 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -60.81 -40.04 91.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 110.918 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HG23 ' HE2' ' A' ' 33' ' ' MET . 85.8 mt -68.18 -40.06 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.4 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 35' ' ' ASP . 39.6 mmt180 -116.34 140.18 49.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 111.965 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.83 139.99 55.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -60.11 -39.08 84.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -39.95 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.821 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.93 87.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.404 HD22 HG23 ' A' ' 30' ' ' ILE . 28.0 m120 -60.03 -41.4 92.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.14 6.92 38.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.714 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.61 171.9 29.54 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.534 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -99.45 18.29 56.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.211 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.3 mttt -100.24 131.41 46.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.2 pt -119.8 151.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.934 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 88' ' ' ILE . 94.4 m-85 -101.81 131.38 48.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.145 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.724 ' HG ' HG22 ' A' ' 94' ' ' VAL . 5.0 mp -135.86 160.95 65.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 0.0 111.814 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.581 ' CG ' ' HA2' ' A' ' 92' ' ' GLY . 32.3 Cg_exo -63.78 135.68 49.65 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.91 2.406 . . . . 0.0 112.364 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.456 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 37.0 Cg_exo -60.4 -20.12 61.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.697 2.265 . . . . 0.0 112.916 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.3 m -60.01 -40.52 89.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.872 0.368 . . . . 0.0 110.781 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.9 93.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.269 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 59.1 tp -59.97 -40.21 88.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.113 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -59.98 -39.98 87.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -60.76 -39.95 90.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.378 0.609 . . . . 0.0 110.376 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD21 ' OG ' ' A' ' 116' ' ' SER . 87.7 mt -60.04 -39.5 86.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.8 t -57.76 -38.31 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.3 mtt -60.0 -37.06 78.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.403 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 HD11 ' CD1' ' A' ' 21' ' ' PHE . 87.6 mt -80.08 -0.06 34.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 59.95 40.06 19.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.697 0.284 . . . . 0.0 111.588 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -86.72 120.07 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 110.436 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -83.56 151.2 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.733 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.447 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 32.6 p90 -87.1 159.85 50.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HG2' HD13 ' A' ' 188' ' ' ILE . 23.4 Cg_exo -65.65 147.53 73.14 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.866 0.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.6 mtt -95.58 138.92 32.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.775 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' A' ' 117' ' ' THR . 32.3 mt -114.05 139.34 49.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.527 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.6 m-85 -131.55 145.42 51.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.235 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HB3' ' ND1' ' A' ' 81' ' ' HIS . 22.4 pttp -122.21 140.32 52.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 HD11 ' A' ' 96' ' ' LEU . 88.6 mt -98.58 128.09 44.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 113' ' ' GLN . 23.0 p -105.17 136.4 44.74 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.07 113.79 22.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.724 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -65.92 -39.07 90.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.814 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.89 -40.09 87.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.924 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 104' ' ' LEU . 74.3 p -102.96 -14.49 16.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.94 41.49 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.744 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -101.22 140.16 35.89 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.022 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 72' ' ' THR . 41.6 t -119.99 121.41 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.685 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 80.1 p -102.45 156.34 17.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.647 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 93.0 m-70 -101.76 114.85 29.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.37 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.24 167.1 17.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.756 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.636 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.99 162.91 26.49 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.539 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 84' ' ' VAL . 8.0 p -129.67 131.99 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 111.709 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.2 tp -93.38 -80.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.115 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.9 161.04 43.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 89.1 m-85 -95.3 116.48 28.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 49' ' ' PHE . 46.1 pt -125.57 -4.62 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -88.84 98.12 11.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.136 0.493 . . . . 0.0 111.557 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.07 75.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.96 -30.35 69.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.887 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.581 ' HA2' ' CG ' ' A' ' 51' ' ' PRO . . . 112.35 49.3 0.61 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.611 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.1 149.48 42.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.84 0.353 . . . . 0.0 111.558 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.724 HG22 ' HG ' ' A' ' 50' ' ' LEU . 7.4 p -128.93 142.82 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.002 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 97.5 m-85 -114.02 137.6 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 101' ' ' MET . 1.8 tp -119.57 137.57 25.65 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' A' ' 96' ' ' LEU . 52.6 Cg_exo -53.25 145.55 43.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.45 2.1 . . . . 0.0 112.372 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 59.0 tt0 -60.05 -43.66 95.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.829 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.541 ' CH2' ' HE3' ' A' ' 100' ' ' MET . 59.1 p-90 -69.98 -41.18 74.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.541 ' HE3' ' CH2' ' A' ' 99' ' ' TRP . 43.8 tpp -61.18 -40.32 93.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.563 ' HA ' HD23 ' A' ' 96' ' ' LEU . 57.1 ttm -60.06 -41.23 91.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.124 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.1 -40.07 94.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.519 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.02 -40.07 96.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 76' ' ' THR . 85.5 mt -69.44 -23.63 63.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.216 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.76 34.85 29.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.998 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.408 HG13 ' CG ' ' A' ' 101' ' ' MET . 45.1 pt -119.77 146.99 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -95.8 157.15 36.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.428 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.39 138.07 30.83 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.399 2.066 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.9 75.74 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.15 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 53.6 m -71.03 149.98 46.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.096 0.448 . . . . 0.0 110.669 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.4 tt -71.04 140.15 50.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 110.681 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 59.3 tp -126.76 130.46 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.61 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 93.7 mt-30 -109.19 130.31 55.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.527 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 18.7 tt -118.29 128.38 75.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 111.443 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 42.3 t -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.859 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.625 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 61.4 m -70.11 130.24 41.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.7 m -120.08 130.03 54.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.831 0.348 . . . . 0.0 111.086 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 98.0 m-20 -119.33 120.04 35.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.227 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.442 HG11 ' OG ' ' A' ' 184' ' ' SER . 34.9 m -112.15 153.62 44.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.911 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.28 17.69 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.823 2.348 . . . . 0.0 112.292 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.521 HD22 ' OG1' ' A' ' 190' ' ' THR . 0.2 OUTLIER 70.11 100.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.974 0.416 . . . . 0.0 111.968 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -57.02 156.82 12.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.244 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.24 -27.22 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -139.56 130.92 26.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.971 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.672 ' HA ' HG13 ' A' ' 176' ' ' VAL . 2.6 p -130.02 130.19 65.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.211 0.529 . . . . 0.0 111.548 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.681 ' HE2' HD12 ' A' ' 174' ' ' LEU . 87.9 tttt -99.42 120.73 40.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.503 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.76 135.51 49.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.408 . . . . 0.0 111.57 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.869 ' HB2' ' HG ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -107.39 119.92 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.905 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 198' ' ' PRO . 91.2 Cg_endo -81.46 169.1 15.86 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.16 1.907 . . . . 0.0 111.573 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -138.25 121.62 17.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER 63.32 26.74 15.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 131' ' ' SER . 2.9 m 36.84 27.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.372 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.468 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 96.2 m-20 -68.54 -39.95 80.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 140' ' ' PRO . 64.0 t80 -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.61 -24.13 63.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.423 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.4 mt -57.5 139.01 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.83 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -60.28 -40.04 88.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.57 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -121.68 75.16 35.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.772 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.465 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 42.3 Cg_endo -69.07 -34.93 15.73 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.786 2.324 . . . . 0.0 112.232 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.64 -40.65 92.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.49 98.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.551 ' O ' HG21 ' A' ' 147' ' ' VAL . 70.8 t -61.14 -42.58 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.1 tm? -60.09 -42.48 94.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.28 -42.27 95.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.56 -40.04 95.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 143' ' ' VAL . 95.5 t -62.01 -40.32 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.004 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.31 -40.48 90.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.03 -39.96 87.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.531 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.79 -40.03 93.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.106 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.404 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.6 m-85 -103.0 121.42 42.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.518 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.475 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 74.0 m -61.15 -40.02 92.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.544 ' HB ' HD23 ' A' ' 68' ' ' LEU . 4.8 t -136.35 147.8 47.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.355 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.39 138.47 54.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.364 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' A' ' 81' ' ' HIS . 54.6 m -116.08 136.08 53.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' A' ' 176' ' ' VAL . 7.2 p -59.81 -39.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.485 ' N ' HG13 ' A' ' 156' ' ' VAL . 4.5 p-10 -83.06 -21.16 33.85 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.613 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.7 t0 -78.95 136.28 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.515 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 159' ' ' VAL . 15.7 m -100.34 120.66 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.167 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.15 138.93 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.284 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 96.5 mt-10 -120.05 139.99 51.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 147' ' ' VAL . 45.6 pt -129.31 140.04 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.3 t -110.13 114.5 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.378 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.13 122.3 40.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.595 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.2 t30 56.41 39.99 29.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.11 12.31 84.19 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.126 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 163' ' ' SER . 58.3 mttm -118.19 139.07 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.903 0.352 . . . . 0.0 110.664 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.5 p -109.53 133.62 52.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.1 m-85 -119.99 138.65 53.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 99.6 mttt -104.76 122.66 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.02 119.97 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.393 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -115.39 130.03 56.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.682 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -81.71 104.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.947 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.869 ' HG ' ' HB2' ' A' ' 128' ' ' GLU . 80.7 mt -60.53 -48.96 79.47 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.1 mt-10 -158.89 139.91 12.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.864 HG22 ' HB ' ' A' ' 156' ' ' VAL . 11.1 m -143.23 151.62 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.957 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -116.93 103.16 52.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.395 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 97.3 Cg_endo -100.08 12.32 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.734 2.956 . . . . 0.0 112.278 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 80.7 tt0 60.75 20.01 10.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.451 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 79.3 p -146.78 152.82 39.4 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.7 m -70.0 -18.56 63.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.548 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.7 t -59.9 -25.52 65.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 60.18 40.04 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 0.0 110.89 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.442 ' OG ' HG11 ' A' ' 119' ' ' VAL . 28.8 p -122.38 142.65 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.224 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 44.9 pt -130.18 140.03 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 68' ' ' LEU . 44.1 t -134.65 138.11 44.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.042 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.597 HG21 ' HB ' ' A' ' 190' ' ' THR . 8.2 p -170.11 67.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.3 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.535 HD13 ' HG2' ' A' ' 66' ' ' PRO . 84.8 mt -70.0 -40.02 78.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.53 -10.08 8.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.686 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.597 ' HB ' HG21 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -78.95 174.49 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.42 118.35 36.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.399 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.591 HD22 HG11 ' A' ' 187' ' ' VAL . 25.2 tp -120.4 138.01 54.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.134 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 26.4 t -92.43 119.99 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.406 HG23 ' CG1' ' A' ' 125' ' ' VAL . 65.9 p -120.87 140.61 51.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.339 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -121.15 139.44 53.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.326 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -105.41 120.0 40.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -132.64 107.65 13.05 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 129' ' ' PRO . 71.0 Cg_endo . . . . . 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 113.149 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.462 -0.353 0 CA-C-O 120.739 0.224 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 97.0 mt-30 -103.27 123.25 46.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.722 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 116' ' ' SER . 9.0 t -129.98 139.93 50.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 115' ' ' SER . 69.2 t80 -121.58 139.99 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.558 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -104.67 130.41 52.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.84 147.62 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.0 120.11 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HB2' HG12 ' A' ' 94' ' ' VAL . 47.2 m-85 -140.69 151.77 44.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.997 0.427 . . . . 0.0 111.221 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.06 131.78 35.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 19.3 p -90.17 143.4 26.81 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.304 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 43.6 m-85 -138.37 157.22 72.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.203 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.91 109.11 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.507 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 95' ' ' TYR . 85.6 mt -60.15 -40.03 82.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -59.69 -23.79 63.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.3 ttp -68.2 -36.62 79.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 97.0 mtp -59.91 141.8 54.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.11 151.9 25.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.702 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -54.03 -29.96 45.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.282 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 ttt-85 -60.05 -39.9 87.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.531 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -113.06 10.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.143 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.617 ' NE ' ' HA ' ' A' ' 31' ' ' ALA . 41.7 ttt180 -113.59 129.99 56.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.008 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.25 129.21 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.36 -40.21 89.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.161 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -64.24 -40.0 95.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.89 91.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.428 HD22 ' NE ' ' A' ' 38' ' ' ARG . 92.5 m-20 -59.97 -40.18 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.36 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.92 2.22 34.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.676 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.94 175.3 32.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.148 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.53 10.49 61.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.392 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HD3' HD13 ' A' ' 85' ' ' LEU . 63.7 mttp -80.54 129.78 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.7 pt -120.06 154.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.446 ' CD1' HD12 ' A' ' 88' ' ' ILE . 96.0 m-85 -99.33 134.46 42.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.629 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.4 mm? -131.16 160.08 68.65 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.609 ' CB ' ' HA2' ' A' ' 92' ' ' GLY . 97.6 Cg_endo -83.51 149.44 12.97 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.002 1.801 . . . . 0.0 112.735 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.2 Cg_exo -61.15 -29.1 86.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.116 2.544 . . . . 0.0 112.861 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.94 87.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.26 86.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.094 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 87' ' ' PHE . 58.5 tp -60.03 -39.99 87.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -60.03 -40.08 88.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 98.8 mttt -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.68 -39.87 92.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.612 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -59.75 -37.54 79.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.84 -35.94 75.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.448 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.1 mt -79.98 -3.88 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.238 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 60.0 40.13 19.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.794 0.33 . . . . 0.0 111.538 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.2 mt -76.23 129.94 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.999 0.428 . . . . 0.0 111.09 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -73.3 141.93 47.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.376 0.608 . . . . 0.0 111.892 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.1 p90 -87.63 153.62 52.94 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.78 152.18 94.68 Favored 'Cis proline' 0 C--N 1.35 0.611 0 C-N-CA 123.486 -1.464 . . . . 0.0 112.912 0.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.5 mtt -84.69 140.49 31.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.81 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' A' ' 117' ' ' THR . 67.1 mt -111.2 137.33 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.081 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.536 ' HD2' ' HB ' ' A' ' 84' ' ' VAL . 50.6 m-85 -130.59 143.74 50.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.069 0.461 . . . . 0.0 111.54 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.609 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 4.5 ttpm? -120.03 137.44 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.64 131.19 43.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.9 m -119.71 130.01 54.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.28 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.73 114.26 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.53 -39.98 89.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.4 -40.04 89.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.211 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -102.67 -9.09 20.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.717 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.95 12.85 16.69 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.85 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.65 140.34 37.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.698 0.285 . . . . 0.0 110.564 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.88 119.79 61.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.063 0.459 . . . . 0.0 111.727 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 76.4 p -105.99 143.4 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.51 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.609 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 80.0 m80 -93.76 114.55 26.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.752 0.311 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.13 159.98 13.78 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.817 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.727 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.91 162.84 26.55 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.386 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 10.8 p -124.74 130.61 73.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.0 112.19 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.1 tp -90.14 -79.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.22 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.01 160.13 42.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 86.1 m-85 -92.78 116.46 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.915 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 49' ' ' PHE . 46.2 pt -122.99 -6.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . . . -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.723 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -39.99 76.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.887 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -67.22 -30.77 70.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.609 ' HA2' ' CB ' ' A' ' 51' ' ' PRO . . . 110.99 67.81 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.848 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' HG2' ' HB3' ' A' ' 89' ' ' ALA . 22.5 ptt-85 -135.05 154.92 51.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 111.158 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 25' ' ' PHE . 11.9 p -129.19 140.17 49.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.776 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.07 139.96 51.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.262 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 27' ' ' CYS . 1.7 pt? -131.17 156.28 80.35 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.685 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 57.9 Cg_endo -68.12 160.01 50.62 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.712 2.275 . . . . 0.0 112.094 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.22 -40.25 89.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 50.5 p-90 -65.19 -40.06 93.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.886 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.463 ' HE2' ' CZ2' ' A' ' 99' ' ' TRP . 61.0 mtt -63.44 -40.18 96.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.462 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 ttp -60.06 -40.49 89.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.582 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.8 m -68.39 -39.96 81.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.697 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.97 -24.01 63.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.25 30.18 69.69 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.125 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.46 ' HB ' ' HG ' ' A' ' 110' ' ' SER . 45.7 pt -119.18 149.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.491 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 36.1 mt-30 -95.86 159.85 31.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.608 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 26.6 Cg_endo -62.61 0.09 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.424 2.083 . . . . 0.0 113.147 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.94 -20.38 9.93 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.46 ' HG ' ' HB ' ' A' ' 106' ' ' ILE . 80.3 p -80.8 160.13 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.2 151.74 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 59.5 tp -120.13 130.88 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.573 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.9 123.31 47.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.871 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 HD11 ' A' ' 50' ' ' LEU . 20.5 tt -119.5 121.65 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 46.6 t -120.04 126.53 51.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 20' ' ' THR . 34.9 t -63.69 131.0 46.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.6 m -120.0 130.01 54.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 96.1 m-20 -118.55 125.44 49.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.139 0.495 . . . . 0.0 110.438 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 121' ' ' LEU . 33.6 m -114.2 150.9 44.43 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.589 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 73.0 Cg_endo -73.89 18.55 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.834 2.356 . . . . 0.0 112.531 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.468 HD13 ' OG1' ' A' ' 190' ' ' THR . 6.1 tt 61.23 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.874 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.41 34.01 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.615 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.02 -16.8 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -140.0 142.18 36.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.816 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.812 HG13 ' HG ' ' A' ' 192' ' ' LEU . 8.4 p -137.71 136.09 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.722 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 29.2 mmtm -98.91 124.7 44.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.431 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.491 HD22 HG13 ' A' ' 173' ' ' ILE . 83.7 mt -113.73 131.0 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.013 0.435 . . . . 0.0 111.598 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -104.49 119.33 54.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 94.9 Cg_endo -77.83 160.39 30.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -125.93 121.4 33.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.983 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t 56.77 160.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.155 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 m -71.89 -21.59 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -59.98 -40.09 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.702 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.75 -40.22 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.046 0.451 . . . . 0.0 110.496 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.06 -0.41 57.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.298 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -60.01 -40.04 87.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.466 HG23 ' H ' ' A' ' 139' ' ' ASP . 84.8 mt -55.21 139.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.938 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.9 p -60.18 -40.66 90.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.466 ' H ' HG23 ' A' ' 137' ' ' ILE . 1.2 m-20 -120.94 76.68 29.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.33 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.94 -28.69 16.05 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.425 2.084 . . . . 0.0 111.927 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.71 -40.05 93.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.93 98.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.18 -40.29 88.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.522 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.0 tm? -60.36 -41.26 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.28 88.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.274 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.72 -39.96 95.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 110.367 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.449 HG13 ' CG2' ' A' ' 162' ' ' ILE . 84.5 t -61.75 -40.02 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.98 -40.17 88.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -62.77 -40.01 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.99 93.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.934 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.18 121.84 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 111.071 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.497 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 36.1 p -70.07 -39.93 75.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.598 HG22 HD21 ' A' ' 68' ' ' LEU . 11.1 p -119.37 138.59 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.418 ' HA ' HD21 ' A' ' 154' ' ' LEU . 87.0 mt -124.0 124.87 43.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.4 ' OG1' ' ND1' ' A' ' 81' ' ' HIS . 22.8 m -121.36 139.17 53.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.56 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.879 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 31.1 m -60.19 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.325 0.583 . . . . 0.0 111.336 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -68.23 -40.06 82.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.621 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.91 140.24 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.126 0.488 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.3 p -105.18 121.88 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.286 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.3 pt -105.96 138.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 111.277 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.453 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.0 mt-10 -120.07 140.12 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.504 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.449 ' CG2' HG13 ' A' ' 147' ' ' VAL . 45.9 pt -129.72 141.6 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.099 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 17.8 m -107.5 120.87 43.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 111.569 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.496 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 65.0 t80 -120.67 119.56 33.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.223 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.496 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 12.4 m120 54.44 40.11 31.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.657 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.75 83.73 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.691 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -114.37 139.25 49.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.756 0.278 . . . . 0.0 110.473 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.563 HG22 ' OG ' ' A' ' 163' ' ' SER . 68.1 p -108.89 127.64 54.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.331 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.02 139.98 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.483 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.453 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 98.2 mttt -99.99 123.37 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.875 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.98 119.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.833 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -120.11 126.65 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.769 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.879 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -80.95 111.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.0 tt -59.02 -58.26 9.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.722 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.3 tt0 -158.89 141.47 14.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.263 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 125' ' ' VAL . 18.6 m -130.05 160.02 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.94 103.94 22.56 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.0 Cg_endo -103.48 166.81 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.768 2.978 . . . . 0.0 112.125 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.589 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.9 mt-10 -99.96 3.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 159.88 41.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 69.6 p -70.11 -10.14 57.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.07 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -59.84 -19.94 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 111.114 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 56.65 39.82 29.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.029 0.442 . . . . 0.0 111.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -129.94 141.91 50.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.908 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 176' ' ' VAL . 45.3 pt -128.51 141.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.108 0.48 . . . . 0.0 112.033 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.8 t -129.22 125.73 37.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.093 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.6 ' CG1' HD21 ' A' ' 192' ' ' LEU . 11.0 p -155.05 64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.049 0.452 . . . . 0.0 111.395 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 152' ' ' SER . 85.0 mt -68.65 -39.98 81.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.137 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.13 -10.12 9.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.107 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.468 ' OG1' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -81.38 176.34 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.248 0.547 . . . . 0.0 111.404 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.56 117.2 33.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.316 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.812 ' HG ' HG13 ' A' ' 125' ' ' VAL . 30.9 tp -120.49 137.25 54.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.754 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.97 121.16 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.368 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.6 p -115.69 144.27 44.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.799 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -126.5 140.07 52.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.631 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -103.33 126.56 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.416 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -127.75 105.25 20.86 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.518 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 C--N 1.344 0.307 0 C-N-CA 122.419 2.08 . . . . 0.0 112.464 -179.405 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.23 0.115 0 CA-C-O 120.866 0.277 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -108.69 128.87 55.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.532 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.5 m -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.7 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 20.1 t80 -133.65 130.26 38.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HA ' ' HG ' ' A' ' 115' ' ' SER . 86.4 tt0 -118.42 134.26 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 112.04 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.4 mt-10 -139.26 159.12 42.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.894 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -121.26 136.88 54.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.439 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 94.7 m-85 -147.13 160.08 42.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.338 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -89.13 121.95 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 110.408 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.669 ' HB2' HD22 ' A' ' 96' ' ' LEU . 32.0 p -95.44 141.76 28.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.569 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 53.8 m-85 -123.98 148.35 56.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.508 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 16.4 Cg_exo -68.87 108.74 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.788 2.325 . . . . 0.0 112.305 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.586 ' CG2' ' HD2' ' A' ' 38' ' ' ARG . 91.2 mt -59.97 -38.77 77.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.206 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.02 30.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.454 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 70.6 mtm -67.88 -39.58 83.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.827 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . 93.1 mtp -60.19 144.78 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.904 0.383 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.0 m-20 -60.05 145.56 46.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.799 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -60.05 -39.89 87.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.103 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -59.95 -40.04 87.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.7 mt -83.72 -1.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.827 ' HD3' ' HB2' ' A' ' 33' ' ' MET . 44.4 mtm180 -119.48 155.51 31.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.982 0.42 . . . . 0.0 111.882 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.63 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 87.6 tttt -100.56 131.49 46.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.332 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.634 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.63 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.2 m-20 -62.58 -39.96 95.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.95 95.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.03 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.284 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.4 -0.0 30.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.563 0.221 . . . . 0.0 111.403 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -99.78 -179.6 30.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.62 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.11 23.39 34.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.134 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.4 mttt -81.1 126.97 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.968 0.413 . . . . 0.0 111.752 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.685 HG12 ' O ' ' A' ' 83' ' ' GLY . 49.3 pt -119.99 150.04 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.86 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -102.71 133.92 46.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.9 mp -138.13 161.69 58.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.265 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 59.7 Cg_endo -71.98 149.16 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.114 1.876 . . . . 0.0 112.238 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.98 -23.66 67.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.589 2.192 . . . . 0.0 112.591 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.6 p -60.14 -39.9 87.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.71 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.07 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 87' ' ' PHE . 58.6 tp -63.9 -40.12 95.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.835 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.0 m -60.02 -41.33 91.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 111.049 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 88.1 tttt -61.95 -39.87 93.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.321 0.581 . . . . 0.0 110.382 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 21' ' ' PHE . 88.3 mt -59.99 -39.41 85.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.638 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.1 m -59.96 -39.06 84.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 ttm -59.98 -38.45 82.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.772 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.86 -3.87 43.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.643 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.06 40.03 19.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.649 HG22 ' CE ' ' A' ' 67' ' ' MET . 11.0 tt -77.59 137.21 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.712 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -70.08 140.01 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.014 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 30.7 p90 -95.25 157.35 36.52 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.359 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 188' ' ' ILE . 15.6 Cg_exo -69.55 171.34 53.25 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.746 -1.356 . . . . 0.0 112.77 0.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 63' ' ' ILE . 81.7 mmm -85.92 139.87 30.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.092 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 116' ' ' SER . 64.4 mt -108.34 128.42 54.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . 13.5 m-85 -121.95 140.04 52.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.638 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 50.2 pttt -126.38 138.22 53.53 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.247 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 112' ' ' LEU . 8.1 mp -99.0 120.31 39.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.42 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.58 ' CG2' ' HB2' ' A' ' 113' ' ' GLN . 7.6 t -109.62 122.97 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 111.264 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.25 28.16 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.041 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -60.38 -39.99 89.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.894 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -103.27 -10.66 18.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.87 12.19 41.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.302 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -103.47 133.06 49.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.416 ' CG2' ' OG1' ' A' ' 72' ' ' THR . 39.8 t -119.96 119.71 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.204 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.4 p -103.12 160.03 15.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.192 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 80.6 m80 -100.65 114.28 27.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.119 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.31 169.72 19.86 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.833 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.06 163.64 23.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.179 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 12.2 p -127.88 130.02 69.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.189 0.494 . . . . 0.0 112.084 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 60.6 tp -91.33 -78.16 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.191 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -154.63 160.53 41.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.003 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 91.3 m-85 -95.03 116.48 28.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -130.9 -4.82 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -86.91 97.85 10.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.07 0.462 . . . . 0.0 111.232 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -39.95 75.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.749 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.67 -30.5 68.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.663 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.9 49.77 0.72 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.113 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -116.27 148.44 40.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 11.2 p -130.08 142.4 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.152 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.569 ' CE2' ' HB2' ' A' ' 28' ' ' TYR . 87.0 m-85 -119.93 139.96 51.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 27' ' ' CYS . 2.3 pt? -122.81 148.7 54.42 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 111.388 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.66 149.22 69.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.69 2.26 . . . . 0.0 112.084 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -60.03 -41.08 91.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.479 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -70.0 -40.02 75.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.528 ' SD ' HD22 ' A' ' 71' ' ' LEU . 57.6 ttm -61.41 -40.07 93.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.4 ttm -60.37 -40.75 91.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.218 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.77 -39.99 94.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 110.496 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.2 -40.05 96.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.536 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.46 -24.02 63.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.25 31.84 53.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.684 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -111.98 140.0 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.407 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 30.0 pt20 -96.93 160.24 29.61 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 96.1 Cg_exo -43.44 136.09 6.22 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.655 2.236 . . . . 0.0 112.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.76 79.23 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.466 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.6 t -70.02 153.15 43.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.39 141.22 28.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.586 HD13 HD21 ' A' ' 71' ' ' LEU . 59.4 tp -125.53 129.91 50.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.58 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 95.8 mt-30 -111.32 130.93 55.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 69' ' ' PHE . 86.1 mt -109.97 129.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.896 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.638 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 20.2 m -121.96 132.54 54.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 29.4 t -88.67 116.16 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.237 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 81.8 p -125.77 139.84 53.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.507 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -111.11 114.74 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.09 148.52 45.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 34.7 Cg_exo -62.04 175.26 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.342 2.028 . . . . 0.0 112.301 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.553 ' CD1' HG21 ' A' ' 187' ' ' VAL . 0.3 OUTLIER -94.97 120.88 35.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.718 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -69.87 133.63 25.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.85 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.39 -44.01 96.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.633 0.254 . . . . 0.0 111.521 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.461 ' CE1' ' CG1' ' A' ' 193' ' ' VAL . 12.2 m-85 -138.67 145.31 40.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.126 0.489 . . . . 0.0 112.223 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.669 ' HA ' HG12 ' A' ' 176' ' ' VAL . 6.5 p -131.81 130.38 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.928 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.89 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 30.4 mttm -97.61 126.42 42.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.306 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 144' ' ' LEU . 85.1 mt -111.48 134.98 52.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.38 109.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.19 159.96 48.46 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.471 2.114 . . . . 0.0 112.417 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.3 tt0 -129.36 121.37 27.28 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m 69.55 130.68 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.03 -25.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.435 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -39.97 87.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.99 -39.91 87.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.27 -10.64 58.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.354 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.02 -12.32 61.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.72 0.295 . . . . 0.0 111.384 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.475 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -60.01 138.79 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.579 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 t -60.81 -40.08 91.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.457 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 137' ' ' ILE . 21.8 m-20 -129.89 74.55 80.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 60.2 Cg_endo -73.4 -26.62 14.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.482 2.121 . . . . 0.0 111.92 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.03 -40.07 88.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.68 88.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.85 -40.34 87.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.401 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.66 HD21 HD11 ' A' ' 127' ' ' LEU . 2.9 tm? -60.93 -43.04 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.506 ' HG3' ' OG1' ' A' ' 190' ' ' THR . 86.3 tt0 -59.94 -40.65 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.14 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.12 -40.06 92.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.632 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 162' ' ' ILE . 95.4 t -60.04 -41.16 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.367 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.08 -40.15 88.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -62.27 -39.97 94.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.844 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.12 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.05 117.25 33.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 0.0 111.205 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.613 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 67.4 m -63.11 -40.06 96.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 68' ' ' LEU . 81.1 p -123.38 140.54 52.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.864 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.9 mt -119.85 127.21 52.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.207 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.495 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 94.6 m -118.7 137.41 53.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.779 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.733 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.4 t -60.06 -41.11 85.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.382 0.611 . . . . 0.0 111.188 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.83 -38.99 73.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.485 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.495 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.5 t0 -66.19 134.25 52.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.626 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.597 HG13 ' HE2' ' A' ' 172' ' ' LYS . 15.4 m -98.96 119.98 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.129 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 171' ' ' ILE . 48.3 pt -102.36 134.84 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.983 0.42 . . . . 0.0 111.351 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 98.1 mt-10 -120.09 139.97 51.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.149 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.489 HD11 HG23 ' A' ' 147' ' ' VAL . 45.2 pt -126.22 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.9 t -103.95 118.32 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.7 t80 -121.98 119.13 30.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.158 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 53.02 40.05 30.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.251 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.0 75.82 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.198 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.4 mttt -119.93 137.93 53.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.885 0.343 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.8 p -107.99 130.86 55.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.407 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 87.4 m-85 -119.97 140.05 51.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.741 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 58.7 mttp -100.79 128.0 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.846 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.577 ' HB ' HG13 ' A' ' 160' ' ' ILE . 48.7 mm -119.97 120.36 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.597 ' HE2' HG13 ' A' ' 159' ' ' VAL . 99.0 mttt -114.58 131.15 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.733 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.6 OUTLIER -73.8 96.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.424 ' O ' ' HG3' ' A' ' 175' ' ' GLU . 8.7 tt -59.82 -52.08 66.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.89 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -160.87 142.52 12.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -142.1 161.36 20.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -118.5 102.78 49.78 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 77.6 Cg_endo -100.77 175.9 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.683 2.922 . . . . 0.0 112.638 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.7 mt-10 -97.42 -0.04 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.798 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.472 ' HG ' ' HG2' ' A' ' 120' ' ' PRO . 55.2 m -133.65 156.05 48.59 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.114 0.483 . . . . 0.0 111.458 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 55.5 m -70.7 -10.61 59.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.3 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -59.86 -23.87 63.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 111.291 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.41 40.03 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.428 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 66.2 m -127.74 142.77 51.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.523 HD11 ' HB ' ' A' ' 176' ' ' VAL . 13.9 mt -119.91 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 68' ' ' LEU . 82.4 m -143.31 151.71 40.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 121' ' ' LEU . 7.3 p -178.16 -55.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.661 ' O ' HG21 ' A' ' 188' ' ' ILE . 54.7 mt 68.66 -1.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.692 ' O ' HG23 ' A' ' 190' ' ' THR . 99.9 mt-10 -99.71 9.83 42.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.986 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 189' ' ' GLU . 7.1 t 48.27 41.38 16.0 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -108.76 20.03 18.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.635 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.493 HD22 ' HB ' ' A' ' 125' ' ' VAL . 0.8 OUTLIER -106.73 139.73 40.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.465 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.461 ' CG1' ' CE1' ' A' ' 124' ' ' PHE . 23.4 t -90.09 121.2 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.766 0.317 . . . . 0.0 110.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.632 ' HA ' HG11 ' A' ' 125' ' ' VAL . 16.4 p -113.19 140.58 47.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 111.73 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -120.6 145.21 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.401 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.26 134.55 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 111.603 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.32 161.29 33.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.461 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.38 2.053 . . . . 0.0 112.433 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.463 -0.271 0 CA-C-O 121.003 0.335 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' THR . 62.6 tt0 -117.74 137.77 52.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 m -119.97 130.98 55.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 56.1 t80 -133.64 132.79 41.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.391 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.49 135.82 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.622 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 99.6 mt-10 -140.74 150.87 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.722 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.4 123.14 48.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 110.931 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CD2' ' HB ' ' A' ' 114' ' ' ILE . 83.5 m-85 -130.89 147.22 52.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.966 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HB2' ' HE1' ' A' ' 28' ' ' TYR . 94.8 mtt-85 -81.75 149.46 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 21.9 m -84.95 133.36 34.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.557 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 86.7 m-85 -133.69 149.96 73.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -87.73 100.56 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.049 2.499 . . . . 0.0 113.514 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.74 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 87.6 mt -62.67 -41.37 91.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 110.349 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . . . -60.25 -39.23 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.412 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 98.1 mtp -68.1 -29.2 68.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.42 ' CE ' HG22 ' A' ' 37' ' ' ILE . 13.4 ttt -60.07 152.64 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.408 ' HB3' HD11 ' A' ' 37' ' ' ILE . 49.8 t30 -58.83 139.28 56.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 111.342 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ARG . 96.0 m-20 -63.93 -40.15 95.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -60.21 -40.71 91.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.324 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 HG22 ' CE ' ' A' ' 33' ' ' MET . 85.5 mt -64.38 -48.66 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.455 HH21 HD11 ' A' ' 88' ' ' ILE . 97.3 mtt180 -125.0 143.36 50.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.072 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.41 148.78 47.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -60.12 -26.7 66.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.99 -39.7 86.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.355 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.38 82.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 97' ' ' PRO . 97.8 m-20 -59.99 -39.73 86.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.733 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.88 8.27 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.581 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.28 29.4 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.73 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.65 22.82 38.14 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HE3' ' HB2' ' A' ' 85' ' ' LEU . 72.1 tttt -98.33 124.44 42.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 0.0 111.15 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.2 pt -113.44 149.69 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.3 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 88' ' ' ILE . 95.7 m-85 -101.58 134.44 44.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 110.732 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 5.3 mp -134.08 161.78 61.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.246 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 73.9 Cg_endo -75.13 158.73 41.55 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.65 2.234 . . . . 0.0 113.188 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' HA ' HD23 ' A' ' 55' ' ' LEU . 73.8 Cg_endo -74.87 -13.39 21.73 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.054 2.503 . . . . 0.0 113.125 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -59.99 -40.0 87.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 111.525 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.524 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.615 HD22 ' CG ' ' A' ' 87' ' ' PHE . 3.2 mm? -59.97 -40.02 87.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.78 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -59.98 -39.95 87.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.958 0.408 . . . . 0.0 110.092 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 98.6 mttt -69.12 -40.04 78.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.321 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 54' ' ' ALA . 92.3 mt -59.9 -40.0 87.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.134 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -40.03 88.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.3 mtp -59.93 -40.03 87.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.792 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.509 ' HB3' HE22 ' A' ' 19' ' ' GLN . 80.9 mt -82.32 -1.95 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.784 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.1 t30 59.87 40.1 19.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.584 HG21 ' HE2' ' A' ' 67' ' ' MET . 58.6 mt -82.64 131.29 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.857 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -81.84 149.96 28.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 49.8 p90 -87.35 157.97 52.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.664 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 74.4 Cg_endo -75.13 161.55 94.54 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.608 -1.414 . . . . 0.0 112.771 0.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.584 ' HE2' HG21 ' A' ' 63' ' ' ILE . 66.4 mmm -87.27 139.04 30.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 117' ' ' THR . 75.5 mt -108.85 134.35 51.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.585 ' CD2' HG12 ' A' ' 84' ' ' VAL . 14.7 m-85 -120.05 140.65 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 112.301 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -114.92 128.17 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.783 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.701 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 91.0 mt -99.01 127.54 44.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.486 ' OG1' HG13 ' A' ' 79' ' ' VAL . 88.5 m -120.02 130.08 54.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.117 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 117.98 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.91 -39.87 75.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -39.95 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.044 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.426 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 28.0 m -105.09 -15.38 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.793 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 5.11 57.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.223 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.69 140.05 34.45 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.125 0.488 . . . . 0.0 110.279 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.486 HG13 ' OG1' ' A' ' 72' ' ' THR . 24.6 m -120.05 117.53 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.873 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 82.2 p -102.75 144.63 30.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.566 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -85.97 114.4 22.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.32 144.93 17.35 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.082 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.29 130.52 10.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.977 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 69' ' ' PHE . 8.6 p -119.88 130.79 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.32 . . . . 0.0 111.479 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.547 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 88.8 mt -110.24 -33.41 6.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.133 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.13 154.42 40.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 112.325 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CG ' HD22 ' A' ' 55' ' ' LEU . 81.8 m-85 -107.89 118.91 37.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.625 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD12 ' CD1' ' A' ' 49' ' ' PHE . 46.8 pt -125.41 -5.01 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -89.17 98.71 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 0.0 111.414 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -40.03 78.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.941 0.4 . . . . 0.0 111.187 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.77 -29.88 67.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.278 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.91 49.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.928 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 28' ' ' TYR . 89.1 mtm180 -119.44 149.8 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.523 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 25' ' ' PHE . 9.9 p -124.97 142.24 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.393 0.616 . . . . 0.0 111.24 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.74 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.4 m-85 -120.04 139.92 51.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.185 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.616 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.74 152.8 79.48 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 32.5 Cg_exo -61.0 154.78 54.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.557 2.172 . . . . 0.0 111.77 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 97.7 mt-30 -61.69 -40.16 94.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.423 ' NE1' ' CB ' ' A' ' 97' ' ' PRO . 67.2 p-90 -64.02 -40.11 95.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 58.3 ttm -60.46 -43.25 97.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.973 0.416 . . . . 0.0 110.787 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.62 ' HE2' ' HA ' ' A' ' 108' ' ' PRO . 57.4 ttm -60.76 -40.49 92.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.5 -39.99 94.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.4 m -63.72 -40.41 96.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.13 -24.01 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.426 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.45 30.58 56.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.302 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 101' ' ' MET . 45.6 pt -120.01 157.83 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -96.51 160.38 29.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.68 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.62 ' HA ' ' HE2' ' A' ' 101' ' ' MET . 35.1 Cg_exo -57.75 -3.41 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.76 -15.99 13.79 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.215 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 54.8 m -74.23 150.84 40.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.714 0.293 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.49 153.06 37.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.903 0.383 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.69 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 58.0 tp -119.96 132.7 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.282 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -99.96 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.671 HG12 ' CD2' ' A' ' 71' ' ' LEU . 86.9 mt -116.37 122.7 70.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.762 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.9 m -120.01 128.46 53.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.675 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -84.87 106.81 16.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.307 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.3 t -134.23 145.8 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.115 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.75 120.28 41.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.467 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.439 HG22 ' SG ' ' A' ' 186' ' ' CYS . 31.9 m -112.65 150.43 42.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.16 0.505 . . . . 0.0 111.753 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.665 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 45.0 Cg_endo -68.38 160.11 50.49 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.641 2.227 . . . . 0.0 111.44 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -75.0 120.2 20.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.45 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.24 151.21 50.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.138 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.452 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 94.7 mm-40 -101.73 -18.0 16.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.525 ' CE1' HG11 ' A' ' 193' ' ' VAL . 1.3 m-85 -149.13 134.81 18.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 194' ' ' THR . 3.6 p -137.43 130.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.335 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.708 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 67.4 mttm -92.9 121.41 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.714 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.436 HD22 HG13 ' A' ' 173' ' ' ILE . 82.6 mt -117.67 130.92 56.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.051 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.29 110.01 51.1 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.07 -176.71 2.97 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.654 2.236 . . . . 0.0 112.256 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 131' ' ' SER . 92.7 mt-30 -130.46 124.62 32.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.384 0.612 . . . . 0.0 110.378 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 1.2 m 71.05 166.97 0.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.956 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.7 -14.98 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.95 -40.07 87.73 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 111.066 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.93 -40.12 87.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.756 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 135' ' ' LEU . 9.8 mp -81.78 -9.55 59.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.543 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.9 -19.58 63.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.487 0.184 . . . . 0.0 111.435 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -61.99 132.11 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.666 0.269 . . . . 0.0 110.483 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.3 p -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.359 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -124.51 77.97 62.62 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.407 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.744 ' O ' HD22 ' A' ' 144' ' ' LEU . 52.2 Cg_endo -69.47 -33.91 16.67 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.52 2.147 . . . . 0.0 112.266 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.09 -40.34 89.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.271 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.93 95.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 147' ' ' VAL . 97.5 t -61.94 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -59.98 -40.1 87.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.401 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -42.32 93.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -63.29 -39.94 95.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.459 . . . . 0.0 110.295 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 162' ' ' ILE . 83.3 t -62.47 -41.96 93.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.945 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 95.3 mt -60.02 -40.03 87.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -63.02 -39.96 96.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.62 -39.96 93.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.4 m-85 -99.35 120.29 39.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.235 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 15.9 t -69.97 -39.97 75.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.511 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.525 ' CB ' ' HB3' ' A' ' 81' ' ' HIS . 71.6 p -121.63 140.02 52.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 151' ' ' PHE . 95.1 mt -135.25 141.22 45.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 111.813 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.499 HG21 ' CG ' ' A' ' 81' ' ' HIS . 37.3 p -138.88 154.32 48.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.541 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 94.2 t -60.06 -39.95 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.324 0.583 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.1 -38.89 75.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.411 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.3 t0 -69.37 129.97 41.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.469 ' O ' HG11 ' A' ' 159' ' ' VAL . 7.1 p -102.41 120.01 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.549 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.444 HD12 HG12 ' A' ' 147' ' ' VAL . 47.1 pt -105.12 140.01 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.942 0.401 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.678 ' HG2' ' CB ' ' A' ' 170' ' ' LYS . 99.8 mt-10 -120.0 141.23 49.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.584 HG23 HG23 ' A' ' 147' ' ' VAL . 46.0 pt -129.87 140.13 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.383 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.7 t -112.17 120.03 40.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -123.79 129.56 51.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.999 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 53.75 39.95 30.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.565 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.2 9.71 86.76 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.135 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.3 mttm -108.85 137.15 47.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.724 0.262 . . . . 0.0 110.383 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -105.56 120.54 41.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 111.021 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.02 140.06 51.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.678 ' CB ' ' HG2' ' A' ' 161' ' ' GLU . 53.0 pttt -124.19 130.57 52.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.06 140.81 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.721 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -119.73 137.4 53.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.972 0.415 . . . . 0.0 110.61 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 5.2 mp -81.47 112.85 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -57.26 7.14 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.708 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 86.4 tt0 -155.93 144.1 19.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.356 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 125' ' ' VAL . 8.3 m -138.3 151.2 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.369 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -98.73 104.76 26.55 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 94.5 Cg_endo -100.23 177.16 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.437 2.758 . . . . 0.0 112.676 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.665 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 68.6 mm-40 -99.96 5.01 45.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 85.2 p -139.83 159.67 41.65 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.081 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.4 p -70.04 -18.54 63.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.892 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.9 p -59.98 -20.63 58.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.446 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 60.03 39.82 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 111.07 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 m -130.02 139.93 50.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.78 140.27 47.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 153' ' ' THR . 75.3 m -129.48 100.31 5.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.619 HG21 HD22 ' A' ' 121' ' ' LEU . 5.7 p -126.87 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.631 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 152' ' ' SER . 82.0 mt -105.62 -26.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.621 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.97 -79.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.382 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 13.5 t -169.84 -158.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 0.0 111.102 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.9 m-20 75.74 25.09 1.2 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.892 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.549 HD23 ' CG1' ' A' ' 187' ' ' VAL . 28.4 tp -119.51 131.46 55.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 124' ' ' PHE . 20.8 t -92.84 129.0 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.76 0.314 . . . . 0.0 110.627 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.77 ' HA ' HG11 ' A' ' 125' ' ' VAL . 75.3 p -118.53 142.08 47.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -119.78 142.54 48.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.81 139.98 41.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 111.416 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.427 ' HB3' ' HD2' ' A' ' 198' ' ' PRO . . . -118.2 165.08 17.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.771 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 197' ' ' ALA . 19.9 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 88.0 Cg_exo . . . . . 0 N--CA 1.465 -0.2 0 CA-C-O 120.579 0.158 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 78.2 mt-30 -100.08 120.01 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.716 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 116' ' ' SER . 25.2 m -124.28 131.76 53.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 111.689 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CB ' ' HB3' ' A' ' 116' ' ' SER . 22.3 t80 -120.24 139.88 52.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.613 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.93 133.07 55.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.616 ' OE1' ' HB3' ' A' ' 54' ' ' ALA . 72.1 mt-10 -152.71 160.02 43.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.67 132.64 56.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -139.67 159.99 40.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -94.56 126.32 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.471 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' HB2' HD22 ' A' ' 96' ' ' LEU . 29.8 p -91.06 141.79 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.346 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.499 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.4 m-85 -130.42 153.16 81.28 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.675 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.65 104.53 1.89 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.695 2.264 . . . . 0.0 112.628 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.734 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 90.7 mt -60.0 -39.82 81.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.385 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.734 ' HA ' HH11 ' A' ' 38' ' ' ARG . . . -59.33 -29.29 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.583 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.8 ttp -67.09 -37.72 84.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.281 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.98 140.04 57.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.18 151.75 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.587 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -59.97 -36.66 77.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.209 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -60.0 -34.06 72.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.667 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 37' ' ' ILE . 25.2 mt -110.24 9.11 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.377 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.734 HH11 ' HA ' ' A' ' 31' ' ' ALA . 28.5 ttp180 -119.95 137.15 54.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.607 ' HE2' ' HB3' ' A' ' 41' ' ' ASP . 86.0 tttt -100.47 127.11 46.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.03 -40.08 88.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.607 ' HB3' ' HE2' ' A' ' 39' ' ' LYS . 52.4 t0 -59.98 -41.45 92.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.06 91.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.11 -40.06 88.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.78 18.7 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.19 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.58 163.33 23.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.209 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.91 11.39 64.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.859 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.8 mttt -115.7 140.05 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.5 pt -110.33 152.58 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.473 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.626 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 87.4 m-85 -93.12 132.07 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.733 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -142.42 160.21 55.15 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.292 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' LEU . 45.9 Cg_endo -65.63 144.58 79.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.081 2.521 . . . . 0.0 113.525 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.493 ' HA ' HD11 ' A' ' 55' ' ' LEU . 25.8 Cg_endo -62.63 -20.33 70.55 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.059 2.506 . . . . 0.0 113.315 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.4 p -60.0 -43.58 95.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.648 0.261 . . . . 0.0 111.322 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.616 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . . . -70.64 -41.46 72.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 111.313 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 51' ' ' PRO . 1.1 mp -60.07 -39.9 87.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -59.71 -39.38 84.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -59.98 -39.29 85.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.387 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.638 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 91.9 mt -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -59.98 -39.97 87.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.94 -37.39 82.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.454 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.68 0.61 29.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.651 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.07 43.8 13.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.0 111.54 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 58' ' ' LEU . 43.5 mm -72.24 130.24 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.618 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -69.76 140.41 53.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.477 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.529 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 25.1 t80 -87.43 141.75 32.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.762 ' HD3' HD12 ' A' ' 188' ' ' ILE . 3.7 Cg_exo -74.84 160.36 96.6 Favored 'Cis proline' 0 C--N 1.348 0.552 0 C-N-CA 124.217 -1.16 . . . . 0.0 112.822 0.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.498 ' HE3' HD22 ' A' ' 55' ' ' LEU . 75.4 mtm -75.18 140.12 43.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.924 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 117' ' ' THR . 79.1 mt -112.12 136.76 51.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.081 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 33.6 m-85 -131.86 147.08 52.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.171 0.51 . . . . 0.0 112.008 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 40.0 ttpt -122.68 129.29 51.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.332 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 114' ' ' ILE . 86.6 mt -100.38 125.6 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 111.049 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.497 HG21 HG22 ' A' ' 79' ' ' VAL . 97.5 m -119.96 130.02 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.965 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB3' HD23 ' A' ' 104' ' ' LEU . . . -107.83 118.09 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.7 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.361 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.12 -39.9 87.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.32 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 104' ' ' LEU . 73.8 p -108.51 -11.63 15.11 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 68.16 14.32 65.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.68 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -100.0 139.95 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.562 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.531 HG12 ' HD2' ' A' ' 70' ' ' LYS . 52.7 t -121.32 127.23 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.016 0.436 . . . . 0.0 111.215 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.434 ' OG1' ' HE1' ' A' ' 100' ' ' MET . 8.4 t -118.39 129.68 55.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.731 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 17.8 m-70 -83.76 139.61 32.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.363 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.73 -139.53 3.66 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.138 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.567 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -166.79 -164.0 21.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.38 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.62 ' HB ' ' HE2' ' A' ' 69' ' ' PHE . 6.5 p -124.85 129.96 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.145 0.498 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 34.4 tp -92.62 -77.39 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -140.19 168.19 20.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.76 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CD2' HD11 ' A' ' 55' ' ' LEU . 2.5 m-85 -90.94 116.33 28.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 49' ' ' PHE . 31.6 pt -141.83 -5.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 93' ' ' ARG . . . -97.94 97.1 8.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 111.676 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.95 -40.12 72.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.504 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -85.8 -23.34 27.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.563 ' HA2' ' HG3' ' A' ' 51' ' ' PRO . . . 114.76 46.5 0.6 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.558 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 21.6 mtm180 -111.0 149.47 30.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 111.069 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.92 140.27 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.734 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.5 m-85 -119.94 139.95 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 27' ' ' CYS . 1.6 pt? -122.65 149.87 56.85 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.627 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 47.7 Cg_exo -53.64 158.84 7.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.87 2.38 . . . . 0.0 112.618 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.548 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mt-30 -60.07 -43.85 95.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.605 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.47 ' HZ3' ' O ' ' A' ' 159' ' ' VAL . 33.0 p-90 -68.88 -35.71 77.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.615 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.601 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.5 mmm -60.05 -40.1 88.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG2' HD13 ' A' ' 96' ' ' LEU . 98.0 mtp -61.3 -40.09 92.88 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.061 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.64 -40.08 88.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.964 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -64.91 -40.03 94.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.756 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 76' ' ' THR . 86.9 mt -69.92 -25.08 63.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.2 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.06 74.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.402 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.439 ' HB ' ' CB ' ' A' ' 110' ' ' SER . 45.8 pt -113.4 139.42 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 111.893 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 8.2 pt20 -97.01 165.76 15.18 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 98.1 Cg_exo -43.92 140.51 4.93 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.658 2.239 . . . . 0.0 112.607 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.0 -9.99 75.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.439 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 58.0 m -70.06 153.08 43.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 113' ' ' GLN . 9.9 tt -93.5 136.74 33.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.116 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.497 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 60.1 tp -121.55 130.09 53.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.043 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 111' ' ' LEU . 96.6 mt-30 -111.77 133.28 54.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.667 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 71' ' ' LEU . 85.4 mt -110.07 125.53 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.7 t -120.77 129.54 53.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.9 t -70.22 122.98 20.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.632 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 95.5 m -121.96 128.93 52.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 96.5 m-20 -123.94 120.02 31.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.55 154.36 50.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.796 0.331 . . . . 0.0 111.618 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 93.6 Cg_endo -78.18 19.36 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.679 2.253 . . . . 0.0 112.555 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 186' ' ' CYS . 10.0 mp 67.96 100.39 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.16 164.07 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.3 -22.17 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.413 ' HE1' ' HE2' ' A' ' 126' ' ' LYS . 64.3 t80 -142.71 131.18 22.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.497 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.75 HG13 ' HA ' ' A' ' 194' ' ' THR . 3.3 p -135.95 132.4 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.258 0.551 . . . . 0.0 111.511 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.717 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 34.6 mttm -95.42 122.15 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.27 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 171' ' ' ILE . 86.0 mt -118.05 132.86 56.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.566 ' HB2' HD11 ' A' ' 174' ' ' LEU . 4.2 tt0 -116.58 113.51 40.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.461 ' HG3' HD11 ' A' ' 135' ' ' LEU . 83.7 Cg_endo -78.39 174.44 12.38 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.722 2.281 . . . . 0.0 112.439 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.526 HE22 ' HE2' ' A' ' 170' ' ' LYS . 98.4 mt-30 -125.7 123.93 39.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER 70.17 133.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.421 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -60.04 -24.82 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.186 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -39.92 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.67 -39.98 90.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.775 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 129' ' ' PRO . 95.6 mt -82.19 -10.19 59.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -10.14 57.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.627 0.251 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 138' ' ' SER . 85.6 mt -59.98 140.71 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.452 ' N ' HG23 ' A' ' 137' ' ' ILE . 69.4 m -59.92 -40.15 87.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.287 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.66 75.84 64.11 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.749 0.309 . . . . 0.0 110.775 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.582 ' O ' HD22 ' A' ' 144' ' ' LEU . 36.0 Cg_exo -60.05 -33.76 95.13 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.632 2.221 . . . . 0.0 111.858 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.92 -40.12 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.4 -43.57 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.87 -40.08 91.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.2 -40.35 89.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -66.59 -40.07 88.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.131 0.491 . . . . 0.0 109.866 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.763 HG21 HG22 ' A' ' 162' ' ' ILE . 56.3 t -62.56 -40.1 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.93 -40.85 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.205 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.34 -40.07 96.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 110.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 89.2 m-85 -105.72 120.75 42.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.448 . . . . 0.0 111.781 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.3 m -60.16 -40.01 88.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.151 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.731 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 67.0 p -135.74 151.91 50.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.324 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.6 mp -117.43 130.45 56.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.568 ' HG1' ' HB2' ' A' ' 81' ' ' HIS . 17.3 m -119.6 142.3 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.614 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.859 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 92.0 t -60.08 -45.05 96.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.199 0.523 . . . . 0.0 110.764 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -39.19 76.14 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.693 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.503 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 53.2 t0 -67.96 132.48 47.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.47 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 14.3 m -100.35 123.79 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.053 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 170' ' ' LYS . 48.3 pt -104.72 138.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.873 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 98.9 mt-10 -120.03 140.09 51.52 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.598 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.763 HG22 HG21 ' A' ' 147' ' ' VAL . 44.9 pt -130.02 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.937 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.1 t -108.79 113.3 26.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -119.91 119.18 32.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.503 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.5 m-20 51.14 39.35 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.22 -7.13 82.44 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.545 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' SER . 57.8 mtpt -100.03 137.4 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.966 0.383 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 168' ' ' THR . 8.9 t -112.19 120.66 42.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.237 0.542 . . . . 0.0 111.59 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.454 ' CZ ' ' HE2' ' A' ' 167' ' ' LYS . 86.8 m-85 -120.01 140.0 51.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.042 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.873 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 51.4 pttt -119.93 136.82 54.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.117 0.484 . . . . 0.0 111.035 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.644 HG21 HD21 ' A' ' 127' ' ' LEU . 85.9 mt -119.98 120.07 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.094 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.56 127.3 49.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.859 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 mp -81.97 120.04 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.634 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 128' ' ' GLU . 10.6 mp -69.79 -57.34 5.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.834 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.717 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.9 mt-10 -155.01 148.02 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' A' ' 125' ' ' VAL . 5.3 m -140.33 147.63 23.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -92.26 104.45 10.97 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 63.9 Cg_endo -102.47 163.93 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.639 2.893 . . . . 0.0 112.551 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.458 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.5 mt-10 -100.12 6.21 44.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.9 m -139.85 159.23 42.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.0 111.231 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.8 m -70.05 -12.9 61.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.7 m -59.17 -25.88 64.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 111.11 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.02 39.58 19.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.661 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.1 p -127.47 146.57 50.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.901 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.468 HD12 HG21 ' A' ' 125' ' ' VAL . 46.2 pt -128.39 136.87 58.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.065 0.46 . . . . 0.0 111.5 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.698 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 42.7 t -141.15 114.06 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.239 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 187' ' ' VAL . 7.2 p -120.84 112.52 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.496 0.665 . . . . 0.0 110.385 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.762 HD12 ' HD3' ' A' ' 66' ' ' PRO . 18.4 tt -79.97 -49.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 188' ' ' ILE . 77.2 mm-40 -91.03 -79.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 t -168.97 30.78 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.606 0.241 . . . . 0.0 111.604 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.541 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 95.9 m-20 -82.46 2.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.545 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.594 ' HG ' HG11 ' A' ' 125' ' ' VAL . 62.4 tp -111.93 130.71 55.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 125' ' ' VAL . 31.6 t -95.37 123.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.169 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.75 ' HA ' HG13 ' A' ' 125' ' ' VAL . 74.8 p -101.91 144.94 29.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -129.53 137.69 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.387 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.32 136.28 44.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.87 163.25 25.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo . . . . . 0 N--CA 1.463 -0.315 0 C-N-CA 122.361 2.041 . . . . 0.0 112.126 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.464 -0.235 0 CA-C-O 120.858 0.274 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 117' ' ' THR . 95.1 mt-30 -101.27 123.15 44.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 ' OG1' ' A' ' 117' ' ' THR . 73.9 p -119.99 130.38 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 111.646 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.754 ' HB3' ' OG ' ' A' ' 116' ' ' SER . 86.2 t80 -121.27 126.66 50.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.761 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.18 130.87 54.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.208 0.528 . . . . 0.0 112.332 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.45 156.07 42.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.199 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.64 126.17 49.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.076 0.465 . . . . 0.0 111.773 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 97.5 m-85 -130.07 150.24 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HE ' ' HH ' ' A' ' 28' ' ' TYR . 70.6 mtp85 -81.59 132.29 35.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.394 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 31.7 p -106.5 142.39 36.24 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.623 ' HH ' ' HE ' ' A' ' 26' ' ' ARG . 63.6 m-85 -140.37 152.75 67.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.547 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HG2' ' SD ' ' A' ' 32' ' ' MET . 36.1 Cg_endo -65.66 119.76 6.84 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.232 1.955 . . . . 0.0 111.964 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 95' ' ' TYR . 88.6 mt -59.93 -38.52 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -50.03 -20.54 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.527 ' SD ' ' HG2' ' A' ' 29' ' ' PRO . 94.5 mtp -68.75 -32.65 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.98 143.19 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.99 151.04 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.143 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.78 -34.66 73.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.01 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -107.08 -0.17 9.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.116 0.484 . . . . 0.0 110.628 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 51.8 ttt-85 -105.01 129.96 53.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.287 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -105.08 133.37 49.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.1 -40.07 88.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.381 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.68 -39.91 95.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.12 91.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.276 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.24 -40.0 88.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.659 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -100.14 1.7 42.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.181 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 180.0 35.69 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.61 29.97 9.75 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.713 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.3 mttt -100.01 122.47 42.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 83' ' ' GLY . 47.5 pt -115.33 149.9 17.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.449 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 97.5 m-85 -102.9 133.62 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.565 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 1.6 mp -131.34 165.6 34.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.208 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.639 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 56.6 Cg_endo -71.59 157.38 56.09 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.163 1.908 . . . . 0.0 112.662 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.88 -23.08 30.66 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.737 2.291 . . . . 0.0 112.785 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -60.08 -40.09 88.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.229 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -70.22 -42.55 72.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' HE1' ' A' ' 67' ' ' MET . 58.4 tp -61.91 -41.02 97.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.382 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -59.86 -43.35 94.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 85.3 tttt -60.33 -40.08 89.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.798 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 54' ' ' ALA . 87.3 mt -59.93 -40.08 87.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -59.67 -38.23 80.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.265 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.0 -39.18 84.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.04 -2.52 40.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.425 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.4 t30 60.02 40.26 18.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.588 0.233 . . . . 0.0 111.587 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 ' CD1' HD22 ' A' ' 58' ' ' LEU . 86.3 mt -70.2 130.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.47 142.75 38.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 16.0 p90 -87.68 158.29 51.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.49 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 9.5 Cg_exo -72.82 146.84 88.01 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.758 -1.351 . . . . 0.0 112.708 0.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.659 ' HE1' HD12 ' A' ' 55' ' ' LEU . 63.3 mtt -72.18 140.01 48.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.474 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD21 HG22 ' A' ' 153' ' ' THR . 21.5 mt -115.84 132.09 56.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.711 ' HB3' HG21 ' A' ' 114' ' ' ILE . 11.6 m-85 -120.53 140.28 51.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.095 0.474 . . . . 0.0 111.638 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 115' ' ' SER . 87.3 tttt -115.65 129.96 56.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.779 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 96.8 mt -98.38 131.12 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.368 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 87.0 m -120.01 129.61 54.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.986 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.2 115.62 27.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -68.39 -40.02 81.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.49 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -40.02 87.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.4 m -100.62 -17.38 17.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.742 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.34 1.14 41.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.685 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -100.22 141.18 33.41 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.717 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 79' ' ' VAL . 20.2 m -119.97 119.87 61.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.403 ' OG1' HD23 ' A' ' 104' ' ' LEU . 36.2 p -110.34 139.46 45.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.37 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 77.7 m80 -84.8 114.39 22.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 0.0 110.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.33 158.49 20.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.34 165.26 27.5 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.73 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -128.69 133.1 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 117.361 0.581 . . . . 0.0 112.336 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.6 tp -92.22 -79.05 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.535 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -149.55 160.45 43.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD1' HD22 ' A' ' 55' ' ' LEU . 80.3 m-85 -97.37 116.76 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.292 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.25 -4.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -88.33 97.83 11.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.378 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -39.92 76.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.459 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.97 -20.13 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.345 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 97.18 54.16 1.3 Allowed Glycine 0 C--O 1.23 -0.107 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.154 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -121.2 145.09 48.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.132 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 93.6 t -120.4 131.72 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.311 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.722 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.8 138.91 53.79 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 27' ' ' CYS . 1.8 pt? -134.56 159.04 73.74 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.63 0.252 . . . . 0.0 110.475 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 65.1 Cg_endo -70.52 158.25 56.5 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.659 2.239 . . . . 0.0 112.824 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.7 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 78.0 mt-30 -61.71 -40.0 93.5 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 48.9 p-90 -62.83 -39.93 95.86 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.518 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.561 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 96.7 mtp -68.22 -40.0 82.2 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.332 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.7 ' HE3' ' HA ' ' A' ' 98' ' ' GLN . 76.4 mtm -61.01 -39.98 91.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.48 -40.1 92.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.7 m -63.21 -40.03 96.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.403 HD23 ' OG1' ' A' ' 80' ' ' THR . 83.9 mt -86.24 -10.06 55.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.692 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.22 41.6 99.72 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.046 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.95 133.53 54.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.137 0.494 . . . . 0.0 110.749 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.477 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 5.7 mt-30 -96.43 160.0 30.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 18.3 Cg_endo -59.93 -1.97 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.299 2.0 . . . . 0.0 112.964 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.83 -12.54 24.04 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 m -94.46 151.52 19.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.313 . . . . 0.0 111.154 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.557 ' CD2' ' HG2' ' A' ' 26' ' ' ARG . 89.9 mt -79.98 158.11 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.588 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.2 tp -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.9 mt-30 -101.73 120.34 40.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.346 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 69' ' ' PHE . 87.8 mt -110.27 126.21 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.4 t -119.78 120.3 36.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.754 ' OG ' ' HB3' ' A' ' 21' ' ' PHE . 48.5 p -88.76 111.16 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.585 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 5.3 t -133.95 150.43 51.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.286 0.565 . . . . 0.0 112.251 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -104.74 119.16 38.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.711 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.49 ' CG2' ' HB2' ' A' ' 186' ' ' CYS . 15.9 m -115.5 152.51 47.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 180' ' ' SER . 51.5 Cg_exo -57.84 166.25 5.49 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.917 1.744 . . . . 0.0 111.257 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.624 HD21 ' O ' ' A' ' 122' ' ' GLY . 8.0 tt -93.98 120.12 33.79 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.63 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.624 ' O ' HD21 ' A' ' 121' ' ' LEU . . . -68.86 146.11 44.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.228 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.23 -19.85 16.9 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 195' ' ' ASP . 64.7 t80 -145.78 131.49 18.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.665 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.847 ' HA ' HG13 ' A' ' 176' ' ' VAL . 7.5 p -131.0 129.44 63.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.671 0.748 . . . . 0.0 111.785 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 173' ' ' ILE . 63.5 tttp -97.01 120.31 37.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.696 HD21 HG13 ' A' ' 173' ' ' ILE . 77.0 mt -113.94 135.3 54.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.673 ' HB2' HD11 ' A' ' 174' ' ' LEU . 2.6 tt0 -100.22 127.81 32.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.403 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HD2' ' HG3' ' A' ' 128' ' ' GLU . 86.5 Cg_endo -79.78 172.83 13.66 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.322 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.587 ' HG3' ' HG3' ' A' ' 170' ' ' LYS . 29.9 mm100 -135.62 121.16 19.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER 59.88 24.89 13.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.513 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 131' ' ' SER . 2.5 m 41.95 24.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.86 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' CB ' ' HE2' ' A' ' 169' ' ' PHE . 95.5 m-20 -70.0 -40.01 75.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.412 . . . . 0.0 110.188 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.543 ' CE1' ' CE2' ' A' ' 196' ' ' PHE . 64.8 t80 -60.71 -40.06 90.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.763 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.418 ' N ' HD13 ' A' ' 135' ' ' LEU . 9.7 mp -65.16 -24.28 67.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.02 -19.61 63.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.16 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.6 137.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.6 m -60.12 -39.92 87.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -129.7 71.87 82.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 0.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.503 ' HB3' ' CE1' ' A' ' 134' ' ' PHE . 21.3 Cg_exo -64.68 -30.51 59.9 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.94 -41.0 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.14 98.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.6 -41.04 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.824 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.585 HD12 ' CG2' ' A' ' 194' ' ' THR . 1.8 tm? -60.0 -43.19 95.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.12 -40.27 89.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 0.0 110.75 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -61.97 -40.08 94.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.965 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 160' ' ' ILE . 59.4 t -59.89 -40.48 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.516 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 188' ' ' ILE . 86.4 mt -60.23 -40.09 88.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.47 -40.02 77.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.183 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.97 -40.01 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.747 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.642 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 91.3 m-85 -102.71 118.02 35.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.101 0.476 . . . . 0.0 111.374 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.49 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 69.2 m -63.2 -39.94 96.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.032 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.662 HG22 HD21 ' A' ' 68' ' ' LEU . 34.4 p -123.13 140.66 52.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.012 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 185' ' ' ILE . 86.5 mt -120.87 127.19 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.79 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.0 m -126.46 142.9 51.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 173' ' ' ILE . 59.6 t -60.03 -42.08 88.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.357 0.598 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.413 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.35 140.09 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.552 ' O ' HG11 ' A' ' 159' ' ' VAL . 7.3 p -107.89 121.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.467 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.642 ' HB ' ' CZ ' ' A' ' 151' ' ' PHE . 46.2 pt -104.12 138.69 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.669 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 47.9 mt-10 -121.06 140.62 51.7 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.756 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 147' ' ' VAL . 43.4 pt -127.55 142.85 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.211 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 31.6 t -111.54 115.94 30.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 54.6 t80 -121.14 122.93 41.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.955 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.36 39.99 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.535 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.85 89.91 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.932 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 163' ' ' SER . 97.5 mttt -104.48 136.97 43.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.8 p -108.67 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 111.413 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' HE2' ' CB ' ' A' ' 133' ' ' ASP . 87.2 m-85 -119.94 139.98 51.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.444 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.669 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 61.5 pttt -121.33 135.49 55.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.264 0.554 . . . . 0.0 111.245 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.419 ' CD1' HD23 ' A' ' 127' ' ' LEU . 45.9 pt -128.4 139.52 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.11 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -116.36 129.21 56.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.696 HG13 HD21 ' A' ' 127' ' ' LEU . 3.4 mp -77.92 80.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.09 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 128' ' ' GLU . 88.0 mt -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.5 mt-10 -146.27 139.4 25.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.791 0.329 . . . . 0.0 111.459 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.847 HG13 ' HA ' ' A' ' 125' ' ' VAL . 32.5 m -144.6 160.03 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.631 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 104.0 54.15 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 66.9 Cg_endo -99.26 167.34 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.252 2.635 . . . . 0.0 113.053 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.91 9.9 42.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.709 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 43.6 t -139.85 162.02 36.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.67 -15.12 62.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.132 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.4 p -61.38 -21.07 63.73 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.729 0.3 . . . . 0.0 111.032 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.414 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.4 mmtt 60.08 40.21 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.625 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.4 p -129.76 150.69 50.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.125 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.415 HG23 HD22 ' A' ' 192' ' ' LEU . 7.3 mm -117.94 118.36 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.49 ' HB2' ' CG2' ' A' ' 119' ' ' VAL . 10.9 m -143.2 160.59 40.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.833 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 186' ' ' CYS . 17.2 t 77.06 121.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.427 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 148' ' ' LEU . 14.8 mt -120.64 84.04 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.33 -20.42 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -110.63 20.04 18.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.7 m-20 70.47 94.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.415 HD22 HG23 ' A' ' 185' ' ' ILE . 4.1 tp -75.61 142.02 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.453 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.768 ' O ' HG12 ' A' ' 125' ' ' VAL . 26.3 t -99.99 128.36 51.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.018 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.585 ' CG2' HD12 ' A' ' 144' ' ' LEU . 70.1 p -117.87 144.57 45.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 124' ' ' PHE . 55.6 t0 -126.41 139.97 52.85 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.907 0.384 . . . . 0.0 110.973 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.543 ' CE2' ' CE1' ' A' ' 134' ' ' PHE . 96.6 m-85 -108.75 140.38 42.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.63 129.65 25.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.524 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 122.682 2.254 . . . . 0.0 112.653 179.605 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 N--CA 1.463 -0.275 0 CA-C-O 120.714 0.214 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.5 mt-30 -113.03 126.28 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.0 m -120.13 130.54 54.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.308 0.575 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.727 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 58.2 t80 -133.24 130.04 38.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.621 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.65 135.93 49.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 54' ' ' ALA . 48.6 mt-10 -142.07 159.9 41.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.282 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -119.85 128.94 54.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.291 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' HB3' HG12 ' A' ' 94' ' ' VAL . 84.6 m-85 -139.08 153.15 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.587 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -81.07 140.7 34.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.547 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 49.8 t -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 111.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 18.5 m-85 -120.43 150.71 52.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.594 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.642 ' HG3' ' HB3' ' A' ' 108' ' ' PRO . 6.2 Cg_exo -80.31 113.92 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.76 2.307 . . . . 0.0 112.232 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.807 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 95.8 mt -61.14 -39.91 84.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 38' ' ' ARG . . . -59.79 -29.22 68.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.519 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 96.8 mmm -68.3 -36.66 79.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 110.214 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.444 ' HE2' HD13 ' A' ' 37' ' ' ILE . 98.2 mtp -61.04 140.05 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.36 143.59 52.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 112.044 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.9 m-20 -59.87 -26.27 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.103 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -60.05 -38.75 83.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.91 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.444 HD13 ' HE2' ' A' ' 33' ' ' MET . 46.7 pt -108.05 -9.76 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.245 0.545 . . . . 0.0 110.494 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 31' ' ' ALA . 66.4 ttt180 -89.23 139.77 30.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.732 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 86.0 tttt -101.16 125.51 47.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.376 . . . . 0.0 110.512 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.14 -40.82 91.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.659 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.0 m-20 -61.49 -39.99 92.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.1 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.14 90.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.98 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.79 -40.1 87.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.335 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 163' ' ' SER . 90.0 m-85 -102.7 6.04 39.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.56 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.41 160.72 22.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.105 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.15 10.75 73.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.336 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 22.2 mttm -104.45 143.18 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 50' ' ' LEU . 32.6 pt -121.5 169.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 96.3 m-85 -100.45 131.48 46.35 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.512 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' HG ' HG21 ' A' ' 94' ' ' VAL . 3.9 mp -140.6 163.37 43.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.613 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HB3' ' O ' ' A' ' 89' ' ' ALA . 60.6 Cg_endo -72.22 133.78 21.78 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.14 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 34.6 Cg_exo -57.9 -11.9 10.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.691 2.261 . . . . 0.0 112.89 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.3 p -60.11 -39.05 84.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 23' ' ' GLU . . . -60.01 -35.54 75.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.382 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 87' ' ' PHE . 85.4 mt -60.03 -40.61 89.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.356 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -60.11 -40.03 88.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.601 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 33.6 mttm -67.5 -39.91 85.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.18 -39.35 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.595 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -60.09 -39.79 87.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.17 -39.85 87.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.28 -0.36 40.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.712 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.89 43.32 15.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.245 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.407 HG22 ' OD2' ' A' ' 118' ' ' ASP . 47.8 mm -64.34 129.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.434 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -70.54 140.01 51.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -88.17 143.59 33.08 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.856 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.89 163.83 89.0 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.397 0.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 55.2 mtt -83.86 133.9 34.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -122.12 137.98 54.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.566 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 97.5 m-85 -123.69 140.49 52.94 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.152 0.501 . . . . 0.0 111.712 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 39.6 ttpt -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.099 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD1' HD22 ' A' ' 96' ' ' LEU . 88.6 mt -89.97 122.57 33.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.542 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -99.42 122.25 42.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.454 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . . . -117.36 133.89 55.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.352 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 62.27 139.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.103 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -40.0 87.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 p -129.81 17.72 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.489 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.15 -102.95 0.51 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.783 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -139.98 146.34 38.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.876 0.369 . . . . 0.0 111.267 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 71' ' ' LEU . 62.5 t -120.77 119.21 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.901 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.8 p -102.11 163.47 12.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.886 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.437 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 79.1 m80 -103.96 114.83 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.84 159.86 17.27 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.981 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 152' ' ' SER . . . -94.18 170.33 30.1 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.245 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 84' ' ' VAL . 8.5 p -123.57 125.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 111.595 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.3 tp -92.75 -79.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.34 152.38 35.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.515 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 74.8 m-85 -99.33 115.7 29.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.591 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.04 -5.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 51' ' ' PRO . . . -88.78 98.89 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.18 -39.86 82.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.04 0.447 . . . . 0.0 110.714 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.32 -30.64 70.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.047 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.43 50.47 0.71 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.444 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -117.65 140.04 50.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.623 HG21 ' HG ' ' A' ' 50' ' ' LEU . 10.2 p -127.74 143.83 39.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.009 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.807 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.5 m-85 -119.97 140.45 50.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.257 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 71' ' ' LEU . 19.2 mt -114.92 137.9 23.1 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.707 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 42.3 Cg_exo -53.83 161.03 5.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.7 2.266 . . . . 0.0 112.325 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.02 -44.13 94.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.685 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CH2' ' SD ' ' A' ' 100' ' ' MET . 23.5 p-90 -69.66 -37.85 76.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.434 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.1 mmm -60.17 -39.98 88.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.1 mmm -60.16 -40.57 90.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -40.7 78.83 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -60.26 -39.95 88.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 0.0 110.02 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 45.0 mt -80.9 -16.59 53.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.312 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.37 73.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.059 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.3 pt -111.41 143.99 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.54 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 pt20 -100.58 161.14 24.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.802 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.642 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.3 Cg_endo -48.9 134.76 28.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.675 2.25 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.44 -9.98 75.87 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.964 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 52.1 m -70.87 150.85 45.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.813 0.307 . . . . 0.0 110.61 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.51 141.21 50.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.693 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 63.3 tp -123.87 130.02 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.692 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -113.37 120.0 39.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.993 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' CD2' ' A' ' 25' ' ' PHE . 21.0 tt -117.06 127.57 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.6 p -120.11 138.82 53.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.927 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.727 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -80.76 110.19 16.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 94.5 m -119.94 129.98 54.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.424 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 63' ' ' ILE . 96.2 m-20 -105.73 119.98 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 32.7 m -115.92 149.41 43.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.964 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.486 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 7.5 Cg_exo -70.81 161.79 44.85 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.335 2.023 . . . . 0.0 110.508 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.586 HD22 ' OG1' ' A' ' 190' ' ' THR . 1.3 mt -90.85 120.13 31.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.442 0.639 . . . . 0.0 112.277 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.74 165.79 47.45 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.7 -28.03 9.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -136.98 132.55 34.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.64 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.59 ' HA ' HG11 ' A' ' 176' ' ' VAL . 2.9 p -133.67 131.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.727 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 61.9 mttp -94.97 124.86 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 194' ' ' THR . 82.5 mt -105.61 131.06 53.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.74 0.305 . . . . 0.0 110.778 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -106.71 109.69 63.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.47 164.92 32.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.61 2.206 . . . . 0.0 112.062 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.645 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.1 tt0 -124.52 120.98 33.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.938 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.98 146.76 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.002 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.39 -22.12 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.432 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.99 -39.61 86.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.797 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 171' ' ' ILE . 65.6 t80 -59.9 -40.1 87.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 0.0 110.755 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.31 -8.22 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.965 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.02 -34.84 73.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.659 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.5 mt -55.68 137.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.702 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -60.01 -40.09 88.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.743 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -129.95 79.76 72.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.931 0.396 . . . . 0.0 111.311 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.02 -25.53 16.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.57 2.18 . . . . 0.0 111.937 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.07 -41.4 92.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.73 -42.1 95.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.456 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.94 -40.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.549 HD13 HG22 ' A' ' 194' ' ' THR . 3.4 tm? -61.72 -39.99 93.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.862 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.16 -40.06 93.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -64.66 -42.18 95.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.75 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.764 HG13 HD12 ' A' ' 162' ' ' ILE . 22.4 m -67.35 -36.44 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.401 ' CD1' HD11 ' A' ' 144' ' ' LEU . 86.6 mt -59.98 -40.09 87.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.2 -40.04 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.6 -39.86 89.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.44 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.15 119.6 34.94 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.693 ' HA ' HG12 ' A' ' 188' ' ' ILE . 50.1 m -62.11 -40.02 94.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.497 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.437 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 71.2 p -127.39 143.01 51.28 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.176 0.512 . . . . 0.0 111.33 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 185' ' ' ILE . 8.2 tt -121.69 124.03 43.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.157 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 93.1 m -119.51 135.69 54.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.894 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.843 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 58.1 t -59.9 -41.76 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.161 0.505 . . . . 0.0 111.53 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.798 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.1 m-20 -74.31 146.04 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.339 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 119.99 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.339 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 pt -97.89 140.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.69 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -119.64 140.59 50.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.194 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.764 HD12 HG13 ' A' ' 147' ' ' VAL . 43.3 pt -136.09 145.81 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 29.0 t -115.39 119.4 36.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.701 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.437 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 53.2 t80 -125.84 120.49 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.437 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 59.96 31.45 20.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.443 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.75 -9.85 75.74 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.075 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -101.78 140.05 36.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.496 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 68.3 p -108.8 130.14 55.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.037 0.446 . . . . 0.0 111.505 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 139.97 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.184 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.69 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.7 mttt -103.33 133.28 48.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.961 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 134' ' ' PHE . 48.5 mm -119.91 119.89 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.05 130.5 54.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.843 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.5 mp -83.88 132.26 31.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.325 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.04 -70.46 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.978 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 50.4 tp10 -140.3 139.86 35.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.945 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 125' ' ' VAL . 3.8 m -139.18 149.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.038 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -99.91 104.23 27.24 Favored Pre-proline 0 C--O 1.232 0.158 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 68.6 Cg_endo -102.9 177.97 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.691 2.928 . . . . 0.0 112.732 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.4 mt-10 -99.95 -0.01 40.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.82 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.3 m -138.29 151.65 47.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.028 0.442 . . . . 0.0 111.462 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 79.6 p -70.03 -10.03 57.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.706 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 46.9 t -55.68 -28.84 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.32 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 69.8 23.24 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.6 p -124.59 139.94 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.854 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.663 HD12 HD21 ' A' ' 154' ' ' LEU . 15.0 pt -132.2 140.05 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.415 ' HB2' HG22 ' A' ' 153' ' ' THR . 11.2 t -119.76 109.75 15.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 187' ' ' VAL . 12.0 p -141.09 99.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.603 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.693 HG12 ' HA ' ' A' ' 152' ' ' SER . 74.8 mt -97.18 -67.81 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.278 0.561 . . . . 0.0 111.566 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -94.1 -6.25 45.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.257 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.586 ' OG1' HD22 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -80.29 174.58 11.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -103.21 119.97 39.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.932 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.579 ' HG ' HG11 ' A' ' 125' ' ' VAL . 18.1 tp -120.26 140.09 51.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.254 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.454 ' O ' HG11 ' A' ' 125' ' ' VAL . 38.3 t -89.27 120.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.522 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.549 HG22 HD13 ' A' ' 144' ' ' LEU . 76.2 p -113.85 146.47 39.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 196' ' ' PHE . 49.4 t0 -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 195' ' ' ASP . 11.2 m-85 -93.31 139.98 30.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 111.408 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -119.83 166.46 14.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.446 2.097 . . . . 0.0 112.13 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 73.1 Cg_exo . . . . . 0 N--CA 1.464 -0.254 0 CA-C-O 120.77 0.237 . . . . 0.0 112.123 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.9 mt-30 -101.0 130.21 46.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.8 p -121.67 130.11 53.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 115' ' ' SER . 50.7 t80 -131.55 130.28 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -113.97 136.8 52.5 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mm-40 -149.99 160.03 43.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 120.04 38.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' HB ' ' A' ' 114' ' ' ILE . 86.2 m-85 -126.47 149.47 49.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -81.32 133.44 35.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.601 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.913 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 53.2 t -99.95 121.95 42.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 111.357 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.624 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 88.9 m-85 -120.42 150.06 51.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.992 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.554 ' HG3' ' HG3' ' A' ' 108' ' ' PRO . 7.2 Cg_exo -75.68 107.02 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.848 2.366 . . . . 0.0 112.699 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.749 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.2 mt -61.09 -40.84 87.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.62 77.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.866 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.446 ' HB2' ' HB2' ' A' ' 29' ' ' PRO . 98.9 mmm -68.25 -30.29 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 96.5 mmm -59.94 142.24 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.26 154.49 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.673 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -55.16 -29.17 57.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.404 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -60.01 -39.9 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mt -111.48 8.88 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.626 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 74.8 ttt180 -104.65 123.18 47.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.049 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.07 129.29 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.896 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.21 -40.09 88.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.269 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.88 -39.97 95.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.91 95.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.763 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.08 -40.1 88.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.351 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.38 14.53 22.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.273 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.57 164.0 24.06 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.119 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA2' ' HE3' ' A' ' 100' ' ' MET . . . -98.52 11.78 63.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.472 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 67.9 mttm -109.86 145.12 37.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.609 HG23 HD22 ' A' ' 96' ' ' LEU . 48.0 pt -121.55 162.99 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.909 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 94.3 m-85 -96.58 133.24 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.504 HD23 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -134.25 165.47 36.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.239 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 84.6 Cg_endo -79.53 152.73 23.25 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.21 1.94 . . . . 0.0 112.67 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.1 Cg_exo -66.88 -21.74 49.96 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.961 2.441 . . . . 0.0 112.829 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 m -60.08 -40.07 88.28 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.37 80.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.226 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD11 ' CG ' ' A' ' 87' ' ' PHE . 6.5 mp -59.96 -40.04 87.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.391 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -59.97 -42.76 94.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.59 -39.97 92.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.378 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' SD ' ' A' ' 67' ' ' MET . 84.6 mt -63.34 -38.56 91.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.375 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.6 m -59.76 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.97 -39.48 85.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.489 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -81.76 -0.05 41.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.681 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.4 m120 59.98 42.43 16.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.704 0.288 . . . . 0.0 111.422 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.02 130.02 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -72.05 139.59 48.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.781 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.706 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 28.9 t80 -88.42 146.52 37.86 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.863 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.706 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 59.9 Cg_endo -71.62 160.38 93.04 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.228 -1.155 . . . . 0.0 113.551 0.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.402 ' SD ' HD11 ' A' ' 58' ' ' LEU . 63.6 mtt -71.86 139.98 49.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 116' ' ' SER . 95.4 mt -110.04 123.03 48.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CE2' HD22 ' A' ' 50' ' ' LEU . 14.9 m-85 -119.99 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 28.4 ttpp -114.66 130.0 56.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.723 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 80' ' ' THR . 71.6 mt -94.17 121.72 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.581 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 29.8 m -106.76 119.93 40.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -112.51 132.46 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.094 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 61.77 148.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 0.0 110.074 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.04 -40.06 88.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.56 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 72.0 p -135.48 13.71 3.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.356 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 -106.85 0.14 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.073 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -128.53 147.54 50.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 0.0 111.68 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.441 ' CG1' HG23 ' A' ' 72' ' ' THR . 35.9 m -130.06 130.8 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 71' ' ' LEU . 7.2 t -112.77 132.43 55.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 111.531 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.428 ' CG ' HG21 ' A' ' 155' ' ' THR . 78.3 m80 -84.42 161.56 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.35 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.24 169.74 42.78 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.94 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.1 -177.26 29.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.985 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.2 131.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.333 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.1 tp -89.99 -79.21 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.056 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -139.66 155.18 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.705 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.651 ' CG ' HD11 ' A' ' 55' ' ' LEU . 86.1 m-85 -99.9 116.53 32.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.931 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 49' ' ' PHE . 48.5 pt -124.79 -5.47 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -91.88 100.11 12.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.01 0.433 . . . . 0.0 111.263 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.52 -39.97 77.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -66.54 -30.5 70.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 111.8 49.24 0.64 Allowed Glycine 0 C--N 1.319 -0.39 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.051 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -118.45 149.22 41.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.986 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 25' ' ' PHE . 10.0 p -129.37 142.32 44.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.019 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.749 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.26 139.95 50.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.704 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 48' ' ' ILE . 80.0 mt -120.39 148.18 46.95 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.583 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.52 157.98 29.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.655 2.237 . . . . 0.0 112.016 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -60.79 -40.56 93.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 44.6 p-90 -70.05 -40.03 75.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.201 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.447 ' HE3' ' HA2' ' A' ' 46' ' ' GLY . 52.5 mtt -65.32 -39.92 93.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.432 ' CE ' ' HA ' ' A' ' 29' ' ' PRO . 57.6 ttm -60.09 -40.32 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.6 -40.03 95.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.978 0.418 . . . . 0.0 110.379 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.6 -40.08 95.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.583 HD23 ' HB1' ' A' ' 73' ' ' ALA . 96.5 mt -83.72 -12.15 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.594 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.65 42.23 99.21 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.96 132.52 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.136 0.493 . . . . 0.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -100.11 159.22 30.39 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.554 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 38.9 Cg_exo -52.44 131.03 38.77 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.501 2.134 . . . . 0.0 112.01 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.27 77.9 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.668 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t -76.82 153.3 35.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD21 ' A' ' 111' ' ' LEU . 10.4 tt -70.59 140.78 51.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.461 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.913 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.2 tp -126.9 139.95 52.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 95.6 mt-30 -113.91 127.15 55.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.598 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 85.3 mt -119.98 124.46 72.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.9 t -119.13 121.06 38.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.66 108.07 17.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 9.2 t -131.37 140.93 49.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.933 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.0 t0 -99.66 120.01 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.738 HG21 ' N ' ' A' ' 186' ' ' CYS . 27.3 m -103.97 155.71 36.69 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.432 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 185' ' ' ILE . 12.3 Cg_exo -70.05 149.72 65.42 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.322 2.015 . . . . 0.0 111.333 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.721 HD12 ' HB ' ' A' ' 190' ' ' THR . 8.3 tt -70.19 127.42 32.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.465 ' N ' ' HB ' ' A' ' 185' ' ' ILE . . . -82.85 152.19 29.8 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.283 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -108.48 -29.97 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.445 ' HE2' ' CG ' ' A' ' 126' ' ' LYS . 70.2 t80 -140.85 134.24 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.716 ' HA ' HG12 ' A' ' 176' ' ' VAL . 5.7 p -130.1 130.85 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.111 0.481 . . . . 0.0 112.148 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 99.5 mttt -99.18 122.02 41.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.323 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.506 ' CD2' HG13 ' A' ' 173' ' ' ILE . 86.4 mt -111.71 131.09 55.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.0 0.429 . . . . 0.0 111.292 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.06 110.42 62.36 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.354 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 95.9 Cg_endo -84.26 162.15 13.21 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.676 2.25 . . . . 0.0 112.651 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.609 ' OE1' ' HE3' ' A' ' 170' ' ' LYS . 61.5 tt0 -129.31 122.88 30.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.755 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.5 OUTLIER 75.9 131.05 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.66 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.21 -17.5 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.728 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.435 ' HA ' ' OD2' ' A' ' 136' ' ' ASP . 96.0 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.628 0.251 . . . . 0.0 110.842 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.457 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 59.5 t80 -59.94 -40.13 87.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 0.0 111.059 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 196' ' ' PHE . 95.7 mt -85.57 -4.77 59.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' A' ' 133' ' ' ASP . 94.1 m-20 -70.05 -16.83 63.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.39 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.459 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 86.0 mt -61.18 139.26 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.419 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.3 p -61.41 -39.94 92.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.43 73.98 81.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.783 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 74.5 Cg_endo -76.0 -29.77 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.479 2.119 . . . . 0.0 112.117 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.06 -40.13 88.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.112 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.4 89.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 147' ' ' VAL . 87.1 t -62.87 -41.98 94.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 144' ' ' LEU . 3.1 tm? -60.01 -42.81 95.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -41.36 92.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -61.92 -40.26 94.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 143' ' ' VAL . 57.5 t -60.96 -42.61 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.021 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.12 -40.06 88.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.783 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.66 -39.93 90.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.486 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.479 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 93.9 m-85 -96.18 121.46 37.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.4 p -61.19 -39.94 92.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.51 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.585 ' HB ' HD23 ' A' ' 68' ' ' LEU . 7.3 t -128.32 141.23 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 0.0 111.075 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.5 HD21 HD13 ' A' ' 185' ' ' ILE . 62.3 tp -113.4 120.13 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.428 HG21 ' CG ' ' A' ' 81' ' ' HIS . 34.2 p -119.94 145.87 46.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.184 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 173' ' ' ILE . 72.1 t -60.07 -39.94 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 111.73 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.18 -38.68 78.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.595 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -67.14 131.69 46.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.249 0.547 . . . . 0.0 112.325 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.404 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 60.0 t -104.01 120.12 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.846 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.479 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 49.1 pt -106.27 134.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 111.998 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 49.0 mt-10 -120.58 140.03 52.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.462 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 HG23 ' A' ' 147' ' ' VAL . 44.3 pt -131.08 140.83 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 65.2 m -105.92 120.99 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.495 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 60.1 t80 -119.97 120.0 35.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.495 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 55.36 40.0 31.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.432 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.99 8.7 87.42 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.027 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.4 mttp -106.19 132.62 52.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -101.13 119.96 39.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.391 . . . . 0.0 111.223 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.457 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 98.3 m-85 -120.82 140.07 52.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 55.3 pttt -117.83 131.91 56.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.639 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.429 HD12 ' HZ ' ' A' ' 134' ' ' PHE . 85.4 mt -120.01 120.12 62.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.249 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -107.29 130.01 54.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.368 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.663 ' O ' HG13 ' A' ' 156' ' ' VAL . 5.3 mp -80.52 113.37 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.526 ' HG ' ' H ' ' A' ' 175' ' ' GLU . 1.5 pp -73.64 -56.51 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.729 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.526 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 99.0 mt-10 -155.57 136.42 13.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 125' ' ' VAL . 21.4 m -130.57 159.96 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -105.08 104.11 45.29 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.78 0.324 . . . . 0.0 110.219 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.532 ' HB3' HG21 ' A' ' 185' ' ' ILE . 68.7 Cg_endo -100.19 179.17 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.733 2.956 . . . . 0.0 112.509 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.0 mt-10 -95.41 0.03 52.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 88.2 p -140.31 159.88 41.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.031 0.443 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.05 -11.53 60.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.668 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.9 t -59.95 -18.58 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.415 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 66.77 26.41 9.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 110.702 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.8 m -125.9 139.98 53.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.104 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 120' ' ' PRO . 45.7 pt -127.52 143.87 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.738 ' N ' HG21 ' A' ' 119' ' ' VAL . 40.5 t -92.04 100.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.078 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.477 ' CG2' HD21 ' A' ' 192' ' ' LEU . 97.6 t -109.96 93.83 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.093 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.547 HD12 ' SG ' ' A' ' 186' ' ' CYS . 84.2 mt -110.59 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.836 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.78 10.78 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.721 ' HB ' HD12 ' A' ' 121' ' ' LEU . 5.8 t -84.98 171.71 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.207 0.527 . . . . 0.0 111.992 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.49 119.45 37.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.79 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.516 ' HG ' ' CG1' ' A' ' 125' ' ' VAL . 31.4 tp -120.37 131.29 54.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.476 ' O ' HG11 ' A' ' 125' ' ' VAL . 36.3 t -89.35 126.91 42.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.167 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.9 t -116.96 140.3 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.575 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -120.07 131.74 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.544 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.413 ' CD1' HD22 ' A' ' 135' ' ' LEU . 87.4 m-85 -100.14 122.34 42.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.38 . . . . 0.0 111.532 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.403 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -121.16 108.39 36.32 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 112.468 -179.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 120.885 0.285 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.704 ' O ' ' HA ' ' A' ' 117' ' ' THR . 57.2 tt0 -101.49 119.99 39.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.473 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' SER . 82.6 p -119.6 137.56 53.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.942 0.401 . . . . 0.0 111.637 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 115' ' ' SER . 75.2 t80 -125.74 130.52 51.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.618 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.15 136.7 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 112.052 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 98.6 mt-10 -140.53 153.6 46.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.067 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -120.14 122.57 41.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 92.3 m-85 -139.91 160.37 40.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.819 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -84.1 139.66 32.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.911 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 36.2 t -100.0 123.78 44.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 111.458 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.586 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 82.8 m-85 -121.67 149.92 54.11 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.237 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.607 ' HG2' ' HB3' ' A' ' 32' ' ' MET . 65.0 Cg_endo -79.45 111.17 2.79 Favored 'Trans proline' 0 N--CA 1.467 -0.081 0 C-N-CA 123.194 2.596 . . . . 0.0 112.647 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.671 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mt -60.77 -40.03 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 110.682 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.52 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.321 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.607 ' HB3' ' HG2' ' A' ' 29' ' ' PRO . 57.7 ttm -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 98.3 mtp -58.98 155.69 12.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.737 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.567 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.1 139.99 57.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.041 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -59.97 -37.09 78.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.05 -39.75 87.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG12 ' HB2' ' A' ' 34' ' ' ASN . 47.7 pt -90.3 -0.66 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 18.5 mtp-105 -99.39 139.94 34.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.857 0.361 . . . . 0.0 110.905 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -96.13 139.71 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.731 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 33.6 p-10 -60.01 -40.03 87.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.8 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.71 92.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 44' ' ' PHE . 27.3 p30 -62.53 -40.01 95.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 37.8 m-85 -110.0 18.23 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.587 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.09 173.35 28.96 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.14 24.22 19.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 71.5 mmtt -111.52 142.29 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 111.231 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.732 HG23 HD21 ' A' ' 96' ' ' LEU . 47.3 pt -121.24 155.96 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.56 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.4 m-85 -100.82 133.96 44.51 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.533 ' CD1' HG11 ' A' ' 84' ' ' VAL . 4.1 mp -140.18 164.54 36.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.596 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 69.3 Cg_endo -73.29 156.26 50.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.268 1.978 . . . . 0.0 112.715 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 74.3 Cg_endo -75.26 -15.6 20.11 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.906 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -60.0 -40.3 88.73 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.59 83.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.709 HD11 ' CG ' ' A' ' 87' ' ' PHE . 6.6 mp -60.13 -39.79 87.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.576 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.4 p -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 110.474 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 21' ' ' PHE . 23.6 tptm -69.45 -40.04 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.258 0.551 . . . . 0.0 110.167 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.409 HD12 ' SD ' ' A' ' 67' ' ' MET . 90.8 mt -59.95 -39.6 86.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.112 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -57.84 -39.27 77.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -59.88 -37.26 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.406 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 98.2 mt -80.46 -0.05 35.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.597 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.03 40.44 18.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.659 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 HG12 ' OE1' ' A' ' 19' ' ' GLN . 85.8 mt -86.63 120.01 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.789 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -91.73 149.13 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.305 0.574 . . . . 0.0 111.854 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 3.2 p90 -87.39 157.79 52.66 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.529 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 30.3 Cg_endo -63.74 147.61 64.42 Favored 'Cis proline' 0 C--N 1.352 0.759 0 C-N-CA 123.771 -1.346 . . . . 0.0 112.742 0.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.43 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 59.0 mtt -93.59 139.59 30.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.677 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 117' ' ' THR . 6.6 mp -101.49 120.9 41.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.025 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.667 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.0 m-85 -128.35 142.3 51.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.607 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 60.7 pttt -120.74 140.11 52.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -99.32 115.46 29.23 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.394 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.4 m -99.26 121.44 41.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.941 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.39 117.64 35.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.281 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -68.99 -39.99 79.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.433 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.906 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -105.4 -7.7 18.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.12 40.53 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.644 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -104.79 140.09 38.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.668 0.27 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 3.1 p -124.01 130.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.4 p -97.54 154.88 17.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.146 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.511 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 81.0 m80 -119.47 131.18 55.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.153 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.85 -173.72 36.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.538 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.488 ' CA ' ' HB2' ' A' ' 152' ' ' SER . . . -107.62 -170.72 21.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.937 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.537 HG12 ' CD2' ' A' ' 69' ' ' PHE . 32.6 m -130.05 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 121.279 -0.168 . . . . 0.0 110.815 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 58.2 tp -89.99 -78.1 0.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.39 . . . . 0.0 110.544 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -147.72 159.8 43.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.886 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.709 ' CG ' HD11 ' A' ' 55' ' ' LEU . 88.3 m-85 -99.87 116.15 31.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.276 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.16 -4.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.077 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -87.45 100.41 12.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.38 -39.98 77.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.92 -30.85 71.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.095 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.596 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.57 50.32 0.71 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.386 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -117.64 148.23 42.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.948 0.404 . . . . 0.0 111.501 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 8.0 p -129.81 140.81 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.02 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.671 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.72 139.96 50.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.927 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.732 HD21 HG23 ' A' ' 48' ' ' ILE . 21.3 mt -114.81 139.58 24.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 101' ' ' MET . 57.5 Cg_exo -55.01 155.59 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.699 2.266 . . . . 0.0 112.3 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.19 91.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.638 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.671 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 55.2 p-90 -69.95 -37.87 75.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.732 0.301 . . . . 0.0 111.356 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.63 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 98.1 mtp -69.94 -39.98 75.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.1 mtp -60.01 -40.94 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.037 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 21.3 pt-20 -64.12 -40.02 95.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.48 -40.06 95.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.522 HD11 HD13 ' A' ' 96' ' ' LEU . 82.9 mt -70.04 -24.13 63.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.369 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.66 29.97 60.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.432 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.8 pt -114.35 139.92 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 111.713 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.7 pt20 -95.25 160.01 31.63 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.415 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.531 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.5 Cg_endo -49.15 137.79 29.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.754 2.302 . . . . 0.0 112.48 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.09 -8.13 80.37 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.987 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 89.8 p -71.04 160.36 33.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.753 0.276 . . . . 0.0 110.605 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.65 145.2 30.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.473 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.911 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.1 tp -130.24 130.33 44.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 94.2 mt-30 -110.52 127.59 55.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.667 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 19.0 tt -118.44 127.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.407 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 47.0 t -120.02 130.03 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 23.4 t -89.9 116.03 27.66 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.857 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.725 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.6 t -129.98 138.83 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.74 121.07 44.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.537 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 186' ' ' CYS . 32.7 m -119.16 154.45 53.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.634 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.587 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 59.6 Cg_endo -72.5 153.31 55.11 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.791 2.327 . . . . 0.0 111.325 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 191' ' ' ASP . 4.7 mp -64.29 130.05 42.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.954 0.407 . . . . 0.0 111.137 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.95 151.4 49.01 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.53 -20.05 15.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.516 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' OD2' ' A' ' 195' ' ' ASP . 60.4 t80 -145.79 131.16 18.6 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.681 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 194' ' ' THR . 11.5 p -134.0 134.44 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.267 0.556 . . . . 0.0 111.529 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.78 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 64.3 mttp -99.43 122.37 42.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.359 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.25 128.59 56.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.417 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -111.7 112.22 53.81 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.105 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' CB ' HD12 ' A' ' 135' ' ' LEU . 84.2 Cg_endo -82.08 167.78 15.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.67 2.247 . . . . 0.0 112.462 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -126.07 121.22 32.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.6 142.15 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.03 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.09 -20.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.412 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.0 -39.56 86.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.138 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 64.3 t80 -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 135' ' ' LEU . 9.9 mp -81.95 -11.21 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.543 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.08 -19.99 63.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.743 0.306 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.15 130.2 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.5 p -69.54 150.75 46.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.26 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 2.5 m-20 53.66 53.37 10.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.464 ' O ' HD23 ' A' ' 144' ' ' LEU . 31.0 Cg_endo -63.83 -34.65 60.17 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.351 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.08 -40.04 88.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.071 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.88 95.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.607 ' O ' HG21 ' A' ' 147' ' ' VAL . 81.6 t -60.1 -43.19 92.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 144' ' ' LEU . 3.9 mm? -60.0 -40.57 89.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.57 -41.17 94.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.45 -39.94 89.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.176 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 143' ' ' VAL . 60.4 t -60.33 -42.07 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.86 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -41.27 91.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.548 ' HA ' HG23 ' A' ' 188' ' ' ILE . 16.8 tpt180 -61.71 -40.0 93.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.222 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.488 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 98.6 m-20 -62.05 -39.99 94.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.822 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.01 122.67 43.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.318 . . . . 0.0 111.4 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.75 ' HA ' HD13 ' A' ' 188' ' ' ILE . 51.8 m -60.03 -40.02 87.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.5 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 10.0 t -136.06 149.97 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.613 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.04 128.2 53.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.3 m -119.05 140.19 50.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.685 HG12 ' HA ' ' A' ' 175' ' ' GLU . 63.5 t -59.96 -42.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.398 0.618 . . . . 0.0 111.343 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.98 -39.71 75.77 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.678 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 81' ' ' HIS . 96.0 m-20 -65.53 140.39 58.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 112.449 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -105.77 120.02 55.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.654 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.488 HG13 ' CG1' ' A' ' 171' ' ' ILE . 48.0 pt -106.94 141.4 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.798 0.332 . . . . 0.0 111.377 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.642 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 99.9 mt-10 -118.99 140.69 49.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.581 HG22 HG23 ' A' ' 147' ' ' VAL . 46.7 pt -130.31 139.98 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.425 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 58.6 m -107.55 118.46 36.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -119.95 121.77 39.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.6 t30 55.07 40.03 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.421 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.88 9.9 86.23 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.891 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.6 mttt -110.38 138.05 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.807 0.303 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.1 m -106.63 121.16 43.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 90.3 m-85 -120.03 140.03 51.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.642 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 58.9 mtpt -106.07 123.99 48.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.354 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.488 ' CG1' HG13 ' A' ' 160' ' ' ILE . 46.0 pt -122.42 131.13 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 110.639 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -119.64 135.88 54.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.666 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -84.62 120.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.083 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 126' ' ' LYS . 89.1 mt -68.79 -59.32 3.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.429 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.78 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.28 146.66 18.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.76 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.633 HG12 ' CG2' ' A' ' 125' ' ' VAL . 4.3 m -139.02 145.15 28.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -88.94 104.7 8.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.327 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.1 Cg_endo -104.07 174.36 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.861 3.041 . . . . 0.0 112.351 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.587 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.6 mt-10 -100.03 0.73 41.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.1 m -132.81 150.03 52.2 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 111.184 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.5 m -70.98 -12.2 61.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.928 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -62.9 -10.39 13.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.0 mttm 59.93 24.58 13.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 111.425 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 64.2 m -121.08 135.76 55.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 46.7 pt -129.97 159.14 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.399 0.618 . . . . 0.0 112.355 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.608 ' HB2' HD21 ' A' ' 68' ' ' LEU . 53.0 t -140.53 104.57 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.932 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 192' ' ' LEU . 7.5 p -139.79 87.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.69 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.75 HD13 ' HA ' ' A' ' 152' ' ' SER . 72.0 mt -99.49 -3.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.796 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' A' ' 190' ' ' THR . 99.6 mt-10 -90.0 -80.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.291 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 13.1 t 177.38 36.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 121' ' ' LEU . 95.5 m-20 -109.64 16.77 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.436 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.651 ' HG ' HG12 ' A' ' 125' ' ' VAL . 19.0 tp -116.38 132.45 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 0.0 111.185 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.47 ' O ' HG11 ' A' ' 125' ' ' VAL . 39.9 t -95.11 120.01 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.04 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.707 ' HA ' HG11 ' A' ' 125' ' ' VAL . 81.6 p -103.31 141.2 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.0 111.895 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . 0.401 ' OD2' ' CE2' ' A' ' 124' ' ' PHE . 96.0 m-20 -129.21 144.7 51.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.071 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.68 139.98 48.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 111.415 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.61 166.26 13.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.374 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.184 1.923 . . . . 0.0 112.1 -179.857 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.652 0.188 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.7 mt-30 -99.94 120.32 39.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.451 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.694 ' HA ' ' O ' ' A' ' 116' ' ' SER . 8.9 t -130.0 139.95 50.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.136 0.493 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 55.2 t80 -128.82 130.19 46.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.98 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.08 135.71 48.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.0 mt-10 -144.48 160.05 41.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -119.13 135.46 54.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.417 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -149.7 160.02 43.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.943 0.401 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.83 132.67 39.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.77 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 31.4 p -96.48 141.81 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.482 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.533 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.9 m-85 -127.07 153.92 76.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.693 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 5.7 Cg_exo -78.27 107.09 2.25 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.733 2.288 . . . . 0.0 113.016 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.552 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 87.2 mt -64.29 -40.03 87.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.87 80.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.276 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.466 ' CB ' ' HB2' ' A' ' 29' ' ' PRO . 57.6 ttm -67.6 -32.54 73.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.946 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.0 159.54 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.01 144.49 49.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.44 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.18 -38.96 81.11 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.99 -39.9 87.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.72 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.258 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 30' ' ' ILE . 62.4 mtm180 -99.68 138.97 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.261 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 42' ' ' ALA . 98.6 mttt -103.67 132.47 49.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 111.242 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 96.1 m-20 -66.28 -40.06 89.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . . . -63.33 -39.95 95.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.733 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.14 -39.89 87.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.563 ' HA ' ' HE1' ' A' ' 99' ' ' TRP . 86.4 m-85 -105.52 6.44 32.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.768 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -96.07 173.4 30.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.714 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.8 24.33 21.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.261 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.35 136.03 41.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.6 pt -121.08 158.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 65.6 m-85 -100.08 131.6 45.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 1.9 mp -131.78 162.65 55.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.042 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.558 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.5 Cg_endo -77.78 144.17 21.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.148 1.898 . . . . 0.0 112.155 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.68 -23.93 73.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.603 2.202 . . . . 0.0 112.782 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -60.03 -39.93 87.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.116 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -67.31 -38.82 85.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.156 0.503 . . . . 0.0 110.753 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 34.7 tp -61.5 -39.94 92.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.771 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.3 p -60.06 -39.04 84.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.143 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 98.8 mttt -64.37 -40.06 95.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.96 0.41 . . . . 0.0 110.5 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.08 -35.45 77.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.7 m -60.01 -38.64 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.442 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.775 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -60.03 -36.43 77.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.304 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.94 -1.31 38.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.317 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.05 39.99 19.14 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -79.48 126.59 39.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -85.35 142.77 29.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 0.0 111.897 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.499 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 47.4 p90 -87.34 157.82 52.8 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.941 ' HG2' HG21 ' A' ' 188' ' ' ILE . 25.2 Cg_exo -65.24 157.77 75.89 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.542 0.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.455 ' HE2' HD13 ' A' ' 55' ' ' LEU . 65.6 mtm -100.14 145.77 27.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.189 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 153' ' ' THR . 1.3 pt? -116.16 133.7 55.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.583 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . 15.7 m-85 -120.03 140.02 51.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.681 ' HE2' HG22 ' A' ' 79' ' ' VAL . 81.1 tttt -115.08 120.02 38.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.274 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 6.5 mp -97.99 127.36 43.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.589 ' OG1' HG23 ' A' ' 79' ' ' VAL . 89.9 m -115.03 130.23 56.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.831 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.09 110.72 22.04 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.23 -40.07 88.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 104' ' ' LEU . 74.4 p -101.6 -10.41 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.61 6.56 16.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.615 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -104.1 141.31 36.45 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG22 ' HE2' ' A' ' 70' ' ' LYS . 7.2 p -121.18 124.42 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.355 0.598 . . . . 0.0 111.626 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.42 ' CG2' HG22 ' A' ' 103' ' ' THR . 68.9 p -104.3 151.12 23.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.34 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.401 ' NE2' ' HD2' ' A' ' 70' ' ' LYS . 77.4 m80 -100.91 115.06 29.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 0.0 110.814 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.503 ' HA3' ' CE ' ' A' ' 100' ' ' MET . . . -114.74 139.55 15.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.182 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -84.24 163.97 39.84 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.564 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.7 p -126.01 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 64.9 tp -90.33 -74.1 0.5 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.16 160.65 41.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.291 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 89.3 m-85 -95.72 116.76 29.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 88' ' ' ILE . 45.7 pt -125.2 -5.38 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.063 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -90.23 97.77 11.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.023 0.44 . . . . 0.0 111.412 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.95 -39.94 75.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.11 0.481 . . . . 0.0 110.796 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.08 -30.03 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.902 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.03 50.15 0.69 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.167 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -118.45 151.28 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 12.4 p -130.03 142.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 28' ' ' TYR . 88.6 m-85 -119.08 140.02 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -123.56 147.96 54.46 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.894 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.21 -173.08 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.405 2.07 . . . . 0.0 112.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.91 -20.85 63.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.563 ' HE1' ' HA ' ' A' ' 44' ' ' PHE . 14.4 m95 -60.01 -49.91 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.575 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.503 ' CE ' ' HA3' ' A' ' 82' ' ' GLY . 67.6 mtt -70.01 -39.97 75.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.495 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.615 ' HE1' ' HA ' ' A' ' 29' ' ' PRO . 67.8 mtt -63.89 -47.8 79.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.568 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.98 -40.12 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.235 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.42 HG22 ' CG2' ' A' ' 80' ' ' THR . 94.3 m -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.938 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.632 ' O ' HG22 ' A' ' 76' ' ' THR . 92.9 mt -95.16 -19.05 20.4 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 101' ' ' MET . . . 58.89 47.76 88.97 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -113.49 150.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.031 0.443 . . . . 0.0 111.439 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.35 161.69 30.13 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.573 ' CG ' ' HG3' ' A' ' 29' ' ' PRO . 40.0 Cg_exo -59.62 -5.89 3.84 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.886 2.391 . . . . 0.0 113.421 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.13 -6.82 56.69 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.773 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.4 m -85.02 143.77 28.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.736 0.303 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.97 145.0 52.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.629 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.542 HD21 HD23 ' A' ' 71' ' ' LEU . 54.1 tp -124.83 125.16 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.969 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -111.33 132.08 54.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.954 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 69' ' ' PHE . 88.9 mt -111.56 130.01 65.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.417 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 82.3 p -126.33 134.43 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.287 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 20' ' ' THR . 67.2 m -83.8 120.84 26.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 70.8 p -126.34 139.95 52.89 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -112.69 110.8 21.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.58 151.06 45.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.34 133.3 15.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.427 2.084 . . . . 0.0 110.958 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.691 HD21 ' HA ' ' A' ' 187' ' ' VAL . 5.0 mt -62.21 130.91 47.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.213 0.53 . . . . 0.0 112.091 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 159.2 50.31 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.058 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -105.66 -22.7 12.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -136.51 134.56 37.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 111.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' HG13 ' A' ' 176' ' ' VAL . 3.2 p -133.52 130.34 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.133 0.492 . . . . 0.0 111.54 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 99.4 mttt -96.86 123.12 40.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.428 ' CD2' HG13 ' A' ' 173' ' ' ILE . 90.9 mt -116.74 136.6 52.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.06 114.7 64.21 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.458 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.87 158.98 21.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.101 . . . . 0.0 112.83 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 96.9 mt-30 -122.72 121.6 36.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 130' ' ' GLN . 47.3 t 69.13 133.98 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.564 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.57 -23.05 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.94 -40.03 87.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.239 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.432 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 67.2 t80 -59.98 -40.13 88.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.97 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.36 -9.95 59.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.63 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.48 -10.18 58.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.573 0.225 . . . . 0.0 111.356 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -59.81 138.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 110.492 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.0 t -60.04 -40.04 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.531 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.75 71.24 82.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.927 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.689 ' O ' HD23 ' A' ' 144' ' ' LEU . 21.2 Cg_exo -65.11 -32.73 52.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.729 2.286 . . . . 0.0 111.909 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.01 -40.03 87.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.285 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.38 98.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.33 -41.33 91.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -63.43 -40.1 96.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -45.8 91.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -60.28 -41.36 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.051 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 151' ' ' PHE . 62.6 t -60.29 -44.21 95.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.226 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.06 -40.05 88.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.4 mtp85 -65.1 -40.02 93.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.094 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.15 -40.08 88.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.539 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 147' ' ' VAL . 90.6 m-85 -97.74 120.15 37.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.177 0.513 . . . . 0.0 111.439 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.4 m -60.16 -39.91 88.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.022 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 41.9 p -126.87 145.23 50.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.866 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.3 tp -119.88 119.4 33.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.999 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 73.6 p -124.28 141.37 52.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.674 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 97.9 t -59.99 -40.18 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 111.841 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.77 -39.78 87.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.869 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.43 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 97.0 m-20 -74.5 140.11 44.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 112.325 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.04 121.93 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.489 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 46.0 pt -107.97 131.07 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 19.6 pt-20 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.403 ' CG2' HG22 ' A' ' 147' ' ' VAL . 45.6 pt -121.15 148.97 24.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.632 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 82.3 p -109.01 117.55 34.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.206 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 64.6 t80 -119.99 120.06 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 10.9 m120 54.07 40.13 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.28 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.15 10.19 85.77 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.14 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 163' ' ' SER . 63.2 mttp -109.72 133.45 53.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.751 0.275 . . . . 0.0 110.368 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -107.38 123.9 49.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.3 m-85 -119.99 140.04 51.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.414 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 56.4 mttm -103.6 129.74 50.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.02 120.16 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.488 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.15 127.14 55.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.674 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -81.6 110.0 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.449 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.58 -58.8 5.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.838 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.746 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.38 143.03 16.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.615 HG13 ' CG2' ' A' ' 125' ' ' VAL . 7.2 m -137.55 142.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.042 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.47 104.71 11.87 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 57.1 Cg_endo -102.99 -0.88 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.882 3.054 . . . . 0.0 112.966 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.48 21.54 12.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.9 p -141.09 155.56 46.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.7 p -70.01 -23.08 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.334 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 22.5 t -59.93 -36.63 77.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 29.8 mmtm 69.68 19.96 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.9 m -130.03 140.01 50.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.094 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 44.6 pt -130.36 157.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 112.412 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 153' ' ' THR . 34.0 t -120.81 99.8 6.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.226 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 187' ' ' VAL . 14.7 p -119.91 107.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.237 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.941 HG21 ' HG2' ' A' ' 66' ' ' PRO . 24.0 mt -95.54 -80.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.102 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.87 3.69 49.75 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.479 ' HB ' HG22 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -78.92 171.1 15.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.085 0.469 . . . . 0.0 111.248 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -100.11 123.25 44.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.354 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 192' ' ' LEU . 13.6 tp -120.29 131.49 54.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.561 ' O ' HG11 ' A' ' 125' ' ' VAL . 39.4 t -90.53 120.08 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.875 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.8 t -118.15 148.14 42.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.109 0.481 . . . . 0.0 111.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -120.15 139.74 52.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -99.72 122.43 42.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.29 110.67 34.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.394 2.063 . . . . 0.0 112.269 -179.579 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.464 -0.219 0 CA-C-O 120.722 0.218 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 117' ' ' THR . 72.0 tp60 -100.02 119.86 38.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.033 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 116' ' ' SER . 73.0 p -120.01 133.08 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 115' ' ' SER . 57.4 t80 -120.0 124.96 47.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -105.68 135.06 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.438 ' OE2' ' HG3' ' A' ' 91' ' ' GLU . 85.3 tt0 -145.05 155.28 43.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.706 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.62 120.03 41.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.17 0.51 . . . . 0.0 111.995 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' HE2' ' HG3' ' A' ' 51' ' ' PRO . 87.1 m-85 -121.06 140.01 52.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.734 ' O ' HG12 ' A' ' 94' ' ' VAL . 36.8 ptt180 -80.02 153.34 28.89 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 69.3 m -83.69 132.79 34.84 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 112.337 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.647 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 3.0 m-85 -130.53 126.29 21.95 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.078 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.69 ' O ' ' HG2' ' A' ' 32' ' ' MET . 16.0 Cg_exo -70.02 113.29 3.37 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.553 2.169 . . . . 0.0 112.016 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 95' ' ' TYR . 91.4 mt -66.21 -36.79 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 110.818 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.17 83.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.261 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.69 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.0 ptm -68.43 -20.07 64.62 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.134 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 96.9 mmm -64.69 156.92 28.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 28.2 m120 -60.06 141.36 55.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -39.66 86.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -59.93 -39.83 86.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 37' ' ' ILE . 85.5 mt -87.26 -7.76 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.232 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 22.4 mtp-105 -98.96 140.04 33.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.086 0.469 . . . . 0.0 111.917 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.94 130.82 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.93 -40.11 87.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.28 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -64.0 -39.96 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.85 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.95 96.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.009 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.08 -40.02 88.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.58 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -105.14 2.01 28.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.626 0.25 . . . . 0.0 111.565 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.48 173.9 30.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -100.39 14.88 59.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.403 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.6 mttt -95.32 133.36 39.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 96' ' ' LEU . 45.9 pt -118.85 164.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.811 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CD1' HG12 ' A' ' 88' ' ' ILE . 98.7 m-85 -100.5 131.54 46.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -129.74 166.77 23.64 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.767 -179.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.844 ' HG3' ' HA ' ' A' ' 91' ' ' GLU . 31.6 Cg_endo -83.13 147.72 13.07 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.821 2.347 . . . . 0.0 113.4 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 37.1 Cg_exo -61.93 -21.27 71.97 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.5 p -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.0 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.545 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 87' ' ' PHE . 6.5 mp -59.97 -40.25 88.44 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.544 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -40.0 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -69.24 -40.01 78.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.383 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 HD22 ' CB ' ' A' ' 116' ' ' SER . 88.2 mt -60.24 -39.81 88.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.033 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.4 m -59.99 -39.73 86.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.487 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.0 -38.89 83.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.355 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.06 0.01 33.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.517 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 59.97 42.77 15.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.811 0.339 . . . . 0.0 111.511 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.9 mm -76.33 129.99 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -83.88 146.71 27.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.3 m-85 -87.58 153.53 53.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.65 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.07 163.09 86.27 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.659 0.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.424 ' HE3' ' CE1' ' A' ' 87' ' ' PHE . 76.0 mtm -84.09 137.0 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.358 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.741 ' HB2' ' O ' ' A' ' 117' ' ' THR . 76.7 mt -115.3 131.91 56.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.498 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.501 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 95.4 m-85 -129.6 144.1 51.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.53 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 28.3 ttpp -119.53 130.46 55.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD23 HD22 ' A' ' 112' ' ' LEU . 7.5 mp -100.02 121.82 41.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.6 m -114.17 130.04 56.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.983 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.19 30.95 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.487 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -68.42 -39.63 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.766 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.721 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 29.8 m -103.58 -15.97 15.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.57 7.92 62.07 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.536 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -99.4 140.17 33.97 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.85 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.54 HG13 ' HD2' ' A' ' 70' ' ' LYS . 59.3 t -119.95 120.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.5 p -109.28 138.35 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.273 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.587 ' CE1' ' HD3' ' A' ' 70' ' ' LYS . 3.1 m-70 -84.12 114.14 21.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.08 146.16 16.03 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.177 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 152' ' ' SER . . . -96.51 162.62 22.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.771 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 84' ' ' VAL . 8.1 p -120.73 126.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.57 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 48.6 tp -91.63 -74.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.9 159.96 41.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.245 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.631 ' CE2' HD12 ' A' ' 55' ' ' LEU . 70.8 m-85 -100.79 116.21 32.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.826 0.346 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.447 HG12 ' CD1' ' A' ' 49' ' ' PHE . 48.3 pt -137.99 -4.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.827 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -104.29 158.02 16.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 110.889 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HB2' ' HG2' ' A' ' 93' ' ' ARG . 97.9 mt-10 -76.67 158.17 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.333 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.844 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 85.8 tt0 -59.99 -30.35 69.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.598 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -81.81 1.24 86.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.308 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 46.6 ptt85 -144.23 145.88 32.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 26' ' ' ARG . 7.7 p -142.89 150.41 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.664 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.749 ' HB3' HG12 ' A' ' 30' ' ' ILE . 85.3 m-85 -118.63 139.99 50.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.456 ' HA ' HG21 ' A' ' 48' ' ' ILE . 1.7 pt? -134.34 159.05 73.76 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.66 147.97 90.14 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.792 2.328 . . . . 0.0 112.13 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -60.01 -42.29 94.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.163 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -68.72 -40.04 80.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.5 ttm -60.03 -40.28 88.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG3' HG13 ' A' ' 106' ' ' ILE . 67.4 ttp -60.62 -41.27 94.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.46 -39.99 95.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.0 m -62.55 -40.01 95.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 -23.82 63.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.564 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.32 35.0 43.97 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.739 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.521 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.5 pt -118.11 147.43 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.969 0.414 . . . . 0.0 111.3 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.524 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.1 pt20 -98.18 161.63 24.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 8.5 Cg_endo -49.34 136.44 31.83 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.74 2.293 . . . . 0.0 112.162 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 -9.9 75.75 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.612 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.521 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 70.4 p -70.11 161.08 30.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.682 0.277 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.25 140.65 29.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.644 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 60.2 tp -120.07 127.99 53.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.93 119.95 40.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.18 0.514 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 18.9 tt -120.97 128.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 79.8 p -120.69 138.83 53.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 20' ' ' THR . 44.9 t -80.17 110.72 15.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.741 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 92.9 m -119.51 129.4 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -101.5 119.23 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.453 HG22 ' SG ' ' A' ' 186' ' ' CYS . 22.1 m -120.12 152.6 54.65 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 49.4 Cg_endo -67.78 175.29 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.423 2.082 . . . . 0.0 110.684 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 122' ' ' GLY . 7.7 tt -94.41 120.04 34.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.938 0.399 . . . . 0.0 111.257 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.561 ' O ' HD21 ' A' ' 121' ' ' LEU . . . -62.35 151.25 46.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.919 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.412 ' O ' HG22 ' A' ' 193' ' ' VAL . 97.8 mt-30 -101.33 -17.02 16.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.065 0.433 . . . . 0.0 111.767 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.496 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 69.0 t80 -150.27 134.78 17.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.741 ' HA ' HG13 ' A' ' 176' ' ' VAL . 7.7 p -139.21 130.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.344 0.592 . . . . 0.0 111.419 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.775 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 83.8 mttt -94.98 126.3 40.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.487 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.57 HD11 HD22 ' A' ' 144' ' ' LEU . 56.1 mt -115.3 133.28 56.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.88 0.372 . . . . 0.0 110.954 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -109.19 110.59 60.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.762 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.52 175.59 10.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.579 2.186 . . . . 0.0 112.395 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -124.02 121.35 35.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.304 0.573 . . . . 0.0 110.089 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.423 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 6.3 t 59.83 168.78 0.07 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.086 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.26 -19.99 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.702 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' PHE . 47.7 p-10 -60.03 -39.93 87.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.01 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 66.9 t80 -59.96 -40.04 87.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.348 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.1 -7.71 59.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.717 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.94 -12.78 61.87 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.482 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.4 mt -60.33 138.82 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.4 m -60.07 -39.99 87.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 111.314 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 137' ' ' ILE . 36.4 m-20 -125.9 75.73 71.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 25.2 Cg_endo -62.17 -40.61 40.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.5 2.133 . . . . 0.0 112.203 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.29 -40.02 88.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.36 96.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 147' ' ' VAL . 84.6 t -60.66 -41.96 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.247 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 194' ' ' THR . 3.0 tm? -59.98 -41.69 92.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.23 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.01 -40.47 89.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 111.043 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.97 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.544 HG11 HD11 ' A' ' 160' ' ' ILE . 77.2 t -61.89 -43.49 97.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.054 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.98 -40.95 90.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.02 0.438 . . . . 0.0 110.557 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -64.28 -40.15 95.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.28 -40.05 92.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.478 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.58 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 97.7 m-85 -101.16 120.02 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.496 . . . . 0.0 110.911 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.487 ' HA ' ' CG2' ' A' ' 188' ' ' ILE . 10.0 t -68.63 -39.99 80.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.864 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 74.1 p -124.41 140.06 53.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.219 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 151' ' ' PHE . 86.9 mt -131.18 136.89 48.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.962 0.411 . . . . 0.0 111.819 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 21.7 m -118.77 145.49 45.56 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.679 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.5 t -60.02 -41.6 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.42 0.629 . . . . 0.0 110.646 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.98 -40.01 65.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.675 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.442 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 54.0 t0 -61.01 135.21 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.999 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.27 120.03 53.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.31 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.544 HD11 HG11 ' A' ' 147' ' ' VAL . 46.9 pt -103.92 140.61 21.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.337 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.524 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.1 mt-10 -118.26 141.36 48.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 111.495 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.496 ' CG2' HG12 ' A' ' 147' ' ' VAL . 48.2 pt -125.63 139.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 33.2 p -105.81 108.16 19.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.919 0.39 . . . . 0.0 111.654 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 39.6 m-85 -120.49 123.75 43.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.707 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 59.29 34.34 22.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.39 83.4 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.062 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.5 mttt -119.45 138.43 53.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.791 0.295 . . . . 0.0 111.09 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 9.6 t -108.6 131.79 54.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.115 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.4 m-85 -120.01 140.03 51.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.524 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 96.8 mttt -97.2 127.25 43.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.12 134.5 54.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.679 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -79.49 122.26 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.522 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 84.6 mt -73.03 -57.9 3.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.083 0.468 . . . . 0.0 111.195 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.775 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.1 mt-10 -159.92 145.84 15.67 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.869 HG23 ' HE3' ' A' ' 183' ' ' LYS . 5.4 m -140.24 160.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -110.93 103.66 55.06 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 81.0 Cg_endo -100.25 171.18 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.605 2.87 . . . . 0.0 113.041 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.501 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 70.5 mm-40 -99.97 3.74 44.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.038 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.4 m -136.25 160.52 38.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.09 -13.11 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.341 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.8 p -67.9 -13.1 61.88 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.652 0.263 . . . . 0.0 111.428 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.869 ' HE3' HG23 ' A' ' 176' ' ' VAL . 4.8 tptm 49.99 41.84 23.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.322 0.582 . . . . 0.0 110.843 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.1 m -123.71 144.73 49.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.471 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 176' ' ' VAL . 20.2 mt -119.3 134.08 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.385 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.526 ' HB3' HD21 ' A' ' 68' ' ' LEU . 64.2 m -142.21 100.09 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.011 0.434 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.626 HG12 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -149.42 113.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.856 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 152' ' ' SER . 44.1 pt -103.21 -10.13 9.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.3 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -89.96 -79.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 14.6 t -172.52 -161.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.439 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' THR . 96.5 m-20 71.75 24.7 3.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.033 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.626 ' HB2' HG12 ' A' ' 187' ' ' VAL . 21.1 tp -117.98 132.41 56.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 125' ' ' VAL . 47.1 t -94.59 124.84 47.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.654 HG23 HD11 ' A' ' 144' ' ' LEU . 76.3 p -115.93 149.77 38.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.28 135.82 52.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.76 138.85 39.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.157 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.435 ' HB3' ' HD2' ' A' ' 198' ' ' PRO . . . -117.7 162.49 28.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 197' ' ' ALA . 53.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 121.966 1.777 . . . . 0.0 112.03 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 35.6 Cg_exo . . . . . 0 N--CA 1.472 0.233 0 CA-C-O 120.722 0.218 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.8 mt-30 -105.77 118.53 36.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.48 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 116' ' ' SER . 58.5 p -121.07 126.55 50.11 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 115' ' ' SER . 72.6 t80 -121.09 120.42 35.27 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -98.29 140.99 31.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -149.96 159.99 43.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.615 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 55.2 p90 -100.2 120.21 39.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.162 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CD2' HG12 ' A' ' 114' ' ' ILE . 94.4 m-85 -120.19 140.36 51.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.632 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 76.4 mtp85 -82.31 142.66 31.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.393 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 50.6 m -84.48 135.4 34.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.899 0.38 . . . . 0.0 111.796 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.596 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 21.5 m-85 -129.71 137.21 30.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.249 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 33' ' ' MET . 95.4 Cg_endo -79.26 92.24 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.684 2.256 . . . . 0.0 112.965 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.777 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 85.0 mt -59.96 -40.02 81.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.983 0.421 . . . . 0.0 110.601 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.87 87.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.729 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.42 -31.07 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.71 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.546 ' CB ' ' HG3' ' A' ' 38' ' ' ARG . 94.4 mmm -59.21 145.01 44.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.54 ' HB3' HG12 ' A' ' 37' ' ' ILE . 19.6 t-20 -59.88 139.87 57.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.372 0.606 . . . . 0.0 112.359 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.91 -38.89 83.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.023 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 92.7 mtt-85 -59.87 -40.0 87.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.366 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 34' ' ' ASN . 47.6 pt -95.49 -1.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.546 ' HG3' ' CB ' ' A' ' 33' ' ' MET . 79.2 mmt-85 -125.43 155.75 39.93 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.033 0.444 . . . . 0.0 111.793 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -101.01 133.25 45.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.555 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -39.92 88.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.218 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -39.86 87.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.08 84.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.45 HD22 HG23 ' A' ' 30' ' ' ILE . 27.2 m120 -60.01 -40.27 88.65 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 111.308 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.45 4.12 40.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.642 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.11 -174.49 28.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.232 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.35 32.46 6.8 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.599 ' CG ' ' HB2' ' A' ' 85' ' ' LEU . 36.6 ttpt -102.55 129.5 49.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.208 -0.496 . . . . 0.0 112.096 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.745 HG21 ' HE2' ' A' ' 100' ' ' MET . 41.7 pt -131.73 161.07 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.06 133.39 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.062 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.3 mm? -133.08 157.58 77.96 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.391 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.1 Cg_endo -75.24 132.55 15.22 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.21 2.607 . . . . 0.0 112.753 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 52.2 Cg_exo -53.59 -15.23 6.03 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 113.32 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 m -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.146 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.69 87.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.049 0.452 . . . . 0.0 111.088 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 87' ' ' PHE . 68.7 mt -59.92 -39.75 86.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 109.974 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.683 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 73.3 mmtt -66.67 -39.94 88.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.294 0.569 . . . . 0.0 109.976 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.584 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -56.69 -38.19 71.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.037 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.683 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -59.98 -38.27 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.77 1.34 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.04 39.96 19.22 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.784 0.326 . . . . 0.0 111.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.1 mt -88.5 120.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.186 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -95.77 140.21 30.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.619 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.534 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 51.8 p90 -87.17 159.67 50.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 34.9 Cg_exo -60.53 134.41 12.05 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.522 0.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.425 ' CE ' ' CD2' ' A' ' 55' ' ' LEU . 74.3 mtm -98.82 140.4 33.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.208 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.886 HD22 ' HB ' ' A' ' 153' ' ' THR . 1.9 mp -97.42 127.46 43.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.215 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CD1' HG11 ' A' ' 84' ' ' VAL . 89.3 m-85 -119.95 140.08 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.506 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.02 129.98 55.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.151 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.591 HD22 ' SD ' ' A' ' 100' ' ' MET . 1.4 mp -97.14 123.22 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.686 0.279 . . . . 0.0 111.078 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 90.8 m -114.02 121.28 43.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.398 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -117.23 139.18 51.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 62.27 147.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.344 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.96 -40.67 89.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -133.13 8.41 4.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.404 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.92 -105.73 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.849 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.41 157.41 46.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.924 0.392 . . . . 0.0 111.287 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 71' ' ' LEU . 33.3 m -129.77 136.69 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.615 HG21 ' HG2' ' A' ' 100' ' ' MET . 41.9 m -99.04 148.79 23.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.42 ' N ' HG23 ' A' ' 80' ' ' THR . 76.9 m80 -119.74 131.12 55.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.759 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.16 175.24 44.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.716 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.64 -175.06 25.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.478 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 69' ' ' PHE . 33.0 m -129.96 159.97 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 0.0 111.559 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.599 ' HB2' ' CG ' ' A' ' 47' ' ' LYS . 65.0 tp -93.4 -79.98 0.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.341 0.591 . . . . 0.0 110.863 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -152.44 159.21 43.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.587 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 7.2 m-85 -100.97 118.0 36.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.16 -4.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -88.96 99.68 12.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.391 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.09 -39.93 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.1 -30.26 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.633 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 104.34 68.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.421 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 84.8 mtt85 -119.98 141.05 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.918 0.39 . . . . 0.0 110.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.632 ' HB ' ' O ' ' A' ' 26' ' ' ARG . 88.9 t -129.24 133.41 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 112.173 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.777 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 85.5 m-85 -117.23 139.12 51.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.615 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -132.86 147.11 64.17 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 100' ' ' MET . 93.3 Cg_endo -83.97 -170.44 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 112.626 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.5 -27.1 68.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.036 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.481 ' CH2' ' HZ ' ' A' ' 151' ' ' PHE . 19.6 m95 -59.95 -49.49 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.916 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.745 ' HE2' HG21 ' A' ' 48' ' ' ILE . 65.1 mtt -68.57 -40.04 80.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.315 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 57.8 ttm -62.37 -49.87 73.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.794 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.26 -39.92 78.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.423 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.512 HG21 ' HA ' ' A' ' 80' ' ' THR . 93.9 m -67.47 -40.07 85.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.223 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.546 ' HG ' ' OG1' ' A' ' 80' ' ' THR . 86.0 mt -88.57 -20.59 24.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.502 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.57 76.39 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 101' ' ' MET . 45.1 pt -112.97 140.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 111.738 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.9 pm0 -95.91 162.33 24.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 99.5 Cg_exo -43.32 146.17 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.581 2.187 . . . . 0.0 112.694 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.97 75.51 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.105 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 89.4 p -77.31 163.14 26.74 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.769 -0.253 . . . . 0.0 110.718 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.49 139.85 30.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.726 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 67.8 tp -126.5 124.86 41.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -111.97 120.1 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.857 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.764 HG12 ' CD2' ' A' ' 25' ' ' PHE . 47.2 pt -118.18 134.58 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.126 0.489 . . . . 0.0 111.047 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 30.7 t -119.99 128.72 53.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.956 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.2 t -65.6 117.66 8.38 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 90.6 m -119.27 129.87 55.13 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.433 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.1 t0 -100.39 117.67 35.05 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' ' 186' ' ' CYS . 26.4 m -113.09 151.6 44.32 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.982 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.461 ' CB ' ' HB2' ' A' ' 179' ' ' GLU . 88.8 Cg_endo -78.87 159.32 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.572 2.181 . . . . 0.0 111.539 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD11 ' N ' ' A' ' 121' ' ' LEU . 6.5 mp -74.94 126.42 30.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.09 157.15 46.44 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.503 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.43 -28.97 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.739 0.27 . . . . 0.0 111.69 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.522 ' HE2' ' HE3' ' A' ' 126' ' ' LYS . 65.0 t80 -142.23 130.18 21.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.869 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.836 ' HA ' HG13 ' A' ' 176' ' ' VAL . 13.2 p -132.89 131.85 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.878 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 96.1 mttt -102.04 125.81 48.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.455 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 171' ' ' ILE . 89.8 mt -110.02 136.06 49.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.523 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -99.54 111.3 61.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.58 160.37 31.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.736 2.29 . . . . 0.0 112.615 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.49 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 95.1 mt-30 -128.83 122.13 29.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.191 0.519 . . . . 0.0 110.289 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 69.09 134.28 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.524 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.3 -21.39 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.94 -40.54 89.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 75.6 t80 -59.93 -40.55 89.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.31 -9.06 59.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.712 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.99 -12.82 61.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.565 0.222 . . . . 0.0 111.395 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -59.98 139.59 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.3 p -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.506 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.428 ' H ' HG21 ' A' ' 137' ' ' ILE . 13.1 m-20 -129.26 74.34 81.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.514 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 56.9 Cg_endo -71.94 -35.51 7.19 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.569 2.179 . . . . 0.0 112.239 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.91 97.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.846 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.435 HG13 ' CZ ' ' A' ' 164' ' ' TYR . 97.4 t -60.43 -42.2 90.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 140' ' ' PRO . 4.1 mm? -59.91 -40.11 87.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.94 -42.93 95.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.666 0.269 . . . . 0.0 110.636 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -62.28 -41.0 98.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 143' ' ' VAL . 84.4 t -63.35 -40.2 88.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.385 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.07 -40.45 89.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -63.14 -39.93 96.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.117 0.484 . . . . 0.0 110.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.96 -39.93 91.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.708 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HZ ' ' CH2' ' A' ' 99' ' ' TRP . 42.1 m-85 -94.68 122.25 37.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 111.174 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.514 ' HB2' HG12 ' A' ' 188' ' ' ILE . 90.0 p -71.5 -33.68 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.657 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.886 ' HB ' HD22 ' A' ' 68' ' ' LEU . 7.8 t -136.26 141.21 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 111.907 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.53 ' HG ' ' CG1' ' A' ' 187' ' ' VAL . 83.6 mt -119.92 127.23 52.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.466 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 38.2 p -121.5 145.27 48.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.5 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.728 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.7 t -60.07 -39.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 0.0 111.309 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.74 -37.02 83.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.845 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.479 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.0 t0 -68.72 129.99 41.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.58 119.98 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.532 HG13 ' HB ' ' A' ' 171' ' ' ILE . 45.8 pt -99.89 134.82 38.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 112.061 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 50.4 mt-10 -113.97 141.13 47.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.593 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 169' ' ' PHE . 16.7 tt -121.26 129.98 75.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.355 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 23.3 p -108.7 110.07 21.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 111.753 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CD1' HG12 ' A' ' 162' ' ' ILE . 5.5 m-85 -126.24 126.71 44.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.33 34.22 23.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.239 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.0 16.01 77.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.6 mttm -117.75 138.49 52.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.782 0.291 . . . . 0.0 110.57 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.2 p -110.93 131.08 55.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.058 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 93.7 m-85 -119.98 139.9 51.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 61.7 mtpt -103.81 127.19 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 160' ' ' ILE . 49.0 mm -119.96 129.21 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -114.92 133.32 56.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.633 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.9 OUTLIER -70.0 98.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.119 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.02 -52.25 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.709 0.29 . . . . 0.0 111.742 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.878 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 83.4 tt0 -162.7 139.02 7.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.347 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.836 HG13 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -141.26 152.88 19.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.201 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 103.87 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 71.8 Cg_endo -100.68 175.15 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.72 2.946 . . . . 0.0 112.435 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.8 mt-10 -94.05 0.04 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.976 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -136.64 154.33 50.68 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.956 0.408 . . . . 0.0 111.34 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.03 -11.84 61.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.523 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.1 m -69.96 -9.42 55.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.498 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 59.95 38.67 20.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.224 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 56.2 m -130.05 135.79 48.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.612 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.544 ' C ' HG22 ' A' ' 119' ' ' VAL . 45.3 pt -129.96 160.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 111.768 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.608 ' N ' HG22 ' A' ' 119' ' ' VAL . 46.4 t -99.94 120.46 39.83 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.53 ' CG1' ' HG ' ' A' ' 154' ' ' LEU . 9.7 p -110.66 14.59 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.412 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.541 HD13 ' CG ' ' A' ' 68' ' ' LEU . 91.0 mt -59.96 -46.28 94.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 188' ' ' ILE . 98.9 mt-10 -155.88 81.59 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.229 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 121' ' ' LEU . 12.7 t -150.05 157.36 43.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.899 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -87.93 103.78 16.0 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.8 tp -119.94 134.17 55.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.523 ' O ' HG11 ' A' ' 125' ' ' VAL . 34.2 t -97.3 122.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.484 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.58 HG23 ' CG1' ' A' ' 125' ' ' VAL . 70.2 p -102.5 142.46 33.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.568 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -129.55 146.54 51.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.68 139.91 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.319 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -108.92 165.95 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.621 2.214 . . . . 0.0 112.461 -179.619 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 13.8 Cg_endo . . . . . 0 N--CA 1.463 -0.291 0 CA-C-O 120.716 0.215 . . . . 0.0 111.779 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.1 mt-30 -99.83 126.69 45.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.6 p -119.8 126.28 50.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.1 0.476 . . . . 0.0 111.76 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 115' ' ' SER . 65.9 t80 -120.17 124.35 45.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.618 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.51 129.94 55.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CD ' ' CZ ' ' A' ' 25' ' ' PHE . 81.7 tt0 -148.05 154.93 40.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.128 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -105.25 127.19 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.712 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 95.6 m-85 -133.47 159.98 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.719 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -96.06 127.88 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.605 ' HB2' HD23 ' A' ' 96' ' ' LEU . 28.7 p -91.37 143.62 26.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.517 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 93' ' ' ARG . 20.1 m-85 -129.95 153.34 80.97 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.502 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HB2' ' HG2' ' A' ' 32' ' ' MET . 89.6 Cg_endo -78.28 103.67 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.798 2.332 . . . . 0.0 112.968 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.744 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.5 mt -60.75 -40.07 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.113 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.7 68.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.389 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 97.2 mmm -67.71 -38.68 83.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 91.2 mtp -64.89 148.66 51.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -59.53 140.94 55.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.057 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.51 -21.02 63.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.056 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.973 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 pt -99.99 1.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.094 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -127.03 159.33 34.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.151 0.501 . . . . 0.0 111.691 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -99.96 129.71 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.969 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.12 88.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.23 -39.95 88.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.262 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.21 76.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.605 HD22 ' HG3' ' A' ' 98' ' ' GLN . 20.5 t-20 -60.07 -40.61 90.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.033 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.83 1.52 40.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.242 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.29 -170.63 34.86 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.99 31.48 7.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.817 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.741 ' HD3' HD11 ' A' ' 85' ' ' LEU . 62.0 mttp -99.71 121.96 42.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.98 0.419 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.4 pt -119.42 149.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 65.3 t80 -104.77 127.84 52.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.632 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 2.0 mp -133.39 160.02 70.26 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.646 0.26 . . . . 0.0 111.512 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 62.8 Cg_endo -72.32 147.76 47.87 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.766 2.31 . . . . 0.0 112.595 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 89' ' ' ALA . 27.3 Cg_exo -62.55 -19.0 66.48 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.866 2.377 . . . . 0.0 112.878 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.42 90.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.092 0.473 . . . . 0.0 110.961 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.626 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 57.9 tp -60.28 -42.23 94.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.233 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -60.11 -40.1 88.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.065 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -40.09 90.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 21' ' ' PHE . 96.7 mt -63.63 -38.39 90.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.7 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.4 m -60.01 -37.96 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.11 -36.55 77.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.28 -1.77 42.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.296 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.96 40.59 18.75 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 58' ' ' LEU . 85.4 mt -73.17 130.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.404 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -66.08 140.08 58.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.654 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.66 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 16.3 t80 -96.53 147.17 32.54 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 24.4 Cg_exo -66.96 155.45 84.14 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.149 -1.188 . . . . 0.0 113.062 0.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.428 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 66.6 mtt -90.86 140.29 29.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.671 ' HB2' ' O ' ' A' ' 117' ' ' THR . 35.7 mt -105.75 141.0 37.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.079 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.689 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 60.5 m-85 -133.41 147.0 51.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.431 . . . . 0.0 112.108 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 97.7 mttt -121.39 137.91 54.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.19 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD23 HD23 ' A' ' 112' ' ' LEU . 86.5 mt -99.2 119.99 38.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.29 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.434 ' OG1' HG21 ' A' ' 79' ' ' VAL . 30.6 m -108.05 125.52 51.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.751 0.31 . . . . 0.0 111.665 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB1' HD22 ' A' ' 104' ' ' LEU . . . -100.49 119.97 39.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.921 0.391 . . . . 0.0 110.676 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.15 -39.87 82.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.04 -39.84 87.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -106.16 -13.81 15.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 70.08 8.17 61.04 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -100.18 140.0 35.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.434 HG21 ' OG1' ' A' ' 72' ' ' THR . 9.7 p -123.64 122.76 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.525 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 60.5 m -106.06 134.84 48.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.323 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.622 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 3.4 t-80 -84.41 114.72 22.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.02 172.72 20.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.281 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -100.09 162.29 19.18 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.443 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.654 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 9.7 p -130.01 136.59 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 0.0 111.78 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.741 HD11 ' HD3' ' A' ' 47' ' ' LYS . 94.3 mt -91.01 -77.21 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.529 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -148.69 160.08 43.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.057 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 55' ' ' LEU . 96.7 m-85 -106.22 116.63 32.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.585 HG13 ' C ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -140.78 11.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.784 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.577 ' N ' ' HD3' ' A' ' 52' ' ' PRO . . . -85.14 99.9 11.37 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.82 -40.0 72.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.01 0.433 . . . . 0.0 110.649 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.14 -30.29 67.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.385 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.502 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 100.07 64.59 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.07 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.517 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 35.6 ptt-85 -123.41 143.42 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 25' ' ' PHE . 97.5 t -123.28 132.78 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.542 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.744 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.0 m-85 -120.41 139.88 52.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.605 HD23 ' HB2' ' A' ' 27' ' ' CYS . 1.7 pt? -134.49 159.49 72.05 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.297 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' HG2' ' CG ' ' A' ' 100' ' ' MET . 58.7 Cg_endo -68.91 159.21 54.82 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.655 2.236 . . . . 0.0 112.744 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.605 ' HG3' HD22 ' A' ' 43' ' ' ASN . 77.9 mt-30 -60.07 -43.02 95.76 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.517 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 29.4 p-90 -64.52 -40.0 94.81 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.595 ' CG ' ' HG2' ' A' ' 97' ' ' PRO . 93.9 mmm -63.49 -40.15 96.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.751 0.31 . . . . 0.0 111.307 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.3 ttp -61.8 -42.42 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.57 -39.98 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -65.61 -40.35 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.449 HD22 ' HB1' ' A' ' 73' ' ' ALA . 93.1 mt -69.97 -23.73 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.49 72.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.901 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.683 ' HB ' ' HG ' ' A' ' 110' ' ' SER . 44.9 pt -120.4 151.58 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.49 160.45 32.99 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.05 -2.82 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.589 2.192 . . . . 0.0 113.323 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.51 -14.06 22.76 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.626 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.683 ' HG ' ' HB ' ' A' ' 106' ' ' ILE . 90.8 p -81.48 161.29 23.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.991 0.424 . . . . 0.0 111.132 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.42 140.02 51.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.37 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 60.5 tp -118.94 129.38 55.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 64.0 tt0 -106.75 125.85 51.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 14.9 tt -117.97 126.63 75.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.62 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 44.8 t -120.13 131.77 55.16 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 1.2 m -83.46 114.9 21.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.488 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 34.3 p -122.07 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 112.203 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 57.4 t0 -115.19 113.11 23.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.933 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.401 HG21 ' N ' ' A' ' 186' ' ' CYS . 34.4 m -119.36 150.38 49.41 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.929 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 -175.6 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.484 2.123 . . . . 0.0 111.407 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.761 HD22 ' HB2' ' A' ' 191' ' ' ASP . 3.8 mp -95.27 119.47 33.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 0.0 110.709 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 192' ' ' LEU . . . -60.0 159.14 23.92 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.732 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.29 -29.03 9.54 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.613 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 126' ' ' LYS . 69.2 t80 -145.28 130.25 18.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.69 0.281 . . . . 0.0 111.395 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.699 ' HA ' HG11 ' A' ' 176' ' ' VAL . 4.2 p -133.78 130.08 55.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.093 0.473 . . . . 0.0 112.187 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HD2' ' HG2' ' A' ' 175' ' ' GLU . 85.4 mttt -99.73 121.62 41.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -105.31 131.35 52.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 172' ' ' LYS . 37.8 tt0 -114.63 109.52 47.93 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.68 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.436 ' HG3' HD12 ' A' ' 135' ' ' LEU . 88.2 Cg_endo -83.94 -168.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.648 2.232 . . . . 0.0 112.601 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -121.84 121.19 36.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.293 0.568 . . . . 0.0 109.982 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t 59.52 178.0 0.08 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.96 -11.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.695 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.08 -40.39 89.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.539 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.35 -40.27 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.647 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.436 HD12 ' HG3' ' A' ' 129' ' ' PRO . 9.6 mp -80.47 -10.03 59.75 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.776 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.89 -19.31 63.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.601 0.239 . . . . 0.0 111.277 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.6 mt -60.43 133.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.2 m -60.1 -39.98 88.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.417 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.04 76.5 71.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.32 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.719 ' O ' HD21 ' A' ' 144' ' ' LEU . 40.8 Cg_endo -68.79 -30.13 27.69 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.426 2.084 . . . . 0.0 112.071 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.12 99.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.635 ' O ' HG21 ' A' ' 147' ' ' VAL . 98.1 t -61.73 -49.67 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.588 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.719 HD21 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.2 -39.99 88.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.659 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.01 -46.35 89.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -60.57 -40.39 91.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 0.0 110.247 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.635 HG21 ' O ' ' A' ' 143' ' ' VAL . 62.4 t -63.12 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.169 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.04 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -66.5 -40.01 88.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.11 -40.04 92.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.676 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 96.7 m-85 -101.6 118.74 37.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.6 m -62.65 -39.92 95.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.361 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.554 ' CG2' HD22 ' A' ' 68' ' ' LEU . 33.7 p -125.56 149.84 47.99 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 111.737 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 192' ' ' LEU . 86.1 mt -116.02 121.72 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.428 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 94.3 m -119.95 130.07 54.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.002 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.705 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.8 t -59.95 -40.03 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 111.684 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.92 -38.61 76.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.304 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.514 ' CG ' HG21 ' A' ' 80' ' ' THR . 87.9 m-20 -69.54 134.85 49.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.552 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.486 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 6.1 m -102.53 119.93 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.465 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.542 HG13 ' CG1' ' A' ' 171' ' ' ILE . 46.7 pt -104.29 140.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 111.52 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -120.01 140.55 50.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.485 HG21 ' CG2' ' A' ' 147' ' ' VAL . 46.2 pt -128.01 140.4 49.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.993 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 50.8 m -105.36 119.97 40.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.422 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -122.59 119.97 32.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.423 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.497 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.03 40.14 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 13.6 81.86 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.252 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -116.72 139.28 50.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.808 0.304 . . . . 0.0 110.393 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.5 m -113.38 129.73 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.81 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.0 139.98 51.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.406 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.8 mttt -103.5 123.49 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.072 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.542 ' CG1' HG13 ' A' ' 160' ' ' ILE . 45.6 pt -124.51 131.82 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.947 0.403 . . . . 0.0 110.787 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 62.9 tttp -119.58 134.6 55.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.959 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.705 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -77.55 118.39 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.424 ' CD2' ' HG2' ' A' ' 175' ' ' GLU . 9.1 tt -62.62 -60.04 4.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.653 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.698 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 22.0 pt-20 -163.02 159.3 23.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.699 HG11 ' HA ' ' A' ' 125' ' ' VAL . 13.6 m -147.77 159.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.896 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.71 102.89 51.76 Favored Pre-proline 0 C--O 1.233 0.226 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.451 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 57.4 Cg_endo -104.71 0.24 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.166 3.244 . . . . 0.0 113.009 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.3 21.33 11.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -143.82 156.56 44.52 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.198 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 80.3 p -71.25 -20.15 62.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.485 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 60.8 m -59.99 -39.89 87.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 68.34 20.0 8.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.2 t -128.06 131.09 49.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.835 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -131.04 159.83 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.304 0.574 . . . . 0.0 112.514 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . 0.534 ' HB2' HG21 ' A' ' 153' ' ' THR . 35.2 t -129.56 126.05 37.65 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.26 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -148.63 83.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.814 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 85.3 mt -69.83 -40.06 78.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 190' ' ' THR . 86.5 tt0 -66.02 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.794 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 10.4 t -179.98 41.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.761 ' HB2' HD22 ' A' ' 121' ' ' LEU . 91.2 m-20 -98.38 7.75 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.473 ' CD2' HG12 ' A' ' 125' ' ' VAL . 12.5 tp -107.38 129.57 54.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 110.782 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.587 ' O ' HG11 ' A' ' 125' ' ' VAL . 38.3 t -96.79 120.4 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.285 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' THR . . . . . 0.578 ' HA ' HG11 ' A' ' 125' ' ' VAL . 59.6 p -99.99 145.57 27.72 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -130.01 140.05 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.961 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PHE . . . . . 0.442 ' CZ ' ' HG ' ' A' ' 144' ' ' LEU . 97.3 m-85 -101.15 120.29 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.468 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.42 118.51 12.72 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.346 0.424 0 C-N-CA 122.315 2.01 . . . . 0.0 112.139 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.809 0.337 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -119.96 139.96 51.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.683 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.5 t -120.37 130.0 54.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.142 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.97 76.78 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.353 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 64.69 28.83 13.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.966 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.4 p -130.04 140.0 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.718 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -120.05 129.71 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -119.74 124.7 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.65 -129.86 49.42 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.74 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.03 75.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.679 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.17 -40.43 71.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.394 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.06 -39.8 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 3.1 31.13 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.213 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' HE1' ' OD1' ' A' ' 16' ' ' ASN . 64.5 t80 -99.03 130.55 45.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.962 0.381 . . . . 0.0 110.198 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.91 125.11 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.418 ' OD1' ' HE1' ' A' ' 14' ' ' PHE . 98.4 m-20 -79.16 139.59 37.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.21 116.79 64.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.01 162.09 9.69 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.455 2.103 . . . . 0.0 112.149 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.595 ' O ' ' HA ' ' A' ' 117' ' ' THR . 92.3 mm-40 -100.09 123.6 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -119.59 128.08 53.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.181 0.515 . . . . 0.0 111.927 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.756 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 50.5 t80 -133.7 138.49 45.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.96 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -116.75 136.71 52.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.979 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.2 mt-10 -140.05 148.96 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.461 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -121.84 126.81 49.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.537 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 89.6 m-85 -149.94 161.72 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HG2' HD23 ' A' ' 111' ' ' LEU . 90.0 mtt180 -92.85 130.82 38.33 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.898 ' HB2' HD13 ' A' ' 96' ' ' LEU . 17.5 p -101.19 147.81 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.95 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -130.11 148.74 70.94 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.69 ' O ' ' HG2' ' A' ' 32' ' ' MET . 55.4 Cg_endo -70.68 109.81 2.58 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.25 1.967 . . . . 0.0 112.44 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.623 HG12 ' HB3' ' A' ' 95' ' ' TYR . 84.1 mt -60.01 -26.7 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.476 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' HA ' HH12 ' A' ' 38' ' ' ARG . . . -58.24 -38.62 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.123 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.69 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.1 ptm -68.99 -23.64 64.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.742 0.306 . . . . 0.0 111.07 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.435 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 98.9 mtp -61.9 139.81 58.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 111.235 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.694 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.08 141.58 55.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.645 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.95 -39.91 87.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -60.0 -39.7 86.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.527 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.694 HG12 ' HB2' ' A' ' 34' ' ' ASN . 49.4 pt -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 34' ' ' ASN . 22.0 ptt180 -128.29 160.1 33.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.588 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 88.1 tttt -100.46 134.56 43.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.07 -40.02 88.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.588 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 96.0 m-20 -61.5 -39.97 92.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.14 92.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.09 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.08 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.84 5.4 41.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.83 179.08 35.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.327 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -109.97 25.57 16.18 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.305 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 61.0 mttm -101.24 135.25 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.272 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.3 pt -120.24 156.54 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.256 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.561 ' C ' HD23 ' A' ' 50' ' ' LEU . 90.4 m-85 -100.25 130.48 46.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.569 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 49' ' ' PHE . 4.0 mm? -129.8 163.31 47.91 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.831 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.685 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 60.4 Cg_endo -77.1 149.45 28.52 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.244 1.963 . . . . 0.0 112.82 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.82 -23.8 62.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -59.97 -39.99 87.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.075 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.488 ' HB3' ' CD ' ' A' ' 23' ' ' GLU . . . -68.07 -41.28 82.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.996 0.426 . . . . 0.0 110.998 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 58.8 tp -60.95 -43.25 98.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.5 m -60.2 -40.27 89.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.54 -40.01 94.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.2 0.524 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' CD2' ' A' ' 21' ' ' PHE . 88.2 mt -60.05 -39.98 87.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.046 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.2 m -59.83 -40.01 87.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.123 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -59.97 -36.27 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.254 0.549 . . . . 0.0 110.092 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' HG ' HD12 ' A' ' 63' ' ' ILE . 12.4 tp -79.98 1.11 28.75 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.51 47.99 8.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.6 HD12 ' HG ' ' A' ' 61' ' ' LEU . 49.2 mm -86.46 121.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -70.21 140.0 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.717 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 40.3 t80 -88.25 147.14 39.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.716 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.717 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 15.0 Cg_exo -71.09 158.91 94.52 Favored 'Cis proline' 0 C--N 1.352 0.752 0 C-N-CA 124.567 -1.014 . . . . 0.0 113.138 0.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.541 ' HG2' HG23 ' A' ' 63' ' ' ILE . 68.0 mtt -95.52 139.45 31.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.476 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 117' ' ' THR . 82.4 mt -107.16 138.33 43.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.716 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.757 ' HB3' HG22 ' A' ' 114' ' ' ILE . 12.3 m-30 -120.09 140.02 51.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.044 0.449 . . . . 0.0 112.027 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HB3' ' OG ' ' A' ' 115' ' ' SER . 62.6 tttp -119.02 130.18 55.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.744 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.635 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -94.25 133.21 38.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 94.2 m -120.01 129.94 54.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.318 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.13 110.82 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.193 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -67.65 -40.0 84.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.531 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -39.92 87.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 104' ' ' LEU . 67.1 p -101.29 -13.48 18.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.487 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 0.25 26.11 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.795 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -100.4 139.95 35.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 72' ' ' THR . 13.1 m -121.7 117.42 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.021 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.414 HG23 ' OD1' ' A' ' 158' ' ' ASP . 72.0 p -100.97 155.87 17.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.434 ' CE1' ' NZ ' ' A' ' 70' ' ' LYS . 63.3 m80 -100.4 114.84 28.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 110.621 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.74 160.01 15.66 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.923 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.713 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.99 164.3 22.56 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.027 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -127.83 133.52 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 117.26 0.53 . . . . 0.0 112.266 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.5 tp -92.03 -78.83 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.911 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -150.78 160.02 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 76.1 m-85 -94.93 116.63 28.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 49' ' ' PHE . 47.7 pt -125.89 -8.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -99.55 103.68 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.379 . . . . 0.0 111.786 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.56 -39.98 92.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.293 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.65 -30.33 69.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.179 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.685 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.66 74.38 0.79 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.522 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -119.9 140.72 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.323 . . . . 0.0 110.775 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 25' ' ' PHE . 57.3 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.623 ' HB3' HG12 ' A' ' 30' ' ' ILE . 87.1 m-85 -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.545 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.898 HD13 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -137.6 156.85 74.58 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.917 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.672 ' HG2' ' HB2' ' A' ' 100' ' ' MET . 37.8 Cg_endo -68.8 158.54 57.43 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.045 1.83 . . . . 0.0 111.459 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.25 -41.13 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 48.1 p-90 -65.76 -38.55 89.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.672 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . 58.2 ttm -60.04 -40.12 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.358 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.597 ' CG ' HD22 ' A' ' 96' ' ' LEU . 97.8 mtp -59.89 -40.01 87.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.92 -40.06 94.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -66.89 -40.23 87.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.357 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.513 ' O ' HG22 ' A' ' 76' ' ' THR . 85.2 mt -70.58 -24.31 62.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.329 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.53 28.85 66.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.5 pt -117.75 142.87 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.409 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -96.39 159.96 30.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.746 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.7 138.42 8.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.564 2.176 . . . . 0.0 112.537 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.03 -9.98 75.53 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.765 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.5 m -71.58 150.04 45.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 26' ' ' ARG . 87.3 mt -75.68 144.65 41.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.544 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.0 tp -127.05 130.98 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.079 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.635 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 97.4 mt-30 -104.3 128.95 52.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 69' ' ' PHE . 91.9 mt -119.4 122.69 69.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 74.7 p -121.6 139.28 53.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.53 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.756 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 32.4 m -85.29 122.39 29.39 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 10.0 t -130.02 138.44 50.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.47 128.8 54.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.385 . . . . 0.0 110.344 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.52 152.25 46.92 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.731 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HB2' ' OE1' ' A' ' 179' ' ' GLU . 67.4 Cg_endo -73.84 16.46 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.187 1.925 . . . . 0.0 112.537 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.56 HD21 ' HB2' ' A' ' 191' ' ' ASP . 10.8 mp 64.57 108.32 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.369 . . . . 0.0 111.454 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.93 167.94 1.6 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.55 -28.2 9.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.675 0.238 . . . . 0.0 111.585 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -142.46 132.1 23.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.369 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.588 HG13 HG23 ' A' ' 194' ' ' THR . 2.7 p -131.33 130.17 62.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 111.327 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HE2' HD11 ' A' ' 174' ' ' LEU . 88.3 tttt -99.7 120.09 39.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.66 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.707 HD22 HG13 ' A' ' 173' ' ' ILE . 85.5 mt -111.44 140.49 45.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 111.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.889 ' HG3' ' HG3' ' A' ' 199' ' ' PRO . 45.0 tt0 -91.71 117.2 67.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.454 ' HG2' ' HD3' ' A' ' 199' ' ' PRO . 71.9 Cg_endo -75.03 159.79 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.516 2.144 . . . . 0.0 112.167 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -136.19 121.51 19.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.2 m 66.79 135.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.29 -21.13 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.87 -40.06 87.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.414 ' HE1' ' CE1' ' A' ' 196' ' ' PHE . 60.9 t80 -60.03 -40.06 88.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.756 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' N ' HD13 ' A' ' 135' ' ' LEU . 9.8 mp -80.72 -10.53 59.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.5 -10.22 59.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.281 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 138' ' ' SER . 84.0 mt -64.18 139.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.745 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.436 ' N ' HG21 ' A' ' 137' ' ' ILE . 83.1 p -59.96 -40.05 87.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.349 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -127.12 71.92 76.29 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.788 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.92 -32.99 93.12 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.631 2.221 . . . . 0.0 111.879 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.19 -40.2 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.12 97.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.3 t -60.06 -41.15 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 127' ' ' LEU . 3.1 tm? -60.3 -44.01 95.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.194 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.1 -39.93 87.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.6 -40.03 95.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.535 HG21 HD13 ' A' ' 162' ' ' ILE . 75.7 t -61.78 -42.95 96.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.01 -40.05 87.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.821 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -65.04 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.86 -40.02 96.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.518 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.434 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 96.9 m-85 -105.56 119.69 39.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.768 0.318 . . . . 0.0 111.179 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.442 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 42.7 p -69.83 -35.79 75.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.627 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 34.3 p -124.56 140.32 53.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 111.607 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.651 ' HB2' HG13 ' A' ' 185' ' ' ILE . 90.5 mt -122.1 130.17 53.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.6 m -119.78 140.12 51.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.015 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.533 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 98.3 t -60.05 -40.47 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.175 0.512 . . . . 0.0 110.652 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -74.74 -29.43 61.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.875 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.458 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 93.9 m-20 -78.45 140.14 38.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.93 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.68 120.07 55.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.921 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.482 HD13 ' CG1' ' A' ' 147' ' ' VAL . 46.7 pt -103.38 137.93 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.927 0.394 . . . . 0.0 111.379 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 170' ' ' LYS . 99.0 mt-10 -119.98 140.05 51.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.205 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 147' ' ' VAL . 6.0 tt -116.21 135.61 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.729 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.0 t -109.76 115.19 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -123.56 127.35 48.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.5 t30 51.73 40.05 26.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.687 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.56 9.8 86.51 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.975 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 163' ' ' SER . 59.5 mttm -111.1 144.1 40.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.8 m -114.75 130.79 56.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.79 140.07 51.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.67 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.417 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 62.4 mttp -100.32 121.62 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.552 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.432 ' HB ' HG13 ' A' ' 160' ' ' ILE . 85.3 mt -120.02 120.01 61.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.711 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.872 ' HE3' HD22 ' A' ' 174' ' ' LEU . 38.5 ttpt -116.2 125.55 52.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.707 HG13 HD22 ' A' ' 127' ' ' LEU . 4.9 mp -78.45 83.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.429 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.872 HD22 ' HE3' ' A' ' 172' ' ' LYS . 76.3 mt -59.99 -49.97 75.6 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 126' ' ' LYS . 98.9 mt-10 -152.39 138.99 18.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.024 0.44 . . . . 0.0 111.735 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.561 HG12 ' CG2' ' A' ' 125' ' ' VAL . 16.7 m -140.33 151.57 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.686 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -96.18 104.77 18.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 65.0 Cg_endo -100.3 167.42 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.286 2.657 . . . . 0.0 112.706 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.422 ' OE1' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.92 -0.08 40.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.4 p -139.83 159.79 41.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.007 0.432 . . . . 0.0 111.376 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.2 m -70.08 -10.3 58.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 t -57.76 -25.75 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.286 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 181' ' ' SER . 34.2 mmtp 60.02 39.97 19.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.756 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -128.29 139.69 52.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.64 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 154' ' ' LEU . 39.9 pt -127.32 131.53 70.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.534 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 23.3 m -139.97 119.95 13.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.08 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 187' ' ' VAL . 9.1 p -118.15 112.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.749 0.785 . . . . 0.0 111.171 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.593 HD13 ' HD2' ' A' ' 66' ' ' PRO . 55.5 mt -71.59 -60.72 2.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.547 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.08 -79.94 0.33 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.1 t -168.05 41.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.56 ' HB2' HD21 ' A' ' 121' ' ' LEU . 94.7 m-20 -88.76 2.09 54.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.548 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.584 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.1 tp -111.6 130.32 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 25.6 t -97.35 129.07 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.588 HG23 HG13 ' A' ' 125' ' ' VAL . 69.7 p -112.95 139.82 48.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.36 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.03 140.88 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.414 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 98.3 m-85 -100.02 121.11 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.48 110.48 28.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -62.52 110.3 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.256 1.97 . . . . 0.0 112.26 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.889 ' HG3' ' HG3' ' A' ' 128' ' ' GLU . 82.3 Cg_endo -99.32 -2.07 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.775 2.984 . . . . 0.0 112.555 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.593 HG11 ' H ' ' A' ' 202' ' ' TYR . 14.8 t -97.37 127.62 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -96.74 10.06 66.38 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.82 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.593 ' H ' HG11 ' A' ' 200' ' ' VAL . 94.7 m-85 -94.27 139.68 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 203' ' ' VAL . 9.5 p -120.48 130.41 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -95.27 130.04 33.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.67 153.67 70.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.5 2.133 . . . . 0.0 112.309 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -83.91 132.86 34.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 207' ' ' TYR . 53.2 p90 -99.97 120.45 39.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.811 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.031 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.828 0.346 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.02 -40.0 75.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.97 130.03 54.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.026 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.07 -8.03 24.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.758 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.03 139.97 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 110.991 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.5 m -106.8 139.86 40.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.7 m -89.99 140.05 30.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -60.04 -39.98 87.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.93 9.29 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.653 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.88 151.14 42.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.251 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.63 -74.19 0.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -143.77 160.08 41.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.43 -179.7 17.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.48 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.95 140.01 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 15' ' ' VAL . 8.7 p -114.7 127.18 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.992 0.425 . . . . 0.0 111.025 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.03 137.05 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.14 120.05 52.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 65.0 Cg_exo -50.85 120.46 6.63 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.345 2.03 . . . . 0.0 111.879 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.501 ' OE1' HD12 ' A' ' 63' ' ' ILE . 78.1 mt-30 -112.11 127.15 55.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.0 m -120.02 131.12 55.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.024 0.44 . . . . 0.0 111.755 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 27.7 t80 -124.11 141.06 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.301 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.04 130.58 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.16 0.505 . . . . 0.0 112.045 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -141.83 156.54 45.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.438 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -116.06 124.36 50.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.747 0.308 . . . . 0.0 110.692 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CB ' HG12 ' A' ' 94' ' ' VAL . 90.8 m-85 -136.03 150.92 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.681 ' HD2' ' HG2' ' A' ' 93' ' ' ARG . 7.4 ptp180 -82.24 143.76 31.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.842 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.746 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 46.5 t -98.99 123.14 43.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 112.175 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CB ' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m-85 -117.85 146.24 38.47 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 32' ' ' MET . 71.8 Cg_endo -77.72 105.27 2.0 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.717 2.278 . . . . 0.0 112.953 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.824 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.4 mt -61.39 -40.02 84.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.847 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.02 75.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.814 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.407 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . 97.7 mmm -68.34 -30.98 70.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.453 ' CE ' HG21 ' A' ' 37' ' ' ILE . 99.7 mmm -60.34 148.54 36.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -59.94 150.24 29.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.98 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.6 m-20 -59.93 -40.05 87.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -64.4 -40.19 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 HG21 ' CE ' ' A' ' 33' ' ' MET . 85.6 mt -70.77 -40.91 77.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.592 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.452 ' NH1' HG23 ' A' ' 37' ' ' ILE . 84.5 mmt-85 -122.58 140.08 53.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.798 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 9.8 mtpm? -80.58 149.35 29.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.1 -40.03 88.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.04 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.99 87.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.88 80.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.071 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.645 ' OD1' HG22 ' A' ' 30' ' ' ILE . 98.5 m-20 -60.03 -39.89 87.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.964 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.65 16.76 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.98 168.6 26.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.329 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.15 16.36 58.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.118 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.1 mttt -100.72 135.57 41.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 111.129 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.698 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.5 pt -118.75 150.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.201 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 90.1 m-85 -100.51 131.91 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.986 0.422 . . . . 0.0 111.018 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD21 HG21 ' A' ' 114' ' ' ILE . 5.4 mp -132.67 162.0 59.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 80.3 Cg_endo -77.28 153.05 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.166 1.91 . . . . 0.0 112.904 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.27 -18.31 55.47 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.145 2.563 . . . . 0.0 112.545 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.8 t -60.01 -40.0 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.18 82.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.16 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD23 ' CE1' ' A' ' 87' ' ' PHE . 81.5 mt -60.09 -41.37 92.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.695 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.1 m -60.02 -40.12 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.417 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -68.23 -39.99 82.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' CD2' HG13 ' A' ' 63' ' ' ILE . 95.7 mt -60.1 -39.88 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.158 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -59.97 -40.05 87.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 110.261 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -60.01 -39.96 87.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.508 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD11 ' CD1' ' A' ' 21' ' ' PHE . 88.6 mt -81.24 -0.07 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.821 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 39.96 19.29 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.48 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.501 HD12 ' OE1' ' A' ' 19' ' ' GLN . 41.4 mm -68.13 136.79 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.682 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -92.42 140.2 29.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.421 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.469 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 43.7 p90 -87.29 155.74 54.4 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 18.0 Cg_exo -66.88 162.49 74.09 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.758 0.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -95.0 130.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.821 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 117' ' ' THR . 65.0 mt -114.67 140.1 49.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.618 ' HB3' HG22 ' A' ' 114' ' ' ILE . 35.7 m-85 -120.01 140.08 51.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.734 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.654 ' HG2' HG13 ' A' ' 79' ' ' VAL . 86.6 tttt -117.03 130.38 56.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.978 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD12 HD23 ' A' ' 96' ' ' LEU . 50.9 mt -96.0 120.98 37.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 113' ' ' GLN . 97.3 m -104.03 120.06 40.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.28 115.38 30.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.605 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -67.83 -39.96 83.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.957 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 m -97.16 -14.96 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.34 -6.08 4.69 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.682 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.597 HH21 ' HB3' ' A' ' 157' ' ' ASP . 78.8 ttt180 -100.68 139.97 35.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 70' ' ' LYS . 47.3 t -118.08 119.99 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.3 p -99.93 159.62 14.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.621 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 74.5 m80 -101.74 115.14 29.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 110.655 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.21 158.26 18.93 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.939 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -91.68 157.07 24.28 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.593 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 8.4 p -127.97 134.07 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 117.294 0.547 . . . . 0.0 112.341 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.658 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 44.4 tp -91.84 -79.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.558 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -142.65 159.71 41.7 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.719 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.621 ' CE1' HD23 ' A' ' 55' ' ' LEU . 72.5 m-85 -97.72 116.39 29.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' A' ' 49' ' ' PHE . 47.9 pt -127.61 -4.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -84.58 98.17 10.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.417 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.87 -39.88 76.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 0.0 110.519 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.51 -30.67 71.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.363 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.0 42.97 1.14 Allowed Glycine 0 C--N 1.32 -0.323 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.684 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.681 ' HG2' ' HD2' ' A' ' 26' ' ' ARG . 29.4 mtm105 -117.15 150.9 37.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 112.151 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.771 HG13 HD22 ' A' ' 112' ' ' LEU . 14.8 p -128.78 145.03 36.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.219 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.824 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.1 m-85 -120.54 141.93 49.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.44 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD23 HD12 ' A' ' 71' ' ' LEU . 69.8 mt -120.21 142.49 33.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.925 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 101' ' ' MET . 51.3 Cg_exo -57.95 156.97 26.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.511 2.141 . . . . 0.0 111.836 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.03 -41.97 93.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.789 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.621 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 49.3 p-90 -70.0 -40.11 75.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.281 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.621 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 97.4 mtp -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.647 0.26 . . . . 0.0 111.037 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.2 mtp -60.06 -40.03 88.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.052 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 -40.01 94.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 110.496 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.966 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.09 -24.25 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.29 29.96 65.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.589 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.575 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 45.6 pt -116.29 144.8 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.333 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.478 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -97.4 160.2 29.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.605 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 7.8 Cg_endo -49.2 135.22 31.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.591 2.194 . . . . 0.0 112.136 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 -6.51 82.64 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.699 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.575 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 93.1 p -74.61 157.39 35.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 110.659 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.85 140.03 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.981 0.42 . . . . 0.0 111.02 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.771 HD22 HG13 ' A' ' 94' ' ' VAL . 61.6 tp -127.05 130.13 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.417 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.63 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 64.0 tt0 -107.7 120.24 41.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.618 HG22 ' HB3' ' A' ' 69' ' ' PHE . 86.1 mt -111.37 129.98 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.442 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.619 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 80.6 p -126.38 139.85 52.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 20' ' ' THR . 20.7 t -77.52 120.61 22.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.72 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.2 m -119.99 130.0 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.039 0.447 . . . . 0.0 111.899 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 96.5 m-20 -121.41 119.96 33.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.453 HG13 ' OG ' ' A' ' 184' ' ' SER . 16.7 m -120.93 150.02 52.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.78 142.92 16.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.907 2.405 . . . . 0.0 109.917 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.664 HD22 ' O ' ' A' ' 186' ' ' CYS . 9.8 mt -60.91 120.3 9.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.211 0.529 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.42 160.36 54.02 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 96.6 mt-30 -99.98 -19.94 16.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.154 -0.219 . . . . 0.0 111.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.13 134.96 23.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 111.729 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.864 HG11 ' HA ' ' A' ' 194' ' ' THR . 2.4 p -136.4 129.74 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.534 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 84.7 tttt -97.06 119.97 36.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.022 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.565 HD12 HD22 ' A' ' 144' ' ' LEU . 88.0 mt -113.55 130.44 56.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.223 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 10.2 tt0 -104.28 110.03 63.54 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 199' ' ' PRO . 89.7 Cg_endo -80.45 170.29 16.13 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.596 2.197 . . . . 0.0 112.437 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.471 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 94.1 mt-30 -132.67 122.86 25.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.981 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.498 ' N ' ' HB2' ' A' ' 199' ' ' PRO . 52.0 m 67.87 137.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.755 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.27 -18.26 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.685 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.01 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.527 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 66.4 t80 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.68 -2.0 58.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.7 mt -58.08 138.99 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.2 p -59.96 -37.65 80.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.555 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.4 m-20 -118.75 80.45 17.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.8 -32.01 30.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.623 2.216 . . . . 0.0 112.271 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -60.06 -40.84 90.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.09 98.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 147' ' ' VAL . 94.1 t -64.0 -42.55 96.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.565 HD22 HD12 ' A' ' 127' ' ' LEU . 3.1 tm? -59.91 -42.33 93.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.04 -42.11 93.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -59.97 -40.06 87.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.088 0.47 . . . . 0.0 110.59 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.673 HG23 HG23 ' A' ' 162' ' ' ILE . 57.7 t -61.46 -43.78 97.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.249 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.96 -40.24 92.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.803 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -63.32 -40.01 96.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.655 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -59.98 -39.97 87.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.313 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 88.5 m-85 -102.34 122.07 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.046 0.45 . . . . 0.0 111.676 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.426 ' C ' HD21 ' A' ' 68' ' ' LEU . 66.2 m -61.1 -39.98 91.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.218 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.586 ' HB ' HD21 ' A' ' 68' ' ' LEU . 8.2 t -128.05 140.76 51.77 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.983 0.421 . . . . 0.0 111.187 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.479 ' HB3' HG13 ' A' ' 185' ' ' ILE . 49.8 tp -114.8 121.5 43.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.449 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 53.4 m -119.38 140.29 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.744 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 90.0 t -59.98 -41.51 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.48 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.597 ' HB3' HH21 ' A' ' 78' ' ' ARG . 95.9 m-20 -70.05 -34.92 73.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.412 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 95.7 m-20 -73.58 139.34 45.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.252 0.549 . . . . 0.0 112.412 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.31 120.0 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.57 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.582 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 45.2 pt -106.96 138.42 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.043 0.449 . . . . 0.0 112.109 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.673 HG23 HG23 ' A' ' 147' ' ' VAL . 44.6 pt -127.34 141.37 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.663 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.2 t -110.73 117.86 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.179 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.459 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 54.0 t80 -120.45 120.28 35.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 56.21 40.05 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.577 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.96 9.89 86.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.089 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.9 mttt -112.74 137.42 51.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.785 0.293 . . . . 0.0 110.381 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.7 p -109.99 129.08 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 111.486 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.527 ' CD1' ' HD1' ' A' ' 134' ' ' PHE . 89.2 m-85 -120.06 140.0 51.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.592 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 97.7 mttt -101.12 124.57 47.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.247 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -119.27 128.95 54.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.006 0.432 . . . . 0.0 110.684 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.3 mp -83.63 109.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 128' ' ' GLU . 84.4 mt -67.89 -54.07 21.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 49.8 mt-10 -157.65 140.36 14.86 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.349 . . . . 0.0 111.212 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.637 HG11 ' HA ' ' A' ' 125' ' ' VAL . 4.5 m -140.05 154.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -110.18 102.59 51.59 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.494 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.494 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 63.6 Cg_endo -104.04 -2.69 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.144 3.229 . . . . 0.0 113.201 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 61.67 27.87 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.4 p -140.16 147.37 40.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.985 0.422 . . . . 0.0 111.186 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.7 m -61.66 -40.03 93.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.0 p -60.01 -20.18 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 50.5 mttt 57.23 39.8 28.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.0 111.432 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.453 ' OG ' HG13 ' A' ' 119' ' ' VAL . 41.4 t -121.62 140.81 51.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.153 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.494 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 17.7 pt -125.24 148.5 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.414 . . . . 0.0 111.475 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.664 ' O ' HD22 ' A' ' 121' ' ' LEU . 53.0 t -139.27 99.38 3.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.574 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 187' ' ' VAL . 11.7 p -117.45 113.27 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.783 0.801 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mt -77.26 -62.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.29 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.02 -79.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.4 t -161.18 42.87 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.739 0.304 . . . . 0.0 111.662 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.455 ' HB2' HD21 ' A' ' 121' ' ' LEU . 92.7 m-20 -89.74 6.13 42.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' A' ' 125' ' ' VAL . 31.8 tp -120.45 130.09 54.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.869 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 123' ' ' GLN . 33.0 t -90.45 121.89 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.864 ' HA ' HG11 ' A' ' 125' ' ' VAL . 52.6 p -100.99 151.98 21.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.463 0.649 . . . . 0.0 112.411 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -129.65 139.1 51.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.541 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.84 137.02 46.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.756 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB3' ' HD2' ' A' ' 198' ' ' PRO . . . -121.18 165.88 17.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.365 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 197' ' ' ALA . 13.7 Cg_endo -56.05 124.67 16.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.143 1.895 . . . . 0.0 111.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.498 ' HB2' ' N ' ' A' ' 131' ' ' SER . 92.3 Cg_endo -80.66 129.46 7.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.597 2.198 . . . . 0.0 112.916 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.24 140.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 -118.68 1.87 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.247 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.77 130.04 46.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.67 120.31 64.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -100.32 120.09 57.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.069 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.3 119.95 6.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.431 2.087 . . . . 0.0 112.296 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -97.14 133.25 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -100.03 120.08 39.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.825 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -119.93 140.03 51.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.7 t -120.16 130.1 54.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.77 167.5 34.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.248 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -120.02 135.3 54.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 m -60.13 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.758 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.07 34.33 23.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -63.13 -39.99 96.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.51 159.77 33.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.174 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -11.55 74.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.562 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 -15.91 6.87 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.296 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -120.48 130.02 54.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.915 0.358 . . . . 0.0 110.95 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.87 142.17 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.83 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -120.03 139.93 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.613 0.244 . . . . 0.0 110.676 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -100.68 119.99 39.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.63 119.78 51.48 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.273 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 46.3 Cg_exo -57.51 152.83 45.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.329 2.019 . . . . 0.0 112.092 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 96.5 mt-30 -105.45 120.44 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 116' ' ' SER . 72.6 p -121.17 129.79 53.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 111.689 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 78.6 t80 -119.85 139.43 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -106.26 134.86 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.137 0.494 . . . . 0.0 111.976 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.0 mt-10 -141.1 151.37 43.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.92 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -120.53 136.78 54.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.992 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -152.57 159.97 43.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.848 0.356 . . . . 0.0 111.082 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 94' ' ' VAL . 89.2 mtt180 -84.35 140.31 31.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 17.3 t -97.66 125.75 42.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.571 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.45 149.79 44.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.298 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.93 100.47 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.923 2.416 . . . . 0.0 112.326 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.573 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 83.6 mt -60.5 -40.1 83.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 110.406 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 98' ' ' GLN . . . -60.01 -32.54 70.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.294 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.2 ttm -66.98 -39.02 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.407 ' HE2' HG23 ' A' ' 37' ' ' ILE . 94.8 mtp -60.9 151.72 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.45 143.8 48.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.184 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.8 m-20 -60.03 -40.05 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.072 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -60.81 -40.04 91.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 110.918 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HG23 ' HE2' ' A' ' 33' ' ' MET . 85.8 mt -68.18 -40.06 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.4 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 35' ' ' ASP . 39.6 mmt180 -116.34 140.18 49.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 111.965 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.83 139.99 55.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -60.11 -39.08 84.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -39.95 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.821 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.93 87.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.404 HD22 HG23 ' A' ' 30' ' ' ILE . 28.0 m120 -60.03 -41.4 92.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.14 6.92 38.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.714 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.61 171.9 29.54 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.534 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -99.45 18.29 56.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.211 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.3 mttt -100.24 131.41 46.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.2 pt -119.8 151.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.934 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 88' ' ' ILE . 94.4 m-85 -101.81 131.38 48.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.145 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.724 ' HG ' HG22 ' A' ' 94' ' ' VAL . 5.0 mp -135.86 160.95 65.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 0.0 111.814 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.581 ' CG ' ' HA2' ' A' ' 92' ' ' GLY . 32.3 Cg_exo -63.78 135.68 49.65 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.91 2.406 . . . . 0.0 112.364 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.456 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 37.0 Cg_exo -60.4 -20.12 61.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.697 2.265 . . . . 0.0 112.916 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.3 m -60.01 -40.52 89.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.872 0.368 . . . . 0.0 110.781 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.75 -39.9 93.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.269 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 59.1 tp -59.97 -40.21 88.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.113 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -59.98 -39.98 87.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -60.76 -39.95 90.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.378 0.609 . . . . 0.0 110.376 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD21 ' OG ' ' A' ' 116' ' ' SER . 87.7 mt -60.04 -39.5 86.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.8 t -57.76 -38.31 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.3 mtt -60.0 -37.06 78.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.403 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 HD11 ' CD1' ' A' ' 21' ' ' PHE . 87.6 mt -80.08 -0.06 34.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 59.95 40.06 19.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.697 0.284 . . . . 0.0 111.588 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -86.72 120.07 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 110.436 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -83.56 151.2 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.733 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.447 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 32.6 p90 -87.1 159.85 50.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HG2' HD13 ' A' ' 188' ' ' ILE . 23.4 Cg_exo -65.65 147.53 73.14 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.866 0.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.6 mtt -95.58 138.92 32.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.775 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' A' ' 117' ' ' THR . 32.3 mt -114.05 139.34 49.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.527 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.6 m-85 -131.55 145.42 51.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.235 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' HB3' ' ND1' ' A' ' 81' ' ' HIS . 22.4 pttp -122.21 140.32 52.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 HD11 ' A' ' 96' ' ' LEU . 88.6 mt -98.58 128.09 44.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 113' ' ' GLN . 23.0 p -105.17 136.4 44.74 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.07 113.79 22.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.724 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -65.92 -39.07 90.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.814 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.89 -40.09 87.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.924 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 104' ' ' LEU . 74.3 p -102.96 -14.49 16.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.94 41.49 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.744 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -101.22 140.16 35.89 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.022 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.502 HG23 ' HA ' ' A' ' 72' ' ' THR . 41.6 t -119.99 121.41 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.685 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 80.1 p -102.45 156.34 17.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.647 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 93.0 m-70 -101.76 114.85 29.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.37 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.24 167.1 17.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.756 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.636 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.99 162.91 26.49 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.539 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 84' ' ' VAL . 8.0 p -129.67 131.99 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 111.709 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.67 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.2 tp -93.38 -80.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.115 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.9 161.04 43.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 89.1 m-85 -95.3 116.48 28.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.468 HD13 ' CD1' ' A' ' 49' ' ' PHE . 46.1 pt -125.57 -4.62 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -88.84 98.12 11.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.136 0.493 . . . . 0.0 111.557 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.07 75.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.96 -30.35 69.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.887 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.581 ' HA2' ' CG ' ' A' ' 51' ' ' PRO . . . 112.35 49.3 0.61 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.611 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -121.1 149.48 42.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.84 0.353 . . . . 0.0 111.558 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.724 HG22 ' HG ' ' A' ' 50' ' ' LEU . 7.4 p -128.93 142.82 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.002 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 97.5 m-85 -114.02 137.6 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 101' ' ' MET . 1.8 tp -119.57 137.57 25.65 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' A' ' 96' ' ' LEU . 52.6 Cg_exo -53.25 145.55 43.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.45 2.1 . . . . 0.0 112.372 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 59.0 tt0 -60.05 -43.66 95.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.829 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.541 ' CH2' ' HE3' ' A' ' 100' ' ' MET . 59.1 p-90 -69.98 -41.18 74.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.541 ' HE3' ' CH2' ' A' ' 99' ' ' TRP . 43.8 tpp -61.18 -40.32 93.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.563 ' HA ' HD23 ' A' ' 96' ' ' LEU . 57.1 ttm -60.06 -41.23 91.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.124 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.1 -40.07 94.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.519 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.02 -40.07 96.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 76' ' ' THR . 85.5 mt -69.44 -23.63 63.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.216 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.76 34.85 29.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.998 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.408 HG13 ' CG ' ' A' ' 101' ' ' MET . 45.1 pt -119.77 146.99 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -95.8 157.15 36.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.428 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.39 138.07 30.83 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.399 2.066 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.9 75.74 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.15 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 53.6 m -71.03 149.98 46.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.096 0.448 . . . . 0.0 110.669 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.4 tt -71.04 140.15 50.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 110.681 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 59.3 tp -126.76 130.46 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.61 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 93.7 mt-30 -109.19 130.31 55.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.527 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 18.7 tt -118.29 128.38 75.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 111.443 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.528 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 42.3 t -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.859 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.625 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 61.4 m -70.11 130.24 41.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.7 m -120.08 130.03 54.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.831 0.348 . . . . 0.0 111.086 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 98.0 m-20 -119.33 120.04 35.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.227 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.442 HG11 ' OG ' ' A' ' 184' ' ' SER . 34.9 m -112.15 153.62 44.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.911 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.28 17.69 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.823 2.348 . . . . 0.0 112.292 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.521 HD22 ' OG1' ' A' ' 190' ' ' THR . 0.2 OUTLIER 70.11 100.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.974 0.416 . . . . 0.0 111.968 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -57.02 156.82 12.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.244 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.24 -27.22 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -139.56 130.92 26.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.971 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.672 ' HA ' HG13 ' A' ' 176' ' ' VAL . 2.6 p -130.02 130.19 65.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.211 0.529 . . . . 0.0 111.548 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.681 ' HE2' HD12 ' A' ' 174' ' ' LEU . 87.9 tttt -99.42 120.73 40.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.503 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.76 135.51 49.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.408 . . . . 0.0 111.57 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.869 ' HB2' ' HG ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -107.39 119.92 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.905 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 198' ' ' PRO . 91.2 Cg_endo -81.46 169.1 15.86 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.16 1.907 . . . . 0.0 111.573 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -138.25 121.62 17.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.5 OUTLIER 63.32 26.74 15.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 131' ' ' SER . 2.9 m 36.84 27.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.372 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.468 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 96.2 m-20 -68.54 -39.95 80.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 140' ' ' PRO . 64.0 t80 -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.61 -24.13 63.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.423 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.4 mt -57.5 139.01 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.83 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -60.28 -40.04 88.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.57 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -121.68 75.16 35.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.772 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.465 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 42.3 Cg_endo -69.07 -34.93 15.73 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.786 2.324 . . . . 0.0 112.232 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.64 -40.65 92.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.49 98.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.551 ' O ' HG21 ' A' ' 147' ' ' VAL . 70.8 t -61.14 -42.58 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.1 tm? -60.09 -42.48 94.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.28 -42.27 95.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.56 -40.04 95.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 143' ' ' VAL . 95.5 t -62.01 -40.32 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.004 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.31 -40.48 90.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.03 -39.96 87.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.531 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.79 -40.03 93.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.106 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.404 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.6 m-85 -103.0 121.42 42.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.518 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.475 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 74.0 m -61.15 -40.02 92.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.544 ' HB ' HD23 ' A' ' 68' ' ' LEU . 4.8 t -136.35 147.8 47.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.355 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.9 mt -121.39 138.47 54.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.364 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' A' ' 81' ' ' HIS . 54.6 m -116.08 136.08 53.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' A' ' 176' ' ' VAL . 7.2 p -59.81 -39.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.485 ' N ' HG13 ' A' ' 156' ' ' VAL . 4.5 p-10 -83.06 -21.16 33.85 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.613 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.7 t0 -78.95 136.28 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.515 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 159' ' ' VAL . 15.7 m -100.34 120.66 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.167 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.15 138.93 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.284 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 96.5 mt-10 -120.05 139.99 51.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 147' ' ' VAL . 45.6 pt -129.31 140.04 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.3 t -110.13 114.5 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.378 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.13 122.3 40.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.595 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.2 t30 56.41 39.99 29.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.11 12.31 84.19 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.126 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.676 ' O ' ' HA ' ' A' ' 163' ' ' SER . 58.3 mttm -118.19 139.07 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.903 0.352 . . . . 0.0 110.664 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.5 p -109.53 133.62 52.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.1 m-85 -119.99 138.65 53.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.402 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 99.6 mttt -104.76 122.66 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.02 119.97 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.393 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -115.39 130.03 56.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.682 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -81.71 104.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.947 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.869 ' HG ' ' HB2' ' A' ' 128' ' ' GLU . 80.7 mt -60.53 -48.96 79.47 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.1 mt-10 -158.89 139.91 12.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.864 HG22 ' HB ' ' A' ' 156' ' ' VAL . 11.1 m -143.23 151.62 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.957 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -116.93 103.16 52.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.395 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 97.3 Cg_endo -100.08 12.32 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.734 2.956 . . . . 0.0 112.278 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 80.7 tt0 60.75 20.01 10.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.451 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 79.3 p -146.78 152.82 39.4 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.7 m -70.0 -18.56 63.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.548 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.7 t -59.9 -25.52 65.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 60.18 40.04 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 0.0 110.89 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.442 ' OG ' HG11 ' A' ' 119' ' ' VAL . 28.8 p -122.38 142.65 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.224 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 44.9 pt -130.18 140.03 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.456 ' SG ' HD12 ' A' ' 68' ' ' LEU . 44.1 t -134.65 138.11 44.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.042 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.597 HG21 ' HB ' ' A' ' 190' ' ' THR . 8.2 p -170.11 67.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.3 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.535 HD13 ' HG2' ' A' ' 66' ' ' PRO . 84.8 mt -70.0 -40.02 78.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.53 -10.08 8.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.686 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.597 ' HB ' HG21 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -78.95 174.49 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.42 118.35 36.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.399 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.591 HD22 HG11 ' A' ' 187' ' ' VAL . 25.2 tp -120.4 138.01 54.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.134 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 26.4 t -92.43 119.99 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.406 HG23 ' CG1' ' A' ' 125' ' ' VAL . 65.9 p -120.87 140.61 51.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.339 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -121.15 139.44 53.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.326 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -105.41 120.0 40.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -132.64 107.65 13.05 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.586 ' HA ' ' HG2' ' A' ' 129' ' ' PRO . 71.0 Cg_endo -73.71 120.34 6.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 113.149 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.578 ' HG3' ' CG ' ' A' ' 128' ' ' GLU . 45.0 Cg_endo -93.59 6.75 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.303 2.668 . . . . 0.0 112.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 29.6 m -89.32 119.93 37.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.043 0.449 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -167.55 -107.28 0.2 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.382 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.02 131.84 44.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.26 129.96 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 205' ' ' PRO . 11.2 tt0 -82.78 129.67 61.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.408 ' HD2' ' HG3' ' A' ' 204' ' ' GLU . 27.2 Cg_endo -61.86 82.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.341 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -96.9 132.84 42.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -69.87 139.96 53.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.02 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.93 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.722 0.296 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -100.2 130.01 46.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.2 m -128.44 143.03 50.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 0.0 111.099 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.91 96.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.412 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.88 140.01 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 110.556 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.6 p -87.2 146.25 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.029 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.4 m -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.9 -39.97 87.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.712 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.86 -166.08 42.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.523 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.93 -119.24 14.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.657 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.15 -9.93 75.78 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.672 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -100.06 10.6 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.287 . . . . 0.0 111.167 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.4 168.4 54.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.658 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 181' ' ' SER . 87.3 m-85 -120.03 140.7 50.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.96 -40.04 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 179' ' ' GLU . 97.0 m-20 -100.48 119.93 39.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -108.15 120.0 48.13 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.253 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.78 154.94 49.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.301 2.001 . . . . 0.0 111.809 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 97.0 mt-30 -103.27 123.25 46.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.722 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 116' ' ' SER . 9.0 t -129.98 139.93 50.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 115' ' ' SER . 69.2 t80 -121.58 139.99 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.558 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -104.67 130.41 52.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.84 147.62 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.0 120.11 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HB2' HG12 ' A' ' 94' ' ' VAL . 47.2 m-85 -140.69 151.77 44.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.997 0.427 . . . . 0.0 111.221 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.06 131.78 35.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 19.3 p -90.17 143.4 26.81 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.304 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.538 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 43.6 m-85 -138.37 157.22 72.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.203 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.91 109.11 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.507 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 95' ' ' TYR . 85.6 mt -60.15 -40.03 82.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -59.69 -23.79 63.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.3 ttp -68.2 -36.62 79.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 97.0 mtp -59.91 141.8 54.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.11 151.9 25.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.702 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.554 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -54.03 -29.96 45.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.282 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 ttt-85 -60.05 -39.9 87.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.531 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -113.06 10.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.143 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.617 ' NE ' ' HA ' ' A' ' 31' ' ' ALA . 41.7 ttt180 -113.59 129.99 56.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.008 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.25 129.21 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.36 -40.21 89.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.161 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -64.24 -40.0 95.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.89 91.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.428 HD22 ' NE ' ' A' ' 38' ' ' ARG . 92.5 m-20 -59.97 -40.18 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.36 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.92 2.22 34.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.676 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.94 175.3 32.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.148 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.53 10.49 61.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.392 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HD3' HD13 ' A' ' 85' ' ' LEU . 63.7 mttp -80.54 129.78 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.727 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.7 pt -120.06 154.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.446 ' CD1' HD12 ' A' ' 88' ' ' ILE . 96.0 m-85 -99.33 134.46 42.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.629 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.4 mm? -131.16 160.08 68.65 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.609 ' CB ' ' HA2' ' A' ' 92' ' ' GLY . 97.6 Cg_endo -83.51 149.44 12.97 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.002 1.801 . . . . 0.0 112.735 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.2 Cg_exo -61.15 -29.1 86.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.116 2.544 . . . . 0.0 112.861 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.94 87.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.26 86.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.094 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 87' ' ' PHE . 58.5 tp -60.03 -39.99 87.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -60.03 -40.08 88.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 98.8 mttt -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.68 -39.87 92.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.612 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -59.75 -37.54 79.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.84 -35.94 75.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.448 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.1 mt -79.98 -3.88 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.238 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 60.0 40.13 19.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.794 0.33 . . . . 0.0 111.538 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.2 mt -76.23 129.94 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.999 0.428 . . . . 0.0 111.09 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -73.3 141.93 47.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.376 0.608 . . . . 0.0 111.892 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.449 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.1 p90 -87.63 153.62 52.94 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.78 152.18 94.68 Favored 'Cis proline' 0 C--N 1.35 0.611 0 C-N-CA 123.486 -1.464 . . . . 0.0 112.912 0.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 67.5 mtt -84.69 140.49 31.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.81 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.689 ' HB2' ' O ' ' A' ' 117' ' ' THR . 67.1 mt -111.2 137.33 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.081 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.536 ' HD2' ' HB ' ' A' ' 84' ' ' VAL . 50.6 m-85 -130.59 143.74 50.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.069 0.461 . . . . 0.0 111.54 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.609 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 4.5 ttpm? -120.03 137.44 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.64 131.19 43.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.9 m -119.71 130.01 54.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.28 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.73 114.26 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.53 -39.98 89.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.4 -40.04 89.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.211 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -102.67 -9.09 20.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.717 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.95 12.85 16.69 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.85 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.65 140.34 37.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.698 0.285 . . . . 0.0 110.564 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.88 119.79 61.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.063 0.459 . . . . 0.0 111.727 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.451 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 76.4 p -105.99 143.4 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.51 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.609 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 80.0 m80 -93.76 114.55 26.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.752 0.311 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.13 159.98 13.78 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.817 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.727 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.91 162.84 26.55 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.386 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 10.8 p -124.74 130.61 73.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.0 112.19 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.1 tp -90.14 -79.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.22 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.01 160.13 42.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 86.1 m-85 -92.78 116.46 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.915 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 49' ' ' PHE . 46.2 pt -122.99 -6.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB3' ' HG2' ' A' ' 93' ' ' ARG . . . -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.723 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -39.99 76.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.887 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -67.22 -30.77 70.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.609 ' HA2' ' CB ' ' A' ' 51' ' ' PRO . . . 110.99 67.81 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.848 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' HG2' ' HB3' ' A' ' 89' ' ' ALA . 22.5 ptt-85 -135.05 154.92 51.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 111.158 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 HG12 ' HB2' ' A' ' 25' ' ' PHE . 11.9 p -129.19 140.17 49.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.776 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.07 139.96 51.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.262 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 27' ' ' CYS . 1.7 pt? -131.17 156.28 80.35 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.685 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 57.9 Cg_endo -68.12 160.01 50.62 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.712 2.275 . . . . 0.0 112.094 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.22 -40.25 89.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 50.5 p-90 -65.19 -40.06 93.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.886 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.463 ' HE2' ' CZ2' ' A' ' 99' ' ' TRP . 61.0 mtt -63.44 -40.18 96.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.462 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 ttp -60.06 -40.49 89.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.582 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.8 m -68.39 -39.96 81.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.697 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.97 -24.01 63.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.25 30.18 69.69 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.125 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.46 ' HB ' ' HG ' ' A' ' 110' ' ' SER . 45.7 pt -119.18 149.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.491 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 36.1 mt-30 -95.86 159.85 31.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.608 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 26.6 Cg_endo -62.61 0.09 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.424 2.083 . . . . 0.0 113.147 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.94 -20.38 9.93 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.46 ' HG ' ' HB ' ' A' ' 106' ' ' ILE . 80.3 p -80.8 160.13 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 111.09 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.2 151.74 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 59.5 tp -120.13 130.88 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.573 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.9 123.31 47.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.871 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 HD11 ' A' ' 50' ' ' LEU . 20.5 tt -119.5 121.65 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 46.6 t -120.04 126.53 51.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.677 ' O ' ' HA ' ' A' ' 20' ' ' THR . 34.9 t -63.69 131.0 46.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.689 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.6 m -120.0 130.01 54.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 96.1 m-20 -118.55 125.44 49.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.139 0.495 . . . . 0.0 110.438 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.419 ' C ' ' H ' ' A' ' 121' ' ' LEU . 33.6 m -114.2 150.9 44.43 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.589 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 73.0 Cg_endo -73.89 18.55 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.834 2.356 . . . . 0.0 112.531 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.468 HD13 ' OG1' ' A' ' 190' ' ' THR . 6.1 tt 61.23 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.874 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.41 34.01 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.615 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.02 -16.8 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -140.0 142.18 36.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.816 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.812 HG13 ' HG ' ' A' ' 192' ' ' LEU . 8.4 p -137.71 136.09 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.722 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 29.2 mmtm -98.91 124.7 44.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.431 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.491 HD22 HG13 ' A' ' 173' ' ' ILE . 83.7 mt -113.73 131.0 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.013 0.435 . . . . 0.0 111.598 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -104.49 119.33 54.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 94.9 Cg_endo -77.83 160.39 30.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -125.93 121.4 33.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.983 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t 56.77 160.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.155 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 m -71.89 -21.59 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -59.98 -40.09 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.702 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.75 -40.22 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.046 0.451 . . . . 0.0 110.496 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.06 -0.41 57.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.298 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -60.01 -40.04 87.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.466 HG23 ' H ' ' A' ' 139' ' ' ASP . 84.8 mt -55.21 139.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.938 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.9 p -60.18 -40.66 90.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.466 ' H ' HG23 ' A' ' 137' ' ' ILE . 1.2 m-20 -120.94 76.68 29.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.33 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.94 -28.69 16.05 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.425 2.084 . . . . 0.0 111.927 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.71 -40.05 93.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.93 98.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.18 -40.29 88.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.522 ' C ' HD12 ' A' ' 144' ' ' LEU . 3.0 tm? -60.36 -41.26 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.28 88.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.274 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.72 -39.96 95.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 110.367 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.449 HG13 ' CG2' ' A' ' 162' ' ' ILE . 84.5 t -61.75 -40.02 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.98 -40.17 88.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -62.77 -40.01 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.99 93.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.934 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.18 121.84 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 111.071 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.497 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 36.1 p -70.07 -39.93 75.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.598 HG22 HD21 ' A' ' 68' ' ' LEU . 11.1 p -119.37 138.59 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.418 ' HA ' HD21 ' A' ' 154' ' ' LEU . 87.0 mt -124.0 124.87 43.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.4 ' OG1' ' ND1' ' A' ' 81' ' ' HIS . 22.8 m -121.36 139.17 53.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.56 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.879 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 31.1 m -60.19 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.325 0.583 . . . . 0.0 111.336 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -68.23 -40.06 82.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.621 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.91 140.24 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.126 0.488 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.3 p -105.18 121.88 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.286 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.3 pt -105.96 138.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 111.277 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.453 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.0 mt-10 -120.07 140.12 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.504 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.449 ' CG2' HG13 ' A' ' 147' ' ' VAL . 45.9 pt -129.72 141.6 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.099 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 17.8 m -107.5 120.87 43.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 111.569 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.496 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 65.0 t80 -120.67 119.56 33.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.223 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.496 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 12.4 m120 54.44 40.11 31.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.657 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.75 83.73 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.691 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -114.37 139.25 49.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.756 0.278 . . . . 0.0 110.473 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.563 HG22 ' OG ' ' A' ' 163' ' ' SER . 68.1 p -108.89 127.64 54.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.331 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.02 139.98 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.483 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.453 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 98.2 mttt -99.99 123.37 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.875 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.98 119.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.833 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -120.11 126.65 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.769 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.879 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -80.95 111.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.0 tt -59.02 -58.26 9.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.722 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.3 tt0 -158.89 141.47 14.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.263 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.633 HG11 ' HA ' ' A' ' 125' ' ' VAL . 18.6 m -130.05 160.02 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.94 103.94 22.56 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.0 Cg_endo -103.48 166.81 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.768 2.978 . . . . 0.0 112.125 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.589 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.9 mt-10 -99.96 3.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 159.88 41.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 69.6 p -70.11 -10.14 57.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.07 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -59.84 -19.94 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 111.114 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 56.65 39.82 29.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.029 0.442 . . . . 0.0 111.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -129.94 141.91 50.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.908 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 176' ' ' VAL . 45.3 pt -128.51 141.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.108 0.48 . . . . 0.0 112.033 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.406 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.8 t -129.22 125.73 37.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.093 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.6 ' CG1' HD21 ' A' ' 192' ' ' LEU . 11.0 p -155.05 64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.049 0.452 . . . . 0.0 111.395 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 152' ' ' SER . 85.0 mt -68.65 -39.98 81.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.137 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.13 -10.12 9.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.107 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.468 ' OG1' HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -81.38 176.34 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.248 0.547 . . . . 0.0 111.404 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.56 117.2 33.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.316 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.812 ' HG ' HG13 ' A' ' 125' ' ' VAL . 30.9 tp -120.49 137.25 54.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.754 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.97 121.16 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.368 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 62.6 p -115.69 144.27 44.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.799 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -126.5 140.07 52.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.631 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -103.33 126.56 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.416 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.481 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -127.75 105.25 20.86 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.518 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.2 119.41 6.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.419 2.08 . . . . 0.0 112.464 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -93.16 -5.1 3.04 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.872 2.381 . . . . 0.0 112.435 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.69 139.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.84 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -99.92 130.32 46.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.34 140.07 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.97 128.45 45.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 112.11 3.03 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -86.16 132.88 33.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.848 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.0 127.83 46.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.88 -179.882 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.86 0.362 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.03 139.99 51.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.794 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -121.86 139.98 52.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.56 -139.8 11.24 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.57 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -66.5 140.23 57.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.834 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t -119.75 138.5 53.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.0 p -60.09 -39.1 84.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -118.06 140.0 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.99 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.96 6.61 58.75 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.042 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.85 16.24 63.8 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.49 19.94 70.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.395 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -113.94 129.59 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 179.59 52.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.471 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.98 140.01 51.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.737 0.303 . . . . 0.0 111.065 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.6 121.25 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.054 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -107.65 119.98 40.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.077 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 ttp -100.56 119.86 57.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 141.7 97.78 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.252 1.968 . . . . 0.0 112.075 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -108.69 128.87 55.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.532 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.5 m -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.7 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 20.1 t80 -133.65 130.26 38.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HA ' ' HG ' ' A' ' 115' ' ' SER . 86.4 tt0 -118.42 134.26 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 112.04 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.4 mt-10 -139.26 159.12 42.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.894 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -121.26 136.88 54.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.439 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 94.7 m-85 -147.13 160.08 42.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.338 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -89.13 121.95 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 110.408 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.669 ' HB2' HD22 ' A' ' 96' ' ' LEU . 32.0 p -95.44 141.76 28.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.569 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 53.8 m-85 -123.98 148.35 56.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.508 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 16.4 Cg_exo -68.87 108.74 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.788 2.325 . . . . 0.0 112.305 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.586 ' CG2' ' HD2' ' A' ' 38' ' ' ARG . 91.2 mt -59.97 -38.77 77.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.206 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.02 30.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.454 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 70.6 mtm -67.88 -39.58 83.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.827 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . 93.1 mtp -60.19 144.78 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.904 0.383 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.0 m-20 -60.05 145.56 46.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.799 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -60.05 -39.89 87.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.103 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -59.95 -40.04 87.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.7 mt -83.72 -1.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.827 ' HD3' ' HB2' ' A' ' 33' ' ' MET . 44.4 mtm180 -119.48 155.51 31.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.982 0.42 . . . . 0.0 111.882 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.63 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 87.6 tttt -100.56 131.49 46.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.332 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.634 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.63 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.2 m-20 -62.58 -39.96 95.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.95 95.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.03 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.284 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.4 -0.0 30.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.563 0.221 . . . . 0.0 111.403 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -99.78 -179.6 30.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.62 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.11 23.39 34.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.134 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.4 mttt -81.1 126.97 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.968 0.413 . . . . 0.0 111.752 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.685 HG12 ' O ' ' A' ' 83' ' ' GLY . 49.3 pt -119.99 150.04 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.86 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -102.71 133.92 46.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.9 mp -138.13 161.69 58.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.265 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 59.7 Cg_endo -71.98 149.16 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.114 1.876 . . . . 0.0 112.238 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.98 -23.66 67.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.589 2.192 . . . . 0.0 112.591 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.6 p -60.14 -39.9 87.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.71 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.07 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD22 ' CD1' ' A' ' 87' ' ' PHE . 58.6 tp -63.9 -40.12 95.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.835 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.0 m -60.02 -41.33 91.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 111.049 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 88.1 tttt -61.95 -39.87 93.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.321 0.581 . . . . 0.0 110.382 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 21' ' ' PHE . 88.3 mt -59.99 -39.41 85.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.638 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.1 m -59.96 -39.06 84.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 ttm -59.98 -38.45 82.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.772 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.86 -3.87 43.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.643 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.06 40.03 19.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.649 HG22 ' CE ' ' A' ' 67' ' ' MET . 11.0 tt -77.59 137.21 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.712 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -70.08 140.01 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.014 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 30.7 p90 -95.25 157.35 36.52 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.359 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HB2' ' CD1' ' A' ' 188' ' ' ILE . 15.6 Cg_exo -69.55 171.34 53.25 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.746 -1.356 . . . . 0.0 112.77 0.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 63' ' ' ILE . 81.7 mmm -85.92 139.87 30.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.092 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.708 ' O ' ' HA ' ' A' ' 116' ' ' SER . 64.4 mt -108.34 128.42 54.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . 13.5 m-85 -121.95 140.04 52.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.638 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 50.2 pttt -126.38 138.22 53.53 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.247 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.586 HD21 HD13 ' A' ' 112' ' ' LEU . 8.1 mp -99.0 120.31 39.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.42 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.58 ' CG2' ' HB2' ' A' ' 113' ' ' GLN . 7.6 t -109.62 122.97 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 111.264 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.25 28.16 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.041 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -60.38 -39.99 89.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.894 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -103.27 -10.66 18.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.87 12.19 41.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.302 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -103.47 133.06 49.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.416 ' CG2' ' OG1' ' A' ' 72' ' ' THR . 39.8 t -119.96 119.71 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.204 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.4 p -103.12 160.03 15.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.192 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 80.6 m80 -100.65 114.28 27.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.119 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.31 169.72 19.86 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.833 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.06 163.64 23.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.179 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 12.2 p -127.88 130.02 69.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.189 0.494 . . . . 0.0 112.084 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 60.6 tp -91.33 -78.16 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.191 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -154.63 160.53 41.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.003 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 91.3 m-85 -95.03 116.48 28.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -130.9 -4.82 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -86.91 97.85 10.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.07 0.462 . . . . 0.0 111.232 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -39.95 75.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.749 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.67 -30.5 68.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.663 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.9 49.77 0.72 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.113 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -116.27 148.44 40.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 11.2 p -130.08 142.4 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.152 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.569 ' CE2' ' HB2' ' A' ' 28' ' ' TYR . 87.0 m-85 -119.93 139.96 51.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.669 HD22 ' HB2' ' A' ' 27' ' ' CYS . 2.3 pt? -122.81 148.7 54.42 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 111.388 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.66 149.22 69.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.69 2.26 . . . . 0.0 112.084 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -60.03 -41.08 91.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.479 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -70.0 -40.02 75.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.528 ' SD ' HD22 ' A' ' 71' ' ' LEU . 57.6 ttm -61.41 -40.07 93.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.4 ttm -60.37 -40.75 91.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.218 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.77 -39.99 94.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 110.496 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.2 -40.05 96.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.536 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.46 -24.02 63.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.25 31.84 53.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.684 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -111.98 140.0 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.407 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.414 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 30.0 pt20 -96.93 160.24 29.61 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 96.1 Cg_exo -43.44 136.09 6.22 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.655 2.236 . . . . 0.0 112.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.76 79.23 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.466 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.6 t -70.02 153.15 43.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.39 141.22 28.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.586 HD13 HD21 ' A' ' 71' ' ' LEU . 59.4 tp -125.53 129.91 50.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.58 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 95.8 mt-30 -111.32 130.93 55.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 69' ' ' PHE . 86.1 mt -109.97 129.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.896 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.638 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 20.2 m -121.96 132.54 54.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.708 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 29.4 t -88.67 116.16 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.237 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 81.8 p -125.77 139.84 53.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.507 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -111.11 114.74 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.09 148.52 45.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 34.7 Cg_exo -62.04 175.26 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.342 2.028 . . . . 0.0 112.301 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.553 ' CD1' HG21 ' A' ' 187' ' ' VAL . 0.3 OUTLIER -94.97 120.88 35.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.718 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -69.87 133.63 25.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.85 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.39 -44.01 96.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.633 0.254 . . . . 0.0 111.521 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.461 ' CE1' ' CG1' ' A' ' 193' ' ' VAL . 12.2 m-85 -138.67 145.31 40.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.126 0.489 . . . . 0.0 112.223 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.669 ' HA ' HG12 ' A' ' 176' ' ' VAL . 6.5 p -131.81 130.38 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.928 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.89 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 30.4 mttm -97.61 126.42 42.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.306 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.66 HD11 HD21 ' A' ' 144' ' ' LEU . 85.1 mt -111.48 134.98 52.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.38 109.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 199' ' ' PRO . 6.5 Cg_exo -72.19 159.96 48.46 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.471 2.114 . . . . 0.0 112.417 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.3 tt0 -129.36 121.37 27.28 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m 69.55 130.68 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.03 -25.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.435 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -39.97 87.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.99 -39.91 87.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.27 -10.64 58.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.354 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.02 -12.32 61.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.72 0.295 . . . . 0.0 111.384 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.475 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -60.01 138.79 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.579 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 t -60.81 -40.08 91.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.457 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 137' ' ' ILE . 21.8 m-20 -129.89 74.55 80.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 60.2 Cg_endo -73.4 -26.62 14.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.482 2.121 . . . . 0.0 111.92 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.03 -40.07 88.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.68 88.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.85 -40.34 87.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.401 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.66 HD21 HD11 ' A' ' 127' ' ' LEU . 2.9 tm? -60.93 -43.04 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.506 ' HG3' ' OG1' ' A' ' 190' ' ' THR . 86.3 tt0 -59.94 -40.65 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.14 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.12 -40.06 92.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.632 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.489 HG23 HD11 ' A' ' 162' ' ' ILE . 95.4 t -60.04 -41.16 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.367 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.08 -40.15 88.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -62.27 -39.97 94.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.844 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.12 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.05 117.25 33.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 0.0 111.205 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.613 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 67.4 m -63.11 -40.06 96.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 68' ' ' LEU . 81.1 p -123.38 140.54 52.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.864 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.9 mt -119.85 127.21 52.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.207 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.495 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 94.6 m -118.7 137.41 53.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.779 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.733 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.4 t -60.06 -41.11 85.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.382 0.611 . . . . 0.0 111.188 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.83 -38.99 73.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.485 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.495 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.5 t0 -66.19 134.25 52.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.626 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.597 HG13 ' HE2' ' A' ' 172' ' ' LYS . 15.4 m -98.96 119.98 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.129 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 171' ' ' ILE . 48.3 pt -102.36 134.84 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.983 0.42 . . . . 0.0 111.351 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 98.1 mt-10 -120.09 139.97 51.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.149 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.489 HD11 HG23 ' A' ' 147' ' ' VAL . 45.2 pt -126.22 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.9 t -103.95 118.32 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.7 t80 -121.98 119.13 30.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.158 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 53.02 40.05 30.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.251 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.0 75.82 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.198 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.666 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.4 mttt -119.93 137.93 53.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.885 0.343 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.8 p -107.99 130.86 55.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.407 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 87.4 m-85 -119.97 140.05 51.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.741 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 58.7 mttp -100.79 128.0 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.846 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.577 ' HB ' HG13 ' A' ' 160' ' ' ILE . 48.7 mm -119.97 120.36 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.597 ' HE2' HG13 ' A' ' 159' ' ' VAL . 99.0 mttt -114.58 131.15 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.733 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.6 OUTLIER -73.8 96.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.424 ' O ' ' HG3' ' A' ' 175' ' ' GLU . 8.7 tt -59.82 -52.08 66.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.89 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -160.87 142.52 12.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -142.1 161.36 20.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -118.5 102.78 49.78 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.448 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 77.6 Cg_endo -100.77 175.9 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.683 2.922 . . . . 0.0 112.638 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.543 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.7 mt-10 -97.42 -0.04 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.798 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.472 ' HG ' ' HG2' ' A' ' 120' ' ' PRO . 55.2 m -133.65 156.05 48.59 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.114 0.483 . . . . 0.0 111.458 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 55.5 m -70.7 -10.61 59.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.3 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -59.86 -23.87 63.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 111.291 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.41 40.03 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.428 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 66.2 m -127.74 142.77 51.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.523 HD11 ' HB ' ' A' ' 176' ' ' VAL . 13.9 mt -119.91 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 68' ' ' LEU . 82.4 m -143.31 151.71 40.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.553 HG21 ' CD1' ' A' ' 121' ' ' LEU . 7.3 p -178.16 -55.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.661 ' O ' HG21 ' A' ' 188' ' ' ILE . 54.7 mt 68.66 -1.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.692 ' O ' HG23 ' A' ' 190' ' ' THR . 99.9 mt-10 -99.71 9.83 42.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.986 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 189' ' ' GLU . 7.1 t 48.27 41.38 16.0 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -108.76 20.03 18.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.635 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.493 HD22 ' HB ' ' A' ' 125' ' ' VAL . 0.8 OUTLIER -106.73 139.73 40.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.465 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.461 ' CG1' ' CE1' ' A' ' 124' ' ' PHE . 23.4 t -90.09 121.2 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.766 0.317 . . . . 0.0 110.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.632 ' HA ' HG11 ' A' ' 125' ' ' VAL . 16.4 p -113.19 140.58 47.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 111.73 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -120.6 145.21 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.401 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.26 134.55 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 111.603 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.32 161.29 33.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.461 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.75 129.95 25.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.38 2.053 . . . . 0.0 112.433 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.593 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 98.9 Cg_endo -80.04 168.37 18.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.784 2.323 . . . . 0.0 112.838 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.3 t -81.84 134.69 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.13 -137.27 3.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.633 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.01 139.97 52.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.667 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.09 130.02 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -91.96 125.86 55.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.042 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.28 157.25 22.28 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.13 137.59 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -100.13 125.52 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.999 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.708 179.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.737 0.304 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -39.93 87.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t -69.95 134.27 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.687 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.79 24.15 0.41 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.135 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.51 138.39 43.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -72.15 157.95 36.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -120.02 134.89 55.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -99.9 129.52 45.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.34 117.59 2.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.298 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.93 175.87 48.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.456 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.63 89.37 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.801 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -126.24 140.06 52.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.0 -2.22 81.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.78 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -100.06 120.61 40.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.617 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.8 m -109.18 131.21 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -100.05 119.95 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.709 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.5 mtt -99.97 120.02 58.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.84 128.57 15.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.375 2.05 . . . . 0.0 111.846 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 117' ' ' THR . 62.6 tt0 -117.74 137.77 52.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 m -119.97 130.98 55.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 56.1 t80 -133.64 132.79 41.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.391 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.49 135.82 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.622 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 99.6 mt-10 -140.74 150.87 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.722 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.4 123.14 48.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 110.931 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CD2' ' HB ' ' A' ' 114' ' ' ILE . 83.5 m-85 -130.89 147.22 52.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.966 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HB2' ' HE1' ' A' ' 28' ' ' TYR . 94.8 mtt-85 -81.75 149.46 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 21.9 m -84.95 133.36 34.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.557 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 86.7 m-85 -133.69 149.96 73.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -87.73 100.56 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.049 2.499 . . . . 0.0 113.514 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.74 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 87.6 mt -62.67 -41.37 91.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 110.349 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.496 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . . . -60.25 -39.23 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.412 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 98.1 mtp -68.1 -29.2 68.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.42 ' CE ' HG22 ' A' ' 37' ' ' ILE . 13.4 ttt -60.07 152.64 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.408 ' HB3' HD11 ' A' ' 37' ' ' ILE . 49.8 t30 -58.83 139.28 56.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 111.342 -178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ARG . 96.0 m-20 -63.93 -40.15 95.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -60.21 -40.71 91.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.324 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 HG22 ' CE ' ' A' ' 33' ' ' MET . 85.5 mt -64.38 -48.66 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.455 HH21 HD11 ' A' ' 88' ' ' ILE . 97.3 mtt180 -125.0 143.36 50.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.072 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.41 148.78 47.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -60.12 -26.7 66.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.99 -39.7 86.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.355 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.38 82.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 97' ' ' PRO . 97.8 m-20 -59.99 -39.73 86.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.733 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.88 8.27 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.581 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.28 29.4 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.73 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.65 22.82 38.14 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HE3' ' HB2' ' A' ' 85' ' ' LEU . 72.1 tttt -98.33 124.44 42.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 0.0 111.15 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.2 pt -113.44 149.69 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.3 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CD1' HD12 ' A' ' 88' ' ' ILE . 95.7 m-85 -101.58 134.44 44.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 110.732 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 5.3 mp -134.08 161.78 61.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.246 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 73.9 Cg_endo -75.13 158.73 41.55 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.65 2.234 . . . . 0.0 113.188 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' HA ' HD23 ' A' ' 55' ' ' LEU . 73.8 Cg_endo -74.87 -13.39 21.73 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.054 2.503 . . . . 0.0 113.125 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -59.99 -40.0 87.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 111.525 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.524 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.615 HD22 ' CG ' ' A' ' 87' ' ' PHE . 3.2 mm? -59.97 -40.02 87.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.78 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -59.98 -39.95 87.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.958 0.408 . . . . 0.0 110.092 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 98.6 mttt -69.12 -40.04 78.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.321 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 54' ' ' ALA . 92.3 mt -59.9 -40.0 87.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.134 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -40.03 88.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.3 mtp -59.93 -40.03 87.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.792 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.509 ' HB3' HE22 ' A' ' 19' ' ' GLN . 80.9 mt -82.32 -1.95 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.784 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.1 t30 59.87 40.1 19.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.584 HG21 ' HE2' ' A' ' 67' ' ' MET . 58.6 mt -82.64 131.29 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.857 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -81.84 149.96 28.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 49.8 p90 -87.35 157.97 52.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.664 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 74.4 Cg_endo -75.13 161.55 94.54 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.608 -1.414 . . . . 0.0 112.771 0.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.584 ' HE2' HG21 ' A' ' 63' ' ' ILE . 66.4 mmm -87.27 139.04 30.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 117' ' ' THR . 75.5 mt -108.85 134.35 51.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.585 ' CD2' HG12 ' A' ' 84' ' ' VAL . 14.7 m-85 -120.05 140.65 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 112.301 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -114.92 128.17 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.783 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.701 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 91.0 mt -99.01 127.54 44.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.486 ' OG1' HG13 ' A' ' 79' ' ' VAL . 88.5 m -120.02 130.08 54.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.117 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 117.98 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.91 -39.87 75.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -39.95 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.044 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.426 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 28.0 m -105.09 -15.38 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.793 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 5.11 57.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.223 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.69 140.05 34.45 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.125 0.488 . . . . 0.0 110.279 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG13 ' OG1' ' A' ' 72' ' ' THR . 24.6 m -120.05 117.53 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.873 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 82.2 p -102.75 144.63 30.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.566 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -85.97 114.4 22.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.32 144.93 17.35 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.082 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.29 130.52 10.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.977 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 69' ' ' PHE . 8.6 p -119.88 130.79 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.32 . . . . 0.0 111.479 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.547 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 88.8 mt -110.24 -33.41 6.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.133 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.13 154.42 40.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 112.325 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CG ' HD22 ' A' ' 55' ' ' LEU . 81.8 m-85 -107.89 118.91 37.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.625 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD12 ' CD1' ' A' ' 49' ' ' PHE . 46.8 pt -125.41 -5.01 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -89.17 98.71 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 0.0 111.414 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -40.03 78.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.941 0.4 . . . . 0.0 111.187 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.77 -29.88 67.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.278 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.561 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.91 49.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.928 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 28' ' ' TYR . 89.1 mtm180 -119.44 149.8 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.523 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 25' ' ' PHE . 9.9 p -124.97 142.24 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.393 0.616 . . . . 0.0 111.24 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.74 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.4 m-85 -120.04 139.92 51.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.185 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.616 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.74 152.8 79.48 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 32.5 Cg_exo -61.0 154.78 54.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.557 2.172 . . . . 0.0 111.77 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.496 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 97.7 mt-30 -61.69 -40.16 94.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.423 ' NE1' ' CB ' ' A' ' 97' ' ' PRO . 67.2 p-90 -64.02 -40.11 95.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 58.3 ttm -60.46 -43.25 97.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.973 0.416 . . . . 0.0 110.787 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.62 ' HE2' ' HA ' ' A' ' 108' ' ' PRO . 57.4 ttm -60.76 -40.49 92.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.5 -39.99 94.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.4 m -63.72 -40.41 96.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.13 -24.01 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.426 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.45 30.58 56.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.302 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 101' ' ' MET . 45.6 pt -120.01 157.83 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -96.51 160.38 29.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.68 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.62 ' HA ' ' HE2' ' A' ' 101' ' ' MET . 35.1 Cg_exo -57.75 -3.41 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.76 -15.99 13.79 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.215 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 54.8 m -74.23 150.84 40.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.714 0.293 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.49 153.06 37.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.903 0.383 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.69 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 58.0 tp -119.96 132.7 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.282 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.701 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -99.96 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.671 HG12 ' CD2' ' A' ' 71' ' ' LEU . 86.9 mt -116.37 122.7 70.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.762 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.9 m -120.01 128.46 53.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.675 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -84.87 106.81 16.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.307 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.656 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.3 t -134.23 145.8 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.115 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -107.75 120.28 41.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.467 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.439 HG22 ' SG ' ' A' ' 186' ' ' CYS . 31.9 m -112.65 150.43 42.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.16 0.505 . . . . 0.0 111.753 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.665 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 45.0 Cg_endo -68.38 160.11 50.49 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.641 2.227 . . . . 0.0 111.44 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -75.0 120.2 20.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.45 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.24 151.21 50.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.138 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.452 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 94.7 mm-40 -101.73 -18.0 16.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.525 ' CE1' HG11 ' A' ' 193' ' ' VAL . 1.3 m-85 -149.13 134.81 18.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 194' ' ' THR . 3.6 p -137.43 130.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.335 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.708 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 67.4 mttm -92.9 121.41 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.714 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.436 HD22 HG13 ' A' ' 173' ' ' ILE . 82.6 mt -117.67 130.92 56.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.051 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.29 110.01 51.1 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.07 -176.71 2.97 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.654 2.236 . . . . 0.0 112.256 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 131' ' ' SER . 92.7 mt-30 -130.46 124.62 32.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.384 0.612 . . . . 0.0 110.378 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 1.2 m 71.05 166.97 0.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.956 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.7 -14.98 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.95 -40.07 87.73 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 111.066 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.93 -40.12 87.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.756 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 135' ' ' LEU . 9.8 mp -81.78 -9.55 59.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.543 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.9 -19.58 63.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.487 0.184 . . . . 0.0 111.435 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -61.99 132.11 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.666 0.269 . . . . 0.0 110.483 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.3 p -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.359 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -124.51 77.97 62.62 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.407 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.744 ' O ' HD22 ' A' ' 144' ' ' LEU . 52.2 Cg_endo -69.47 -33.91 16.67 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.52 2.147 . . . . 0.0 112.266 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.09 -40.34 89.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.271 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.93 95.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.451 ' O ' HG22 ' A' ' 147' ' ' VAL . 97.5 t -61.94 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -59.98 -40.1 87.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.401 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -42.32 93.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -63.29 -39.94 95.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.459 . . . . 0.0 110.295 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.584 HG23 HG23 ' A' ' 162' ' ' ILE . 83.3 t -62.47 -41.96 93.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.945 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 95.3 mt -60.02 -40.03 87.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -63.02 -39.96 96.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.62 -39.96 93.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.4 m-85 -99.35 120.29 39.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.235 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 15.9 t -69.97 -39.97 75.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.511 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.525 ' CB ' ' HB3' ' A' ' 81' ' ' HIS . 71.6 p -121.63 140.02 52.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 151' ' ' PHE . 95.1 mt -135.25 141.22 45.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 111.813 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.499 HG21 ' CG ' ' A' ' 81' ' ' HIS . 37.3 p -138.88 154.32 48.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.541 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 94.2 t -60.06 -39.95 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.324 0.583 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.1 -38.89 75.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.411 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.3 t0 -69.37 129.97 41.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.469 ' O ' HG11 ' A' ' 159' ' ' VAL . 7.1 p -102.41 120.01 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.549 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.444 HD12 HG12 ' A' ' 147' ' ' VAL . 47.1 pt -105.12 140.01 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.942 0.401 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.678 ' HG2' ' CB ' ' A' ' 170' ' ' LYS . 99.8 mt-10 -120.0 141.23 49.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.584 HG23 HG23 ' A' ' 147' ' ' VAL . 46.0 pt -129.87 140.13 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.383 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.7 t -112.17 120.03 40.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -123.79 129.56 51.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.999 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 53.75 39.95 30.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.565 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.2 9.71 86.76 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.135 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.3 mttm -108.85 137.15 47.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.724 0.262 . . . . 0.0 110.383 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -105.56 120.54 41.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 111.021 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.02 140.06 51.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.678 ' CB ' ' HG2' ' A' ' 161' ' ' GLU . 53.0 pttt -124.19 130.57 52.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.06 140.81 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.721 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -119.73 137.4 53.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.972 0.415 . . . . 0.0 110.61 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 5.2 mp -81.47 112.85 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -57.26 7.14 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.708 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 86.4 tt0 -155.93 144.1 19.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.356 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 125' ' ' VAL . 8.3 m -138.3 151.2 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.369 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -98.73 104.76 26.55 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 94.5 Cg_endo -100.23 177.16 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.437 2.758 . . . . 0.0 112.676 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.665 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 68.6 mm-40 -99.96 5.01 45.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 85.2 p -139.83 159.67 41.65 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.081 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.4 p -70.04 -18.54 63.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.892 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.9 p -59.98 -20.63 58.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.446 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.458 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 60.03 39.82 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 111.07 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 m -130.02 139.93 50.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.78 140.27 47.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 153' ' ' THR . 75.3 m -129.48 100.31 5.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.619 HG21 HD22 ' A' ' 121' ' ' LEU . 5.7 p -126.87 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.631 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.491 ' CD1' ' HA ' ' A' ' 152' ' ' SER . 82.0 mt -105.62 -26.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.621 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -89.97 -79.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.382 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 13.5 t -169.84 -158.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 0.0 111.102 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.9 m-20 75.74 25.09 1.2 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.892 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.549 HD23 ' CG1' ' A' ' 187' ' ' VAL . 28.4 tp -119.51 131.46 55.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 124' ' ' PHE . 20.8 t -92.84 129.0 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.76 0.314 . . . . 0.0 110.627 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.77 ' HA ' HG11 ' A' ' 125' ' ' VAL . 75.3 p -118.53 142.08 47.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -119.78 142.54 48.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.81 139.98 41.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 111.416 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.427 ' HB3' ' HD2' ' A' ' 198' ' ' PRO . . . -118.2 165.08 17.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.771 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 197' ' ' ALA . 19.9 Cg_endo -59.56 144.86 99.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.08 155.53 38.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.575 2.183 . . . . 0.0 112.57 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -80.04 140.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 135.32 140.35 4.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.388 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.4 132.85 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.803 0.335 . . . . 0.0 110.808 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.06 130.05 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -95.2 130.47 32.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.7 95.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.246 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.87 121.15 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -100.05 122.19 42.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.849 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.777 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.913 0.387 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' A' ' 5' ' ' PHE . 87.3 m-85 -119.99 140.03 51.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.027 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -129.99 145.54 51.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.09 77.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.076 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.448 ' HD2' ' HB3' ' A' ' 2' ' ' PHE . 52.8 m-85 -109.97 134.01 52.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.88 0.371 . . . . 0.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.7 m -128.24 140.03 52.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -128.81 140.93 51.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.96 153.64 46.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.29 117.44 0.76 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.675 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.88 14.53 80.72 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.009 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.08 -79.06 0.88 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.712 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m120 59.69 30.08 19.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.887 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.04 75.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.906 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -125.92 127.34 45.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.33 119.99 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.766 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.76 -15.61 18.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm -101.09 143.5 26.73 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.822 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 88.0 Cg_exo -48.15 160.79 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.431 2.088 . . . . 0.0 112.071 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 78.2 mt-30 -100.08 120.01 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.716 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 116' ' ' SER . 25.2 m -124.28 131.76 53.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 111.689 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.5 ' CB ' ' HB3' ' A' ' 116' ' ' SER . 22.3 t80 -120.24 139.88 52.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.613 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.93 133.07 55.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' OE1' ' HB3' ' A' ' 54' ' ' ALA . 72.1 mt-10 -152.71 160.02 43.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.67 132.64 56.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -139.67 159.99 40.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -94.56 126.32 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.471 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' HB2' HD22 ' A' ' 96' ' ' LEU . 29.8 p -91.06 141.79 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.346 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.499 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.4 m-85 -130.42 153.16 81.28 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.675 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.65 104.53 1.89 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.695 2.264 . . . . 0.0 112.628 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.734 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 90.7 mt -60.0 -39.82 81.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.385 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.734 ' HA ' HH11 ' A' ' 38' ' ' ARG . . . -59.33 -29.29 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.583 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.8 ttp -67.09 -37.72 84.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.281 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.98 140.04 57.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.18 151.75 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.587 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -59.97 -36.66 77.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.209 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -60.0 -34.06 72.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.667 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 37' ' ' ILE . 25.2 mt -110.24 9.11 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.377 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.734 HH11 ' HA ' ' A' ' 31' ' ' ALA . 28.5 ttp180 -119.95 137.15 54.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.607 ' HE2' ' HB3' ' A' ' 41' ' ' ASP . 86.0 tttt -100.47 127.11 46.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.03 -40.08 88.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.607 ' HB3' ' HE2' ' A' ' 39' ' ' LYS . 52.4 t0 -59.98 -41.45 92.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.06 91.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.11 -40.06 88.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.78 18.7 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.19 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.58 163.33 23.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.209 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.91 11.39 64.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.859 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.8 mttt -115.7 140.05 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.5 pt -110.33 152.58 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.473 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.626 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 87.4 m-85 -93.12 132.07 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.733 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -142.42 160.21 55.15 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.292 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' LEU . 45.9 Cg_endo -65.63 144.58 79.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.081 2.521 . . . . 0.0 113.525 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.493 ' HA ' HD11 ' A' ' 55' ' ' LEU . 25.8 Cg_endo -62.63 -20.33 70.55 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.059 2.506 . . . . 0.0 113.315 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.4 p -60.0 -43.58 95.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.648 0.261 . . . . 0.0 111.322 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.616 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . . . -70.64 -41.46 72.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 111.313 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 51' ' ' PRO . 1.1 mp -60.07 -39.9 87.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -59.71 -39.38 84.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -59.98 -39.29 85.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.387 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.638 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 91.9 mt -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -59.98 -39.97 87.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.94 -37.39 82.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.454 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.68 0.61 29.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.651 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.07 43.8 13.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.0 111.54 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 58' ' ' LEU . 43.5 mm -72.24 130.24 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.618 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -69.76 140.41 53.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.477 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.529 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 25.1 t80 -87.43 141.75 32.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.762 ' HD3' HD12 ' A' ' 188' ' ' ILE . 3.7 Cg_exo -74.84 160.36 96.6 Favored 'Cis proline' 0 C--N 1.348 0.552 0 C-N-CA 124.217 -1.16 . . . . 0.0 112.822 0.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.498 ' HE3' HD22 ' A' ' 55' ' ' LEU . 75.4 mtm -75.18 140.12 43.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.924 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 117' ' ' THR . 79.1 mt -112.12 136.76 51.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.081 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.638 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 33.6 m-85 -131.86 147.08 52.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.171 0.51 . . . . 0.0 112.008 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 40.0 ttpt -122.68 129.29 51.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.332 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD21 HG12 ' A' ' 114' ' ' ILE . 86.6 mt -100.38 125.6 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 111.049 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.497 HG21 HG22 ' A' ' 79' ' ' VAL . 97.5 m -119.96 130.02 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.965 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB3' HD23 ' A' ' 104' ' ' LEU . . . -107.83 118.09 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.7 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.361 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.12 -39.9 87.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.32 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 104' ' ' LEU . 73.8 p -108.51 -11.63 15.11 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 68.16 14.32 65.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.68 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -100.0 139.95 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.562 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.531 HG12 ' HD2' ' A' ' 70' ' ' LYS . 52.7 t -121.32 127.23 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.016 0.436 . . . . 0.0 111.215 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.434 ' OG1' ' HE1' ' A' ' 100' ' ' MET . 8.4 t -118.39 129.68 55.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.731 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 17.8 m-70 -83.76 139.61 32.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.363 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.73 -139.53 3.66 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.138 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.567 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -166.79 -164.0 21.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.38 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.62 ' HB ' ' HE2' ' A' ' 69' ' ' PHE . 6.5 p -124.85 129.96 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.145 0.498 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.626 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 34.4 tp -92.62 -77.39 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -140.19 168.19 20.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.76 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.665 ' CD2' HD11 ' A' ' 55' ' ' LEU . 2.5 m-85 -90.94 116.33 28.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.522 HG12 ' HB3' ' A' ' 49' ' ' PHE . 31.6 pt -141.83 -5.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 93' ' ' ARG . . . -97.94 97.1 8.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 111.676 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.95 -40.12 72.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.504 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -85.8 -23.34 27.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.563 ' HA2' ' HG3' ' A' ' 51' ' ' PRO . . . 114.76 46.5 0.6 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.558 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 21.6 mtm180 -111.0 149.47 30.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 111.069 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.8 p -129.92 140.27 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.734 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.5 m-85 -119.94 139.95 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 27' ' ' CYS . 1.6 pt? -122.65 149.87 56.85 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.627 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 47.7 Cg_exo -53.64 158.84 7.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.87 2.38 . . . . 0.0 112.618 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.548 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mt-30 -60.07 -43.85 95.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.605 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.47 ' HZ3' ' O ' ' A' ' 159' ' ' VAL . 33.0 p-90 -68.88 -35.71 77.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.615 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.601 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.5 mmm -60.05 -40.1 88.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG2' HD13 ' A' ' 96' ' ' LEU . 98.0 mtp -61.3 -40.09 92.88 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.061 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.64 -40.08 88.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.964 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -64.91 -40.03 94.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.756 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 76' ' ' THR . 86.9 mt -69.92 -25.08 63.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.2 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.06 74.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.402 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.439 ' HB ' ' CB ' ' A' ' 110' ' ' SER . 45.8 pt -113.4 139.42 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 111.893 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.547 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 8.2 pt20 -97.01 165.76 15.18 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 98.1 Cg_exo -43.92 140.51 4.93 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.658 2.239 . . . . 0.0 112.607 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.0 -9.99 75.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.439 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 58.0 m -70.06 153.08 43.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 113' ' ' GLN . 9.9 tt -93.5 136.74 33.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.116 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.497 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 60.1 tp -121.55 130.09 53.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.043 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 111' ' ' LEU . 96.6 mt-30 -111.77 133.28 54.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.667 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.645 HG12 HD21 ' A' ' 71' ' ' LEU . 85.4 mt -110.07 125.53 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.7 t -120.77 129.54 53.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.9 t -70.22 122.98 20.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.632 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 95.5 m -121.96 128.93 52.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 96.5 m-20 -123.94 120.02 31.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.6 m -117.55 154.36 50.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.796 0.331 . . . . 0.0 111.618 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 93.6 Cg_endo -78.18 19.36 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.679 2.253 . . . . 0.0 112.555 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 186' ' ' CYS . 10.0 mp 67.96 100.39 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.16 164.07 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.3 -22.17 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.413 ' HE1' ' HE2' ' A' ' 126' ' ' LYS . 64.3 t80 -142.71 131.18 22.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.497 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.75 HG13 ' HA ' ' A' ' 194' ' ' THR . 3.3 p -135.95 132.4 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.258 0.551 . . . . 0.0 111.511 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.717 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 34.6 mttm -95.42 122.15 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.27 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 171' ' ' ILE . 86.0 mt -118.05 132.86 56.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.566 ' HB2' HD11 ' A' ' 174' ' ' LEU . 4.2 tt0 -116.58 113.51 40.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.461 ' HG3' HD11 ' A' ' 135' ' ' LEU . 83.7 Cg_endo -78.39 174.44 12.38 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.722 2.281 . . . . 0.0 112.439 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.526 HE22 ' HE2' ' A' ' 170' ' ' LYS . 98.4 mt-30 -125.7 123.93 39.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER 70.17 133.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.421 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.63 HG12 ' HG3' ' A' ' 199' ' ' PRO . 27.8 m -60.04 -24.82 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.186 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -39.92 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.67 -39.98 90.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.775 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.461 HD11 ' HG3' ' A' ' 129' ' ' PRO . 95.6 mt -82.19 -10.19 59.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -10.14 57.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.627 0.251 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 138' ' ' SER . 85.6 mt -59.98 140.71 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.452 ' N ' HG23 ' A' ' 137' ' ' ILE . 69.4 m -59.92 -40.15 87.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.287 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.66 75.84 64.11 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.749 0.309 . . . . 0.0 110.775 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.582 ' O ' HD22 ' A' ' 144' ' ' LEU . 36.0 Cg_exo -60.05 -33.76 95.13 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.632 2.221 . . . . 0.0 111.858 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.92 -40.12 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.4 -43.57 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.87 -40.08 91.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.2 -40.35 89.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -66.59 -40.07 88.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.131 0.491 . . . . 0.0 109.866 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.763 HG21 HG22 ' A' ' 162' ' ' ILE . 56.3 t -62.56 -40.1 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.93 -40.85 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.205 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.34 -40.07 96.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 110.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 89.2 m-85 -105.72 120.75 42.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.448 . . . . 0.0 111.781 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.3 m -60.16 -40.01 88.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.151 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.731 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 67.0 p -135.74 151.91 50.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.324 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.6 mp -117.43 130.45 56.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.568 ' HG1' ' HB2' ' A' ' 81' ' ' HIS . 17.3 m -119.6 142.3 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.614 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.859 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 92.0 t -60.08 -45.05 96.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.199 0.523 . . . . 0.0 110.764 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -39.19 76.14 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.693 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.503 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 53.2 t0 -67.96 132.48 47.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.47 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 14.3 m -100.35 123.79 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.053 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 170' ' ' LYS . 48.3 pt -104.72 138.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.873 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 98.9 mt-10 -120.03 140.09 51.52 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.598 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.763 HG22 HG21 ' A' ' 147' ' ' VAL . 44.9 pt -130.02 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.937 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.1 t -108.79 113.3 26.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -119.91 119.18 32.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.503 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.5 m-20 51.14 39.35 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.22 -7.13 82.44 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.545 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 163' ' ' SER . 57.8 mtpt -100.03 137.4 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.966 0.383 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.452 ' O ' HG21 ' A' ' 168' ' ' THR . 8.9 t -112.19 120.66 42.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.237 0.542 . . . . 0.0 111.59 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.454 ' CZ ' ' HE2' ' A' ' 167' ' ' LYS . 86.8 m-85 -120.01 140.0 51.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.042 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.873 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 51.4 pttt -119.93 136.82 54.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.117 0.484 . . . . 0.0 111.035 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.644 HG21 HD21 ' A' ' 127' ' ' LEU . 85.9 mt -119.98 120.07 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.094 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.56 127.3 49.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.859 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 mp -81.97 120.04 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.634 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 128' ' ' GLU . 10.6 mp -69.79 -57.34 5.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.834 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.717 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.9 mt-10 -155.01 148.02 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.704 HG13 ' HA ' ' A' ' 125' ' ' VAL . 5.3 m -140.33 147.63 23.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -92.26 104.45 10.97 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 63.9 Cg_endo -102.47 163.93 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.639 2.893 . . . . 0.0 112.551 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.458 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.5 mt-10 -100.12 6.21 44.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.9 m -139.85 159.23 42.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.0 111.231 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.8 m -70.05 -12.9 61.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.7 m -59.17 -25.88 64.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 111.11 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.02 39.58 19.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.661 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.1 p -127.47 146.57 50.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.901 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.468 HD12 HG21 ' A' ' 125' ' ' VAL . 46.2 pt -128.39 136.87 58.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.065 0.46 . . . . 0.0 111.5 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.698 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 42.7 t -141.15 114.06 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.239 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 187' ' ' VAL . 7.2 p -120.84 112.52 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.496 0.665 . . . . 0.0 110.385 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.762 HD12 ' HD3' ' A' ' 66' ' ' PRO . 18.4 tt -79.97 -49.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.451 ' HG2' HG21 ' A' ' 188' ' ' ILE . 77.2 mm-40 -91.03 -79.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 t -168.97 30.78 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.606 0.241 . . . . 0.0 111.604 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.541 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 95.9 m-20 -82.46 2.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.545 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.594 ' HG ' HG11 ' A' ' 125' ' ' VAL . 62.4 tp -111.93 130.71 55.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 125' ' ' VAL . 31.6 t -95.37 123.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.169 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.75 ' HA ' HG13 ' A' ' 125' ' ' VAL . 74.8 p -101.91 144.94 29.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -129.53 137.69 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.387 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.32 136.28 44.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.87 163.25 25.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.652 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.69 140.06 37.95 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.361 2.041 . . . . 0.0 112.126 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.63 ' HG3' HG12 ' A' ' 132' ' ' VAL . 14.5 Cg_endo -56.96 159.92 13.61 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.741 2.294 . . . . 0.0 112.249 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.95 131.17 35.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.206 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 149.07 130.01 1.84 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.506 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -99.96 133.19 44.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.757 0.313 . . . . 0.0 110.766 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.416 ' O ' HG21 ' A' ' 203' ' ' VAL . 18.7 m -115.13 130.05 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.304 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -100.14 121.41 53.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.04 153.31 74.52 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.308 2.006 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -99.79 122.97 43.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -99.53 123.5 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.867 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.6 pttm . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -121.14 139.92 52.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.216 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.7 t -131.4 144.83 51.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.14 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.82 97.54 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.32 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.478 ' HB2' ' HD1' ' A' ' 8' ' ' PHE . 85.4 m-85 -122.45 140.32 52.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.632 0.253 . . . . 0.0 110.833 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.4 p -69.04 -39.91 78.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.744 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.2 p -60.09 -40.85 91.06 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.478 ' HD1' ' HB2' ' A' ' 5' ' ' PHE . 44.5 m-85 -60.24 -40.07 88.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.042 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.34 -121.41 26.16 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.333 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.55 81.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.862 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.01 -163.52 11.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 60.05 39.91 19.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 0.0 110.835 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.04 -13.78 24.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.634 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 140.05 51.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 17' ' ' MET . 33.9 t -100.85 120.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -97.98 -0.03 45.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.677 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.434 ' H ' HG12 ' A' ' 15' ' ' VAL . 1.1 tpp -82.88 124.19 77.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.03 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.7 159.94 38.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.541 2.16 . . . . 0.0 112.259 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 117' ' ' THR . 95.1 mt-30 -101.27 123.15 44.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 ' OG1' ' A' ' 117' ' ' THR . 73.9 p -119.99 130.38 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 111.646 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.754 ' HB3' ' OG ' ' A' ' 116' ' ' SER . 86.2 t80 -121.27 126.66 50.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.761 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.18 130.87 54.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.208 0.528 . . . . 0.0 112.332 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.45 156.07 42.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.199 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.64 126.17 49.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.076 0.465 . . . . 0.0 111.773 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 97.5 m-85 -130.07 150.24 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.623 ' HE ' ' HH ' ' A' ' 28' ' ' TYR . 70.6 mtp85 -81.59 132.29 35.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.394 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 31.7 p -106.5 142.39 36.24 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.623 ' HH ' ' HE ' ' A' ' 26' ' ' ARG . 63.6 m-85 -140.37 152.75 67.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.547 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HG2' ' SD ' ' A' ' 32' ' ' MET . 36.1 Cg_endo -65.66 119.76 6.84 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.232 1.955 . . . . 0.0 111.964 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 95' ' ' TYR . 88.6 mt -59.93 -38.52 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -50.03 -20.54 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.527 ' SD ' ' HG2' ' A' ' 29' ' ' PRO . 94.5 mtp -68.75 -32.65 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.98 143.19 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.99 151.04 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.143 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.509 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.78 -34.66 73.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.01 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 69.7 mt -107.08 -0.17 9.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.116 0.484 . . . . 0.0 110.628 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 51.8 ttt-85 -105.01 129.96 53.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.287 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -105.08 133.37 49.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.1 -40.07 88.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.381 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.68 -39.91 95.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.12 91.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.276 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -60.24 -40.0 88.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.659 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -100.14 1.7 42.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.181 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 180.0 35.69 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.61 29.97 9.75 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.713 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.3 mttt -100.01 122.47 42.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 83' ' ' GLY . 47.5 pt -115.33 149.9 17.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' CZ ' HD21 ' A' ' 85' ' ' LEU . 97.5 m-85 -102.9 133.62 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.565 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 1.6 mp -131.34 165.6 34.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.208 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.639 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 56.6 Cg_endo -71.59 157.38 56.09 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.163 1.908 . . . . 0.0 112.662 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.88 -23.08 30.66 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.737 2.291 . . . . 0.0 112.785 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -60.08 -40.09 88.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.229 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -70.22 -42.55 72.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD12 ' HE1' ' A' ' 67' ' ' MET . 58.4 tp -61.91 -41.02 97.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.382 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -59.86 -43.35 94.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 85.3 tttt -60.33 -40.08 89.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.798 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 54' ' ' ALA . 87.3 mt -59.93 -40.08 87.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -59.67 -38.23 80.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.265 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.0 -39.18 84.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.04 -2.52 40.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.425 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.4 t30 60.02 40.26 18.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.588 0.233 . . . . 0.0 111.587 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 ' CD1' HD22 ' A' ' 58' ' ' LEU . 86.3 mt -70.2 130.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.47 142.75 38.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.458 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 16.0 p90 -87.68 158.29 51.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.49 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 9.5 Cg_exo -72.82 146.84 88.01 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.758 -1.351 . . . . 0.0 112.708 0.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.659 ' HE1' HD12 ' A' ' 55' ' ' LEU . 63.3 mtt -72.18 140.01 48.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.474 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD21 HG22 ' A' ' 153' ' ' THR . 21.5 mt -115.84 132.09 56.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.711 ' HB3' HG21 ' A' ' 114' ' ' ILE . 11.6 m-85 -120.53 140.28 51.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.095 0.474 . . . . 0.0 111.638 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 115' ' ' SER . 87.3 tttt -115.65 129.96 56.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.779 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 96.8 mt -98.38 131.12 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.368 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 87.0 m -120.01 129.61 54.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.986 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.2 115.62 27.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -68.39 -40.02 81.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.49 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -40.02 87.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.4 m -100.62 -17.38 17.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.742 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.34 1.14 41.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.685 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -100.22 141.18 33.41 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.717 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 79' ' ' VAL . 20.2 m -119.97 119.87 61.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.403 ' OG1' HD23 ' A' ' 104' ' ' LEU . 36.2 p -110.34 139.46 45.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.37 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 77.7 m80 -84.8 114.39 22.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 0.0 110.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.33 158.49 20.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.667 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.34 165.26 27.5 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.73 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -128.69 133.1 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 117.361 0.581 . . . . 0.0 112.336 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.6 tp -92.22 -79.05 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.535 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -149.55 160.45 43.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CD1' HD22 ' A' ' 55' ' ' LEU . 80.3 m-85 -97.37 116.76 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.292 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.25 -4.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -88.33 97.83 11.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.378 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -39.92 76.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.459 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.97 -20.13 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.345 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.639 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 97.18 54.16 1.3 Allowed Glycine 0 C--O 1.23 -0.107 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.154 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -121.2 145.09 48.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.132 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 93.6 t -120.4 131.72 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.311 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.722 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.8 138.91 53.79 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 27' ' ' CYS . 1.8 pt? -134.56 159.04 73.74 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.63 0.252 . . . . 0.0 110.475 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.528 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 65.1 Cg_endo -70.52 158.25 56.5 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.659 2.239 . . . . 0.0 112.824 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.7 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 78.0 mt-30 -61.71 -40.0 93.5 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.561 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 48.9 p-90 -62.83 -39.93 95.86 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.518 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.561 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 96.7 mtp -68.22 -40.0 82.2 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.332 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.7 ' HE3' ' HA ' ' A' ' 98' ' ' GLN . 76.4 mtm -61.01 -39.98 91.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.48 -40.1 92.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.7 m -63.21 -40.03 96.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.403 HD23 ' OG1' ' A' ' 80' ' ' THR . 83.9 mt -86.24 -10.06 55.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.692 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.22 41.6 99.72 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.046 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.95 133.53 54.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.137 0.494 . . . . 0.0 110.749 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.477 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 5.7 mt-30 -96.43 160.0 30.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 18.3 Cg_endo -59.93 -1.97 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.299 2.0 . . . . 0.0 112.964 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.83 -12.54 24.04 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 m -94.46 151.52 19.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.313 . . . . 0.0 111.154 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.557 ' CD2' ' HG2' ' A' ' 26' ' ' ARG . 89.9 mt -79.98 158.11 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.588 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.2 tp -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.9 mt-30 -101.73 120.34 40.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.346 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 69' ' ' PHE . 87.8 mt -110.27 126.21 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.587 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.4 t -119.78 120.3 36.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.754 ' OG ' ' HB3' ' A' ' 21' ' ' PHE . 48.5 p -88.76 111.16 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.585 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 5.3 t -133.95 150.43 51.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.286 0.565 . . . . 0.0 112.251 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -104.74 119.16 38.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.711 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 ' CG2' ' HB2' ' A' ' 186' ' ' CYS . 15.9 m -115.5 152.51 47.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 180' ' ' SER . 51.5 Cg_exo -57.84 166.25 5.49 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.917 1.744 . . . . 0.0 111.257 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.624 HD21 ' O ' ' A' ' 122' ' ' GLY . 8.0 tt -93.98 120.12 33.79 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.63 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.624 ' O ' HD21 ' A' ' 121' ' ' LEU . . . -68.86 146.11 44.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.228 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.23 -19.85 16.9 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 195' ' ' ASP . 64.7 t80 -145.78 131.49 18.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.665 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.847 ' HA ' HG13 ' A' ' 176' ' ' VAL . 7.5 p -131.0 129.44 63.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.671 0.748 . . . . 0.0 111.785 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 173' ' ' ILE . 63.5 tttp -97.01 120.31 37.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.696 HD21 HG13 ' A' ' 173' ' ' ILE . 77.0 mt -113.94 135.3 54.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.673 ' HB2' HD11 ' A' ' 174' ' ' LEU . 2.6 tt0 -100.22 127.81 32.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.403 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HD2' ' HG3' ' A' ' 128' ' ' GLU . 86.5 Cg_endo -79.78 172.83 13.66 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.322 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.587 ' HG3' ' HG3' ' A' ' 170' ' ' LYS . 29.9 mm100 -135.62 121.16 19.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.476 ' H ' ' HE1' ' A' ' 202' ' ' TYR . 0.5 OUTLIER 59.88 24.89 13.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.513 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 131' ' ' SER . 2.5 m 41.95 24.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.86 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' CB ' ' HE2' ' A' ' 169' ' ' PHE . 95.5 m-20 -70.0 -40.01 75.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.412 . . . . 0.0 110.188 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.543 ' CE1' ' CE2' ' A' ' 196' ' ' PHE . 64.8 t80 -60.71 -40.06 90.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.763 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.418 ' N ' HD13 ' A' ' 135' ' ' LEU . 9.7 mp -65.16 -24.28 67.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.146 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.02 -19.61 63.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.16 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.6 137.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.566 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.6 m -60.12 -39.92 87.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -129.7 71.87 82.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 0.0 110.38 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.503 ' HB3' ' CE1' ' A' ' 134' ' ' PHE . 21.3 Cg_exo -64.68 -30.51 59.9 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.94 -41.0 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.14 98.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.6 -41.04 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.824 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.585 HD12 ' CG2' ' A' ' 194' ' ' THR . 1.8 tm? -60.0 -43.19 95.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.12 -40.27 89.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 0.0 110.75 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -61.97 -40.08 94.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.965 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 160' ' ' ILE . 59.4 t -59.89 -40.48 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.516 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HB3' ' CD1' ' A' ' 188' ' ' ILE . 86.4 mt -60.23 -40.09 88.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.47 -40.02 77.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.183 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.97 -40.01 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.747 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.642 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 91.3 m-85 -102.71 118.02 35.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.101 0.476 . . . . 0.0 111.374 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.49 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 69.2 m -63.2 -39.94 96.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.032 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.662 HG22 HD21 ' A' ' 68' ' ' LEU . 34.4 p -123.13 140.66 52.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.012 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 185' ' ' ILE . 86.5 mt -120.87 127.19 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.79 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 25.0 m -126.46 142.9 51.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 173' ' ' ILE . 59.6 t -60.03 -42.08 88.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.357 0.598 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.413 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.35 140.09 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.552 ' O ' HG11 ' A' ' 159' ' ' VAL . 7.3 p -107.89 121.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.467 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.642 ' HB ' ' CZ ' ' A' ' 151' ' ' PHE . 46.2 pt -104.12 138.69 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.669 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 47.9 mt-10 -121.06 140.62 51.7 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.756 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 147' ' ' VAL . 43.4 pt -127.55 142.85 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.211 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 31.6 t -111.54 115.94 30.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 54.6 t80 -121.14 122.93 41.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.955 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.36 39.99 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.535 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.85 89.91 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.932 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 163' ' ' SER . 97.5 mttt -104.48 136.97 43.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.8 p -108.67 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 111.413 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' HE2' ' CB ' ' A' ' 133' ' ' ASP . 87.2 m-85 -119.94 139.98 51.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.444 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.669 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 61.5 pttt -121.33 135.49 55.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.264 0.554 . . . . 0.0 111.245 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.419 ' CD1' HD23 ' A' ' 127' ' ' LEU . 45.9 pt -128.4 139.52 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.11 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -116.36 129.21 56.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.696 HG13 HD21 ' A' ' 127' ' ' LEU . 3.4 mp -77.92 80.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.09 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.673 HD11 ' HB2' ' A' ' 128' ' ' GLU . 88.0 mt -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.5 mt-10 -146.27 139.4 25.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.791 0.329 . . . . 0.0 111.459 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.847 HG13 ' HA ' ' A' ' 125' ' ' VAL . 32.5 m -144.6 160.03 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.631 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 104.0 54.15 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.414 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 66.9 Cg_endo -99.26 167.34 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.252 2.635 . . . . 0.0 113.053 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.91 9.9 42.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.709 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 43.6 t -139.85 162.02 36.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.67 -15.12 62.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.132 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.4 p -61.38 -21.07 63.73 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.729 0.3 . . . . 0.0 111.032 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.414 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.4 mmtt 60.08 40.21 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.625 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.4 p -129.76 150.69 50.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.125 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.415 HG23 HD22 ' A' ' 192' ' ' LEU . 7.3 mm -117.94 118.36 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.49 ' HB2' ' CG2' ' A' ' 119' ' ' VAL . 10.9 m -143.2 160.59 40.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.833 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 186' ' ' CYS . 17.2 t 77.06 121.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.427 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 148' ' ' LEU . 14.8 mt -120.64 84.04 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -126.33 -20.42 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -110.63 20.04 18.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.7 m-20 70.47 94.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.415 HD22 HG23 ' A' ' 185' ' ' ILE . 4.1 tp -75.61 142.02 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.453 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.768 ' O ' HG12 ' A' ' 125' ' ' VAL . 26.3 t -99.99 128.36 51.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.018 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.585 ' CG2' HD12 ' A' ' 144' ' ' LEU . 70.1 p -117.87 144.57 45.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 124' ' ' PHE . 55.6 t0 -126.41 139.97 52.85 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.907 0.384 . . . . 0.0 110.973 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.543 ' CE2' ' CE1' ' A' ' 134' ' ' PHE . 96.6 m-85 -108.75 140.38 42.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.63 129.65 25.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.524 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.587 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 74.0 Cg_exo -49.53 -49.26 16.18 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.682 2.254 . . . . 0.0 112.653 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 198' ' ' PRO . 11.5 Cg_endo -54.84 141.79 76.31 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.785 1.657 . . . . 0.0 112.094 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.52 ' HB ' ' HD1' ' A' ' 202' ' ' TYR . 27.8 m -82.54 142.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.587 ' HA3' ' HG2' ' A' ' 128' ' ' GLU . . . -82.66 44.1 3.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.771 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.52 ' HD1' ' HB ' ' A' ' 200' ' ' VAL . 89.6 m-85 -98.93 131.95 44.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 117.247 0.523 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.77 129.78 73.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.294 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.64 120.18 62.49 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.44 105.92 2.05 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.372 2.048 . . . . 0.0 112.389 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.07 122.22 42.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.62 125.94 44.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.828 -179.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -68.67 -38.67 80.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -120.01 140.08 51.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.785 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.19 157.75 1.46 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.03 139.95 51.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.7 t -60.92 -40.11 91.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.6 t -116.71 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -68.12 140.0 56.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.052 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.71 179.59 53.33 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.273 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.95 174.72 46.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.647 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.55 10.01 75.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.764 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -100.1 129.68 46.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.23 168.08 42.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.348 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.01 139.92 51.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.53 123.92 67.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.519 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -100.07 118.18 35.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.6 mmt -104.4 130.66 22.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.15 159.67 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.246 1.964 . . . . 0.0 111.589 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 117' ' ' THR . 94.5 mt-30 -113.03 126.28 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.0 m -120.13 130.54 54.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.308 0.575 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.727 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 58.2 t80 -133.24 130.04 38.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.621 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.65 135.93 49.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 54' ' ' ALA . 48.6 mt-10 -142.07 159.9 41.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.282 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -119.85 128.94 54.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.291 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' HB3' HG12 ' A' ' 94' ' ' VAL . 84.6 m-85 -139.08 153.15 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.587 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -81.07 140.7 34.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.547 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.693 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 49.8 t -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 111.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 18.5 m-85 -120.43 150.71 52.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.594 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.642 ' HG3' ' HB3' ' A' ' 108' ' ' PRO . 6.2 Cg_exo -80.31 113.92 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.76 2.307 . . . . 0.0 112.232 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.807 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 95.8 mt -61.14 -39.91 84.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 38' ' ' ARG . . . -59.79 -29.22 68.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.519 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 96.8 mmm -68.3 -36.66 79.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 110.214 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.444 ' HE2' HD13 ' A' ' 37' ' ' ILE . 98.2 mtp -61.04 140.05 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.36 143.59 52.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 112.044 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.9 m-20 -59.87 -26.27 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.103 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -60.05 -38.75 83.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.91 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.444 HD13 ' HE2' ' A' ' 33' ' ' MET . 46.7 pt -108.05 -9.76 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.245 0.545 . . . . 0.0 110.494 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 31' ' ' ALA . 66.4 ttt180 -89.23 139.77 30.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.732 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 86.0 tttt -101.16 125.51 47.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.376 . . . . 0.0 110.512 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.14 -40.82 91.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.659 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.0 m-20 -61.49 -39.99 92.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.1 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.14 90.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.98 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.79 -40.1 87.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.335 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 163' ' ' SER . 90.0 m-85 -102.7 6.04 39.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.56 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.41 160.72 22.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.105 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.15 10.75 73.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.336 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.701 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 22.2 mttm -104.45 143.18 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 HG13 ' CD1' ' A' ' 50' ' ' LEU . 32.6 pt -121.5 169.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.601 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 96.3 m-85 -100.45 131.48 46.35 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.512 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' HG ' HG21 ' A' ' 94' ' ' VAL . 3.9 mp -140.6 163.37 43.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.613 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HB3' ' O ' ' A' ' 89' ' ' ALA . 60.6 Cg_endo -72.22 133.78 21.78 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.14 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 34.6 Cg_exo -57.9 -11.9 10.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.691 2.261 . . . . 0.0 112.89 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.3 p -60.11 -39.05 84.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 23' ' ' GLU . . . -60.01 -35.54 75.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.382 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD11 ' CD1' ' A' ' 87' ' ' PHE . 85.4 mt -60.03 -40.61 89.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.356 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -60.11 -40.03 88.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.601 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 33.6 mttm -67.5 -39.91 85.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.18 -39.35 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.595 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -60.09 -39.79 87.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.17 -39.85 87.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.6 mt -81.28 -0.36 40.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.712 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.89 43.32 15.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.245 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.407 HG22 ' OD2' ' A' ' 118' ' ' ASP . 47.8 mm -64.34 129.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.434 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -70.54 140.01 51.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -88.17 143.59 33.08 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.856 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.89 163.83 89.0 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.397 0.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 55.2 mtt -83.86 133.9 34.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -122.12 137.98 54.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.566 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 97.5 m-85 -123.69 140.49 52.94 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.152 0.501 . . . . 0.0 111.712 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 39.6 ttpt -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.099 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.472 ' CD1' HD22 ' A' ' 96' ' ' LEU . 88.6 mt -89.97 122.57 33.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.542 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.2 m -99.42 122.25 42.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.454 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . . . -117.36 133.89 55.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.352 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 62.27 139.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.103 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -40.0 87.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 p -129.81 17.72 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.489 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.15 -102.95 0.51 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.783 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -139.98 146.34 38.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.876 0.369 . . . . 0.0 111.267 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 71' ' ' LEU . 62.5 t -120.77 119.21 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.901 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.8 p -102.11 163.47 12.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.886 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.437 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 79.1 m80 -103.96 114.83 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.84 159.86 17.27 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.981 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 152' ' ' SER . . . -94.18 170.33 30.1 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.245 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 84' ' ' VAL . 8.5 p -123.57 125.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 111.595 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.3 tp -92.75 -79.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.34 152.38 35.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.515 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 74.8 m-85 -99.33 115.7 29.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.591 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.04 -5.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 51' ' ' PRO . . . -88.78 98.89 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.18 -39.86 82.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.04 0.447 . . . . 0.0 110.714 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.32 -30.64 70.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.047 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.43 50.47 0.71 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.444 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -117.65 140.04 50.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.623 HG21 ' HG ' ' A' ' 50' ' ' LEU . 10.2 p -127.74 143.83 39.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.009 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.807 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.5 m-85 -119.97 140.45 50.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.257 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 71' ' ' LEU . 19.2 mt -114.92 137.9 23.1 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.707 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 42.3 Cg_exo -53.83 161.03 5.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.7 2.266 . . . . 0.0 112.325 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.02 -44.13 94.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.685 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CH2' ' SD ' ' A' ' 100' ' ' MET . 23.5 p-90 -69.66 -37.85 76.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.434 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.1 mmm -60.17 -39.98 88.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.1 mmm -60.16 -40.57 90.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -40.7 78.83 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -60.26 -39.95 88.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 0.0 110.02 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 45.0 mt -80.9 -16.59 53.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.312 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.37 73.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.059 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.3 pt -111.41 143.99 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.54 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 pt20 -100.58 161.14 24.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.802 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.642 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.3 Cg_endo -48.9 134.76 28.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.675 2.25 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.44 -9.98 75.87 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.964 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.619 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 52.1 m -70.87 150.85 45.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.813 0.307 . . . . 0.0 110.61 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.2 mt -71.51 141.21 50.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.693 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 63.3 tp -123.87 130.02 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.692 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -113.37 120.0 39.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.993 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.477 ' CG2' ' CD2' ' A' ' 25' ' ' PHE . 21.0 tt -117.06 127.57 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.6 p -120.11 138.82 53.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.927 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.727 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -80.76 110.19 16.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.496 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 94.5 m -119.94 129.98 54.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.424 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 63' ' ' ILE . 96.2 m-20 -105.73 119.98 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 32.7 m -115.92 149.41 43.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.964 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.486 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 7.5 Cg_exo -70.81 161.79 44.85 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.335 2.023 . . . . 0.0 110.508 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.586 HD22 ' OG1' ' A' ' 190' ' ' THR . 1.3 mt -90.85 120.13 31.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.442 0.639 . . . . 0.0 112.277 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.74 165.79 47.45 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.7 -28.03 9.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -136.98 132.55 34.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.64 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.59 ' HA ' HG11 ' A' ' 176' ' ' VAL . 2.9 p -133.67 131.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.727 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 61.9 mttp -94.97 124.86 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 194' ' ' THR . 82.5 mt -105.61 131.06 53.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.74 0.305 . . . . 0.0 110.778 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -106.71 109.69 63.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.47 164.92 32.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.61 2.206 . . . . 0.0 112.062 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.645 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.1 tt0 -124.52 120.98 33.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.938 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.98 146.76 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.002 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.39 -22.12 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.432 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.99 -39.61 86.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.797 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 171' ' ' ILE . 65.6 t80 -59.9 -40.1 87.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 0.0 110.755 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.31 -8.22 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.965 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.02 -34.84 73.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.659 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.5 mt -55.68 137.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.702 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -60.01 -40.09 88.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.743 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -129.95 79.76 72.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.931 0.396 . . . . 0.0 111.311 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.02 -25.53 16.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.57 2.18 . . . . 0.0 111.937 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.07 -41.4 92.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.73 -42.1 95.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.456 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.94 -40.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.549 HD13 HG22 ' A' ' 194' ' ' THR . 3.4 tm? -61.72 -39.99 93.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.862 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.16 -40.06 93.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -64.66 -42.18 95.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.75 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.764 HG13 HD12 ' A' ' 162' ' ' ILE . 22.4 m -67.35 -36.44 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.401 ' CD1' HD11 ' A' ' 144' ' ' LEU . 86.6 mt -59.98 -40.09 87.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.2 -40.04 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.6 -39.86 89.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.44 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.15 119.6 34.94 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.693 ' HA ' HG12 ' A' ' 188' ' ' ILE . 50.1 m -62.11 -40.02 94.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.497 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.437 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 71.2 p -127.39 143.01 51.28 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.176 0.512 . . . . 0.0 111.33 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 185' ' ' ILE . 8.2 tt -121.69 124.03 43.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.157 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 93.1 m -119.51 135.69 54.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.894 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.843 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 58.1 t -59.9 -41.76 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.161 0.505 . . . . 0.0 111.53 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.798 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.1 m-20 -74.31 146.04 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.339 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 119.99 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.339 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 pt -97.89 140.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.69 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -119.64 140.59 50.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.194 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.764 HD12 HG13 ' A' ' 147' ' ' VAL . 43.3 pt -136.09 145.81 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 29.0 t -115.39 119.4 36.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.701 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.437 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 53.2 t80 -125.84 120.49 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.437 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 59.96 31.45 20.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.443 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.75 -9.85 75.74 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.075 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -101.78 140.05 36.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.496 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 68.3 p -108.8 130.14 55.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.037 0.446 . . . . 0.0 111.505 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 139.97 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.184 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.69 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.7 mttt -103.33 133.28 48.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.961 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 134' ' ' PHE . 48.5 mm -119.91 119.89 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.05 130.5 54.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.843 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.5 mp -83.88 132.26 31.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.325 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.04 -70.46 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.978 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.727 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 50.4 tp10 -140.3 139.86 35.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.945 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 125' ' ' VAL . 3.8 m -139.18 149.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.038 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -99.91 104.23 27.24 Favored Pre-proline 0 C--O 1.232 0.158 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 68.6 Cg_endo -102.9 177.97 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.691 2.928 . . . . 0.0 112.732 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.4 mt-10 -99.95 -0.01 40.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.82 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.3 m -138.29 151.65 47.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.028 0.442 . . . . 0.0 111.462 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 79.6 p -70.03 -10.03 57.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.706 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 46.9 t -55.68 -28.84 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.32 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 69.8 23.24 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.6 p -124.59 139.94 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.854 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.663 HD12 HD21 ' A' ' 154' ' ' LEU . 15.0 pt -132.2 140.05 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.415 ' HB2' HG22 ' A' ' 153' ' ' THR . 11.2 t -119.76 109.75 15.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 187' ' ' VAL . 12.0 p -141.09 99.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.603 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.693 HG12 ' HA ' ' A' ' 152' ' ' SER . 74.8 mt -97.18 -67.81 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.278 0.561 . . . . 0.0 111.566 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -94.1 -6.25 45.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.257 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.586 ' OG1' HD22 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -80.29 174.58 11.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -103.21 119.97 39.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.932 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.579 ' HG ' HG11 ' A' ' 125' ' ' VAL . 18.1 tp -120.26 140.09 51.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.254 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.454 ' O ' HG11 ' A' ' 125' ' ' VAL . 38.3 t -89.27 120.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.522 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.549 HG22 HD13 ' A' ' 144' ' ' LEU . 76.2 p -113.85 146.47 39.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 196' ' ' PHE . 49.4 t0 -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 195' ' ' ASP . 11.2 m-85 -93.31 139.98 30.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 111.408 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -119.83 166.46 14.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.68 142.31 41.08 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.446 2.097 . . . . 0.0 112.13 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.1 160.1 48.97 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.569 2.18 . . . . 0.0 112.409 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.48 133.94 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.99 59.93 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -100.07 138.48 37.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.78 125.13 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.738 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.16 119.83 58.24 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.977 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.9 107.5 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.518 2.145 . . . . 0.0 112.278 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.93 120.86 40.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.56 124.01 44.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.806 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.74 0.305 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.01 -40.02 75.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.3 t -126.42 135.45 51.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.41 170.1 51.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.1 139.98 51.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.7 m -127.62 135.52 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.856 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.5 p -82.68 159.08 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.01 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.637 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.73 137.92 20.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.551 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.12 143.53 20.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.49 -173.0 49.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.731 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -103.11 120.18 40.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.057 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.28 164.36 54.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.95 140.0 51.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.31 130.07 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.343 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.58 -0.03 52.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.449 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -95.43 137.62 22.01 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.665 0.269 . . . . 0.0 110.662 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 73.1 Cg_exo -49.6 167.45 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.369 2.046 . . . . 0.0 112.123 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.9 mt-30 -101.0 130.21 46.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.8 p -121.67 130.11 53.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 115' ' ' SER . 50.7 t80 -131.55 130.28 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -113.97 136.8 52.5 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mm-40 -149.99 160.03 43.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 120.04 38.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' HB ' ' A' ' 114' ' ' ILE . 86.2 m-85 -126.47 149.47 49.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -81.32 133.44 35.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.601 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.913 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 53.2 t -99.95 121.95 42.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 111.357 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.624 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 88.9 m-85 -120.42 150.06 51.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.992 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.554 ' HG3' ' HG3' ' A' ' 108' ' ' PRO . 7.2 Cg_exo -75.68 107.02 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.848 2.366 . . . . 0.0 112.699 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.749 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.2 mt -61.09 -40.84 87.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.62 77.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.866 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.446 ' HB2' ' HB2' ' A' ' 29' ' ' PRO . 98.9 mmm -68.25 -30.29 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 96.5 mmm -59.94 142.24 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.26 154.49 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.673 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.626 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -55.16 -29.17 57.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.404 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -60.01 -39.9 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mt -111.48 8.88 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.648 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.626 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 74.8 ttt180 -104.65 123.18 47.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.049 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.07 129.29 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.896 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.21 -40.09 88.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.269 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.88 -39.97 95.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.91 95.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.763 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.08 -40.1 88.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.351 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.38 14.53 22.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.273 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.57 164.0 24.06 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.119 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA2' ' HE3' ' A' ' 100' ' ' MET . . . -98.52 11.78 63.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.472 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 67.9 mttm -109.86 145.12 37.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.609 HG23 HD22 ' A' ' 96' ' ' LEU . 48.0 pt -121.55 162.99 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.909 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 94.3 m-85 -96.58 133.24 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD23 HD12 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -134.25 165.47 36.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.239 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 84.6 Cg_endo -79.53 152.73 23.25 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.21 1.94 . . . . 0.0 112.67 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 19.1 Cg_exo -66.88 -21.74 49.96 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.961 2.441 . . . . 0.0 112.829 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 m -60.08 -40.07 88.28 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.37 80.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.226 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD11 ' CG ' ' A' ' 87' ' ' PHE . 6.5 mp -59.96 -40.04 87.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.391 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -59.97 -42.76 94.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.59 -39.97 92.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.378 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD11 ' SD ' ' A' ' 67' ' ' MET . 84.6 mt -63.34 -38.56 91.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.375 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.6 m -59.76 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.97 -39.48 85.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.489 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -81.76 -0.05 41.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.681 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.4 m120 59.98 42.43 16.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.704 0.288 . . . . 0.0 111.422 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -70.02 130.02 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.744 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -72.05 139.59 48.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.781 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.706 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 28.9 t80 -88.42 146.52 37.86 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.863 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.706 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 59.9 Cg_endo -71.62 160.38 93.04 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.228 -1.155 . . . . 0.0 113.551 0.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.402 ' SD ' HD11 ' A' ' 58' ' ' LEU . 63.6 mtt -71.86 139.98 49.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 116' ' ' SER . 95.4 mt -110.04 123.03 48.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CE2' HD22 ' A' ' 50' ' ' LEU . 14.9 m-85 -119.99 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 28.4 ttpp -114.66 130.0 56.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.723 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 80' ' ' THR . 71.6 mt -94.17 121.72 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.581 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 29.8 m -106.76 119.93 40.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HB1' HD23 ' A' ' 104' ' ' LEU . . . -112.51 132.46 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.094 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 61.77 148.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 0.0 110.074 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.04 -40.06 88.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.56 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 72.0 p -135.48 13.71 3.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.356 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 -106.85 0.14 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.073 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -128.53 147.54 50.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 0.0 111.68 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.441 ' CG1' HG23 ' A' ' 72' ' ' THR . 35.9 m -130.06 130.8 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 71' ' ' LEU . 7.2 t -112.77 132.43 55.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 111.531 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.428 ' CG ' HG21 ' A' ' 155' ' ' THR . 78.3 m80 -84.42 161.56 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.35 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.24 169.74 42.78 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.94 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.1 -177.26 29.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.985 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.2 131.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.333 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.1 tp -89.99 -79.21 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.056 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -139.66 155.18 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.705 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.651 ' CG ' HD11 ' A' ' 55' ' ' LEU . 86.1 m-85 -99.9 116.53 32.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.931 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 49' ' ' PHE . 48.5 pt -124.79 -5.47 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -91.88 100.11 12.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.01 0.433 . . . . 0.0 111.263 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.52 -39.97 77.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -66.54 -30.5 70.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 111.8 49.24 0.64 Allowed Glycine 0 C--N 1.319 -0.39 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.051 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -118.45 149.22 41.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.986 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 25' ' ' PHE . 10.0 p -129.37 142.32 44.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.019 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.749 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.26 139.95 50.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.704 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 48' ' ' ILE . 80.0 mt -120.39 148.18 46.95 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.583 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.52 157.98 29.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.655 2.237 . . . . 0.0 112.016 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -60.79 -40.56 93.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.439 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 44.6 p-90 -70.05 -40.03 75.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.201 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.447 ' HE3' ' HA2' ' A' ' 46' ' ' GLY . 52.5 mtt -65.32 -39.92 93.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.432 ' CE ' ' HA ' ' A' ' 29' ' ' PRO . 57.6 ttm -60.09 -40.32 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.6 -40.03 95.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.978 0.418 . . . . 0.0 110.379 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.6 -40.08 95.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.583 HD23 ' HB1' ' A' ' 73' ' ' ALA . 96.5 mt -83.72 -12.15 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.594 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.65 42.23 99.21 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.96 132.52 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.136 0.493 . . . . 0.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -100.11 159.22 30.39 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.554 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 38.9 Cg_exo -52.44 131.03 38.77 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.501 2.134 . . . . 0.0 112.01 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.27 77.9 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.668 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t -76.82 153.3 35.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.471 ' C ' HD21 ' A' ' 111' ' ' LEU . 10.4 tt -70.59 140.78 51.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.461 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.913 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.2 tp -126.9 139.95 52.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 95.6 mt-30 -113.91 127.15 55.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.598 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 85.3 mt -119.98 124.46 72.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.9 t -119.13 121.06 38.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.66 108.07 17.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 9.2 t -131.37 140.93 49.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.933 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.0 t0 -99.66 120.01 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.738 HG21 ' N ' ' A' ' 186' ' ' CYS . 27.3 m -103.97 155.71 36.69 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.432 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 185' ' ' ILE . 12.3 Cg_exo -70.05 149.72 65.42 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.322 2.015 . . . . 0.0 111.333 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.721 HD12 ' HB ' ' A' ' 190' ' ' THR . 8.3 tt -70.19 127.42 32.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.465 ' N ' ' HB ' ' A' ' 185' ' ' ILE . . . -82.85 152.19 29.8 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.283 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -108.48 -29.97 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.445 ' HE2' ' CG ' ' A' ' 126' ' ' LYS . 70.2 t80 -140.85 134.24 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.716 ' HA ' HG12 ' A' ' 176' ' ' VAL . 5.7 p -130.1 130.85 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.111 0.481 . . . . 0.0 112.148 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 99.5 mttt -99.18 122.02 41.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.323 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.506 ' CD2' HG13 ' A' ' 173' ' ' ILE . 86.4 mt -111.71 131.09 55.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.0 0.429 . . . . 0.0 111.292 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.06 110.42 62.36 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.354 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 95.9 Cg_endo -84.26 162.15 13.21 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.676 2.25 . . . . 0.0 112.651 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.609 ' OE1' ' HE3' ' A' ' 170' ' ' LYS . 61.5 tt0 -129.31 122.88 30.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.755 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.5 OUTLIER 75.9 131.05 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.66 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.21 -17.5 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.728 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' HA ' ' OD2' ' A' ' 136' ' ' ASP . 96.0 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.628 0.251 . . . . 0.0 110.842 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.457 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 59.5 t80 -59.94 -40.13 87.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 0.0 111.059 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.413 HD22 ' CD1' ' A' ' 196' ' ' PHE . 95.7 mt -85.57 -4.77 59.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' A' ' 133' ' ' ASP . 94.1 m-20 -70.05 -16.83 63.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.39 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.459 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 86.0 mt -61.18 139.26 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.419 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.3 p -61.41 -39.94 92.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.43 73.98 81.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.783 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 74.5 Cg_endo -76.0 -29.77 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.479 2.119 . . . . 0.0 112.117 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.06 -40.13 88.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.112 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.4 89.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.548 ' O ' HG22 ' A' ' 147' ' ' VAL . 87.1 t -62.87 -41.98 94.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 144' ' ' LEU . 3.1 tm? -60.01 -42.81 95.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -41.36 92.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -61.92 -40.26 94.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 143' ' ' VAL . 57.5 t -60.96 -42.61 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.021 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.12 -40.06 88.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.783 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.66 -39.93 90.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.486 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.479 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 93.9 m-85 -96.18 121.46 37.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.4 p -61.19 -39.94 92.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.51 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.585 ' HB ' HD23 ' A' ' 68' ' ' LEU . 7.3 t -128.32 141.23 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 0.0 111.075 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.5 HD21 HD13 ' A' ' 185' ' ' ILE . 62.3 tp -113.4 120.13 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.428 HG21 ' CG ' ' A' ' 81' ' ' HIS . 34.2 p -119.94 145.87 46.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.184 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 173' ' ' ILE . 72.1 t -60.07 -39.94 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 111.73 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.18 -38.68 78.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.595 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -67.14 131.69 46.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.249 0.547 . . . . 0.0 112.325 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.404 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 60.0 t -104.01 120.12 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.846 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.479 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 49.1 pt -106.27 134.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 111.998 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 49.0 mt-10 -120.58 140.03 52.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.462 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 HG23 ' A' ' 147' ' ' VAL . 44.3 pt -131.08 140.83 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 65.2 m -105.92 120.99 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.495 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 60.1 t80 -119.97 120.0 35.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.495 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 55.36 40.0 31.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.432 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.99 8.7 87.42 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.027 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.4 mttp -106.19 132.62 52.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -101.13 119.96 39.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.391 . . . . 0.0 111.223 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.457 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 98.3 m-85 -120.82 140.07 52.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 55.3 pttt -117.83 131.91 56.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.639 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.429 HD12 ' HZ ' ' A' ' 134' ' ' PHE . 85.4 mt -120.01 120.12 62.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.249 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -107.29 130.01 54.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.368 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.663 ' O ' HG13 ' A' ' 156' ' ' VAL . 5.3 mp -80.52 113.37 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.526 ' HG ' ' H ' ' A' ' 175' ' ' GLU . 1.5 pp -73.64 -56.51 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.729 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.526 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 99.0 mt-10 -155.57 136.42 13.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 125' ' ' VAL . 21.4 m -130.57 159.96 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -105.08 104.11 45.29 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.78 0.324 . . . . 0.0 110.219 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.532 ' HB3' HG21 ' A' ' 185' ' ' ILE . 68.7 Cg_endo -100.19 179.17 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.733 2.956 . . . . 0.0 112.509 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.0 mt-10 -95.41 0.03 52.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 88.2 p -140.31 159.88 41.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.031 0.443 . . . . 0.0 111.213 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.05 -11.53 60.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.668 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.9 t -59.95 -18.58 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.415 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 66.77 26.41 9.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 110.702 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.8 m -125.9 139.98 53.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.104 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.626 ' HA ' ' O ' ' A' ' 120' ' ' PRO . 45.7 pt -127.52 143.87 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.738 ' N ' HG21 ' A' ' 119' ' ' VAL . 40.5 t -92.04 100.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.078 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.477 ' CG2' HD21 ' A' ' 192' ' ' LEU . 97.6 t -109.96 93.83 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.093 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.547 HD12 ' SG ' ' A' ' 186' ' ' CYS . 84.2 mt -110.59 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.836 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -117.78 10.78 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.721 ' HB ' HD12 ' A' ' 121' ' ' LEU . 5.8 t -84.98 171.71 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.207 0.527 . . . . 0.0 111.992 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.49 119.45 37.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.79 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.516 ' HG ' ' CG1' ' A' ' 125' ' ' VAL . 31.4 tp -120.37 131.29 54.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.476 ' O ' HG11 ' A' ' 125' ' ' VAL . 36.3 t -89.35 126.91 42.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.167 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 3.9 t -116.96 140.3 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.575 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -120.07 131.74 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.544 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.413 ' CD1' HD22 ' A' ' 135' ' ' LEU . 87.4 m-85 -100.14 122.34 42.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.38 . . . . 0.0 111.532 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.403 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -121.16 108.39 36.32 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.67 109.96 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 112.468 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.96 3.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.011 2.474 . . . . 0.0 112.641 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.95 139.0 18.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 111.546 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.57 25.95 2.94 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.223 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.2 136.65 38.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.087 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.93 139.71 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -96.68 124.34 50.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.7 116.5 3.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.397 2.064 . . . . 0.0 112.272 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -84.66 140.03 31.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -96.46 125.91 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.8 -179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.859 0.362 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.95 -40.43 88.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.8 m -125.71 136.66 53.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.69 170.59 3.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.427 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.04 -39.92 75.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.3 m -130.01 140.02 50.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.3 m -79.41 150.27 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.89 130.01 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.49 -166.71 54.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.237 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.44 177.79 43.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.62 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.95 167.74 51.55 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.582 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.13 120.03 39.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.864 0.364 . . . . 0.0 110.742 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.98 -139.86 29.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.47 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -104.91 132.54 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -109.75 135.46 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -80.07 139.96 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.3 mtp -101.09 119.97 56.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.981 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.18 156.28 59.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.275 1.983 . . . . 0.0 111.773 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.704 ' O ' ' HA ' ' A' ' 117' ' ' THR . 57.2 tt0 -101.49 119.99 39.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.473 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' SER . 82.6 p -119.6 137.56 53.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.942 0.401 . . . . 0.0 111.637 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 115' ' ' SER . 75.2 t80 -125.74 130.52 51.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.618 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.15 136.7 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 112.052 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 98.6 mt-10 -140.53 153.6 46.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.067 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -120.14 122.57 41.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 92.3 m-85 -139.91 160.37 40.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.819 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -84.1 139.66 32.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.911 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 36.2 t -100.0 123.78 44.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 111.458 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.586 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 82.8 m-85 -121.67 149.92 54.11 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.237 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.607 ' HG2' ' HB3' ' A' ' 32' ' ' MET . 65.0 Cg_endo -79.45 111.17 2.79 Favored 'Trans proline' 0 N--CA 1.467 -0.081 0 C-N-CA 123.194 2.596 . . . . 0.0 112.647 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.671 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mt -60.77 -40.03 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 110.682 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.52 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.321 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.607 ' HB3' ' HG2' ' A' ' 29' ' ' PRO . 57.7 ttm -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.433 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 98.3 mtp -58.98 155.69 12.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.737 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.567 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.1 139.99 57.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.041 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -59.97 -37.09 78.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.05 -39.75 87.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG12 ' HB2' ' A' ' 34' ' ' ASN . 47.7 pt -90.3 -0.66 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 18.5 mtp-105 -99.39 139.94 34.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.857 0.361 . . . . 0.0 110.905 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -96.13 139.71 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.731 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 33.6 p-10 -60.01 -40.03 87.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.8 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.71 92.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.472 ' OD1' ' N ' ' A' ' 44' ' ' PHE . 27.3 p30 -62.53 -40.01 95.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 37.8 m-85 -110.0 18.23 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.587 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.09 173.35 28.96 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.14 24.22 19.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.722 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 71.5 mmtt -111.52 142.29 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 111.231 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.732 HG23 HD21 ' A' ' 96' ' ' LEU . 47.3 pt -121.24 155.96 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.56 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.626 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.4 m-85 -100.82 133.96 44.51 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.533 ' CD1' HG11 ' A' ' 84' ' ' VAL . 4.1 mp -140.18 164.54 36.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.596 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 69.3 Cg_endo -73.29 156.26 50.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.268 1.978 . . . . 0.0 112.715 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 74.3 Cg_endo -75.26 -15.6 20.11 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.906 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -60.0 -40.3 88.73 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.59 83.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.709 HD11 ' CG ' ' A' ' 87' ' ' PHE . 6.6 mp -60.13 -39.79 87.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.576 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.4 p -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 110.474 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 21' ' ' PHE . 23.6 tptm -69.45 -40.04 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.258 0.551 . . . . 0.0 110.167 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.409 HD12 ' SD ' ' A' ' 67' ' ' MET . 90.8 mt -59.95 -39.6 86.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.112 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -57.84 -39.27 77.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -59.88 -37.26 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.406 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 98.2 mt -80.46 -0.05 35.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.597 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.03 40.44 18.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.659 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 HG12 ' OE1' ' A' ' 19' ' ' GLN . 85.8 mt -86.63 120.01 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.789 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -91.73 149.13 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.305 0.574 . . . . 0.0 111.854 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 3.2 p90 -87.39 157.79 52.66 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.529 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 30.3 Cg_endo -63.74 147.61 64.42 Favored 'Cis proline' 0 C--N 1.352 0.759 0 C-N-CA 123.771 -1.346 . . . . 0.0 112.742 0.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.43 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 59.0 mtt -93.59 139.59 30.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.677 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 117' ' ' THR . 6.6 mp -101.49 120.9 41.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.025 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.667 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.0 m-85 -128.35 142.3 51.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.607 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 60.7 pttt -120.74 140.11 52.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.698 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -99.32 115.46 29.23 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.394 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.4 m -99.26 121.44 41.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.941 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.39 117.64 35.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.281 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -68.99 -39.99 79.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.433 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.906 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -105.4 -7.7 18.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.12 40.53 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.644 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -104.79 140.09 38.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.668 0.27 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 3.1 p -124.01 130.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.4 p -97.54 154.88 17.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.146 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.511 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 81.0 m80 -119.47 131.18 55.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.153 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.85 -173.72 36.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.538 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.488 ' CA ' ' HB2' ' A' ' 152' ' ' SER . . . -107.62 -170.72 21.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.937 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.537 HG12 ' CD2' ' A' ' 69' ' ' PHE . 32.6 m -130.05 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 121.279 -0.168 . . . . 0.0 110.815 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 58.2 tp -89.99 -78.1 0.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.39 . . . . 0.0 110.544 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -147.72 159.8 43.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.886 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.709 ' CG ' HD11 ' A' ' 55' ' ' LEU . 88.3 m-85 -99.87 116.15 31.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.276 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.16 -4.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.077 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -87.45 100.41 12.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.38 -39.98 77.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.92 -30.85 71.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.095 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.596 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.57 50.32 0.71 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.386 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -117.64 148.23 42.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.948 0.404 . . . . 0.0 111.501 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 8.0 p -129.81 140.81 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.02 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.671 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.72 139.96 50.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.927 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.732 HD21 HG23 ' A' ' 48' ' ' ILE . 21.3 mt -114.81 139.58 24.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 101' ' ' MET . 57.5 Cg_exo -55.01 155.59 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.699 2.266 . . . . 0.0 112.3 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.19 91.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.638 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.671 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 55.2 p-90 -69.95 -37.87 75.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.732 0.301 . . . . 0.0 111.356 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.63 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 98.1 mtp -69.94 -39.98 75.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.459 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.1 mtp -60.01 -40.94 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.037 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 21.3 pt-20 -64.12 -40.02 95.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.48 -40.06 95.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.522 HD11 HD13 ' A' ' 96' ' ' LEU . 82.9 mt -70.04 -24.13 63.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.369 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.66 29.97 60.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.432 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.8 pt -114.35 139.92 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 111.713 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.7 pt20 -95.25 160.01 31.63 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.415 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.531 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.5 Cg_endo -49.15 137.79 29.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.754 2.302 . . . . 0.0 112.48 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.09 -8.13 80.37 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.987 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 89.8 p -71.04 160.36 33.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.753 0.276 . . . . 0.0 110.605 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.65 145.2 30.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.473 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.911 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.1 tp -130.24 130.33 44.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 94.2 mt-30 -110.52 127.59 55.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.667 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 19.0 tt -118.44 127.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.407 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 47.0 t -120.02 130.03 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 23.4 t -89.9 116.03 27.66 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.857 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.725 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.6 t -129.98 138.83 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.74 121.07 44.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.537 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 186' ' ' CYS . 32.7 m -119.16 154.45 53.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.634 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.587 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 59.6 Cg_endo -72.5 153.31 55.11 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.791 2.327 . . . . 0.0 111.325 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 191' ' ' ASP . 4.7 mp -64.29 130.05 42.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.954 0.407 . . . . 0.0 111.137 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.95 151.4 49.01 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.53 -20.05 15.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.516 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' OD2' ' A' ' 195' ' ' ASP . 60.4 t80 -145.79 131.16 18.6 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.681 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 194' ' ' THR . 11.5 p -134.0 134.44 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.267 0.556 . . . . 0.0 111.529 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.78 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 64.3 mttp -99.43 122.37 42.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.359 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.25 128.59 56.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.417 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -111.7 112.22 53.81 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.105 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' CB ' HD12 ' A' ' 135' ' ' LEU . 84.2 Cg_endo -82.08 167.78 15.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.67 2.247 . . . . 0.0 112.462 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -126.07 121.22 32.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.428 ' N ' ' HB2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER 67.6 142.15 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.03 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.09 -20.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.412 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.0 -39.56 86.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.138 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 64.3 t80 -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.464 HD11 ' N ' ' A' ' 135' ' ' LEU . 9.9 mp -81.95 -11.21 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.543 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.08 -19.99 63.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.743 0.306 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.15 130.2 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.5 p -69.54 150.75 46.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.26 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 2.5 m-20 53.66 53.37 10.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.464 ' O ' HD23 ' A' ' 144' ' ' LEU . 31.0 Cg_endo -63.83 -34.65 60.17 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.351 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.08 -40.04 88.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.071 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.88 95.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.607 ' O ' HG21 ' A' ' 147' ' ' VAL . 81.6 t -60.1 -43.19 92.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 144' ' ' LEU . 3.9 mm? -60.0 -40.57 89.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.57 -41.17 94.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.45 -39.94 89.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.176 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 143' ' ' VAL . 60.4 t -60.33 -42.07 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.86 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -41.27 91.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.548 ' HA ' HG23 ' A' ' 188' ' ' ILE . 16.8 tpt180 -61.71 -40.0 93.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.222 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.488 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 98.6 m-20 -62.05 -39.99 94.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.822 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.01 122.67 43.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.318 . . . . 0.0 111.4 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.75 ' HA ' HD13 ' A' ' 188' ' ' ILE . 51.8 m -60.03 -40.02 87.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.5 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 10.0 t -136.06 149.97 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.613 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 64.8 tp -120.04 128.2 53.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.3 m -119.05 140.19 50.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.685 HG12 ' HA ' ' A' ' 175' ' ' GLU . 63.5 t -59.96 -42.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.398 0.618 . . . . 0.0 111.343 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.98 -39.71 75.77 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.678 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 81' ' ' HIS . 96.0 m-20 -65.53 140.39 58.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 112.449 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -105.77 120.02 55.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.654 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.488 HG13 ' CG1' ' A' ' 171' ' ' ILE . 48.0 pt -106.94 141.4 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.798 0.332 . . . . 0.0 111.377 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.642 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 99.9 mt-10 -118.99 140.69 49.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.581 HG22 HG23 ' A' ' 147' ' ' VAL . 46.7 pt -130.31 139.98 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.425 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 58.6 m -107.55 118.46 36.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -119.95 121.77 39.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.6 t30 55.07 40.03 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.421 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.88 9.9 86.23 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.891 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.6 mttt -110.38 138.05 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.807 0.303 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.1 m -106.63 121.16 43.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 90.3 m-85 -120.03 140.03 51.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.642 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 58.9 mtpt -106.07 123.99 48.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.354 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.488 ' CG1' HG13 ' A' ' 160' ' ' ILE . 46.0 pt -122.42 131.13 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 110.639 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -119.64 135.88 54.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.666 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -84.62 120.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.083 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 126' ' ' LYS . 89.1 mt -68.79 -59.32 3.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.429 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.78 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.28 146.66 18.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.76 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.633 HG12 ' CG2' ' A' ' 125' ' ' VAL . 4.3 m -139.02 145.15 28.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -88.94 104.7 8.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.327 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.1 Cg_endo -104.07 174.36 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.861 3.041 . . . . 0.0 112.351 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.587 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.6 mt-10 -100.03 0.73 41.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.1 m -132.81 150.03 52.2 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 111.184 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.5 m -70.98 -12.2 61.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.928 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -62.9 -10.39 13.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.0 mttm 59.93 24.58 13.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 111.425 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 64.2 m -121.08 135.76 55.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 46.7 pt -129.97 159.14 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.399 0.618 . . . . 0.0 112.355 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.608 ' HB2' HD21 ' A' ' 68' ' ' LEU . 53.0 t -140.53 104.57 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.932 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 192' ' ' LEU . 7.5 p -139.79 87.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.69 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.75 HD13 ' HA ' ' A' ' 152' ' ' SER . 72.0 mt -99.49 -3.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.796 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' A' ' 190' ' ' THR . 99.6 mt-10 -90.0 -80.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.291 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 13.1 t 177.38 36.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.598 ' HB2' HD21 ' A' ' 121' ' ' LEU . 95.5 m-20 -109.64 16.77 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.436 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.651 ' HG ' HG12 ' A' ' 125' ' ' VAL . 19.0 tp -116.38 132.45 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 0.0 111.185 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.47 ' O ' HG11 ' A' ' 125' ' ' VAL . 39.9 t -95.11 120.01 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.04 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.707 ' HA ' HG11 ' A' ' 125' ' ' VAL . 81.6 p -103.31 141.2 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.0 111.895 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . 0.401 ' OD2' ' CE2' ' A' ' 124' ' ' PHE . 96.0 m-20 -129.21 144.7 51.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.071 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.68 139.98 48.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 111.415 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -117.61 166.26 13.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.374 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.94 129.88 27.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.184 1.923 . . . . 0.0 112.1 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.428 ' HB2' ' N ' ' A' ' 131' ' ' SER . 73.2 Cg_endo -76.09 162.2 34.62 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.643 2.229 . . . . 0.0 112.477 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.8 t -86.19 128.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.169 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.33 -5.02 34.96 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.715 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -100.05 136.65 39.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.795 0.331 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.5 p -119.95 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.76 125.64 41.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.74 125.83 13.8 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.415 2.076 . . . . 0.0 112.276 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.98 119.98 39.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -100.0 123.17 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.818 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 63.3 tttm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.871 -179.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 59.96 38.21 21.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.102 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.1 t -99.91 120.06 39.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.17 32.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 60.03 40.67 18.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.047 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.5 m -114.18 138.42 50.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.453 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -109.35 122.68 47.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.889 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 138.42 15.17 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.4 120.02 6.12 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.647 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 -23.89 1.54 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.91 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.08 140.04 53.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.82 -147.56 18.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.659 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.96 140.02 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.66 -5.56 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.722 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.91 138.8 37.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.9 mtt -110.23 110.45 58.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.255 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.37 169.36 4.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.311 2.008 . . . . 0.0 111.678 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.564 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.7 mt-30 -99.94 120.32 39.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.451 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.694 ' HA ' ' O ' ' A' ' 116' ' ' SER . 8.9 t -130.0 139.95 50.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.136 0.493 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 55.2 t80 -128.82 130.19 46.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.98 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.08 135.71 48.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.0 mt-10 -144.48 160.05 41.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -119.13 135.46 54.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.417 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -149.7 160.02 43.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.943 0.401 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.83 132.67 39.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.77 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 31.4 p -96.48 141.81 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.482 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.533 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.9 m-85 -127.07 153.92 76.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.693 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 5.7 Cg_exo -78.27 107.09 2.25 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.733 2.288 . . . . 0.0 113.016 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.552 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 87.2 mt -64.29 -40.03 87.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.87 80.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.276 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.466 ' CB ' ' HB2' ' A' ' 29' ' ' PRO . 57.6 ttm -67.6 -32.54 73.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.946 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.0 159.54 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.01 144.49 49.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.44 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.18 -38.96 81.11 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.99 -39.9 87.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.72 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.258 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 30' ' ' ILE . 62.4 mtm180 -99.68 138.97 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.261 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 42' ' ' ALA . 98.6 mttt -103.67 132.47 49.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 111.242 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 96.1 m-20 -66.28 -40.06 89.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . . . -63.33 -39.95 95.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.733 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.14 -39.89 87.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.563 ' HA ' ' HE1' ' A' ' 99' ' ' TRP . 86.4 m-85 -105.52 6.44 32.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.768 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -96.07 173.4 30.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.714 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.8 24.33 21.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.261 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.35 136.03 41.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.6 pt -121.08 158.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 65.6 m-85 -100.08 131.6 45.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 1.9 mp -131.78 162.65 55.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.042 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.558 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.5 Cg_endo -77.78 144.17 21.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.148 1.898 . . . . 0.0 112.155 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.68 -23.93 73.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.603 2.202 . . . . 0.0 112.782 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -60.03 -39.93 87.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.116 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -67.31 -38.82 85.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.156 0.503 . . . . 0.0 110.753 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 34.7 tp -61.5 -39.94 92.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.771 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.3 p -60.06 -39.04 84.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.143 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.775 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 98.8 mttt -64.37 -40.06 95.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.96 0.41 . . . . 0.0 110.5 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.08 -35.45 77.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.11 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.7 m -60.01 -38.64 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.442 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.775 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -60.03 -36.43 77.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.304 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.94 -1.31 38.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.317 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.05 39.99 19.14 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -79.48 126.59 39.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -85.35 142.77 29.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 0.0 111.897 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.499 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 47.4 p90 -87.34 157.82 52.8 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.941 ' HG2' HG21 ' A' ' 188' ' ' ILE . 25.2 Cg_exo -65.24 157.77 75.89 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.542 0.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.455 ' HE2' HD13 ' A' ' 55' ' ' LEU . 65.6 mtm -100.14 145.77 27.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.189 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 153' ' ' THR . 1.3 pt? -116.16 133.7 55.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.583 ' HB3' ' CG2' ' A' ' 114' ' ' ILE . 15.7 m-85 -120.03 140.02 51.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.681 ' HE2' HG22 ' A' ' 79' ' ' VAL . 81.1 tttt -115.08 120.02 38.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.274 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 6.5 mp -97.99 127.36 43.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.589 ' OG1' HG23 ' A' ' 79' ' ' VAL . 89.9 m -115.03 130.23 56.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.831 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.09 110.72 22.04 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.23 -40.07 88.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 104' ' ' LEU . 74.4 p -101.6 -10.41 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.61 6.56 16.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.615 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -104.1 141.31 36.45 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG22 ' HE2' ' A' ' 70' ' ' LYS . 7.2 p -121.18 124.42 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.355 0.598 . . . . 0.0 111.626 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.42 ' CG2' HG22 ' A' ' 103' ' ' THR . 68.9 p -104.3 151.12 23.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.34 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.401 ' NE2' ' HD2' ' A' ' 70' ' ' LYS . 77.4 m80 -100.91 115.06 29.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 0.0 110.814 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.503 ' HA3' ' CE ' ' A' ' 100' ' ' MET . . . -114.74 139.55 15.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.182 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -84.24 163.97 39.84 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.564 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.7 p -126.01 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 64.9 tp -90.33 -74.1 0.5 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.16 160.65 41.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.291 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 89.3 m-85 -95.72 116.76 29.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 88' ' ' ILE . 45.7 pt -125.2 -5.38 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.063 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -90.23 97.77 11.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.023 0.44 . . . . 0.0 111.412 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.95 -39.94 75.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.11 0.481 . . . . 0.0 110.796 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.08 -30.03 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.902 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.03 50.15 0.69 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.167 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -118.45 151.28 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.848 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 12.4 p -130.03 142.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 28' ' ' TYR . 88.6 m-85 -119.08 140.02 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -123.56 147.96 54.46 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.894 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.21 -173.08 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.405 2.07 . . . . 0.0 112.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.91 -20.85 63.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.563 ' HE1' ' HA ' ' A' ' 44' ' ' PHE . 14.4 m95 -60.01 -49.91 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.575 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.503 ' CE ' ' HA3' ' A' ' 82' ' ' GLY . 67.6 mtt -70.01 -39.97 75.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.495 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.615 ' HE1' ' HA ' ' A' ' 29' ' ' PRO . 67.8 mtt -63.89 -47.8 79.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.568 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.98 -40.12 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.235 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.42 HG22 ' CG2' ' A' ' 80' ' ' THR . 94.3 m -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.938 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.632 ' O ' HG22 ' A' ' 76' ' ' THR . 92.9 mt -95.16 -19.05 20.4 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 101' ' ' MET . . . 58.89 47.76 88.97 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -113.49 150.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.031 0.443 . . . . 0.0 111.439 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.35 161.69 30.13 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.573 ' CG ' ' HG3' ' A' ' 29' ' ' PRO . 40.0 Cg_exo -59.62 -5.89 3.84 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.886 2.391 . . . . 0.0 113.421 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.13 -6.82 56.69 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.773 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.4 m -85.02 143.77 28.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.736 0.303 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.97 145.0 52.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.629 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.542 HD21 HD23 ' A' ' 71' ' ' LEU . 54.1 tp -124.83 125.16 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.969 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -111.33 132.08 54.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.954 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 69' ' ' PHE . 88.9 mt -111.56 130.01 65.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.417 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 82.3 p -126.33 134.43 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.287 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.694 ' O ' ' HA ' ' A' ' 20' ' ' THR . 67.2 m -83.8 120.84 26.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 70.8 p -126.34 139.95 52.89 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -112.69 110.8 21.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.1 m -115.58 151.06 45.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.34 133.3 15.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.427 2.084 . . . . 0.0 110.958 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.691 HD21 ' HA ' ' A' ' 187' ' ' VAL . 5.0 mt -62.21 130.91 47.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.213 0.53 . . . . 0.0 112.091 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 159.2 50.31 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.058 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -105.66 -22.7 12.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -136.51 134.56 37.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 111.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' HG13 ' A' ' 176' ' ' VAL . 3.2 p -133.52 130.34 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.133 0.492 . . . . 0.0 111.54 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 99.4 mttt -96.86 123.12 40.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.428 ' CD2' HG13 ' A' ' 173' ' ' ILE . 90.9 mt -116.74 136.6 52.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.438 ' CD ' ' HB3' ' A' ' 199' ' ' PRO . 0.6 OUTLIER -104.06 114.7 64.21 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.87 158.98 21.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.101 . . . . 0.0 112.83 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 96.9 mt-30 -122.72 121.6 36.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 130' ' ' GLN . 47.3 t 69.13 133.98 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.564 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.57 -23.05 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.94 -40.03 87.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.239 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.432 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 67.2 t80 -59.98 -40.13 88.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.97 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.36 -9.95 59.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.63 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.48 -10.18 58.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.573 0.225 . . . . 0.0 111.356 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -59.81 138.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 110.492 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.0 t -60.04 -40.04 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.531 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.75 71.24 82.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.927 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.689 ' O ' HD23 ' A' ' 144' ' ' LEU . 21.2 Cg_exo -65.11 -32.73 52.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.729 2.286 . . . . 0.0 111.909 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.01 -40.03 87.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.285 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.38 98.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.33 -41.33 91.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.689 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -63.43 -40.1 96.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -45.8 91.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -60.28 -41.36 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.051 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 151' ' ' PHE . 62.6 t -60.29 -44.21 95.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.226 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.06 -40.05 88.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.4 mtp85 -65.1 -40.02 93.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.094 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.15 -40.08 88.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.539 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 147' ' ' VAL . 90.6 m-85 -97.74 120.15 37.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.177 0.513 . . . . 0.0 111.439 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.4 m -60.16 -39.91 88.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.022 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 41.9 p -126.87 145.23 50.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.866 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.3 tp -119.88 119.4 33.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.999 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 73.6 p -124.28 141.37 52.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.674 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 97.9 t -59.99 -40.18 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 111.841 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.77 -39.78 87.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.869 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.43 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 97.0 m-20 -74.5 140.11 44.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 112.325 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.04 121.93 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.489 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 46.0 pt -107.97 131.07 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 19.6 pt-20 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.403 ' CG2' HG22 ' A' ' 147' ' ' VAL . 45.6 pt -121.15 148.97 24.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.632 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 82.3 p -109.01 117.55 34.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.206 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 64.6 t80 -119.99 120.06 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 10.9 m120 54.07 40.13 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.28 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.15 10.19 85.77 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.14 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 163' ' ' SER . 63.2 mttp -109.72 133.45 53.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.751 0.275 . . . . 0.0 110.368 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -107.38 123.9 49.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.3 m-85 -119.99 140.04 51.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 56.4 mttm -103.6 129.74 50.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.8 mt -120.02 120.16 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.488 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -111.15 127.14 55.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.674 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -81.6 110.0 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.449 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.58 -58.8 5.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.838 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.746 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.38 143.03 16.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.615 HG13 ' CG2' ' A' ' 125' ' ' VAL . 7.2 m -137.55 142.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.042 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.47 104.71 11.87 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 57.1 Cg_endo -102.99 -0.88 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.882 3.054 . . . . 0.0 112.966 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.48 21.54 12.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.9 p -141.09 155.56 46.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.7 p -70.01 -23.08 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.334 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 22.5 t -59.93 -36.63 77.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 29.8 mmtm 69.68 19.96 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 52.9 m -130.03 140.01 50.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.094 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 44.6 pt -130.36 157.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 112.412 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 153' ' ' THR . 34.0 t -120.81 99.8 6.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.226 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 187' ' ' VAL . 14.7 p -119.91 107.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.237 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.941 HG21 ' HG2' ' A' ' 66' ' ' PRO . 24.0 mt -95.54 -80.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.102 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.87 3.69 49.75 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.479 ' HB ' HG22 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -78.92 171.1 15.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.085 0.469 . . . . 0.0 111.248 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -100.11 123.25 44.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.354 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 192' ' ' LEU . 13.6 tp -120.29 131.49 54.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.561 ' O ' HG11 ' A' ' 125' ' ' VAL . 39.4 t -90.53 120.08 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.875 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.8 t -118.15 148.14 42.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.109 0.481 . . . . 0.0 111.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -120.15 139.74 52.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -99.72 122.43 42.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.29 110.67 34.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.8 117.48 4.32 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.394 2.063 . . . . 0.0 112.269 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.438 ' HB3' ' CD ' ' A' ' 128' ' ' GLU . 81.1 Cg_endo -93.99 -3.21 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.934 2.423 . . . . 0.0 112.803 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.54 139.61 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.319 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.61 -65.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.054 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -100.01 128.96 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.751 0.31 . . . . 0.0 110.507 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.82 129.99 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.007 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 206' ' ' ASP . 8.2 tt0 -106.11 110.19 63.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.053 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.85 10.02 1.8 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.672 2.248 . . . . 0.0 112.711 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.417 ' HB2' ' HG2' ' A' ' 204' ' ' GLU . 96.0 m-20 -82.35 134.56 35.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.735 0.302 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.04 126.87 46.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.958 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.672 0.272 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.98 -44.03 94.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.619 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.9 m -59.96 -40.03 87.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.76 75.35 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.686 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.98 140.02 51.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -118.46 124.36 47.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.853 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -120.06 130.67 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -120.07 139.97 51.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.17 -9.38 76.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.943 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.04 74.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.824 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.99 21.4 78.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.345 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -100.06 120.02 39.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.068 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.52 -148.1 0.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.738 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.91 140.04 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 110.895 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.34 10.03 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.54 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.12 -0.01 42.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.303 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 mmt -82.39 139.98 44.98 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.681 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.33 159.73 51.97 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.382 2.055 . . . . 0.0 112.001 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 117' ' ' THR . 72.0 tp60 -100.02 119.86 38.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.033 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 116' ' ' SER . 73.0 p -120.01 133.08 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.525 ' O ' ' HA ' ' A' ' 115' ' ' SER . 57.4 t80 -120.0 124.96 47.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -105.68 135.06 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.438 ' OE2' ' HG3' ' A' ' 91' ' ' GLU . 85.3 tt0 -145.05 155.28 43.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.706 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.62 120.03 41.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.17 0.51 . . . . 0.0 111.995 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' HE2' ' HG3' ' A' ' 51' ' ' PRO . 87.1 m-85 -121.06 140.01 52.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.734 ' O ' HG12 ' A' ' 94' ' ' VAL . 36.8 ptt180 -80.02 153.34 28.89 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 69.3 m -83.69 132.79 34.84 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 112.337 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.647 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 3.0 m-85 -130.53 126.29 21.95 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.078 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.69 ' O ' ' HG2' ' A' ' 32' ' ' MET . 16.0 Cg_exo -70.02 113.29 3.37 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.553 2.169 . . . . 0.0 112.016 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG12 ' HB3' ' A' ' 95' ' ' TYR . 91.4 mt -66.21 -36.79 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 110.818 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.17 83.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.261 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.69 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.0 ptm -68.43 -20.07 64.62 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.134 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 30' ' ' ILE . 96.9 mmm -64.69 156.92 28.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 28.2 m120 -60.06 141.36 55.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -39.66 86.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -59.93 -39.83 86.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 37' ' ' ILE . 85.5 mt -87.26 -7.76 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.232 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 22.4 mtp-105 -98.96 140.04 33.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.086 0.469 . . . . 0.0 111.917 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.94 130.82 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.93 -40.11 87.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.28 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -64.0 -39.96 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.85 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.95 96.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.009 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.08 -40.02 88.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.58 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -105.14 2.01 28.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.626 0.25 . . . . 0.0 111.565 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.48 173.9 30.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -100.39 14.88 59.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.403 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.6 mttt -95.32 133.36 39.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 96' ' ' LEU . 45.9 pt -118.85 164.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.811 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.447 ' CD1' HG12 ' A' ' 88' ' ' ILE . 98.7 m-85 -100.5 131.54 46.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -129.74 166.77 23.64 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.767 -179.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.844 ' HG3' ' HA ' ' A' ' 91' ' ' GLU . 31.6 Cg_endo -83.13 147.72 13.07 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.821 2.347 . . . . 0.0 113.4 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 37.1 Cg_exo -61.93 -21.27 71.97 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.5 p -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.0 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.545 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 87' ' ' PHE . 6.5 mp -59.97 -40.25 88.44 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.544 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -40.0 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -69.24 -40.01 78.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.383 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 HD22 ' CB ' ' A' ' 116' ' ' SER . 88.2 mt -60.24 -39.81 88.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.033 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.4 m -59.99 -39.73 86.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.487 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.0 -38.89 83.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.355 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.06 0.01 33.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.517 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 59.97 42.77 15.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.811 0.339 . . . . 0.0 111.511 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.9 mm -76.33 129.99 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -83.88 146.71 27.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.3 m-85 -87.58 153.53 53.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.65 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.07 163.09 86.27 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.659 0.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.424 ' HE3' ' CE1' ' A' ' 87' ' ' PHE . 76.0 mtm -84.09 137.0 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.358 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.741 ' HB2' ' O ' ' A' ' 117' ' ' THR . 76.7 mt -115.3 131.91 56.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.498 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.501 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 95.4 m-85 -129.6 144.1 51.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.53 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.587 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 28.3 ttpp -119.53 130.46 55.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD23 HD22 ' A' ' 112' ' ' LEU . 7.5 mp -100.02 121.82 41.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 98.6 m -114.17 130.04 56.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.983 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.19 30.95 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.487 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -68.42 -39.63 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.766 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.721 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 29.8 m -103.58 -15.97 15.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.57 7.92 62.07 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.536 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -99.4 140.17 33.97 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.85 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG13 ' HD2' ' A' ' 70' ' ' LYS . 59.3 t -119.95 120.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.5 p -109.28 138.35 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.273 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.587 ' CE1' ' HD3' ' A' ' 70' ' ' LYS . 3.1 m-70 -84.12 114.14 21.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.08 146.16 16.03 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.177 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 152' ' ' SER . . . -96.51 162.62 22.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.771 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 84' ' ' VAL . 8.1 p -120.73 126.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.57 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 48.6 tp -91.63 -74.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.9 159.96 41.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.245 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.631 ' CE2' HD12 ' A' ' 55' ' ' LEU . 70.8 m-85 -100.79 116.21 32.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.826 0.346 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.447 HG12 ' CD1' ' A' ' 49' ' ' PHE . 48.3 pt -137.99 -4.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.827 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -104.29 158.02 16.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 110.889 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' HB2' ' HG2' ' A' ' 93' ' ' ARG . 97.9 mt-10 -76.67 158.17 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.333 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.844 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 85.8 tt0 -59.99 -30.35 69.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.598 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -81.81 1.24 86.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.308 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.51 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 46.6 ptt85 -144.23 145.88 32.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 26' ' ' ARG . 7.7 p -142.89 150.41 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.664 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.749 ' HB3' HG12 ' A' ' 30' ' ' ILE . 85.3 m-85 -118.63 139.99 50.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.456 ' HA ' HG21 ' A' ' 48' ' ' ILE . 1.7 pt? -134.34 159.05 73.76 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.66 147.97 90.14 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.792 2.328 . . . . 0.0 112.13 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -60.01 -42.29 94.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.163 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -68.72 -40.04 80.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.5 ttm -60.03 -40.28 88.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG3' HG13 ' A' ' 106' ' ' ILE . 67.4 ttp -60.62 -41.27 94.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.46 -39.99 95.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.0 m -62.55 -40.01 95.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 -23.82 63.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.564 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.32 35.0 43.97 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.739 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.521 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.5 pt -118.11 147.43 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.969 0.414 . . . . 0.0 111.3 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.524 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.1 pt20 -98.18 161.63 24.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 8.5 Cg_endo -49.34 136.44 31.83 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.74 2.293 . . . . 0.0 112.162 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 -9.9 75.75 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.612 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.521 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 70.4 p -70.11 161.08 30.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.682 0.277 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.25 140.65 29.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.644 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 60.2 tp -120.07 127.99 53.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.93 119.95 40.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.18 0.514 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 18.9 tt -120.97 128.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 79.8 p -120.69 138.83 53.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.616 ' O ' ' HA ' ' A' ' 20' ' ' THR . 44.9 t -80.17 110.72 15.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.741 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 92.9 m -119.51 129.4 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -101.5 119.23 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.453 HG22 ' SG ' ' A' ' 186' ' ' CYS . 22.1 m -120.12 152.6 54.65 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.501 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 49.4 Cg_endo -67.78 175.29 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.423 2.082 . . . . 0.0 110.684 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 122' ' ' GLY . 7.7 tt -94.41 120.04 34.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.938 0.399 . . . . 0.0 111.257 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.561 ' O ' HD21 ' A' ' 121' ' ' LEU . . . -62.35 151.25 46.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.919 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.412 ' O ' HG22 ' A' ' 193' ' ' VAL . 97.8 mt-30 -101.33 -17.02 16.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.065 0.433 . . . . 0.0 111.767 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.496 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 69.0 t80 -150.27 134.78 17.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.741 ' HA ' HG13 ' A' ' 176' ' ' VAL . 7.7 p -139.21 130.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.344 0.592 . . . . 0.0 111.419 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.775 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 83.8 mttt -94.98 126.3 40.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.487 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.57 HD11 HD22 ' A' ' 144' ' ' LEU . 56.1 mt -115.3 133.28 56.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.88 0.372 . . . . 0.0 110.954 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -109.19 110.59 60.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.762 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.52 175.59 10.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.579 2.186 . . . . 0.0 112.395 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -124.02 121.35 35.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.304 0.573 . . . . 0.0 110.089 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.482 ' CA ' ' HB3' ' A' ' 199' ' ' PRO . 6.3 t 59.83 168.78 0.07 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.086 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.403 ' CG2' ' HG2' ' A' ' 199' ' ' PRO . 16.4 t -77.26 -19.99 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.702 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' PHE . 47.7 p-10 -60.03 -39.93 87.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.01 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 66.9 t80 -59.96 -40.04 87.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.348 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.1 -7.71 59.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.717 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.94 -12.78 61.87 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.482 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.4 mt -60.33 138.82 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.4 m -60.07 -39.99 87.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 111.314 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 137' ' ' ILE . 36.4 m-20 -125.9 75.73 71.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 25.2 Cg_endo -62.17 -40.61 40.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.5 2.133 . . . . 0.0 112.203 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.29 -40.02 88.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.36 96.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.526 ' O ' HG22 ' A' ' 147' ' ' VAL . 84.6 t -60.66 -41.96 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.247 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 194' ' ' THR . 3.0 tm? -59.98 -41.69 92.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.23 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.01 -40.47 89.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 111.043 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.97 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.544 HG11 HD11 ' A' ' 160' ' ' ILE . 77.2 t -61.89 -43.49 97.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.054 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.98 -40.95 90.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.02 0.438 . . . . 0.0 110.557 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -64.28 -40.15 95.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.28 -40.05 92.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.478 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.58 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 97.7 m-85 -101.16 120.02 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.496 . . . . 0.0 110.911 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.487 ' HA ' ' CG2' ' A' ' 188' ' ' ILE . 10.0 t -68.63 -39.99 80.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.864 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 74.1 p -124.41 140.06 53.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.219 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 151' ' ' PHE . 86.9 mt -131.18 136.89 48.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.962 0.411 . . . . 0.0 111.819 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 21.7 m -118.77 145.49 45.56 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.679 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.5 t -60.02 -41.6 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.42 0.629 . . . . 0.0 110.646 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -72.98 -40.01 65.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.675 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.442 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 54.0 t0 -61.01 135.21 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.999 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.27 120.03 53.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.31 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.544 HD11 HG11 ' A' ' 147' ' ' VAL . 46.9 pt -103.92 140.61 21.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.337 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.524 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.1 mt-10 -118.26 141.36 48.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 111.495 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.496 ' CG2' HG12 ' A' ' 147' ' ' VAL . 48.2 pt -125.63 139.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 33.2 p -105.81 108.16 19.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.919 0.39 . . . . 0.0 111.654 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CZ ' HG11 ' A' ' 143' ' ' VAL . 39.6 m-85 -120.49 123.75 43.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.707 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 59.29 34.34 22.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.39 83.4 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.062 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.5 mttt -119.45 138.43 53.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.791 0.295 . . . . 0.0 111.09 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 9.6 t -108.6 131.79 54.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.115 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.4 m-85 -120.01 140.03 51.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.524 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 96.8 mttt -97.2 127.25 43.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.12 134.5 54.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.679 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -79.49 122.26 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.522 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 84.6 mt -73.03 -57.9 3.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.083 0.468 . . . . 0.0 111.195 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.775 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.1 mt-10 -159.92 145.84 15.67 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.869 HG23 ' HE3' ' A' ' 183' ' ' LYS . 5.4 m -140.24 160.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -110.93 103.66 55.06 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 81.0 Cg_endo -100.25 171.18 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.605 2.87 . . . . 0.0 113.041 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.501 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 70.5 mm-40 -99.97 3.74 44.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.038 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.4 m -136.25 160.52 38.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.09 -13.11 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.341 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.8 p -67.9 -13.1 61.88 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.652 0.263 . . . . 0.0 111.428 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.869 ' HE3' HG23 ' A' ' 176' ' ' VAL . 4.8 tptm 49.99 41.84 23.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.322 0.582 . . . . 0.0 110.843 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.1 m -123.71 144.73 49.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.471 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.619 HD11 HG11 ' A' ' 176' ' ' VAL . 20.2 mt -119.3 134.08 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.385 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.526 ' HB3' HD21 ' A' ' 68' ' ' LEU . 64.2 m -142.21 100.09 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.011 0.434 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.626 HG12 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -149.42 113.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.856 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.487 ' CG2' ' HA ' ' A' ' 152' ' ' SER . 44.1 pt -103.21 -10.13 9.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.3 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -89.96 -79.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 14.6 t -172.52 -161.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.439 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 190' ' ' THR . 96.5 m-20 71.75 24.7 3.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.033 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.626 ' HB2' HG12 ' A' ' 187' ' ' VAL . 21.1 tp -117.98 132.41 56.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 125' ' ' VAL . 47.1 t -94.59 124.84 47.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.654 HG23 HD11 ' A' ' 144' ' ' LEU . 76.3 p -115.93 149.77 38.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.28 135.82 52.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.76 138.85 39.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.157 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.435 ' HB3' ' HD2' ' A' ' 198' ' ' PRO . . . -117.7 162.49 28.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 197' ' ' ALA . 53.0 Cg_endo -68.24 153.61 74.11 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.966 1.777 . . . . 0.0 112.03 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.482 ' HB3' ' CA ' ' A' ' 131' ' ' SER . 75.8 Cg_exo -51.09 169.2 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.626 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 17.1 m -90.31 119.98 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.098 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.22 25.44 20.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.239 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.95 129.74 45.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.972 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.28 139.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.956 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -93.58 120.81 65.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.92 16.41 1.48 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.543 2.162 . . . . 0.0 112.798 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.84 140.03 36.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -97.66 122.55 40.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.797 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CE2' ' HA2' ' A' ' 4' ' ' GLY . 47.1 p90 -148.02 160.35 42.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -59.9 -38.95 83.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.328 . . . . 0.0 110.993 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 2' ' ' PHE . . . 100.8 16.93 24.8 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.337 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.491 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 64.9 t80 -73.8 133.46 43.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -59.88 139.76 57.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.426 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -60.27 -39.92 88.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.686 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.84 139.7 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.231 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.66 -172.58 40.97 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.715 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 5' ' ' PHE . . . 179.97 179.04 48.8 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.75 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.28 -1.0 87.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.849 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -100.03 120.01 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.536 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.23 -162.39 33.71 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.391 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.01 140.04 51.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.23 122.56 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.15 7.55 46.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.625 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.9 ttt -95.45 119.79 64.76 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.621 0.248 . . . . 0.0 111.167 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 35.6 Cg_exo -61.27 157.67 39.15 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.73 2.287 . . . . 0.0 112.442 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.8 mt-30 -105.77 118.53 36.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.48 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 116' ' ' SER . 58.5 p -121.07 126.55 50.11 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 115' ' ' SER . 72.6 t80 -121.09 120.42 35.27 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -98.29 140.99 31.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -149.96 159.99 43.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.615 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 55.2 p90 -100.2 120.21 39.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.162 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CD2' HG12 ' A' ' 114' ' ' ILE . 94.4 m-85 -120.19 140.36 51.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.632 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 76.4 mtp85 -82.31 142.66 31.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.393 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 50.6 m -84.48 135.4 34.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.899 0.38 . . . . 0.0 111.796 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.596 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 21.5 m-85 -129.71 137.21 30.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.249 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 33' ' ' MET . 95.4 Cg_endo -79.26 92.24 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.684 2.256 . . . . 0.0 112.965 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.777 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 85.0 mt -59.96 -40.02 81.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.983 0.421 . . . . 0.0 110.601 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.87 87.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.729 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.42 -31.07 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.71 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.546 ' CB ' ' HG3' ' A' ' 38' ' ' ARG . 94.4 mmm -59.21 145.01 44.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.54 ' HB3' HG12 ' A' ' 37' ' ' ILE . 19.6 t-20 -59.88 139.87 57.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.372 0.606 . . . . 0.0 112.359 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.91 -38.89 83.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.023 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 92.7 mtt-85 -59.87 -40.0 87.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.366 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 34' ' ' ASN . 47.6 pt -95.49 -1.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.546 ' HG3' ' CB ' ' A' ' 33' ' ' MET . 79.2 mmt-85 -125.43 155.75 39.93 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.033 0.444 . . . . 0.0 111.793 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -101.01 133.25 45.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.555 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -39.92 88.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.218 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -39.86 87.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.08 84.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.45 HD22 HG23 ' A' ' 30' ' ' ILE . 27.2 m120 -60.01 -40.27 88.65 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 111.308 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.45 4.12 40.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.642 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.11 -174.49 28.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.232 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.35 32.46 6.8 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.599 ' CG ' ' HB2' ' A' ' 85' ' ' LEU . 36.6 ttpt -102.55 129.5 49.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.208 -0.496 . . . . 0.0 112.096 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.745 HG21 ' HE2' ' A' ' 100' ' ' MET . 41.7 pt -131.73 161.07 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.06 133.39 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.062 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.3 mm? -133.08 157.58 77.96 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.391 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.1 Cg_endo -75.24 132.55 15.22 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.21 2.607 . . . . 0.0 112.753 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 52.2 Cg_exo -53.59 -15.23 6.03 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 113.32 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 m -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.146 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.69 87.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.049 0.452 . . . . 0.0 111.088 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 87' ' ' PHE . 68.7 mt -59.92 -39.75 86.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 109.974 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.683 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 73.3 mmtt -66.67 -39.94 88.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.294 0.569 . . . . 0.0 109.976 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.584 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -56.69 -38.19 71.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.037 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.683 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -59.98 -38.27 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.77 1.34 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.04 39.96 19.22 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.784 0.326 . . . . 0.0 111.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 82.1 mt -88.5 120.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.186 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -95.77 140.21 30.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.619 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.534 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 51.8 p90 -87.17 159.67 50.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 34.9 Cg_exo -60.53 134.41 12.05 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.522 0.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.425 ' CE ' ' CD2' ' A' ' 55' ' ' LEU . 74.3 mtm -98.82 140.4 33.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.208 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.886 HD22 ' HB ' ' A' ' 153' ' ' THR . 1.9 mp -97.42 127.46 43.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.215 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.633 ' CD1' HG11 ' A' ' 84' ' ' VAL . 89.3 m-85 -119.95 140.08 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.506 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.02 129.98 55.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.151 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.591 HD22 ' SD ' ' A' ' 100' ' ' MET . 1.4 mp -97.14 123.22 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.686 0.279 . . . . 0.0 111.078 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 90.8 m -114.02 121.28 43.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.398 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -117.23 139.18 51.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 62.27 147.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.344 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.96 -40.67 89.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -133.13 8.41 4.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.404 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.92 -105.73 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.849 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.41 157.41 46.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.924 0.392 . . . . 0.0 111.287 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 71' ' ' LEU . 33.3 m -129.77 136.69 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.615 HG21 ' HG2' ' A' ' 100' ' ' MET . 41.9 m -99.04 148.79 23.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.42 ' N ' HG23 ' A' ' 80' ' ' THR . 76.9 m80 -119.74 131.12 55.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.759 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.16 175.24 44.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.716 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.64 -175.06 25.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.478 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 69' ' ' PHE . 33.0 m -129.96 159.97 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 0.0 111.559 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.599 ' HB2' ' CG ' ' A' ' 47' ' ' LYS . 65.0 tp -93.4 -79.98 0.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.341 0.591 . . . . 0.0 110.863 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -152.44 159.21 43.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.587 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 7.2 m-85 -100.97 118.0 36.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.16 -4.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -88.96 99.68 12.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.391 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.09 -39.93 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.1 -30.26 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.633 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 104.34 68.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.421 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 84.8 mtt85 -119.98 141.05 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.918 0.39 . . . . 0.0 110.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.632 ' HB ' ' O ' ' A' ' 26' ' ' ARG . 88.9 t -129.24 133.41 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 112.173 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.777 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 85.5 m-85 -117.23 139.12 51.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.615 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -132.86 147.11 64.17 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.485 ' HD2' ' SD ' ' A' ' 100' ' ' MET . 93.3 Cg_endo -83.97 -170.44 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 112.626 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.5 -27.1 68.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.036 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.481 ' CH2' ' HZ ' ' A' ' 151' ' ' PHE . 19.6 m95 -59.95 -49.49 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.916 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.745 ' HE2' HG21 ' A' ' 48' ' ' ILE . 65.1 mtt -68.57 -40.04 80.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.315 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 57.8 ttm -62.37 -49.87 73.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.794 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.26 -39.92 78.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.423 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.512 HG21 ' HA ' ' A' ' 80' ' ' THR . 93.9 m -67.47 -40.07 85.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.223 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.546 ' HG ' ' OG1' ' A' ' 80' ' ' THR . 86.0 mt -88.57 -20.59 24.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.502 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.57 76.39 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.425 ' O ' ' HG3' ' A' ' 101' ' ' MET . 45.1 pt -112.97 140.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 111.738 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.9 pm0 -95.91 162.33 24.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 99.5 Cg_exo -43.32 146.17 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.581 2.187 . . . . 0.0 112.694 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.97 75.51 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.105 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 89.4 p -77.31 163.14 26.74 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.769 -0.253 . . . . 0.0 110.718 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.49 139.85 30.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.726 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.567 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 67.8 tp -126.5 124.86 41.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -111.97 120.1 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.857 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.764 HG12 ' CD2' ' A' ' 25' ' ' PHE . 47.2 pt -118.18 134.58 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.126 0.489 . . . . 0.0 111.047 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 30.7 t -119.99 128.72 53.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.956 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.688 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.2 t -65.6 117.66 8.38 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 90.6 m -119.27 129.87 55.13 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.433 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.1 t0 -100.39 117.67 35.05 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.608 HG22 ' N ' ' A' ' 186' ' ' CYS . 26.4 m -113.09 151.6 44.32 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.982 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.461 ' CB ' ' HB2' ' A' ' 179' ' ' GLU . 88.8 Cg_endo -78.87 159.32 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.572 2.181 . . . . 0.0 111.539 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD11 ' N ' ' A' ' 121' ' ' LEU . 6.5 mp -74.94 126.42 30.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.09 157.15 46.44 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.503 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.43 -28.97 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.739 0.27 . . . . 0.0 111.69 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.522 ' HE2' ' HE3' ' A' ' 126' ' ' LYS . 65.0 t80 -142.23 130.18 21.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.869 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.836 ' HA ' HG13 ' A' ' 176' ' ' VAL . 13.2 p -132.89 131.85 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.878 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 96.1 mttt -102.04 125.81 48.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.455 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.473 HD22 HG22 ' A' ' 171' ' ' ILE . 89.8 mt -110.02 136.06 49.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.523 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -99.54 111.3 61.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.58 160.37 31.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.736 2.29 . . . . 0.0 112.615 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.49 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 95.1 mt-30 -128.83 122.13 29.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.191 0.519 . . . . 0.0 110.289 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 69.09 134.28 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.524 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.3 -21.39 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.94 -40.54 89.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 75.6 t80 -59.93 -40.55 89.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.31 -9.06 59.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.712 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.99 -12.82 61.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.565 0.222 . . . . 0.0 111.395 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.497 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -59.98 139.59 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.3 p -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.506 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.428 ' H ' HG21 ' A' ' 137' ' ' ILE . 13.1 m-20 -129.26 74.34 81.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.514 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 56.9 Cg_endo -71.94 -35.51 7.19 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.569 2.179 . . . . 0.0 112.239 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.91 97.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.846 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.435 HG13 ' CZ ' ' A' ' 164' ' ' TYR . 97.4 t -60.43 -42.2 90.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 140' ' ' PRO . 4.1 mm? -59.91 -40.11 87.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.94 -42.93 95.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.666 0.269 . . . . 0.0 110.636 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -62.28 -41.0 98.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 143' ' ' VAL . 84.4 t -63.35 -40.2 88.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.385 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.07 -40.45 89.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -63.14 -39.93 96.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.117 0.484 . . . . 0.0 110.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.96 -39.93 91.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.708 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HZ ' ' CH2' ' A' ' 99' ' ' TRP . 42.1 m-85 -94.68 122.25 37.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 111.174 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.514 ' HB2' HG12 ' A' ' 188' ' ' ILE . 90.0 p -71.5 -33.68 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.657 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.886 ' HB ' HD22 ' A' ' 68' ' ' LEU . 7.8 t -136.26 141.21 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 111.907 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.53 ' HG ' ' CG1' ' A' ' 187' ' ' VAL . 83.6 mt -119.92 127.23 52.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.466 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 38.2 p -121.5 145.27 48.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.5 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.728 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.7 t -60.07 -39.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 0.0 111.309 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.74 -37.02 83.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.845 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.479 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.0 t0 -68.72 129.99 41.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.58 119.98 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.532 HG13 ' HB ' ' A' ' 171' ' ' ILE . 45.8 pt -99.89 134.82 38.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 112.061 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 50.4 mt-10 -113.97 141.13 47.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.593 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 169' ' ' PHE . 16.7 tt -121.26 129.98 75.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.355 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 23.3 p -108.7 110.07 21.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 111.753 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CD1' HG12 ' A' ' 162' ' ' ILE . 5.5 m-85 -126.24 126.71 44.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.33 34.22 23.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.239 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.0 16.01 77.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.6 mttm -117.75 138.49 52.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.782 0.291 . . . . 0.0 110.57 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.2 p -110.93 131.08 55.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.058 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 93.7 m-85 -119.98 139.9 51.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.49 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 61.7 mtpt -103.81 127.19 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 160' ' ' ILE . 49.0 mm -119.96 129.21 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -114.92 133.32 56.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.633 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.728 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.9 OUTLIER -70.0 98.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.119 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.02 -52.25 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.709 0.29 . . . . 0.0 111.742 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.878 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 83.4 tt0 -162.7 139.02 7.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.347 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.836 HG13 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -141.26 152.88 19.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.201 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 103.87 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 71.8 Cg_endo -100.68 175.15 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.72 2.946 . . . . 0.0 112.435 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.461 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.8 mt-10 -94.05 0.04 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.976 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -136.64 154.33 50.68 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.956 0.408 . . . . 0.0 111.34 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.03 -11.84 61.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.523 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.1 m -69.96 -9.42 55.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.498 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 59.95 38.67 20.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.224 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 56.2 m -130.05 135.79 48.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.612 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.544 ' C ' HG22 ' A' ' 119' ' ' VAL . 45.3 pt -129.96 160.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 111.768 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.608 ' N ' HG22 ' A' ' 119' ' ' VAL . 46.4 t -99.94 120.46 39.83 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.53 ' CG1' ' HG ' ' A' ' 154' ' ' LEU . 9.7 p -110.66 14.59 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.412 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.541 HD13 ' CG ' ' A' ' 68' ' ' LEU . 91.0 mt -59.96 -46.28 94.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 188' ' ' ILE . 98.9 mt-10 -155.88 81.59 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.229 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 121' ' ' LEU . 12.7 t -150.05 157.36 43.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.899 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -87.93 103.78 16.0 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.8 tp -119.94 134.17 55.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.523 ' O ' HG11 ' A' ' 125' ' ' VAL . 34.2 t -97.3 122.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.484 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.58 HG23 ' CG1' ' A' ' 125' ' ' VAL . 70.2 p -102.5 142.46 33.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.568 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -129.55 146.54 51.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.68 139.91 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.319 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -108.92 165.95 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.24 149.79 15.74 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.621 2.214 . . . . 0.0 112.461 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.95 164.16 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.685 2.256 . . . . 0.0 112.469 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.94 135.1 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.222 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.14 -28.64 10.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.572 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -101.53 127.09 48.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.97 130.84 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.406 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.96 119.99 58.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.25 140.9 73.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.42 2.08 . . . . 0.0 112.291 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.28 129.04 45.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.755 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -99.01 127.05 44.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.871 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.901 0.381 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.08 139.82 51.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.566 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 29.0 t -130.83 138.75 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.639 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.39 74.29 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.214 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 3' ' ' SER . 98.8 m-85 61.56 19.99 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.099 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -130.58 139.71 50.44 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.697 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.5 m -120.31 124.05 44.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.193 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 71.9 t80 -60.31 -40.0 88.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.59 -7.27 82.23 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.078 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' H ' ' HD2' ' A' ' 8' ' ' PHE . . . -119.94 -14.04 5.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.489 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.3 -153.21 51.67 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.983 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.16 -39.94 88.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 0.0 110.791 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.9 46.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.216 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -99.72 113.34 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.097 0.475 . . . . 0.0 109.972 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.69 HG21 ' HG3' ' A' ' 17' ' ' MET . 4.1 m -134.14 11.37 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.439 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.5 t30 59.97 36.32 21.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.09 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.69 ' HG3' HG21 ' A' ' 15' ' ' VAL . 4.1 mtt -104.41 132.26 21.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.009 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.446 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 13.8 Cg_endo -55.6 158.4 13.26 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.608 2.205 . . . . 0.0 111.779 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.1 mt-30 -99.83 126.69 45.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.6 p -119.8 126.28 50.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.1 0.476 . . . . 0.0 111.76 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.608 ' O ' ' HA ' ' A' ' 115' ' ' SER . 65.9 t80 -120.17 124.35 45.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.618 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.51 129.94 55.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CD ' ' CZ ' ' A' ' 25' ' ' PHE . 81.7 tt0 -148.05 154.93 40.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.128 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -105.25 127.19 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.712 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' HB3' ' CG2' ' A' ' 94' ' ' VAL . 95.6 m-85 -133.47 159.98 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.719 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -96.06 127.88 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.605 ' HB2' HD23 ' A' ' 96' ' ' LEU . 28.7 p -91.37 143.62 26.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.517 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 93' ' ' ARG . 20.1 m-85 -129.95 153.34 80.97 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.502 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HB2' ' HG2' ' A' ' 32' ' ' MET . 89.6 Cg_endo -78.28 103.67 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.798 2.332 . . . . 0.0 112.968 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.744 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.5 mt -60.75 -40.07 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.113 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.7 68.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.389 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 97.2 mmm -67.71 -38.68 83.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 91.2 mtp -64.89 148.66 51.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -59.53 140.94 55.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.057 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.51 -21.02 63.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.056 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.973 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 pt -99.99 1.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.094 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -127.03 159.33 34.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.151 0.501 . . . . 0.0 111.691 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -99.96 129.71 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.969 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.12 88.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.23 -39.95 88.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.262 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.21 76.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.605 HD22 ' HG3' ' A' ' 98' ' ' GLN . 20.5 t-20 -60.07 -40.61 90.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.033 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.83 1.52 40.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.242 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.29 -170.63 34.86 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.99 31.48 7.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.817 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.741 ' HD3' HD11 ' A' ' 85' ' ' LEU . 62.0 mttp -99.71 121.96 42.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.98 0.419 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.4 pt -119.42 149.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 65.3 t80 -104.77 127.84 52.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.632 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 2.0 mp -133.39 160.02 70.26 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.646 0.26 . . . . 0.0 111.512 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 62.8 Cg_endo -72.32 147.76 47.87 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.766 2.31 . . . . 0.0 112.595 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 89' ' ' ALA . 27.3 Cg_exo -62.55 -19.0 66.48 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.866 2.377 . . . . 0.0 112.878 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.51 -43.42 90.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.092 0.473 . . . . 0.0 110.961 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.626 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 57.9 tp -60.28 -42.23 94.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.233 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -60.11 -40.1 88.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.065 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -40.09 90.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 21' ' ' PHE . 96.7 mt -63.63 -38.39 90.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.7 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.4 m -60.01 -37.96 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.11 -36.55 77.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.28 -1.77 42.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.296 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.96 40.59 18.75 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' ' 58' ' ' LEU . 85.4 mt -73.17 130.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.404 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -66.08 140.08 58.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.654 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.66 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 16.3 t80 -96.53 147.17 32.54 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 24.4 Cg_exo -66.96 155.45 84.14 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.149 -1.188 . . . . 0.0 113.062 0.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.428 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 66.6 mtt -90.86 140.29 29.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.671 ' HB2' ' O ' ' A' ' 117' ' ' THR . 35.7 mt -105.75 141.0 37.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.079 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.689 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 60.5 m-85 -133.41 147.0 51.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.431 . . . . 0.0 112.108 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 97.7 mttt -121.39 137.91 54.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.19 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD23 HD23 ' A' ' 112' ' ' LEU . 86.5 mt -99.2 119.99 38.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.29 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.434 ' OG1' HG21 ' A' ' 79' ' ' VAL . 30.6 m -108.05 125.52 51.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.751 0.31 . . . . 0.0 111.665 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB1' HD22 ' A' ' 104' ' ' LEU . . . -100.49 119.97 39.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.921 0.391 . . . . 0.0 110.676 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.15 -39.87 82.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.04 -39.84 87.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -106.16 -13.81 15.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 70.08 8.17 61.04 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -100.18 140.0 35.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.434 HG21 ' OG1' ' A' ' 72' ' ' THR . 9.7 p -123.64 122.76 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.525 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 60.5 m -106.06 134.84 48.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.323 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.622 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 3.4 t-80 -84.41 114.72 22.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.02 172.72 20.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.281 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -100.09 162.29 19.18 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.443 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.654 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 9.7 p -130.01 136.59 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 0.0 111.78 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.741 HD11 ' HD3' ' A' ' 47' ' ' LYS . 94.3 mt -91.01 -77.21 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.529 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -148.69 160.08 43.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.057 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.626 ' CD1' ' HB2' ' A' ' 55' ' ' LEU . 96.7 m-85 -106.22 116.63 32.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.585 HG13 ' C ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -140.78 11.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.784 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.577 ' N ' ' HD3' ' A' ' 52' ' ' PRO . . . -85.14 99.9 11.37 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.82 -40.0 72.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.01 0.433 . . . . 0.0 110.649 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.14 -30.29 67.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.385 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.502 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 100.07 64.59 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.07 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.517 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 35.6 ptt-85 -123.41 143.42 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.553 ' CG2' ' HB3' ' A' ' 25' ' ' PHE . 97.5 t -123.28 132.78 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.542 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.744 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.0 m-85 -120.41 139.88 52.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.605 HD23 ' HB2' ' A' ' 27' ' ' CYS . 1.7 pt? -134.49 159.49 72.05 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.297 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' HG2' ' CG ' ' A' ' 100' ' ' MET . 58.7 Cg_endo -68.91 159.21 54.82 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.655 2.236 . . . . 0.0 112.744 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.605 ' HG3' HD22 ' A' ' 43' ' ' ASN . 77.9 mt-30 -60.07 -43.02 95.76 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.517 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 29.4 p-90 -64.52 -40.0 94.81 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.595 ' CG ' ' HG2' ' A' ' 97' ' ' PRO . 93.9 mmm -63.49 -40.15 96.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.751 0.31 . . . . 0.0 111.307 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.3 ttp -61.8 -42.42 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.57 -39.98 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -65.61 -40.35 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.449 HD22 ' HB1' ' A' ' 73' ' ' ALA . 93.1 mt -69.97 -23.73 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.49 72.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.901 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.683 ' HB ' ' HG ' ' A' ' 110' ' ' SER . 44.9 pt -120.4 151.58 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.49 160.45 32.99 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.05 -2.82 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.589 2.192 . . . . 0.0 113.323 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.51 -14.06 22.76 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.626 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.683 ' HG ' ' HB ' ' A' ' 106' ' ' ILE . 90.8 p -81.48 161.29 23.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.991 0.424 . . . . 0.0 111.132 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.42 140.02 51.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.37 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 60.5 tp -118.94 129.38 55.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 64.0 tt0 -106.75 125.85 51.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.689 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 14.9 tt -117.97 126.63 75.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.62 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 44.8 t -120.13 131.77 55.16 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 1.2 m -83.46 114.9 21.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.488 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.671 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 34.3 p -122.07 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 112.203 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 57.4 t0 -115.19 113.11 23.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.933 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.401 HG21 ' N ' ' A' ' 186' ' ' CYS . 34.4 m -119.36 150.38 49.41 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.929 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 -175.6 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.484 2.123 . . . . 0.0 111.407 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.761 HD22 ' HB2' ' A' ' 191' ' ' ASP . 3.8 mp -95.27 119.47 33.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 0.0 110.709 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 192' ' ' LEU . . . -60.0 159.14 23.92 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.732 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.29 -29.03 9.54 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.613 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 126' ' ' LYS . 69.2 t80 -145.28 130.25 18.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.69 0.281 . . . . 0.0 111.395 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.699 ' HA ' HG11 ' A' ' 176' ' ' VAL . 4.2 p -133.78 130.08 55.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.093 0.473 . . . . 0.0 112.187 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HD2' ' HG2' ' A' ' 175' ' ' GLU . 85.4 mttt -99.73 121.62 41.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.6 mt -105.31 131.35 52.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 199' ' ' PRO . 37.8 tt0 -114.63 109.52 47.93 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.68 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.436 ' HG3' HD12 ' A' ' 135' ' ' LEU . 88.2 Cg_endo -83.94 -168.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.648 2.232 . . . . 0.0 112.601 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -121.84 121.19 36.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.293 0.568 . . . . 0.0 109.982 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t 59.52 178.0 0.08 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.96 -11.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.695 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.08 -40.39 89.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.539 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.35 -40.27 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.647 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.436 HD12 ' HG3' ' A' ' 129' ' ' PRO . 9.6 mp -80.47 -10.03 59.75 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.776 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.89 -19.31 63.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.601 0.239 . . . . 0.0 111.277 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.6 mt -60.43 133.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.2 m -60.1 -39.98 88.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.417 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.04 76.5 71.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.32 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.719 ' O ' HD21 ' A' ' 144' ' ' LEU . 40.8 Cg_endo -68.79 -30.13 27.69 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.426 2.084 . . . . 0.0 112.071 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.12 99.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.635 ' O ' HG21 ' A' ' 147' ' ' VAL . 98.1 t -61.73 -49.67 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.588 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.719 HD21 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.2 -39.99 88.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.659 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.01 -46.35 89.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -60.57 -40.39 91.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 0.0 110.247 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.635 HG21 ' O ' ' A' ' 143' ' ' VAL . 62.4 t -63.12 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.169 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.04 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -66.5 -40.01 88.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.11 -40.04 92.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.676 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 96.7 m-85 -101.6 118.74 37.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.6 m -62.65 -39.92 95.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.361 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.554 ' CG2' HD22 ' A' ' 68' ' ' LEU . 33.7 p -125.56 149.84 47.99 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 111.737 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 192' ' ' LEU . 86.1 mt -116.02 121.72 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.428 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 94.3 m -119.95 130.07 54.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.002 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.705 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.8 t -59.95 -40.03 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 111.684 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.92 -38.61 76.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.304 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.514 ' CG ' HG21 ' A' ' 80' ' ' THR . 87.9 m-20 -69.54 134.85 49.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.552 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.486 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 6.1 m -102.53 119.93 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.465 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.542 HG13 ' CG1' ' A' ' 171' ' ' ILE . 46.7 pt -104.29 140.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 111.52 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -120.01 140.55 50.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.485 HG21 ' CG2' ' A' ' 147' ' ' VAL . 46.2 pt -128.01 140.4 49.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.993 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 50.8 m -105.36 119.97 40.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.422 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -122.59 119.97 32.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.423 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.497 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.03 40.14 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 13.6 81.86 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.252 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.673 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -116.72 139.28 50.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.808 0.304 . . . . 0.0 110.393 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.5 m -113.38 129.73 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.81 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.0 139.98 51.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.406 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.8 mttt -103.5 123.49 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.072 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.542 ' CG1' HG13 ' A' ' 160' ' ' ILE . 45.6 pt -124.51 131.82 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.947 0.403 . . . . 0.0 110.787 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 62.9 tttp -119.58 134.6 55.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.959 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.705 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -77.55 118.39 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.424 ' CD2' ' HG2' ' A' ' 175' ' ' GLU . 9.1 tt -62.62 -60.04 4.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.653 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.698 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 22.0 pt-20 -163.02 159.3 23.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.699 HG11 ' HA ' ' A' ' 125' ' ' VAL . 13.6 m -147.77 159.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.896 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.71 102.89 51.76 Favored Pre-proline 0 C--O 1.233 0.226 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.451 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.556 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 57.4 Cg_endo -104.71 0.24 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.166 3.244 . . . . 0.0 113.009 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.3 21.33 11.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -143.82 156.56 44.52 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.198 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 80.3 p -71.25 -20.15 62.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.485 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 60.8 m -59.99 -39.89 87.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.556 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 68.34 20.0 8.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.2 t -128.06 131.09 49.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.835 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 178' ' ' PRO . 0.2 OUTLIER -131.04 159.83 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.304 0.574 . . . . 0.0 112.514 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . 0.534 ' HB2' HG21 ' A' ' 153' ' ' THR . 35.2 t -129.56 126.05 37.65 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.26 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -148.63 83.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.814 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 85.3 mt -69.83 -40.06 78.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 190' ' ' THR . 86.5 tt0 -66.02 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.794 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 10.4 t -179.98 41.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.761 ' HB2' HD22 ' A' ' 121' ' ' LEU . 91.2 m-20 -98.38 7.75 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.473 ' CD2' HG12 ' A' ' 125' ' ' VAL . 12.5 tp -107.38 129.57 54.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 110.782 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.587 ' O ' HG11 ' A' ' 125' ' ' VAL . 38.3 t -96.79 120.4 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.285 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' THR . . . . . 0.578 ' HA ' HG11 ' A' ' 125' ' ' VAL . 59.6 p -99.99 145.57 27.72 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -130.01 140.05 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.961 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.442 ' CZ ' ' HG ' ' A' ' 144' ' ' LEU . 97.3 m-85 -101.15 120.29 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.468 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.42 118.51 12.72 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.99 130.24 18.72 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.315 2.01 . . . . 0.0 112.139 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.495 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 23.8 Cg_endo -94.48 -3.28 2.63 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.116 2.544 . . . . 0.0 112.693 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.2 136.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 111.217 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.22 84.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.579 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -98.7 123.5 42.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.93 139.1 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.942 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.05 110.7 60.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.79 27.02 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.803 2.335 . . . . 0.0 112.653 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -100.01 122.13 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.59 123.67 44.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.776 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.876 0.282 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 117' ' ' THR . 92.3 mm-40 -100.09 123.6 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -119.59 128.08 53.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.181 0.515 . . . . 0.0 111.927 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 50.5 t80 -133.7 138.49 45.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.96 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -116.75 136.71 52.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.979 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 99.2 mt-10 -140.05 148.96 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.461 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -121.84 126.81 49.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.537 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HB2' HG21 ' A' ' 94' ' ' VAL . 89.6 m-85 -149.94 161.72 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 111' ' ' LEU . 90.0 mtt180 -92.85 130.82 38.33 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.879 ' HB2' HD11 ' A' ' 96' ' ' LEU . 17.5 p -101.19 147.81 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.95 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -130.11 148.74 70.94 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.709 ' O ' ' HG2' ' A' ' 32' ' ' MET . 55.4 Cg_endo -70.68 109.81 2.58 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.25 1.967 . . . . 0.0 112.44 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' A' ' 95' ' ' TYR . 84.1 mt -60.01 -26.7 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.476 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' HA ' HH12 ' A' ' 38' ' ' ARG . . . -58.24 -38.62 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.123 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.1 ptm -68.99 -23.64 64.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.742 0.306 . . . . 0.0 111.07 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.438 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 98.9 mtp -61.9 139.81 58.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 111.235 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.709 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.08 141.58 55.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.645 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.95 -39.91 87.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -60.0 -39.7 86.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.527 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.709 HG12 ' HB2' ' A' ' 34' ' ' ASN . 49.4 pt -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' HA ' ' A' ' 35' ' ' ASP . 22.0 ptt180 -128.29 160.1 33.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 88.1 tttt -100.46 134.56 43.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.07 -40.02 88.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.579 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 96.0 m-20 -61.5 -39.97 92.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.14 92.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.09 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.08 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.84 5.4 41.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.83 179.08 35.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.327 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -109.97 25.57 16.18 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.305 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.751 ' HD3' HD13 ' A' ' 85' ' ' LEU . 61.0 mttm -101.24 135.25 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.272 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.732 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.3 pt -120.24 156.54 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.256 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.5 ' O ' HD22 ' A' ' 50' ' ' LEU . 90.4 m-85 -100.25 130.48 46.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.569 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 HD12 ' A' ' 114' ' ' ILE . 4.0 mm? -129.8 163.31 47.91 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.831 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 60.4 Cg_endo -77.1 149.45 28.52 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.244 1.963 . . . . 0.0 112.82 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.82 -23.8 62.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -59.97 -39.99 87.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.075 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -68.07 -41.28 82.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.996 0.426 . . . . 0.0 110.998 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CD1' ' A' ' 87' ' ' PHE . 58.8 tp -60.95 -43.25 98.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.5 m -60.2 -40.27 89.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.54 -40.01 94.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.2 0.524 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 21' ' ' PHE . 88.2 mt -60.05 -39.98 87.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.046 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.2 m -59.83 -40.01 87.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.123 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -59.97 -36.27 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.254 0.549 . . . . 0.0 110.092 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' A' ' 63' ' ' ILE . 12.4 tp -79.98 1.11 28.75 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.51 47.99 8.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 61' ' ' LEU . 49.2 mm -86.46 121.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -70.21 140.0 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.746 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 40.3 t80 -88.25 147.14 39.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.716 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.746 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 15.0 Cg_exo -71.09 158.91 94.52 Favored 'Cis proline' 0 C--N 1.352 0.752 0 C-N-CA 124.567 -1.014 . . . . 0.0 113.138 0.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 58' ' ' LEU . 68.0 mtt -95.52 139.45 31.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.476 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD22 HG23 ' A' ' 153' ' ' THR . 82.4 mt -107.16 138.33 43.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.716 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.799 ' HB3' HG23 ' A' ' 114' ' ' ILE . 12.3 m-30 -120.09 140.02 51.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.044 0.449 . . . . 0.0 112.027 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HD2' ' CE1' ' A' ' 81' ' ' HIS . 62.6 tttp -119.02 130.18 55.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.744 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -94.25 133.21 38.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.955 ' HA ' HG12 ' A' ' 79' ' ' VAL . 94.2 m -120.01 129.94 54.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.318 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.13 110.82 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.193 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -67.65 -40.0 84.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.531 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -39.92 87.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.502 HG21 ' HA3' ' A' ' 105' ' ' GLY . 67.1 p -101.29 -13.48 18.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.487 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 0.25 26.11 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.795 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -100.4 139.95 35.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 72' ' ' THR . 13.1 m -121.7 117.42 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.021 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.411 HG22 ' OD1' ' A' ' 158' ' ' ASP . 72.0 p -100.97 155.87 17.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.623 ' CD2' ' OG1' ' A' ' 155' ' ' THR . 74.9 m-70 -100.4 114.84 28.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 110.621 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.74 160.01 15.66 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.923 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.732 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.99 164.3 22.56 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.027 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -127.83 133.52 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 117.26 0.53 . . . . 0.0 112.266 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.5 tp -92.03 -78.83 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.911 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -150.78 160.02 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.595 ' CD1' HD22 ' A' ' 55' ' ' LEU . 76.1 m-85 -94.93 116.63 28.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.7 pt -125.89 -8.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -99.55 103.68 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.379 . . . . 0.0 111.786 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.56 -39.98 92.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.293 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.65 -30.33 69.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.179 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.66 74.38 0.79 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.522 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -119.9 140.72 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.323 . . . . 0.0 110.775 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 50' ' ' LEU . 57.3 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 30' ' ' ILE . 87.1 m-85 -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.545 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.879 HD11 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -137.6 156.85 74.58 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.917 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.728 ' HG2' ' HB2' ' A' ' 100' ' ' MET . 37.8 Cg_endo -68.8 158.54 57.43 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.045 1.83 . . . . 0.0 111.459 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.25 -41.13 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 48.1 p-90 -65.76 -38.55 89.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.728 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . 58.2 ttm -60.04 -40.12 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.358 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.615 ' HG3' HD23 ' A' ' 96' ' ' LEU . 97.8 mtp -59.89 -40.01 87.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.92 -40.06 94.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -66.89 -40.23 87.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.357 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.2 mt -70.58 -24.31 62.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.329 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.502 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 72.53 28.85 66.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.5 pt -117.75 142.87 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.409 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.9 pt20 -96.39 159.96 30.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.746 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 85.5 Cg_exo -44.7 138.42 8.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.564 2.176 . . . . 0.0 112.537 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.03 -9.98 75.53 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.765 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.5 m -71.58 150.04 45.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 26' ' ' ARG . 87.3 mt -75.68 144.65 41.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.684 HD23 HG11 ' A' ' 94' ' ' VAL . 59.0 tp -127.05 130.98 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.079 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 97.4 mt-30 -104.3 128.95 52.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.01 HD12 HD11 ' A' ' 50' ' ' LEU . 91.9 mt -119.4 122.69 69.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 74.7 p -121.6 139.28 53.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.53 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.785 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 32.4 m -85.29 122.39 29.39 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 10.0 t -130.02 138.44 50.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.47 128.8 54.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.385 . . . . 0.0 110.344 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 121' ' ' LEU . 33.2 m -115.52 152.25 46.92 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.731 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HB2' ' OE1' ' A' ' 179' ' ' GLU . 67.4 Cg_endo -73.84 16.46 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.187 1.925 . . . . 0.0 112.537 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.929 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.8 mp 64.57 108.32 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.369 . . . . 0.0 111.454 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.93 167.94 1.6 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.55 -28.2 9.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.675 0.238 . . . . 0.0 111.585 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -142.46 132.1 23.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.369 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.7 p -131.33 130.17 62.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 111.327 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 88.3 tttt -99.7 120.09 39.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.66 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 171' ' ' ILE . 85.5 mt -111.44 140.49 45.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 111.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.536 ' OE1' ' HE2' ' A' ' 172' ' ' LYS . 45.0 tt0 -91.71 117.2 67.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.03 159.79 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.516 2.144 . . . . 0.0 112.167 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -136.19 121.51 19.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.2 m 66.79 135.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.29 -21.13 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.87 -40.06 87.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.488 ' HD1' HD12 ' A' ' 135' ' ' LEU . 60.9 t80 -60.03 -40.06 88.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.756 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.488 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -80.72 -10.53 59.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.5 -10.22 59.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.281 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.0 mt -64.18 139.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.745 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.1 p -59.96 -40.05 87.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.349 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 137' ' ' ILE . 6.6 m-20 -127.12 71.92 76.29 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.788 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.92 -32.99 93.12 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.631 2.221 . . . . 0.0 111.879 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.19 -40.2 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.12 97.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.3 t -60.06 -41.15 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 194' ' ' THR . 3.1 tm? -60.3 -44.01 95.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.194 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.1 -39.93 87.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.6 -40.03 95.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 162' ' ' ILE . 75.7 t -61.78 -42.95 96.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HD11 ' A' ' 154' ' ' LEU . 89.6 mt -60.01 -40.05 87.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -65.04 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.86 -40.02 96.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.518 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 96.9 m-85 -105.56 119.69 39.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.768 0.318 . . . . 0.0 111.179 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.465 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 42.7 p -69.83 -35.79 75.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.721 HG23 HD22 ' A' ' 68' ' ' LEU . 34.3 p -124.56 140.32 53.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 111.607 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.683 ' HB2' HG13 ' A' ' 185' ' ' ILE . 90.5 mt -122.1 130.17 53.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.623 ' OG1' ' CD2' ' A' ' 81' ' ' HIS . 25.6 m -119.78 140.12 51.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.015 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 176' ' ' VAL . 98.3 t -60.05 -40.47 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.175 0.512 . . . . 0.0 110.652 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 155' ' ' THR . 11.0 t70 -74.74 -29.43 61.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 93.9 m-20 -78.45 140.14 38.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.93 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.68 120.07 55.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.921 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.454 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.7 pt -103.38 137.93 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.927 0.394 . . . . 0.0 111.379 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 170' ' ' LYS . 99.0 mt-10 -119.98 140.05 51.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.205 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 147' ' ' VAL . 6.0 tt -116.21 135.61 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.729 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.0 t -109.76 115.19 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -123.56 127.35 48.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.5 t30 51.73 40.05 26.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.687 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.56 9.8 86.51 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.975 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 59.5 mttm -111.1 144.1 40.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.8 m -114.75 130.79 56.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.79 140.07 51.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.67 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 62.4 mttp -100.32 121.62 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.552 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.876 HG22 HD22 ' A' ' 127' ' ' LEU . 85.3 mt -120.02 120.01 61.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.711 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 38.5 ttpt -116.2 125.55 52.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 156' ' ' VAL . 4.9 mp -78.45 83.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.429 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 172' ' ' LYS . 76.3 mt -59.99 -49.97 75.6 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 98.9 mt-10 -152.39 138.99 18.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.024 0.44 . . . . 0.0 111.735 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.848 HG11 HD13 ' A' ' 185' ' ' ILE . 16.7 m -140.33 151.57 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.686 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -96.18 104.77 18.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 65.0 Cg_endo -100.3 167.42 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.286 2.657 . . . . 0.0 112.706 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.92 -0.08 40.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.4 p -139.83 159.79 41.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.007 0.432 . . . . 0.0 111.376 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.2 m -70.08 -10.3 58.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 t -57.76 -25.75 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.286 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 181' ' ' SER . 34.2 mmtp 60.02 39.97 19.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.756 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -128.29 139.69 52.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.64 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.848 HD13 HG11 ' A' ' 176' ' ' VAL . 39.9 pt -127.32 131.53 70.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 153' ' ' THR . 23.3 m -139.97 119.95 13.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.08 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 187' ' ' VAL . 9.1 p -118.15 112.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.749 0.785 . . . . 0.0 111.171 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.619 HD13 ' HD2' ' A' ' 66' ' ' PRO . 55.5 mt -71.59 -60.72 2.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.547 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.08 -79.94 0.33 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.1 t -168.05 41.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.929 ' HB2' HD23 ' A' ' 121' ' ' LEU . 94.7 m-20 -88.76 2.09 54.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.548 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.425 ' H ' HG21 ' A' ' 187' ' ' VAL . 56.1 tp -111.6 130.32 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 125' ' ' VAL . 25.6 t -97.35 129.07 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.754 HG21 HD11 ' A' ' 144' ' ' LEU . 69.7 p -112.95 139.82 48.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.36 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.03 140.88 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.417 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 98.3 m-85 -100.02 121.11 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.48 110.48 28.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo . . . . . 0 C--N 1.347 0.488 0 C-N-CA 122.256 1.97 . . . . 0.0 112.26 -179.63 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 65.0 Cg_exo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.825 0.26 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.582 ' OE1' HD13 ' A' ' 63' ' ' ILE . 78.1 mt-30 -112.11 127.15 55.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.0 m -120.02 131.12 55.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.024 0.44 . . . . 0.0 111.755 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 27.7 t80 -124.11 141.06 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.301 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.04 130.58 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.16 0.505 . . . . 0.0 112.045 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -141.83 156.54 45.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.438 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -116.06 124.36 50.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.747 0.308 . . . . 0.0 110.692 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' ' 114' ' ' ILE . 90.8 m-85 -136.03 150.92 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' HD2' ' HG2' ' A' ' 93' ' ' ARG . 7.4 ptp180 -82.24 143.76 31.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.842 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.785 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 46.5 t -98.99 123.14 43.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 112.175 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CB ' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m-85 -117.85 146.24 38.47 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 32' ' ' MET . 71.8 Cg_endo -77.72 105.27 2.0 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.717 2.278 . . . . 0.0 112.953 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.852 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.4 mt -61.39 -40.02 84.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.847 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.02 75.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.814 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . 97.7 mmm -68.34 -30.98 70.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 99.7 mmm -60.34 148.54 36.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -59.94 150.24 29.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.98 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.6 m-20 -59.93 -40.05 87.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -64.4 -40.19 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.77 -40.91 77.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 35' ' ' ASP . 84.5 mmt-85 -122.58 140.08 53.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.798 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 9.8 mtpm? -80.58 149.35 29.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.1 -40.03 88.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.04 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.99 87.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.88 80.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.071 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.659 ' OD1' HG22 ' A' ' 30' ' ' ILE . 98.5 m-20 -60.03 -39.89 87.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.964 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.65 16.76 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.98 168.6 26.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.329 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.15 16.36 58.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.118 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.719 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.1 mttt -100.72 135.57 41.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 111.129 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.5 pt -118.75 150.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.201 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.753 ' O ' HG23 ' A' ' 94' ' ' VAL . 90.1 m-85 -100.51 131.91 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.986 0.422 . . . . 0.0 111.018 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 114' ' ' ILE . 5.4 mp -132.67 162.0 59.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 80.3 Cg_endo -77.28 153.05 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.166 1.91 . . . . 0.0 112.904 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 18.9 Cg_exo -66.27 -18.31 55.47 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.145 2.563 . . . . 0.0 112.545 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.8 t -60.01 -40.0 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.18 82.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.16 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.684 HD21 ' CE1' ' A' ' 87' ' ' PHE . 81.5 mt -60.09 -41.37 92.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.695 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.1 m -60.02 -40.12 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.417 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -68.23 -39.99 82.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 HG13 ' A' ' 63' ' ' ILE . 95.7 mt -60.1 -39.88 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.158 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -59.97 -40.05 87.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 110.261 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -60.01 -39.96 87.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.508 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 21' ' ' PHE . 88.6 mt -81.24 -0.07 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.821 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 39.96 19.29 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.48 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD13 ' OE1' ' A' ' 19' ' ' GLN . 41.4 mm -68.13 136.79 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.682 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -92.42 140.2 29.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.421 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.486 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 43.7 p90 -87.29 155.74 54.4 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.788 ' CD ' HD11 ' A' ' 188' ' ' ILE . 18.0 Cg_exo -66.88 162.49 74.09 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.758 0.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -95.0 130.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.821 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.874 HD11 ' SG ' ' A' ' 186' ' ' CYS . 65.0 mt -114.67 140.1 49.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.653 ' HB3' HG23 ' A' ' 114' ' ' ILE . 35.7 m-85 -120.01 140.08 51.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.734 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.754 ' HG2' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -117.03 130.38 56.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.978 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 112' ' ' LEU . 50.9 mt -96.0 120.98 37.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.82 HG23 HG22 ' A' ' 79' ' ' VAL . 97.3 m -104.03 120.06 40.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.28 115.38 30.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.605 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -67.83 -39.96 83.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.957 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 m -97.16 -14.96 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.34 -6.08 4.69 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.682 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.632 HH21 ' HB3' ' A' ' 157' ' ' ASP . 78.8 ttt180 -100.68 139.97 35.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.82 HG22 HG23 ' A' ' 72' ' ' THR . 47.3 t -118.08 119.99 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.3 p -99.93 159.62 14.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.621 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 74.5 m80 -101.74 115.14 29.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 110.655 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.21 158.26 18.93 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.939 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -91.68 157.07 24.28 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 8.4 p -127.97 134.07 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 117.294 0.547 . . . . 0.0 112.341 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 ' HD3' ' A' ' 47' ' ' LYS . 44.4 tp -91.84 -79.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.558 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -142.65 159.71 41.7 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.719 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 55' ' ' LEU . 72.5 m-85 -97.72 116.39 29.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.61 -4.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -84.58 98.17 10.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.417 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.87 -39.88 76.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 0.0 110.519 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.51 -30.67 71.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.363 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.0 42.97 1.14 Allowed Glycine 0 C--N 1.32 -0.323 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.684 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.671 ' HG2' ' HD2' ' A' ' 26' ' ' ARG . 29.4 mtm105 -117.15 150.9 37.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 112.151 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.769 HG21 HD11 ' A' ' 114' ' ' ILE . 14.8 p -128.78 145.03 36.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.219 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.852 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.1 m-85 -120.54 141.93 49.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.44 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 30' ' ' ILE . 69.8 mt -120.21 142.49 33.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.925 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' MET . 51.3 Cg_exo -57.95 156.97 26.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.511 2.141 . . . . 0.0 111.836 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.03 -41.97 93.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.789 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.645 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 49.3 p-90 -70.0 -40.11 75.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.281 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.645 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 97.4 mtp -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.647 0.26 . . . . 0.0 111.037 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.2 mtp -60.06 -40.03 88.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.052 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 -40.01 94.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 110.496 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.966 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 71' ' ' LEU . 85.8 mt -69.09 -24.25 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.29 29.96 65.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.589 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.593 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 45.6 pt -116.29 144.8 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.333 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -97.4 160.2 29.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.605 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 7.8 Cg_endo -49.2 135.22 31.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.591 2.194 . . . . 0.0 112.136 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 -6.51 82.64 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.699 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.593 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 93.1 p -74.61 157.39 35.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 110.659 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.85 140.03 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.981 0.42 . . . . 0.0 111.02 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.907 HD11 HD22 ' A' ' 71' ' ' LEU . 61.6 tp -127.05 130.13 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.417 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.685 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 64.0 tt0 -107.7 120.24 41.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.769 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -111.37 129.98 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.442 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.637 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 80.6 p -126.38 139.85 52.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' THR . 20.7 t -77.52 120.61 22.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.732 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.2 m -119.99 130.0 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.039 0.447 . . . . 0.0 111.899 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 96.5 m-20 -121.41 119.96 33.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 184' ' ' SER . 16.7 m -120.93 150.02 52.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 2.1 Cg_endo -79.78 142.92 16.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.907 2.405 . . . . 0.0 109.917 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 191' ' ' ASP . 9.8 mt -60.91 120.3 9.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.211 0.529 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.42 160.36 54.02 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 96.6 mt-30 -99.98 -19.94 16.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.154 -0.219 . . . . 0.0 111.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.13 134.96 23.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 111.729 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 ' HA ' ' A' ' 194' ' ' THR . 2.4 p -136.4 129.74 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.612 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 84.7 tttt -97.06 119.97 36.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.022 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.53 HD23 HG13 ' A' ' 173' ' ' ILE . 88.0 mt -113.55 130.44 56.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.223 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.412 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 10.2 tt0 -104.28 110.03 63.54 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.45 170.29 16.13 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.596 2.197 . . . . 0.0 112.437 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 94.1 mt-30 -132.67 122.86 25.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.981 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.0 m 67.87 137.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.755 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.27 -18.26 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.685 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.01 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.533 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 66.4 t80 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.68 -2.0 58.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.551 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.7 mt -58.08 138.99 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.2 p -59.96 -37.65 80.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.555 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.551 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.4 m-20 -118.75 80.45 17.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.8 -32.01 30.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.623 2.216 . . . . 0.0 112.271 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -60.06 -40.84 90.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.09 98.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 147' ' ' VAL . 94.1 t -64.0 -42.55 96.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -59.91 -42.33 93.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.04 -42.11 93.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -59.97 -40.06 87.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.088 0.47 . . . . 0.0 110.59 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.788 HG22 HD13 ' A' ' 162' ' ' ILE . 57.7 t -61.46 -43.78 97.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.249 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.96 -40.24 92.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.803 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -63.32 -40.01 96.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.655 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -59.98 -39.97 87.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.313 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 88.5 m-85 -102.34 122.07 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.046 0.45 . . . . 0.0 111.676 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 68' ' ' LEU . 66.2 m -61.1 -39.98 91.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.218 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.684 ' HB ' HD22 ' A' ' 68' ' ' LEU . 8.2 t -128.05 140.76 51.77 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.983 0.421 . . . . 0.0 111.187 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.732 HD11 HD11 ' A' ' 173' ' ' ILE . 49.8 tp -114.8 121.5 43.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.449 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 157' ' ' ASP . 53.4 m -119.38 140.29 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 176' ' ' VAL . 90.0 t -59.98 -41.51 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.48 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.632 ' HB3' HH21 ' A' ' 78' ' ' ARG . 95.9 m-20 -70.05 -34.92 73.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 95.7 m-20 -73.58 139.34 45.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.252 0.549 . . . . 0.0 112.412 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.9 p -107.31 120.0 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.57 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.595 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 45.2 pt -106.96 138.42 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.043 0.449 . . . . 0.0 112.109 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.788 HD13 HG22 ' A' ' 147' ' ' VAL . 44.6 pt -127.34 141.37 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.2 t -110.73 117.86 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.179 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.459 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 54.0 t80 -120.45 120.28 35.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 56.21 40.05 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.577 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.96 9.89 86.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.089 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.9 mttt -112.74 137.42 51.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.785 0.293 . . . . 0.0 110.381 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.7 p -109.99 129.08 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 111.486 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.533 ' CD1' ' HD1' ' A' ' 134' ' ' PHE . 89.2 m-85 -120.06 140.0 51.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.592 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 97.7 mttt -101.12 124.57 47.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.247 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -119.27 128.95 54.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.006 0.432 . . . . 0.0 110.684 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.768 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.3 mp -83.63 109.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.429 HD12 ' HE2' ' A' ' 126' ' ' LYS . 84.4 mt -67.89 -54.07 21.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.612 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 49.8 mt-10 -157.65 140.36 14.86 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.349 . . . . 0.0 111.212 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 125' ' ' VAL . 4.5 m -140.05 154.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -110.18 102.59 51.59 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.494 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.503 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 63.6 Cg_endo -104.04 -2.69 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.144 3.229 . . . . 0.0 113.201 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 61.67 27.87 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.4 p -140.16 147.37 40.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.985 0.422 . . . . 0.0 111.186 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.7 m -61.66 -40.03 93.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.0 p -60.01 -20.18 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 50.5 mttt 57.23 39.8 28.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.0 111.432 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.611 ' CB ' HG11 ' A' ' 119' ' ' VAL . 41.4 t -121.62 140.81 51.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.153 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 192' ' ' LEU . 17.7 pt -125.24 148.5 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.414 . . . . 0.0 111.475 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.874 ' SG ' HD11 ' A' ' 68' ' ' LEU . 53.0 t -139.27 99.38 3.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.574 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.76 ' HA ' HD21 ' A' ' 121' ' ' LEU . 11.7 p -117.45 113.27 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.783 0.801 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.788 HD11 ' CD ' ' A' ' 66' ' ' PRO . 20.6 mt -77.26 -62.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.29 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.02 -79.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.4 t -161.18 42.87 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.739 0.304 . . . . 0.0 111.662 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.786 ' HB2' HD22 ' A' ' 121' ' ' LEU . 92.7 m-20 -89.74 6.13 42.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 185' ' ' ILE . 31.8 tp -120.45 130.09 54.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.869 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 125' ' ' VAL . 33.0 t -90.45 121.89 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.79 ' HA ' HG13 ' A' ' 125' ' ' VAL . 52.6 p -100.99 151.98 21.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.463 0.649 . . . . 0.0 112.411 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -129.65 139.1 51.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.541 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.84 137.02 46.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.756 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -121.18 165.88 17.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.365 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 13.7 Cg_endo . . . . . 0 C--N 1.344 0.318 0 C-N-CA 122.143 1.895 . . . . 0.0 111.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 46.3 Cg_exo . . . . . 0 C--O 1.23 0.101 0 CA-C-O 120.855 0.273 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.519 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 96.5 mt-30 -105.45 120.44 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 116' ' ' SER . 72.6 p -121.17 129.79 53.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 111.689 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.647 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 78.6 t80 -119.85 139.43 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -106.26 134.86 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.137 0.494 . . . . 0.0 111.976 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.0 mt-10 -141.1 151.37 43.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.92 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -120.53 136.78 54.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.992 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.667 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.3 m-85 -152.57 159.97 43.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.848 0.356 . . . . 0.0 111.082 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.35 140.31 31.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 17.3 t -97.66 125.75 42.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.571 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.45 149.79 44.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.298 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.93 100.47 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.923 2.416 . . . . 0.0 112.326 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.591 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 83.6 mt -60.5 -40.1 83.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 110.406 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -60.01 -32.54 70.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.294 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.2 ttm -66.98 -39.02 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 94.8 mtp -60.9 151.72 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HB2' HD12 ' A' ' 37' ' ' ILE . 98.6 m-20 -59.45 143.8 48.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.184 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.8 m-20 -60.03 -40.05 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.072 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -60.81 -40.04 91.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 110.918 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 34' ' ' ASN . 85.8 mt -68.18 -40.06 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.4 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 35' ' ' ASP . 39.6 mmt180 -116.34 140.18 49.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 111.965 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.83 139.99 55.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -60.11 -39.08 84.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -39.95 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.821 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.93 87.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 30' ' ' ILE . 28.0 m120 -60.03 -41.4 92.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.14 6.92 38.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.714 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.61 171.9 29.54 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.534 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -99.45 18.29 56.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.211 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.852 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.24 131.41 46.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 97' ' ' PRO . 46.2 pt -119.8 151.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.934 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.4 m-85 -101.81 131.38 48.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.145 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 48' ' ' ILE . 5.0 mp -135.86 160.95 65.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 0.0 111.814 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.591 ' CG ' ' HA2' ' A' ' 92' ' ' GLY . 32.3 Cg_exo -63.78 135.68 49.65 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.91 2.406 . . . . 0.0 112.364 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 37.0 Cg_exo -60.4 -20.12 61.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.697 2.265 . . . . 0.0 112.916 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.3 m -60.01 -40.52 89.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.872 0.368 . . . . 0.0 110.781 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -61.75 -39.9 93.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.269 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 59.1 tp -59.97 -40.21 88.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.113 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -59.98 -39.98 87.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -60.76 -39.95 90.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.378 0.609 . . . . 0.0 110.376 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 55' ' ' LEU . 87.7 mt -60.04 -39.5 86.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.8 t -57.76 -38.31 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.3 mtt -60.0 -37.06 78.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.403 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 21' ' ' PHE . 87.6 mt -80.08 -0.06 34.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 59.95 40.06 19.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.697 0.284 . . . . 0.0 111.588 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -86.72 120.07 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 110.436 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -83.56 151.2 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.733 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.507 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 32.6 p90 -87.1 159.85 50.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 23.4 Cg_exo -65.65 147.53 73.14 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.866 0.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.6 mtt -95.58 138.92 32.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.775 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.855 HD22 ' HB ' ' A' ' 153' ' ' THR . 32.3 mt -114.05 139.34 49.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.667 ' HB3' HD11 ' A' ' 114' ' ' ILE . 94.6 m-85 -131.55 145.42 51.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.235 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.75 ' HB3' ' CD2' ' A' ' 81' ' ' HIS . 22.4 pttp -122.21 140.32 52.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -98.58 128.09 44.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 113' ' ' GLN . 23.0 p -105.17 136.4 44.74 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.07 113.79 22.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.724 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -65.92 -39.07 90.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.814 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.89 -40.09 87.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.924 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -102.96 -14.49 16.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.94 41.49 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.744 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -101.22 140.16 35.89 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.022 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.553 ' CG1' HG22 ' A' ' 72' ' ' THR . 41.6 t -119.99 121.41 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.685 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 80.1 p -102.45 156.34 17.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.75 ' CD2' ' HB3' ' A' ' 70' ' ' LYS . 77.5 m80 -101.76 114.85 29.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.37 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.24 167.1 17.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.756 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.649 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.99 162.91 26.49 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.539 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.0 p -129.67 131.99 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 111.709 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.852 HD13 ' HD3' ' A' ' 47' ' ' LYS . 61.2 tp -93.38 -80.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.115 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.9 161.04 43.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 89.1 m-85 -95.3 116.48 28.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 pt -125.57 -4.62 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.84 98.12 11.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.136 0.493 . . . . 0.0 111.557 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.07 75.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.96 -30.35 69.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.887 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.591 ' HA2' ' CG ' ' A' ' 51' ' ' PRO . . . 112.35 49.3 0.61 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.611 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.661 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 99.6 mtt180 -121.1 149.48 42.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.84 0.353 . . . . 0.0 111.558 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 49' ' ' PHE . 7.4 p -128.93 142.82 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.002 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 97.5 m-85 -114.02 137.6 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 97' ' ' PRO . 1.8 tp -119.57 137.57 25.65 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 96' ' ' LEU . 52.6 Cg_exo -53.25 145.55 43.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.45 2.1 . . . . 0.0 112.372 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 59.0 tt0 -60.05 -43.66 95.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.829 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 100' ' ' MET . 59.1 p-90 -69.98 -41.18 74.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.558 ' CG ' HD11 ' A' ' 96' ' ' LEU . 43.8 tpp -61.18 -40.32 93.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.555 ' HA ' HD21 ' A' ' 96' ' ' LEU . 57.1 ttm -60.06 -41.23 91.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.124 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.1 -40.07 94.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.519 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.02 -40.07 96.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.44 -23.63 63.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.216 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.76 34.85 29.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.998 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 101' ' ' MET . 45.1 pt -119.77 146.99 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -95.8 157.15 36.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.428 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.39 138.07 30.83 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.399 2.066 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.9 75.74 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.15 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 53.6 m -71.03 149.98 46.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.096 0.448 . . . . 0.0 110.669 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 112' ' ' LEU . 10.4 tt -71.04 140.15 50.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 71' ' ' LEU . 59.3 tp -126.76 130.46 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.639 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 93.7 mt-30 -109.19 130.31 55.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 69' ' ' PHE . 18.7 tt -118.29 128.38 75.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 111.443 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 42.3 t -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.859 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 61.4 m -70.11 130.24 41.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.704 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.7 m -120.08 130.03 54.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.831 0.348 . . . . 0.0 111.086 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 98.0 m-20 -119.33 120.04 35.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.227 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.15 153.62 44.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.911 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.28 17.69 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.823 2.348 . . . . 0.0 112.292 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.603 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.2 OUTLIER 70.11 100.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.974 0.416 . . . . 0.0 111.968 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -57.02 156.82 12.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.244 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.24 -27.22 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -139.56 130.92 26.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.971 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 1.043 HG13 HG22 ' A' ' 194' ' ' THR . 2.6 p -130.02 130.19 65.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.211 0.529 . . . . 0.0 111.548 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.557 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 87.9 tttt -99.42 120.73 40.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.503 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.72 HD22 ' CG2' ' A' ' 171' ' ' ILE . 83.6 mt -108.76 135.51 49.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.408 . . . . 0.0 111.57 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.89 ' HB2' ' HG ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -107.39 119.92 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.905 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' A' ' 198' ' ' PRO . 91.2 Cg_endo -81.46 169.1 15.86 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.16 1.907 . . . . 0.0 111.573 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -138.25 121.62 17.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' ASP . 0.5 OUTLIER 63.32 26.74 15.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m 36.84 27.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.372 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 96.2 m-20 -68.54 -39.95 80.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 140' ' ' PRO . 64.0 t80 -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.61 -24.13 63.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.4 mt -57.5 139.01 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.83 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -60.28 -40.04 88.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.57 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 137' ' ' ILE . 79.7 m-20 -121.68 75.16 35.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.772 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 42.3 Cg_endo -69.07 -34.93 15.73 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.786 2.324 . . . . 0.0 112.232 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.64 -40.65 92.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.49 98.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 147' ' ' VAL . 70.8 t -61.14 -42.58 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.09 -42.48 94.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.28 -42.27 95.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.56 -40.04 95.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 143' ' ' VAL . 95.5 t -62.01 -40.32 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.004 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.774 HD23 HD11 ' A' ' 154' ' ' LEU . 90.3 mt -60.31 -40.48 90.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.03 -39.96 87.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.531 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.79 -40.03 93.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.106 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.6 m-85 -103.0 121.42 42.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.518 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.496 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 74.0 m -61.15 -40.02 92.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.855 ' HB ' HD22 ' A' ' 68' ' ' LEU . 4.8 t -136.35 147.8 47.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.355 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.774 HD11 HD23 ' A' ' 148' ' ' LEU . 84.9 mt -121.39 138.47 54.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.364 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 81' ' ' HIS . 54.6 m -116.08 136.08 53.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.701 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 7.2 p -59.81 -39.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.06 -21.16 33.85 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.7 t0 -78.95 136.28 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.515 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.407 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 15.7 m -100.34 120.66 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.167 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.15 138.93 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.284 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 96.5 mt-10 -120.05 139.99 51.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -129.31 140.04 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.3 t -110.13 114.5 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.378 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.13 122.3 40.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.595 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.2 t30 56.41 39.99 29.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.11 12.31 84.19 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.126 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 163' ' ' SER . 58.3 mttm -118.19 139.07 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.903 0.352 . . . . 0.0 110.664 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.5 p -109.53 133.62 52.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.1 m-85 -119.99 138.65 53.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 99.6 mttt -104.76 122.66 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.72 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 119.97 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.393 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -115.39 130.03 56.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -81.71 104.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.947 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' ' 128' ' ' GLU . 80.7 mt -60.53 -48.96 79.47 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.1 mt-10 -158.89 139.91 12.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 156' ' ' VAL . 11.1 m -143.23 151.62 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.957 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -116.93 103.16 52.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.395 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.505 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 97.3 Cg_endo -100.08 12.32 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.734 2.956 . . . . 0.0 112.278 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 80.7 tt0 60.75 20.01 10.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.451 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 79.3 p -146.78 152.82 39.4 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.7 m -70.0 -18.56 63.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.548 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.7 t -59.9 -25.52 65.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 60.18 40.04 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 0.0 110.89 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 p -122.38 142.65 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.224 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 44.9 pt -130.18 140.03 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 68' ' ' LEU . 44.1 t -134.65 138.11 44.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.042 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.721 HG23 ' CB ' ' A' ' 190' ' ' THR . 8.2 p -170.11 67.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.3 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 152' ' ' SER . 84.8 mt -70.0 -40.02 78.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.53 -10.08 8.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.686 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.721 ' CB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -78.95 174.49 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.42 118.35 36.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.399 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 187' ' ' VAL . 25.2 tp -120.4 138.01 54.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.134 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 26.4 t -92.43 119.99 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' THR . . . . . 1.043 HG22 HG13 ' A' ' 125' ' ' VAL . 65.9 p -120.87 140.61 51.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.339 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -121.15 139.44 53.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.326 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -105.41 120.0 40.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -132.64 107.65 13.05 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 129' ' ' PRO . 71.0 Cg_endo . . . . . 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 113.149 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.462 -0.353 0 CA-C-O 120.739 0.224 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 97.0 mt-30 -103.27 123.25 46.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.722 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 116' ' ' SER . 9.0 t -129.98 139.93 50.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 115' ' ' SER . 69.2 t80 -121.58 139.99 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.558 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -104.67 130.41 52.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.84 147.62 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.0 120.11 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.727 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 47.2 m-85 -140.69 151.77 44.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.997 0.427 . . . . 0.0 111.221 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.06 131.78 35.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 19.3 p -90.17 143.4 26.81 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.304 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 43.6 m-85 -138.37 157.22 72.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.203 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.91 109.11 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.507 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.836 HG12 ' HB3' ' A' ' 95' ' ' TYR . 85.6 mt -60.15 -40.03 82.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -59.69 -23.79 63.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.3 ttp -68.2 -36.62 79.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.493 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 97.0 mtp -59.91 141.8 54.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.11 151.9 25.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.702 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -54.03 -29.96 45.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.282 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 ttt-85 -60.05 -39.9 87.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.531 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -113.06 10.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.143 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 31' ' ' ALA . 41.7 ttt180 -113.59 129.99 56.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.008 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.25 129.21 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.36 -40.21 89.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.161 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -64.24 -40.0 95.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.89 91.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -59.97 -40.18 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.36 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.92 2.22 34.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.676 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.94 175.3 32.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.148 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.53 10.49 61.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.392 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 85' ' ' LEU . 63.7 mttp -80.54 129.78 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.7 pt -120.06 154.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.789 ' C ' HD22 ' A' ' 50' ' ' LEU . 96.0 m-85 -99.33 134.46 42.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.629 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.4 mm? -131.16 160.08 68.65 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.651 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 97.6 Cg_endo -83.51 149.44 12.97 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.002 1.801 . . . . 0.0 112.735 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.2 Cg_exo -61.15 -29.1 86.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.116 2.544 . . . . 0.0 112.861 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.94 87.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -67.29 -40.26 86.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.094 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.5 tp -60.03 -39.99 87.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -60.03 -40.08 88.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 98.8 mttt -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 69' ' ' PHE . 87.1 mt -61.68 -39.87 92.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.612 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -59.75 -37.54 79.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.84 -35.94 75.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.448 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HD1' ' A' ' 21' ' ' PHE . 93.1 mt -79.98 -3.88 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.238 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 60.0 40.13 19.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.794 0.33 . . . . 0.0 111.538 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 58' ' ' LEU . 85.2 mt -76.23 129.94 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.999 0.428 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -73.3 141.93 47.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.376 0.608 . . . . 0.0 111.892 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.515 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.1 p90 -87.63 153.62 52.94 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 56.5 Cg_endo -70.78 152.18 94.68 Favored 'Cis proline' 0 C--N 1.35 0.611 0 C-N-CA 123.486 -1.464 . . . . 0.0 112.912 0.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 58' ' ' LEU . 67.5 mtt -84.69 140.49 31.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.866 HD13 HG22 ' A' ' 153' ' ' THR . 67.1 mt -111.2 137.33 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.081 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 58' ' ' LEU . 50.6 m-85 -130.59 143.74 50.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.069 0.461 . . . . 0.0 111.54 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 4.5 ttpm? -120.03 137.44 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.64 131.19 43.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.5 ' OG1' HG12 ' A' ' 79' ' ' VAL . 63.9 m -119.71 130.01 54.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.28 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.73 114.26 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.53 -39.98 89.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.4 -40.04 89.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.211 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -102.67 -9.09 20.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.717 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.95 12.85 16.69 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.85 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.65 140.34 37.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.698 0.285 . . . . 0.0 110.564 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG12 ' OG1' ' A' ' 72' ' ' THR . 27.1 m -119.88 119.79 61.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.063 0.459 . . . . 0.0 111.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 76.4 p -105.99 143.4 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.51 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.696 ' HE2' HG21 ' A' ' 117' ' ' THR . 80.0 m80 -93.76 114.55 26.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.752 0.311 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.13 159.98 13.78 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.817 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.91 162.84 26.55 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.386 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.676 HG23 HD23 ' A' ' 50' ' ' LEU . 10.8 p -124.74 130.61 73.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.0 112.19 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.541 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.1 tp -90.14 -79.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.22 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.01 160.13 42.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 86.1 m-85 -92.78 116.46 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.915 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.2 pt -122.99 -6.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB1' ' HG2' ' A' ' 93' ' ' ARG . . . -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.723 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -39.99 76.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.887 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -67.22 -30.77 70.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.99 67.81 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.848 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.746 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 22.5 ptt-85 -135.05 154.92 51.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 111.158 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.494 ' CG1' HD23 ' A' ' 112' ' ' LEU . 11.9 p -129.19 140.17 49.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.836 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.07 139.96 51.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.262 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -131.17 156.28 80.35 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.685 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 57.9 Cg_endo -68.12 160.01 50.62 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.712 2.275 . . . . 0.0 112.094 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.22 -40.25 89.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 50.5 p-90 -65.19 -40.06 93.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.886 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.428 ' HG3' ' HG2' ' A' ' 97' ' ' PRO . 61.0 mtt -63.44 -40.18 96.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.462 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 ttp -60.06 -40.49 89.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.582 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.8 m -68.39 -39.96 81.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.697 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.97 -24.01 63.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.25 30.18 69.69 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.125 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.18 149.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.491 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 36.1 mt-30 -95.86 159.85 31.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.608 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 26.6 Cg_endo -62.61 0.09 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.424 2.083 . . . . 0.0 113.147 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.94 -20.38 9.93 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.3 p -80.8 160.13 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 111.09 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.2 151.74 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 59.5 tp -120.13 130.88 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.573 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.9 123.31 47.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.871 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 23' ' ' GLU . 20.5 tt -119.5 121.65 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 46.6 t -120.04 126.53 51.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' THR . 34.9 t -63.69 131.0 46.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.6 m -120.0 130.01 54.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 96.1 m-20 -118.55 125.44 49.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.139 0.495 . . . . 0.0 110.438 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 186' ' ' CYS . 33.6 m -114.2 150.9 44.43 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.605 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 73.0 Cg_endo -73.89 18.55 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.834 2.356 . . . . 0.0 112.531 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 190' ' ' THR . 6.1 tt 61.23 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.874 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.41 34.01 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.615 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.02 -16.8 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -140.0 142.18 36.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.816 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.878 ' CG1' HG22 ' A' ' 194' ' ' THR . 8.4 p -137.71 136.09 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.823 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 29.2 mmtm -98.91 124.7 44.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.431 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.687 HD12 ' HB ' ' A' ' 194' ' ' THR . 83.7 mt -113.73 131.0 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.013 0.435 . . . . 0.0 111.598 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -104.49 119.33 54.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 94.9 Cg_endo -77.83 160.39 30.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -125.93 121.4 33.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.983 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t 56.77 160.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.155 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 m -71.89 -21.59 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -59.98 -40.09 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.702 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.75 -40.22 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.046 0.451 . . . . 0.0 110.496 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.06 -0.41 57.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.298 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -60.01 -40.04 87.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.8 mt -55.21 139.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.938 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.9 p -60.18 -40.66 90.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -120.94 76.68 29.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.33 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.94 -28.69 16.05 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.425 2.084 . . . . 0.0 111.927 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.71 -40.05 93.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.93 98.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.18 -40.29 88.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -60.36 -41.26 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.28 88.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.274 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.72 -39.96 95.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 110.367 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 162' ' ' ILE . 84.5 t -61.75 -40.02 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.547 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -59.98 -40.17 88.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -62.77 -40.01 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.99 93.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.934 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.18 121.84 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 111.071 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 188' ' ' ILE . 36.1 p -70.07 -39.93 75.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.866 HG22 HD13 ' A' ' 68' ' ' LEU . 11.1 p -119.37 138.59 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.547 HD11 HD22 ' A' ' 148' ' ' LEU . 87.0 mt -124.0 124.87 43.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 22.8 m -121.36 139.17 53.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.56 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.91 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 31.1 m -60.19 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.325 0.583 . . . . 0.0 111.336 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -68.23 -40.06 82.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.621 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.91 140.24 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.126 0.488 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.3 p -105.18 121.88 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.286 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.3 pt -105.96 138.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 111.277 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.472 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.0 mt-10 -120.07 140.12 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.504 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.819 HD13 HG21 ' A' ' 147' ' ' VAL . 45.9 pt -129.72 141.6 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.099 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.696 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 17.8 m -107.5 120.87 43.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 111.569 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.496 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 65.0 t80 -120.67 119.56 33.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.223 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.496 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 12.4 m120 54.44 40.11 31.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.657 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.75 83.73 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -114.37 139.25 49.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.756 0.278 . . . . 0.0 110.473 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.526 HG22 ' OG ' ' A' ' 163' ' ' SER . 68.1 p -108.89 127.64 54.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.331 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.02 139.98 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.483 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 98.2 mttt -99.99 123.37 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.875 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.98 119.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.833 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -120.11 126.65 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.769 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.91 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -80.95 111.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 174' ' ' LEU . 8.0 tt -59.02 -58.26 9.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.823 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.3 tt0 -158.89 141.47 14.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.263 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.839 HG13 ' CG1' ' A' ' 156' ' ' VAL . 18.6 m -130.05 160.02 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.94 103.94 22.56 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.0 Cg_endo -103.48 166.81 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.768 2.978 . . . . 0.0 112.125 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.9 mt-10 -99.96 3.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 159.88 41.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 69.6 p -70.11 -10.14 57.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.07 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -59.84 -19.94 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 111.114 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 56.65 39.82 29.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.029 0.442 . . . . 0.0 111.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -129.94 141.91 50.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.908 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 192' ' ' LEU . 45.3 pt -128.51 141.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.108 0.48 . . . . 0.0 112.033 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.637 ' SG ' HD11 ' A' ' 68' ' ' LEU . 41.8 t -129.22 125.73 37.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.093 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.779 HG23 ' OG1' ' A' ' 190' ' ' THR . 11.0 p -155.05 64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.049 0.452 . . . . 0.0 111.395 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 152' ' ' SER . 85.0 mt -68.65 -39.98 81.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.137 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.13 -10.12 9.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.107 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.779 ' OG1' HG23 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -81.38 176.34 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.248 0.547 . . . . 0.0 111.404 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.56 117.2 33.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.316 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 125' ' ' VAL . 30.9 tp -120.49 137.25 54.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.754 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.97 121.16 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.368 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.878 HG22 ' CG1' ' A' ' 125' ' ' VAL . 62.6 p -115.69 144.27 44.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.799 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -126.5 140.07 52.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.631 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -103.33 126.56 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.416 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -127.75 105.25 20.86 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.518 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 C--N 1.344 0.307 0 C-N-CA 122.419 2.08 . . . . 0.0 112.464 -179.405 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.23 0.115 0 CA-C-O 120.866 0.277 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -108.69 128.87 55.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.532 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.5 m -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.7 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 20.1 t80 -133.65 130.26 38.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.42 134.26 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 112.04 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.4 mt-10 -139.26 159.12 42.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.894 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -121.26 136.88 54.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.439 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 94.7 m-85 -147.13 160.08 42.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.338 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.427 ' O ' HG12 ' A' ' 94' ' ' VAL . 98.2 mtt180 -89.13 121.95 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 110.408 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.843 ' HB2' HD22 ' A' ' 96' ' ' LEU . 32.0 p -95.44 141.76 28.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 53.8 m-85 -123.98 148.35 56.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.508 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 16.4 Cg_exo -68.87 108.74 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.788 2.325 . . . . 0.0 112.305 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.621 ' CG2' ' HD2' ' A' ' 38' ' ' ARG . 91.2 mt -59.97 -38.77 77.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.206 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.02 30.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.445 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 70.6 mtm -67.88 -39.58 83.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.871 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . 93.1 mtp -60.19 144.78 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.904 0.383 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.0 m-20 -60.05 145.56 46.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.799 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -60.05 -39.89 87.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.103 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -59.95 -40.04 87.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.7 mt -83.72 -1.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.871 ' HD3' ' HB2' ' A' ' 33' ' ' MET . 44.4 mtm180 -119.48 155.51 31.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.982 0.42 . . . . 0.0 111.882 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 87.6 tttt -100.56 131.49 46.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.332 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.634 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.637 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.2 m-20 -62.58 -39.96 95.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.95 95.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.03 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.284 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.4 -0.0 30.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.563 0.221 . . . . 0.0 111.403 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -99.78 -179.6 30.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.62 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.11 23.39 34.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.134 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.4 mttt -81.1 126.97 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.968 0.413 . . . . 0.0 111.752 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.89 HD12 HD13 ' A' ' 114' ' ' ILE . 49.3 pt -119.99 150.04 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.86 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 94' ' ' VAL . 91.3 m-85 -102.71 133.92 46.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 48' ' ' ILE . 3.9 mp -138.13 161.69 58.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.265 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 59.7 Cg_endo -71.98 149.16 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.114 1.876 . . . . 0.0 112.238 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.98 -23.66 67.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.589 2.192 . . . . 0.0 112.591 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.6 p -60.14 -39.9 87.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.71 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.07 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' A' ' 58' ' ' LEU . 58.6 tp -63.9 -40.12 95.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.835 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.0 m -60.02 -41.33 91.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 111.049 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 88.1 tttt -61.95 -39.87 93.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.321 0.581 . . . . 0.0 110.382 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.762 HD13 ' HE2' ' A' ' 67' ' ' MET . 88.3 mt -59.99 -39.41 85.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.638 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.1 m -59.96 -39.06 84.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 ttm -59.98 -38.45 82.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.772 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.86 -3.87 43.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.643 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.06 40.03 19.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.707 HG21 ' HE1' ' A' ' 67' ' ' MET . 11.0 tt -77.59 137.21 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.712 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -70.08 140.01 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.014 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 30.7 p90 -95.25 157.35 36.52 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.359 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 188' ' ' ILE . 15.6 Cg_exo -69.55 171.34 53.25 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.746 -1.356 . . . . 0.0 112.77 0.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.762 ' HE2' HD13 ' A' ' 58' ' ' LEU . 81.7 mmm -85.92 139.87 30.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.092 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.731 HD22 HG22 ' A' ' 153' ' ' THR . 64.4 mt -108.34 128.42 54.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.664 ' HB3' HG23 ' A' ' 114' ' ' ILE . 13.5 m-85 -121.95 140.04 52.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 50.2 pttt -126.38 138.22 53.53 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.247 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 112' ' ' LEU . 8.1 mp -99.0 120.31 39.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.42 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.737 ' CB ' HG22 ' A' ' 79' ' ' VAL . 7.6 t -109.62 122.97 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 111.264 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.25 28.16 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.041 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -60.38 -39.99 89.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.894 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -103.27 -10.66 18.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.87 12.19 41.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.302 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -103.47 133.06 49.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' CB ' ' A' ' 72' ' ' THR . 39.8 t -119.96 119.71 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.204 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.4 p -103.12 160.03 15.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.192 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 80.6 m80 -100.65 114.28 27.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.119 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.31 169.72 19.86 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.833 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.06 163.64 23.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.179 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.505 HG21 ' CE2' ' A' ' 69' ' ' PHE . 12.2 p -127.88 130.02 69.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.189 0.494 . . . . 0.0 112.084 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 ' HD3' ' A' ' 47' ' ' LYS . 60.6 tp -91.33 -78.16 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.191 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -154.63 160.53 41.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.003 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 91.3 m-85 -95.03 116.48 28.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -130.9 -4.82 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -86.91 97.85 10.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.07 0.462 . . . . 0.0 111.232 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -39.95 75.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.749 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.67 -30.5 68.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.663 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.9 49.77 0.72 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.113 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.71 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 84.3 mtm180 -116.27 148.44 40.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.881 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 114' ' ' ILE . 11.2 p -130.08 142.4 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.152 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 28' ' ' TYR . 87.0 m-85 -119.93 139.96 51.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 27' ' ' CYS . 2.3 pt? -122.81 148.7 54.42 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 111.388 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.66 149.22 69.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.69 2.26 . . . . 0.0 112.084 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -60.03 -41.08 91.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.479 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -70.0 -40.02 75.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 71' ' ' LEU . 57.6 ttm -61.41 -40.07 93.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.667 ' HE2' HD21 ' A' ' 96' ' ' LEU . 58.4 ttm -60.37 -40.75 91.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.218 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.77 -39.99 94.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 110.496 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.2 -40.05 96.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.536 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.46 -24.02 63.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.25 31.84 53.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.684 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -111.98 140.0 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.407 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 30.0 pt20 -96.93 160.24 29.61 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 96.1 Cg_exo -43.44 136.09 6.22 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.655 2.236 . . . . 0.0 112.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.76 79.23 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.466 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.6 t -70.02 153.15 43.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.39 141.22 28.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.654 HD21 ' CD2' ' A' ' 71' ' ' LEU . 59.4 tp -125.53 129.91 50.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.61 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 95.8 mt-30 -111.32 130.93 55.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -109.97 129.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.896 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.662 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 20.2 m -121.96 132.54 54.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 29.4 t -88.67 116.16 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.237 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 81.8 p -125.77 139.84 53.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.507 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -111.11 114.74 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.09 148.52 45.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 34.7 Cg_exo -62.04 175.26 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.342 2.028 . . . . 0.0 112.301 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 187' ' ' VAL . 0.3 OUTLIER -94.97 120.88 35.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.718 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -69.87 133.63 25.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.85 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' CD2' ' A' ' 124' ' ' PHE . 58.4 tt0 -60.39 -44.01 96.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.633 0.254 . . . . 0.0 111.521 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.5 ' CE1' HG11 ' A' ' 193' ' ' VAL . 12.2 m-85 -138.67 145.31 40.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.126 0.489 . . . . 0.0 112.223 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.891 ' CG1' HG22 ' A' ' 194' ' ' THR . 6.5 p -131.81 130.38 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.928 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.915 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 30.4 mttm -97.61 126.42 42.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.306 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 144' ' ' LEU . 85.1 mt -111.48 134.98 52.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.38 109.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.407 ' HG2' ' O ' ' A' ' 197' ' ' ALA . 6.5 Cg_exo -72.19 159.96 48.46 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.471 2.114 . . . . 0.0 112.417 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.3 tt0 -129.36 121.37 27.28 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m 69.55 130.68 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.03 -25.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.435 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -39.97 87.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.99 -39.91 87.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.27 -10.64 58.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.354 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.02 -12.32 61.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.72 0.295 . . . . 0.0 111.384 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -60.01 138.79 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.579 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 t -60.81 -40.08 91.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.457 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 21.8 m-20 -129.89 74.55 80.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 60.2 Cg_endo -73.4 -26.62 14.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.482 2.121 . . . . 0.0 111.92 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.03 -40.07 88.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.68 88.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.1 t -65.85 -40.34 87.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 127' ' ' LEU . 2.9 tm? -60.93 -43.04 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.521 ' HG3' ' OG1' ' A' ' 190' ' ' THR . 86.3 tt0 -59.94 -40.65 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.14 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.12 -40.06 92.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.632 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 162' ' ' ILE . 95.4 t -60.04 -41.16 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.367 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -60.08 -40.15 88.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -62.27 -39.97 94.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.844 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.12 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.05 117.25 33.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 0.0 111.205 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.649 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 67.4 m -63.11 -40.06 96.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.731 HG22 HD22 ' A' ' 68' ' ' LEU . 81.1 p -123.38 140.54 52.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.864 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 148' ' ' LEU . 88.9 mt -119.85 127.21 52.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.207 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 94.6 m -118.7 137.41 53.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.779 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.75 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.4 t -60.06 -41.11 85.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.382 0.611 . . . . 0.0 111.188 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 155' ' ' THR . 95.7 m-20 -70.83 -38.99 73.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.485 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.505 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.5 t0 -66.19 134.25 52.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.626 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 1.078 HG12 ' HG2' ' A' ' 172' ' ' LYS . 15.4 m -98.96 119.98 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.129 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 171' ' ' ILE . 48.3 pt -102.36 134.84 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.983 0.42 . . . . 0.0 111.351 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 98.1 mt-10 -120.09 139.97 51.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.149 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 147' ' ' VAL . 45.2 pt -126.22 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.683 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.9 t -103.95 118.32 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.7 t80 -121.98 119.13 30.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.158 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 53.02 40.05 30.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.251 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.0 75.82 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.198 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.4 mttt -119.93 137.93 53.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.885 0.343 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.8 p -107.99 130.86 55.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.407 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 87.4 m-85 -119.97 140.05 51.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.741 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 58.7 mttp -100.79 128.0 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.846 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.617 ' HB ' HG13 ' A' ' 160' ' ' ILE . 48.7 mm -119.97 120.36 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 1.078 ' HG2' HG12 ' A' ' 159' ' ' VAL . 99.0 mttt -114.58 131.15 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.75 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.6 OUTLIER -73.8 96.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.787 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.7 tt -59.82 -52.08 66.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.915 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -160.87 142.52 12.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 185' ' ' ILE . 11.5 m -142.1 161.36 20.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -118.5 102.78 49.78 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 77.6 Cg_endo -100.77 175.9 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.683 2.922 . . . . 0.0 112.638 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.7 mt-10 -97.42 -0.04 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.798 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.2 m -133.65 156.05 48.59 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.114 0.483 . . . . 0.0 111.458 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 55.5 m -70.7 -10.61 59.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.3 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -59.86 -23.87 63.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 111.291 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 60.41 40.03 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.428 . . . . 0.0 110.904 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 66.2 m -127.74 142.77 51.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 176' ' ' VAL . 13.9 mt -119.91 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' A' ' 68' ' ' LEU . 82.4 m -143.31 151.71 40.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.783 HG22 ' H ' ' A' ' 189' ' ' GLU . 7.3 p -178.16 -55.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 152' ' ' SER . 54.7 mt 68.66 -1.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 187' ' ' VAL . 99.9 mt-10 -99.71 9.83 42.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.986 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.521 ' OG1' ' HG3' ' A' ' 145' ' ' GLU . 7.1 t 48.27 41.38 16.0 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -108.76 20.03 18.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.635 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.595 ' CD1' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -106.73 139.73 40.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.465 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 124' ' ' PHE . 23.4 t -90.09 121.2 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.766 0.317 . . . . 0.0 110.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.891 HG22 ' CG1' ' A' ' 125' ' ' VAL . 16.4 p -113.19 140.58 47.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 111.73 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -120.6 145.21 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.401 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.26 134.55 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 111.603 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . -117.32 161.29 33.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.38 2.053 . . . . 0.0 112.433 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.463 -0.271 0 CA-C-O 121.003 0.335 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 117' ' ' THR . 7.2 tt0 -117.74 137.77 52.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 m -119.97 130.98 55.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 56.1 t80 -133.64 132.79 41.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.391 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.49 135.82 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.74 150.87 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.722 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.4 123.14 48.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 110.931 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 114' ' ' ILE . 83.5 m-85 -130.89 147.22 52.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.966 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 94' ' ' VAL . 94.8 mtt-85 -81.75 149.46 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 21.9 m -84.95 133.36 34.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.582 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 86.7 m-85 -133.69 149.96 73.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -87.73 100.56 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.049 2.499 . . . . 0.0 113.514 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.858 HG22 ' OD1' ' A' ' 43' ' ' ASN . 87.6 mt -62.67 -41.37 91.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 110.349 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.23 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.412 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 98.1 mtp -68.1 -29.2 68.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.4 ttt -60.07 152.64 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -58.83 139.28 56.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 111.342 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ARG . 96.0 m-20 -63.93 -40.15 95.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -60.21 -40.71 91.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.324 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.38 -48.66 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 35' ' ' ASP . 97.3 mtt180 -125.0 143.36 50.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.072 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.41 148.78 47.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -60.12 -26.7 66.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.99 -39.7 86.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.355 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.38 82.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.858 ' OD1' HG22 ' A' ' 30' ' ' ILE . 97.8 m-20 -59.99 -39.73 86.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.733 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.88 8.27 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.581 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.28 29.4 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.73 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.65 22.82 38.14 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 85' ' ' LEU . 72.1 tttt -98.33 124.44 42.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 0.0 111.15 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.592 ' CD1' HD11 ' A' ' 50' ' ' LEU . 44.2 pt -113.44 149.69 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.3 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 94' ' ' VAL . 95.7 m-85 -101.58 134.44 44.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 110.732 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 69' ' ' PHE . 5.3 mp -134.08 161.78 61.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.246 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 73.9 Cg_endo -75.13 158.73 41.55 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.65 2.234 . . . . 0.0 113.188 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.856 ' HA ' HD23 ' A' ' 55' ' ' LEU . 73.8 Cg_endo -74.87 -13.39 21.73 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.054 2.503 . . . . 0.0 113.125 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -59.99 -40.0 87.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 111.525 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.524 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 52' ' ' PRO . 3.2 mm? -59.97 -40.02 87.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.78 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -59.98 -39.95 87.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.958 0.408 . . . . 0.0 110.092 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 98.6 mttt -69.12 -40.04 78.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.321 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.729 HD12 HD13 ' A' ' 55' ' ' LEU . 92.3 mt -59.9 -40.0 87.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.134 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -40.03 88.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.3 mtp -59.93 -40.03 87.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.792 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -82.32 -1.95 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.784 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.1 t30 59.87 40.1 19.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.596 HG12 ' NE2' ' A' ' 19' ' ' GLN . 58.6 mt -82.64 131.29 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.857 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -81.84 149.96 28.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.511 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 49.8 p90 -87.35 157.97 52.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.664 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 74.4 Cg_endo -75.13 161.55 94.54 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.608 -1.414 . . . . 0.0 112.771 0.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.503 ' HE1' HD22 ' A' ' 58' ' ' LEU . 66.4 mmm -87.27 139.04 30.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 117' ' ' THR . 75.5 mt -108.85 134.35 51.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.7 m-85 -120.05 140.65 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 112.301 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -114.92 128.17 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.783 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 91.0 mt -99.01 127.54 44.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.9 ' HA ' HG12 ' A' ' 79' ' ' VAL . 88.5 m -120.02 130.08 54.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.117 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 117.98 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.91 -39.87 75.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -39.95 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.044 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 28.0 m -105.09 -15.38 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.793 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 5.11 57.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.223 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.69 140.05 34.45 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.125 0.488 . . . . 0.0 110.279 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 72' ' ' THR . 24.6 m -120.05 117.53 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.873 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.614 ' OG1' HD21 ' A' ' 104' ' ' LEU . 82.2 p -102.75 144.63 30.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.566 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.689 ' CD2' HG23 ' A' ' 155' ' ' THR . 0.1 OUTLIER -85.97 114.4 22.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.32 144.93 17.35 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.082 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.29 130.52 10.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.977 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.6 p -119.88 130.79 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.32 . . . . 0.0 111.479 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 47' ' ' LYS . 88.8 mt -110.24 -33.41 6.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.133 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.13 154.42 40.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 112.325 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 55' ' ' LEU . 81.8 m-85 -107.89 118.91 37.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.625 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 38' ' ' ARG . 46.8 pt -125.41 -5.01 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.669 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -89.17 98.71 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 0.0 111.414 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -40.03 78.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.941 0.4 . . . . 0.0 111.187 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.77 -29.88 67.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.278 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.91 49.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.928 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.669 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 89.1 mtm180 -119.44 149.8 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.523 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 114' ' ' ILE . 9.9 p -124.97 142.24 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.393 0.616 . . . . 0.0 111.24 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.799 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.4 m-85 -120.04 139.92 51.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.185 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.733 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.74 152.8 79.48 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 32.5 Cg_exo -61.0 154.78 54.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.557 2.172 . . . . 0.0 111.77 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.69 -40.16 94.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.343 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.423 ' NE1' ' CB ' ' A' ' 97' ' ' PRO . 67.2 p-90 -64.02 -40.11 95.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 58.3 ttm -60.46 -43.25 97.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.973 0.416 . . . . 0.0 110.787 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 106' ' ' ILE . 57.4 ttm -60.76 -40.49 92.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.5 -39.99 94.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.4 m -63.72 -40.41 96.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.614 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.4 mt -71.13 -24.01 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.45 30.58 56.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.302 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 101' ' ' MET . 45.6 pt -120.01 157.83 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -96.51 160.38 29.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.68 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.75 -3.41 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.76 -15.99 13.79 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.215 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 54.8 m -74.23 150.84 40.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.714 0.293 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.49 153.06 37.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.903 0.383 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 58.0 tp -119.96 132.7 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.282 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.72 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -99.96 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.848 HG23 ' HB3' ' A' ' 69' ' ' PHE . 86.9 mt -116.37 122.7 70.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.762 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.9 m -120.01 128.46 53.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -84.87 106.81 16.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.307 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.3 t -134.23 145.8 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.115 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 68' ' ' LEU . 96.2 m-20 -107.75 120.28 41.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.467 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' SG ' ' A' ' 186' ' ' CYS . 31.9 m -112.65 150.43 42.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.16 0.505 . . . . 0.0 111.753 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.685 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 45.0 Cg_endo -68.38 160.11 50.49 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.641 2.227 . . . . 0.0 111.44 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -75.0 120.2 20.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.45 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 192' ' ' LEU . . . -64.24 151.21 50.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.138 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 94.7 mm-40 -101.73 -18.0 16.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.13 134.81 18.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.823 ' CG1' HG22 ' A' ' 194' ' ' THR . 3.6 p -137.43 130.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.335 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.743 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 67.4 mttm -92.9 121.41 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.714 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 171' ' ' ILE . 82.6 mt -117.67 130.92 56.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.051 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.29 110.01 51.1 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HG3' HD11 ' A' ' 135' ' ' LEU . 97.2 Cg_endo -83.07 -176.71 2.97 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.654 2.236 . . . . 0.0 112.256 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 131' ' ' SER . 92.7 mt-30 -130.46 124.62 32.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.384 0.612 . . . . 0.0 110.378 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 1.2 m 71.05 166.97 0.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.956 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.7 -14.98 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.95 -40.07 87.73 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 111.066 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.503 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.4 t80 -59.93 -40.12 87.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.756 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -81.78 -9.55 59.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.543 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.9 -19.58 63.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.487 0.184 . . . . 0.0 111.435 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -61.99 132.11 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.666 0.269 . . . . 0.0 110.483 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.3 p -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.359 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -124.51 77.97 62.62 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.407 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.702 ' O ' HD23 ' A' ' 144' ' ' LEU . 52.2 Cg_endo -69.47 -33.91 16.67 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.52 2.147 . . . . 0.0 112.266 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.09 -40.34 89.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.271 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.93 95.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 147' ' ' VAL . 97.5 t -61.94 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -59.98 -40.1 87.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.401 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -42.32 93.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -63.29 -39.94 95.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.459 . . . . 0.0 110.295 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 162' ' ' ILE . 83.3 t -62.47 -41.96 93.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.945 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 95.3 mt -60.02 -40.03 87.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 188' ' ' ILE . 69.9 ttp85 -63.02 -39.96 96.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.62 -39.96 93.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.47 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.4 m-85 -99.35 120.29 39.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.235 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.534 ' HA ' HD11 ' A' ' 188' ' ' ILE . 15.9 t -69.97 -39.97 75.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.511 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.53 ' CB ' ' HB3' ' A' ' 81' ' ' HIS . 71.6 p -121.63 140.02 52.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 151' ' ' PHE . 95.1 mt -135.25 141.22 45.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 111.813 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.689 HG23 ' CD2' ' A' ' 81' ' ' HIS . 37.3 p -138.88 154.32 48.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.679 ' CG2' HG22 ' A' ' 176' ' ' VAL . 94.2 t -60.06 -39.95 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.324 0.583 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.1 -38.89 75.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.3 t0 -69.37 129.97 41.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.1 p -102.41 120.01 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.549 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.1 pt -105.12 140.01 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.942 0.401 . . . . 0.0 112.055 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.696 ' HG2' ' CB ' ' A' ' 170' ' ' LYS . 99.8 mt-10 -120.0 141.23 49.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.763 HD13 HG21 ' A' ' 147' ' ' VAL . 46.0 pt -129.87 140.13 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.383 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.7 t -112.17 120.03 40.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -123.79 129.56 51.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.999 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 53.75 39.95 30.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.565 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.2 9.71 86.76 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.135 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.3 mttm -108.85 137.15 47.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.724 0.262 . . . . 0.0 110.383 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -105.56 120.54 41.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 111.021 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.02 140.06 51.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.696 ' CB ' ' HG2' ' A' ' 161' ' ' GLU . 53.0 pttt -124.19 130.57 52.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.635 HD12 HD22 ' A' ' 127' ' ' LEU . 45.6 pt -132.06 140.81 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -119.73 137.4 53.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.972 0.415 . . . . 0.0 110.61 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.574 HG13 HD23 ' A' ' 127' ' ' LEU . 5.2 mp -81.47 112.85 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -57.26 7.14 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.743 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.4 tt0 -155.93 144.1 19.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.356 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' CG2' ' A' ' 156' ' ' VAL . 8.3 m -138.3 151.2 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.369 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -98.73 104.76 26.55 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 94.5 Cg_endo -100.23 177.16 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.437 2.758 . . . . 0.0 112.676 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.685 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 68.6 mm-40 -99.96 5.01 45.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 85.2 p -139.83 159.67 41.65 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.081 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.4 p -70.04 -18.54 63.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.892 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.9 p -59.98 -20.63 58.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.446 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 60.03 39.82 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 111.07 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 m -130.02 139.93 50.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.78 140.27 47.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' LEU . 75.3 m -129.48 100.31 5.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.802 HG11 HD22 ' A' ' 192' ' ' LEU . 5.7 p -126.87 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.631 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 149' ' ' ARG . 82.0 mt -105.62 -26.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.621 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.4 tt0 -89.97 -79.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.382 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 13.5 t -169.84 -158.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 0.0 111.102 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.9 m-20 75.74 25.09 1.2 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.892 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.802 HD22 HG11 ' A' ' 187' ' ' VAL . 28.4 tp -119.51 131.46 55.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 125' ' ' VAL . 20.8 t -92.84 129.0 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.76 0.314 . . . . 0.0 110.627 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.823 HG22 ' CG1' ' A' ' 125' ' ' VAL . 75.3 p -118.53 142.08 47.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -119.78 142.54 48.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.81 139.98 41.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 111.416 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -118.2 165.08 17.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.771 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 19.9 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 88.0 Cg_exo . . . . . 0 N--CA 1.465 -0.2 0 CA-C-O 120.579 0.158 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.405 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 78.2 mt-30 -100.08 120.01 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.716 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 116' ' ' SER . 25.2 m -124.28 131.76 53.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 111.689 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 116' ' ' SER . 22.3 t80 -120.24 139.88 52.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.613 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.93 133.07 55.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 57' ' ' LYS . 72.1 mt-10 -152.71 160.02 43.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.67 132.64 56.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.507 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 49.7 m-85 -139.67 159.99 40.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -94.56 126.32 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.471 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 29.8 p -91.06 141.79 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.346 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.4 m-85 -130.42 153.16 81.28 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.675 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.65 104.53 1.89 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.695 2.264 . . . . 0.0 112.628 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.756 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 90.7 mt -60.0 -39.82 81.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.385 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.768 ' HA ' HH11 ' A' ' 38' ' ' ARG . . . -59.33 -29.29 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.583 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.8 ttp -67.09 -37.72 84.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.281 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.98 140.04 57.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.18 151.75 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.587 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -59.97 -36.66 77.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.209 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -60.0 -34.06 72.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.667 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 37' ' ' ILE . 25.2 mt -110.24 9.11 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.377 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.768 HH11 ' HA ' ' A' ' 31' ' ' ALA . 28.5 ttp180 -119.95 137.15 54.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HE2' ' HB3' ' A' ' 41' ' ' ASP . 86.0 tttt -100.47 127.11 46.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.03 -40.08 88.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.633 ' HB3' ' HE2' ' A' ' 39' ' ' LYS . 52.4 t0 -59.98 -41.45 92.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.06 91.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.11 -40.06 88.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.78 18.7 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.19 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.58 163.33 23.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.209 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.91 11.39 64.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.859 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.8 mttt -115.7 140.05 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.5 pt -110.33 152.58 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.473 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.826 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 87.4 m-85 -93.12 132.07 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.733 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -142.42 160.21 55.15 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.292 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.759 ' O ' HD12 ' A' ' 55' ' ' LEU . 45.9 Cg_endo -65.63 144.58 79.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.081 2.521 . . . . 0.0 113.525 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 89' ' ' ALA . 25.8 Cg_endo -62.63 -20.33 70.55 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.059 2.506 . . . . 0.0 113.315 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.4 p -60.0 -43.58 95.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.648 0.261 . . . . 0.0 111.322 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -70.64 -41.46 72.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 111.313 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 84' ' ' VAL . 1.1 mp -60.07 -39.9 87.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -59.71 -39.38 84.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HD2' ' OE2' ' A' ' 23' ' ' GLU . 59.5 mttp -59.98 -39.29 85.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.667 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 91.9 mt -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -59.98 -39.97 87.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.94 -37.39 82.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.454 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.68 0.61 29.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.651 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.07 43.8 13.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.0 111.54 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.501 HG13 HD22 ' A' ' 58' ' ' LEU . 43.5 mm -72.24 130.24 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.618 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -69.76 140.41 53.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.477 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.541 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 25.1 t80 -87.43 141.75 32.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 188' ' ' ILE . 3.7 Cg_exo -74.84 160.36 96.6 Favored 'Cis proline' 0 C--N 1.348 0.552 0 C-N-CA 124.217 -1.16 . . . . 0.0 112.822 0.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.714 ' CE ' HD23 ' A' ' 55' ' ' LEU . 75.4 mtm -75.18 140.12 43.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.924 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.844 HD22 HG23 ' A' ' 153' ' ' THR . 79.1 mt -112.12 136.76 51.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.081 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.667 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 33.6 m-85 -131.86 147.08 52.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.171 0.51 . . . . 0.0 112.008 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 40.0 ttpt -122.68 129.29 51.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.332 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 112' ' ' LEU . 86.6 mt -100.38 125.6 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 111.049 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 79' ' ' VAL . 97.5 m -119.96 130.02 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.965 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . -107.83 118.09 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.7 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.361 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.12 -39.9 87.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.32 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.413 HG21 ' HA3' ' A' ' 105' ' ' GLY . 73.8 p -108.51 -11.63 15.11 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 68.16 14.32 65.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.68 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -100.0 139.95 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.562 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 71' ' ' LEU . 52.7 t -121.32 127.23 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.016 0.436 . . . . 0.0 111.215 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.599 HG21 ' HE3' ' A' ' 100' ' ' MET . 8.4 t -118.39 129.68 55.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.742 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 5.3 m80 -83.76 139.61 32.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.363 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.73 -139.53 3.66 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.138 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -166.79 -164.0 21.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.38 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 55' ' ' LEU . 6.5 p -124.85 129.96 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.145 0.498 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.826 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 34.4 tp -92.62 -77.39 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -140.19 168.19 20.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.76 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 2.5 m-85 -90.94 116.33 28.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 49' ' ' PHE . 31.6 pt -141.83 -5.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.808 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -97.94 97.1 8.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 111.676 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.95 -40.12 72.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.504 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -85.8 -23.34 27.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 51' ' ' PRO . . . 114.76 46.5 0.6 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.558 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.808 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 21.6 mtm180 -111.0 149.47 30.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 111.069 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.864 HG21 HD11 ' A' ' 114' ' ' ILE . 10.8 p -129.92 140.27 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.756 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.5 m-85 -119.94 139.95 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.6 pt? -122.65 149.87 56.85 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.627 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.603 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 47.7 Cg_exo -53.64 158.84 7.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.87 2.38 . . . . 0.0 112.618 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.75 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mt-30 -60.07 -43.85 95.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.605 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.476 ' HZ3' ' O ' ' A' ' 159' ' ' VAL . 33.0 p-90 -68.88 -35.71 77.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.615 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.603 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.5 mmm -60.05 -40.1 88.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.3 -40.09 92.88 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.061 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.64 -40.08 88.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.964 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -64.91 -40.03 94.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.756 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 80' ' ' THR . 86.9 mt -69.92 -25.08 63.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.2 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.413 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 67.8 30.06 74.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.402 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 110' ' ' SER . 45.8 pt -113.4 139.42 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 111.893 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 8.2 pt20 -97.01 165.76 15.18 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 98.1 Cg_exo -43.92 140.51 4.93 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.658 2.239 . . . . 0.0 112.607 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.0 -9.99 75.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 58.0 m -70.06 153.08 43.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.502 ' CD2' ' HG3' ' A' ' 113' ' ' GLN . 9.9 tt -93.5 136.74 33.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.116 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 71' ' ' LEU . 60.1 tp -121.55 130.09 53.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.043 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.502 ' HG3' ' CD2' ' A' ' 111' ' ' LEU . 96.6 mt-30 -111.77 133.28 54.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.667 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HG21 ' A' ' 94' ' ' VAL . 85.4 mt -110.07 125.53 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.7 t -120.77 129.54 53.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.663 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.9 t -70.22 122.98 20.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 95.5 m -121.96 128.93 52.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 96.5 m-20 -123.94 120.02 31.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 186' ' ' CYS . 34.6 m -117.55 154.36 50.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.796 0.331 . . . . 0.0 111.618 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 93.6 Cg_endo -78.18 19.36 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.679 2.253 . . . . 0.0 112.555 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.808 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.0 mp 67.96 100.39 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.16 164.07 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.3 -22.17 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.412 ' HE1' ' HE2' ' A' ' 126' ' ' LYS . 64.3 t80 -142.71 131.18 22.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.497 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 194' ' ' THR . 3.3 p -135.95 132.4 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.258 0.551 . . . . 0.0 111.511 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 34.6 mttm -95.42 122.15 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.27 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 173' ' ' ILE . 86.0 mt -118.05 132.86 56.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 4.2 tt0 -116.58 113.51 40.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.818 ' HG3' HD11 ' A' ' 135' ' ' LEU . 83.7 Cg_endo -78.39 174.44 12.38 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.722 2.281 . . . . 0.0 112.439 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.713 HE22 ' HG2' ' A' ' 170' ' ' LYS . 29.2 mt-30 -125.7 123.93 39.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER 70.17 133.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.421 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -60.04 -24.82 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.186 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -39.92 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.67 -39.98 90.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.775 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.818 HD11 ' HG3' ' A' ' 129' ' ' PRO . 95.6 mt -82.19 -10.19 59.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -10.14 57.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.627 0.251 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.98 140.71 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.4 m -59.92 -40.15 87.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.287 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -124.66 75.84 64.11 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.749 0.309 . . . . 0.0 110.775 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 144' ' ' LEU . 36.0 Cg_exo -60.05 -33.76 95.13 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.632 2.221 . . . . 0.0 111.858 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.92 -40.12 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 147' ' ' VAL . 85.8 t -61.4 -43.57 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.87 -40.08 91.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.2 -40.35 89.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -66.59 -40.07 88.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.131 0.491 . . . . 0.0 109.866 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 162' ' ' ILE . 56.3 t -62.56 -40.1 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.93 -40.85 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.205 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.34 -40.07 96.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 110.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 89.2 m-85 -105.72 120.75 42.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.448 . . . . 0.0 111.781 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.3 m -60.16 -40.01 88.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.151 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.844 HG23 HD22 ' A' ' 68' ' ' LEU . 67.0 p -135.74 151.91 50.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.324 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.6 mp -117.43 130.45 56.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 173' ' ' ILE . 17.3 m -119.6 142.3 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.614 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.958 HG22 HG13 ' A' ' 176' ' ' VAL . 92.0 t -60.08 -45.05 96.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.199 0.523 . . . . 0.0 110.764 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -39.19 76.14 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.693 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.499 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 53.2 t0 -67.96 132.48 47.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 14.3 m -100.35 123.79 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.053 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 ' CG1' ' A' ' 147' ' ' VAL . 48.3 pt -104.72 138.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 98.9 mt-10 -120.03 140.09 51.52 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.598 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 147' ' ' VAL . 44.9 pt -130.02 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.937 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.1 t -108.79 113.3 26.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -119.91 119.18 32.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.503 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.5 m-20 51.14 39.35 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.22 -7.13 82.44 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.545 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 163' ' ' SER . 57.8 mtpt -100.03 137.4 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.966 0.383 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 8.9 t -112.19 120.66 42.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.237 0.542 . . . . 0.0 111.59 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CZ ' ' HE2' ' A' ' 167' ' ' LYS . 86.8 m-85 -120.01 140.0 51.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.042 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.924 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 51.4 pttt -119.93 136.82 54.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.117 0.484 . . . . 0.0 111.035 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.98 120.07 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.094 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.56 127.3 49.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.889 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 mp -81.97 120.04 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.634 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 128' ' ' GLU . 10.6 mp -69.79 -57.34 5.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.834 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.789 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.9 mt-10 -155.01 148.02 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.958 HG13 HG22 ' A' ' 156' ' ' VAL . 5.3 m -140.33 147.63 23.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -92.26 104.45 10.97 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 63.9 Cg_endo -102.47 163.93 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.639 2.893 . . . . 0.0 112.551 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.5 mt-10 -100.12 6.21 44.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.9 m -139.85 159.23 42.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.0 111.231 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.8 m -70.05 -12.9 61.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.7 m -59.17 -25.88 64.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 111.11 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.02 39.58 19.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.661 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 80.1 p -127.47 146.57 50.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.901 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.899 HD12 HD21 ' A' ' 192' ' ' LEU . 46.2 pt -128.39 136.87 58.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.065 0.46 . . . . 0.0 111.5 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 42.7 t -141.15 114.06 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.239 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 192' ' ' LEU . 7.2 p -120.84 112.52 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.496 0.665 . . . . 0.0 110.385 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.659 HD12 ' HD3' ' A' ' 66' ' ' PRO . 18.4 tt -79.97 -49.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 188' ' ' ILE . 77.2 mm-40 -91.03 -79.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 t -168.97 30.78 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.606 0.241 . . . . 0.0 111.604 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.808 ' HB2' HD23 ' A' ' 121' ' ' LEU . 95.9 m-20 -82.46 2.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.545 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 185' ' ' ILE . 62.4 tp -111.93 130.71 55.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 125' ' ' VAL . 31.6 t -95.37 123.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.169 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 125' ' ' VAL . 74.8 p -101.91 144.94 29.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -129.53 137.69 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.387 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.32 136.28 44.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.87 163.25 25.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.6 Cg_exo . . . . . 0 N--CA 1.463 -0.315 0 C-N-CA 122.361 2.041 . . . . 0.0 112.126 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.464 -0.235 0 CA-C-O 120.858 0.274 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' THR . 95.1 mt-30 -101.27 123.15 44.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 117' ' ' THR . 73.9 p -119.99 130.38 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 111.646 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.776 ' HB3' ' OG ' ' A' ' 116' ' ' SER . 86.2 t80 -121.27 126.66 50.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.761 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.18 130.87 54.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.208 0.528 . . . . 0.0 112.332 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.45 156.07 42.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.199 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.64 126.17 49.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.076 0.465 . . . . 0.0 111.773 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 97.5 m-85 -130.07 150.24 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.583 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 70.6 mtp85 -81.59 132.29 35.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.394 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 31.7 p -106.5 142.39 36.24 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.566 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 63.6 m-85 -140.37 152.75 67.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.547 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.56 ' HG2' ' SD ' ' A' ' 32' ' ' MET . 36.1 Cg_endo -65.66 119.76 6.84 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.232 1.955 . . . . 0.0 111.964 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.795 HG12 ' HB3' ' A' ' 95' ' ' TYR . 88.6 mt -59.93 -38.52 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -50.03 -20.54 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 29' ' ' PRO . 94.5 mtp -68.75 -32.65 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.98 143.19 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.99 151.04 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.143 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.78 -34.66 73.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.01 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 37' ' ' ILE . 69.7 mt -107.08 -0.17 9.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.116 0.484 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 51.8 ttt-85 -105.01 129.96 53.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.287 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -105.08 133.37 49.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.1 -40.07 88.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.381 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.68 -39.91 95.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.12 91.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.276 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.402 HD21 ' HE ' ' A' ' 38' ' ' ARG . 25.8 m120 -60.24 -40.0 88.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.659 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -100.14 1.7 42.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.181 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 180.0 35.69 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.61 29.97 9.75 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.845 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.01 122.47 42.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 83' ' ' GLY . 47.5 pt -115.33 149.9 17.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.499 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 97.5 m-85 -102.9 133.62 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.565 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 114' ' ' ILE . 1.6 mp -131.34 165.6 34.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.208 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.672 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 56.6 Cg_endo -71.59 157.38 56.09 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.163 1.908 . . . . 0.0 112.662 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.88 -23.08 30.66 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.737 2.291 . . . . 0.0 112.785 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -60.08 -40.09 88.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.229 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . . . -70.22 -42.55 72.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.785 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.4 tp -61.91 -41.02 97.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.382 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -59.86 -43.35 94.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 85.3 tttt -60.33 -40.08 89.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.798 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 ' CD1' ' A' ' 63' ' ' ILE . 87.3 mt -59.93 -40.08 87.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -59.67 -38.23 80.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.265 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.0 -39.18 84.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.04 -2.52 40.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.425 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.4 t30 60.02 40.26 18.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.588 0.233 . . . . 0.0 111.587 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CD1' HD22 ' A' ' 58' ' ' LEU . 86.3 mt -70.2 130.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.47 142.75 38.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 16.0 p90 -87.68 158.29 51.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.49 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 9.5 Cg_exo -72.82 146.84 88.01 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.758 -1.351 . . . . 0.0 112.708 0.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.18 140.01 48.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.474 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' SER . 21.5 mt -115.84 132.09 56.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 114' ' ' ILE . 11.6 m-85 -120.53 140.28 51.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.095 0.474 . . . . 0.0 111.638 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 115' ' ' SER . 87.3 tttt -115.65 129.96 56.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.779 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 96.8 mt -98.38 131.12 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.368 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.796 ' HA ' HG12 ' A' ' 79' ' ' VAL . 87.0 m -120.01 129.61 54.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.986 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.2 115.62 27.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -68.39 -40.02 81.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.49 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -40.02 87.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.4 m -100.62 -17.38 17.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.742 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.34 1.14 41.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.685 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -100.22 141.18 33.41 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.717 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 72' ' ' THR . 20.2 m -119.97 119.87 61.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.469 ' H ' HD21 ' A' ' 104' ' ' LEU . 36.2 p -110.34 139.46 45.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.37 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 77.7 m80 -84.8 114.39 22.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 0.0 110.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.33 158.49 20.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.34 165.26 27.5 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.73 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -128.69 133.1 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 117.361 0.581 . . . . 0.0 112.336 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.845 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.6 tp -92.22 -79.05 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.535 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -149.55 160.45 43.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CE1' HD13 ' A' ' 55' ' ' LEU . 80.3 m-85 -97.37 116.76 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.292 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.25 -4.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.601 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.33 97.83 11.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.378 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -39.92 76.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.459 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.97 -20.13 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.345 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 97.18 54.16 1.3 Allowed Glycine 0 C--O 1.23 -0.107 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.154 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.601 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 87.3 mtt180 -121.2 145.09 48.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.132 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 114' ' ' ILE . 93.6 t -120.4 131.72 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.311 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.795 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.8 138.91 53.79 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 101' ' ' MET . 1.8 pt? -134.56 159.04 73.74 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.63 0.252 . . . . 0.0 110.475 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 65.1 Cg_endo -70.52 158.25 56.5 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.659 2.239 . . . . 0.0 112.824 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.478 ' HA ' ' CE ' ' A' ' 101' ' ' MET . 78.0 mt-30 -61.71 -40.0 93.5 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.586 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 48.9 p-90 -62.83 -39.93 95.86 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.518 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.586 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 96.7 mtp -68.22 -40.0 82.2 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.332 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.739 ' HG2' HD11 ' A' ' 96' ' ' LEU . 76.4 mtm -61.01 -39.98 91.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.48 -40.1 92.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.7 m -63.21 -40.03 96.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.469 HD21 ' H ' ' A' ' 80' ' ' THR . 83.9 mt -86.24 -10.06 55.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.692 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.22 41.6 99.72 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.046 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.95 133.53 54.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.137 0.494 . . . . 0.0 110.749 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 5.7 mt-30 -96.43 160.0 30.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 18.3 Cg_endo -59.93 -1.97 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.299 2.0 . . . . 0.0 112.964 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.83 -12.54 24.04 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 m -94.46 151.52 19.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.313 . . . . 0.0 111.154 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.583 ' CD2' ' HG2' ' A' ' 26' ' ' ARG . 89.9 mt -79.98 158.11 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.597 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.2 tp -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.9 mt-30 -101.73 120.34 40.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.346 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 50' ' ' LEU . 87.8 mt -110.27 126.21 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.4 t -119.78 120.3 36.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.776 ' OG ' ' HB3' ' A' ' 21' ' ' PHE . 48.5 p -88.76 111.16 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.585 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 5.3 t -133.95 150.43 51.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.286 0.565 . . . . 0.0 112.251 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' OD2' HG23 ' A' ' 63' ' ' ILE . 97.7 m-20 -104.74 119.16 38.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.711 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 ' SG ' ' A' ' 186' ' ' CYS . 15.9 m -115.5 152.51 47.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 180' ' ' SER . 51.5 Cg_exo -57.84 166.25 5.49 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.917 1.744 . . . . 0.0 111.257 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 122' ' ' GLY . 8.0 tt -93.98 120.12 33.79 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.63 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.8 ' HA3' HG23 ' A' ' 185' ' ' ILE . . . -68.86 146.11 44.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.228 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.23 -19.85 16.9 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 195' ' ' ASP . 64.7 t80 -145.78 131.49 18.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.665 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 176' ' ' VAL . 7.5 p -131.0 129.44 63.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.671 0.748 . . . . 0.0 111.785 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 63.5 tttp -97.01 120.31 37.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.686 ' CD1' HD21 ' A' ' 144' ' ' LEU . 77.0 mt -113.94 135.3 54.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.65 ' CD ' HD11 ' A' ' 174' ' ' LEU . 2.6 tt0 -100.22 127.81 32.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.403 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 128' ' ' GLU . 86.5 Cg_endo -79.78 172.83 13.66 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.322 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.649 ' HG3' ' HG3' ' A' ' 170' ' ' LYS . 29.9 mm100 -135.62 121.16 19.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.88 24.89 13.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.513 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 m 41.95 24.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.86 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.43 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 95.5 m-20 -70.0 -40.01 75.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.412 . . . . 0.0 110.188 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.543 ' CE1' ' CE2' ' A' ' 196' ' ' PHE . 64.8 t80 -60.71 -40.06 90.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.763 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.16 -24.28 67.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.146 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.02 -19.61 63.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.16 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.9 mt -66.6 137.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.566 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.6 m -60.12 -39.92 87.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.518 ' H ' HG22 ' A' ' 137' ' ' ILE . 67.6 m-20 -129.7 71.87 82.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 134' ' ' PHE . 21.3 Cg_exo -64.68 -30.51 59.9 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.94 -41.0 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.14 98.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 147' ' ' VAL . 72.8 t -64.6 -41.04 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 1.087 HD11 HG21 ' A' ' 194' ' ' THR . 1.8 tm? -60.0 -43.19 95.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.12 -40.27 89.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 0.0 110.75 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -61.97 -40.08 94.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.965 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 162' ' ' ILE . 59.4 t -59.89 -40.48 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.516 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 188' ' ' ILE . 86.4 mt -60.23 -40.09 88.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.47 -40.02 77.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.183 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.97 -40.01 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.747 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.649 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 91.3 m-85 -102.71 118.02 35.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.101 0.476 . . . . 0.0 111.374 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.525 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 69.2 m -63.2 -39.94 96.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.032 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 68' ' ' LEU . 34.4 p -123.13 140.66 52.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.012 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 185' ' ' ILE . 86.5 mt -120.87 127.19 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.79 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 157' ' ' ASP . 25.0 m -126.46 142.9 51.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 173' ' ' ILE . 59.6 t -60.03 -42.08 88.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.357 0.598 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 155' ' ' THR . 96.0 m-20 -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.413 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.0 m-20 -75.35 140.09 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 121.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.467 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.649 ' HB ' ' CZ ' ' A' ' 151' ' ' PHE . 46.2 pt -104.12 138.69 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.702 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 47.9 mt-10 -121.06 140.62 51.7 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.756 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 147' ' ' VAL . 43.4 pt -127.55 142.85 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.211 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 31.6 t -111.54 115.94 30.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 54.6 t80 -121.14 122.93 41.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.955 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.36 39.99 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.535 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.85 89.91 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.932 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 163' ' ' SER . 97.5 mttt -104.48 136.97 43.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.8 p -108.67 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 111.413 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.43 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.2 m-85 -119.94 139.98 51.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.444 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 61.5 pttt -121.33 135.49 55.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.264 0.554 . . . . 0.0 111.245 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.638 HD11 HD11 ' A' ' 160' ' ' ILE . 45.9 pt -128.4 139.52 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.11 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -116.36 129.21 56.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.723 ' O ' HG13 ' A' ' 156' ' ' VAL . 3.4 mp -77.92 80.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.09 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.65 HD11 ' CD ' ' A' ' 128' ' ' GLU . 88.0 mt -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.5 mt-10 -146.27 139.4 25.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.791 0.329 . . . . 0.0 111.459 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 125' ' ' VAL . 32.5 m -144.6 160.03 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.631 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 104.0 54.15 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.453 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 66.9 Cg_endo -99.26 167.34 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.252 2.635 . . . . 0.0 113.053 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.91 9.9 42.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.757 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 43.6 t -139.85 162.02 36.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.1 m -70.67 -15.12 62.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.132 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.4 p -61.38 -21.07 63.73 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.729 0.3 . . . . 0.0 111.032 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.4 mmtt 60.08 40.21 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.625 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.523 ' C ' HD13 ' A' ' 185' ' ' ILE . 80.4 p -129.76 150.69 50.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.8 HG23 ' HA3' ' A' ' 122' ' ' GLY . 7.3 mm -117.94 118.36 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.519 ' SG ' HG21 ' A' ' 119' ' ' VAL . 10.9 m -143.2 160.59 40.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.833 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 186' ' ' CYS . 17.2 t 77.06 121.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.427 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 148' ' ' LEU . 14.8 mt -120.64 84.04 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.479 ' H ' HD11 ' A' ' 121' ' ' LEU . 99.4 mt-10 -126.33 -20.42 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -110.63 20.04 18.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.7 m-20 70.47 94.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 122' ' ' GLY . 4.1 tp -75.61 142.02 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.453 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 125' ' ' VAL . 26.3 t -99.99 128.36 51.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.018 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' THR . . . . . 1.087 HG21 HD11 ' A' ' 144' ' ' LEU . 70.1 p -117.87 144.57 45.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 124' ' ' PHE . 55.6 t0 -126.41 139.97 52.85 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.907 0.384 . . . . 0.0 110.973 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.543 ' CE2' ' CE1' ' A' ' 134' ' ' PHE . 96.6 m-85 -108.75 140.38 42.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.63 129.65 25.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.524 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 122.682 2.254 . . . . 0.0 112.653 179.605 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 N--CA 1.463 -0.275 0 CA-C-O 120.714 0.214 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.5 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.5 mt-30 -113.03 126.28 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.0 m -120.13 130.54 54.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.308 0.575 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 58.2 t80 -133.24 130.04 38.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.621 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.65 135.93 49.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -142.07 159.9 41.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.282 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CZ ' HD13 ' A' ' 111' ' ' LEU . 64.6 t80 -119.85 128.94 54.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.719 ' HD2' HG22 ' A' ' 114' ' ' ILE . 84.6 m-85 -139.08 153.15 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.587 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -81.07 140.7 34.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.547 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 49.8 t -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 111.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 18.5 m-85 -120.43 150.71 52.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.594 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' PRO . 6.2 Cg_exo -80.31 113.92 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.76 2.307 . . . . 0.0 112.232 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.837 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 95.8 mt -61.14 -39.91 84.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HA ' ' CZ ' ' A' ' 38' ' ' ARG . . . -59.79 -29.22 68.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 96.8 mmm -68.3 -36.66 79.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 110.214 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -61.04 140.05 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.36 143.59 52.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 112.044 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.9 m-20 -59.87 -26.27 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.103 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -60.05 -38.75 83.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.91 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.7 pt -108.05 -9.76 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.245 0.545 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.725 ' CZ ' ' HA ' ' A' ' 31' ' ' ALA . 66.4 ttt180 -89.23 139.77 30.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 86.0 tttt -101.16 125.51 47.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.376 . . . . 0.0 110.512 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.14 -40.82 91.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.659 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.763 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.0 m-20 -61.49 -39.99 92.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.1 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.14 90.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.98 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.79 -40.1 87.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.335 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 163' ' ' SER . 90.0 m-85 -102.7 6.04 39.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.56 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.41 160.72 22.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.105 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.15 10.75 73.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.336 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 22.2 mttm -104.45 143.18 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 96' ' ' LEU . 32.6 pt -121.5 169.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.725 ' O ' HG23 ' A' ' 94' ' ' VAL . 96.3 m-85 -100.45 131.48 46.35 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.512 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 48' ' ' ILE . 3.9 mp -140.6 163.37 43.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.613 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.552 ' HB3' ' O ' ' A' ' 89' ' ' ALA . 60.6 Cg_endo -72.22 133.78 21.78 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.14 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 34.6 Cg_exo -57.9 -11.9 10.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.691 2.261 . . . . 0.0 112.89 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.3 p -60.11 -39.05 84.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.54 75.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.382 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 58' ' ' LEU . 85.4 mt -60.03 -40.61 89.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.356 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -60.11 -40.03 88.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 33.6 mttm -67.5 -39.91 85.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.596 HD22 HG13 ' A' ' 63' ' ' ILE . 89.7 mt -60.18 -39.35 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.595 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -60.09 -39.79 87.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.17 -39.85 87.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 21' ' ' PHE . 89.6 mt -81.28 -0.36 40.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.712 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.89 43.32 15.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.245 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.596 HG13 HD22 ' A' ' 58' ' ' LEU . 47.8 mm -64.34 129.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.434 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -70.54 140.01 51.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -88.17 143.59 33.08 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.856 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 188' ' ' ILE . 7.6 Cg_exo -73.89 163.83 89.0 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.397 0.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.472 ' SD ' HD13 ' A' ' 58' ' ' LEU . 55.2 mtt -83.86 133.9 34.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.791 HD13 ' CB ' ' A' ' 186' ' ' CYS . 0.2 OUTLIER -122.12 137.98 54.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.566 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CB ' HD11 ' A' ' 114' ' ' ILE . 97.5 m-85 -123.69 140.49 52.94 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.152 0.501 . . . . 0.0 111.712 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 39.6 ttpt -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.099 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CE ' ' A' ' 100' ' ' MET . 88.6 mt -89.97 122.57 33.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.542 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 79' ' ' VAL . 60.2 m -99.42 122.25 42.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.454 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -117.36 133.89 55.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.352 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 62.27 139.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.103 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -40.0 87.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 p -129.81 17.72 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.489 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.15 -102.95 0.51 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.783 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -139.98 146.34 38.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.876 0.369 . . . . 0.0 111.267 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 72' ' ' THR . 62.5 t -120.77 119.21 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.901 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 103' ' ' THR . 30.8 p -102.11 163.47 12.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.886 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.459 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 79.1 m80 -103.96 114.83 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.84 159.86 17.27 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.981 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' A' ' 152' ' ' SER . . . -94.18 170.33 30.1 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.245 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.57 125.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 111.595 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.3 tp -92.75 -79.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.34 152.38 35.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.515 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 74.8 m-85 -99.33 115.7 29.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.591 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.04 -5.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.78 98.89 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.18 -39.86 82.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.04 0.447 . . . . 0.0 110.714 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.32 -30.64 70.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.047 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.43 50.47 0.71 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.444 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.562 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 50.4 ttp180 -117.65 140.04 50.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 49' ' ' PHE . 10.2 p -127.74 143.83 39.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.009 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.837 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.5 m-85 -119.97 140.45 50.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.257 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 48' ' ' ILE . 19.2 mt -114.92 137.9 23.1 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.707 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG22 ' A' ' 48' ' ' ILE . 42.3 Cg_exo -53.83 161.03 5.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.7 2.266 . . . . 0.0 112.325 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.02 -44.13 94.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.685 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CH2' ' SD ' ' A' ' 100' ' ' MET . 23.5 p-90 -69.66 -37.85 76.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.1 mmm -60.17 -39.98 88.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.1 mmm -60.16 -40.57 90.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -40.7 78.83 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.546 HG22 HG21 ' A' ' 80' ' ' THR . 94.2 m -60.26 -39.95 88.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 0.0 110.02 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.969 HD22 ' HB2' ' A' ' 73' ' ' ALA . 45.0 mt -80.9 -16.59 53.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.312 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.37 73.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.059 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.3 pt -111.41 143.99 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 pt20 -100.58 161.14 24.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.802 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.678 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.3 Cg_endo -48.9 134.76 28.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.675 2.25 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.44 -9.98 75.87 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.964 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.655 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 52.1 m -70.87 150.85 45.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.813 0.307 . . . . 0.0 110.61 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.518 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 74.2 mt -71.51 141.21 50.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 63.3 tp -123.87 130.02 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.692 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -113.37 120.0 39.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.993 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.719 HG22 ' HD2' ' A' ' 25' ' ' PHE . 21.0 tt -117.06 127.57 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.6 p -120.11 138.82 53.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.927 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -80.76 110.19 16.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 94.5 m -119.94 129.98 54.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.424 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -105.73 119.98 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.599 ' H ' HD11 ' A' ' 68' ' ' LEU . 32.7 m -115.92 149.41 43.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.964 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 7.5 Cg_exo -70.81 161.79 44.85 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.335 2.023 . . . . 0.0 110.508 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 190' ' ' THR . 1.3 mt -90.85 120.13 31.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.442 0.639 . . . . 0.0 112.277 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.74 165.79 47.45 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.7 -28.03 9.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.404 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 65.5 t80 -136.98 132.55 34.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 176' ' ' VAL . 2.9 p -133.67 131.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.748 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 61.9 mttp -94.97 124.86 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 194' ' ' THR . 82.5 mt -105.61 131.06 53.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.74 0.305 . . . . 0.0 110.778 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -106.71 109.69 63.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.47 164.92 32.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.61 2.206 . . . . 0.0 112.062 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.65 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.1 tt0 -124.52 120.98 33.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.938 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.98 146.76 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.002 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.39 -22.12 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.432 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.99 -39.61 86.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.797 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.641 ' CE1' HD11 ' A' ' 171' ' ' ILE . 65.6 t80 -59.9 -40.1 87.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 0.0 110.755 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.31 -8.22 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.965 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.02 -34.84 73.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.659 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.5 mt -55.68 137.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -60.01 -40.09 88.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.743 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 137' ' ' ILE . 42.5 t0 -129.95 79.76 72.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.931 0.396 . . . . 0.0 111.311 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.02 -25.53 16.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.57 2.18 . . . . 0.0 111.937 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.07 -41.4 92.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.441 ' HB2' ' OD2' ' A' ' 139' ' ' ASP . . . -64.73 -42.1 95.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.456 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.94 -40.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.679 HD13 ' O ' ' A' ' 144' ' ' LEU . 3.4 tm? -61.72 -39.99 93.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.862 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.16 -40.06 93.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -64.66 -42.18 95.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.75 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 162' ' ' ILE . 22.4 m -67.35 -36.44 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.512 HD11 ' CD1' ' A' ' 144' ' ' LEU . 86.6 mt -59.98 -40.09 87.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.2 -40.04 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.6 -39.86 89.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.44 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.15 119.6 34.94 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.711 ' HA ' HG12 ' A' ' 188' ' ' ILE . 50.1 m -62.11 -40.02 94.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.497 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 71.2 p -127.39 143.01 51.28 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.176 0.512 . . . . 0.0 111.33 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.831 HD21 HG12 ' A' ' 173' ' ' ILE . 8.2 tt -121.69 124.03 43.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.157 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 93.1 m -119.51 135.69 54.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.894 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.896 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 58.1 t -59.9 -41.76 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.161 0.505 . . . . 0.0 111.53 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.798 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.1 m-20 -74.31 146.04 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.339 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 119.99 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.339 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.406 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.3 pt -97.89 140.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.713 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -119.64 140.59 50.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.194 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.719 HD13 HG11 ' A' ' 147' ' ' VAL . 43.3 pt -136.09 145.81 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 29.0 t -115.39 119.4 36.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.701 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.437 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 53.2 t80 -125.84 120.49 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.437 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 59.96 31.45 20.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.443 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.75 -9.85 75.74 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.075 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -101.78 140.05 36.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.496 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 163' ' ' SER . 68.3 p -108.8 130.14 55.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.037 0.446 . . . . 0.0 111.505 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 139.97 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.184 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.713 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.7 mttt -103.33 133.28 48.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.961 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.641 HD11 ' CE1' ' A' ' 134' ' ' PHE . 48.5 mm -119.91 119.89 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.05 130.5 54.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.896 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.5 mp -83.88 132.26 31.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.325 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.04 -70.46 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.978 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 50.4 tp10 -140.3 139.86 35.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.945 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 156' ' ' VAL . 3.8 m -139.18 149.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.038 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -99.91 104.23 27.24 Favored Pre-proline 0 C--O 1.232 0.158 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 68.6 Cg_endo -102.9 177.97 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.691 2.928 . . . . 0.0 112.732 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.4 mt-10 -99.95 -0.01 40.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.82 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.3 m -138.29 151.65 47.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.028 0.442 . . . . 0.0 111.462 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 79.6 p -70.03 -10.03 57.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.706 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 46.9 t -55.68 -28.84 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.32 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 69.8 23.24 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.6 p -124.59 139.94 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.854 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.526 HD11 HD22 ' A' ' 154' ' ' LEU . 15.0 pt -132.2 140.05 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.791 ' CB ' HD13 ' A' ' 68' ' ' LEU . 11.2 t -119.76 109.75 15.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.816 HG11 HD22 ' A' ' 192' ' ' LEU . 12.0 p -141.09 99.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.603 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.711 HG12 ' HA ' ' A' ' 152' ' ' SER . 74.8 mt -97.18 -67.81 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.278 0.561 . . . . 0.0 111.566 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 189' ' ' GLU . 86.4 tt0 -94.1 -6.25 45.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.257 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -80.29 174.58 11.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -103.21 119.97 39.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.932 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.816 HD22 HG11 ' A' ' 187' ' ' VAL . 18.1 tp -120.26 140.09 51.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.254 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -89.27 120.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.522 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.595 HG22 HG13 ' A' ' 125' ' ' VAL . 76.2 p -113.85 146.47 39.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 196' ' ' PHE . 49.4 t0 -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 195' ' ' ASP . 11.2 m-85 -93.31 139.98 30.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 111.408 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -119.83 166.46 14.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.2 Cg_exo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.446 2.097 . . . . 0.0 112.13 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 73.1 Cg_exo . . . . . 0 N--CA 1.464 -0.254 0 CA-C-O 120.77 0.237 . . . . 0.0 112.123 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.9 mt-30 -101.0 130.21 46.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.8 p -121.67 130.11 53.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 50.7 t80 -131.55 130.28 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -113.97 136.8 52.5 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mm-40 -149.99 160.03 43.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 120.04 38.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.71 ' CD2' HD12 ' A' ' 114' ' ' ILE . 86.2 m-85 -126.47 149.47 49.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -81.32 133.44 35.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.601 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.974 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 53.2 t -99.95 121.95 42.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 111.357 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.655 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 88.9 m-85 -120.42 150.06 51.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.992 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 108' ' ' PRO . 7.2 Cg_exo -75.68 107.02 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.848 2.366 . . . . 0.0 112.699 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.2 mt -61.09 -40.84 87.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.62 77.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.866 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.469 ' CG ' ' HB2' ' A' ' 29' ' ' PRO . 98.9 mmm -68.25 -30.29 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 96.5 mmm -59.94 142.24 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.26 154.49 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.673 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -55.16 -29.17 57.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.404 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -60.01 -39.9 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.2 mt -111.48 8.88 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.648 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 74.8 ttt180 -104.65 123.18 47.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.049 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.07 129.29 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.896 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.21 -40.09 88.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.269 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.88 -39.97 95.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.91 95.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.763 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.08 -40.1 88.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.351 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.38 14.53 22.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.273 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.57 164.0 24.06 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.119 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.52 11.78 63.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.472 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 67.9 mttm -109.86 145.12 37.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.567 HG21 ' CD2' ' A' ' 96' ' ' LEU . 48.0 pt -121.55 162.99 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.909 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.3 m-85 -96.58 133.24 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -134.25 165.47 36.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.239 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 84.6 Cg_endo -79.53 152.73 23.25 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.21 1.94 . . . . 0.0 112.67 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.973 ' HA ' HD13 ' A' ' 55' ' ' LEU . 19.1 Cg_exo -66.88 -21.74 49.96 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.961 2.441 . . . . 0.0 112.829 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 m -60.08 -40.07 88.28 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.37 80.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.226 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.96 -40.04 87.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.391 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -59.97 -42.76 94.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.59 -39.97 92.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.378 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 116' ' ' SER . 84.6 mt -63.34 -38.56 91.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.375 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.6 m -59.76 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.97 -39.48 85.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.489 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -81.76 -0.05 41.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.681 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.4 m120 59.98 42.43 16.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.704 0.288 . . . . 0.0 111.422 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.499 HG13 HD22 ' A' ' 58' ' ' LEU . 42.7 mm -70.02 130.02 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.744 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -72.05 139.59 48.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.781 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.743 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 28.9 t80 -88.42 146.52 37.86 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.863 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 1.0 ' HD2' HD13 ' A' ' 188' ' ' ILE . 59.9 Cg_endo -71.62 160.38 93.04 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.228 -1.155 . . . . 0.0 113.551 0.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.545 ' HB2' HG11 ' A' ' 84' ' ' VAL . 63.6 mtt -71.86 139.98 49.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' HB ' ' A' ' 153' ' ' THR . 95.4 mt -110.04 123.03 48.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.9 m-85 -119.99 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 28.4 ttpp -114.66 130.0 56.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.723 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 80' ' ' THR . 71.6 mt -94.17 121.72 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.581 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 29.8 m -106.76 119.93 40.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 78' ' ' ARG . . . -112.51 132.46 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.094 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 61.77 148.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 0.0 110.074 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.04 -40.06 88.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.56 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 72.0 p -135.48 13.71 3.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.356 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 -106.85 0.14 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.073 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.747 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 83.0 mtt85 -128.53 147.54 50.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 0.0 111.68 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 72' ' ' THR . 35.9 m -130.06 130.8 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.966 HG22 HD21 ' A' ' 104' ' ' LEU . 7.2 t -112.77 132.43 55.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 111.531 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.435 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 78.3 m80 -84.42 161.56 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.35 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.24 169.74 42.78 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.94 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.1 -177.26 29.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.985 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 67' ' ' MET . 9.0 p -130.2 131.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.333 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.1 tp -89.99 -79.21 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.056 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -139.66 155.18 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.705 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CG ' HD11 ' A' ' 55' ' ' LEU . 86.1 m-85 -99.9 116.53 32.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.931 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.5 pt -124.79 -5.47 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -91.88 100.11 12.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.01 0.433 . . . . 0.0 111.263 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.52 -39.97 77.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -66.54 -30.5 70.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 111.8 49.24 0.64 Allowed Glycine 0 C--N 1.319 -0.39 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.051 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.584 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 92.9 mtt180 -118.45 149.22 41.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.986 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.773 HG21 HD11 ' A' ' 114' ' ' ILE . 10.0 p -129.37 142.32 44.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.019 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.774 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.26 139.95 50.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.704 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -120.39 148.18 46.95 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.583 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.52 157.98 29.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.655 2.237 . . . . 0.0 112.016 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -60.79 -40.56 93.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CZ2' ' HE3' ' A' ' 100' ' ' MET . 44.6 p-90 -70.05 -40.03 75.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.201 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.509 ' HE3' ' CZ2' ' A' ' 99' ' ' TRP . 52.5 mtt -65.32 -39.92 93.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.09 -40.32 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.6 -40.03 95.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.978 0.418 . . . . 0.0 110.379 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.6 -40.08 95.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.966 HD21 HG22 ' A' ' 80' ' ' THR . 96.5 mt -83.72 -12.15 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.594 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.65 42.23 99.21 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.96 132.52 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.136 0.493 . . . . 0.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -100.11 159.22 30.39 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 38.9 Cg_exo -52.44 131.03 38.77 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.501 2.134 . . . . 0.0 112.01 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.27 77.9 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.668 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t -76.82 153.3 35.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 111' ' ' LEU . 10.4 tt -70.59 140.78 51.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.461 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.974 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.2 tp -126.9 139.95 52.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.645 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 95.6 mt-30 -113.91 127.15 55.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 50' ' ' LEU . 85.3 mt -119.98 124.46 72.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.9 t -119.13 121.06 38.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.66 108.07 17.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.29 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 9.2 t -131.37 140.93 49.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.933 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.567 ' HA ' HD12 ' A' ' 68' ' ' LEU . 58.0 t0 -99.66 120.01 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.652 HG23 ' N ' ' A' ' 186' ' ' CYS . 27.3 m -103.97 155.71 36.69 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.432 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.625 ' O ' ' HA ' ' A' ' 185' ' ' ILE . 12.3 Cg_exo -70.05 149.72 65.42 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.322 2.015 . . . . 0.0 111.333 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 190' ' ' THR . 8.3 tt -70.19 127.42 32.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.85 152.19 29.8 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.283 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -108.48 -29.97 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.454 ' HE2' ' CG ' ' A' ' 126' ' ' LYS . 70.2 t80 -140.85 134.24 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.832 HG23 ' CG1' ' A' ' 176' ' ' VAL . 5.7 p -130.1 130.85 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.111 0.481 . . . . 0.0 112.148 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD3' HD11 ' A' ' 174' ' ' LEU . 99.5 mttt -99.18 122.02 41.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.323 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' OG1' ' A' ' 194' ' ' THR . 86.4 mt -111.71 131.09 55.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.0 0.429 . . . . 0.0 111.292 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.06 110.42 62.36 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.354 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 95.9 Cg_endo -84.26 162.15 13.21 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.676 2.25 . . . . 0.0 112.651 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.633 ' OE1' ' HE3' ' A' ' 170' ' ' LYS . 61.5 tt0 -129.31 122.88 30.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.755 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.5 OUTLIER 75.9 131.05 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.66 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.21 -17.5 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.728 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HA ' ' OD2' ' A' ' 136' ' ' ASP . 96.0 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.628 0.251 . . . . 0.0 110.842 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 59.5 t80 -59.94 -40.13 87.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 0.0 111.059 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 196' ' ' PHE . 95.7 mt -85.57 -4.77 59.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 133' ' ' ASP . 94.1 m-20 -70.05 -16.83 63.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.39 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 139' ' ' ASP . 86.0 mt -61.18 139.26 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.419 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.3 p -61.41 -39.94 92.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.508 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.0 OUTLIER -129.43 73.98 81.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.783 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 74.5 Cg_endo -76.0 -29.77 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.479 2.119 . . . . 0.0 112.117 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.06 -40.13 88.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.112 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.4 89.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 147' ' ' VAL . 87.1 t -62.87 -41.98 94.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.553 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.01 -42.81 95.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -41.36 92.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -61.92 -40.26 94.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 162' ' ' ILE . 57.5 t -60.96 -42.61 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.021 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.12 -40.06 88.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.783 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.66 -39.93 90.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.486 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.484 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 93.9 m-85 -96.18 121.46 37.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.402 ' OG ' HD23 ' A' ' 68' ' ' LEU . 89.4 p -61.19 -39.94 92.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.51 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.689 ' HB ' HD22 ' A' ' 68' ' ' LEU . 7.3 t -128.32 141.23 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 0.0 111.075 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -113.4 120.13 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.2 p -119.94 145.87 46.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.184 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.789 ' CG2' HG22 ' A' ' 176' ' ' VAL . 72.1 t -60.07 -39.94 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 111.73 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.18 -38.68 78.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.595 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -67.14 131.69 46.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.249 0.547 . . . . 0.0 112.325 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.406 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 60.0 t -104.01 120.12 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.846 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 ' CG1' ' A' ' 147' ' ' VAL . 49.1 pt -106.27 134.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 111.998 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 49.0 mt-10 -120.58 140.03 52.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.462 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 147' ' ' VAL . 44.3 pt -131.08 140.83 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 65.2 m -105.92 120.99 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.495 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 60.1 t80 -119.97 120.0 35.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.495 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 55.36 40.0 31.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.432 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.99 8.7 87.42 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.027 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.4 mttp -106.19 132.62 52.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -101.13 119.96 39.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.391 . . . . 0.0 111.223 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 98.3 m-85 -120.82 140.07 52.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 55.3 pttt -117.83 131.91 56.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.639 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 127' ' ' LEU . 85.4 mt -120.01 120.12 62.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.249 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -107.29 130.01 54.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.368 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 5.3 mp -80.52 113.37 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 126' ' ' LYS . 1.5 pp -73.64 -56.51 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.729 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.53 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 99.0 mt-10 -155.57 136.42 13.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.832 ' CG1' HG23 ' A' ' 125' ' ' VAL . 21.4 m -130.57 159.96 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -105.08 104.11 45.29 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.78 0.324 . . . . 0.0 110.219 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.426 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 68.7 Cg_endo -100.19 179.17 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.733 2.956 . . . . 0.0 112.509 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.0 mt-10 -95.41 0.03 52.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 120' ' ' PRO . 88.2 p -140.31 159.88 41.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.031 0.443 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.05 -11.53 60.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.668 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.9 t -59.95 -18.58 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.415 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 66.77 26.41 9.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 110.702 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.8 m -125.9 139.98 53.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.104 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' PRO . 45.7 pt -127.52 143.87 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.652 ' N ' HG23 ' A' ' 119' ' ' VAL . 40.5 t -92.04 100.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.078 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.755 HG21 HD22 ' A' ' 192' ' ' LEU . 97.6 t -109.96 93.83 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.093 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 1.0 HD13 ' HD2' ' A' ' 66' ' ' PRO . 84.2 mt -110.59 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.836 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 188' ' ' ILE . 99.0 mt-10 -117.78 10.78 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.67 ' CB ' HD11 ' A' ' 121' ' ' LEU . 5.8 t -84.98 171.71 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.207 0.527 . . . . 0.0 111.992 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.49 119.45 37.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.79 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.755 HD22 HG21 ' A' ' 187' ' ' VAL . 31.4 tp -120.37 131.29 54.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 36.3 t -89.35 126.91 42.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.167 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.593 ' OG1' HD12 ' A' ' 127' ' ' LEU . 3.9 t -116.96 140.3 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.575 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -120.07 131.74 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.544 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.427 ' CD1' HD21 ' A' ' 135' ' ' LEU . 87.4 m-85 -100.14 122.34 42.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.38 . . . . 0.0 111.532 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -121.16 108.39 36.32 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 112.468 -179.542 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 120.885 0.285 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' A' ' 117' ' ' THR . 57.2 tt0 -101.49 119.99 39.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.473 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 116' ' ' SER . 82.6 p -119.6 137.56 53.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.942 0.401 . . . . 0.0 111.637 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 57' ' ' LYS . 75.2 t80 -125.74 130.52 51.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.618 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.15 136.7 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 112.052 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 98.6 mt-10 -140.53 153.6 46.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.067 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -120.14 122.57 41.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 92.3 m-85 -139.91 160.37 40.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.819 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -84.1 139.66 32.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.934 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 36.2 t -100.0 123.78 44.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 111.458 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.618 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 82.8 m-85 -121.67 149.92 54.11 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.237 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 32' ' ' MET . 65.0 Cg_endo -79.45 111.17 2.79 Favored 'Trans proline' 0 N--CA 1.467 -0.081 0 C-N-CA 123.194 2.596 . . . . 0.0 112.647 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.691 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mt -60.77 -40.03 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 110.682 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.52 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.321 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.651 ' HB3' ' HG2' ' A' ' 29' ' ' PRO . 57.7 ttm -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.462 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 98.3 mtp -58.98 155.69 12.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.737 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.584 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.1 139.99 57.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.041 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -59.97 -37.09 78.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.05 -39.75 87.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.584 HG12 ' HB2' ' A' ' 34' ' ' ASN . 47.7 pt -90.3 -0.66 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 18.5 mtp-105 -99.39 139.94 34.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.857 0.361 . . . . 0.0 110.905 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -96.13 139.71 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.731 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.6 p-10 -60.01 -40.03 87.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.8 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.71 92.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 40' ' ' ASP . 27.3 p30 -62.53 -40.01 95.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 37.8 m-85 -110.0 18.23 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.587 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.09 173.35 28.96 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.14 24.22 19.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 71.5 mmtt -111.52 142.29 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 111.231 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.698 ' CG1' HG12 ' A' ' 84' ' ' VAL . 47.3 pt -121.24 155.96 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.56 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.4 m-85 -100.82 133.96 44.51 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 114' ' ' ILE . 4.1 mp -140.18 164.54 36.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 69.3 Cg_endo -73.29 156.26 50.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.268 1.978 . . . . 0.0 112.715 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.978 ' HA ' HD13 ' A' ' 55' ' ' LEU . 74.3 Cg_endo -75.26 -15.6 20.11 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.906 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -60.0 -40.3 88.73 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -61.35 -37.59 83.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.978 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.6 mp -60.13 -39.79 87.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.576 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.4 p -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 110.474 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 21' ' ' PHE . 23.6 tptm -69.45 -40.04 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.258 0.551 . . . . 0.0 110.167 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 55' ' ' LEU . 90.8 mt -59.95 -39.6 86.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.112 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -57.84 -39.27 77.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -59.88 -37.26 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 98.2 mt -80.46 -0.05 35.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.597 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.03 40.44 18.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.659 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.423 HG12 ' OE1' ' A' ' 19' ' ' GLN . 85.8 mt -86.63 120.01 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.789 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -91.73 149.13 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.305 0.574 . . . . 0.0 111.854 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.521 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.2 p90 -87.39 157.79 52.66 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.529 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 30.3 Cg_endo -63.74 147.61 64.42 Favored 'Cis proline' 0 C--N 1.352 0.759 0 C-N-CA 123.771 -1.346 . . . . 0.0 112.742 0.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 59.0 mtt -93.59 139.59 30.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.677 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 186' ' ' CYS . 6.6 mp -101.49 120.9 41.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.025 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.682 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.0 m-85 -128.35 142.3 51.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.607 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 60.7 pttt -120.74 140.11 52.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -99.32 115.46 29.23 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.394 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.4 m -99.26 121.44 41.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.941 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.39 117.64 35.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.281 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -68.99 -39.99 79.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.433 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.906 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.434 HG21 ' HA3' ' A' ' 105' ' ' GLY . 77.8 p -105.4 -7.7 18.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.12 40.53 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.644 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -104.79 140.09 38.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.668 0.27 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 3.1 p -124.01 130.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.636 ' OG1' HD23 ' A' ' 71' ' ' LEU . 67.4 p -97.54 154.88 17.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.146 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 81.0 m80 -119.47 131.18 55.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.153 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.85 -173.72 36.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.538 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 152' ' ' SER . . . -107.62 -170.72 21.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.937 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.698 HG12 ' CG1' ' A' ' 48' ' ' ILE . 32.6 m -130.05 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 121.279 -0.168 . . . . 0.0 110.815 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 58.2 tp -89.99 -78.1 0.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.39 . . . . 0.0 110.544 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -147.72 159.8 43.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.886 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.865 ' CD2' HD11 ' A' ' 55' ' ' LEU . 88.3 m-85 -99.87 116.15 31.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.276 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.16 -4.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.077 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -87.45 100.41 12.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.38 -39.98 77.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.92 -30.85 71.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.095 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.57 50.32 0.71 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.386 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.549 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 98.8 mtt180 -117.64 148.23 42.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.948 0.404 . . . . 0.0 111.501 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 8.0 p -129.81 140.81 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.02 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.691 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.72 139.96 50.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.927 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.564 HD23 HG21 ' A' ' 48' ' ' ILE . 21.3 mt -114.81 139.58 24.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 48' ' ' ILE . 57.5 Cg_exo -55.01 155.59 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.699 2.266 . . . . 0.0 112.3 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.19 91.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.638 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.698 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 55.2 p-90 -69.95 -37.87 75.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.732 0.301 . . . . 0.0 111.356 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.655 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 98.1 mtp -69.94 -39.98 75.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.1 mtp -60.01 -40.94 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.037 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 21.3 pt-20 -64.12 -40.02 95.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.48 -40.06 95.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HG23 ' A' ' 80' ' ' THR . 82.9 mt -70.04 -24.13 63.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.369 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 74.66 29.97 60.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.8 pt -114.35 139.92 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 111.713 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.7 pt20 -95.25 160.01 31.63 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.415 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.5 Cg_endo -49.15 137.79 29.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.754 2.302 . . . . 0.0 112.48 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.09 -8.13 80.37 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.987 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 89.8 p -71.04 160.36 33.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.753 0.276 . . . . 0.0 110.605 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.65 145.2 30.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.473 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.934 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.1 tp -130.24 130.33 44.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 94.2 mt-30 -110.52 127.59 55.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.682 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 19.0 tt -118.44 127.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.407 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 47.0 t -120.02 130.03 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 23.4 t -89.9 116.03 27.66 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.857 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.752 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.6 t -129.98 138.83 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.74 121.07 44.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.537 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 120' ' ' PRO . 32.7 m -119.16 154.45 53.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.634 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.608 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 59.6 Cg_endo -72.5 153.31 55.11 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.791 2.327 . . . . 0.0 111.325 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.85 HD23 HG23 ' A' ' 187' ' ' VAL . 4.7 mp -64.29 130.05 42.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.954 0.407 . . . . 0.0 111.137 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.95 151.4 49.01 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.53 -20.05 15.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.516 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' OD2' ' A' ' 195' ' ' ASP . 60.4 t80 -145.79 131.16 18.6 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.681 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.699 HG23 ' CG1' ' A' ' 176' ' ' VAL . 11.5 p -134.0 134.44 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.267 0.556 . . . . 0.0 111.529 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.834 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 64.3 mttp -99.43 122.37 42.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.359 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 194' ' ' THR . 86.0 mt -113.25 128.59 56.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.417 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -111.7 112.22 53.81 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.105 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.509 ' CB ' HD11 ' A' ' 135' ' ' LEU . 84.2 Cg_endo -82.08 167.78 15.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.67 2.247 . . . . 0.0 112.462 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -126.07 121.22 32.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.6 142.15 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.03 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.09 -20.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.412 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.0 -39.56 86.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.138 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.3 t80 -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.9 mp -81.95 -11.21 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.543 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.08 -19.99 63.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.743 0.306 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.15 130.2 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.5 p -69.54 150.75 46.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.26 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 2.5 m-20 53.66 53.37 10.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 144' ' ' LEU . 31.0 Cg_endo -63.83 -34.65 60.17 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.351 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.08 -40.04 88.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.071 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.88 95.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 147' ' ' VAL . 81.6 t -60.1 -43.19 92.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.9 mm? -60.0 -40.57 89.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.57 -41.17 94.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.45 -39.94 89.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.176 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 143' ' ' VAL . 60.4 t -60.33 -42.07 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.86 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -41.27 91.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 188' ' ' ILE . 16.8 tpt180 -61.71 -40.0 93.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.222 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.483 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 98.6 m-20 -62.05 -39.99 94.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.822 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.01 122.67 43.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.318 . . . . 0.0 111.4 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.639 ' HA ' HD11 ' A' ' 188' ' ' ILE . 51.8 m -60.03 -40.02 87.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.527 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 10.0 t -136.06 149.97 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.613 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 173' ' ' ILE . 64.8 tp -120.04 128.2 53.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.3 m -119.05 140.19 50.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 176' ' ' VAL . 63.5 t -59.96 -42.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.398 0.618 . . . . 0.0 111.343 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.98 -39.71 75.77 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.678 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 81' ' ' HIS . 96.0 m-20 -65.53 140.39 58.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 112.449 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.403 HG22 ' CE ' ' A' ' 172' ' ' LYS . 53.1 t -105.77 120.02 55.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.654 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 171' ' ' ILE . 48.0 pt -106.94 141.4 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.798 0.332 . . . . 0.0 111.377 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.688 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 99.9 mt-10 -118.99 140.69 49.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 147' ' ' VAL . 46.7 pt -130.31 139.98 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.425 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 58.6 m -107.55 118.46 36.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -119.95 121.77 39.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.6 t30 55.07 40.03 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.421 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.88 9.9 86.23 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.891 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.6 mttt -110.38 138.05 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.807 0.303 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.1 m -106.63 121.16 43.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.545 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 90.3 m-85 -120.03 140.03 51.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.688 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 58.9 mtpt -106.07 123.99 48.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.354 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 160' ' ' ILE . 46.0 pt -122.42 131.13 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 110.639 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.403 ' CE ' HG22 ' A' ' 159' ' ' VAL . 35.0 ttmt -119.64 135.88 54.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.778 HD11 HD11 ' A' ' 154' ' ' LEU . 4.6 mp -84.62 120.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.083 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 126' ' ' LYS . 89.1 mt -68.79 -59.32 3.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.429 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.834 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.28 146.66 18.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.76 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 156' ' ' VAL . 4.3 m -139.02 145.15 28.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -88.94 104.7 8.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.327 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.1 Cg_endo -104.07 174.36 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.861 3.041 . . . . 0.0 112.351 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.6 mt-10 -100.03 0.73 41.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.1 m -132.81 150.03 52.2 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 111.184 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.5 m -70.98 -12.2 61.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.928 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -62.9 -10.39 13.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.0 mttm 59.93 24.58 13.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 111.425 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 64.2 m -121.08 135.76 55.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 46.7 pt -129.97 159.14 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.399 0.618 . . . . 0.0 112.355 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HD21 ' A' ' 68' ' ' LEU . 53.0 t -140.53 104.57 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.932 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.85 HG23 HD23 ' A' ' 121' ' ' LEU . 7.5 p -139.79 87.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.69 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 152' ' ' SER . 72.0 mt -99.49 -3.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.796 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 190' ' ' THR . 99.6 mt-10 -90.0 -80.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.291 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 13.1 t 177.38 36.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -109.64 16.77 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.436 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.825 ' HB2' HG11 ' A' ' 187' ' ' VAL . 19.0 tp -116.38 132.45 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 0.0 111.185 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 125' ' ' VAL . 39.9 t -95.11 120.01 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.04 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.65 HG22 HG11 ' A' ' 125' ' ' VAL . 81.6 p -103.31 141.2 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.0 111.895 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.401 ' OD2' ' CE2' ' A' ' 124' ' ' PHE . 96.0 m-20 -129.21 144.7 51.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.071 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.68 139.98 48.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 111.415 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.61 166.26 13.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.374 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 28.9 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.184 1.923 . . . . 0.0 112.1 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.652 0.188 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.7 mt-30 -99.94 120.32 39.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.451 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 116' ' ' SER . 8.9 t -130.0 139.95 50.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.136 0.493 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 55.2 t80 -128.82 130.19 46.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.98 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.08 135.71 48.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.0 mt-10 -144.48 160.05 41.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -119.13 135.46 54.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.417 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -149.7 160.02 43.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.943 0.401 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.83 132.67 39.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.79 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 31.4 p -96.48 141.81 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.482 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.9 m-85 -127.07 153.92 76.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.693 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HG3' ' CG ' ' A' ' 108' ' ' PRO . 5.7 Cg_exo -78.27 107.09 2.25 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.733 2.288 . . . . 0.0 113.016 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 87.2 mt -64.29 -40.03 87.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.87 80.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.276 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.488 ' CB ' ' HB2' ' A' ' 29' ' ' PRO . 57.6 ttm -67.6 -32.54 73.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.946 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.0 159.54 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.01 144.49 49.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.44 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.18 -38.96 81.11 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.99 -39.9 87.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 37' ' ' ILE . 83.2 mt -88.72 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.258 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 30' ' ' ILE . 62.4 mtm180 -99.68 138.97 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.261 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -103.67 132.47 49.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.455 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 111.242 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 96.1 m-20 -66.28 -40.06 89.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.95 95.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.14 -39.89 87.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 99' ' ' TRP . 86.4 m-85 -105.52 6.44 32.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.768 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -96.07 173.4 30.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.714 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.8 24.33 21.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.261 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.73 ' HD3' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.35 136.03 41.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 50' ' ' LEU . 45.6 pt -121.08 158.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 94' ' ' VAL . 65.6 m-85 -100.08 131.6 45.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.577 HD13 ' CE2' ' A' ' 69' ' ' PHE . 1.9 mp -131.78 162.65 55.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.042 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.59 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.5 Cg_endo -77.78 144.17 21.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.148 1.898 . . . . 0.0 112.155 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.1 Cg_exo -59.68 -23.93 73.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.603 2.202 . . . . 0.0 112.782 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -60.03 -39.93 87.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.116 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.82 85.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.156 0.503 . . . . 0.0 110.753 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.644 HD13 ' HE1' ' A' ' 67' ' ' MET . 34.7 tp -61.5 -39.94 92.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.771 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.3 p -60.06 -39.04 84.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.143 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HA ' ' CE ' ' A' ' 60' ' ' MET . 98.8 mttt -64.37 -40.06 95.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.96 0.41 . . . . 0.0 110.5 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 63' ' ' ILE . 96.1 mt -61.08 -35.45 77.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.11 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.7 m -60.01 -38.64 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.442 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.436 ' CE ' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -60.03 -36.43 77.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.304 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.94 -1.31 38.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.317 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.05 39.99 19.14 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 58' ' ' LEU . 85.4 mt -79.48 126.59 39.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -85.35 142.77 29.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 0.0 111.897 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.516 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 47.4 p90 -87.34 157.82 52.8 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.993 ' HG2' HG21 ' A' ' 188' ' ' ILE . 25.2 Cg_exo -65.24 157.77 75.89 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.542 0.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.644 ' HE1' HD13 ' A' ' 55' ' ' LEU . 65.6 mtm -100.14 145.77 27.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.189 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 186' ' ' CYS . 1.3 pt? -116.16 133.7 55.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.88 ' HB3' HG23 ' A' ' 114' ' ' ILE . 15.7 m-85 -120.03 140.02 51.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HE2' HG21 ' A' ' 79' ' ' VAL . 81.1 tttt -115.08 120.02 38.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.274 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.823 HD22 ' SD ' ' A' ' 100' ' ' MET . 6.5 mp -97.99 127.36 43.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -115.03 130.23 56.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.831 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.09 110.72 22.04 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.23 -40.07 88.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.687 HG21 ' O ' ' A' ' 104' ' ' LEU . 74.4 p -101.6 -10.41 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.61 6.56 16.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.615 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -104.1 141.31 36.45 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 71' ' ' LEU . 7.2 p -121.18 124.42 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.355 0.598 . . . . 0.0 111.626 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.569 HG23 HD21 ' A' ' 104' ' ' LEU . 68.9 p -104.3 151.12 23.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.34 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.414 ' ND1' HG21 ' A' ' 155' ' ' THR . 77.4 m80 -100.91 115.06 29.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 0.0 110.814 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CE ' ' A' ' 100' ' ' MET . . . -114.74 139.55 15.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.182 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -84.24 163.97 39.84 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.564 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.7 p -126.01 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.73 HD22 ' HD3' ' A' ' 47' ' ' LYS . 64.9 tp -90.33 -74.1 0.5 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.16 160.65 41.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.291 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.608 ' CD1' HD22 ' A' ' 55' ' ' LEU . 89.3 m-85 -95.72 116.76 29.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.2 -5.38 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.063 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -90.23 97.77 11.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.023 0.44 . . . . 0.0 111.412 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.95 -39.94 75.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.11 0.481 . . . . 0.0 110.796 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.08 -30.03 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.902 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.03 50.15 0.69 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.167 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.704 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 mtt180 -118.45 151.28 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.848 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 114' ' ' ILE . 12.4 p -130.03 142.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 28' ' ' TYR . 88.6 m-85 -119.08 140.02 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -123.56 147.96 54.46 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.894 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.21 -173.08 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.405 2.07 . . . . 0.0 112.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.91 -20.85 63.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.615 ' HE1' ' HA ' ' A' ' 44' ' ' PHE . 14.4 m95 -60.01 -49.91 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.575 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.823 ' SD ' HD22 ' A' ' 71' ' ' LEU . 67.6 mtt -70.01 -39.97 75.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.495 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 29' ' ' PRO . 67.8 mtt -63.89 -47.8 79.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.568 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.98 -40.12 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.235 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.938 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.687 ' O ' HG21 ' A' ' 76' ' ' THR . 92.9 mt -95.16 -19.05 20.4 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 101' ' ' MET . . . 58.89 47.76 88.97 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -113.49 150.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.031 0.443 . . . . 0.0 111.439 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.35 161.69 30.13 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.595 ' CG ' ' HG3' ' A' ' 29' ' ' PRO . 40.0 Cg_exo -59.62 -5.89 3.84 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.886 2.391 . . . . 0.0 113.421 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.13 -6.82 56.69 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.773 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.4 m -85.02 143.77 28.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.736 0.303 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.97 145.0 52.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.629 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 96' ' ' LEU . 54.1 tp -124.83 125.16 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.969 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -111.33 132.08 54.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.954 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 94' ' ' VAL . 88.9 mt -111.56 130.01 65.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.417 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 82.3 p -126.33 134.43 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.287 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' THR . 67.2 m -83.8 120.84 26.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.592 ' O ' HD21 ' A' ' 68' ' ' LEU . 70.8 p -126.34 139.95 52.89 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -112.69 110.8 21.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 186' ' ' CYS . 35.1 m -115.58 151.06 45.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.34 133.3 15.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.427 2.084 . . . . 0.0 110.958 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 190' ' ' THR . 5.0 mt -62.21 130.91 47.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.213 0.53 . . . . 0.0 112.091 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 159.2 50.31 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.058 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -105.66 -22.7 12.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -136.51 134.56 37.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 111.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.725 HG21 HD21 ' A' ' 154' ' ' LEU . 3.2 p -133.52 130.34 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.133 0.492 . . . . 0.0 111.54 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.813 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 99.4 mttt -96.86 123.12 40.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD22 ' CG2' ' A' ' 171' ' ' ILE . 90.9 mt -116.74 136.6 52.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.06 114.7 64.21 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.458 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.87 158.98 21.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.101 . . . . 0.0 112.83 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 131' ' ' SER . 96.9 mt-30 -122.72 121.6 36.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 130' ' ' GLN . 47.3 t 69.13 133.98 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.564 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.57 -23.05 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.94 -40.03 87.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.239 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 67.2 t80 -59.98 -40.13 88.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.97 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.36 -9.95 59.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.63 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.48 -10.18 58.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.573 0.225 . . . . 0.0 111.356 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.81 138.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 110.492 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.0 t -60.04 -40.04 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.531 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -129.75 71.24 82.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.927 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.686 ' O ' HD23 ' A' ' 144' ' ' LEU . 21.2 Cg_exo -65.11 -32.73 52.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.729 2.286 . . . . 0.0 111.909 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.01 -40.03 87.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.285 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.38 98.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 147' ' ' VAL . 64.2 t -62.33 -41.33 91.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -63.43 -40.1 96.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -45.8 91.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -60.28 -41.36 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.051 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 143' ' ' VAL . 62.6 t -60.29 -44.21 95.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.226 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.06 -40.05 88.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.4 mtp85 -65.1 -40.02 93.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.094 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.15 -40.08 88.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.539 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 147' ' ' VAL . 90.6 m-85 -97.74 120.15 37.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.177 0.513 . . . . 0.0 111.439 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.4 m -60.16 -39.91 88.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.022 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 41.9 p -126.87 145.23 50.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.866 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.725 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -119.88 119.4 33.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.999 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 184' ' ' SER . 73.6 p -124.28 141.37 52.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 176' ' ' VAL . 97.9 t -59.99 -40.18 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 111.841 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.77 -39.78 87.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.869 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 97.0 m-20 -74.5 140.11 44.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 112.325 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 ' CG ' ' A' ' 172' ' ' LYS . 7.2 p -106.04 121.93 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.492 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 46.0 pt -107.97 131.07 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 19.6 pt-20 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.727 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -121.15 148.97 24.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 82.3 p -109.01 117.55 34.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.206 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 64.6 t80 -119.99 120.06 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 10.9 m120 54.07 40.13 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.28 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.15 10.19 85.77 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.14 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 163' ' ' SER . 63.2 mttp -109.72 133.45 53.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.751 0.275 . . . . 0.0 110.368 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -107.38 123.9 49.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.3 m-85 -119.99 140.04 51.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 56.4 mttm -103.6 129.74 50.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.612 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 120.16 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.488 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.479 ' CG ' HG23 ' A' ' 159' ' ' VAL . 61.2 mttp -111.15 127.14 55.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.709 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -81.6 110.0 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.449 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.5 tt -63.58 -58.8 5.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.838 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.832 ' HG3' HD23 ' A' ' 174' ' ' LEU . 99.4 mt-10 -158.38 143.03 16.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.739 HG22 ' CG2' ' A' ' 156' ' ' VAL . 7.2 m -137.55 142.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.042 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.47 104.71 11.87 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.679 ' HB3' HG23 ' A' ' 185' ' ' ILE . 57.1 Cg_endo -102.99 -0.88 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.882 3.054 . . . . 0.0 112.966 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.48 21.54 12.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.9 p -141.09 155.56 46.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.7 p -70.01 -23.08 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.334 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 22.5 t -59.93 -36.63 77.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.577 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 29.8 mmtm 69.68 19.96 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 155' ' ' THR . 52.9 m -130.03 140.01 50.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.094 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 178' ' ' PRO . 44.6 pt -130.36 157.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 112.412 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.611 ' HB2' HD13 ' A' ' 68' ' ' LEU . 34.0 t -120.81 99.8 6.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.226 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.737 HG11 HD22 ' A' ' 192' ' ' LEU . 14.7 p -119.91 107.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.237 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.993 HG21 ' HG2' ' A' ' 66' ' ' PRO . 24.0 mt -95.54 -80.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.102 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.87 3.69 49.75 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.829 HG21 HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -78.92 171.1 15.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.085 0.469 . . . . 0.0 111.248 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -100.11 123.25 44.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.354 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.737 HD22 HG11 ' A' ' 187' ' ' VAL . 13.6 tp -120.29 131.49 54.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.53 120.08 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.8 t -118.15 148.14 42.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.109 0.481 . . . . 0.0 111.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -120.15 139.74 52.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -99.72 122.43 42.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.29 110.67 34.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.394 2.063 . . . . 0.0 112.269 -179.579 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.464 -0.219 0 CA-C-O 120.722 0.218 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 117' ' ' THR . 72.0 tp60 -100.02 119.86 38.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.033 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 116' ' ' SER . 73.0 p -120.01 133.08 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 57.4 t80 -120.0 124.96 47.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -105.68 135.06 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' OE2' ' HG3' ' A' ' 91' ' ' GLU . 85.3 tt0 -145.05 155.28 43.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.706 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.62 120.03 41.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.17 0.51 . . . . 0.0 111.995 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' HE2' ' HG3' ' A' ' 51' ' ' PRO . 87.1 m-85 -121.06 140.01 52.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.628 ' O ' HG12 ' A' ' 94' ' ' VAL . 36.8 ptt180 -80.02 153.34 28.89 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 69.3 m -83.69 132.79 34.84 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 112.337 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.668 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 3.0 m-85 -130.53 126.29 21.95 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.078 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' MET . 16.0 Cg_exo -70.02 113.29 3.37 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.553 2.169 . . . . 0.0 112.016 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 95' ' ' TYR . 91.4 mt -66.21 -36.79 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 110.818 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.17 83.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.261 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.0 ptm -68.43 -20.07 64.62 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.134 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 96.9 mmm -64.69 156.92 28.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 28.2 m120 -60.06 141.36 55.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -39.66 86.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -59.93 -39.83 86.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.5 mt -87.26 -7.76 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.232 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 22.4 mtp-105 -98.96 140.04 33.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.086 0.469 . . . . 0.0 111.917 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.94 130.82 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.93 -40.11 87.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.28 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -64.0 -39.96 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.85 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.95 96.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.009 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -60.08 -40.02 88.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.58 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -105.14 2.01 28.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.626 0.25 . . . . 0.0 111.565 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.48 173.9 30.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -100.39 14.88 59.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.403 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.6 mttt -95.32 133.36 39.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.597 HD11 ' CD1' ' A' ' 114' ' ' ILE . 45.9 pt -118.85 164.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.811 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.445 ' CD1' HG12 ' A' ' 88' ' ' ILE . 98.7 m-85 -100.5 131.54 46.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -129.74 166.77 23.64 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.767 -179.248 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.862 ' HG3' ' HA ' ' A' ' 91' ' ' GLU . 31.6 Cg_endo -83.13 147.72 13.07 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.821 2.347 . . . . 0.0 113.4 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 55' ' ' LEU . 37.1 Cg_exo -61.93 -21.27 71.97 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.5 p -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.0 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.545 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.967 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.97 -40.25 88.44 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.544 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -40.0 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 60.9 mttp -69.24 -40.01 78.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.383 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.524 HD21 ' CB ' ' A' ' 116' ' ' SER . 88.2 mt -60.24 -39.81 88.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.033 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.4 m -59.99 -39.73 86.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.487 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.0 -38.89 83.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.355 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.06 0.01 33.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.517 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 59.97 42.77 15.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.811 0.339 . . . . 0.0 111.511 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD11 ' HG2' ' A' ' 19' ' ' GLN . 43.9 mm -76.33 129.99 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -83.88 146.71 27.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.432 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.3 m-85 -87.58 153.53 53.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.65 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.559 ' CG ' HD11 ' A' ' 188' ' ' ILE . 12.3 Cg_exo -71.07 163.09 86.27 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.659 0.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.432 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 76.0 mtm -84.09 137.0 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.358 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.766 ' HB2' ' O ' ' A' ' 117' ' ' THR . 76.7 mt -115.3 131.91 56.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.498 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE1' HG11 ' A' ' 84' ' ' VAL . 95.4 m-85 -129.6 144.1 51.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.53 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 81' ' ' HIS . 28.3 ttpp -119.53 130.46 55.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 112' ' ' LEU . 7.5 mp -100.02 121.82 41.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 79' ' ' VAL . 98.6 m -114.17 130.04 56.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.983 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.19 30.95 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.487 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -68.42 -39.63 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.766 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.721 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 29.8 m -103.58 -15.97 15.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.57 7.92 62.07 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.536 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -99.4 140.17 33.97 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.85 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 72' ' ' THR . 59.3 t -119.95 120.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.5 p -109.28 138.35 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.273 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.576 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 2.0 m170 -84.12 114.14 21.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.08 146.16 16.03 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.177 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' A' ' 152' ' ' SER . . . -96.51 162.62 22.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.771 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.617 HG11 ' HE1' ' A' ' 69' ' ' PHE . 8.1 p -120.73 126.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 48.6 tp -91.63 -74.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.9 159.96 41.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.245 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 55' ' ' LEU . 70.8 m-85 -100.79 116.21 32.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.826 0.346 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 HG12 ' CD1' ' A' ' 49' ' ' PHE . 48.3 pt -137.99 -4.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.827 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -104.29 158.02 16.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 110.889 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 93' ' ' ARG . 97.9 mt-10 -76.67 158.17 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.333 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.862 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 85.8 tt0 -59.99 -30.35 69.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.598 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -81.81 1.24 86.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.308 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 46.6 ptt85 -144.23 145.88 32.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 26' ' ' ARG . 7.7 p -142.89 150.41 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.664 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.776 ' HB3' HG12 ' A' ' 30' ' ' ILE . 85.3 m-85 -118.63 139.99 50.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -134.34 159.05 73.76 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 48' ' ' ILE . 22.9 Cg_exo -64.66 147.97 90.14 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.792 2.328 . . . . 0.0 112.13 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -60.01 -42.29 94.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.163 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -68.72 -40.04 80.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.5 ttm -60.03 -40.28 88.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' HG13 ' A' ' 106' ' ' ILE . 67.4 ttp -60.62 -41.27 94.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.46 -39.99 95.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.0 m -62.55 -40.01 95.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 -23.82 63.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.564 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.32 35.0 43.97 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.739 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.538 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.5 pt -118.11 147.43 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.969 0.414 . . . . 0.0 111.3 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.1 pt20 -98.18 161.63 24.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 8.5 Cg_endo -49.34 136.44 31.83 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.74 2.293 . . . . 0.0 112.162 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 -9.9 75.75 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.612 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.538 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 70.4 p -70.11 161.08 30.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.682 0.277 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.25 140.65 29.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 60.2 tp -120.07 127.99 53.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -106.93 119.95 40.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.18 0.514 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.836 HD13 HD21 ' A' ' 50' ' ' LEU . 18.9 tt -120.97 128.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 79.8 p -120.69 138.83 53.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 20' ' ' THR . 44.9 t -80.17 110.72 15.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 92.9 m -119.51 129.4 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -101.5 119.23 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 186' ' ' CYS . 22.1 m -120.12 152.6 54.65 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 49.4 Cg_endo -67.78 175.29 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.423 2.082 . . . . 0.0 110.684 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 122' ' ' GLY . 7.7 tt -94.41 120.04 34.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.938 0.399 . . . . 0.0 111.257 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.692 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -62.35 151.25 46.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.919 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -101.33 -17.02 16.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.065 0.433 . . . . 0.0 111.767 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.523 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 69.0 t80 -150.27 134.78 17.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.766 ' CG1' HG22 ' A' ' 194' ' ' THR . 7.7 p -139.21 130.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.344 0.592 . . . . 0.0 111.419 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.843 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 83.8 mttt -94.98 126.3 40.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.487 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.3 133.28 56.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.88 0.372 . . . . 0.0 110.954 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -109.19 110.59 60.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.762 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.52 175.59 10.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.579 2.186 . . . . 0.0 112.395 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -124.02 121.35 35.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.304 0.573 . . . . 0.0 110.089 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 6.3 t 59.83 168.78 0.07 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.086 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.26 -19.99 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.702 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' PHE . 47.7 p-10 -60.03 -39.93 87.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.01 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 66.9 t80 -59.96 -40.04 87.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.348 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.1 -7.71 59.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.717 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.94 -12.78 61.87 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 143' ' ' VAL . 85.4 mt -60.33 138.82 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.4 m -60.07 -39.99 87.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 111.314 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 137' ' ' ILE . 36.4 m-20 -125.9 75.73 71.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 25.2 Cg_endo -62.17 -40.61 40.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.5 2.133 . . . . 0.0 112.203 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.29 -40.02 88.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.36 96.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 137' ' ' ILE . 84.6 t -60.66 -41.96 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.247 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -59.98 -41.69 92.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.23 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.01 -40.47 89.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 111.043 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.97 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.8 HG22 HG21 ' A' ' 162' ' ' ILE . 77.2 t -61.89 -43.49 97.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.054 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.98 -40.95 90.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.02 0.438 . . . . 0.0 110.557 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -64.28 -40.15 95.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 96.7 m-20 -61.28 -40.05 92.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.478 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 97.7 m-85 -101.16 120.02 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.496 . . . . 0.0 110.911 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.524 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t -68.63 -39.99 80.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.864 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 74.1 p -124.41 140.06 53.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.219 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 151' ' ' PHE . 86.9 mt -131.18 136.89 48.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.962 0.411 . . . . 0.0 111.819 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 157' ' ' ASP . 21.7 m -118.77 145.49 45.56 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.704 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.5 t -60.02 -41.6 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.42 0.629 . . . . 0.0 110.646 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 155' ' ' THR . 95.9 m-20 -72.98 -40.01 65.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.675 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 54.0 t0 -61.01 135.21 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.999 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.27 120.03 53.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.31 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.9 pt -103.92 140.61 21.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.337 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.543 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.1 mt-10 -118.26 141.36 48.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 111.495 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.826 HD12 ' CE1' ' A' ' 164' ' ' TYR . 48.2 pt -125.63 139.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 33.2 p -105.81 108.16 19.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.919 0.39 . . . . 0.0 111.654 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.826 ' CE1' HD12 ' A' ' 162' ' ' ILE . 39.6 m-85 -120.49 123.75 43.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.707 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 59.29 34.34 22.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.39 83.4 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.062 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.5 mttt -119.45 138.43 53.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.791 0.295 . . . . 0.0 111.09 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 9.6 t -108.6 131.79 54.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.115 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.4 m-85 -120.01 140.03 51.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 96.8 mttt -97.2 127.25 43.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.12 134.5 54.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -79.49 122.26 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.522 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 84.6 mt -73.03 -57.9 3.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.083 0.468 . . . . 0.0 111.195 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.843 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.1 mt-10 -159.92 145.84 15.67 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.852 ' CB ' HD11 ' A' ' 185' ' ' ILE . 5.4 m -140.24 160.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -110.93 103.66 55.06 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 81.0 Cg_endo -100.25 171.18 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.605 2.87 . . . . 0.0 113.041 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 70.5 mm-40 -99.97 3.74 44.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.038 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.4 m -136.25 160.52 38.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.09 -13.11 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.341 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.8 p -67.9 -13.1 61.88 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.652 0.263 . . . . 0.0 111.428 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.681 ' HE3' HG22 ' A' ' 176' ' ' VAL . 4.8 tptm 49.99 41.84 23.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.322 0.582 . . . . 0.0 110.843 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.1 m -123.71 144.73 49.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.471 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 176' ' ' VAL . 20.2 mt -119.3 134.08 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.385 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 119' ' ' VAL . 64.2 m -142.21 100.09 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.011 0.434 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -149.42 113.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.856 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 66' ' ' PRO . 44.1 pt -103.21 -10.13 9.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.3 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -89.96 -79.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 14.6 t -172.52 -161.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.439 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' THR . 96.5 m-20 71.75 24.7 3.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.033 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 187' ' ' VAL . 21.1 tp -117.98 132.41 56.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 125' ' ' VAL . 47.1 t -94.59 124.84 47.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.766 HG22 ' CG1' ' A' ' 125' ' ' VAL . 76.3 p -115.93 149.77 38.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.28 135.82 52.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.76 138.85 39.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.157 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.7 162.49 28.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 53.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 121.966 1.777 . . . . 0.0 112.03 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 35.6 Cg_exo . . . . . 0 N--CA 1.472 0.233 0 CA-C-O 120.722 0.218 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.643 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.8 mt-30 -105.77 118.53 36.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.48 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.716 ' HA ' ' O ' ' A' ' 116' ' ' SER . 58.5 p -121.07 126.55 50.11 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 115' ' ' SER . 72.6 t80 -121.09 120.42 35.27 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 98.9 mt-10 -98.29 140.99 31.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 71.3 mt-10 -149.96 159.99 43.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.615 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 55.2 p90 -100.2 120.21 39.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.162 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.957 ' HB3' HG21 ' A' ' 94' ' ' VAL . 94.4 m-85 -120.19 140.36 51.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 76.4 mtp85 -82.31 142.66 31.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.393 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 50.6 m -84.48 135.4 34.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.899 0.38 . . . . 0.0 111.796 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 21.5 m-85 -129.71 137.21 30.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.249 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 33' ' ' MET . 95.4 Cg_endo -79.26 92.24 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.684 2.256 . . . . 0.0 112.965 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.797 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 85.0 mt -59.96 -40.02 81.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.983 0.421 . . . . 0.0 110.601 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.87 87.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.729 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.42 -31.07 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.71 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.575 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 94.4 mmm -59.21 145.01 44.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.546 ' HB3' HG12 ' A' ' 37' ' ' ILE . 19.6 t-20 -59.88 139.87 57.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.372 0.606 . . . . 0.0 112.359 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.91 -38.89 83.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.023 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 92.7 mtt-85 -59.87 -40.0 87.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.366 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 34' ' ' ASN . 47.6 pt -95.49 -1.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.575 ' HG3' ' HB2' ' A' ' 33' ' ' MET . 79.2 mmt-85 -125.43 155.75 39.93 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.033 0.444 . . . . 0.0 111.793 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -101.01 133.25 45.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.555 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -39.92 88.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.218 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -39.86 87.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.08 84.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -60.01 -40.27 88.65 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 111.308 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.45 4.12 40.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.642 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.11 -174.49 28.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.232 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.35 32.46 6.8 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.695 ' HD2' HD13 ' A' ' 85' ' ' LEU . 36.6 ttpt -102.55 129.5 49.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.208 -0.496 . . . . 0.0 112.096 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 50' ' ' LEU . 41.7 pt -131.73 161.07 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.818 ' C ' HD22 ' A' ' 50' ' ' LEU . 93.0 m-85 -104.06 133.39 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.062 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.3 mm? -133.08 157.58 77.96 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.391 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.1 Cg_endo -75.24 132.55 15.22 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.21 2.607 . . . . 0.0 112.753 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.497 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 52.2 Cg_exo -53.59 -15.23 6.03 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 113.32 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 m -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.146 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.69 87.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.049 0.452 . . . . 0.0 111.088 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.881 HD21 ' CE1' ' A' ' 87' ' ' PHE . 68.7 mt -59.92 -39.75 86.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 109.974 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 73.3 mmtt -66.67 -39.94 88.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.294 0.569 . . . . 0.0 109.976 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.863 HD13 ' SD ' ' A' ' 67' ' ' MET . 90.8 mt -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -56.69 -38.19 71.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.037 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.666 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -59.98 -38.27 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.77 1.34 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.04 39.96 19.22 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.784 0.326 . . . . 0.0 111.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.592 HG22 ' HG2' ' A' ' 67' ' ' MET . 82.1 mt -88.5 120.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.186 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -95.77 140.21 30.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.619 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.553 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 51.8 p90 -87.17 159.67 50.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 34.9 Cg_exo -60.53 134.41 12.05 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.522 0.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.863 ' SD ' HD13 ' A' ' 58' ' ' LEU . 74.3 mtm -98.82 140.4 33.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.208 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 153' ' ' THR . 1.9 mp -97.42 127.46 43.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.215 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 116' ' ' SER . 89.3 m-85 -119.95 140.08 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.506 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.02 129.98 55.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.151 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 114' ' ' ILE . 1.4 mp -97.14 123.22 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.686 0.279 . . . . 0.0 111.078 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.701 ' HA ' HG12 ' A' ' 79' ' ' VAL . 90.8 m -114.02 121.28 43.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.398 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . . . -117.23 139.18 51.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 98.6 m-20 62.27 147.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.344 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.96 -40.67 89.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -133.13 8.41 4.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.404 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . -67.92 -105.73 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.849 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.41 157.41 46.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.924 0.392 . . . . 0.0 111.287 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 72' ' ' THR . 33.3 m -129.77 136.69 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.553 ' OG1' ' HG ' ' A' ' 104' ' ' LEU . 41.9 m -99.04 148.79 23.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -119.74 131.12 55.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.759 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.16 175.24 44.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.716 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.64 -175.06 25.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.478 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.97 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 0.0 111.559 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.695 HD13 ' HD2' ' A' ' 47' ' ' LYS . 65.0 tp -93.4 -79.98 0.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.341 0.591 . . . . 0.0 110.863 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -152.44 159.21 43.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.587 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.881 ' CE1' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -100.97 118.0 36.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.16 -4.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.96 99.68 12.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.391 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.09 -39.93 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.1 -30.26 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.633 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.688 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 104.34 68.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.421 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 84.8 mtt85 -119.98 141.05 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.918 0.39 . . . . 0.0 110.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.957 HG21 ' HB3' ' A' ' 25' ' ' PHE . 88.9 t -129.24 133.41 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 112.173 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.797 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 85.5 m-85 -117.23 139.12 51.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -132.86 147.11 64.17 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' HD2' ' SD ' ' A' ' 100' ' ' MET . 93.3 Cg_endo -83.97 -170.44 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 112.626 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.5 -27.1 68.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.036 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.492 ' CH2' ' HZ ' ' A' ' 151' ' ' PHE . 19.6 m95 -59.95 -49.49 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.916 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.551 ' HA ' HG21 ' A' ' 80' ' ' THR . 65.1 mtt -68.57 -40.04 80.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.315 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 57.8 ttm -62.37 -49.87 73.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.794 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.26 -39.92 78.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.423 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -67.47 -40.07 85.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.223 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.79 HD22 ' CB ' ' A' ' 73' ' ' ALA . 86.0 mt -88.57 -20.59 24.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.502 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.57 76.39 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.454 HD12 ' OG ' ' A' ' 110' ' ' SER . 45.1 pt -112.97 140.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 111.738 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.9 pm0 -95.91 162.33 24.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 99.5 Cg_exo -43.32 146.17 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.581 2.187 . . . . 0.0 112.694 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.97 75.51 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.105 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 106' ' ' ILE . 89.4 p -77.31 163.14 26.74 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.769 -0.253 . . . . 0.0 110.718 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.49 139.85 30.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.726 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 67.8 tp -126.5 124.86 41.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -111.97 120.1 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.857 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 ' CD2' ' A' ' 25' ' ' PHE . 47.2 pt -118.18 134.58 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.126 0.489 . . . . 0.0 111.047 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 30.7 t -119.99 128.72 53.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.956 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.2 t -65.6 117.66 8.38 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 90.6 m -119.27 129.87 55.13 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.433 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.1 t0 -100.39 117.67 35.05 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 186' ' ' CYS . 26.4 m -113.09 151.6 44.32 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.982 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 88.8 Cg_endo -78.87 159.32 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.572 2.181 . . . . 0.0 111.539 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 121' ' ' LEU . 6.5 mp -74.94 126.42 30.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.09 157.15 46.44 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.503 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.43 -28.97 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.739 0.27 . . . . 0.0 111.69 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.54 ' HE2' ' HE3' ' A' ' 126' ' ' LYS . 65.0 t80 -142.23 130.18 21.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.869 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 176' ' ' VAL . 13.2 p -132.89 131.85 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.905 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 96.1 mttt -102.04 125.81 48.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.455 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 171' ' ' ILE . 89.8 mt -110.02 136.06 49.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.523 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -99.54 111.3 61.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.58 160.37 31.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.736 2.29 . . . . 0.0 112.615 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.495 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 95.1 mt-30 -128.83 122.13 29.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.191 0.519 . . . . 0.0 110.289 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 69.09 134.28 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.524 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.3 -21.39 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.94 -40.54 89.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 75.6 t80 -59.93 -40.55 89.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.31 -9.06 59.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.712 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.99 -12.82 61.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.565 0.222 . . . . 0.0 111.395 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -59.98 139.59 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.3 p -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.506 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 137' ' ' ILE . 13.1 m-20 -129.26 74.34 81.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.514 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.704 ' O ' HD23 ' A' ' 144' ' ' LEU . 56.9 Cg_endo -71.94 -35.51 7.19 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.569 2.179 . . . . 0.0 112.239 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.91 97.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.846 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.629 HG13 ' CZ ' ' A' ' 164' ' ' TYR . 97.4 t -60.43 -42.2 90.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 140' ' ' PRO . 4.1 mm? -59.91 -40.11 87.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.94 -42.93 95.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.666 0.269 . . . . 0.0 110.636 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -62.28 -41.0 98.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.595 HG21 HD12 ' A' ' 162' ' ' ILE . 84.4 t -63.35 -40.2 88.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.385 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.52 ' CD2' HD11 ' A' ' 154' ' ' LEU . 94.3 mt -60.07 -40.45 89.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -63.14 -39.93 96.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.117 0.484 . . . . 0.0 110.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.96 -39.93 91.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.708 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.608 ' O ' HG13 ' A' ' 187' ' ' VAL . 42.1 m-85 -94.68 122.25 37.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 111.174 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.542 ' HB2' HG12 ' A' ' 188' ' ' ILE . 90.0 p -71.5 -33.68 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.657 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.783 ' HB ' HD23 ' A' ' 68' ' ' LEU . 7.8 t -136.26 141.21 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 111.907 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.725 ' HG ' HG11 ' A' ' 187' ' ' VAL . 83.6 mt -119.92 127.23 52.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.466 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 38.2 p -121.5 145.27 48.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.5 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.747 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.7 t -60.07 -39.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 0.0 111.309 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.74 -37.02 83.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.845 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.0 t0 -68.72 129.99 41.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.9 p -98.58 119.98 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 171' ' ' ILE . 45.8 pt -99.89 134.82 38.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 112.061 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 50.4 mt-10 -113.97 141.13 47.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.593 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.761 HD11 ' CE1' ' A' ' 164' ' ' TYR . 16.7 tt -121.26 129.98 75.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.355 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 23.3 p -108.7 110.07 21.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 111.753 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.761 ' CE1' HD11 ' A' ' 162' ' ' ILE . 5.5 m-85 -126.24 126.71 44.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.33 34.22 23.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.239 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.0 16.01 77.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.6 mttm -117.75 138.49 52.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.782 0.291 . . . . 0.0 110.57 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.2 p -110.93 131.08 55.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.058 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 93.7 m-85 -119.98 139.9 51.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.495 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 61.7 mtpt -103.81 127.19 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 160' ' ' ILE . 49.0 mm -119.96 129.21 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -114.92 133.32 56.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.633 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.747 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.9 OUTLIER -70.0 98.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.119 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.487 HD22 ' HD3' ' A' ' 126' ' ' LYS . 8.8 tt -60.02 -52.25 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.709 0.29 . . . . 0.0 111.742 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.905 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 83.4 tt0 -162.7 139.02 7.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.347 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -141.26 152.88 19.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.201 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 103.87 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 71.8 Cg_endo -100.68 175.15 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.72 2.946 . . . . 0.0 112.435 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.8 mt-10 -94.05 0.04 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.976 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -136.64 154.33 50.68 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.956 0.408 . . . . 0.0 111.34 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.03 -11.84 61.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.523 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.1 m -69.96 -9.42 55.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.498 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 59.95 38.67 20.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.224 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 56.2 m -130.05 135.79 48.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.612 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.3 pt -129.96 160.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 111.768 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HG23 ' A' ' 119' ' ' VAL . 46.4 t -99.94 120.46 39.83 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.725 HG11 ' HG ' ' A' ' 154' ' ' LEU . 9.7 p -110.66 14.59 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.412 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.748 HD11 ' HG ' ' A' ' 68' ' ' LEU . 91.0 mt -59.96 -46.28 94.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.481 ' HG3' HG22 ' A' ' 188' ' ' ILE . 98.9 mt-10 -155.88 81.59 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.229 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 187' ' ' VAL . 12.7 t -150.05 157.36 43.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.899 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -87.93 103.78 16.0 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.509 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.8 tp -119.94 134.17 55.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.2 t -97.3 122.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.484 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 70.2 p -102.5 142.46 33.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.568 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -129.55 146.54 51.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.68 139.91 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.319 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -108.92 165.95 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 77.4 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.621 2.214 . . . . 0.0 112.461 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 13.8 Cg_endo . . . . . 0 N--CA 1.463 -0.291 0 CA-C-O 120.716 0.215 . . . . 0.0 111.779 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.1 mt-30 -99.83 126.69 45.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.6 p -119.8 126.28 50.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.1 0.476 . . . . 0.0 111.76 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 115' ' ' SER . 65.9 t80 -120.17 124.35 45.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.618 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.51 129.94 55.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CD ' ' CZ ' ' A' ' 25' ' ' PHE . 81.7 tt0 -148.05 154.93 40.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.128 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -105.25 127.19 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.712 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.676 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.6 m-85 -133.47 159.98 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.719 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -96.06 127.88 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.512 ' HB3' HD22 ' A' ' 112' ' ' LEU . 28.7 p -91.37 143.62 26.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.517 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 93' ' ' ARG . 20.1 m-85 -129.95 153.34 80.97 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.502 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HB2' ' HG2' ' A' ' 32' ' ' MET . 89.6 Cg_endo -78.28 103.67 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.798 2.332 . . . . 0.0 112.968 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.766 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.5 mt -60.75 -40.07 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.113 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.7 68.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.389 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.615 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 97.2 mmm -67.71 -38.68 83.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 91.2 mtp -64.89 148.66 51.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -59.53 140.94 55.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.057 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.51 -21.02 63.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.056 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.973 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 pt -99.99 1.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.094 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -127.03 159.33 34.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.151 0.501 . . . . 0.0 111.691 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -99.96 129.71 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.969 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.12 88.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.23 -39.95 88.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.262 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.21 76.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -60.07 -40.61 90.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.033 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.83 1.52 40.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.242 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.29 -170.63 34.86 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.99 31.48 7.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.817 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' HD11 ' A' ' 85' ' ' LEU . 62.0 mttp -99.71 121.96 42.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.98 0.419 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.715 HD12 HD11 ' A' ' 50' ' ' LEU . 48.4 pt -119.42 149.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.745 ' CE1' ' HB2' ' A' ' 89' ' ' ALA . 65.3 t80 -104.77 127.84 52.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.632 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 114' ' ' ILE . 2.0 mp -133.39 160.02 70.26 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.646 0.26 . . . . 0.0 111.512 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.674 ' CA ' ' HB3' ' A' ' 89' ' ' ALA . 62.8 Cg_endo -72.32 147.76 47.87 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.766 2.31 . . . . 0.0 112.595 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 89' ' ' ALA . 27.3 Cg_exo -62.55 -19.0 66.48 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.866 2.377 . . . . 0.0 112.878 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.676 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -65.51 -43.42 90.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.092 0.473 . . . . 0.0 110.961 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 57.9 tp -60.28 -42.23 94.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.233 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -60.11 -40.1 88.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.065 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -40.09 90.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 69' ' ' PHE . 96.7 mt -63.63 -38.39 90.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.7 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.4 m -60.01 -37.96 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.11 -36.55 77.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.28 -1.77 42.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.296 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.96 40.59 18.75 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.595 ' CD1' HD22 ' A' ' 58' ' ' LEU . 85.4 mt -73.17 130.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.404 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -66.08 140.08 58.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.654 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.717 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 16.3 t80 -96.53 147.17 32.54 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.717 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 24.4 Cg_exo -66.96 155.45 84.14 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.149 -1.188 . . . . 0.0 113.062 0.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.441 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 66.6 mtt -90.86 140.29 29.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 117' ' ' THR . 35.7 mt -105.75 141.0 37.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.079 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.711 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 60.5 m-85 -133.41 147.0 51.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.431 . . . . 0.0 112.108 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 97.7 mttt -121.39 137.91 54.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.19 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.671 ' C ' HG23 ' A' ' 79' ' ' VAL . 86.5 mt -99.2 119.99 38.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.29 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -108.05 125.52 51.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.751 0.31 . . . . 0.0 111.665 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . . . -100.49 119.97 39.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.921 0.391 . . . . 0.0 110.676 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.15 -39.87 82.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.04 -39.84 87.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -106.16 -13.81 15.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 70.08 8.17 61.04 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -100.18 140.0 35.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 71' ' ' LEU . 9.7 p -123.64 122.76 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.628 HG23 ' CG ' ' A' ' 158' ' ' ASP . 60.5 m -106.06 134.84 48.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.323 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.64 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 3.4 t-80 -84.41 114.72 22.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.02 172.72 20.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.281 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -100.09 162.29 19.18 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.443 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.674 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 9.7 p -130.01 136.59 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 0.0 111.78 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.702 HD11 ' HD3' ' A' ' 47' ' ' LYS . 94.3 mt -91.01 -77.21 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.529 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -148.69 160.08 43.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.057 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 55' ' ' LEU . 96.7 m-85 -106.22 116.63 32.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.602 HG13 ' C ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -140.78 11.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.784 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . . . -85.14 99.9 11.37 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.82 -40.0 72.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.01 0.433 . . . . 0.0 110.649 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.14 -30.29 67.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.385 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 100.07 64.59 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.07 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . 35.6 ptt-85 -123.41 143.42 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HG ' ' A' ' 50' ' ' LEU . 97.5 t -123.28 132.78 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.542 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.766 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.0 m-85 -120.41 139.88 52.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 96' ' ' LEU . 1.7 pt? -134.49 159.49 72.05 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.297 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.634 ' HG2' ' CG ' ' A' ' 100' ' ' MET . 58.7 Cg_endo -68.91 159.21 54.82 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.655 2.236 . . . . 0.0 112.744 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.07 -43.02 95.76 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 29.4 p-90 -64.52 -40.0 94.81 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.634 ' CG ' ' HG2' ' A' ' 97' ' ' PRO . 93.9 mmm -63.49 -40.15 96.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.751 0.31 . . . . 0.0 111.307 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.3 ttp -61.8 -42.42 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.57 -39.98 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -65.61 -40.35 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 93.1 mt -69.97 -23.73 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.49 72.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.901 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.9 pt -120.4 151.58 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.49 160.45 32.99 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.05 -2.82 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.589 2.192 . . . . 0.0 113.323 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.51 -14.06 22.76 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.626 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.532 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 90.8 p -81.48 161.29 23.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.991 0.424 . . . . 0.0 111.132 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.42 140.02 51.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.37 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 27' ' ' CYS . 60.5 tp -118.94 129.38 55.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 64.0 tt0 -106.75 125.85 51.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 50' ' ' LEU . 14.9 tt -117.97 126.63 75.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.62 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 44.8 t -120.13 131.77 55.16 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 1.2 m -83.46 114.9 21.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.488 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 34.3 p -122.07 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 112.203 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 57.4 t0 -115.19 113.11 23.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.933 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 186' ' ' CYS . 34.4 m -119.36 150.38 49.41 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.929 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 -175.6 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.484 2.123 . . . . 0.0 111.407 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 187' ' ' VAL . 3.8 mp -95.27 119.47 33.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 0.0 110.709 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -60.0 159.14 23.92 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.732 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.29 -29.03 9.54 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.613 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 126' ' ' LYS . 69.2 t80 -145.28 130.25 18.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.69 0.281 . . . . 0.0 111.395 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.784 HG23 ' CG1' ' A' ' 176' ' ' VAL . 4.2 p -133.78 130.08 55.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.093 0.473 . . . . 0.0 112.187 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD2' ' HG2' ' A' ' 175' ' ' GLU . 85.4 mttt -99.73 121.62 41.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 144' ' ' LEU . 85.6 mt -105.31 131.35 52.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 172' ' ' LYS . 37.8 tt0 -114.63 109.52 47.93 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.68 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HG3' HD11 ' A' ' 135' ' ' LEU . 88.2 Cg_endo -83.94 -168.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.648 2.232 . . . . 0.0 112.601 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -121.84 121.19 36.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.293 0.568 . . . . 0.0 109.982 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t 59.52 178.0 0.08 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.96 -11.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.695 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.08 -40.39 89.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.539 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HD2' HD12 ' A' ' 135' ' ' LEU . 64.9 t80 -60.35 -40.27 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.647 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 129' ' ' PRO . 9.6 mp -80.47 -10.03 59.75 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.776 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.89 -19.31 63.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.601 0.239 . . . . 0.0 111.277 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.46 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.6 mt -60.43 133.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.2 m -60.1 -39.98 88.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.417 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.1 m-20 -126.04 76.5 71.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 144' ' ' LEU . 40.8 Cg_endo -68.79 -30.13 27.69 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.426 2.084 . . . . 0.0 112.071 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.12 99.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 147' ' ' VAL . 98.1 t -61.73 -49.67 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.588 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.2 -39.99 88.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.659 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.01 -46.35 89.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -60.57 -40.39 91.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 0.0 110.247 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 162' ' ' ILE . 62.4 t -63.12 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.169 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 154' ' ' LEU . 86.9 mt -60.04 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -66.5 -40.01 88.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.11 -40.04 92.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.676 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 96.7 m-85 -101.6 118.74 37.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.6 m -62.65 -39.92 95.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.361 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.537 ' CG2' HD22 ' A' ' 68' ' ' LEU . 33.7 p -125.56 149.84 47.99 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 111.737 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 192' ' ' LEU . 86.1 mt -116.02 121.72 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.428 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 94.3 m -119.95 130.07 54.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.002 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.8 t -59.95 -40.03 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 111.684 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.92 -38.61 76.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.304 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.628 ' CG ' HG23 ' A' ' 80' ' ' THR . 87.9 m-20 -69.54 134.85 49.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.552 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.49 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 6.1 m -102.53 119.93 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.465 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 171' ' ' ILE . 46.7 pt -104.29 140.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 111.52 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -120.01 140.55 50.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 147' ' ' VAL . 46.2 pt -128.01 140.4 49.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.993 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 50.8 m -105.36 119.97 40.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.422 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -122.59 119.97 32.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.423 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.497 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.03 40.14 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 13.6 81.86 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.252 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -116.72 139.28 50.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.808 0.304 . . . . 0.0 110.393 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.5 m -113.38 129.73 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.81 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.0 139.98 51.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.8 mttt -103.5 123.49 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.072 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 160' ' ' ILE . 45.6 pt -124.51 131.82 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.947 0.403 . . . . 0.0 110.787 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 62.9 tttp -119.58 134.6 55.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.959 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -77.55 118.39 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.436 HD22 ' HG2' ' A' ' 175' ' ' GLU . 9.1 tt -62.62 -60.04 4.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.653 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.746 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 22.0 pt-20 -163.02 159.3 23.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.784 ' CG1' HG23 ' A' ' 125' ' ' VAL . 13.6 m -147.77 159.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.896 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.71 102.89 51.76 Favored Pre-proline 0 C--O 1.233 0.226 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.451 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 57.4 Cg_endo -104.71 0.24 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.166 3.244 . . . . 0.0 113.009 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.3 21.33 11.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -143.82 156.56 44.52 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.198 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 80.3 p -71.25 -20.15 62.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.485 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 60.8 m -59.99 -39.89 87.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.602 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 68.34 20.0 8.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.2 t -128.06 131.09 49.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.835 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.732 ' H ' HD13 ' A' ' 185' ' ' ILE . 0.2 OUTLIER -131.04 159.83 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.304 0.574 . . . . 0.0 112.514 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.501 ' HB2' HG22 ' A' ' 153' ' ' THR . 35.2 t -129.56 126.05 37.65 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.26 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -148.63 83.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.814 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 85.3 mt -69.83 -40.06 78.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.5 tt0 -66.02 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.794 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 189' ' ' GLU . 10.4 t -179.98 41.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.5 ' H ' ' CG2' ' A' ' 187' ' ' VAL . 91.2 m-20 -98.38 7.75 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.872 ' HB2' HG11 ' A' ' 187' ' ' VAL . 12.5 tp -107.38 129.57 54.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 110.782 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -96.79 120.4 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.285 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' THR . . . . . 0.649 ' HA ' HG13 ' A' ' 125' ' ' VAL . 59.6 p -99.99 145.57 27.72 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -130.01 140.05 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.961 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 144' ' ' LEU . 97.3 m-85 -101.15 120.29 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.468 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.42 118.51 12.72 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.346 0.424 0 C-N-CA 122.315 2.01 . . . . 0.0 112.139 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.809 0.337 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -119.96 139.96 51.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.683 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.5 t -120.37 130.0 54.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.142 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.97 76.78 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.353 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 64.69 28.83 13.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.966 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.4 p -130.04 140.0 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.718 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -120.05 129.71 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -119.74 124.7 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.65 -129.86 49.42 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.74 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.03 75.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.679 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.17 -40.43 71.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.394 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.06 -39.8 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 3.1 31.13 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.213 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' HE1' ' OD1' ' A' ' 16' ' ' ASN . 64.5 t80 -99.03 130.55 45.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.962 0.381 . . . . 0.0 110.198 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.91 125.11 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' HE1' ' A' ' 14' ' ' PHE . 98.4 m-20 -79.16 139.59 37.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.21 116.79 64.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.01 162.09 9.69 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.455 2.103 . . . . 0.0 112.149 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 117' ' ' THR . 92.3 mm-40 -100.09 123.6 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -119.59 128.08 53.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.181 0.515 . . . . 0.0 111.927 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 50.5 t80 -133.7 138.49 45.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.96 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -116.75 136.71 52.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.979 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 99.2 mt-10 -140.05 148.96 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.461 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -121.84 126.81 49.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.537 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HB2' HG21 ' A' ' 94' ' ' VAL . 89.6 m-85 -149.94 161.72 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 111' ' ' LEU . 90.0 mtt180 -92.85 130.82 38.33 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.879 ' HB2' HD11 ' A' ' 96' ' ' LEU . 17.5 p -101.19 147.81 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.95 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -130.11 148.74 70.94 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.709 ' O ' ' HG2' ' A' ' 32' ' ' MET . 55.4 Cg_endo -70.68 109.81 2.58 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.25 1.967 . . . . 0.0 112.44 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' A' ' 95' ' ' TYR . 84.1 mt -60.01 -26.7 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.476 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' HA ' HH12 ' A' ' 38' ' ' ARG . . . -58.24 -38.62 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.123 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.1 ptm -68.99 -23.64 64.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.742 0.306 . . . . 0.0 111.07 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.438 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 98.9 mtp -61.9 139.81 58.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 111.235 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.709 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.08 141.58 55.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.645 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.95 -39.91 87.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -60.0 -39.7 86.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.527 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.709 HG12 ' HB2' ' A' ' 34' ' ' ASN . 49.4 pt -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' HA ' ' A' ' 35' ' ' ASP . 22.0 ptt180 -128.29 160.1 33.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 88.1 tttt -100.46 134.56 43.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.07 -40.02 88.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 96.0 m-20 -61.5 -39.97 92.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.14 92.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.09 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.08 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.84 5.4 41.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.83 179.08 35.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.327 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -109.97 25.57 16.18 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.305 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.751 ' HD3' HD13 ' A' ' 85' ' ' LEU . 61.0 mttm -101.24 135.25 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.272 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.732 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.3 pt -120.24 156.54 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.256 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.5 ' O ' HD22 ' A' ' 50' ' ' LEU . 90.4 m-85 -100.25 130.48 46.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.569 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 HD12 ' A' ' 114' ' ' ILE . 4.0 mm? -129.8 163.31 47.91 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.831 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 60.4 Cg_endo -77.1 149.45 28.52 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.244 1.963 . . . . 0.0 112.82 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.82 -23.8 62.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -59.97 -39.99 87.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.075 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -68.07 -41.28 82.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.996 0.426 . . . . 0.0 110.998 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CD1' ' A' ' 87' ' ' PHE . 58.8 tp -60.95 -43.25 98.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.5 m -60.2 -40.27 89.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.54 -40.01 94.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.2 0.524 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 21' ' ' PHE . 88.2 mt -60.05 -39.98 87.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.046 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.2 m -59.83 -40.01 87.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.123 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -59.97 -36.27 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.254 0.549 . . . . 0.0 110.092 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' A' ' 63' ' ' ILE . 12.4 tp -79.98 1.11 28.75 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.51 47.99 8.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 61' ' ' LEU . 49.2 mm -86.46 121.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -70.21 140.0 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.746 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 40.3 t80 -88.25 147.14 39.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.716 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.746 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 15.0 Cg_exo -71.09 158.91 94.52 Favored 'Cis proline' 0 C--N 1.352 0.752 0 C-N-CA 124.567 -1.014 . . . . 0.0 113.138 0.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 58' ' ' LEU . 68.0 mtt -95.52 139.45 31.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.476 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.721 HD22 HG23 ' A' ' 153' ' ' THR . 82.4 mt -107.16 138.33 43.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.716 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.799 ' HB3' HG23 ' A' ' 114' ' ' ILE . 12.3 m-30 -120.09 140.02 51.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.044 0.449 . . . . 0.0 112.027 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HD2' ' CE1' ' A' ' 81' ' ' HIS . 62.6 tttp -119.02 130.18 55.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.744 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -94.25 133.21 38.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.955 ' HA ' HG12 ' A' ' 79' ' ' VAL . 94.2 m -120.01 129.94 54.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.318 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.13 110.82 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.193 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -67.65 -40.0 84.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.531 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -39.92 87.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.502 HG21 ' HA3' ' A' ' 105' ' ' GLY . 67.1 p -101.29 -13.48 18.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.487 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 0.25 26.11 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.795 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -100.4 139.95 35.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 72' ' ' THR . 13.1 m -121.7 117.42 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.021 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.411 HG22 ' OD1' ' A' ' 158' ' ' ASP . 72.0 p -100.97 155.87 17.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.623 ' CD2' ' OG1' ' A' ' 155' ' ' THR . 74.9 m-70 -100.4 114.84 28.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 110.621 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.74 160.01 15.66 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.923 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.732 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.99 164.3 22.56 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.027 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -127.83 133.52 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 117.26 0.53 . . . . 0.0 112.266 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.5 tp -92.03 -78.83 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.911 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -150.78 160.02 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.595 ' CD1' HD22 ' A' ' 55' ' ' LEU . 76.1 m-85 -94.93 116.63 28.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.7 pt -125.89 -8.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -99.55 103.68 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.379 . . . . 0.0 111.786 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.56 -39.98 92.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.293 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.65 -30.33 69.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.179 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.66 74.38 0.79 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.522 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -119.9 140.72 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.323 . . . . 0.0 110.775 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 50' ' ' LEU . 57.3 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 30' ' ' ILE . 87.1 m-85 -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.545 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.879 HD11 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -137.6 156.85 74.58 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.917 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.728 ' HG2' ' HB2' ' A' ' 100' ' ' MET . 37.8 Cg_endo -68.8 158.54 57.43 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.045 1.83 . . . . 0.0 111.459 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.25 -41.13 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 48.1 p-90 -65.76 -38.55 89.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.728 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . 58.2 ttm -60.04 -40.12 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.358 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.615 ' HG3' HD23 ' A' ' 96' ' ' LEU . 97.8 mtp -59.89 -40.01 87.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.92 -40.06 94.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -66.89 -40.23 87.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.357 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.2 mt -70.58 -24.31 62.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.329 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.502 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 72.53 28.85 66.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.5 pt -117.75 142.87 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.409 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.9 pt20 -96.39 159.96 30.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.746 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 85.5 Cg_exo -44.7 138.42 8.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.564 2.176 . . . . 0.0 112.537 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.03 -9.98 75.53 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.765 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.5 m -71.58 150.04 45.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 26' ' ' ARG . 87.3 mt -75.68 144.65 41.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.684 HD23 HG11 ' A' ' 94' ' ' VAL . 59.0 tp -127.05 130.98 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.079 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 97.4 mt-30 -104.3 128.95 52.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.01 HD12 HD11 ' A' ' 50' ' ' LEU . 91.9 mt -119.4 122.69 69.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 74.7 p -121.6 139.28 53.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.53 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.785 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 32.4 m -85.29 122.39 29.39 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 10.0 t -130.02 138.44 50.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.47 128.8 54.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.385 . . . . 0.0 110.344 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 121' ' ' LEU . 33.2 m -115.52 152.25 46.92 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.731 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HB2' ' OE1' ' A' ' 179' ' ' GLU . 67.4 Cg_endo -73.84 16.46 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.187 1.925 . . . . 0.0 112.537 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.929 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.8 mp 64.57 108.32 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.369 . . . . 0.0 111.454 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.93 167.94 1.6 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.55 -28.2 9.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.675 0.238 . . . . 0.0 111.585 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -142.46 132.1 23.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.369 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.7 p -131.33 130.17 62.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 111.327 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 88.3 tttt -99.7 120.09 39.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.66 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 171' ' ' ILE . 85.5 mt -111.44 140.49 45.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 111.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.946 ' HG3' ' HG3' ' A' ' 199' ' ' PRO . 45.0 tt0 -91.71 117.2 67.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' A' ' 199' ' ' PRO . 71.9 Cg_endo -75.03 159.79 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.516 2.144 . . . . 0.0 112.167 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -136.19 121.51 19.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.2 m 66.79 135.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.29 -21.13 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.87 -40.06 87.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.488 ' HD1' HD12 ' A' ' 135' ' ' LEU . 60.9 t80 -60.03 -40.06 88.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.756 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.488 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -80.72 -10.53 59.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.5 -10.22 59.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.281 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.0 mt -64.18 139.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.745 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.1 p -59.96 -40.05 87.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.349 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 137' ' ' ILE . 6.6 m-20 -127.12 71.92 76.29 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.788 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.92 -32.99 93.12 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.631 2.221 . . . . 0.0 111.879 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.19 -40.2 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.12 97.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.3 t -60.06 -41.15 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 194' ' ' THR . 3.1 tm? -60.3 -44.01 95.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.194 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.1 -39.93 87.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.6 -40.03 95.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 162' ' ' ILE . 75.7 t -61.78 -42.95 96.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HD11 ' A' ' 154' ' ' LEU . 89.6 mt -60.01 -40.05 87.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -65.04 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.86 -40.02 96.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.518 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 96.9 m-85 -105.56 119.69 39.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.768 0.318 . . . . 0.0 111.179 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.465 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 42.7 p -69.83 -35.79 75.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.721 HG23 HD22 ' A' ' 68' ' ' LEU . 34.3 p -124.56 140.32 53.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 111.607 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.683 ' HB2' HG13 ' A' ' 185' ' ' ILE . 90.5 mt -122.1 130.17 53.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.623 ' OG1' ' CD2' ' A' ' 81' ' ' HIS . 25.6 m -119.78 140.12 51.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.015 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 176' ' ' VAL . 98.3 t -60.05 -40.47 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.175 0.512 . . . . 0.0 110.652 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 155' ' ' THR . 11.0 t70 -74.74 -29.43 61.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 93.9 m-20 -78.45 140.14 38.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.93 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.68 120.07 55.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.921 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.454 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.7 pt -103.38 137.93 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.927 0.394 . . . . 0.0 111.379 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 170' ' ' LYS . 99.0 mt-10 -119.98 140.05 51.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.205 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 147' ' ' VAL . 6.0 tt -116.21 135.61 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.729 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.0 t -109.76 115.19 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -123.56 127.35 48.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.5 t30 51.73 40.05 26.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.687 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.56 9.8 86.51 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.975 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 59.5 mttm -111.1 144.1 40.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.8 m -114.75 130.79 56.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.79 140.07 51.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.67 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 62.4 mttp -100.32 121.62 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.552 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.876 HG22 HD22 ' A' ' 127' ' ' LEU . 85.3 mt -120.02 120.01 61.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.711 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 38.5 ttpt -116.2 125.55 52.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 156' ' ' VAL . 4.9 mp -78.45 83.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.429 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 172' ' ' LYS . 76.3 mt -59.99 -49.97 75.6 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 98.9 mt-10 -152.39 138.99 18.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.024 0.44 . . . . 0.0 111.735 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.848 HG11 HD13 ' A' ' 185' ' ' ILE . 16.7 m -140.33 151.57 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.686 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -96.18 104.77 18.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 65.0 Cg_endo -100.3 167.42 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.286 2.657 . . . . 0.0 112.706 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.92 -0.08 40.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.4 p -139.83 159.79 41.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.007 0.432 . . . . 0.0 111.376 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.2 m -70.08 -10.3 58.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 t -57.76 -25.75 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.286 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 181' ' ' SER . 34.2 mmtp 60.02 39.97 19.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.756 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -128.29 139.69 52.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.64 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.848 HD13 HG11 ' A' ' 176' ' ' VAL . 39.9 pt -127.32 131.53 70.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 153' ' ' THR . 23.3 m -139.97 119.95 13.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.08 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 187' ' ' VAL . 9.1 p -118.15 112.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.749 0.785 . . . . 0.0 111.171 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.619 HD13 ' HD2' ' A' ' 66' ' ' PRO . 55.5 mt -71.59 -60.72 2.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.547 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.08 -79.94 0.33 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.1 t -168.05 41.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.929 ' HB2' HD23 ' A' ' 121' ' ' LEU . 94.7 m-20 -88.76 2.09 54.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.548 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.425 ' H ' HG21 ' A' ' 187' ' ' VAL . 56.1 tp -111.6 130.32 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 125' ' ' VAL . 25.6 t -97.35 129.07 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.754 HG21 HD11 ' A' ' 144' ' ' LEU . 69.7 p -112.95 139.82 48.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.36 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.03 140.88 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.417 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 98.3 m-85 -100.02 121.11 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.48 110.48 28.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -62.52 110.3 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.256 1.97 . . . . 0.0 112.26 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.946 ' HG3' ' HG3' ' A' ' 128' ' ' GLU . 82.3 Cg_endo -99.32 -2.07 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.775 2.984 . . . . 0.0 112.555 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 202' ' ' TYR . 14.8 t -97.37 127.62 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -96.74 10.06 66.38 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.82 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.651 ' H ' HG12 ' A' ' 200' ' ' VAL . 94.7 m-85 -94.27 139.68 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.48 130.41 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -95.27 130.04 33.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.67 153.67 70.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.5 2.133 . . . . 0.0 112.309 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -83.91 132.86 34.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 207' ' ' TYR . 53.2 p90 -99.97 120.45 39.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.811 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.031 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.828 0.346 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.02 -40.0 75.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.97 130.03 54.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.026 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.07 -8.03 24.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.758 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.03 139.97 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 110.991 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.5 m -106.8 139.86 40.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.7 m -89.99 140.05 30.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -60.04 -39.98 87.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.93 9.29 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.653 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.88 151.14 42.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.251 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.63 -74.19 0.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -143.77 160.08 41.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.43 -179.7 17.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.48 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.95 140.01 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -114.7 127.18 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.992 0.425 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.03 137.05 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.14 120.05 52.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 65.0 Cg_exo -50.85 120.46 6.63 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.345 2.03 . . . . 0.0 111.879 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.582 ' OE1' HD13 ' A' ' 63' ' ' ILE . 78.1 mt-30 -112.11 127.15 55.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.0 m -120.02 131.12 55.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.024 0.44 . . . . 0.0 111.755 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 27.7 t80 -124.11 141.06 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.301 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.04 130.58 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.16 0.505 . . . . 0.0 112.045 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -141.83 156.54 45.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.438 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -116.06 124.36 50.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.747 0.308 . . . . 0.0 110.692 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' ' 114' ' ' ILE . 90.8 m-85 -136.03 150.92 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' HD2' ' HG2' ' A' ' 93' ' ' ARG . 7.4 ptp180 -82.24 143.76 31.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.842 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.785 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 46.5 t -98.99 123.14 43.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 112.175 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CB ' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m-85 -117.85 146.24 38.47 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 32' ' ' MET . 71.8 Cg_endo -77.72 105.27 2.0 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.717 2.278 . . . . 0.0 112.953 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.852 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.4 mt -61.39 -40.02 84.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.847 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.02 75.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.814 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.425 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . 97.7 mmm -68.34 -30.98 70.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 99.7 mmm -60.34 148.54 36.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -59.94 150.24 29.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.98 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.6 m-20 -59.93 -40.05 87.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -64.4 -40.19 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.77 -40.91 77.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 35' ' ' ASP . 84.5 mmt-85 -122.58 140.08 53.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.798 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 9.8 mtpm? -80.58 149.35 29.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.1 -40.03 88.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.04 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.99 87.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.88 80.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.071 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.659 ' OD1' HG22 ' A' ' 30' ' ' ILE . 98.5 m-20 -60.03 -39.89 87.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.964 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.65 16.76 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.98 168.6 26.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.329 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.15 16.36 58.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.118 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.719 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.1 mttt -100.72 135.57 41.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 111.129 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.5 pt -118.75 150.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.201 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.753 ' O ' HG23 ' A' ' 94' ' ' VAL . 90.1 m-85 -100.51 131.91 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.986 0.422 . . . . 0.0 111.018 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 114' ' ' ILE . 5.4 mp -132.67 162.0 59.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 80.3 Cg_endo -77.28 153.05 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.166 1.91 . . . . 0.0 112.904 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 18.9 Cg_exo -66.27 -18.31 55.47 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.145 2.563 . . . . 0.0 112.545 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.8 t -60.01 -40.0 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.18 82.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.16 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.684 HD21 ' CE1' ' A' ' 87' ' ' PHE . 81.5 mt -60.09 -41.37 92.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.695 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.1 m -60.02 -40.12 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.417 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -68.23 -39.99 82.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 HG13 ' A' ' 63' ' ' ILE . 95.7 mt -60.1 -39.88 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.158 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -59.97 -40.05 87.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 110.261 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -60.01 -39.96 87.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.508 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 21' ' ' PHE . 88.6 mt -81.24 -0.07 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.821 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 39.96 19.29 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.48 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD13 ' OE1' ' A' ' 19' ' ' GLN . 41.4 mm -68.13 136.79 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.682 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -92.42 140.2 29.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.421 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.486 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 43.7 p90 -87.29 155.74 54.4 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.788 ' CD ' HD11 ' A' ' 188' ' ' ILE . 18.0 Cg_exo -66.88 162.49 74.09 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.758 0.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -95.0 130.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.821 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.874 HD11 ' SG ' ' A' ' 186' ' ' CYS . 65.0 mt -114.67 140.1 49.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.653 ' HB3' HG23 ' A' ' 114' ' ' ILE . 35.7 m-85 -120.01 140.08 51.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.734 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.754 ' HG2' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -117.03 130.38 56.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.978 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 112' ' ' LEU . 50.9 mt -96.0 120.98 37.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.82 HG23 HG22 ' A' ' 79' ' ' VAL . 97.3 m -104.03 120.06 40.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.28 115.38 30.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.605 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -67.83 -39.96 83.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.957 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 m -97.16 -14.96 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.34 -6.08 4.69 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.682 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.632 HH21 ' HB3' ' A' ' 157' ' ' ASP . 78.8 ttt180 -100.68 139.97 35.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.82 HG22 HG23 ' A' ' 72' ' ' THR . 47.3 t -118.08 119.99 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.3 p -99.93 159.62 14.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.621 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 74.5 m80 -101.74 115.14 29.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 110.655 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.21 158.26 18.93 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.939 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -91.68 157.07 24.28 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 8.4 p -127.97 134.07 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 117.294 0.547 . . . . 0.0 112.341 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 ' HD3' ' A' ' 47' ' ' LYS . 44.4 tp -91.84 -79.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.558 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -142.65 159.71 41.7 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.719 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 55' ' ' LEU . 72.5 m-85 -97.72 116.39 29.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.61 -4.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -84.58 98.17 10.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.417 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.87 -39.88 76.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 0.0 110.519 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.51 -30.67 71.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.363 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.0 42.97 1.14 Allowed Glycine 0 C--N 1.32 -0.323 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.684 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.671 ' HG2' ' HD2' ' A' ' 26' ' ' ARG . 29.4 mtm105 -117.15 150.9 37.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 112.151 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.769 HG21 HD11 ' A' ' 114' ' ' ILE . 14.8 p -128.78 145.03 36.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.219 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.852 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.1 m-85 -120.54 141.93 49.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.44 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 30' ' ' ILE . 69.8 mt -120.21 142.49 33.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.925 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' MET . 51.3 Cg_exo -57.95 156.97 26.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.511 2.141 . . . . 0.0 111.836 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.03 -41.97 93.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.789 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.645 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 49.3 p-90 -70.0 -40.11 75.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.281 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.645 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 97.4 mtp -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.647 0.26 . . . . 0.0 111.037 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.2 mtp -60.06 -40.03 88.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.052 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 -40.01 94.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 110.496 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.966 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 71' ' ' LEU . 85.8 mt -69.09 -24.25 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.29 29.96 65.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.589 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.593 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 45.6 pt -116.29 144.8 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.333 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -97.4 160.2 29.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.605 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 7.8 Cg_endo -49.2 135.22 31.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.591 2.194 . . . . 0.0 112.136 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 -6.51 82.64 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.699 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.593 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 93.1 p -74.61 157.39 35.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 110.659 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.85 140.03 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.981 0.42 . . . . 0.0 111.02 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.907 HD11 HD22 ' A' ' 71' ' ' LEU . 61.6 tp -127.05 130.13 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.417 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.685 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 64.0 tt0 -107.7 120.24 41.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.769 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -111.37 129.98 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.442 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.637 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 80.6 p -126.38 139.85 52.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' THR . 20.7 t -77.52 120.61 22.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.732 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.2 m -119.99 130.0 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.039 0.447 . . . . 0.0 111.899 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 96.5 m-20 -121.41 119.96 33.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 184' ' ' SER . 16.7 m -120.93 150.02 52.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 2.1 Cg_endo -79.78 142.92 16.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.907 2.405 . . . . 0.0 109.917 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 191' ' ' ASP . 9.8 mt -60.91 120.3 9.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.211 0.529 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.42 160.36 54.02 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 96.6 mt-30 -99.98 -19.94 16.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.154 -0.219 . . . . 0.0 111.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.13 134.96 23.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 111.729 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 ' HA ' ' A' ' 194' ' ' THR . 2.4 p -136.4 129.74 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.612 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 84.7 tttt -97.06 119.97 36.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.022 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.53 HD23 HG13 ' A' ' 173' ' ' ILE . 88.0 mt -113.55 130.44 56.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.223 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.412 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 10.2 tt0 -104.28 110.03 63.54 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 199' ' ' PRO . 89.7 Cg_endo -80.45 170.29 16.13 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.596 2.197 . . . . 0.0 112.437 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 94.1 mt-30 -132.67 122.86 25.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.981 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 199' ' ' PRO . 52.0 m 67.87 137.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.755 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.27 -18.26 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.685 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.01 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.533 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 66.4 t80 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.68 -2.0 58.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.551 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.7 mt -58.08 138.99 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.2 p -59.96 -37.65 80.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.555 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.551 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.4 m-20 -118.75 80.45 17.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.8 -32.01 30.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.623 2.216 . . . . 0.0 112.271 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -60.06 -40.84 90.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.09 98.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 147' ' ' VAL . 94.1 t -64.0 -42.55 96.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -59.91 -42.33 93.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.04 -42.11 93.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -59.97 -40.06 87.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.088 0.47 . . . . 0.0 110.59 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.788 HG22 HD13 ' A' ' 162' ' ' ILE . 57.7 t -61.46 -43.78 97.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.249 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.96 -40.24 92.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.803 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -63.32 -40.01 96.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.655 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -59.98 -39.97 87.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.313 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 88.5 m-85 -102.34 122.07 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.046 0.45 . . . . 0.0 111.676 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 68' ' ' LEU . 66.2 m -61.1 -39.98 91.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.218 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.684 ' HB ' HD22 ' A' ' 68' ' ' LEU . 8.2 t -128.05 140.76 51.77 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.983 0.421 . . . . 0.0 111.187 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.732 HD11 HD11 ' A' ' 173' ' ' ILE . 49.8 tp -114.8 121.5 43.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.449 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 157' ' ' ASP . 53.4 m -119.38 140.29 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 176' ' ' VAL . 90.0 t -59.98 -41.51 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.48 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.632 ' HB3' HH21 ' A' ' 78' ' ' ARG . 95.9 m-20 -70.05 -34.92 73.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 95.7 m-20 -73.58 139.34 45.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.252 0.549 . . . . 0.0 112.412 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.9 p -107.31 120.0 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.57 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.595 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 45.2 pt -106.96 138.42 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.043 0.449 . . . . 0.0 112.109 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.788 HD13 HG22 ' A' ' 147' ' ' VAL . 44.6 pt -127.34 141.37 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.2 t -110.73 117.86 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.179 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.459 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 54.0 t80 -120.45 120.28 35.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 56.21 40.05 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.577 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.96 9.89 86.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.089 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.9 mttt -112.74 137.42 51.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.785 0.293 . . . . 0.0 110.381 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.7 p -109.99 129.08 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 111.486 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.533 ' CD1' ' HD1' ' A' ' 134' ' ' PHE . 89.2 m-85 -120.06 140.0 51.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.592 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 97.7 mttt -101.12 124.57 47.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.247 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -119.27 128.95 54.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.006 0.432 . . . . 0.0 110.684 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.768 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.3 mp -83.63 109.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.429 HD12 ' HE2' ' A' ' 126' ' ' LYS . 84.4 mt -67.89 -54.07 21.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.612 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 49.8 mt-10 -157.65 140.36 14.86 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.349 . . . . 0.0 111.212 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 125' ' ' VAL . 4.5 m -140.05 154.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -110.18 102.59 51.59 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.494 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.503 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 63.6 Cg_endo -104.04 -2.69 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.144 3.229 . . . . 0.0 113.201 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 61.67 27.87 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.4 p -140.16 147.37 40.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.985 0.422 . . . . 0.0 111.186 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.7 m -61.66 -40.03 93.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.0 p -60.01 -20.18 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 50.5 mttt 57.23 39.8 28.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.0 111.432 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.611 ' CB ' HG11 ' A' ' 119' ' ' VAL . 41.4 t -121.62 140.81 51.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.153 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 192' ' ' LEU . 17.7 pt -125.24 148.5 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.414 . . . . 0.0 111.475 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.874 ' SG ' HD11 ' A' ' 68' ' ' LEU . 53.0 t -139.27 99.38 3.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.574 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.76 ' HA ' HD21 ' A' ' 121' ' ' LEU . 11.7 p -117.45 113.27 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.783 0.801 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.788 HD11 ' CD ' ' A' ' 66' ' ' PRO . 20.6 mt -77.26 -62.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.29 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.02 -79.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.4 t -161.18 42.87 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.739 0.304 . . . . 0.0 111.662 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.786 ' HB2' HD22 ' A' ' 121' ' ' LEU . 92.7 m-20 -89.74 6.13 42.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 185' ' ' ILE . 31.8 tp -120.45 130.09 54.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.869 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 125' ' ' VAL . 33.0 t -90.45 121.89 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.79 ' HA ' HG13 ' A' ' 125' ' ' VAL . 52.6 p -100.99 151.98 21.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.463 0.649 . . . . 0.0 112.411 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -129.65 139.1 51.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.541 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.84 137.02 46.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.756 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -121.18 165.88 17.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.365 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 13.7 Cg_endo -56.05 124.67 16.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.143 1.895 . . . . 0.0 111.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.518 ' HB2' ' N ' ' A' ' 131' ' ' SER . 92.3 Cg_endo -80.66 129.46 7.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.597 2.198 . . . . 0.0 112.916 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.24 140.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 -118.68 1.87 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.247 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.77 130.04 46.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.67 120.31 64.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -100.32 120.09 57.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.069 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.3 119.95 6.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.431 2.087 . . . . 0.0 112.296 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -97.14 133.25 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -100.03 120.08 39.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.825 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -119.93 140.03 51.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.7 t -120.16 130.1 54.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.77 167.5 34.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.248 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -120.02 135.3 54.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 m -60.13 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.758 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.07 34.33 23.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -63.13 -39.99 96.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.51 159.77 33.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.174 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -11.55 74.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.562 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 -15.91 6.87 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.296 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -120.48 130.02 54.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.915 0.358 . . . . 0.0 110.95 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.87 142.17 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.83 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -120.03 139.93 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.613 0.244 . . . . 0.0 110.676 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -100.68 119.99 39.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.63 119.78 51.48 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.273 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 46.3 Cg_exo -57.51 152.83 45.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.329 2.019 . . . . 0.0 112.092 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.519 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 96.5 mt-30 -105.45 120.44 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 116' ' ' SER . 72.6 p -121.17 129.79 53.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 111.689 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.647 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 78.6 t80 -119.85 139.43 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -106.26 134.86 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.137 0.494 . . . . 0.0 111.976 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.0 mt-10 -141.1 151.37 43.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.92 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -120.53 136.78 54.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.992 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.667 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.3 m-85 -152.57 159.97 43.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.848 0.356 . . . . 0.0 111.082 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.35 140.31 31.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 17.3 t -97.66 125.75 42.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.571 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.45 149.79 44.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.298 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.93 100.47 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.923 2.416 . . . . 0.0 112.326 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.591 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 83.6 mt -60.5 -40.1 83.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 110.406 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -60.01 -32.54 70.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.294 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.2 ttm -66.98 -39.02 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 94.8 mtp -60.9 151.72 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HB2' HD12 ' A' ' 37' ' ' ILE . 98.6 m-20 -59.45 143.8 48.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.184 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.8 m-20 -60.03 -40.05 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.072 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -60.81 -40.04 91.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 110.918 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 34' ' ' ASN . 85.8 mt -68.18 -40.06 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.4 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 35' ' ' ASP . 39.6 mmt180 -116.34 140.18 49.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 111.965 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.83 139.99 55.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -60.11 -39.08 84.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -39.95 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.821 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.93 87.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 30' ' ' ILE . 28.0 m120 -60.03 -41.4 92.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.14 6.92 38.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.714 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.61 171.9 29.54 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.534 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -99.45 18.29 56.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.211 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.852 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.24 131.41 46.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 97' ' ' PRO . 46.2 pt -119.8 151.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.934 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.4 m-85 -101.81 131.38 48.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.145 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 48' ' ' ILE . 5.0 mp -135.86 160.95 65.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 0.0 111.814 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.591 ' CG ' ' HA2' ' A' ' 92' ' ' GLY . 32.3 Cg_exo -63.78 135.68 49.65 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.91 2.406 . . . . 0.0 112.364 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 37.0 Cg_exo -60.4 -20.12 61.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.697 2.265 . . . . 0.0 112.916 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.3 m -60.01 -40.52 89.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.872 0.368 . . . . 0.0 110.781 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -61.75 -39.9 93.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.269 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 59.1 tp -59.97 -40.21 88.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.113 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -59.98 -39.98 87.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -60.76 -39.95 90.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.378 0.609 . . . . 0.0 110.376 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 55' ' ' LEU . 87.7 mt -60.04 -39.5 86.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.8 t -57.76 -38.31 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.3 mtt -60.0 -37.06 78.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.403 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 21' ' ' PHE . 87.6 mt -80.08 -0.06 34.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 59.95 40.06 19.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.697 0.284 . . . . 0.0 111.588 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -86.72 120.07 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 110.436 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -83.56 151.2 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.733 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.507 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 32.6 p90 -87.1 159.85 50.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 23.4 Cg_exo -65.65 147.53 73.14 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.866 0.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.6 mtt -95.58 138.92 32.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.775 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.855 HD22 ' HB ' ' A' ' 153' ' ' THR . 32.3 mt -114.05 139.34 49.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.667 ' HB3' HD11 ' A' ' 114' ' ' ILE . 94.6 m-85 -131.55 145.42 51.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.235 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.75 ' HB3' ' CD2' ' A' ' 81' ' ' HIS . 22.4 pttp -122.21 140.32 52.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -98.58 128.09 44.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 113' ' ' GLN . 23.0 p -105.17 136.4 44.74 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.07 113.79 22.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.724 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -65.92 -39.07 90.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.814 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.89 -40.09 87.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.924 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -102.96 -14.49 16.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.94 41.49 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.744 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -101.22 140.16 35.89 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.022 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.553 ' CG1' HG22 ' A' ' 72' ' ' THR . 41.6 t -119.99 121.41 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.685 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 80.1 p -102.45 156.34 17.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.75 ' CD2' ' HB3' ' A' ' 70' ' ' LYS . 77.5 m80 -101.76 114.85 29.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.37 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.24 167.1 17.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.756 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.649 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.99 162.91 26.49 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.539 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.0 p -129.67 131.99 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 111.709 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.852 HD13 ' HD3' ' A' ' 47' ' ' LYS . 61.2 tp -93.38 -80.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.115 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.9 161.04 43.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 89.1 m-85 -95.3 116.48 28.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 pt -125.57 -4.62 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.84 98.12 11.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.136 0.493 . . . . 0.0 111.557 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.07 75.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.96 -30.35 69.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.887 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.591 ' HA2' ' CG ' ' A' ' 51' ' ' PRO . . . 112.35 49.3 0.61 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.611 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.661 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 99.6 mtt180 -121.1 149.48 42.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.84 0.353 . . . . 0.0 111.558 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 49' ' ' PHE . 7.4 p -128.93 142.82 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.002 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 97.5 m-85 -114.02 137.6 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 97' ' ' PRO . 1.8 tp -119.57 137.57 25.65 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 96' ' ' LEU . 52.6 Cg_exo -53.25 145.55 43.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.45 2.1 . . . . 0.0 112.372 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 59.0 tt0 -60.05 -43.66 95.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.829 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 100' ' ' MET . 59.1 p-90 -69.98 -41.18 74.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.558 ' CG ' HD11 ' A' ' 96' ' ' LEU . 43.8 tpp -61.18 -40.32 93.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.555 ' HA ' HD21 ' A' ' 96' ' ' LEU . 57.1 ttm -60.06 -41.23 91.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.124 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.1 -40.07 94.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.519 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.02 -40.07 96.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.44 -23.63 63.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.216 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.76 34.85 29.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.998 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 101' ' ' MET . 45.1 pt -119.77 146.99 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -95.8 157.15 36.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.428 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.39 138.07 30.83 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.399 2.066 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.9 75.74 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.15 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 53.6 m -71.03 149.98 46.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.096 0.448 . . . . 0.0 110.669 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 112' ' ' LEU . 10.4 tt -71.04 140.15 50.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 71' ' ' LEU . 59.3 tp -126.76 130.46 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.639 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 93.7 mt-30 -109.19 130.31 55.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 69' ' ' PHE . 18.7 tt -118.29 128.38 75.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 111.443 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 42.3 t -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.859 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 61.4 m -70.11 130.24 41.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.704 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.7 m -120.08 130.03 54.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.831 0.348 . . . . 0.0 111.086 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 98.0 m-20 -119.33 120.04 35.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.227 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.15 153.62 44.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.911 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.28 17.69 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.823 2.348 . . . . 0.0 112.292 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.603 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.2 OUTLIER 70.11 100.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.974 0.416 . . . . 0.0 111.968 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -57.02 156.82 12.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.244 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.24 -27.22 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -139.56 130.92 26.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.971 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 1.043 HG13 HG22 ' A' ' 194' ' ' THR . 2.6 p -130.02 130.19 65.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.211 0.529 . . . . 0.0 111.548 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.557 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 87.9 tttt -99.42 120.73 40.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.503 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.72 HD22 ' CG2' ' A' ' 171' ' ' ILE . 83.6 mt -108.76 135.51 49.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.408 . . . . 0.0 111.57 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.89 ' HB2' ' HG ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -107.39 119.92 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.905 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' A' ' 198' ' ' PRO . 91.2 Cg_endo -81.46 169.1 15.86 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.16 1.907 . . . . 0.0 111.573 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -138.25 121.62 17.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' ASP . 0.5 OUTLIER 63.32 26.74 15.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m 36.84 27.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.372 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 96.2 m-20 -68.54 -39.95 80.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 140' ' ' PRO . 64.0 t80 -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.61 -24.13 63.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.4 mt -57.5 139.01 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.83 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -60.28 -40.04 88.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.57 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 137' ' ' ILE . 79.7 m-20 -121.68 75.16 35.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.772 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 42.3 Cg_endo -69.07 -34.93 15.73 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.786 2.324 . . . . 0.0 112.232 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.64 -40.65 92.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.49 98.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 147' ' ' VAL . 70.8 t -61.14 -42.58 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.09 -42.48 94.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.28 -42.27 95.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.56 -40.04 95.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 143' ' ' VAL . 95.5 t -62.01 -40.32 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.004 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.774 HD23 HD11 ' A' ' 154' ' ' LEU . 90.3 mt -60.31 -40.48 90.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.03 -39.96 87.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.531 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.79 -40.03 93.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.106 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.6 m-85 -103.0 121.42 42.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.518 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.496 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 74.0 m -61.15 -40.02 92.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.855 ' HB ' HD22 ' A' ' 68' ' ' LEU . 4.8 t -136.35 147.8 47.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.355 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.774 HD11 HD23 ' A' ' 148' ' ' LEU . 84.9 mt -121.39 138.47 54.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.364 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 81' ' ' HIS . 54.6 m -116.08 136.08 53.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.701 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 7.2 p -59.81 -39.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.06 -21.16 33.85 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.7 t0 -78.95 136.28 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.515 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.407 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 15.7 m -100.34 120.66 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.167 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.15 138.93 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.284 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 96.5 mt-10 -120.05 139.99 51.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -129.31 140.04 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.3 t -110.13 114.5 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.378 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.13 122.3 40.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.595 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.2 t30 56.41 39.99 29.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.11 12.31 84.19 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.126 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 163' ' ' SER . 58.3 mttm -118.19 139.07 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.903 0.352 . . . . 0.0 110.664 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.5 p -109.53 133.62 52.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.1 m-85 -119.99 138.65 53.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 99.6 mttt -104.76 122.66 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.72 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 119.97 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.393 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -115.39 130.03 56.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -81.71 104.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.947 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' ' 128' ' ' GLU . 80.7 mt -60.53 -48.96 79.47 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.1 mt-10 -158.89 139.91 12.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 156' ' ' VAL . 11.1 m -143.23 151.62 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.957 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -116.93 103.16 52.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.395 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.505 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 97.3 Cg_endo -100.08 12.32 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.734 2.956 . . . . 0.0 112.278 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 80.7 tt0 60.75 20.01 10.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.451 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 79.3 p -146.78 152.82 39.4 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.7 m -70.0 -18.56 63.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.548 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.7 t -59.9 -25.52 65.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 60.18 40.04 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 0.0 110.89 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 p -122.38 142.65 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.224 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 44.9 pt -130.18 140.03 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 68' ' ' LEU . 44.1 t -134.65 138.11 44.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.042 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.721 HG23 ' CB ' ' A' ' 190' ' ' THR . 8.2 p -170.11 67.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.3 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 152' ' ' SER . 84.8 mt -70.0 -40.02 78.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.53 -10.08 8.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.686 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.721 ' CB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -78.95 174.49 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.42 118.35 36.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.399 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 187' ' ' VAL . 25.2 tp -120.4 138.01 54.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.134 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 26.4 t -92.43 119.99 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' THR . . . . . 1.043 HG22 HG13 ' A' ' 125' ' ' VAL . 65.9 p -120.87 140.61 51.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.339 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -121.15 139.44 53.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.326 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -105.41 120.0 40.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -132.64 107.65 13.05 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 129' ' ' PRO . 71.0 Cg_endo -73.71 120.34 6.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 113.149 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.595 ' HG3' ' CG ' ' A' ' 128' ' ' GLU . 45.0 Cg_endo -93.59 6.75 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.303 2.668 . . . . 0.0 112.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 200' ' ' VAL . 29.6 m -89.32 119.93 37.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.043 0.449 . . . . 0.0 110.843 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -167.55 -107.28 0.2 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.382 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.02 131.84 44.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.26 129.96 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 205' ' ' PRO . 11.2 tt0 -82.78 129.67 61.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 204' ' ' GLU . 27.2 Cg_endo -61.86 82.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.341 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -96.9 132.84 42.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -69.87 139.96 53.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.02 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.93 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.722 0.296 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -100.2 130.01 46.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.2 m -128.44 143.03 50.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 0.0 111.099 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.91 96.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.412 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.88 140.01 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 110.556 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.6 p -87.2 146.25 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.029 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.4 m -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.9 -39.97 87.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.712 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.86 -166.08 42.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.523 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.93 -119.24 14.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.657 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.15 -9.93 75.78 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.672 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -100.06 10.6 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.287 . . . . 0.0 111.167 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.4 168.4 54.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.658 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 181' ' ' SER . 87.3 m-85 -120.03 140.7 50.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.96 -40.04 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.422 ' ND2' ' HB3' ' A' ' 179' ' ' GLU . 97.0 m-20 -100.48 119.93 39.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -108.15 120.0 48.13 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.253 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.78 154.94 49.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.301 2.001 . . . . 0.0 111.809 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 97.0 mt-30 -103.27 123.25 46.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.722 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 116' ' ' SER . 9.0 t -129.98 139.93 50.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 115' ' ' SER . 69.2 t80 -121.58 139.99 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.558 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -104.67 130.41 52.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.84 147.62 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.0 120.11 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.727 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 47.2 m-85 -140.69 151.77 44.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.997 0.427 . . . . 0.0 111.221 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.06 131.78 35.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 19.3 p -90.17 143.4 26.81 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.304 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 43.6 m-85 -138.37 157.22 72.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.203 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.91 109.11 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.507 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.836 HG12 ' HB3' ' A' ' 95' ' ' TYR . 85.6 mt -60.15 -40.03 82.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -59.69 -23.79 63.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.3 ttp -68.2 -36.62 79.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.493 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 97.0 mtp -59.91 141.8 54.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.11 151.9 25.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.702 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -54.03 -29.96 45.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.282 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 ttt-85 -60.05 -39.9 87.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.531 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -113.06 10.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.143 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 31' ' ' ALA . 41.7 ttt180 -113.59 129.99 56.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.008 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.25 129.21 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.36 -40.21 89.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.161 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -64.24 -40.0 95.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.89 91.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -59.97 -40.18 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.36 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.92 2.22 34.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.676 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.94 175.3 32.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.148 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.53 10.49 61.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.392 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 85' ' ' LEU . 63.7 mttp -80.54 129.78 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.7 pt -120.06 154.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.789 ' C ' HD22 ' A' ' 50' ' ' LEU . 96.0 m-85 -99.33 134.46 42.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.629 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.4 mm? -131.16 160.08 68.65 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.651 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 97.6 Cg_endo -83.51 149.44 12.97 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.002 1.801 . . . . 0.0 112.735 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.2 Cg_exo -61.15 -29.1 86.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.116 2.544 . . . . 0.0 112.861 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.94 87.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -67.29 -40.26 86.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.094 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.5 tp -60.03 -39.99 87.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -60.03 -40.08 88.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 98.8 mttt -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 69' ' ' PHE . 87.1 mt -61.68 -39.87 92.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.612 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -59.75 -37.54 79.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.84 -35.94 75.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.448 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HD1' ' A' ' 21' ' ' PHE . 93.1 mt -79.98 -3.88 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.238 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 60.0 40.13 19.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.794 0.33 . . . . 0.0 111.538 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 58' ' ' LEU . 85.2 mt -76.23 129.94 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.999 0.428 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -73.3 141.93 47.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.376 0.608 . . . . 0.0 111.892 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.515 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.1 p90 -87.63 153.62 52.94 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 56.5 Cg_endo -70.78 152.18 94.68 Favored 'Cis proline' 0 C--N 1.35 0.611 0 C-N-CA 123.486 -1.464 . . . . 0.0 112.912 0.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 58' ' ' LEU . 67.5 mtt -84.69 140.49 31.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.866 HD13 HG22 ' A' ' 153' ' ' THR . 67.1 mt -111.2 137.33 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.081 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 58' ' ' LEU . 50.6 m-85 -130.59 143.74 50.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.069 0.461 . . . . 0.0 111.54 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 4.5 ttpm? -120.03 137.44 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.64 131.19 43.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.5 ' OG1' HG12 ' A' ' 79' ' ' VAL . 63.9 m -119.71 130.01 54.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.28 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.73 114.26 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.53 -39.98 89.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.4 -40.04 89.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.211 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -102.67 -9.09 20.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.717 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.95 12.85 16.69 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.85 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.65 140.34 37.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.698 0.285 . . . . 0.0 110.564 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG12 ' OG1' ' A' ' 72' ' ' THR . 27.1 m -119.88 119.79 61.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.063 0.459 . . . . 0.0 111.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 76.4 p -105.99 143.4 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.51 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.696 ' HE2' HG21 ' A' ' 117' ' ' THR . 80.0 m80 -93.76 114.55 26.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.752 0.311 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.13 159.98 13.78 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.817 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.91 162.84 26.55 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.386 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.676 HG23 HD23 ' A' ' 50' ' ' LEU . 10.8 p -124.74 130.61 73.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.0 112.19 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.541 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.1 tp -90.14 -79.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.22 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.01 160.13 42.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 86.1 m-85 -92.78 116.46 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.915 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.2 pt -122.99 -6.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB1' ' HG2' ' A' ' 93' ' ' ARG . . . -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.723 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -39.99 76.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.887 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -67.22 -30.77 70.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.99 67.81 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.848 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.746 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 22.5 ptt-85 -135.05 154.92 51.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 111.158 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.494 ' CG1' HD23 ' A' ' 112' ' ' LEU . 11.9 p -129.19 140.17 49.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.836 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.07 139.96 51.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.262 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -131.17 156.28 80.35 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.685 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 57.9 Cg_endo -68.12 160.01 50.62 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.712 2.275 . . . . 0.0 112.094 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.22 -40.25 89.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 50.5 p-90 -65.19 -40.06 93.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.886 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.428 ' HG3' ' HG2' ' A' ' 97' ' ' PRO . 61.0 mtt -63.44 -40.18 96.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.462 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 ttp -60.06 -40.49 89.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.582 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.8 m -68.39 -39.96 81.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.697 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.97 -24.01 63.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.25 30.18 69.69 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.125 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.18 149.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.491 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 36.1 mt-30 -95.86 159.85 31.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.608 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 26.6 Cg_endo -62.61 0.09 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.424 2.083 . . . . 0.0 113.147 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.94 -20.38 9.93 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.3 p -80.8 160.13 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 111.09 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.2 151.74 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 59.5 tp -120.13 130.88 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.573 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.9 123.31 47.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.871 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 23' ' ' GLU . 20.5 tt -119.5 121.65 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 46.6 t -120.04 126.53 51.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' THR . 34.9 t -63.69 131.0 46.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.6 m -120.0 130.01 54.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 96.1 m-20 -118.55 125.44 49.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.139 0.495 . . . . 0.0 110.438 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 186' ' ' CYS . 33.6 m -114.2 150.9 44.43 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.605 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 73.0 Cg_endo -73.89 18.55 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.834 2.356 . . . . 0.0 112.531 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 190' ' ' THR . 6.1 tt 61.23 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.874 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.41 34.01 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.615 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.02 -16.8 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -140.0 142.18 36.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.816 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.878 ' CG1' HG22 ' A' ' 194' ' ' THR . 8.4 p -137.71 136.09 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.823 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 29.2 mmtm -98.91 124.7 44.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.431 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.687 HD12 ' HB ' ' A' ' 194' ' ' THR . 83.7 mt -113.73 131.0 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.013 0.435 . . . . 0.0 111.598 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -104.49 119.33 54.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 94.9 Cg_endo -77.83 160.39 30.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -125.93 121.4 33.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.983 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t 56.77 160.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.155 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 m -71.89 -21.59 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -59.98 -40.09 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.702 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.75 -40.22 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.046 0.451 . . . . 0.0 110.496 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.06 -0.41 57.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.298 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -60.01 -40.04 87.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.8 mt -55.21 139.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.938 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.9 p -60.18 -40.66 90.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -120.94 76.68 29.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.33 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.94 -28.69 16.05 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.425 2.084 . . . . 0.0 111.927 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.71 -40.05 93.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.93 98.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.18 -40.29 88.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -60.36 -41.26 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.28 88.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.274 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.72 -39.96 95.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 110.367 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 162' ' ' ILE . 84.5 t -61.75 -40.02 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.547 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -59.98 -40.17 88.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -62.77 -40.01 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.99 93.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.934 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.18 121.84 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 111.071 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 188' ' ' ILE . 36.1 p -70.07 -39.93 75.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.866 HG22 HD13 ' A' ' 68' ' ' LEU . 11.1 p -119.37 138.59 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.547 HD11 HD22 ' A' ' 148' ' ' LEU . 87.0 mt -124.0 124.87 43.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 22.8 m -121.36 139.17 53.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.56 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.91 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 31.1 m -60.19 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.325 0.583 . . . . 0.0 111.336 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -68.23 -40.06 82.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.621 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.91 140.24 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.126 0.488 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.3 p -105.18 121.88 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.286 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.3 pt -105.96 138.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 111.277 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.472 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.0 mt-10 -120.07 140.12 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.504 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.819 HD13 HG21 ' A' ' 147' ' ' VAL . 45.9 pt -129.72 141.6 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.099 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.696 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 17.8 m -107.5 120.87 43.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 111.569 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.496 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 65.0 t80 -120.67 119.56 33.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.223 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.496 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 12.4 m120 54.44 40.11 31.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.657 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.75 83.73 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -114.37 139.25 49.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.756 0.278 . . . . 0.0 110.473 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.526 HG22 ' OG ' ' A' ' 163' ' ' SER . 68.1 p -108.89 127.64 54.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.331 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.02 139.98 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.483 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 98.2 mttt -99.99 123.37 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.875 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.98 119.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.833 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -120.11 126.65 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.769 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.91 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -80.95 111.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 174' ' ' LEU . 8.0 tt -59.02 -58.26 9.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.823 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.3 tt0 -158.89 141.47 14.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.263 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.839 HG13 ' CG1' ' A' ' 156' ' ' VAL . 18.6 m -130.05 160.02 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.94 103.94 22.56 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.0 Cg_endo -103.48 166.81 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.768 2.978 . . . . 0.0 112.125 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.9 mt-10 -99.96 3.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 159.88 41.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 69.6 p -70.11 -10.14 57.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.07 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -59.84 -19.94 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 111.114 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 56.65 39.82 29.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.029 0.442 . . . . 0.0 111.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -129.94 141.91 50.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.908 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 192' ' ' LEU . 45.3 pt -128.51 141.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.108 0.48 . . . . 0.0 112.033 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.637 ' SG ' HD11 ' A' ' 68' ' ' LEU . 41.8 t -129.22 125.73 37.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.093 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.779 HG23 ' OG1' ' A' ' 190' ' ' THR . 11.0 p -155.05 64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.049 0.452 . . . . 0.0 111.395 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 152' ' ' SER . 85.0 mt -68.65 -39.98 81.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.137 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.13 -10.12 9.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.107 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.779 ' OG1' HG23 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -81.38 176.34 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.248 0.547 . . . . 0.0 111.404 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.56 117.2 33.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.316 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 125' ' ' VAL . 30.9 tp -120.49 137.25 54.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.754 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.97 121.16 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.368 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.878 HG22 ' CG1' ' A' ' 125' ' ' VAL . 62.6 p -115.69 144.27 44.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.799 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -126.5 140.07 52.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.631 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -103.33 126.56 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.416 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -127.75 105.25 20.86 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.518 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.2 119.41 6.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.419 2.08 . . . . 0.0 112.464 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -93.16 -5.1 3.04 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.872 2.381 . . . . 0.0 112.435 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.69 139.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.84 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -99.92 130.32 46.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.34 140.07 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.97 128.45 45.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 112.11 3.03 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -86.16 132.88 33.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.848 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.0 127.83 46.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.88 -179.882 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.86 0.362 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.03 139.99 51.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.794 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -121.86 139.98 52.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.56 -139.8 11.24 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.57 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -66.5 140.23 57.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.834 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t -119.75 138.5 53.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.0 p -60.09 -39.1 84.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -118.06 140.0 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.99 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.96 6.61 58.75 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.042 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.85 16.24 63.8 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.49 19.94 70.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.395 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -113.94 129.59 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 179.59 52.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.471 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.98 140.01 51.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.737 0.303 . . . . 0.0 111.065 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.6 121.25 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.054 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -107.65 119.98 40.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.077 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 ttp -100.56 119.86 57.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 141.7 97.78 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.252 1.968 . . . . 0.0 112.075 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -108.69 128.87 55.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.532 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.5 m -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.7 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 20.1 t80 -133.65 130.26 38.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.42 134.26 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 112.04 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.4 mt-10 -139.26 159.12 42.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.894 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -121.26 136.88 54.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.439 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 94.7 m-85 -147.13 160.08 42.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.338 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.427 ' O ' HG12 ' A' ' 94' ' ' VAL . 98.2 mtt180 -89.13 121.95 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 110.408 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.843 ' HB2' HD22 ' A' ' 96' ' ' LEU . 32.0 p -95.44 141.76 28.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 53.8 m-85 -123.98 148.35 56.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.508 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 16.4 Cg_exo -68.87 108.74 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.788 2.325 . . . . 0.0 112.305 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.621 ' CG2' ' HD2' ' A' ' 38' ' ' ARG . 91.2 mt -59.97 -38.77 77.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.206 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.02 30.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.445 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 70.6 mtm -67.88 -39.58 83.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.871 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . 93.1 mtp -60.19 144.78 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.904 0.383 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.0 m-20 -60.05 145.56 46.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.799 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -60.05 -39.89 87.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.103 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -59.95 -40.04 87.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.7 mt -83.72 -1.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.871 ' HD3' ' HB2' ' A' ' 33' ' ' MET . 44.4 mtm180 -119.48 155.51 31.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.982 0.42 . . . . 0.0 111.882 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 87.6 tttt -100.56 131.49 46.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.332 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.634 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.637 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.2 m-20 -62.58 -39.96 95.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.95 95.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.03 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.284 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.4 -0.0 30.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.563 0.221 . . . . 0.0 111.403 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -99.78 -179.6 30.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.62 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.11 23.39 34.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.134 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.4 mttt -81.1 126.97 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.968 0.413 . . . . 0.0 111.752 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.89 HD12 HD13 ' A' ' 114' ' ' ILE . 49.3 pt -119.99 150.04 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.86 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 94' ' ' VAL . 91.3 m-85 -102.71 133.92 46.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 48' ' ' ILE . 3.9 mp -138.13 161.69 58.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.265 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 59.7 Cg_endo -71.98 149.16 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.114 1.876 . . . . 0.0 112.238 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.98 -23.66 67.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.589 2.192 . . . . 0.0 112.591 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.6 p -60.14 -39.9 87.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.71 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.07 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' A' ' 58' ' ' LEU . 58.6 tp -63.9 -40.12 95.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.835 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.0 m -60.02 -41.33 91.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 111.049 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 88.1 tttt -61.95 -39.87 93.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.321 0.581 . . . . 0.0 110.382 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.762 HD13 ' HE2' ' A' ' 67' ' ' MET . 88.3 mt -59.99 -39.41 85.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.638 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.1 m -59.96 -39.06 84.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 ttm -59.98 -38.45 82.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.772 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.86 -3.87 43.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.643 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.06 40.03 19.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.707 HG21 ' HE1' ' A' ' 67' ' ' MET . 11.0 tt -77.59 137.21 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.712 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -70.08 140.01 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.014 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 30.7 p90 -95.25 157.35 36.52 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.359 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 188' ' ' ILE . 15.6 Cg_exo -69.55 171.34 53.25 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.746 -1.356 . . . . 0.0 112.77 0.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.762 ' HE2' HD13 ' A' ' 58' ' ' LEU . 81.7 mmm -85.92 139.87 30.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.092 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.731 HD22 HG22 ' A' ' 153' ' ' THR . 64.4 mt -108.34 128.42 54.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.664 ' HB3' HG23 ' A' ' 114' ' ' ILE . 13.5 m-85 -121.95 140.04 52.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 50.2 pttt -126.38 138.22 53.53 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.247 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 112' ' ' LEU . 8.1 mp -99.0 120.31 39.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.42 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.737 ' CB ' HG22 ' A' ' 79' ' ' VAL . 7.6 t -109.62 122.97 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 111.264 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.25 28.16 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.041 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -60.38 -39.99 89.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.894 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -103.27 -10.66 18.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.87 12.19 41.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.302 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -103.47 133.06 49.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' CB ' ' A' ' 72' ' ' THR . 39.8 t -119.96 119.71 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.204 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.4 p -103.12 160.03 15.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.192 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 80.6 m80 -100.65 114.28 27.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.119 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.31 169.72 19.86 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.833 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.06 163.64 23.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.179 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.505 HG21 ' CE2' ' A' ' 69' ' ' PHE . 12.2 p -127.88 130.02 69.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.189 0.494 . . . . 0.0 112.084 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 ' HD3' ' A' ' 47' ' ' LYS . 60.6 tp -91.33 -78.16 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.191 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -154.63 160.53 41.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.003 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 91.3 m-85 -95.03 116.48 28.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -130.9 -4.82 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -86.91 97.85 10.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.07 0.462 . . . . 0.0 111.232 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -39.95 75.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.749 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.67 -30.5 68.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.663 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.9 49.77 0.72 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.113 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.71 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 84.3 mtm180 -116.27 148.44 40.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.881 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 114' ' ' ILE . 11.2 p -130.08 142.4 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.152 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 28' ' ' TYR . 87.0 m-85 -119.93 139.96 51.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 27' ' ' CYS . 2.3 pt? -122.81 148.7 54.42 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 111.388 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.66 149.22 69.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.69 2.26 . . . . 0.0 112.084 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -60.03 -41.08 91.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.479 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -70.0 -40.02 75.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 71' ' ' LEU . 57.6 ttm -61.41 -40.07 93.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.667 ' HE2' HD21 ' A' ' 96' ' ' LEU . 58.4 ttm -60.37 -40.75 91.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.218 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.77 -39.99 94.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 110.496 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.2 -40.05 96.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.536 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.46 -24.02 63.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.25 31.84 53.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.684 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -111.98 140.0 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.407 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 30.0 pt20 -96.93 160.24 29.61 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 96.1 Cg_exo -43.44 136.09 6.22 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.655 2.236 . . . . 0.0 112.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.76 79.23 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.466 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.6 t -70.02 153.15 43.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.39 141.22 28.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.654 HD21 ' CD2' ' A' ' 71' ' ' LEU . 59.4 tp -125.53 129.91 50.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.61 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 95.8 mt-30 -111.32 130.93 55.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -109.97 129.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.896 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.662 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 20.2 m -121.96 132.54 54.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 29.4 t -88.67 116.16 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.237 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 81.8 p -125.77 139.84 53.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.507 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -111.11 114.74 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.09 148.52 45.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 34.7 Cg_exo -62.04 175.26 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.342 2.028 . . . . 0.0 112.301 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 187' ' ' VAL . 0.3 OUTLIER -94.97 120.88 35.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.718 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -69.87 133.63 25.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.85 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' CD2' ' A' ' 124' ' ' PHE . 58.4 tt0 -60.39 -44.01 96.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.633 0.254 . . . . 0.0 111.521 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.5 ' CE1' HG11 ' A' ' 193' ' ' VAL . 12.2 m-85 -138.67 145.31 40.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.126 0.489 . . . . 0.0 112.223 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.891 ' CG1' HG22 ' A' ' 194' ' ' THR . 6.5 p -131.81 130.38 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.928 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.915 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 30.4 mttm -97.61 126.42 42.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.306 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 144' ' ' LEU . 85.1 mt -111.48 134.98 52.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.38 109.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 199' ' ' PRO . 6.5 Cg_exo -72.19 159.96 48.46 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.471 2.114 . . . . 0.0 112.417 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.3 tt0 -129.36 121.37 27.28 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m 69.55 130.68 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.03 -25.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.435 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -39.97 87.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.99 -39.91 87.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.27 -10.64 58.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.354 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.02 -12.32 61.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.72 0.295 . . . . 0.0 111.384 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -60.01 138.79 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.579 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 t -60.81 -40.08 91.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.457 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 21.8 m-20 -129.89 74.55 80.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 60.2 Cg_endo -73.4 -26.62 14.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.482 2.121 . . . . 0.0 111.92 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.03 -40.07 88.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.68 88.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.1 t -65.85 -40.34 87.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 127' ' ' LEU . 2.9 tm? -60.93 -43.04 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.521 ' HG3' ' OG1' ' A' ' 190' ' ' THR . 86.3 tt0 -59.94 -40.65 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.14 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.12 -40.06 92.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.632 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 162' ' ' ILE . 95.4 t -60.04 -41.16 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.367 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -60.08 -40.15 88.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -62.27 -39.97 94.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.844 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.12 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.05 117.25 33.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 0.0 111.205 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.649 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 67.4 m -63.11 -40.06 96.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.731 HG22 HD22 ' A' ' 68' ' ' LEU . 81.1 p -123.38 140.54 52.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.864 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 148' ' ' LEU . 88.9 mt -119.85 127.21 52.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.207 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 94.6 m -118.7 137.41 53.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.779 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.75 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.4 t -60.06 -41.11 85.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.382 0.611 . . . . 0.0 111.188 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 155' ' ' THR . 95.7 m-20 -70.83 -38.99 73.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.485 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.505 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.5 t0 -66.19 134.25 52.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.626 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 1.078 HG12 ' HG2' ' A' ' 172' ' ' LYS . 15.4 m -98.96 119.98 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.129 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 171' ' ' ILE . 48.3 pt -102.36 134.84 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.983 0.42 . . . . 0.0 111.351 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 98.1 mt-10 -120.09 139.97 51.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.149 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 147' ' ' VAL . 45.2 pt -126.22 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.683 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.9 t -103.95 118.32 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.7 t80 -121.98 119.13 30.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.158 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 53.02 40.05 30.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.251 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.0 75.82 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.198 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.4 mttt -119.93 137.93 53.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.885 0.343 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.8 p -107.99 130.86 55.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.407 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 87.4 m-85 -119.97 140.05 51.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.741 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 58.7 mttp -100.79 128.0 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.846 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.617 ' HB ' HG13 ' A' ' 160' ' ' ILE . 48.7 mm -119.97 120.36 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 1.078 ' HG2' HG12 ' A' ' 159' ' ' VAL . 99.0 mttt -114.58 131.15 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.75 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.6 OUTLIER -73.8 96.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.787 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.7 tt -59.82 -52.08 66.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.915 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -160.87 142.52 12.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 185' ' ' ILE . 11.5 m -142.1 161.36 20.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -118.5 102.78 49.78 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 77.6 Cg_endo -100.77 175.9 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.683 2.922 . . . . 0.0 112.638 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.7 mt-10 -97.42 -0.04 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.798 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.2 m -133.65 156.05 48.59 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.114 0.483 . . . . 0.0 111.458 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 55.5 m -70.7 -10.61 59.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.3 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -59.86 -23.87 63.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 111.291 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 60.41 40.03 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.428 . . . . 0.0 110.904 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 66.2 m -127.74 142.77 51.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 176' ' ' VAL . 13.9 mt -119.91 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' A' ' 68' ' ' LEU . 82.4 m -143.31 151.71 40.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.783 HG22 ' H ' ' A' ' 189' ' ' GLU . 7.3 p -178.16 -55.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 152' ' ' SER . 54.7 mt 68.66 -1.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 187' ' ' VAL . 99.9 mt-10 -99.71 9.83 42.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.986 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.521 ' OG1' ' HG3' ' A' ' 145' ' ' GLU . 7.1 t 48.27 41.38 16.0 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -108.76 20.03 18.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.635 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.595 ' CD1' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -106.73 139.73 40.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.465 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 124' ' ' PHE . 23.4 t -90.09 121.2 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.766 0.317 . . . . 0.0 110.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.891 HG22 ' CG1' ' A' ' 125' ' ' VAL . 16.4 p -113.19 140.58 47.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 111.73 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -120.6 145.21 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.401 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.26 134.55 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 111.603 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . -117.32 161.29 33.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.75 129.95 25.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.38 2.053 . . . . 0.0 112.433 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 98.9 Cg_endo -80.04 168.37 18.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.784 2.323 . . . . 0.0 112.838 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.3 t -81.84 134.69 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.13 -137.27 3.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.633 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.01 139.97 52.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.667 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.09 130.02 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 205' ' ' PRO . 1.3 mp0 -91.96 125.86 55.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.042 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 204' ' ' GLU . 35.7 Cg_exo -57.28 157.25 22.28 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.13 137.59 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -100.13 125.52 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.999 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.708 179.77 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.737 0.304 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -39.93 87.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t -69.95 134.27 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.687 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.79 24.15 0.41 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.135 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.51 138.39 43.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -72.15 157.95 36.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -120.02 134.89 55.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -99.9 129.52 45.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.34 117.59 2.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.298 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.93 175.87 48.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.456 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.63 89.37 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.801 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -126.24 140.06 52.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.0 -2.22 81.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.78 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -100.06 120.61 40.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.617 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.18 131.21 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -100.05 119.95 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.709 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.5 mtt -99.97 120.02 58.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.84 128.57 15.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.375 2.05 . . . . 0.0 111.846 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 117' ' ' THR . 7.2 tt0 -117.74 137.77 52.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 m -119.97 130.98 55.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 56.1 t80 -133.64 132.79 41.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.391 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.49 135.82 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.74 150.87 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.722 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.4 123.14 48.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 110.931 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 114' ' ' ILE . 83.5 m-85 -130.89 147.22 52.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.966 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 94' ' ' VAL . 94.8 mtt-85 -81.75 149.46 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 21.9 m -84.95 133.36 34.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.582 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 86.7 m-85 -133.69 149.96 73.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -87.73 100.56 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.049 2.499 . . . . 0.0 113.514 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.858 HG22 ' OD1' ' A' ' 43' ' ' ASN . 87.6 mt -62.67 -41.37 91.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 110.349 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.23 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.412 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 98.1 mtp -68.1 -29.2 68.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.4 ttt -60.07 152.64 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -58.83 139.28 56.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 111.342 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ARG . 96.0 m-20 -63.93 -40.15 95.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -60.21 -40.71 91.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.324 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.38 -48.66 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 35' ' ' ASP . 97.3 mtt180 -125.0 143.36 50.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.072 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.41 148.78 47.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -60.12 -26.7 66.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.99 -39.7 86.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.355 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.38 82.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.858 ' OD1' HG22 ' A' ' 30' ' ' ILE . 97.8 m-20 -59.99 -39.73 86.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.733 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.88 8.27 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.581 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.28 29.4 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.73 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.65 22.82 38.14 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 85' ' ' LEU . 72.1 tttt -98.33 124.44 42.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 0.0 111.15 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.592 ' CD1' HD11 ' A' ' 50' ' ' LEU . 44.2 pt -113.44 149.69 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.3 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 94' ' ' VAL . 95.7 m-85 -101.58 134.44 44.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 110.732 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 69' ' ' PHE . 5.3 mp -134.08 161.78 61.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.246 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 73.9 Cg_endo -75.13 158.73 41.55 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.65 2.234 . . . . 0.0 113.188 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.856 ' HA ' HD23 ' A' ' 55' ' ' LEU . 73.8 Cg_endo -74.87 -13.39 21.73 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.054 2.503 . . . . 0.0 113.125 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -59.99 -40.0 87.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 111.525 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.524 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 52' ' ' PRO . 3.2 mm? -59.97 -40.02 87.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.78 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -59.98 -39.95 87.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.958 0.408 . . . . 0.0 110.092 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 98.6 mttt -69.12 -40.04 78.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.321 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.729 HD12 HD13 ' A' ' 55' ' ' LEU . 92.3 mt -59.9 -40.0 87.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.134 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -40.03 88.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.3 mtp -59.93 -40.03 87.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.792 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -82.32 -1.95 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.784 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.1 t30 59.87 40.1 19.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.596 HG12 ' NE2' ' A' ' 19' ' ' GLN . 58.6 mt -82.64 131.29 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.857 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -81.84 149.96 28.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.511 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 49.8 p90 -87.35 157.97 52.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.664 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 74.4 Cg_endo -75.13 161.55 94.54 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.608 -1.414 . . . . 0.0 112.771 0.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.503 ' HE1' HD22 ' A' ' 58' ' ' LEU . 66.4 mmm -87.27 139.04 30.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 117' ' ' THR . 75.5 mt -108.85 134.35 51.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.7 m-85 -120.05 140.65 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 112.301 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -114.92 128.17 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.783 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 91.0 mt -99.01 127.54 44.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.9 ' HA ' HG12 ' A' ' 79' ' ' VAL . 88.5 m -120.02 130.08 54.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.117 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 117.98 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.91 -39.87 75.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -39.95 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.044 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 28.0 m -105.09 -15.38 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.793 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 5.11 57.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.223 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.69 140.05 34.45 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.125 0.488 . . . . 0.0 110.279 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 72' ' ' THR . 24.6 m -120.05 117.53 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.873 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.614 ' OG1' HD21 ' A' ' 104' ' ' LEU . 82.2 p -102.75 144.63 30.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.566 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.689 ' CD2' HG23 ' A' ' 155' ' ' THR . 0.1 OUTLIER -85.97 114.4 22.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.32 144.93 17.35 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.082 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.29 130.52 10.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.977 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.6 p -119.88 130.79 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.32 . . . . 0.0 111.479 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 47' ' ' LYS . 88.8 mt -110.24 -33.41 6.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.133 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.13 154.42 40.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 112.325 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 55' ' ' LEU . 81.8 m-85 -107.89 118.91 37.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.625 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 38' ' ' ARG . 46.8 pt -125.41 -5.01 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.669 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -89.17 98.71 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 0.0 111.414 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -40.03 78.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.941 0.4 . . . . 0.0 111.187 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.77 -29.88 67.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.278 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.91 49.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.928 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.669 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 89.1 mtm180 -119.44 149.8 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.523 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 114' ' ' ILE . 9.9 p -124.97 142.24 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.393 0.616 . . . . 0.0 111.24 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.799 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.4 m-85 -120.04 139.92 51.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.185 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.733 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.74 152.8 79.48 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 32.5 Cg_exo -61.0 154.78 54.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.557 2.172 . . . . 0.0 111.77 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.69 -40.16 94.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.343 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.423 ' NE1' ' CB ' ' A' ' 97' ' ' PRO . 67.2 p-90 -64.02 -40.11 95.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 58.3 ttm -60.46 -43.25 97.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.973 0.416 . . . . 0.0 110.787 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 106' ' ' ILE . 57.4 ttm -60.76 -40.49 92.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.5 -39.99 94.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.4 m -63.72 -40.41 96.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.614 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.4 mt -71.13 -24.01 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.45 30.58 56.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.302 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 101' ' ' MET . 45.6 pt -120.01 157.83 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -96.51 160.38 29.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.68 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.75 -3.41 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.76 -15.99 13.79 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.215 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 54.8 m -74.23 150.84 40.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.714 0.293 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.49 153.06 37.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.903 0.383 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 58.0 tp -119.96 132.7 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.282 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.72 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -99.96 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.848 HG23 ' HB3' ' A' ' 69' ' ' PHE . 86.9 mt -116.37 122.7 70.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.762 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.9 m -120.01 128.46 53.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -84.87 106.81 16.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.307 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.3 t -134.23 145.8 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.115 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 68' ' ' LEU . 96.2 m-20 -107.75 120.28 41.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.467 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' SG ' ' A' ' 186' ' ' CYS . 31.9 m -112.65 150.43 42.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.16 0.505 . . . . 0.0 111.753 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.685 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 45.0 Cg_endo -68.38 160.11 50.49 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.641 2.227 . . . . 0.0 111.44 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -75.0 120.2 20.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.45 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 192' ' ' LEU . . . -64.24 151.21 50.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.138 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 94.7 mm-40 -101.73 -18.0 16.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.13 134.81 18.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.823 ' CG1' HG22 ' A' ' 194' ' ' THR . 3.6 p -137.43 130.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.335 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.743 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 67.4 mttm -92.9 121.41 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.714 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 171' ' ' ILE . 82.6 mt -117.67 130.92 56.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.051 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.29 110.01 51.1 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HG3' HD11 ' A' ' 135' ' ' LEU . 97.2 Cg_endo -83.07 -176.71 2.97 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.654 2.236 . . . . 0.0 112.256 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 131' ' ' SER . 92.7 mt-30 -130.46 124.62 32.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.384 0.612 . . . . 0.0 110.378 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 1.2 m 71.05 166.97 0.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.956 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.7 -14.98 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.95 -40.07 87.73 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 111.066 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.503 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.4 t80 -59.93 -40.12 87.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.756 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -81.78 -9.55 59.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.543 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.9 -19.58 63.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.487 0.184 . . . . 0.0 111.435 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -61.99 132.11 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.666 0.269 . . . . 0.0 110.483 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.3 p -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.359 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -124.51 77.97 62.62 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.407 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.702 ' O ' HD23 ' A' ' 144' ' ' LEU . 52.2 Cg_endo -69.47 -33.91 16.67 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.52 2.147 . . . . 0.0 112.266 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.09 -40.34 89.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.271 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.93 95.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 147' ' ' VAL . 97.5 t -61.94 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -59.98 -40.1 87.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.401 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -42.32 93.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -63.29 -39.94 95.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.459 . . . . 0.0 110.295 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 162' ' ' ILE . 83.3 t -62.47 -41.96 93.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.945 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 95.3 mt -60.02 -40.03 87.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 188' ' ' ILE . 69.9 ttp85 -63.02 -39.96 96.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.62 -39.96 93.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.47 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.4 m-85 -99.35 120.29 39.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.235 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.534 ' HA ' HD11 ' A' ' 188' ' ' ILE . 15.9 t -69.97 -39.97 75.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.511 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.53 ' CB ' ' HB3' ' A' ' 81' ' ' HIS . 71.6 p -121.63 140.02 52.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 151' ' ' PHE . 95.1 mt -135.25 141.22 45.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 111.813 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.689 HG23 ' CD2' ' A' ' 81' ' ' HIS . 37.3 p -138.88 154.32 48.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.679 ' CG2' HG22 ' A' ' 176' ' ' VAL . 94.2 t -60.06 -39.95 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.324 0.583 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.1 -38.89 75.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.3 t0 -69.37 129.97 41.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.1 p -102.41 120.01 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.549 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.1 pt -105.12 140.01 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.942 0.401 . . . . 0.0 112.055 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.696 ' HG2' ' CB ' ' A' ' 170' ' ' LYS . 99.8 mt-10 -120.0 141.23 49.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.763 HD13 HG21 ' A' ' 147' ' ' VAL . 46.0 pt -129.87 140.13 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.383 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.7 t -112.17 120.03 40.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -123.79 129.56 51.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.999 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 53.75 39.95 30.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.565 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.2 9.71 86.76 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.135 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.3 mttm -108.85 137.15 47.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.724 0.262 . . . . 0.0 110.383 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -105.56 120.54 41.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 111.021 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.02 140.06 51.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.696 ' CB ' ' HG2' ' A' ' 161' ' ' GLU . 53.0 pttt -124.19 130.57 52.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.635 HD12 HD22 ' A' ' 127' ' ' LEU . 45.6 pt -132.06 140.81 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -119.73 137.4 53.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.972 0.415 . . . . 0.0 110.61 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.574 HG13 HD23 ' A' ' 127' ' ' LEU . 5.2 mp -81.47 112.85 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -57.26 7.14 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.743 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.4 tt0 -155.93 144.1 19.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.356 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' CG2' ' A' ' 156' ' ' VAL . 8.3 m -138.3 151.2 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.369 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -98.73 104.76 26.55 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 94.5 Cg_endo -100.23 177.16 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.437 2.758 . . . . 0.0 112.676 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.685 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 68.6 mm-40 -99.96 5.01 45.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 85.2 p -139.83 159.67 41.65 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.081 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.4 p -70.04 -18.54 63.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.892 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.9 p -59.98 -20.63 58.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.446 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 60.03 39.82 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 111.07 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 m -130.02 139.93 50.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.78 140.27 47.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' LEU . 75.3 m -129.48 100.31 5.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.802 HG11 HD22 ' A' ' 192' ' ' LEU . 5.7 p -126.87 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.631 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 149' ' ' ARG . 82.0 mt -105.62 -26.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.621 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.4 tt0 -89.97 -79.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.382 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 13.5 t -169.84 -158.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 0.0 111.102 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.9 m-20 75.74 25.09 1.2 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.892 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.802 HD22 HG11 ' A' ' 187' ' ' VAL . 28.4 tp -119.51 131.46 55.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 125' ' ' VAL . 20.8 t -92.84 129.0 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.76 0.314 . . . . 0.0 110.627 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.823 HG22 ' CG1' ' A' ' 125' ' ' VAL . 75.3 p -118.53 142.08 47.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -119.78 142.54 48.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.81 139.98 41.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 111.416 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -118.2 165.08 17.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.771 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 19.9 Cg_endo -59.56 144.86 99.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.08 155.53 38.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.575 2.183 . . . . 0.0 112.57 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -80.04 140.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 135.32 140.35 4.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.388 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.4 132.85 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.803 0.335 . . . . 0.0 110.808 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.06 130.05 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -95.2 130.47 32.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.7 95.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.246 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.87 121.15 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -100.05 122.19 42.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.849 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.777 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.913 0.387 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.47 ' HB3' ' HD2' ' A' ' 5' ' ' PHE . 87.3 m-85 -119.99 140.03 51.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.027 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -129.99 145.54 51.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.09 77.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.076 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' HD2' ' HB3' ' A' ' 2' ' ' PHE . 52.8 m-85 -109.97 134.01 52.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.88 0.371 . . . . 0.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.7 m -128.24 140.03 52.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -128.81 140.93 51.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.96 153.64 46.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.29 117.44 0.76 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.675 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.88 14.53 80.72 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.009 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.08 -79.06 0.88 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.712 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m120 59.69 30.08 19.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.887 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.04 75.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.906 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -125.92 127.34 45.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.33 119.99 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.766 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.76 -15.61 18.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm -101.09 143.5 26.73 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.822 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 88.0 Cg_exo -48.15 160.79 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.431 2.088 . . . . 0.0 112.071 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.405 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 78.2 mt-30 -100.08 120.01 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.716 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 116' ' ' SER . 25.2 m -124.28 131.76 53.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 111.689 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 116' ' ' SER . 22.3 t80 -120.24 139.88 52.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.613 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.93 133.07 55.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 57' ' ' LYS . 72.1 mt-10 -152.71 160.02 43.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.67 132.64 56.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 49.7 m-85 -139.67 159.99 40.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -94.56 126.32 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.471 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 29.8 p -91.06 141.79 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.346 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.4 m-85 -130.42 153.16 81.28 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.675 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.65 104.53 1.89 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.695 2.264 . . . . 0.0 112.628 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.756 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 90.7 mt -60.0 -39.82 81.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.385 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.768 ' HA ' HH11 ' A' ' 38' ' ' ARG . . . -59.33 -29.29 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.583 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.8 ttp -67.09 -37.72 84.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.281 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.98 140.04 57.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.18 151.75 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.587 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -59.97 -36.66 77.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.209 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -60.0 -34.06 72.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.667 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 37' ' ' ILE . 25.2 mt -110.24 9.11 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.377 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.768 HH11 ' HA ' ' A' ' 31' ' ' ALA . 28.5 ttp180 -119.95 137.15 54.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HE2' ' HB3' ' A' ' 41' ' ' ASP . 86.0 tttt -100.47 127.11 46.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.03 -40.08 88.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.633 ' HB3' ' HE2' ' A' ' 39' ' ' LYS . 52.4 t0 -59.98 -41.45 92.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.06 91.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.11 -40.06 88.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.78 18.7 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.19 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.58 163.33 23.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.209 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.91 11.39 64.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.859 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.8 mttt -115.7 140.05 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.5 pt -110.33 152.58 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.473 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.826 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 87.4 m-85 -93.12 132.07 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.733 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -142.42 160.21 55.15 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.292 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.759 ' O ' HD12 ' A' ' 55' ' ' LEU . 45.9 Cg_endo -65.63 144.58 79.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.081 2.521 . . . . 0.0 113.525 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 89' ' ' ALA . 25.8 Cg_endo -62.63 -20.33 70.55 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.059 2.506 . . . . 0.0 113.315 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.4 p -60.0 -43.58 95.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.648 0.261 . . . . 0.0 111.322 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -70.64 -41.46 72.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 111.313 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 84' ' ' VAL . 1.1 mp -60.07 -39.9 87.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -59.71 -39.38 84.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HD2' ' OE2' ' A' ' 23' ' ' GLU . 59.5 mttp -59.98 -39.29 85.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.667 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 91.9 mt -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -59.98 -39.97 87.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.94 -37.39 82.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.454 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.68 0.61 29.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.651 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.07 43.8 13.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.0 111.54 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.501 HG13 HD22 ' A' ' 58' ' ' LEU . 43.5 mm -72.24 130.24 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.618 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -69.76 140.41 53.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.477 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.541 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 25.1 t80 -87.43 141.75 32.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 188' ' ' ILE . 3.7 Cg_exo -74.84 160.36 96.6 Favored 'Cis proline' 0 C--N 1.348 0.552 0 C-N-CA 124.217 -1.16 . . . . 0.0 112.822 0.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.714 ' CE ' HD23 ' A' ' 55' ' ' LEU . 75.4 mtm -75.18 140.12 43.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.924 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.844 HD22 HG23 ' A' ' 153' ' ' THR . 79.1 mt -112.12 136.76 51.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.081 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.667 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 33.6 m-85 -131.86 147.08 52.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.171 0.51 . . . . 0.0 112.008 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 40.0 ttpt -122.68 129.29 51.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.332 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 112' ' ' LEU . 86.6 mt -100.38 125.6 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 111.049 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 79' ' ' VAL . 97.5 m -119.96 130.02 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.965 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . -107.83 118.09 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.7 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.361 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.12 -39.9 87.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.32 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.413 HG21 ' HA3' ' A' ' 105' ' ' GLY . 73.8 p -108.51 -11.63 15.11 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 68.16 14.32 65.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.68 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -100.0 139.95 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.562 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 71' ' ' LEU . 52.7 t -121.32 127.23 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.016 0.436 . . . . 0.0 111.215 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.599 HG21 ' HE3' ' A' ' 100' ' ' MET . 8.4 t -118.39 129.68 55.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.742 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 5.3 m80 -83.76 139.61 32.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.363 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.73 -139.53 3.66 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.138 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -166.79 -164.0 21.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.38 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 55' ' ' LEU . 6.5 p -124.85 129.96 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.145 0.498 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.826 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 34.4 tp -92.62 -77.39 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -140.19 168.19 20.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.76 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 2.5 m-85 -90.94 116.33 28.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 49' ' ' PHE . 31.6 pt -141.83 -5.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.808 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -97.94 97.1 8.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 111.676 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.95 -40.12 72.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.504 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -85.8 -23.34 27.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 51' ' ' PRO . . . 114.76 46.5 0.6 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.558 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.808 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 21.6 mtm180 -111.0 149.47 30.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 111.069 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.864 HG21 HD11 ' A' ' 114' ' ' ILE . 10.8 p -129.92 140.27 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.756 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.5 m-85 -119.94 139.95 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.6 pt? -122.65 149.87 56.85 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.627 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.603 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 47.7 Cg_exo -53.64 158.84 7.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.87 2.38 . . . . 0.0 112.618 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.75 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mt-30 -60.07 -43.85 95.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.605 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.476 ' HZ3' ' O ' ' A' ' 159' ' ' VAL . 33.0 p-90 -68.88 -35.71 77.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.615 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.603 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.5 mmm -60.05 -40.1 88.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.3 -40.09 92.88 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.061 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.64 -40.08 88.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.964 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -64.91 -40.03 94.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.756 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 80' ' ' THR . 86.9 mt -69.92 -25.08 63.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.2 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.413 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 67.8 30.06 74.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.402 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 110' ' ' SER . 45.8 pt -113.4 139.42 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 111.893 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 8.2 pt20 -97.01 165.76 15.18 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 98.1 Cg_exo -43.92 140.51 4.93 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.658 2.239 . . . . 0.0 112.607 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.0 -9.99 75.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 58.0 m -70.06 153.08 43.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.502 ' CD2' ' HG3' ' A' ' 113' ' ' GLN . 9.9 tt -93.5 136.74 33.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.116 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 71' ' ' LEU . 60.1 tp -121.55 130.09 53.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.043 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.502 ' HG3' ' CD2' ' A' ' 111' ' ' LEU . 96.6 mt-30 -111.77 133.28 54.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.667 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HG21 ' A' ' 94' ' ' VAL . 85.4 mt -110.07 125.53 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.7 t -120.77 129.54 53.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.663 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.9 t -70.22 122.98 20.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 95.5 m -121.96 128.93 52.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 96.5 m-20 -123.94 120.02 31.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 186' ' ' CYS . 34.6 m -117.55 154.36 50.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.796 0.331 . . . . 0.0 111.618 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 93.6 Cg_endo -78.18 19.36 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.679 2.253 . . . . 0.0 112.555 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.808 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.0 mp 67.96 100.39 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.16 164.07 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.3 -22.17 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.412 ' HE1' ' HE2' ' A' ' 126' ' ' LYS . 64.3 t80 -142.71 131.18 22.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.497 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 194' ' ' THR . 3.3 p -135.95 132.4 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.258 0.551 . . . . 0.0 111.511 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 34.6 mttm -95.42 122.15 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.27 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 173' ' ' ILE . 86.0 mt -118.05 132.86 56.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 4.2 tt0 -116.58 113.51 40.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.818 ' HG3' HD11 ' A' ' 135' ' ' LEU . 83.7 Cg_endo -78.39 174.44 12.38 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.722 2.281 . . . . 0.0 112.439 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.713 HE22 ' HG2' ' A' ' 170' ' ' LYS . 29.2 mt-30 -125.7 123.93 39.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER 70.17 133.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.421 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.743 HG12 ' HG3' ' A' ' 199' ' ' PRO . 27.8 m -60.04 -24.82 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.186 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -39.92 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.67 -39.98 90.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.775 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.818 HD11 ' HG3' ' A' ' 129' ' ' PRO . 95.6 mt -82.19 -10.19 59.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -10.14 57.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.627 0.251 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.98 140.71 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.4 m -59.92 -40.15 87.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.287 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -124.66 75.84 64.11 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.749 0.309 . . . . 0.0 110.775 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 144' ' ' LEU . 36.0 Cg_exo -60.05 -33.76 95.13 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.632 2.221 . . . . 0.0 111.858 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.92 -40.12 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 147' ' ' VAL . 85.8 t -61.4 -43.57 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.87 -40.08 91.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.2 -40.35 89.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -66.59 -40.07 88.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.131 0.491 . . . . 0.0 109.866 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 162' ' ' ILE . 56.3 t -62.56 -40.1 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.93 -40.85 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.205 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.34 -40.07 96.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 110.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 89.2 m-85 -105.72 120.75 42.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.448 . . . . 0.0 111.781 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.3 m -60.16 -40.01 88.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.151 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.844 HG23 HD22 ' A' ' 68' ' ' LEU . 67.0 p -135.74 151.91 50.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.324 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.6 mp -117.43 130.45 56.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 173' ' ' ILE . 17.3 m -119.6 142.3 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.614 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.958 HG22 HG13 ' A' ' 176' ' ' VAL . 92.0 t -60.08 -45.05 96.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.199 0.523 . . . . 0.0 110.764 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -39.19 76.14 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.693 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.499 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 53.2 t0 -67.96 132.48 47.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 14.3 m -100.35 123.79 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.053 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 ' CG1' ' A' ' 147' ' ' VAL . 48.3 pt -104.72 138.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 98.9 mt-10 -120.03 140.09 51.52 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.598 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 147' ' ' VAL . 44.9 pt -130.02 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.937 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.1 t -108.79 113.3 26.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -119.91 119.18 32.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.503 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.5 m-20 51.14 39.35 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.22 -7.13 82.44 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.545 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 163' ' ' SER . 57.8 mtpt -100.03 137.4 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.966 0.383 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 8.9 t -112.19 120.66 42.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.237 0.542 . . . . 0.0 111.59 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CZ ' ' HE2' ' A' ' 167' ' ' LYS . 86.8 m-85 -120.01 140.0 51.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.042 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.924 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 51.4 pttt -119.93 136.82 54.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.117 0.484 . . . . 0.0 111.035 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.98 120.07 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.094 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.56 127.3 49.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.889 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 mp -81.97 120.04 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.634 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 128' ' ' GLU . 10.6 mp -69.79 -57.34 5.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.834 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.789 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.9 mt-10 -155.01 148.02 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.958 HG13 HG22 ' A' ' 156' ' ' VAL . 5.3 m -140.33 147.63 23.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -92.26 104.45 10.97 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 63.9 Cg_endo -102.47 163.93 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.639 2.893 . . . . 0.0 112.551 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.5 mt-10 -100.12 6.21 44.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.9 m -139.85 159.23 42.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.0 111.231 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.8 m -70.05 -12.9 61.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.7 m -59.17 -25.88 64.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 111.11 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.02 39.58 19.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.661 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 80.1 p -127.47 146.57 50.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.901 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.899 HD12 HD21 ' A' ' 192' ' ' LEU . 46.2 pt -128.39 136.87 58.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.065 0.46 . . . . 0.0 111.5 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 42.7 t -141.15 114.06 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.239 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 192' ' ' LEU . 7.2 p -120.84 112.52 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.496 0.665 . . . . 0.0 110.385 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.659 HD12 ' HD3' ' A' ' 66' ' ' PRO . 18.4 tt -79.97 -49.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 188' ' ' ILE . 77.2 mm-40 -91.03 -79.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 t -168.97 30.78 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.606 0.241 . . . . 0.0 111.604 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.808 ' HB2' HD23 ' A' ' 121' ' ' LEU . 95.9 m-20 -82.46 2.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.545 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 185' ' ' ILE . 62.4 tp -111.93 130.71 55.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 125' ' ' VAL . 31.6 t -95.37 123.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.169 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 125' ' ' VAL . 74.8 p -101.91 144.94 29.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -129.53 137.69 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.387 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.32 136.28 44.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.87 163.25 25.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.6 Cg_exo -50.69 140.06 37.95 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.361 2.041 . . . . 0.0 112.126 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.743 ' HG3' HG12 ' A' ' 132' ' ' VAL . 14.5 Cg_endo -56.96 159.92 13.61 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.741 2.294 . . . . 0.0 112.249 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.95 131.17 35.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.206 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 149.07 130.01 1.84 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.506 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -99.96 133.19 44.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.757 0.313 . . . . 0.0 110.766 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.13 130.05 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.304 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -100.14 121.41 53.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.04 153.31 74.52 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.308 2.006 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -99.79 122.97 43.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -99.53 123.5 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.867 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.6 pttm . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -121.14 139.92 52.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.216 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.7 t -131.4 144.83 51.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.14 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.82 97.54 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.32 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' HB2' ' HD1' ' A' ' 8' ' ' PHE . 85.4 m-85 -122.45 140.32 52.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.632 0.253 . . . . 0.0 110.833 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.4 p -69.04 -39.91 78.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.744 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.2 p -60.09 -40.85 91.06 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.511 ' HD1' ' HB2' ' A' ' 5' ' ' PHE . 44.5 m-85 -60.24 -40.07 88.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.042 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.34 -121.41 26.16 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.333 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.55 81.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.862 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.01 -163.52 11.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 60.05 39.91 19.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 0.0 110.835 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.04 -13.78 24.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.634 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 140.05 51.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.85 120.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -97.98 -0.03 45.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.677 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpp -82.88 124.19 77.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.03 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.7 159.94 38.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.541 2.16 . . . . 0.0 112.259 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' THR . 95.1 mt-30 -101.27 123.15 44.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 117' ' ' THR . 73.9 p -119.99 130.38 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 111.646 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.776 ' HB3' ' OG ' ' A' ' 116' ' ' SER . 86.2 t80 -121.27 126.66 50.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.761 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.18 130.87 54.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.208 0.528 . . . . 0.0 112.332 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.45 156.07 42.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.199 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.64 126.17 49.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.076 0.465 . . . . 0.0 111.773 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 97.5 m-85 -130.07 150.24 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.583 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 70.6 mtp85 -81.59 132.29 35.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.394 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 31.7 p -106.5 142.39 36.24 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.566 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 63.6 m-85 -140.37 152.75 67.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.547 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.56 ' HG2' ' SD ' ' A' ' 32' ' ' MET . 36.1 Cg_endo -65.66 119.76 6.84 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.232 1.955 . . . . 0.0 111.964 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.795 HG12 ' HB3' ' A' ' 95' ' ' TYR . 88.6 mt -59.93 -38.52 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -50.03 -20.54 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 29' ' ' PRO . 94.5 mtp -68.75 -32.65 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.98 143.19 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.99 151.04 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.143 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.78 -34.66 73.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.01 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 37' ' ' ILE . 69.7 mt -107.08 -0.17 9.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.116 0.484 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 51.8 ttt-85 -105.01 129.96 53.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.287 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -105.08 133.37 49.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.1 -40.07 88.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.381 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.68 -39.91 95.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.12 91.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.276 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.402 HD21 ' HE ' ' A' ' 38' ' ' ARG . 25.8 m120 -60.24 -40.0 88.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.659 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -100.14 1.7 42.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.181 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 180.0 35.69 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.61 29.97 9.75 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.845 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.01 122.47 42.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 83' ' ' GLY . 47.5 pt -115.33 149.9 17.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.499 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 97.5 m-85 -102.9 133.62 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.565 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 114' ' ' ILE . 1.6 mp -131.34 165.6 34.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.208 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.672 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 56.6 Cg_endo -71.59 157.38 56.09 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.163 1.908 . . . . 0.0 112.662 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.88 -23.08 30.66 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.737 2.291 . . . . 0.0 112.785 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -60.08 -40.09 88.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.229 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . . . -70.22 -42.55 72.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.785 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.4 tp -61.91 -41.02 97.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.382 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -59.86 -43.35 94.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 85.3 tttt -60.33 -40.08 89.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.798 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 ' CD1' ' A' ' 63' ' ' ILE . 87.3 mt -59.93 -40.08 87.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -59.67 -38.23 80.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.265 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.0 -39.18 84.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.04 -2.52 40.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.425 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.4 t30 60.02 40.26 18.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.588 0.233 . . . . 0.0 111.587 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CD1' HD22 ' A' ' 58' ' ' LEU . 86.3 mt -70.2 130.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.47 142.75 38.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 16.0 p90 -87.68 158.29 51.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.49 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 9.5 Cg_exo -72.82 146.84 88.01 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.758 -1.351 . . . . 0.0 112.708 0.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.18 140.01 48.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.474 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' SER . 21.5 mt -115.84 132.09 56.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 114' ' ' ILE . 11.6 m-85 -120.53 140.28 51.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.095 0.474 . . . . 0.0 111.638 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 115' ' ' SER . 87.3 tttt -115.65 129.96 56.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.779 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 96.8 mt -98.38 131.12 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.368 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.796 ' HA ' HG12 ' A' ' 79' ' ' VAL . 87.0 m -120.01 129.61 54.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.986 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.2 115.62 27.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -68.39 -40.02 81.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.49 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -40.02 87.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.4 m -100.62 -17.38 17.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.742 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.34 1.14 41.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.685 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -100.22 141.18 33.41 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.717 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 72' ' ' THR . 20.2 m -119.97 119.87 61.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.469 ' H ' HD21 ' A' ' 104' ' ' LEU . 36.2 p -110.34 139.46 45.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.37 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 77.7 m80 -84.8 114.39 22.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 0.0 110.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.33 158.49 20.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.34 165.26 27.5 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.73 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -128.69 133.1 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 117.361 0.581 . . . . 0.0 112.336 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.845 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.6 tp -92.22 -79.05 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.535 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -149.55 160.45 43.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CE1' HD13 ' A' ' 55' ' ' LEU . 80.3 m-85 -97.37 116.76 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.292 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.25 -4.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.601 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.33 97.83 11.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.378 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -39.92 76.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.459 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.97 -20.13 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.345 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 97.18 54.16 1.3 Allowed Glycine 0 C--O 1.23 -0.107 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.154 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.601 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 87.3 mtt180 -121.2 145.09 48.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.132 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 114' ' ' ILE . 93.6 t -120.4 131.72 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.311 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.795 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.8 138.91 53.79 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 101' ' ' MET . 1.8 pt? -134.56 159.04 73.74 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.63 0.252 . . . . 0.0 110.475 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 65.1 Cg_endo -70.52 158.25 56.5 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.659 2.239 . . . . 0.0 112.824 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.478 ' HA ' ' CE ' ' A' ' 101' ' ' MET . 78.0 mt-30 -61.71 -40.0 93.5 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.586 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 48.9 p-90 -62.83 -39.93 95.86 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.518 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.586 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 96.7 mtp -68.22 -40.0 82.2 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.332 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.739 ' HG2' HD11 ' A' ' 96' ' ' LEU . 76.4 mtm -61.01 -39.98 91.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.48 -40.1 92.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.7 m -63.21 -40.03 96.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.469 HD21 ' H ' ' A' ' 80' ' ' THR . 83.9 mt -86.24 -10.06 55.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.692 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.22 41.6 99.72 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.046 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.95 133.53 54.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.137 0.494 . . . . 0.0 110.749 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 5.7 mt-30 -96.43 160.0 30.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 18.3 Cg_endo -59.93 -1.97 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.299 2.0 . . . . 0.0 112.964 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.83 -12.54 24.04 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 m -94.46 151.52 19.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.313 . . . . 0.0 111.154 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.583 ' CD2' ' HG2' ' A' ' 26' ' ' ARG . 89.9 mt -79.98 158.11 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.597 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.2 tp -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.9 mt-30 -101.73 120.34 40.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.346 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 50' ' ' LEU . 87.8 mt -110.27 126.21 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.4 t -119.78 120.3 36.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.776 ' OG ' ' HB3' ' A' ' 21' ' ' PHE . 48.5 p -88.76 111.16 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.585 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 5.3 t -133.95 150.43 51.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.286 0.565 . . . . 0.0 112.251 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' OD2' HG23 ' A' ' 63' ' ' ILE . 97.7 m-20 -104.74 119.16 38.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.711 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 ' SG ' ' A' ' 186' ' ' CYS . 15.9 m -115.5 152.51 47.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 180' ' ' SER . 51.5 Cg_exo -57.84 166.25 5.49 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.917 1.744 . . . . 0.0 111.257 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 122' ' ' GLY . 8.0 tt -93.98 120.12 33.79 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.63 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.8 ' HA3' HG23 ' A' ' 185' ' ' ILE . . . -68.86 146.11 44.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.228 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.23 -19.85 16.9 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 195' ' ' ASP . 64.7 t80 -145.78 131.49 18.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.665 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 176' ' ' VAL . 7.5 p -131.0 129.44 63.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.671 0.748 . . . . 0.0 111.785 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 63.5 tttp -97.01 120.31 37.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.686 ' CD1' HD21 ' A' ' 144' ' ' LEU . 77.0 mt -113.94 135.3 54.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.65 ' CD ' HD11 ' A' ' 174' ' ' LEU . 2.6 tt0 -100.22 127.81 32.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.403 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 128' ' ' GLU . 86.5 Cg_endo -79.78 172.83 13.66 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.322 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.649 ' HG3' ' HG3' ' A' ' 170' ' ' LYS . 29.9 mm100 -135.62 121.16 19.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.531 ' H ' ' HE1' ' A' ' 202' ' ' TYR . 0.5 OUTLIER 59.88 24.89 13.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.513 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 m 41.95 24.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.86 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.43 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 95.5 m-20 -70.0 -40.01 75.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.412 . . . . 0.0 110.188 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.543 ' CE1' ' CE2' ' A' ' 196' ' ' PHE . 64.8 t80 -60.71 -40.06 90.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.763 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.16 -24.28 67.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.146 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.02 -19.61 63.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.16 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.9 mt -66.6 137.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.566 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.6 m -60.12 -39.92 87.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.518 ' H ' HG22 ' A' ' 137' ' ' ILE . 67.6 m-20 -129.7 71.87 82.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 134' ' ' PHE . 21.3 Cg_exo -64.68 -30.51 59.9 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.94 -41.0 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.14 98.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 147' ' ' VAL . 72.8 t -64.6 -41.04 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 1.087 HD11 HG21 ' A' ' 194' ' ' THR . 1.8 tm? -60.0 -43.19 95.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.12 -40.27 89.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 0.0 110.75 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -61.97 -40.08 94.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.965 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 162' ' ' ILE . 59.4 t -59.89 -40.48 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.516 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 188' ' ' ILE . 86.4 mt -60.23 -40.09 88.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.47 -40.02 77.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.183 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.97 -40.01 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.747 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.649 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 91.3 m-85 -102.71 118.02 35.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.101 0.476 . . . . 0.0 111.374 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.525 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 69.2 m -63.2 -39.94 96.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.032 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 68' ' ' LEU . 34.4 p -123.13 140.66 52.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.012 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 185' ' ' ILE . 86.5 mt -120.87 127.19 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.79 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 157' ' ' ASP . 25.0 m -126.46 142.9 51.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 173' ' ' ILE . 59.6 t -60.03 -42.08 88.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.357 0.598 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 155' ' ' THR . 96.0 m-20 -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.413 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.0 m-20 -75.35 140.09 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 121.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.467 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.649 ' HB ' ' CZ ' ' A' ' 151' ' ' PHE . 46.2 pt -104.12 138.69 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.702 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 47.9 mt-10 -121.06 140.62 51.7 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.756 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 147' ' ' VAL . 43.4 pt -127.55 142.85 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.211 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 31.6 t -111.54 115.94 30.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 54.6 t80 -121.14 122.93 41.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.955 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.36 39.99 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.535 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.85 89.91 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.932 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 163' ' ' SER . 97.5 mttt -104.48 136.97 43.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.8 p -108.67 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 111.413 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.43 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.2 m-85 -119.94 139.98 51.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.444 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 61.5 pttt -121.33 135.49 55.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.264 0.554 . . . . 0.0 111.245 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.638 HD11 HD11 ' A' ' 160' ' ' ILE . 45.9 pt -128.4 139.52 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.11 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -116.36 129.21 56.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.723 ' O ' HG13 ' A' ' 156' ' ' VAL . 3.4 mp -77.92 80.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.09 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.65 HD11 ' CD ' ' A' ' 128' ' ' GLU . 88.0 mt -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.5 mt-10 -146.27 139.4 25.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.791 0.329 . . . . 0.0 111.459 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 125' ' ' VAL . 32.5 m -144.6 160.03 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.631 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 104.0 54.15 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.453 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 66.9 Cg_endo -99.26 167.34 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.252 2.635 . . . . 0.0 113.053 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.91 9.9 42.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.757 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 43.6 t -139.85 162.02 36.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.1 m -70.67 -15.12 62.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.132 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.4 p -61.38 -21.07 63.73 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.729 0.3 . . . . 0.0 111.032 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.4 mmtt 60.08 40.21 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.625 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.523 ' C ' HD13 ' A' ' 185' ' ' ILE . 80.4 p -129.76 150.69 50.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.8 HG23 ' HA3' ' A' ' 122' ' ' GLY . 7.3 mm -117.94 118.36 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.519 ' SG ' HG21 ' A' ' 119' ' ' VAL . 10.9 m -143.2 160.59 40.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.833 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 186' ' ' CYS . 17.2 t 77.06 121.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.427 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 148' ' ' LEU . 14.8 mt -120.64 84.04 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.479 ' H ' HD11 ' A' ' 121' ' ' LEU . 99.4 mt-10 -126.33 -20.42 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -110.63 20.04 18.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.7 m-20 70.47 94.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 122' ' ' GLY . 4.1 tp -75.61 142.02 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.453 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 125' ' ' VAL . 26.3 t -99.99 128.36 51.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.018 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' THR . . . . . 1.087 HG21 HD11 ' A' ' 144' ' ' LEU . 70.1 p -117.87 144.57 45.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 124' ' ' PHE . 55.6 t0 -126.41 139.97 52.85 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.907 0.384 . . . . 0.0 110.973 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.543 ' CE2' ' CE1' ' A' ' 134' ' ' PHE . 96.6 m-85 -108.75 140.38 42.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.63 129.65 25.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.524 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.604 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 74.0 Cg_exo -49.53 -49.26 16.18 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.682 2.254 . . . . 0.0 112.653 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 198' ' ' PRO . 11.5 Cg_endo -54.84 141.79 76.31 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.785 1.657 . . . . 0.0 112.094 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.543 ' HB ' ' HD1' ' A' ' 202' ' ' TYR . 27.8 m -82.54 142.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.604 ' HA3' ' HG2' ' A' ' 128' ' ' GLU . . . -82.66 44.1 3.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.771 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.543 ' HD1' ' HB ' ' A' ' 200' ' ' VAL . 89.6 m-85 -98.93 131.95 44.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 117.247 0.523 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.77 129.78 73.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.294 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.64 120.18 62.49 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.44 105.92 2.05 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.372 2.048 . . . . 0.0 112.389 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.07 122.22 42.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.62 125.94 44.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.828 -179.892 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -68.67 -38.67 80.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -120.01 140.08 51.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.785 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.19 157.75 1.46 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.03 139.95 51.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.7 t -60.92 -40.11 91.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.6 t -116.71 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -68.12 140.0 56.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.052 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.71 179.59 53.33 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.273 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.95 174.72 46.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.647 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.55 10.01 75.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.764 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -100.1 129.68 46.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.23 168.08 42.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.348 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.01 139.92 51.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.53 123.92 67.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.519 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -100.07 118.18 35.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.6 mmt -104.4 130.66 22.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.15 159.67 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.246 1.964 . . . . 0.0 111.589 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.5 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.5 mt-30 -113.03 126.28 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.0 m -120.13 130.54 54.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.308 0.575 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 58.2 t80 -133.24 130.04 38.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.621 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.65 135.93 49.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -142.07 159.9 41.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.282 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CZ ' HD13 ' A' ' 111' ' ' LEU . 64.6 t80 -119.85 128.94 54.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.719 ' HD2' HG22 ' A' ' 114' ' ' ILE . 84.6 m-85 -139.08 153.15 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.587 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -81.07 140.7 34.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.547 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 49.8 t -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 111.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 18.5 m-85 -120.43 150.71 52.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.594 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' PRO . 6.2 Cg_exo -80.31 113.92 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.76 2.307 . . . . 0.0 112.232 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.837 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 95.8 mt -61.14 -39.91 84.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HA ' ' CZ ' ' A' ' 38' ' ' ARG . . . -59.79 -29.22 68.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 96.8 mmm -68.3 -36.66 79.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 110.214 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -61.04 140.05 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.36 143.59 52.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 112.044 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.9 m-20 -59.87 -26.27 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.103 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -60.05 -38.75 83.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.91 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.7 pt -108.05 -9.76 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.245 0.545 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.725 ' CZ ' ' HA ' ' A' ' 31' ' ' ALA . 66.4 ttt180 -89.23 139.77 30.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 86.0 tttt -101.16 125.51 47.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.376 . . . . 0.0 110.512 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.14 -40.82 91.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.659 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.763 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.0 m-20 -61.49 -39.99 92.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.1 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.14 90.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.98 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.79 -40.1 87.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.335 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 163' ' ' SER . 90.0 m-85 -102.7 6.04 39.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.56 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.41 160.72 22.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.105 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.15 10.75 73.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.336 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 22.2 mttm -104.45 143.18 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 96' ' ' LEU . 32.6 pt -121.5 169.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.725 ' O ' HG23 ' A' ' 94' ' ' VAL . 96.3 m-85 -100.45 131.48 46.35 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.512 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 48' ' ' ILE . 3.9 mp -140.6 163.37 43.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.613 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.552 ' HB3' ' O ' ' A' ' 89' ' ' ALA . 60.6 Cg_endo -72.22 133.78 21.78 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.14 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 34.6 Cg_exo -57.9 -11.9 10.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.691 2.261 . . . . 0.0 112.89 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.3 p -60.11 -39.05 84.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.54 75.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.382 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 58' ' ' LEU . 85.4 mt -60.03 -40.61 89.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.356 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -60.11 -40.03 88.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 33.6 mttm -67.5 -39.91 85.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.596 HD22 HG13 ' A' ' 63' ' ' ILE . 89.7 mt -60.18 -39.35 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.595 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -60.09 -39.79 87.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.17 -39.85 87.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 21' ' ' PHE . 89.6 mt -81.28 -0.36 40.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.712 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.89 43.32 15.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.245 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.596 HG13 HD22 ' A' ' 58' ' ' LEU . 47.8 mm -64.34 129.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.434 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -70.54 140.01 51.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -88.17 143.59 33.08 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.856 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 188' ' ' ILE . 7.6 Cg_exo -73.89 163.83 89.0 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.397 0.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.472 ' SD ' HD13 ' A' ' 58' ' ' LEU . 55.2 mtt -83.86 133.9 34.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.791 HD13 ' CB ' ' A' ' 186' ' ' CYS . 0.2 OUTLIER -122.12 137.98 54.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.566 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CB ' HD11 ' A' ' 114' ' ' ILE . 97.5 m-85 -123.69 140.49 52.94 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.152 0.501 . . . . 0.0 111.712 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 39.6 ttpt -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.099 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CE ' ' A' ' 100' ' ' MET . 88.6 mt -89.97 122.57 33.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.542 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 79' ' ' VAL . 60.2 m -99.42 122.25 42.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.454 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -117.36 133.89 55.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.352 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 62.27 139.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.103 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -40.0 87.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 p -129.81 17.72 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.489 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.15 -102.95 0.51 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.783 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -139.98 146.34 38.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.876 0.369 . . . . 0.0 111.267 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 72' ' ' THR . 62.5 t -120.77 119.21 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.901 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 103' ' ' THR . 30.8 p -102.11 163.47 12.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.886 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.459 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 79.1 m80 -103.96 114.83 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.84 159.86 17.27 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.981 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' A' ' 152' ' ' SER . . . -94.18 170.33 30.1 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.245 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.57 125.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 111.595 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.3 tp -92.75 -79.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.34 152.38 35.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.515 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 74.8 m-85 -99.33 115.7 29.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.591 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.04 -5.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.78 98.89 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.18 -39.86 82.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.04 0.447 . . . . 0.0 110.714 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.32 -30.64 70.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.047 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.43 50.47 0.71 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.444 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.562 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 50.4 ttp180 -117.65 140.04 50.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 49' ' ' PHE . 10.2 p -127.74 143.83 39.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.009 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.837 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.5 m-85 -119.97 140.45 50.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.257 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 48' ' ' ILE . 19.2 mt -114.92 137.9 23.1 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.707 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG22 ' A' ' 48' ' ' ILE . 42.3 Cg_exo -53.83 161.03 5.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.7 2.266 . . . . 0.0 112.325 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.02 -44.13 94.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.685 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CH2' ' SD ' ' A' ' 100' ' ' MET . 23.5 p-90 -69.66 -37.85 76.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.1 mmm -60.17 -39.98 88.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.1 mmm -60.16 -40.57 90.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -40.7 78.83 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.546 HG22 HG21 ' A' ' 80' ' ' THR . 94.2 m -60.26 -39.95 88.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 0.0 110.02 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.969 HD22 ' HB2' ' A' ' 73' ' ' ALA . 45.0 mt -80.9 -16.59 53.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.312 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.37 73.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.059 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.3 pt -111.41 143.99 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 pt20 -100.58 161.14 24.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.802 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.678 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.3 Cg_endo -48.9 134.76 28.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.675 2.25 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.44 -9.98 75.87 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.964 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.655 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 52.1 m -70.87 150.85 45.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.813 0.307 . . . . 0.0 110.61 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.518 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 74.2 mt -71.51 141.21 50.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 63.3 tp -123.87 130.02 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.692 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -113.37 120.0 39.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.993 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.719 HG22 ' HD2' ' A' ' 25' ' ' PHE . 21.0 tt -117.06 127.57 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.6 p -120.11 138.82 53.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.927 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -80.76 110.19 16.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 94.5 m -119.94 129.98 54.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.424 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -105.73 119.98 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.599 ' H ' HD11 ' A' ' 68' ' ' LEU . 32.7 m -115.92 149.41 43.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.964 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 7.5 Cg_exo -70.81 161.79 44.85 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.335 2.023 . . . . 0.0 110.508 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 190' ' ' THR . 1.3 mt -90.85 120.13 31.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.442 0.639 . . . . 0.0 112.277 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.74 165.79 47.45 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.7 -28.03 9.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.404 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 65.5 t80 -136.98 132.55 34.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 176' ' ' VAL . 2.9 p -133.67 131.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.748 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 61.9 mttp -94.97 124.86 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 194' ' ' THR . 82.5 mt -105.61 131.06 53.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.74 0.305 . . . . 0.0 110.778 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -106.71 109.69 63.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.47 164.92 32.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.61 2.206 . . . . 0.0 112.062 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.65 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.1 tt0 -124.52 120.98 33.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.938 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.98 146.76 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.002 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.39 -22.12 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.432 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.99 -39.61 86.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.797 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.641 ' CE1' HD11 ' A' ' 171' ' ' ILE . 65.6 t80 -59.9 -40.1 87.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 0.0 110.755 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.31 -8.22 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.965 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.02 -34.84 73.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.659 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.5 mt -55.68 137.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -60.01 -40.09 88.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.743 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 137' ' ' ILE . 42.5 t0 -129.95 79.76 72.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.931 0.396 . . . . 0.0 111.311 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.02 -25.53 16.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.57 2.18 . . . . 0.0 111.937 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.07 -41.4 92.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.441 ' HB2' ' OD2' ' A' ' 139' ' ' ASP . . . -64.73 -42.1 95.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.456 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.94 -40.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.679 HD13 ' O ' ' A' ' 144' ' ' LEU . 3.4 tm? -61.72 -39.99 93.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.862 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.16 -40.06 93.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -64.66 -42.18 95.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.75 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 162' ' ' ILE . 22.4 m -67.35 -36.44 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.512 HD11 ' CD1' ' A' ' 144' ' ' LEU . 86.6 mt -59.98 -40.09 87.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.2 -40.04 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.6 -39.86 89.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.44 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.15 119.6 34.94 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.711 ' HA ' HG12 ' A' ' 188' ' ' ILE . 50.1 m -62.11 -40.02 94.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.497 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 71.2 p -127.39 143.01 51.28 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.176 0.512 . . . . 0.0 111.33 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.831 HD21 HG12 ' A' ' 173' ' ' ILE . 8.2 tt -121.69 124.03 43.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.157 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 93.1 m -119.51 135.69 54.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.894 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.896 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 58.1 t -59.9 -41.76 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.161 0.505 . . . . 0.0 111.53 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.798 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.1 m-20 -74.31 146.04 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.339 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 119.99 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.339 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.406 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.3 pt -97.89 140.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.713 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -119.64 140.59 50.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.194 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.719 HD13 HG11 ' A' ' 147' ' ' VAL . 43.3 pt -136.09 145.81 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 29.0 t -115.39 119.4 36.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.701 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.437 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 53.2 t80 -125.84 120.49 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.437 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 59.96 31.45 20.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.443 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.75 -9.85 75.74 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.075 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -101.78 140.05 36.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.496 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 163' ' ' SER . 68.3 p -108.8 130.14 55.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.037 0.446 . . . . 0.0 111.505 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 139.97 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.184 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.713 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.7 mttt -103.33 133.28 48.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.961 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.641 HD11 ' CE1' ' A' ' 134' ' ' PHE . 48.5 mm -119.91 119.89 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.05 130.5 54.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.896 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.5 mp -83.88 132.26 31.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.325 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.04 -70.46 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.978 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 50.4 tp10 -140.3 139.86 35.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.945 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 156' ' ' VAL . 3.8 m -139.18 149.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.038 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -99.91 104.23 27.24 Favored Pre-proline 0 C--O 1.232 0.158 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 68.6 Cg_endo -102.9 177.97 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.691 2.928 . . . . 0.0 112.732 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.4 mt-10 -99.95 -0.01 40.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.82 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.3 m -138.29 151.65 47.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.028 0.442 . . . . 0.0 111.462 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 79.6 p -70.03 -10.03 57.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.706 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 46.9 t -55.68 -28.84 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.32 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 69.8 23.24 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.6 p -124.59 139.94 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.854 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.526 HD11 HD22 ' A' ' 154' ' ' LEU . 15.0 pt -132.2 140.05 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.791 ' CB ' HD13 ' A' ' 68' ' ' LEU . 11.2 t -119.76 109.75 15.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.816 HG11 HD22 ' A' ' 192' ' ' LEU . 12.0 p -141.09 99.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.603 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.711 HG12 ' HA ' ' A' ' 152' ' ' SER . 74.8 mt -97.18 -67.81 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.278 0.561 . . . . 0.0 111.566 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 189' ' ' GLU . 86.4 tt0 -94.1 -6.25 45.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.257 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -80.29 174.58 11.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -103.21 119.97 39.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.932 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.816 HD22 HG11 ' A' ' 187' ' ' VAL . 18.1 tp -120.26 140.09 51.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.254 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -89.27 120.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.522 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.595 HG22 HG13 ' A' ' 125' ' ' VAL . 76.2 p -113.85 146.47 39.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 196' ' ' PHE . 49.4 t0 -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 195' ' ' ASP . 11.2 m-85 -93.31 139.98 30.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 111.408 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -119.83 166.46 14.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.2 Cg_exo -51.68 142.31 41.08 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.446 2.097 . . . . 0.0 112.13 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.1 160.1 48.97 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.569 2.18 . . . . 0.0 112.409 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.48 133.94 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.99 59.93 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -100.07 138.48 37.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.78 125.13 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.738 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.16 119.83 58.24 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.977 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.9 107.5 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.518 2.145 . . . . 0.0 112.278 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.93 120.86 40.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.56 124.01 44.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.806 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.74 0.305 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.01 -40.02 75.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.3 t -126.42 135.45 51.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.41 170.1 51.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.1 139.98 51.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.7 m -127.62 135.52 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.856 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.5 p -82.68 159.08 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.01 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.637 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.73 137.92 20.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.551 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.12 143.53 20.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.49 -173.0 49.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.731 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -103.11 120.18 40.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.057 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.28 164.36 54.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.95 140.0 51.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.31 130.07 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.343 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.58 -0.03 52.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.449 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -95.43 137.62 22.01 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.665 0.269 . . . . 0.0 110.662 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 73.1 Cg_exo -49.6 167.45 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.369 2.046 . . . . 0.0 112.123 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.9 mt-30 -101.0 130.21 46.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.8 p -121.67 130.11 53.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 50.7 t80 -131.55 130.28 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -113.97 136.8 52.5 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mm-40 -149.99 160.03 43.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 120.04 38.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.71 ' CD2' HD12 ' A' ' 114' ' ' ILE . 86.2 m-85 -126.47 149.47 49.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -81.32 133.44 35.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.601 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.974 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 53.2 t -99.95 121.95 42.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 111.357 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.655 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 88.9 m-85 -120.42 150.06 51.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.992 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 108' ' ' PRO . 7.2 Cg_exo -75.68 107.02 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.848 2.366 . . . . 0.0 112.699 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.2 mt -61.09 -40.84 87.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.62 77.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.866 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.469 ' CG ' ' HB2' ' A' ' 29' ' ' PRO . 98.9 mmm -68.25 -30.29 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 96.5 mmm -59.94 142.24 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.26 154.49 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.673 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -55.16 -29.17 57.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.404 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -60.01 -39.9 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.2 mt -111.48 8.88 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.648 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 74.8 ttt180 -104.65 123.18 47.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.049 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.07 129.29 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.896 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.21 -40.09 88.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.269 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.88 -39.97 95.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.91 95.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.763 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.08 -40.1 88.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.351 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.38 14.53 22.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.273 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.57 164.0 24.06 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.119 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.52 11.78 63.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.472 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 67.9 mttm -109.86 145.12 37.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.567 HG21 ' CD2' ' A' ' 96' ' ' LEU . 48.0 pt -121.55 162.99 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.909 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.3 m-85 -96.58 133.24 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -134.25 165.47 36.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.239 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 84.6 Cg_endo -79.53 152.73 23.25 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.21 1.94 . . . . 0.0 112.67 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.973 ' HA ' HD13 ' A' ' 55' ' ' LEU . 19.1 Cg_exo -66.88 -21.74 49.96 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.961 2.441 . . . . 0.0 112.829 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 m -60.08 -40.07 88.28 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.37 80.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.226 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.96 -40.04 87.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.391 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -59.97 -42.76 94.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.59 -39.97 92.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.378 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 116' ' ' SER . 84.6 mt -63.34 -38.56 91.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.375 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.6 m -59.76 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.97 -39.48 85.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.489 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -81.76 -0.05 41.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.681 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.4 m120 59.98 42.43 16.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.704 0.288 . . . . 0.0 111.422 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.499 HG13 HD22 ' A' ' 58' ' ' LEU . 42.7 mm -70.02 130.02 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.744 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -72.05 139.59 48.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.781 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.743 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 28.9 t80 -88.42 146.52 37.86 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.863 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 1.0 ' HD2' HD13 ' A' ' 188' ' ' ILE . 59.9 Cg_endo -71.62 160.38 93.04 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.228 -1.155 . . . . 0.0 113.551 0.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.545 ' HB2' HG11 ' A' ' 84' ' ' VAL . 63.6 mtt -71.86 139.98 49.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' HB ' ' A' ' 153' ' ' THR . 95.4 mt -110.04 123.03 48.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.9 m-85 -119.99 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 28.4 ttpp -114.66 130.0 56.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.723 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 80' ' ' THR . 71.6 mt -94.17 121.72 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.581 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 29.8 m -106.76 119.93 40.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 78' ' ' ARG . . . -112.51 132.46 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.094 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 61.77 148.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 0.0 110.074 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.04 -40.06 88.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.56 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 72.0 p -135.48 13.71 3.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.356 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 -106.85 0.14 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.073 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.747 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 83.0 mtt85 -128.53 147.54 50.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 0.0 111.68 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 72' ' ' THR . 35.9 m -130.06 130.8 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.966 HG22 HD21 ' A' ' 104' ' ' LEU . 7.2 t -112.77 132.43 55.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 111.531 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.435 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 78.3 m80 -84.42 161.56 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.35 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.24 169.74 42.78 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.94 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.1 -177.26 29.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.985 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 67' ' ' MET . 9.0 p -130.2 131.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.333 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.1 tp -89.99 -79.21 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.056 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -139.66 155.18 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.705 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CG ' HD11 ' A' ' 55' ' ' LEU . 86.1 m-85 -99.9 116.53 32.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.931 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.5 pt -124.79 -5.47 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -91.88 100.11 12.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.01 0.433 . . . . 0.0 111.263 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.52 -39.97 77.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -66.54 -30.5 70.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 111.8 49.24 0.64 Allowed Glycine 0 C--N 1.319 -0.39 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.051 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.584 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 92.9 mtt180 -118.45 149.22 41.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.986 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.773 HG21 HD11 ' A' ' 114' ' ' ILE . 10.0 p -129.37 142.32 44.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.019 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.774 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.26 139.95 50.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.704 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -120.39 148.18 46.95 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.583 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.52 157.98 29.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.655 2.237 . . . . 0.0 112.016 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -60.79 -40.56 93.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CZ2' ' HE3' ' A' ' 100' ' ' MET . 44.6 p-90 -70.05 -40.03 75.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.201 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.509 ' HE3' ' CZ2' ' A' ' 99' ' ' TRP . 52.5 mtt -65.32 -39.92 93.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.09 -40.32 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.6 -40.03 95.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.978 0.418 . . . . 0.0 110.379 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.6 -40.08 95.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.966 HD21 HG22 ' A' ' 80' ' ' THR . 96.5 mt -83.72 -12.15 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.594 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.65 42.23 99.21 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.96 132.52 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.136 0.493 . . . . 0.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -100.11 159.22 30.39 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 38.9 Cg_exo -52.44 131.03 38.77 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.501 2.134 . . . . 0.0 112.01 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.27 77.9 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.668 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t -76.82 153.3 35.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 111' ' ' LEU . 10.4 tt -70.59 140.78 51.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.461 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.974 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.2 tp -126.9 139.95 52.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.645 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 95.6 mt-30 -113.91 127.15 55.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 50' ' ' LEU . 85.3 mt -119.98 124.46 72.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.9 t -119.13 121.06 38.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.66 108.07 17.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 9.2 t -131.37 140.93 49.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.933 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.567 ' HA ' HD12 ' A' ' 68' ' ' LEU . 58.0 t0 -99.66 120.01 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.652 HG23 ' N ' ' A' ' 186' ' ' CYS . 27.3 m -103.97 155.71 36.69 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.432 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.625 ' O ' ' HA ' ' A' ' 185' ' ' ILE . 12.3 Cg_exo -70.05 149.72 65.42 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.322 2.015 . . . . 0.0 111.333 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 190' ' ' THR . 8.3 tt -70.19 127.42 32.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.85 152.19 29.8 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.283 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -108.48 -29.97 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.454 ' HE2' ' CG ' ' A' ' 126' ' ' LYS . 70.2 t80 -140.85 134.24 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.832 HG23 ' CG1' ' A' ' 176' ' ' VAL . 5.7 p -130.1 130.85 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.111 0.481 . . . . 0.0 112.148 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD3' HD11 ' A' ' 174' ' ' LEU . 99.5 mttt -99.18 122.02 41.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.323 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' OG1' ' A' ' 194' ' ' THR . 86.4 mt -111.71 131.09 55.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.0 0.429 . . . . 0.0 111.292 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.06 110.42 62.36 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.354 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 95.9 Cg_endo -84.26 162.15 13.21 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.676 2.25 . . . . 0.0 112.651 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.633 ' OE1' ' HE3' ' A' ' 170' ' ' LYS . 61.5 tt0 -129.31 122.88 30.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.755 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.5 OUTLIER 75.9 131.05 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.66 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.21 -17.5 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.728 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HA ' ' OD2' ' A' ' 136' ' ' ASP . 96.0 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.628 0.251 . . . . 0.0 110.842 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 59.5 t80 -59.94 -40.13 87.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 0.0 111.059 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 196' ' ' PHE . 95.7 mt -85.57 -4.77 59.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 133' ' ' ASP . 94.1 m-20 -70.05 -16.83 63.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.39 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 139' ' ' ASP . 86.0 mt -61.18 139.26 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.419 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.3 p -61.41 -39.94 92.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.508 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.0 OUTLIER -129.43 73.98 81.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.783 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 74.5 Cg_endo -76.0 -29.77 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.479 2.119 . . . . 0.0 112.117 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.06 -40.13 88.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.112 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.4 89.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 147' ' ' VAL . 87.1 t -62.87 -41.98 94.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.553 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.01 -42.81 95.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -41.36 92.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -61.92 -40.26 94.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 162' ' ' ILE . 57.5 t -60.96 -42.61 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.021 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.12 -40.06 88.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.783 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.66 -39.93 90.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.486 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.484 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 93.9 m-85 -96.18 121.46 37.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.402 ' OG ' HD23 ' A' ' 68' ' ' LEU . 89.4 p -61.19 -39.94 92.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.51 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.689 ' HB ' HD22 ' A' ' 68' ' ' LEU . 7.3 t -128.32 141.23 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 0.0 111.075 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -113.4 120.13 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.2 p -119.94 145.87 46.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.184 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.789 ' CG2' HG22 ' A' ' 176' ' ' VAL . 72.1 t -60.07 -39.94 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 111.73 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.18 -38.68 78.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.595 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -67.14 131.69 46.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.249 0.547 . . . . 0.0 112.325 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.406 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 60.0 t -104.01 120.12 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.846 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 ' CG1' ' A' ' 147' ' ' VAL . 49.1 pt -106.27 134.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 111.998 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 49.0 mt-10 -120.58 140.03 52.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.462 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 147' ' ' VAL . 44.3 pt -131.08 140.83 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 65.2 m -105.92 120.99 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.495 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 60.1 t80 -119.97 120.0 35.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.495 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 55.36 40.0 31.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.432 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.99 8.7 87.42 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.027 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.4 mttp -106.19 132.62 52.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -101.13 119.96 39.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.391 . . . . 0.0 111.223 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 98.3 m-85 -120.82 140.07 52.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 55.3 pttt -117.83 131.91 56.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.639 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 127' ' ' LEU . 85.4 mt -120.01 120.12 62.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.249 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -107.29 130.01 54.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.368 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 5.3 mp -80.52 113.37 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 126' ' ' LYS . 1.5 pp -73.64 -56.51 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.729 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.53 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 99.0 mt-10 -155.57 136.42 13.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.832 ' CG1' HG23 ' A' ' 125' ' ' VAL . 21.4 m -130.57 159.96 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -105.08 104.11 45.29 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.78 0.324 . . . . 0.0 110.219 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.426 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 68.7 Cg_endo -100.19 179.17 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.733 2.956 . . . . 0.0 112.509 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.0 mt-10 -95.41 0.03 52.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 120' ' ' PRO . 88.2 p -140.31 159.88 41.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.031 0.443 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.05 -11.53 60.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.668 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.9 t -59.95 -18.58 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.415 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 66.77 26.41 9.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 110.702 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.8 m -125.9 139.98 53.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.104 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' PRO . 45.7 pt -127.52 143.87 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.652 ' N ' HG23 ' A' ' 119' ' ' VAL . 40.5 t -92.04 100.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.078 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.755 HG21 HD22 ' A' ' 192' ' ' LEU . 97.6 t -109.96 93.83 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.093 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 1.0 HD13 ' HD2' ' A' ' 66' ' ' PRO . 84.2 mt -110.59 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.836 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 188' ' ' ILE . 99.0 mt-10 -117.78 10.78 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.67 ' CB ' HD11 ' A' ' 121' ' ' LEU . 5.8 t -84.98 171.71 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.207 0.527 . . . . 0.0 111.992 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.49 119.45 37.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.79 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.755 HD22 HG21 ' A' ' 187' ' ' VAL . 31.4 tp -120.37 131.29 54.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 36.3 t -89.35 126.91 42.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.167 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.593 ' OG1' HD12 ' A' ' 127' ' ' LEU . 3.9 t -116.96 140.3 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.575 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -120.07 131.74 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.544 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.427 ' CD1' HD21 ' A' ' 135' ' ' LEU . 87.4 m-85 -100.14 122.34 42.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.38 . . . . 0.0 111.532 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -121.16 108.39 36.32 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.67 109.96 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 112.468 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.96 3.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.011 2.474 . . . . 0.0 112.641 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.95 139.0 18.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 111.546 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.57 25.95 2.94 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.223 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.2 136.65 38.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.087 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.93 139.71 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -96.68 124.34 50.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.7 116.5 3.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.397 2.064 . . . . 0.0 112.272 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -84.66 140.03 31.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -96.46 125.91 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.8 -179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.859 0.362 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.95 -40.43 88.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.8 m -125.71 136.66 53.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.69 170.59 3.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.427 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.04 -39.92 75.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.3 m -130.01 140.02 50.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.3 m -79.41 150.27 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.89 130.01 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.49 -166.71 54.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.237 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.44 177.79 43.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.62 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.95 167.74 51.55 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.582 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.13 120.03 39.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.864 0.364 . . . . 0.0 110.742 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.98 -139.86 29.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.47 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -104.91 132.54 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -109.75 135.46 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -80.07 139.96 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.3 mtp -101.09 119.97 56.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.981 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.18 156.28 59.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.275 1.983 . . . . 0.0 111.773 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' A' ' 117' ' ' THR . 57.2 tt0 -101.49 119.99 39.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.473 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 116' ' ' SER . 82.6 p -119.6 137.56 53.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.942 0.401 . . . . 0.0 111.637 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 57' ' ' LYS . 75.2 t80 -125.74 130.52 51.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.618 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.15 136.7 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 112.052 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 98.6 mt-10 -140.53 153.6 46.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.067 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -120.14 122.57 41.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 92.3 m-85 -139.91 160.37 40.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.819 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -84.1 139.66 32.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.934 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 36.2 t -100.0 123.78 44.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 111.458 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.618 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 82.8 m-85 -121.67 149.92 54.11 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.237 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 32' ' ' MET . 65.0 Cg_endo -79.45 111.17 2.79 Favored 'Trans proline' 0 N--CA 1.467 -0.081 0 C-N-CA 123.194 2.596 . . . . 0.0 112.647 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.691 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mt -60.77 -40.03 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 110.682 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.52 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.321 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.651 ' HB3' ' HG2' ' A' ' 29' ' ' PRO . 57.7 ttm -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.462 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 98.3 mtp -58.98 155.69 12.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.737 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.584 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.1 139.99 57.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.041 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -59.97 -37.09 78.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.05 -39.75 87.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.584 HG12 ' HB2' ' A' ' 34' ' ' ASN . 47.7 pt -90.3 -0.66 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 18.5 mtp-105 -99.39 139.94 34.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.857 0.361 . . . . 0.0 110.905 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -96.13 139.71 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.731 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.6 p-10 -60.01 -40.03 87.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.8 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.71 92.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 40' ' ' ASP . 27.3 p30 -62.53 -40.01 95.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 37.8 m-85 -110.0 18.23 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.587 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.09 173.35 28.96 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.14 24.22 19.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 71.5 mmtt -111.52 142.29 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 111.231 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.698 ' CG1' HG12 ' A' ' 84' ' ' VAL . 47.3 pt -121.24 155.96 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.56 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.4 m-85 -100.82 133.96 44.51 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 114' ' ' ILE . 4.1 mp -140.18 164.54 36.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 69.3 Cg_endo -73.29 156.26 50.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.268 1.978 . . . . 0.0 112.715 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.978 ' HA ' HD13 ' A' ' 55' ' ' LEU . 74.3 Cg_endo -75.26 -15.6 20.11 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.906 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -60.0 -40.3 88.73 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -61.35 -37.59 83.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.978 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.6 mp -60.13 -39.79 87.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.576 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.4 p -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 110.474 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 21' ' ' PHE . 23.6 tptm -69.45 -40.04 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.258 0.551 . . . . 0.0 110.167 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 55' ' ' LEU . 90.8 mt -59.95 -39.6 86.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.112 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -57.84 -39.27 77.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -59.88 -37.26 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 98.2 mt -80.46 -0.05 35.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.597 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.03 40.44 18.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.659 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.423 HG12 ' OE1' ' A' ' 19' ' ' GLN . 85.8 mt -86.63 120.01 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.789 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -91.73 149.13 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.305 0.574 . . . . 0.0 111.854 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.521 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.2 p90 -87.39 157.79 52.66 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.529 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 30.3 Cg_endo -63.74 147.61 64.42 Favored 'Cis proline' 0 C--N 1.352 0.759 0 C-N-CA 123.771 -1.346 . . . . 0.0 112.742 0.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 59.0 mtt -93.59 139.59 30.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.677 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 186' ' ' CYS . 6.6 mp -101.49 120.9 41.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.025 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.682 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.0 m-85 -128.35 142.3 51.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.607 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 60.7 pttt -120.74 140.11 52.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -99.32 115.46 29.23 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.394 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.4 m -99.26 121.44 41.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.941 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.39 117.64 35.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.281 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -68.99 -39.99 79.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.433 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.906 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.434 HG21 ' HA3' ' A' ' 105' ' ' GLY . 77.8 p -105.4 -7.7 18.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.12 40.53 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.644 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -104.79 140.09 38.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.668 0.27 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 3.1 p -124.01 130.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.636 ' OG1' HD23 ' A' ' 71' ' ' LEU . 67.4 p -97.54 154.88 17.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.146 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 81.0 m80 -119.47 131.18 55.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.153 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.85 -173.72 36.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.538 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 152' ' ' SER . . . -107.62 -170.72 21.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.937 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.698 HG12 ' CG1' ' A' ' 48' ' ' ILE . 32.6 m -130.05 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 121.279 -0.168 . . . . 0.0 110.815 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 58.2 tp -89.99 -78.1 0.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.39 . . . . 0.0 110.544 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -147.72 159.8 43.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.886 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.865 ' CD2' HD11 ' A' ' 55' ' ' LEU . 88.3 m-85 -99.87 116.15 31.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.276 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.16 -4.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.077 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -87.45 100.41 12.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.38 -39.98 77.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.92 -30.85 71.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.095 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.57 50.32 0.71 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.386 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.549 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 98.8 mtt180 -117.64 148.23 42.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.948 0.404 . . . . 0.0 111.501 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 8.0 p -129.81 140.81 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.02 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.691 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.72 139.96 50.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.927 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.564 HD23 HG21 ' A' ' 48' ' ' ILE . 21.3 mt -114.81 139.58 24.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 48' ' ' ILE . 57.5 Cg_exo -55.01 155.59 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.699 2.266 . . . . 0.0 112.3 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.19 91.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.638 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.698 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 55.2 p-90 -69.95 -37.87 75.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.732 0.301 . . . . 0.0 111.356 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.655 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 98.1 mtp -69.94 -39.98 75.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.1 mtp -60.01 -40.94 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.037 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 21.3 pt-20 -64.12 -40.02 95.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.48 -40.06 95.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HG23 ' A' ' 80' ' ' THR . 82.9 mt -70.04 -24.13 63.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.369 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 74.66 29.97 60.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.8 pt -114.35 139.92 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 111.713 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.7 pt20 -95.25 160.01 31.63 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.415 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.5 Cg_endo -49.15 137.79 29.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.754 2.302 . . . . 0.0 112.48 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.09 -8.13 80.37 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.987 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 89.8 p -71.04 160.36 33.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.753 0.276 . . . . 0.0 110.605 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.65 145.2 30.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.473 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.934 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.1 tp -130.24 130.33 44.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 94.2 mt-30 -110.52 127.59 55.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.682 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 19.0 tt -118.44 127.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.407 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 47.0 t -120.02 130.03 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 23.4 t -89.9 116.03 27.66 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.857 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.752 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.6 t -129.98 138.83 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.74 121.07 44.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.537 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 120' ' ' PRO . 32.7 m -119.16 154.45 53.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.634 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.608 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 59.6 Cg_endo -72.5 153.31 55.11 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.791 2.327 . . . . 0.0 111.325 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.85 HD23 HG23 ' A' ' 187' ' ' VAL . 4.7 mp -64.29 130.05 42.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.954 0.407 . . . . 0.0 111.137 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.95 151.4 49.01 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.53 -20.05 15.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.516 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' OD2' ' A' ' 195' ' ' ASP . 60.4 t80 -145.79 131.16 18.6 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.681 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.699 HG23 ' CG1' ' A' ' 176' ' ' VAL . 11.5 p -134.0 134.44 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.267 0.556 . . . . 0.0 111.529 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.834 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 64.3 mttp -99.43 122.37 42.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.359 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 194' ' ' THR . 86.0 mt -113.25 128.59 56.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.417 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -111.7 112.22 53.81 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.105 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.509 ' CB ' HD11 ' A' ' 135' ' ' LEU . 84.2 Cg_endo -82.08 167.78 15.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.67 2.247 . . . . 0.0 112.462 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -126.07 121.22 32.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.455 ' N ' ' HB2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER 67.6 142.15 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.03 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.09 -20.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.412 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.0 -39.56 86.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.138 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.3 t80 -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.9 mp -81.95 -11.21 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.543 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.08 -19.99 63.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.743 0.306 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.15 130.2 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.5 p -69.54 150.75 46.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.26 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 2.5 m-20 53.66 53.37 10.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 144' ' ' LEU . 31.0 Cg_endo -63.83 -34.65 60.17 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.351 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.08 -40.04 88.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.071 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.88 95.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 147' ' ' VAL . 81.6 t -60.1 -43.19 92.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.9 mm? -60.0 -40.57 89.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.57 -41.17 94.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.45 -39.94 89.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.176 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 143' ' ' VAL . 60.4 t -60.33 -42.07 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.86 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -41.27 91.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 188' ' ' ILE . 16.8 tpt180 -61.71 -40.0 93.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.222 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.483 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 98.6 m-20 -62.05 -39.99 94.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.822 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.01 122.67 43.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.318 . . . . 0.0 111.4 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.639 ' HA ' HD11 ' A' ' 188' ' ' ILE . 51.8 m -60.03 -40.02 87.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.527 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 10.0 t -136.06 149.97 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.613 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 173' ' ' ILE . 64.8 tp -120.04 128.2 53.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.3 m -119.05 140.19 50.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 176' ' ' VAL . 63.5 t -59.96 -42.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.398 0.618 . . . . 0.0 111.343 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.98 -39.71 75.77 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.678 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 81' ' ' HIS . 96.0 m-20 -65.53 140.39 58.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 112.449 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG22 ' CE ' ' A' ' 172' ' ' LYS . 53.1 t -105.77 120.02 55.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.654 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 171' ' ' ILE . 48.0 pt -106.94 141.4 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.798 0.332 . . . . 0.0 111.377 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.688 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 99.9 mt-10 -118.99 140.69 49.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 147' ' ' VAL . 46.7 pt -130.31 139.98 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.425 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 58.6 m -107.55 118.46 36.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -119.95 121.77 39.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.6 t30 55.07 40.03 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.421 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.88 9.9 86.23 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.891 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.6 mttt -110.38 138.05 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.807 0.303 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.1 m -106.63 121.16 43.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.545 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 90.3 m-85 -120.03 140.03 51.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.688 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 58.9 mtpt -106.07 123.99 48.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.354 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 160' ' ' ILE . 46.0 pt -122.42 131.13 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 110.639 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.403 ' CE ' HG22 ' A' ' 159' ' ' VAL . 35.0 ttmt -119.64 135.88 54.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.778 HD11 HD11 ' A' ' 154' ' ' LEU . 4.6 mp -84.62 120.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.083 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 126' ' ' LYS . 89.1 mt -68.79 -59.32 3.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.429 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.834 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.28 146.66 18.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.76 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 156' ' ' VAL . 4.3 m -139.02 145.15 28.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -88.94 104.7 8.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.327 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.1 Cg_endo -104.07 174.36 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.861 3.041 . . . . 0.0 112.351 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.6 mt-10 -100.03 0.73 41.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.1 m -132.81 150.03 52.2 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 111.184 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.5 m -70.98 -12.2 61.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.928 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -62.9 -10.39 13.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.0 mttm 59.93 24.58 13.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 111.425 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 64.2 m -121.08 135.76 55.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 46.7 pt -129.97 159.14 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.399 0.618 . . . . 0.0 112.355 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HD21 ' A' ' 68' ' ' LEU . 53.0 t -140.53 104.57 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.932 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.85 HG23 HD23 ' A' ' 121' ' ' LEU . 7.5 p -139.79 87.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.69 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 152' ' ' SER . 72.0 mt -99.49 -3.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.796 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 190' ' ' THR . 99.6 mt-10 -90.0 -80.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.291 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 13.1 t 177.38 36.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -109.64 16.77 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.436 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.825 ' HB2' HG11 ' A' ' 187' ' ' VAL . 19.0 tp -116.38 132.45 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 0.0 111.185 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 125' ' ' VAL . 39.9 t -95.11 120.01 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.04 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.65 HG22 HG11 ' A' ' 125' ' ' VAL . 81.6 p -103.31 141.2 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.0 111.895 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.401 ' OD2' ' CE2' ' A' ' 124' ' ' PHE . 96.0 m-20 -129.21 144.7 51.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.071 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.68 139.98 48.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 111.415 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.61 166.26 13.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.374 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 28.9 Cg_endo -62.94 129.88 27.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.184 1.923 . . . . 0.0 112.1 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.455 ' HB2' ' N ' ' A' ' 131' ' ' SER . 73.2 Cg_endo -76.09 162.2 34.62 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.643 2.229 . . . . 0.0 112.477 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.8 t -86.19 128.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.169 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.33 -5.02 34.96 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.715 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -100.05 136.65 39.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.795 0.331 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.5 p -119.95 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.76 125.64 41.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.74 125.83 13.8 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.415 2.076 . . . . 0.0 112.276 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.98 119.98 39.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -100.0 123.17 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.818 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 63.3 tttm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.871 -179.884 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 59.96 38.21 21.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.102 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.1 t -99.91 120.06 39.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.17 32.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 60.03 40.67 18.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.047 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.5 m -114.18 138.42 50.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.453 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -109.35 122.68 47.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.889 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 138.42 15.17 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.4 120.02 6.12 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.647 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 -23.89 1.54 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.91 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.08 140.04 53.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.82 -147.56 18.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.659 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.96 140.02 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.66 -5.56 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.722 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.91 138.8 37.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.9 mtt -110.23 110.45 58.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.255 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.37 169.36 4.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.311 2.008 . . . . 0.0 111.678 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.7 mt-30 -99.94 120.32 39.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.451 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 116' ' ' SER . 8.9 t -130.0 139.95 50.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.136 0.493 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 55.2 t80 -128.82 130.19 46.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.98 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.08 135.71 48.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.0 mt-10 -144.48 160.05 41.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -119.13 135.46 54.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.417 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -149.7 160.02 43.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.943 0.401 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.83 132.67 39.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.79 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 31.4 p -96.48 141.81 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.482 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.9 m-85 -127.07 153.92 76.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.693 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HG3' ' CG ' ' A' ' 108' ' ' PRO . 5.7 Cg_exo -78.27 107.09 2.25 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.733 2.288 . . . . 0.0 113.016 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 87.2 mt -64.29 -40.03 87.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.87 80.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.276 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.488 ' CB ' ' HB2' ' A' ' 29' ' ' PRO . 57.6 ttm -67.6 -32.54 73.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.946 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.0 159.54 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.01 144.49 49.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.44 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.18 -38.96 81.11 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.99 -39.9 87.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 37' ' ' ILE . 83.2 mt -88.72 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.258 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 30' ' ' ILE . 62.4 mtm180 -99.68 138.97 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.261 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -103.67 132.47 49.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.455 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 111.242 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 96.1 m-20 -66.28 -40.06 89.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.95 95.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.14 -39.89 87.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 99' ' ' TRP . 86.4 m-85 -105.52 6.44 32.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.768 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -96.07 173.4 30.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.714 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.8 24.33 21.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.261 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.73 ' HD3' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.35 136.03 41.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 50' ' ' LEU . 45.6 pt -121.08 158.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 94' ' ' VAL . 65.6 m-85 -100.08 131.6 45.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.577 HD13 ' CE2' ' A' ' 69' ' ' PHE . 1.9 mp -131.78 162.65 55.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.042 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.59 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.5 Cg_endo -77.78 144.17 21.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.148 1.898 . . . . 0.0 112.155 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.1 Cg_exo -59.68 -23.93 73.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.603 2.202 . . . . 0.0 112.782 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -60.03 -39.93 87.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.116 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.82 85.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.156 0.503 . . . . 0.0 110.753 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.644 HD13 ' HE1' ' A' ' 67' ' ' MET . 34.7 tp -61.5 -39.94 92.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.771 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.3 p -60.06 -39.04 84.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.143 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HA ' ' CE ' ' A' ' 60' ' ' MET . 98.8 mttt -64.37 -40.06 95.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.96 0.41 . . . . 0.0 110.5 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 63' ' ' ILE . 96.1 mt -61.08 -35.45 77.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.11 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.7 m -60.01 -38.64 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.442 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.436 ' CE ' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -60.03 -36.43 77.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.304 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.94 -1.31 38.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.317 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.05 39.99 19.14 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 58' ' ' LEU . 85.4 mt -79.48 126.59 39.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -85.35 142.77 29.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 0.0 111.897 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.516 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 47.4 p90 -87.34 157.82 52.8 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.993 ' HG2' HG21 ' A' ' 188' ' ' ILE . 25.2 Cg_exo -65.24 157.77 75.89 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.542 0.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.644 ' HE1' HD13 ' A' ' 55' ' ' LEU . 65.6 mtm -100.14 145.77 27.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.189 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 186' ' ' CYS . 1.3 pt? -116.16 133.7 55.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.88 ' HB3' HG23 ' A' ' 114' ' ' ILE . 15.7 m-85 -120.03 140.02 51.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HE2' HG21 ' A' ' 79' ' ' VAL . 81.1 tttt -115.08 120.02 38.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.274 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.823 HD22 ' SD ' ' A' ' 100' ' ' MET . 6.5 mp -97.99 127.36 43.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -115.03 130.23 56.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.831 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.09 110.72 22.04 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.23 -40.07 88.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.687 HG21 ' O ' ' A' ' 104' ' ' LEU . 74.4 p -101.6 -10.41 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.61 6.56 16.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.615 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -104.1 141.31 36.45 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 71' ' ' LEU . 7.2 p -121.18 124.42 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.355 0.598 . . . . 0.0 111.626 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.569 HG23 HD21 ' A' ' 104' ' ' LEU . 68.9 p -104.3 151.12 23.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.34 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.414 ' ND1' HG21 ' A' ' 155' ' ' THR . 77.4 m80 -100.91 115.06 29.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 0.0 110.814 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CE ' ' A' ' 100' ' ' MET . . . -114.74 139.55 15.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.182 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -84.24 163.97 39.84 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.564 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.7 p -126.01 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.73 HD22 ' HD3' ' A' ' 47' ' ' LYS . 64.9 tp -90.33 -74.1 0.5 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.16 160.65 41.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.291 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.608 ' CD1' HD22 ' A' ' 55' ' ' LEU . 89.3 m-85 -95.72 116.76 29.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.2 -5.38 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.063 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -90.23 97.77 11.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.023 0.44 . . . . 0.0 111.412 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.95 -39.94 75.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.11 0.481 . . . . 0.0 110.796 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.08 -30.03 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.902 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.03 50.15 0.69 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.167 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.704 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 mtt180 -118.45 151.28 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.848 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 114' ' ' ILE . 12.4 p -130.03 142.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 28' ' ' TYR . 88.6 m-85 -119.08 140.02 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -123.56 147.96 54.46 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.894 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.21 -173.08 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.405 2.07 . . . . 0.0 112.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.91 -20.85 63.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.615 ' HE1' ' HA ' ' A' ' 44' ' ' PHE . 14.4 m95 -60.01 -49.91 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.575 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.823 ' SD ' HD22 ' A' ' 71' ' ' LEU . 67.6 mtt -70.01 -39.97 75.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.495 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 29' ' ' PRO . 67.8 mtt -63.89 -47.8 79.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.568 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.98 -40.12 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.235 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.938 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.687 ' O ' HG21 ' A' ' 76' ' ' THR . 92.9 mt -95.16 -19.05 20.4 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 101' ' ' MET . . . 58.89 47.76 88.97 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -113.49 150.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.031 0.443 . . . . 0.0 111.439 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.35 161.69 30.13 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.595 ' CG ' ' HG3' ' A' ' 29' ' ' PRO . 40.0 Cg_exo -59.62 -5.89 3.84 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.886 2.391 . . . . 0.0 113.421 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.13 -6.82 56.69 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.773 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.4 m -85.02 143.77 28.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.736 0.303 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.97 145.0 52.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.629 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 96' ' ' LEU . 54.1 tp -124.83 125.16 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.969 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -111.33 132.08 54.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.954 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 94' ' ' VAL . 88.9 mt -111.56 130.01 65.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.417 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 82.3 p -126.33 134.43 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.287 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' THR . 67.2 m -83.8 120.84 26.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.592 ' O ' HD21 ' A' ' 68' ' ' LEU . 70.8 p -126.34 139.95 52.89 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -112.69 110.8 21.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 186' ' ' CYS . 35.1 m -115.58 151.06 45.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.34 133.3 15.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.427 2.084 . . . . 0.0 110.958 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 190' ' ' THR . 5.0 mt -62.21 130.91 47.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.213 0.53 . . . . 0.0 112.091 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 159.2 50.31 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.058 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -105.66 -22.7 12.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -136.51 134.56 37.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 111.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.725 HG21 HD21 ' A' ' 154' ' ' LEU . 3.2 p -133.52 130.34 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.133 0.492 . . . . 0.0 111.54 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.813 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 99.4 mttt -96.86 123.12 40.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD22 ' CG2' ' A' ' 171' ' ' ILE . 90.9 mt -116.74 136.6 52.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 199' ' ' PRO . 0.6 OUTLIER -104.06 114.7 64.21 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.87 158.98 21.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.101 . . . . 0.0 112.83 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 131' ' ' SER . 96.9 mt-30 -122.72 121.6 36.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 130' ' ' GLN . 47.3 t 69.13 133.98 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.564 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.57 -23.05 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.94 -40.03 87.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.239 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 67.2 t80 -59.98 -40.13 88.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.97 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.36 -9.95 59.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.63 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.48 -10.18 58.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.573 0.225 . . . . 0.0 111.356 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.81 138.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 110.492 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.0 t -60.04 -40.04 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.531 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -129.75 71.24 82.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.927 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.686 ' O ' HD23 ' A' ' 144' ' ' LEU . 21.2 Cg_exo -65.11 -32.73 52.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.729 2.286 . . . . 0.0 111.909 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.01 -40.03 87.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.285 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.38 98.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 147' ' ' VAL . 64.2 t -62.33 -41.33 91.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -63.43 -40.1 96.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -45.8 91.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -60.28 -41.36 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.051 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 143' ' ' VAL . 62.6 t -60.29 -44.21 95.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.226 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.06 -40.05 88.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.4 mtp85 -65.1 -40.02 93.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.094 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.15 -40.08 88.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.539 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 147' ' ' VAL . 90.6 m-85 -97.74 120.15 37.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.177 0.513 . . . . 0.0 111.439 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.4 m -60.16 -39.91 88.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.022 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 41.9 p -126.87 145.23 50.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.866 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.725 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -119.88 119.4 33.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.999 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 184' ' ' SER . 73.6 p -124.28 141.37 52.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 176' ' ' VAL . 97.9 t -59.99 -40.18 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 111.841 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.77 -39.78 87.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.869 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 97.0 m-20 -74.5 140.11 44.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 112.325 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 ' CG ' ' A' ' 172' ' ' LYS . 7.2 p -106.04 121.93 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.492 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 46.0 pt -107.97 131.07 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 19.6 pt-20 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.727 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -121.15 148.97 24.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 82.3 p -109.01 117.55 34.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.206 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 64.6 t80 -119.99 120.06 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 10.9 m120 54.07 40.13 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.28 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.15 10.19 85.77 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.14 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 163' ' ' SER . 63.2 mttp -109.72 133.45 53.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.751 0.275 . . . . 0.0 110.368 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -107.38 123.9 49.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.3 m-85 -119.99 140.04 51.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 56.4 mttm -103.6 129.74 50.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.612 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 120.16 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.488 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.479 ' CG ' HG23 ' A' ' 159' ' ' VAL . 61.2 mttp -111.15 127.14 55.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.709 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -81.6 110.0 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.449 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.5 tt -63.58 -58.8 5.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.838 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.832 ' HG3' HD23 ' A' ' 174' ' ' LEU . 99.4 mt-10 -158.38 143.03 16.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.739 HG22 ' CG2' ' A' ' 156' ' ' VAL . 7.2 m -137.55 142.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.042 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.47 104.71 11.87 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.679 ' HB3' HG23 ' A' ' 185' ' ' ILE . 57.1 Cg_endo -102.99 -0.88 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.882 3.054 . . . . 0.0 112.966 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.48 21.54 12.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.9 p -141.09 155.56 46.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.7 p -70.01 -23.08 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.334 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 22.5 t -59.93 -36.63 77.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.577 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 29.8 mmtm 69.68 19.96 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 155' ' ' THR . 52.9 m -130.03 140.01 50.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.094 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 178' ' ' PRO . 44.6 pt -130.36 157.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 112.412 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.611 ' HB2' HD13 ' A' ' 68' ' ' LEU . 34.0 t -120.81 99.8 6.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.226 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.737 HG11 HD22 ' A' ' 192' ' ' LEU . 14.7 p -119.91 107.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.237 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.993 HG21 ' HG2' ' A' ' 66' ' ' PRO . 24.0 mt -95.54 -80.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.102 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.87 3.69 49.75 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.829 HG21 HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -78.92 171.1 15.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.085 0.469 . . . . 0.0 111.248 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -100.11 123.25 44.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.354 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.737 HD22 HG11 ' A' ' 187' ' ' VAL . 13.6 tp -120.29 131.49 54.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.53 120.08 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.8 t -118.15 148.14 42.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.109 0.481 . . . . 0.0 111.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -120.15 139.74 52.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -99.72 122.43 42.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.29 110.67 34.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.8 117.48 4.32 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.394 2.063 . . . . 0.0 112.269 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.462 ' HB3' ' CD ' ' A' ' 128' ' ' GLU . 81.1 Cg_endo -93.99 -3.21 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.934 2.423 . . . . 0.0 112.803 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.54 139.61 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.319 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.61 -65.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.054 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -100.01 128.96 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.751 0.31 . . . . 0.0 110.507 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.82 129.99 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.007 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 206' ' ' ASP . 8.2 tt0 -106.11 110.19 63.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.053 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.85 10.02 1.8 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.672 2.248 . . . . 0.0 112.711 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.439 ' HB2' ' HG2' ' A' ' 204' ' ' GLU . 96.0 m-20 -82.35 134.56 35.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.735 0.302 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.04 126.87 46.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.958 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.672 0.272 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.98 -44.03 94.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.619 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.9 m -59.96 -40.03 87.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.76 75.35 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.686 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.98 140.02 51.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -118.46 124.36 47.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.853 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -120.06 130.67 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -120.07 139.97 51.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.17 -9.38 76.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.943 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.04 74.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.824 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.99 21.4 78.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.345 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -100.06 120.02 39.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.068 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.52 -148.1 0.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.738 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.91 140.04 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 110.895 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.34 10.03 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.54 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.12 -0.01 42.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.303 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 mmt -82.39 139.98 44.98 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.681 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.33 159.73 51.97 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.382 2.055 . . . . 0.0 112.001 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 117' ' ' THR . 72.0 tp60 -100.02 119.86 38.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.033 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 116' ' ' SER . 73.0 p -120.01 133.08 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 57.4 t80 -120.0 124.96 47.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -105.68 135.06 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' OE2' ' HG3' ' A' ' 91' ' ' GLU . 85.3 tt0 -145.05 155.28 43.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.706 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.62 120.03 41.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.17 0.51 . . . . 0.0 111.995 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' HE2' ' HG3' ' A' ' 51' ' ' PRO . 87.1 m-85 -121.06 140.01 52.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.628 ' O ' HG12 ' A' ' 94' ' ' VAL . 36.8 ptt180 -80.02 153.34 28.89 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 69.3 m -83.69 132.79 34.84 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 112.337 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.668 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 3.0 m-85 -130.53 126.29 21.95 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.078 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' MET . 16.0 Cg_exo -70.02 113.29 3.37 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.553 2.169 . . . . 0.0 112.016 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 95' ' ' TYR . 91.4 mt -66.21 -36.79 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 110.818 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.17 83.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.261 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.0 ptm -68.43 -20.07 64.62 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.134 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 96.9 mmm -64.69 156.92 28.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 28.2 m120 -60.06 141.36 55.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -39.66 86.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -59.93 -39.83 86.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.5 mt -87.26 -7.76 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.232 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 22.4 mtp-105 -98.96 140.04 33.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.086 0.469 . . . . 0.0 111.917 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.94 130.82 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.93 -40.11 87.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.28 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -64.0 -39.96 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.85 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.95 96.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.009 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -60.08 -40.02 88.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.58 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -105.14 2.01 28.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.626 0.25 . . . . 0.0 111.565 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.48 173.9 30.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -100.39 14.88 59.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.403 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.6 mttt -95.32 133.36 39.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.597 HD11 ' CD1' ' A' ' 114' ' ' ILE . 45.9 pt -118.85 164.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.811 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.445 ' CD1' HG12 ' A' ' 88' ' ' ILE . 98.7 m-85 -100.5 131.54 46.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -129.74 166.77 23.64 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.767 -179.248 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.862 ' HG3' ' HA ' ' A' ' 91' ' ' GLU . 31.6 Cg_endo -83.13 147.72 13.07 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.821 2.347 . . . . 0.0 113.4 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 55' ' ' LEU . 37.1 Cg_exo -61.93 -21.27 71.97 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.5 p -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.0 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.545 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.967 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.97 -40.25 88.44 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.544 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -40.0 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 60.9 mttp -69.24 -40.01 78.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.383 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.524 HD21 ' CB ' ' A' ' 116' ' ' SER . 88.2 mt -60.24 -39.81 88.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.033 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.4 m -59.99 -39.73 86.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.487 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.0 -38.89 83.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.355 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.06 0.01 33.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.517 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 59.97 42.77 15.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.811 0.339 . . . . 0.0 111.511 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD11 ' HG2' ' A' ' 19' ' ' GLN . 43.9 mm -76.33 129.99 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -83.88 146.71 27.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.432 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.3 m-85 -87.58 153.53 53.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.65 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.559 ' CG ' HD11 ' A' ' 188' ' ' ILE . 12.3 Cg_exo -71.07 163.09 86.27 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.659 0.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.432 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 76.0 mtm -84.09 137.0 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.358 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.766 ' HB2' ' O ' ' A' ' 117' ' ' THR . 76.7 mt -115.3 131.91 56.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.498 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE1' HG11 ' A' ' 84' ' ' VAL . 95.4 m-85 -129.6 144.1 51.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.53 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 81' ' ' HIS . 28.3 ttpp -119.53 130.46 55.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 112' ' ' LEU . 7.5 mp -100.02 121.82 41.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 79' ' ' VAL . 98.6 m -114.17 130.04 56.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.983 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.19 30.95 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.487 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -68.42 -39.63 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.766 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.721 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 29.8 m -103.58 -15.97 15.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.57 7.92 62.07 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.536 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -99.4 140.17 33.97 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.85 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 72' ' ' THR . 59.3 t -119.95 120.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.5 p -109.28 138.35 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.273 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.576 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 2.0 m170 -84.12 114.14 21.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.08 146.16 16.03 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.177 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' A' ' 152' ' ' SER . . . -96.51 162.62 22.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.771 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.617 HG11 ' HE1' ' A' ' 69' ' ' PHE . 8.1 p -120.73 126.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 48.6 tp -91.63 -74.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.9 159.96 41.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.245 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 55' ' ' LEU . 70.8 m-85 -100.79 116.21 32.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.826 0.346 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 HG12 ' CD1' ' A' ' 49' ' ' PHE . 48.3 pt -137.99 -4.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.827 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -104.29 158.02 16.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 110.889 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 93' ' ' ARG . 97.9 mt-10 -76.67 158.17 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.333 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.862 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 85.8 tt0 -59.99 -30.35 69.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.598 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -81.81 1.24 86.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.308 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 46.6 ptt85 -144.23 145.88 32.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 26' ' ' ARG . 7.7 p -142.89 150.41 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.664 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.776 ' HB3' HG12 ' A' ' 30' ' ' ILE . 85.3 m-85 -118.63 139.99 50.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -134.34 159.05 73.76 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 48' ' ' ILE . 22.9 Cg_exo -64.66 147.97 90.14 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.792 2.328 . . . . 0.0 112.13 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -60.01 -42.29 94.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.163 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -68.72 -40.04 80.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.5 ttm -60.03 -40.28 88.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' HG13 ' A' ' 106' ' ' ILE . 67.4 ttp -60.62 -41.27 94.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.46 -39.99 95.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.0 m -62.55 -40.01 95.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 -23.82 63.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.564 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.32 35.0 43.97 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.739 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.538 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.5 pt -118.11 147.43 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.969 0.414 . . . . 0.0 111.3 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.1 pt20 -98.18 161.63 24.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 8.5 Cg_endo -49.34 136.44 31.83 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.74 2.293 . . . . 0.0 112.162 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 -9.9 75.75 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.612 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.538 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 70.4 p -70.11 161.08 30.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.682 0.277 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.25 140.65 29.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 60.2 tp -120.07 127.99 53.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -106.93 119.95 40.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.18 0.514 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.836 HD13 HD21 ' A' ' 50' ' ' LEU . 18.9 tt -120.97 128.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 79.8 p -120.69 138.83 53.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 20' ' ' THR . 44.9 t -80.17 110.72 15.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 92.9 m -119.51 129.4 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -101.5 119.23 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 186' ' ' CYS . 22.1 m -120.12 152.6 54.65 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 49.4 Cg_endo -67.78 175.29 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.423 2.082 . . . . 0.0 110.684 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 122' ' ' GLY . 7.7 tt -94.41 120.04 34.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.938 0.399 . . . . 0.0 111.257 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.692 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -62.35 151.25 46.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.919 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -101.33 -17.02 16.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.065 0.433 . . . . 0.0 111.767 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.523 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 69.0 t80 -150.27 134.78 17.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.766 ' CG1' HG22 ' A' ' 194' ' ' THR . 7.7 p -139.21 130.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.344 0.592 . . . . 0.0 111.419 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.843 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 83.8 mttt -94.98 126.3 40.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.487 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.3 133.28 56.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.88 0.372 . . . . 0.0 110.954 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -109.19 110.59 60.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.762 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.52 175.59 10.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.579 2.186 . . . . 0.0 112.395 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -124.02 121.35 35.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.304 0.573 . . . . 0.0 110.089 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.496 ' CA ' ' HB3' ' A' ' 199' ' ' PRO . 6.3 t 59.83 168.78 0.07 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.086 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.794 HG22 ' HG2' ' A' ' 199' ' ' PRO . 16.4 t -77.26 -19.99 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.702 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' PHE . 47.7 p-10 -60.03 -39.93 87.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.01 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 66.9 t80 -59.96 -40.04 87.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.348 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.1 -7.71 59.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.717 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.94 -12.78 61.87 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 143' ' ' VAL . 85.4 mt -60.33 138.82 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.4 m -60.07 -39.99 87.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 111.314 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 137' ' ' ILE . 36.4 m-20 -125.9 75.73 71.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 25.2 Cg_endo -62.17 -40.61 40.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.5 2.133 . . . . 0.0 112.203 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.29 -40.02 88.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.36 96.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 137' ' ' ILE . 84.6 t -60.66 -41.96 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.247 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -59.98 -41.69 92.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.23 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.01 -40.47 89.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 111.043 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.97 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.8 HG22 HG21 ' A' ' 162' ' ' ILE . 77.2 t -61.89 -43.49 97.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.054 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.98 -40.95 90.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.02 0.438 . . . . 0.0 110.557 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -64.28 -40.15 95.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 96.7 m-20 -61.28 -40.05 92.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.478 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 97.7 m-85 -101.16 120.02 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.496 . . . . 0.0 110.911 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.524 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t -68.63 -39.99 80.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.864 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 74.1 p -124.41 140.06 53.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.219 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 151' ' ' PHE . 86.9 mt -131.18 136.89 48.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.962 0.411 . . . . 0.0 111.819 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 157' ' ' ASP . 21.7 m -118.77 145.49 45.56 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.704 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.5 t -60.02 -41.6 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.42 0.629 . . . . 0.0 110.646 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 155' ' ' THR . 95.9 m-20 -72.98 -40.01 65.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.675 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 54.0 t0 -61.01 135.21 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.999 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.27 120.03 53.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.31 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.9 pt -103.92 140.61 21.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.337 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.543 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.1 mt-10 -118.26 141.36 48.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 111.495 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.826 HD12 ' CE1' ' A' ' 164' ' ' TYR . 48.2 pt -125.63 139.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 33.2 p -105.81 108.16 19.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.919 0.39 . . . . 0.0 111.654 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.826 ' CE1' HD12 ' A' ' 162' ' ' ILE . 39.6 m-85 -120.49 123.75 43.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.707 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 59.29 34.34 22.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.39 83.4 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.062 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.5 mttt -119.45 138.43 53.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.791 0.295 . . . . 0.0 111.09 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 9.6 t -108.6 131.79 54.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.115 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.4 m-85 -120.01 140.03 51.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 96.8 mttt -97.2 127.25 43.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.12 134.5 54.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -79.49 122.26 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.522 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 84.6 mt -73.03 -57.9 3.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.083 0.468 . . . . 0.0 111.195 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.843 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.1 mt-10 -159.92 145.84 15.67 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.852 ' CB ' HD11 ' A' ' 185' ' ' ILE . 5.4 m -140.24 160.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -110.93 103.66 55.06 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 81.0 Cg_endo -100.25 171.18 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.605 2.87 . . . . 0.0 113.041 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 70.5 mm-40 -99.97 3.74 44.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.038 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.4 m -136.25 160.52 38.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.09 -13.11 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.341 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.8 p -67.9 -13.1 61.88 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.652 0.263 . . . . 0.0 111.428 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.681 ' HE3' HG22 ' A' ' 176' ' ' VAL . 4.8 tptm 49.99 41.84 23.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.322 0.582 . . . . 0.0 110.843 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.1 m -123.71 144.73 49.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.471 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 176' ' ' VAL . 20.2 mt -119.3 134.08 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.385 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 119' ' ' VAL . 64.2 m -142.21 100.09 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.011 0.434 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -149.42 113.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.856 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 66' ' ' PRO . 44.1 pt -103.21 -10.13 9.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.3 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -89.96 -79.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 14.6 t -172.52 -161.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.439 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' THR . 96.5 m-20 71.75 24.7 3.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.033 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 187' ' ' VAL . 21.1 tp -117.98 132.41 56.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 125' ' ' VAL . 47.1 t -94.59 124.84 47.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.766 HG22 ' CG1' ' A' ' 125' ' ' VAL . 76.3 p -115.93 149.77 38.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.28 135.82 52.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.76 138.85 39.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.157 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.7 162.49 28.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 53.0 Cg_endo -68.24 153.61 74.11 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.966 1.777 . . . . 0.0 112.03 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.794 ' HG2' HG22 ' A' ' 132' ' ' VAL . 75.8 Cg_exo -51.09 169.2 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.626 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 200' ' ' VAL . 17.1 m -90.31 119.98 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.098 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.22 25.44 20.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.239 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.95 129.74 45.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.972 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.28 139.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.956 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -93.58 120.81 65.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.92 16.41 1.48 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.543 2.162 . . . . 0.0 112.798 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.84 140.03 36.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -97.66 122.55 40.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.797 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.465 ' CE2' ' HA2' ' A' ' 4' ' ' GLY . 47.1 p90 -148.02 160.35 42.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -59.9 -38.95 83.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.328 . . . . 0.0 110.993 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 2' ' ' PHE . . . 100.8 16.93 24.8 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.337 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.517 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 64.9 t80 -73.8 133.46 43.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -59.88 139.76 57.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.426 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -60.27 -39.92 88.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.686 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.84 139.7 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.231 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.66 -172.58 40.97 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.715 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 5' ' ' PHE . . . 179.97 179.04 48.8 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.75 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.28 -1.0 87.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.849 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -100.03 120.01 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.536 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.23 -162.39 33.71 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.391 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.01 140.04 51.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 17' ' ' MET . 60.8 t -109.23 122.56 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.15 7.55 46.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.625 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.539 ' H ' HG12 ' A' ' 15' ' ' VAL . 3.9 ttt -95.45 119.79 64.76 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.621 0.248 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' MET . 35.6 Cg_exo -61.27 157.67 39.15 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.73 2.287 . . . . 0.0 112.442 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.643 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.8 mt-30 -105.77 118.53 36.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.48 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.716 ' HA ' ' O ' ' A' ' 116' ' ' SER . 58.5 p -121.07 126.55 50.11 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 115' ' ' SER . 72.6 t80 -121.09 120.42 35.27 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 98.9 mt-10 -98.29 140.99 31.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 71.3 mt-10 -149.96 159.99 43.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.615 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 55.2 p90 -100.2 120.21 39.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.162 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.957 ' HB3' HG21 ' A' ' 94' ' ' VAL . 94.4 m-85 -120.19 140.36 51.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 76.4 mtp85 -82.31 142.66 31.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.393 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 50.6 m -84.48 135.4 34.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.899 0.38 . . . . 0.0 111.796 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 21.5 m-85 -129.71 137.21 30.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.249 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 33' ' ' MET . 95.4 Cg_endo -79.26 92.24 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.684 2.256 . . . . 0.0 112.965 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.797 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 85.0 mt -59.96 -40.02 81.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.983 0.421 . . . . 0.0 110.601 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.87 87.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.729 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.42 -31.07 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.71 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.575 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 94.4 mmm -59.21 145.01 44.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.546 ' HB3' HG12 ' A' ' 37' ' ' ILE . 19.6 t-20 -59.88 139.87 57.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.372 0.606 . . . . 0.0 112.359 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.91 -38.89 83.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.023 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 92.7 mtt-85 -59.87 -40.0 87.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.366 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 34' ' ' ASN . 47.6 pt -95.49 -1.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.575 ' HG3' ' HB2' ' A' ' 33' ' ' MET . 79.2 mmt-85 -125.43 155.75 39.93 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.033 0.444 . . . . 0.0 111.793 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -101.01 133.25 45.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.555 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -39.92 88.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.218 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -39.86 87.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.08 84.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -60.01 -40.27 88.65 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 111.308 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.45 4.12 40.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.642 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.11 -174.49 28.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.232 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.35 32.46 6.8 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.695 ' HD2' HD13 ' A' ' 85' ' ' LEU . 36.6 ttpt -102.55 129.5 49.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.208 -0.496 . . . . 0.0 112.096 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 50' ' ' LEU . 41.7 pt -131.73 161.07 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.818 ' C ' HD22 ' A' ' 50' ' ' LEU . 93.0 m-85 -104.06 133.39 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.062 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.3 mm? -133.08 157.58 77.96 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.391 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.1 Cg_endo -75.24 132.55 15.22 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.21 2.607 . . . . 0.0 112.753 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 52.2 Cg_exo -53.59 -15.23 6.03 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 113.32 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 m -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.146 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.69 87.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.049 0.452 . . . . 0.0 111.088 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.881 HD21 ' CE1' ' A' ' 87' ' ' PHE . 68.7 mt -59.92 -39.75 86.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 109.974 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 73.3 mmtt -66.67 -39.94 88.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.294 0.569 . . . . 0.0 109.976 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.863 HD13 ' SD ' ' A' ' 67' ' ' MET . 90.8 mt -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -56.69 -38.19 71.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.037 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.666 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -59.98 -38.27 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.77 1.34 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.04 39.96 19.22 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.784 0.326 . . . . 0.0 111.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.592 HG22 ' HG2' ' A' ' 67' ' ' MET . 82.1 mt -88.5 120.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.186 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -95.77 140.21 30.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.619 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.553 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 51.8 p90 -87.17 159.67 50.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 34.9 Cg_exo -60.53 134.41 12.05 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.522 0.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.863 ' SD ' HD13 ' A' ' 58' ' ' LEU . 74.3 mtm -98.82 140.4 33.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.208 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 153' ' ' THR . 1.9 mp -97.42 127.46 43.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.215 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 116' ' ' SER . 89.3 m-85 -119.95 140.08 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.506 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.02 129.98 55.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.151 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 114' ' ' ILE . 1.4 mp -97.14 123.22 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.686 0.279 . . . . 0.0 111.078 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.701 ' HA ' HG12 ' A' ' 79' ' ' VAL . 90.8 m -114.02 121.28 43.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.398 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . . . -117.23 139.18 51.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 98.6 m-20 62.27 147.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.344 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.96 -40.67 89.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -133.13 8.41 4.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.404 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . -67.92 -105.73 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.849 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.41 157.41 46.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.924 0.392 . . . . 0.0 111.287 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 72' ' ' THR . 33.3 m -129.77 136.69 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.553 ' OG1' ' HG ' ' A' ' 104' ' ' LEU . 41.9 m -99.04 148.79 23.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -119.74 131.12 55.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.759 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.16 175.24 44.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.716 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.64 -175.06 25.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.478 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.97 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 0.0 111.559 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.695 HD13 ' HD2' ' A' ' 47' ' ' LYS . 65.0 tp -93.4 -79.98 0.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.341 0.591 . . . . 0.0 110.863 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -152.44 159.21 43.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.587 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.881 ' CE1' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -100.97 118.0 36.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.16 -4.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.96 99.68 12.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.391 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.09 -39.93 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.1 -30.26 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.633 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.688 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 104.34 68.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.421 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 84.8 mtt85 -119.98 141.05 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.918 0.39 . . . . 0.0 110.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.957 HG21 ' HB3' ' A' ' 25' ' ' PHE . 88.9 t -129.24 133.41 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 112.173 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.797 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 85.5 m-85 -117.23 139.12 51.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -132.86 147.11 64.17 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' HD2' ' SD ' ' A' ' 100' ' ' MET . 93.3 Cg_endo -83.97 -170.44 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 112.626 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.5 -27.1 68.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.036 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.492 ' CH2' ' HZ ' ' A' ' 151' ' ' PHE . 19.6 m95 -59.95 -49.49 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.916 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.551 ' HA ' HG21 ' A' ' 80' ' ' THR . 65.1 mtt -68.57 -40.04 80.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.315 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 57.8 ttm -62.37 -49.87 73.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.794 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.26 -39.92 78.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.423 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -67.47 -40.07 85.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.223 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.79 HD22 ' CB ' ' A' ' 73' ' ' ALA . 86.0 mt -88.57 -20.59 24.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.502 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.57 76.39 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.454 HD12 ' OG ' ' A' ' 110' ' ' SER . 45.1 pt -112.97 140.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 111.738 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.9 pm0 -95.91 162.33 24.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 99.5 Cg_exo -43.32 146.17 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.581 2.187 . . . . 0.0 112.694 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.97 75.51 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.105 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 106' ' ' ILE . 89.4 p -77.31 163.14 26.74 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.769 -0.253 . . . . 0.0 110.718 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.49 139.85 30.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.726 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 67.8 tp -126.5 124.86 41.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -111.97 120.1 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.857 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 ' CD2' ' A' ' 25' ' ' PHE . 47.2 pt -118.18 134.58 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.126 0.489 . . . . 0.0 111.047 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 30.7 t -119.99 128.72 53.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.956 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.2 t -65.6 117.66 8.38 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 90.6 m -119.27 129.87 55.13 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.433 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.1 t0 -100.39 117.67 35.05 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 186' ' ' CYS . 26.4 m -113.09 151.6 44.32 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.982 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 88.8 Cg_endo -78.87 159.32 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.572 2.181 . . . . 0.0 111.539 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 121' ' ' LEU . 6.5 mp -74.94 126.42 30.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.09 157.15 46.44 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.503 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.43 -28.97 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.739 0.27 . . . . 0.0 111.69 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.54 ' HE2' ' HE3' ' A' ' 126' ' ' LYS . 65.0 t80 -142.23 130.18 21.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.869 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 176' ' ' VAL . 13.2 p -132.89 131.85 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.905 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 96.1 mttt -102.04 125.81 48.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.455 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 171' ' ' ILE . 89.8 mt -110.02 136.06 49.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.523 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -99.54 111.3 61.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.58 160.37 31.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.736 2.29 . . . . 0.0 112.615 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.495 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 95.1 mt-30 -128.83 122.13 29.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.191 0.519 . . . . 0.0 110.289 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 69.09 134.28 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.524 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.3 -21.39 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.94 -40.54 89.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 75.6 t80 -59.93 -40.55 89.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.31 -9.06 59.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.712 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.99 -12.82 61.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.565 0.222 . . . . 0.0 111.395 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -59.98 139.59 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.3 p -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.506 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 137' ' ' ILE . 13.1 m-20 -129.26 74.34 81.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.514 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.704 ' O ' HD23 ' A' ' 144' ' ' LEU . 56.9 Cg_endo -71.94 -35.51 7.19 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.569 2.179 . . . . 0.0 112.239 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.91 97.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.846 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.629 HG13 ' CZ ' ' A' ' 164' ' ' TYR . 97.4 t -60.43 -42.2 90.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 140' ' ' PRO . 4.1 mm? -59.91 -40.11 87.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.94 -42.93 95.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.666 0.269 . . . . 0.0 110.636 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -62.28 -41.0 98.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.595 HG21 HD12 ' A' ' 162' ' ' ILE . 84.4 t -63.35 -40.2 88.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.385 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.52 ' CD2' HD11 ' A' ' 154' ' ' LEU . 94.3 mt -60.07 -40.45 89.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -63.14 -39.93 96.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.117 0.484 . . . . 0.0 110.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.96 -39.93 91.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.708 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.608 ' O ' HG13 ' A' ' 187' ' ' VAL . 42.1 m-85 -94.68 122.25 37.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 111.174 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.542 ' HB2' HG12 ' A' ' 188' ' ' ILE . 90.0 p -71.5 -33.68 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.657 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.783 ' HB ' HD23 ' A' ' 68' ' ' LEU . 7.8 t -136.26 141.21 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 111.907 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.725 ' HG ' HG11 ' A' ' 187' ' ' VAL . 83.6 mt -119.92 127.23 52.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.466 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 38.2 p -121.5 145.27 48.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.5 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.747 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.7 t -60.07 -39.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 0.0 111.309 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.74 -37.02 83.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.845 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.0 t0 -68.72 129.99 41.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.9 p -98.58 119.98 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 171' ' ' ILE . 45.8 pt -99.89 134.82 38.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 112.061 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 50.4 mt-10 -113.97 141.13 47.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.593 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.761 HD11 ' CE1' ' A' ' 164' ' ' TYR . 16.7 tt -121.26 129.98 75.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.355 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 23.3 p -108.7 110.07 21.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 111.753 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.761 ' CE1' HD11 ' A' ' 162' ' ' ILE . 5.5 m-85 -126.24 126.71 44.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.33 34.22 23.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.239 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.0 16.01 77.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.6 mttm -117.75 138.49 52.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.782 0.291 . . . . 0.0 110.57 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.2 p -110.93 131.08 55.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.058 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 93.7 m-85 -119.98 139.9 51.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 61.7 mtpt -103.81 127.19 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 160' ' ' ILE . 49.0 mm -119.96 129.21 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -114.92 133.32 56.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.633 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.747 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.9 OUTLIER -70.0 98.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.119 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.487 HD22 ' HD3' ' A' ' 126' ' ' LYS . 8.8 tt -60.02 -52.25 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.709 0.29 . . . . 0.0 111.742 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.905 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 83.4 tt0 -162.7 139.02 7.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.347 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -141.26 152.88 19.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.201 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 103.87 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 71.8 Cg_endo -100.68 175.15 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.72 2.946 . . . . 0.0 112.435 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.8 mt-10 -94.05 0.04 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.976 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -136.64 154.33 50.68 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.956 0.408 . . . . 0.0 111.34 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.03 -11.84 61.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.523 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.1 m -69.96 -9.42 55.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.498 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 59.95 38.67 20.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.224 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 56.2 m -130.05 135.79 48.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.612 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.3 pt -129.96 160.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 111.768 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HG23 ' A' ' 119' ' ' VAL . 46.4 t -99.94 120.46 39.83 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.725 HG11 ' HG ' ' A' ' 154' ' ' LEU . 9.7 p -110.66 14.59 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.412 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.748 HD11 ' HG ' ' A' ' 68' ' ' LEU . 91.0 mt -59.96 -46.28 94.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.481 ' HG3' HG22 ' A' ' 188' ' ' ILE . 98.9 mt-10 -155.88 81.59 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.229 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 187' ' ' VAL . 12.7 t -150.05 157.36 43.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.899 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -87.93 103.78 16.0 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.509 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.8 tp -119.94 134.17 55.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.2 t -97.3 122.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.484 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 70.2 p -102.5 142.46 33.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.568 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -129.55 146.54 51.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.68 139.91 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.319 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -108.92 165.95 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 77.4 Cg_exo -51.24 149.79 15.74 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.621 2.214 . . . . 0.0 112.461 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.95 164.16 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.685 2.256 . . . . 0.0 112.469 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.94 135.1 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.222 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.14 -28.64 10.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.572 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -101.53 127.09 48.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.97 130.84 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.406 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.96 119.99 58.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.25 140.9 73.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.42 2.08 . . . . 0.0 112.291 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.28 129.04 45.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.755 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -99.01 127.05 44.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.871 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.901 0.381 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.08 139.82 51.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.565 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 29.0 t -130.83 138.75 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.639 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.39 74.29 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.214 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 3' ' ' SER . 98.8 m-85 61.56 19.99 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.099 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -130.58 139.71 50.44 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.697 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.5 m -120.31 124.05 44.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.193 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.592 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 71.9 t80 -60.31 -40.0 88.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.59 -7.27 82.23 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.078 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' H ' ' HD2' ' A' ' 8' ' ' PHE . . . -119.94 -14.04 5.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.489 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.3 -153.21 51.67 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.983 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.16 -39.94 88.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 0.0 110.791 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.9 46.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.216 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -99.72 113.34 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.097 0.475 . . . . 0.0 109.972 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.14 11.37 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.439 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.5 t30 59.97 36.32 21.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.09 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mtt -104.41 132.26 21.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.009 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 13.8 Cg_endo -55.6 158.4 13.26 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.608 2.205 . . . . 0.0 111.779 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.1 mt-30 -99.83 126.69 45.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.6 p -119.8 126.28 50.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.1 0.476 . . . . 0.0 111.76 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 115' ' ' SER . 65.9 t80 -120.17 124.35 45.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.618 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.51 129.94 55.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CD ' ' CZ ' ' A' ' 25' ' ' PHE . 81.7 tt0 -148.05 154.93 40.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.128 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -105.25 127.19 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.712 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.676 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.6 m-85 -133.47 159.98 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.719 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -96.06 127.88 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.512 ' HB3' HD22 ' A' ' 112' ' ' LEU . 28.7 p -91.37 143.62 26.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.517 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 93' ' ' ARG . 20.1 m-85 -129.95 153.34 80.97 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.502 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HB2' ' HG2' ' A' ' 32' ' ' MET . 89.6 Cg_endo -78.28 103.67 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.798 2.332 . . . . 0.0 112.968 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.766 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.5 mt -60.75 -40.07 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.113 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.7 68.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.389 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.615 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 97.2 mmm -67.71 -38.68 83.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 91.2 mtp -64.89 148.66 51.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -59.53 140.94 55.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.057 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.51 -21.02 63.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.056 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.973 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 pt -99.99 1.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.094 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -127.03 159.33 34.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.151 0.501 . . . . 0.0 111.691 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -99.96 129.71 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.969 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.12 88.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.23 -39.95 88.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.262 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.21 76.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -60.07 -40.61 90.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.033 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.83 1.52 40.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.242 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.29 -170.63 34.86 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.99 31.48 7.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.817 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' HD11 ' A' ' 85' ' ' LEU . 62.0 mttp -99.71 121.96 42.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.98 0.419 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.715 HD12 HD11 ' A' ' 50' ' ' LEU . 48.4 pt -119.42 149.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.745 ' CE1' ' HB2' ' A' ' 89' ' ' ALA . 65.3 t80 -104.77 127.84 52.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.632 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 114' ' ' ILE . 2.0 mp -133.39 160.02 70.26 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.646 0.26 . . . . 0.0 111.512 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.674 ' CA ' ' HB3' ' A' ' 89' ' ' ALA . 62.8 Cg_endo -72.32 147.76 47.87 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.766 2.31 . . . . 0.0 112.595 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 89' ' ' ALA . 27.3 Cg_exo -62.55 -19.0 66.48 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.866 2.377 . . . . 0.0 112.878 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.676 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -65.51 -43.42 90.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.092 0.473 . . . . 0.0 110.961 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 57.9 tp -60.28 -42.23 94.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.233 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -60.11 -40.1 88.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.065 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -40.09 90.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 69' ' ' PHE . 96.7 mt -63.63 -38.39 90.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.7 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.4 m -60.01 -37.96 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.11 -36.55 77.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.28 -1.77 42.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.296 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.96 40.59 18.75 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.595 ' CD1' HD22 ' A' ' 58' ' ' LEU . 85.4 mt -73.17 130.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.404 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -66.08 140.08 58.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.654 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.717 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 16.3 t80 -96.53 147.17 32.54 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.717 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 24.4 Cg_exo -66.96 155.45 84.14 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.149 -1.188 . . . . 0.0 113.062 0.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.441 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 66.6 mtt -90.86 140.29 29.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 117' ' ' THR . 35.7 mt -105.75 141.0 37.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.079 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.711 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 60.5 m-85 -133.41 147.0 51.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.431 . . . . 0.0 112.108 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 97.7 mttt -121.39 137.91 54.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.19 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.671 ' C ' HG23 ' A' ' 79' ' ' VAL . 86.5 mt -99.2 119.99 38.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.29 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -108.05 125.52 51.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.751 0.31 . . . . 0.0 111.665 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . . . -100.49 119.97 39.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.921 0.391 . . . . 0.0 110.676 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.15 -39.87 82.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.04 -39.84 87.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -106.16 -13.81 15.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 70.08 8.17 61.04 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -100.18 140.0 35.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 71' ' ' LEU . 9.7 p -123.64 122.76 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.628 HG23 ' CG ' ' A' ' 158' ' ' ASP . 60.5 m -106.06 134.84 48.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.323 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.64 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 3.4 t-80 -84.41 114.72 22.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.02 172.72 20.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.281 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -100.09 162.29 19.18 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.443 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.674 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 9.7 p -130.01 136.59 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 0.0 111.78 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.702 HD11 ' HD3' ' A' ' 47' ' ' LYS . 94.3 mt -91.01 -77.21 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.529 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -148.69 160.08 43.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.057 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 55' ' ' LEU . 96.7 m-85 -106.22 116.63 32.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.602 HG13 ' C ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -140.78 11.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.784 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . . . -85.14 99.9 11.37 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.82 -40.0 72.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.01 0.433 . . . . 0.0 110.649 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.14 -30.29 67.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.385 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 100.07 64.59 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.07 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . 35.6 ptt-85 -123.41 143.42 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HG ' ' A' ' 50' ' ' LEU . 97.5 t -123.28 132.78 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.542 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.766 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.0 m-85 -120.41 139.88 52.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 96' ' ' LEU . 1.7 pt? -134.49 159.49 72.05 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.297 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.634 ' HG2' ' CG ' ' A' ' 100' ' ' MET . 58.7 Cg_endo -68.91 159.21 54.82 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.655 2.236 . . . . 0.0 112.744 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -60.07 -43.02 95.76 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 29.4 p-90 -64.52 -40.0 94.81 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.634 ' CG ' ' HG2' ' A' ' 97' ' ' PRO . 93.9 mmm -63.49 -40.15 96.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.751 0.31 . . . . 0.0 111.307 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.3 ttp -61.8 -42.42 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.57 -39.98 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -65.61 -40.35 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 93.1 mt -69.97 -23.73 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.49 72.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.901 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.9 pt -120.4 151.58 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.49 160.45 32.99 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.05 -2.82 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.589 2.192 . . . . 0.0 113.323 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.51 -14.06 22.76 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.626 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.532 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 90.8 p -81.48 161.29 23.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.991 0.424 . . . . 0.0 111.132 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.42 140.02 51.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.37 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 27' ' ' CYS . 60.5 tp -118.94 129.38 55.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 64.0 tt0 -106.75 125.85 51.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 50' ' ' LEU . 14.9 tt -117.97 126.63 75.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.62 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 44.8 t -120.13 131.77 55.16 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 1.2 m -83.46 114.9 21.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.488 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 34.3 p -122.07 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 112.203 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 57.4 t0 -115.19 113.11 23.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.933 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 186' ' ' CYS . 34.4 m -119.36 150.38 49.41 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.929 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 -175.6 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.484 2.123 . . . . 0.0 111.407 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 187' ' ' VAL . 3.8 mp -95.27 119.47 33.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 0.0 110.709 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -60.0 159.14 23.92 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.732 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.29 -29.03 9.54 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.613 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 126' ' ' LYS . 69.2 t80 -145.28 130.25 18.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.69 0.281 . . . . 0.0 111.395 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.784 HG23 ' CG1' ' A' ' 176' ' ' VAL . 4.2 p -133.78 130.08 55.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.093 0.473 . . . . 0.0 112.187 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD2' ' HG2' ' A' ' 175' ' ' GLU . 85.4 mttt -99.73 121.62 41.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 144' ' ' LEU . 85.6 mt -105.31 131.35 52.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 199' ' ' PRO . 37.8 tt0 -114.63 109.52 47.93 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.68 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HG3' HD11 ' A' ' 135' ' ' LEU . 88.2 Cg_endo -83.94 -168.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.648 2.232 . . . . 0.0 112.601 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -121.84 121.19 36.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.293 0.568 . . . . 0.0 109.982 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t 59.52 178.0 0.08 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.96 -11.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.695 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.08 -40.39 89.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.539 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HD2' HD12 ' A' ' 135' ' ' LEU . 64.9 t80 -60.35 -40.27 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.647 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 129' ' ' PRO . 9.6 mp -80.47 -10.03 59.75 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.776 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.89 -19.31 63.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.601 0.239 . . . . 0.0 111.277 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.46 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.6 mt -60.43 133.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.2 m -60.1 -39.98 88.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.417 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.1 m-20 -126.04 76.5 71.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 144' ' ' LEU . 40.8 Cg_endo -68.79 -30.13 27.69 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.426 2.084 . . . . 0.0 112.071 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.12 99.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 147' ' ' VAL . 98.1 t -61.73 -49.67 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.588 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.2 -39.99 88.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.659 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.01 -46.35 89.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -60.57 -40.39 91.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 0.0 110.247 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 162' ' ' ILE . 62.4 t -63.12 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.169 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 154' ' ' LEU . 86.9 mt -60.04 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -66.5 -40.01 88.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.11 -40.04 92.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.676 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 96.7 m-85 -101.6 118.74 37.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.6 m -62.65 -39.92 95.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.361 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.537 ' CG2' HD22 ' A' ' 68' ' ' LEU . 33.7 p -125.56 149.84 47.99 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 111.737 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 192' ' ' LEU . 86.1 mt -116.02 121.72 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.428 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 94.3 m -119.95 130.07 54.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.002 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.8 t -59.95 -40.03 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 111.684 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.92 -38.61 76.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.304 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.628 ' CG ' HG23 ' A' ' 80' ' ' THR . 87.9 m-20 -69.54 134.85 49.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.552 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.49 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 6.1 m -102.53 119.93 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.465 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 171' ' ' ILE . 46.7 pt -104.29 140.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 111.52 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -120.01 140.55 50.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 147' ' ' VAL . 46.2 pt -128.01 140.4 49.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.993 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 50.8 m -105.36 119.97 40.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.422 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -122.59 119.97 32.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.423 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.497 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.03 40.14 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 13.6 81.86 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.252 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -116.72 139.28 50.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.808 0.304 . . . . 0.0 110.393 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.5 m -113.38 129.73 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.81 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.0 139.98 51.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.8 mttt -103.5 123.49 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.072 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 160' ' ' ILE . 45.6 pt -124.51 131.82 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.947 0.403 . . . . 0.0 110.787 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 62.9 tttp -119.58 134.6 55.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.959 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -77.55 118.39 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.436 HD22 ' HG2' ' A' ' 175' ' ' GLU . 9.1 tt -62.62 -60.04 4.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.653 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.746 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 22.0 pt-20 -163.02 159.3 23.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.784 ' CG1' HG23 ' A' ' 125' ' ' VAL . 13.6 m -147.77 159.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.896 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.71 102.89 51.76 Favored Pre-proline 0 C--O 1.233 0.226 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.451 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 57.4 Cg_endo -104.71 0.24 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.166 3.244 . . . . 0.0 113.009 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.3 21.33 11.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -143.82 156.56 44.52 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.198 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 80.3 p -71.25 -20.15 62.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.485 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 60.8 m -59.99 -39.89 87.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.602 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 68.34 20.0 8.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.2 t -128.06 131.09 49.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.835 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.732 ' H ' HD13 ' A' ' 185' ' ' ILE . 0.2 OUTLIER -131.04 159.83 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.304 0.574 . . . . 0.0 112.514 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.501 ' HB2' HG22 ' A' ' 153' ' ' THR . 35.2 t -129.56 126.05 37.65 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.26 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -148.63 83.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.814 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 85.3 mt -69.83 -40.06 78.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.5 tt0 -66.02 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.794 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 189' ' ' GLU . 10.4 t -179.98 41.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.5 ' H ' ' CG2' ' A' ' 187' ' ' VAL . 91.2 m-20 -98.38 7.75 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.872 ' HB2' HG11 ' A' ' 187' ' ' VAL . 12.5 tp -107.38 129.57 54.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 110.782 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -96.79 120.4 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.285 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' THR . . . . . 0.649 ' HA ' HG13 ' A' ' 125' ' ' VAL . 59.6 p -99.99 145.57 27.72 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -130.01 140.05 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.961 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 144' ' ' LEU . 97.3 m-85 -101.15 120.29 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.468 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.42 118.51 12.72 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 56.5 Cg_endo -69.99 130.24 18.72 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.315 2.01 . . . . 0.0 112.139 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.506 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 23.8 Cg_endo -94.48 -3.28 2.63 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.116 2.544 . . . . 0.0 112.693 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.2 136.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 111.217 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.22 84.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.579 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -98.7 123.5 42.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.93 139.1 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.942 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.05 110.7 60.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.79 27.02 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.803 2.335 . . . . 0.0 112.653 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -100.01 122.13 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.59 123.67 44.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.776 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.876 0.282 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 117' ' ' THR . 92.3 mm-40 -100.09 123.6 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -119.59 128.08 53.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.181 0.515 . . . . 0.0 111.927 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 50.5 t80 -133.7 138.49 45.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.96 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -116.75 136.71 52.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.979 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 99.2 mt-10 -140.05 148.96 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.461 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -121.84 126.81 49.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.537 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HB2' HG21 ' A' ' 94' ' ' VAL . 89.6 m-85 -149.94 161.72 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 111' ' ' LEU . 90.0 mtt180 -92.85 130.82 38.33 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.879 ' HB2' HD11 ' A' ' 96' ' ' LEU . 17.5 p -101.19 147.81 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.95 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -130.11 148.74 70.94 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.709 ' O ' ' HG2' ' A' ' 32' ' ' MET . 55.4 Cg_endo -70.68 109.81 2.58 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.25 1.967 . . . . 0.0 112.44 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' A' ' 95' ' ' TYR . 84.1 mt -60.01 -26.7 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.476 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' HA ' HH12 ' A' ' 38' ' ' ARG . . . -58.24 -38.62 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.123 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.1 ptm -68.99 -23.64 64.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.742 0.306 . . . . 0.0 111.07 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.438 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 98.9 mtp -61.9 139.81 58.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 111.235 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.709 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.08 141.58 55.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.645 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.95 -39.91 87.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -60.0 -39.7 86.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.527 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.709 HG12 ' HB2' ' A' ' 34' ' ' ASN . 49.4 pt -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' HA ' ' A' ' 35' ' ' ASP . 22.0 ptt180 -128.29 160.1 33.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.579 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 88.1 tttt -100.46 134.56 43.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.07 -40.02 88.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.579 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 96.0 m-20 -61.5 -39.97 92.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.14 92.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.09 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.08 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.84 5.4 41.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.83 179.08 35.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.327 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -109.97 25.57 16.18 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.305 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.751 ' HD3' HD13 ' A' ' 85' ' ' LEU . 61.0 mttm -101.24 135.25 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.272 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.732 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.3 pt -120.24 156.54 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.256 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.5 ' O ' HD22 ' A' ' 50' ' ' LEU . 90.4 m-85 -100.25 130.48 46.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.569 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 HD12 ' A' ' 114' ' ' ILE . 4.0 mm? -129.8 163.31 47.91 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.831 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 60.4 Cg_endo -77.1 149.45 28.52 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.244 1.963 . . . . 0.0 112.82 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.82 -23.8 62.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -59.97 -39.99 87.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.075 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -68.07 -41.28 82.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.996 0.426 . . . . 0.0 110.998 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CD1' ' A' ' 87' ' ' PHE . 58.8 tp -60.95 -43.25 98.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.5 m -60.2 -40.27 89.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.54 -40.01 94.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.2 0.524 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 21' ' ' PHE . 88.2 mt -60.05 -39.98 87.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.046 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.2 m -59.83 -40.01 87.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.123 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -59.97 -36.27 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.254 0.549 . . . . 0.0 110.092 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' A' ' 63' ' ' ILE . 12.4 tp -79.98 1.11 28.75 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.51 47.99 8.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 61' ' ' LEU . 49.2 mm -86.46 121.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -70.21 140.0 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.746 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 40.3 t80 -88.25 147.14 39.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.716 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.746 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 15.0 Cg_exo -71.09 158.91 94.52 Favored 'Cis proline' 0 C--N 1.352 0.752 0 C-N-CA 124.567 -1.014 . . . . 0.0 113.138 0.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 58' ' ' LEU . 68.0 mtt -95.52 139.45 31.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.476 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD22 HG23 ' A' ' 153' ' ' THR . 82.4 mt -107.16 138.33 43.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.716 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.799 ' HB3' HG23 ' A' ' 114' ' ' ILE . 12.3 m-30 -120.09 140.02 51.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.044 0.449 . . . . 0.0 112.027 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HB3' ' OG ' ' A' ' 115' ' ' SER . 62.6 tttp -119.02 130.18 55.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.744 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -94.25 133.21 38.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.955 ' HA ' HG12 ' A' ' 79' ' ' VAL . 94.2 m -120.01 129.94 54.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.318 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.13 110.82 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.193 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -67.65 -40.0 84.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.531 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -39.92 87.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.502 HG21 ' HA3' ' A' ' 105' ' ' GLY . 67.1 p -101.29 -13.48 18.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.487 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 0.25 26.11 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.795 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -100.4 139.95 35.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 72' ' ' THR . 13.1 m -121.7 117.42 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.021 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.411 HG22 ' OD1' ' A' ' 158' ' ' ASP . 72.0 p -100.97 155.87 17.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CE1' ' HZ2' ' A' ' 70' ' ' LYS . 63.3 m80 -100.4 114.84 28.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 110.621 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.74 160.01 15.66 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.923 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.732 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.99 164.3 22.56 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.027 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -127.83 133.52 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 117.26 0.53 . . . . 0.0 112.266 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.5 tp -92.03 -78.83 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.911 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -150.78 160.02 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.595 ' CD1' HD22 ' A' ' 55' ' ' LEU . 76.1 m-85 -94.93 116.63 28.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.7 pt -125.89 -8.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -99.55 103.68 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.379 . . . . 0.0 111.786 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.56 -39.98 92.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.293 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.65 -30.33 69.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.179 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.66 74.38 0.79 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.522 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -119.9 140.72 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.323 . . . . 0.0 110.775 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 50' ' ' LEU . 57.3 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 30' ' ' ILE . 87.1 m-85 -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.545 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.879 HD11 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -137.6 156.85 74.58 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.917 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.728 ' HG2' ' HB2' ' A' ' 100' ' ' MET . 37.8 Cg_endo -68.8 158.54 57.43 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.045 1.83 . . . . 0.0 111.459 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.25 -41.13 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 48.1 p-90 -65.76 -38.55 89.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.728 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . 58.2 ttm -60.04 -40.12 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.358 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.615 ' HG3' HD23 ' A' ' 96' ' ' LEU . 97.8 mtp -59.89 -40.01 87.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.92 -40.06 94.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -66.89 -40.23 87.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.357 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.2 mt -70.58 -24.31 62.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.329 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.502 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 72.53 28.85 66.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.5 pt -117.75 142.87 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.409 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.9 pt20 -96.39 159.96 30.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.746 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 85.5 Cg_exo -44.7 138.42 8.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.564 2.176 . . . . 0.0 112.537 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.03 -9.98 75.53 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.765 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.5 m -71.58 150.04 45.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 26' ' ' ARG . 87.3 mt -75.68 144.65 41.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.684 HD23 HG11 ' A' ' 94' ' ' VAL . 59.0 tp -127.05 130.98 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.079 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 97.4 mt-30 -104.3 128.95 52.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.01 HD12 HD11 ' A' ' 50' ' ' LEU . 91.9 mt -119.4 122.69 69.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 74.7 p -121.6 139.28 53.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.53 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.785 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 32.4 m -85.29 122.39 29.39 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 10.0 t -130.02 138.44 50.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.47 128.8 54.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.385 . . . . 0.0 110.344 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 121' ' ' LEU . 33.2 m -115.52 152.25 46.92 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.731 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HB2' ' OE1' ' A' ' 179' ' ' GLU . 67.4 Cg_endo -73.84 16.46 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.187 1.925 . . . . 0.0 112.537 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.929 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.8 mp 64.57 108.32 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.369 . . . . 0.0 111.454 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.93 167.94 1.6 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.55 -28.2 9.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.675 0.238 . . . . 0.0 111.585 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -142.46 132.1 23.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.369 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.7 p -131.33 130.17 62.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 111.327 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 88.3 tttt -99.7 120.09 39.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.66 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 171' ' ' ILE . 85.5 mt -111.44 140.49 45.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 111.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.536 ' OE1' ' HE2' ' A' ' 172' ' ' LYS . 45.0 tt0 -91.71 117.2 67.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.03 159.79 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.516 2.144 . . . . 0.0 112.167 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -136.19 121.51 19.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.2 m 66.79 135.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.29 -21.13 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.87 -40.06 87.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.488 ' HD1' HD12 ' A' ' 135' ' ' LEU . 60.9 t80 -60.03 -40.06 88.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.756 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.488 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -80.72 -10.53 59.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.5 -10.22 59.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.281 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.0 mt -64.18 139.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.745 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.1 p -59.96 -40.05 87.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.349 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 137' ' ' ILE . 6.6 m-20 -127.12 71.92 76.29 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.788 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.92 -32.99 93.12 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.631 2.221 . . . . 0.0 111.879 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.19 -40.2 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.12 97.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.3 t -60.06 -41.15 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 194' ' ' THR . 3.1 tm? -60.3 -44.01 95.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.194 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.1 -39.93 87.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.6 -40.03 95.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 162' ' ' ILE . 75.7 t -61.78 -42.95 96.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HD11 ' A' ' 154' ' ' LEU . 89.6 mt -60.01 -40.05 87.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -65.04 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.86 -40.02 96.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.518 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 96.9 m-85 -105.56 119.69 39.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.768 0.318 . . . . 0.0 111.179 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.465 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 42.7 p -69.83 -35.79 75.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.721 HG23 HD22 ' A' ' 68' ' ' LEU . 34.3 p -124.56 140.32 53.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 111.607 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.683 ' HB2' HG13 ' A' ' 185' ' ' ILE . 90.5 mt -122.1 130.17 53.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.6 m -119.78 140.12 51.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.015 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 176' ' ' VAL . 98.3 t -60.05 -40.47 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.175 0.512 . . . . 0.0 110.652 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 155' ' ' THR . 11.0 t70 -74.74 -29.43 61.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 93.9 m-20 -78.45 140.14 38.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.93 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.68 120.07 55.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.921 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.454 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.7 pt -103.38 137.93 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.927 0.394 . . . . 0.0 111.379 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 170' ' ' LYS . 99.0 mt-10 -119.98 140.05 51.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.205 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 147' ' ' VAL . 6.0 tt -116.21 135.61 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.729 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.0 t -109.76 115.19 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -123.56 127.35 48.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.5 t30 51.73 40.05 26.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.687 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.56 9.8 86.51 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.975 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 59.5 mttm -111.1 144.1 40.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.8 m -114.75 130.79 56.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.79 140.07 51.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.67 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 62.4 mttp -100.32 121.62 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.552 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.876 HG22 HD22 ' A' ' 127' ' ' LEU . 85.3 mt -120.02 120.01 61.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.711 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 38.5 ttpt -116.2 125.55 52.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 156' ' ' VAL . 4.9 mp -78.45 83.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.429 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 172' ' ' LYS . 76.3 mt -59.99 -49.97 75.6 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 98.9 mt-10 -152.39 138.99 18.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.024 0.44 . . . . 0.0 111.735 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.848 HG11 HD13 ' A' ' 185' ' ' ILE . 16.7 m -140.33 151.57 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.686 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -96.18 104.77 18.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 65.0 Cg_endo -100.3 167.42 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.286 2.657 . . . . 0.0 112.706 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.92 -0.08 40.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.4 p -139.83 159.79 41.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.007 0.432 . . . . 0.0 111.376 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.2 m -70.08 -10.3 58.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 t -57.76 -25.75 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.286 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 181' ' ' SER . 34.2 mmtp 60.02 39.97 19.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.756 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -128.29 139.69 52.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.64 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.848 HD13 HG11 ' A' ' 176' ' ' VAL . 39.9 pt -127.32 131.53 70.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 153' ' ' THR . 23.3 m -139.97 119.95 13.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.08 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 187' ' ' VAL . 9.1 p -118.15 112.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.749 0.785 . . . . 0.0 111.171 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.619 HD13 ' HD2' ' A' ' 66' ' ' PRO . 55.5 mt -71.59 -60.72 2.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.547 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.08 -79.94 0.33 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.1 t -168.05 41.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.929 ' HB2' HD23 ' A' ' 121' ' ' LEU . 94.7 m-20 -88.76 2.09 54.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.548 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.425 ' H ' HG21 ' A' ' 187' ' ' VAL . 56.1 tp -111.6 130.32 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 125' ' ' VAL . 25.6 t -97.35 129.07 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.754 HG21 HD11 ' A' ' 144' ' ' LEU . 69.7 p -112.95 139.82 48.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.36 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.03 140.88 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.417 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 98.3 m-85 -100.02 121.11 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.48 110.48 28.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo . . . . . 0 C--N 1.347 0.488 0 C-N-CA 122.256 1.97 . . . . 0.0 112.26 -179.63 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 65.0 Cg_exo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.825 0.26 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.582 ' OE1' HD13 ' A' ' 63' ' ' ILE . 78.1 mt-30 -112.11 127.15 55.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.0 m -120.02 131.12 55.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.024 0.44 . . . . 0.0 111.755 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 27.7 t80 -124.11 141.06 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.301 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.04 130.58 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.16 0.505 . . . . 0.0 112.045 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -141.83 156.54 45.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.438 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -116.06 124.36 50.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.747 0.308 . . . . 0.0 110.692 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' ' 114' ' ' ILE . 90.8 m-85 -136.03 150.92 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.671 ' HD2' ' HG2' ' A' ' 93' ' ' ARG . 7.4 ptp180 -82.24 143.76 31.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.842 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.785 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 46.5 t -98.99 123.14 43.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 112.175 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CB ' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m-85 -117.85 146.24 38.47 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 32' ' ' MET . 71.8 Cg_endo -77.72 105.27 2.0 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.717 2.278 . . . . 0.0 112.953 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.852 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.4 mt -61.39 -40.02 84.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.847 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.02 75.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.814 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.425 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . 97.7 mmm -68.34 -30.98 70.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 99.7 mmm -60.34 148.54 36.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -59.94 150.24 29.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.98 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.6 m-20 -59.93 -40.05 87.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -64.4 -40.19 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.77 -40.91 77.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 35' ' ' ASP . 84.5 mmt-85 -122.58 140.08 53.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.798 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 9.8 mtpm? -80.58 149.35 29.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.1 -40.03 88.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.04 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.99 87.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.88 80.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.071 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.659 ' OD1' HG22 ' A' ' 30' ' ' ILE . 98.5 m-20 -60.03 -39.89 87.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.964 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.65 16.76 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.98 168.6 26.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.329 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.15 16.36 58.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.118 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.719 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.1 mttt -100.72 135.57 41.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 111.129 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.5 pt -118.75 150.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.201 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.753 ' O ' HG23 ' A' ' 94' ' ' VAL . 90.1 m-85 -100.51 131.91 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.986 0.422 . . . . 0.0 111.018 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 114' ' ' ILE . 5.4 mp -132.67 162.0 59.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 80.3 Cg_endo -77.28 153.05 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.166 1.91 . . . . 0.0 112.904 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 18.9 Cg_exo -66.27 -18.31 55.47 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.145 2.563 . . . . 0.0 112.545 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.8 t -60.01 -40.0 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.18 82.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.16 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.684 HD21 ' CE1' ' A' ' 87' ' ' PHE . 81.5 mt -60.09 -41.37 92.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.695 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.1 m -60.02 -40.12 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.417 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -68.23 -39.99 82.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 HG13 ' A' ' 63' ' ' ILE . 95.7 mt -60.1 -39.88 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.158 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -59.97 -40.05 87.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 110.261 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -60.01 -39.96 87.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.508 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 21' ' ' PHE . 88.6 mt -81.24 -0.07 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.821 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 39.96 19.29 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.48 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD13 ' OE1' ' A' ' 19' ' ' GLN . 41.4 mm -68.13 136.79 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.682 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -92.42 140.2 29.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.421 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.486 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 43.7 p90 -87.29 155.74 54.4 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.788 ' CD ' HD11 ' A' ' 188' ' ' ILE . 18.0 Cg_exo -66.88 162.49 74.09 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.758 0.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -95.0 130.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.821 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.874 HD11 ' SG ' ' A' ' 186' ' ' CYS . 65.0 mt -114.67 140.1 49.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.653 ' HB3' HG23 ' A' ' 114' ' ' ILE . 35.7 m-85 -120.01 140.08 51.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.734 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.754 ' HG2' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -117.03 130.38 56.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.978 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 112' ' ' LEU . 50.9 mt -96.0 120.98 37.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.82 HG23 HG22 ' A' ' 79' ' ' VAL . 97.3 m -104.03 120.06 40.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.28 115.38 30.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.605 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -67.83 -39.96 83.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.957 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 m -97.16 -14.96 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.34 -6.08 4.69 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.682 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.632 HH21 ' HB3' ' A' ' 157' ' ' ASP . 78.8 ttt180 -100.68 139.97 35.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.82 HG22 HG23 ' A' ' 72' ' ' THR . 47.3 t -118.08 119.99 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.3 p -99.93 159.62 14.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.621 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 74.5 m80 -101.74 115.14 29.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 110.655 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.21 158.26 18.93 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.939 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -91.68 157.07 24.28 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 8.4 p -127.97 134.07 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 117.294 0.547 . . . . 0.0 112.341 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 ' HD3' ' A' ' 47' ' ' LYS . 44.4 tp -91.84 -79.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.558 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -142.65 159.71 41.7 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.719 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 55' ' ' LEU . 72.5 m-85 -97.72 116.39 29.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.61 -4.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -84.58 98.17 10.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.417 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.87 -39.88 76.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 0.0 110.519 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.51 -30.67 71.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.363 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.0 42.97 1.14 Allowed Glycine 0 C--N 1.32 -0.323 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.684 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.671 ' HG2' ' HD2' ' A' ' 26' ' ' ARG . 29.4 mtm105 -117.15 150.9 37.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 112.151 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.769 HG21 HD11 ' A' ' 114' ' ' ILE . 14.8 p -128.78 145.03 36.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.219 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.852 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.1 m-85 -120.54 141.93 49.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.44 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 30' ' ' ILE . 69.8 mt -120.21 142.49 33.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.925 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' MET . 51.3 Cg_exo -57.95 156.97 26.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.511 2.141 . . . . 0.0 111.836 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.03 -41.97 93.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.789 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.645 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 49.3 p-90 -70.0 -40.11 75.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.281 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.645 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 97.4 mtp -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.647 0.26 . . . . 0.0 111.037 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.2 mtp -60.06 -40.03 88.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.052 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 -40.01 94.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 110.496 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.966 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 71' ' ' LEU . 85.8 mt -69.09 -24.25 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.29 29.96 65.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.589 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.593 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 45.6 pt -116.29 144.8 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.333 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -97.4 160.2 29.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.605 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 7.8 Cg_endo -49.2 135.22 31.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.591 2.194 . . . . 0.0 112.136 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 -6.51 82.64 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.699 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.593 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 93.1 p -74.61 157.39 35.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 110.659 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.85 140.03 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.981 0.42 . . . . 0.0 111.02 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.907 HD11 HD22 ' A' ' 71' ' ' LEU . 61.6 tp -127.05 130.13 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.417 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.685 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 64.0 tt0 -107.7 120.24 41.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.769 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -111.37 129.98 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.442 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.637 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 80.6 p -126.38 139.85 52.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' THR . 20.7 t -77.52 120.61 22.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.732 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.2 m -119.99 130.0 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.039 0.447 . . . . 0.0 111.899 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 96.5 m-20 -121.41 119.96 33.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 184' ' ' SER . 16.7 m -120.93 150.02 52.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 2.1 Cg_endo -79.78 142.92 16.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.907 2.405 . . . . 0.0 109.917 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 191' ' ' ASP . 9.8 mt -60.91 120.3 9.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.211 0.529 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.42 160.36 54.02 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 96.6 mt-30 -99.98 -19.94 16.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.154 -0.219 . . . . 0.0 111.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.13 134.96 23.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 111.729 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 ' HA ' ' A' ' 194' ' ' THR . 2.4 p -136.4 129.74 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.612 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 84.7 tttt -97.06 119.97 36.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.022 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.53 HD23 HG13 ' A' ' 173' ' ' ILE . 88.0 mt -113.55 130.44 56.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.223 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.412 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 10.2 tt0 -104.28 110.03 63.54 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.45 170.29 16.13 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.596 2.197 . . . . 0.0 112.437 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 94.1 mt-30 -132.67 122.86 25.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.981 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.0 m 67.87 137.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.755 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.27 -18.26 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.685 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.01 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.533 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 66.4 t80 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.68 -2.0 58.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.551 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.7 mt -58.08 138.99 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.2 p -59.96 -37.65 80.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.555 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.551 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.4 m-20 -118.75 80.45 17.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.8 -32.01 30.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.623 2.216 . . . . 0.0 112.271 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -60.06 -40.84 90.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.09 98.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 147' ' ' VAL . 94.1 t -64.0 -42.55 96.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -59.91 -42.33 93.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.04 -42.11 93.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -59.97 -40.06 87.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.088 0.47 . . . . 0.0 110.59 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.788 HG22 HD13 ' A' ' 162' ' ' ILE . 57.7 t -61.46 -43.78 97.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.249 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.96 -40.24 92.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.803 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -63.32 -40.01 96.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.655 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -59.98 -39.97 87.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.313 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 88.5 m-85 -102.34 122.07 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.046 0.45 . . . . 0.0 111.676 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 68' ' ' LEU . 66.2 m -61.1 -39.98 91.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.218 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.684 ' HB ' HD22 ' A' ' 68' ' ' LEU . 8.2 t -128.05 140.76 51.77 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.983 0.421 . . . . 0.0 111.187 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.732 HD11 HD11 ' A' ' 173' ' ' ILE . 49.8 tp -114.8 121.5 43.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.449 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 157' ' ' ASP . 53.4 m -119.38 140.29 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 176' ' ' VAL . 90.0 t -59.98 -41.51 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.48 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.632 ' HB3' HH21 ' A' ' 78' ' ' ARG . 95.9 m-20 -70.05 -34.92 73.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 95.7 m-20 -73.58 139.34 45.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.252 0.549 . . . . 0.0 112.412 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.9 p -107.31 120.0 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.57 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.595 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 45.2 pt -106.96 138.42 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.043 0.449 . . . . 0.0 112.109 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.788 HD13 HG22 ' A' ' 147' ' ' VAL . 44.6 pt -127.34 141.37 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.2 t -110.73 117.86 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.179 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.459 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 54.0 t80 -120.45 120.28 35.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 56.21 40.05 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.577 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.96 9.89 86.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.089 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.9 mttt -112.74 137.42 51.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.785 0.293 . . . . 0.0 110.381 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.7 p -109.99 129.08 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 111.486 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.533 ' CD1' ' HD1' ' A' ' 134' ' ' PHE . 89.2 m-85 -120.06 140.0 51.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.592 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 97.7 mttt -101.12 124.57 47.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.247 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -119.27 128.95 54.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.006 0.432 . . . . 0.0 110.684 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.768 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.3 mp -83.63 109.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.429 HD12 ' HE2' ' A' ' 126' ' ' LYS . 84.4 mt -67.89 -54.07 21.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.612 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 49.8 mt-10 -157.65 140.36 14.86 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.349 . . . . 0.0 111.212 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 125' ' ' VAL . 4.5 m -140.05 154.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -110.18 102.59 51.59 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.494 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.503 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 63.6 Cg_endo -104.04 -2.69 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.144 3.229 . . . . 0.0 113.201 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 61.67 27.87 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.4 p -140.16 147.37 40.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.985 0.422 . . . . 0.0 111.186 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.7 m -61.66 -40.03 93.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.0 p -60.01 -20.18 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 50.5 mttt 57.23 39.8 28.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.0 111.432 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.611 ' CB ' HG11 ' A' ' 119' ' ' VAL . 41.4 t -121.62 140.81 51.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.153 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 192' ' ' LEU . 17.7 pt -125.24 148.5 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.414 . . . . 0.0 111.475 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.874 ' SG ' HD11 ' A' ' 68' ' ' LEU . 53.0 t -139.27 99.38 3.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.574 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.76 ' HA ' HD21 ' A' ' 121' ' ' LEU . 11.7 p -117.45 113.27 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.783 0.801 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.788 HD11 ' CD ' ' A' ' 66' ' ' PRO . 20.6 mt -77.26 -62.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.29 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.02 -79.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.4 t -161.18 42.87 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.739 0.304 . . . . 0.0 111.662 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.786 ' HB2' HD22 ' A' ' 121' ' ' LEU . 92.7 m-20 -89.74 6.13 42.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 185' ' ' ILE . 31.8 tp -120.45 130.09 54.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.869 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 125' ' ' VAL . 33.0 t -90.45 121.89 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.79 ' HA ' HG13 ' A' ' 125' ' ' VAL . 52.6 p -100.99 151.98 21.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.463 0.649 . . . . 0.0 112.411 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -129.65 139.1 51.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.541 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.84 137.02 46.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.756 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -121.18 165.88 17.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.365 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 13.7 Cg_endo . . . . . 0 C--N 1.344 0.318 0 C-N-CA 122.143 1.895 . . . . 0.0 111.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 46.3 Cg_exo . . . . . 0 C--O 1.23 0.101 0 CA-C-O 120.855 0.273 . . . . 0.0 112.092 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.519 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 96.5 mt-30 -105.45 120.44 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 116' ' ' SER . 72.6 p -121.17 129.79 53.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 111.689 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.647 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 78.6 t80 -119.85 139.43 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -106.26 134.86 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.137 0.494 . . . . 0.0 111.976 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.0 mt-10 -141.1 151.37 43.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.92 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -120.53 136.78 54.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.992 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.667 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.3 m-85 -152.57 159.97 43.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.848 0.356 . . . . 0.0 111.082 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.35 140.31 31.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 17.3 t -97.66 125.75 42.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.571 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.45 149.79 44.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.298 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.93 100.47 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.923 2.416 . . . . 0.0 112.326 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.591 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 83.6 mt -60.5 -40.1 83.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 110.406 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -60.01 -32.54 70.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.294 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.2 ttm -66.98 -39.02 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 94.8 mtp -60.9 151.72 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HB2' HD12 ' A' ' 37' ' ' ILE . 98.6 m-20 -59.45 143.8 48.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.184 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.8 m-20 -60.03 -40.05 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.072 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -60.81 -40.04 91.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 110.918 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 34' ' ' ASN . 85.8 mt -68.18 -40.06 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.4 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 35' ' ' ASP . 39.6 mmt180 -116.34 140.18 49.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 111.965 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.83 139.99 55.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -60.11 -39.08 84.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -39.95 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.821 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.93 87.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 30' ' ' ILE . 28.0 m120 -60.03 -41.4 92.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.14 6.92 38.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.714 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.61 171.9 29.54 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.534 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -99.45 18.29 56.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.211 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.852 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.24 131.41 46.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 97' ' ' PRO . 46.2 pt -119.8 151.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.934 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.4 m-85 -101.81 131.38 48.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.145 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 48' ' ' ILE . 5.0 mp -135.86 160.95 65.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 0.0 111.814 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.591 ' CG ' ' HA2' ' A' ' 92' ' ' GLY . 32.3 Cg_exo -63.78 135.68 49.65 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.91 2.406 . . . . 0.0 112.364 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 37.0 Cg_exo -60.4 -20.12 61.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.697 2.265 . . . . 0.0 112.916 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.3 m -60.01 -40.52 89.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.872 0.368 . . . . 0.0 110.781 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -61.75 -39.9 93.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.269 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 59.1 tp -59.97 -40.21 88.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.113 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -59.98 -39.98 87.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -60.76 -39.95 90.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.378 0.609 . . . . 0.0 110.376 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 55' ' ' LEU . 87.7 mt -60.04 -39.5 86.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.8 t -57.76 -38.31 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.3 mtt -60.0 -37.06 78.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.403 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 21' ' ' PHE . 87.6 mt -80.08 -0.06 34.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 59.95 40.06 19.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.697 0.284 . . . . 0.0 111.588 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -86.72 120.07 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 110.436 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -83.56 151.2 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.733 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.507 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 32.6 p90 -87.1 159.85 50.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 23.4 Cg_exo -65.65 147.53 73.14 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.866 0.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.6 mtt -95.58 138.92 32.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.775 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.855 HD22 ' HB ' ' A' ' 153' ' ' THR . 32.3 mt -114.05 139.34 49.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.667 ' HB3' HD11 ' A' ' 114' ' ' ILE . 94.6 m-85 -131.55 145.42 51.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.235 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HB3' ' ND1' ' A' ' 81' ' ' HIS . 22.4 pttp -122.21 140.32 52.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -98.58 128.09 44.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 113' ' ' GLN . 23.0 p -105.17 136.4 44.74 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.07 113.79 22.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.724 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -65.92 -39.07 90.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.814 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.89 -40.09 87.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.924 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -102.96 -14.49 16.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.94 41.49 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.744 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -101.22 140.16 35.89 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.022 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.553 ' CG1' HG22 ' A' ' 72' ' ' THR . 41.6 t -119.99 121.41 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.685 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 80.1 p -102.45 156.34 17.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.644 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 93.0 m-70 -101.76 114.85 29.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.37 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.24 167.1 17.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.756 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.649 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.99 162.91 26.49 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.539 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.0 p -129.67 131.99 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 111.709 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.852 HD13 ' HD3' ' A' ' 47' ' ' LYS . 61.2 tp -93.38 -80.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.115 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.9 161.04 43.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 89.1 m-85 -95.3 116.48 28.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 pt -125.57 -4.62 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.84 98.12 11.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.136 0.493 . . . . 0.0 111.557 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.07 75.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.96 -30.35 69.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.887 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.591 ' HA2' ' CG ' ' A' ' 51' ' ' PRO . . . 112.35 49.3 0.61 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.611 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.661 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 99.6 mtt180 -121.1 149.48 42.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.84 0.353 . . . . 0.0 111.558 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 49' ' ' PHE . 7.4 p -128.93 142.82 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.002 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 97.5 m-85 -114.02 137.6 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 97' ' ' PRO . 1.8 tp -119.57 137.57 25.65 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 96' ' ' LEU . 52.6 Cg_exo -53.25 145.55 43.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.45 2.1 . . . . 0.0 112.372 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 59.0 tt0 -60.05 -43.66 95.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.829 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 100' ' ' MET . 59.1 p-90 -69.98 -41.18 74.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.558 ' CG ' HD11 ' A' ' 96' ' ' LEU . 43.8 tpp -61.18 -40.32 93.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.555 ' HA ' HD21 ' A' ' 96' ' ' LEU . 57.1 ttm -60.06 -41.23 91.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.124 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.1 -40.07 94.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.519 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.02 -40.07 96.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.44 -23.63 63.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.216 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.76 34.85 29.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.998 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 101' ' ' MET . 45.1 pt -119.77 146.99 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -95.8 157.15 36.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.428 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.39 138.07 30.83 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.399 2.066 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.9 75.74 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.15 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 53.6 m -71.03 149.98 46.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.096 0.448 . . . . 0.0 110.669 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 112' ' ' LEU . 10.4 tt -71.04 140.15 50.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 71' ' ' LEU . 59.3 tp -126.76 130.46 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.639 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 93.7 mt-30 -109.19 130.31 55.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 69' ' ' PHE . 18.7 tt -118.29 128.38 75.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 111.443 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 42.3 t -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.859 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 61.4 m -70.11 130.24 41.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.704 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.7 m -120.08 130.03 54.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.831 0.348 . . . . 0.0 111.086 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 98.0 m-20 -119.33 120.04 35.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.227 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.15 153.62 44.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.911 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.28 17.69 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.823 2.348 . . . . 0.0 112.292 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.603 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.2 OUTLIER 70.11 100.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.974 0.416 . . . . 0.0 111.968 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -57.02 156.82 12.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.244 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.24 -27.22 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -139.56 130.92 26.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.971 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 1.043 HG13 HG22 ' A' ' 194' ' ' THR . 2.6 p -130.02 130.19 65.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.211 0.529 . . . . 0.0 111.548 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.557 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 87.9 tttt -99.42 120.73 40.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.503 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.72 HD22 ' CG2' ' A' ' 171' ' ' ILE . 83.6 mt -108.76 135.51 49.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.408 . . . . 0.0 111.57 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.89 ' HB2' ' HG ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -107.39 119.92 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.905 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' A' ' 198' ' ' PRO . 91.2 Cg_endo -81.46 169.1 15.86 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.16 1.907 . . . . 0.0 111.573 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -138.25 121.62 17.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' ASP . 0.5 OUTLIER 63.32 26.74 15.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m 36.84 27.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.372 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 96.2 m-20 -68.54 -39.95 80.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 140' ' ' PRO . 64.0 t80 -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.61 -24.13 63.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.4 mt -57.5 139.01 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.83 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -60.28 -40.04 88.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.57 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 137' ' ' ILE . 79.7 m-20 -121.68 75.16 35.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.772 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 42.3 Cg_endo -69.07 -34.93 15.73 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.786 2.324 . . . . 0.0 112.232 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.64 -40.65 92.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.49 98.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 147' ' ' VAL . 70.8 t -61.14 -42.58 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.09 -42.48 94.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.28 -42.27 95.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.56 -40.04 95.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 143' ' ' VAL . 95.5 t -62.01 -40.32 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.004 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.774 HD23 HD11 ' A' ' 154' ' ' LEU . 90.3 mt -60.31 -40.48 90.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.03 -39.96 87.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.531 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.79 -40.03 93.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.106 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.6 m-85 -103.0 121.42 42.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.518 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.496 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 74.0 m -61.15 -40.02 92.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.855 ' HB ' HD22 ' A' ' 68' ' ' LEU . 4.8 t -136.35 147.8 47.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.355 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.774 HD11 HD23 ' A' ' 148' ' ' LEU . 84.9 mt -121.39 138.47 54.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.364 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 81' ' ' HIS . 54.6 m -116.08 136.08 53.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.701 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 7.2 p -59.81 -39.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.06 -21.16 33.85 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.7 t0 -78.95 136.28 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.515 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.407 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 15.7 m -100.34 120.66 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.167 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.15 138.93 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.284 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 96.5 mt-10 -120.05 139.99 51.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -129.31 140.04 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.3 t -110.13 114.5 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.378 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.13 122.3 40.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.595 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.2 t30 56.41 39.99 29.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.11 12.31 84.19 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.126 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 163' ' ' SER . 58.3 mttm -118.19 139.07 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.903 0.352 . . . . 0.0 110.664 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.5 p -109.53 133.62 52.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.1 m-85 -119.99 138.65 53.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 99.6 mttt -104.76 122.66 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.72 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 119.97 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.393 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -115.39 130.03 56.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -81.71 104.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.947 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' ' 128' ' ' GLU . 80.7 mt -60.53 -48.96 79.47 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.1 mt-10 -158.89 139.91 12.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 156' ' ' VAL . 11.1 m -143.23 151.62 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.957 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -116.93 103.16 52.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.395 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.505 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 97.3 Cg_endo -100.08 12.32 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.734 2.956 . . . . 0.0 112.278 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 80.7 tt0 60.75 20.01 10.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.451 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 79.3 p -146.78 152.82 39.4 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.7 m -70.0 -18.56 63.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.548 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.7 t -59.9 -25.52 65.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 60.18 40.04 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 0.0 110.89 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 p -122.38 142.65 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.224 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 44.9 pt -130.18 140.03 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 68' ' ' LEU . 44.1 t -134.65 138.11 44.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.042 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.721 HG23 ' CB ' ' A' ' 190' ' ' THR . 8.2 p -170.11 67.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.3 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 152' ' ' SER . 84.8 mt -70.0 -40.02 78.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.53 -10.08 8.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.686 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.721 ' CB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -78.95 174.49 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.42 118.35 36.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.399 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 187' ' ' VAL . 25.2 tp -120.4 138.01 54.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.134 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 26.4 t -92.43 119.99 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 1.043 HG22 HG13 ' A' ' 125' ' ' VAL . 65.9 p -120.87 140.61 51.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.339 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -121.15 139.44 53.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.326 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -105.41 120.0 40.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -132.64 107.65 13.05 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 129' ' ' PRO . 71.0 Cg_endo . . . . . 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 113.149 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.462 -0.353 0 CA-C-O 120.739 0.224 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 97.0 mt-30 -103.27 123.25 46.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.722 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 116' ' ' SER . 9.0 t -129.98 139.93 50.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 115' ' ' SER . 69.2 t80 -121.58 139.99 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.558 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -104.67 130.41 52.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.84 147.62 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.0 120.11 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.727 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 47.2 m-85 -140.69 151.77 44.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.997 0.427 . . . . 0.0 111.221 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.06 131.78 35.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 19.3 p -90.17 143.4 26.81 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.304 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 43.6 m-85 -138.37 157.22 72.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.203 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.91 109.11 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.507 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.836 HG12 ' HB3' ' A' ' 95' ' ' TYR . 85.6 mt -60.15 -40.03 82.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -59.69 -23.79 63.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.3 ttp -68.2 -36.62 79.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.493 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 97.0 mtp -59.91 141.8 54.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.11 151.9 25.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.702 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -54.03 -29.96 45.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.282 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 ttt-85 -60.05 -39.9 87.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.531 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -113.06 10.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.143 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 31' ' ' ALA . 41.7 ttt180 -113.59 129.99 56.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.008 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.25 129.21 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.36 -40.21 89.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.161 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -64.24 -40.0 95.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.89 91.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.468 HD21 ' NE ' ' A' ' 38' ' ' ARG . 92.5 m-20 -59.97 -40.18 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.36 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.92 2.22 34.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.676 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.94 175.3 32.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.148 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.53 10.49 61.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.392 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 85' ' ' LEU . 63.7 mttp -80.54 129.78 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.7 pt -120.06 154.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.789 ' C ' HD22 ' A' ' 50' ' ' LEU . 96.0 m-85 -99.33 134.46 42.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.629 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.4 mm? -131.16 160.08 68.65 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.651 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 97.6 Cg_endo -83.51 149.44 12.97 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.002 1.801 . . . . 0.0 112.735 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.2 Cg_exo -61.15 -29.1 86.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.116 2.544 . . . . 0.0 112.861 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.94 87.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -67.29 -40.26 86.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.094 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.5 tp -60.03 -39.99 87.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -60.03 -40.08 88.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 98.8 mttt -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 69' ' ' PHE . 87.1 mt -61.68 -39.87 92.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.612 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -59.75 -37.54 79.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.84 -35.94 75.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.448 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HD1' ' A' ' 21' ' ' PHE . 93.1 mt -79.98 -3.88 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.238 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 60.0 40.13 19.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.794 0.33 . . . . 0.0 111.538 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 58' ' ' LEU . 85.2 mt -76.23 129.94 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.999 0.428 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -73.3 141.93 47.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.376 0.608 . . . . 0.0 111.892 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.515 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.1 p90 -87.63 153.62 52.94 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 56.5 Cg_endo -70.78 152.18 94.68 Favored 'Cis proline' 0 C--N 1.35 0.611 0 C-N-CA 123.486 -1.464 . . . . 0.0 112.912 0.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 58' ' ' LEU . 67.5 mtt -84.69 140.49 31.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.866 HD13 HG22 ' A' ' 153' ' ' THR . 67.1 mt -111.2 137.33 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.081 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 58' ' ' LEU . 50.6 m-85 -130.59 143.74 50.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.069 0.461 . . . . 0.0 111.54 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 4.5 ttpm? -120.03 137.44 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.64 131.19 43.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.5 ' OG1' HG12 ' A' ' 79' ' ' VAL . 63.9 m -119.71 130.01 54.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.28 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.73 114.26 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.53 -39.98 89.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.4 -40.04 89.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.211 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -102.67 -9.09 20.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.717 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.95 12.85 16.69 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.85 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.65 140.34 37.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.698 0.285 . . . . 0.0 110.564 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.5 HG12 ' OG1' ' A' ' 72' ' ' THR . 27.1 m -119.88 119.79 61.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.063 0.459 . . . . 0.0 111.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 76.4 p -105.99 143.4 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.51 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.696 ' HE2' HG21 ' A' ' 117' ' ' THR . 80.0 m80 -93.76 114.55 26.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.752 0.311 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.13 159.98 13.78 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.817 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.91 162.84 26.55 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.386 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.676 HG23 HD23 ' A' ' 50' ' ' LEU . 10.8 p -124.74 130.61 73.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.0 112.19 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.541 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.1 tp -90.14 -79.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.22 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.01 160.13 42.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 86.1 m-85 -92.78 116.46 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.915 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.2 pt -122.99 -6.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB1' ' HG2' ' A' ' 93' ' ' ARG . . . -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.723 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -39.99 76.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.887 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -67.22 -30.77 70.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.99 67.81 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.848 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.746 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 22.5 ptt-85 -135.05 154.92 51.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 111.158 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.494 ' CG1' HD23 ' A' ' 112' ' ' LEU . 11.9 p -129.19 140.17 49.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.836 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.07 139.96 51.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.262 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -131.17 156.28 80.35 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.685 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 57.9 Cg_endo -68.12 160.01 50.62 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.712 2.275 . . . . 0.0 112.094 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.22 -40.25 89.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 50.5 p-90 -65.19 -40.06 93.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.886 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.428 ' HG3' ' HG2' ' A' ' 97' ' ' PRO . 61.0 mtt -63.44 -40.18 96.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.462 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 ttp -60.06 -40.49 89.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.582 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.8 m -68.39 -39.96 81.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.697 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.97 -24.01 63.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.25 30.18 69.69 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.125 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.18 149.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.491 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 36.1 mt-30 -95.86 159.85 31.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.608 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 26.6 Cg_endo -62.61 0.09 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.424 2.083 . . . . 0.0 113.147 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.94 -20.38 9.93 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.3 p -80.8 160.13 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 111.09 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.2 151.74 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 59.5 tp -120.13 130.88 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.573 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.9 123.31 47.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.871 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 23' ' ' GLU . 20.5 tt -119.5 121.65 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 46.6 t -120.04 126.53 51.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' THR . 34.9 t -63.69 131.0 46.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.6 m -120.0 130.01 54.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 96.1 m-20 -118.55 125.44 49.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.139 0.495 . . . . 0.0 110.438 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 186' ' ' CYS . 33.6 m -114.2 150.9 44.43 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.605 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 73.0 Cg_endo -73.89 18.55 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.834 2.356 . . . . 0.0 112.531 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 190' ' ' THR . 6.1 tt 61.23 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.874 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.41 34.01 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.615 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.02 -16.8 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -140.0 142.18 36.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.816 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.878 ' CG1' HG22 ' A' ' 194' ' ' THR . 8.4 p -137.71 136.09 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.823 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 29.2 mmtm -98.91 124.7 44.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.431 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.687 HD12 ' HB ' ' A' ' 194' ' ' THR . 83.7 mt -113.73 131.0 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.013 0.435 . . . . 0.0 111.598 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -104.49 119.33 54.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 94.9 Cg_endo -77.83 160.39 30.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -125.93 121.4 33.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.983 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t 56.77 160.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.155 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 m -71.89 -21.59 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -59.98 -40.09 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.702 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.75 -40.22 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.046 0.451 . . . . 0.0 110.496 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.06 -0.41 57.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.298 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -60.01 -40.04 87.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.8 mt -55.21 139.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.938 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.9 p -60.18 -40.66 90.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -120.94 76.68 29.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.33 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.94 -28.69 16.05 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.425 2.084 . . . . 0.0 111.927 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.71 -40.05 93.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.93 98.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.18 -40.29 88.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -60.36 -41.26 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.28 88.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.274 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.72 -39.96 95.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 110.367 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 162' ' ' ILE . 84.5 t -61.75 -40.02 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.547 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -59.98 -40.17 88.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -62.77 -40.01 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.99 93.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.934 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.18 121.84 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 111.071 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 188' ' ' ILE . 36.1 p -70.07 -39.93 75.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.866 HG22 HD13 ' A' ' 68' ' ' LEU . 11.1 p -119.37 138.59 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.547 HD11 HD22 ' A' ' 148' ' ' LEU . 87.0 mt -124.0 124.87 43.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 22.8 m -121.36 139.17 53.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.56 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.91 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 31.1 m -60.19 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.325 0.583 . . . . 0.0 111.336 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -68.23 -40.06 82.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.621 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.91 140.24 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.126 0.488 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.3 p -105.18 121.88 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.286 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.3 pt -105.96 138.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 111.277 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.472 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.0 mt-10 -120.07 140.12 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.504 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.819 HD13 HG21 ' A' ' 147' ' ' VAL . 45.9 pt -129.72 141.6 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.099 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.696 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 17.8 m -107.5 120.87 43.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 111.569 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.496 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 65.0 t80 -120.67 119.56 33.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.223 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.496 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 12.4 m120 54.44 40.11 31.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.657 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.75 83.73 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -114.37 139.25 49.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.756 0.278 . . . . 0.0 110.473 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.526 HG22 ' OG ' ' A' ' 163' ' ' SER . 68.1 p -108.89 127.64 54.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.331 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.02 139.98 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.483 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 98.2 mttt -99.99 123.37 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.875 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.98 119.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.833 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -120.11 126.65 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.769 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.91 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -80.95 111.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 174' ' ' LEU . 8.0 tt -59.02 -58.26 9.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.823 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.3 tt0 -158.89 141.47 14.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.263 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.839 HG13 ' CG1' ' A' ' 156' ' ' VAL . 18.6 m -130.05 160.02 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.94 103.94 22.56 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.0 Cg_endo -103.48 166.81 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.768 2.978 . . . . 0.0 112.125 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.9 mt-10 -99.96 3.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 159.88 41.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 69.6 p -70.11 -10.14 57.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.07 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -59.84 -19.94 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 111.114 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 56.65 39.82 29.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.029 0.442 . . . . 0.0 111.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -129.94 141.91 50.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.908 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 192' ' ' LEU . 45.3 pt -128.51 141.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.108 0.48 . . . . 0.0 112.033 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.637 ' SG ' HD11 ' A' ' 68' ' ' LEU . 41.8 t -129.22 125.73 37.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.093 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.779 HG23 ' OG1' ' A' ' 190' ' ' THR . 11.0 p -155.05 64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.049 0.452 . . . . 0.0 111.395 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 152' ' ' SER . 85.0 mt -68.65 -39.98 81.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.137 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.13 -10.12 9.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.107 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.779 ' OG1' HG23 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -81.38 176.34 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.248 0.547 . . . . 0.0 111.404 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.56 117.2 33.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.316 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 125' ' ' VAL . 30.9 tp -120.49 137.25 54.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.754 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.97 121.16 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.368 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.878 HG22 ' CG1' ' A' ' 125' ' ' VAL . 62.6 p -115.69 144.27 44.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.799 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -126.5 140.07 52.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.631 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -103.33 126.56 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.416 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -127.75 105.25 20.86 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.518 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 C--N 1.344 0.307 0 C-N-CA 122.419 2.08 . . . . 0.0 112.464 -179.405 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.23 0.115 0 CA-C-O 120.866 0.277 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -108.69 128.87 55.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.532 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.5 m -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.7 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 20.1 t80 -133.65 130.26 38.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.42 134.26 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 112.04 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.4 mt-10 -139.26 159.12 42.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.894 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -121.26 136.88 54.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.439 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 94.7 m-85 -147.13 160.08 42.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.338 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.427 ' O ' HG12 ' A' ' 94' ' ' VAL . 98.2 mtt180 -89.13 121.95 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 110.408 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.843 ' HB2' HD22 ' A' ' 96' ' ' LEU . 32.0 p -95.44 141.76 28.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 53.8 m-85 -123.98 148.35 56.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.508 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 16.4 Cg_exo -68.87 108.74 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.788 2.325 . . . . 0.0 112.305 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.621 ' CG2' ' HD2' ' A' ' 38' ' ' ARG . 91.2 mt -59.97 -38.77 77.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.206 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.02 30.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.445 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 70.6 mtm -67.88 -39.58 83.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.871 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . 93.1 mtp -60.19 144.78 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.904 0.383 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.0 m-20 -60.05 145.56 46.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.799 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.429 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -60.05 -39.89 87.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.103 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -59.95 -40.04 87.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.7 mt -83.72 -1.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.871 ' HD3' ' HB2' ' A' ' 33' ' ' MET . 44.4 mtm180 -119.48 155.51 31.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.982 0.42 . . . . 0.0 111.882 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 87.6 tttt -100.56 131.49 46.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.332 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.634 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.637 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.2 m-20 -62.58 -39.96 95.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.95 95.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.03 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.284 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.4 -0.0 30.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.563 0.221 . . . . 0.0 111.403 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -99.78 -179.6 30.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.62 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.11 23.39 34.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.134 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.4 mttt -81.1 126.97 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.968 0.413 . . . . 0.0 111.752 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.89 HD12 HD13 ' A' ' 114' ' ' ILE . 49.3 pt -119.99 150.04 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.86 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 94' ' ' VAL . 91.3 m-85 -102.71 133.92 46.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 48' ' ' ILE . 3.9 mp -138.13 161.69 58.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.265 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 59.7 Cg_endo -71.98 149.16 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.114 1.876 . . . . 0.0 112.238 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.98 -23.66 67.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.589 2.192 . . . . 0.0 112.591 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.6 p -60.14 -39.9 87.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.71 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.07 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' A' ' 58' ' ' LEU . 58.6 tp -63.9 -40.12 95.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.835 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.0 m -60.02 -41.33 91.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 111.049 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 88.1 tttt -61.95 -39.87 93.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.321 0.581 . . . . 0.0 110.382 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.762 HD13 ' HE2' ' A' ' 67' ' ' MET . 88.3 mt -59.99 -39.41 85.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.638 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.1 m -59.96 -39.06 84.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 ttm -59.98 -38.45 82.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.772 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.86 -3.87 43.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.643 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.06 40.03 19.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.707 HG21 ' HE1' ' A' ' 67' ' ' MET . 11.0 tt -77.59 137.21 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.712 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -70.08 140.01 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.014 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 30.7 p90 -95.25 157.35 36.52 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.359 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 188' ' ' ILE . 15.6 Cg_exo -69.55 171.34 53.25 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.746 -1.356 . . . . 0.0 112.77 0.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.762 ' HE2' HD13 ' A' ' 58' ' ' LEU . 81.7 mmm -85.92 139.87 30.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.092 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.731 HD22 HG22 ' A' ' 153' ' ' THR . 64.4 mt -108.34 128.42 54.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.664 ' HB3' HG23 ' A' ' 114' ' ' ILE . 13.5 m-85 -121.95 140.04 52.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 50.2 pttt -126.38 138.22 53.53 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.247 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 112' ' ' LEU . 8.1 mp -99.0 120.31 39.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.42 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.737 ' CB ' HG22 ' A' ' 79' ' ' VAL . 7.6 t -109.62 122.97 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 111.264 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.25 28.16 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.041 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -60.38 -39.99 89.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.894 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -103.27 -10.66 18.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.87 12.19 41.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.302 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -103.47 133.06 49.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' CB ' ' A' ' 72' ' ' THR . 39.8 t -119.96 119.71 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.204 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.4 p -103.12 160.03 15.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.192 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 80.6 m80 -100.65 114.28 27.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.119 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.31 169.72 19.86 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.833 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.06 163.64 23.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.179 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.505 HG21 ' CE2' ' A' ' 69' ' ' PHE . 12.2 p -127.88 130.02 69.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.189 0.494 . . . . 0.0 112.084 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 ' HD3' ' A' ' 47' ' ' LYS . 60.6 tp -91.33 -78.16 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.191 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -154.63 160.53 41.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.003 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 91.3 m-85 -95.03 116.48 28.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -130.9 -4.82 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -86.91 97.85 10.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.07 0.462 . . . . 0.0 111.232 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -39.95 75.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.749 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.67 -30.5 68.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.663 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.9 49.77 0.72 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.113 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.71 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 84.3 mtm180 -116.27 148.44 40.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.881 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 114' ' ' ILE . 11.2 p -130.08 142.4 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.152 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 28' ' ' TYR . 87.0 m-85 -119.93 139.96 51.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 27' ' ' CYS . 2.3 pt? -122.81 148.7 54.42 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 111.388 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.66 149.22 69.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.69 2.26 . . . . 0.0 112.084 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -60.03 -41.08 91.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.479 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -70.0 -40.02 75.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 71' ' ' LEU . 57.6 ttm -61.41 -40.07 93.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.667 ' HE2' HD21 ' A' ' 96' ' ' LEU . 58.4 ttm -60.37 -40.75 91.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.218 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.77 -39.99 94.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 110.496 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.2 -40.05 96.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.536 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.46 -24.02 63.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.25 31.84 53.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.684 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -111.98 140.0 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.407 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 30.0 pt20 -96.93 160.24 29.61 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 96.1 Cg_exo -43.44 136.09 6.22 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.655 2.236 . . . . 0.0 112.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.76 79.23 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.466 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.6 t -70.02 153.15 43.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.39 141.22 28.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.654 HD21 ' CD2' ' A' ' 71' ' ' LEU . 59.4 tp -125.53 129.91 50.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.61 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 95.8 mt-30 -111.32 130.93 55.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -109.97 129.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.896 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.662 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 20.2 m -121.96 132.54 54.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 29.4 t -88.67 116.16 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.237 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 81.8 p -125.77 139.84 53.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.507 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -111.11 114.74 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.09 148.52 45.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 34.7 Cg_exo -62.04 175.26 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.342 2.028 . . . . 0.0 112.301 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 187' ' ' VAL . 0.3 OUTLIER -94.97 120.88 35.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.718 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -69.87 133.63 25.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.85 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' CD2' ' A' ' 124' ' ' PHE . 58.4 tt0 -60.39 -44.01 96.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.633 0.254 . . . . 0.0 111.521 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.5 ' CE1' HG11 ' A' ' 193' ' ' VAL . 12.2 m-85 -138.67 145.31 40.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.126 0.489 . . . . 0.0 112.223 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.891 ' CG1' HG22 ' A' ' 194' ' ' THR . 6.5 p -131.81 130.38 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.928 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.915 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 30.4 mttm -97.61 126.42 42.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.306 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 144' ' ' LEU . 85.1 mt -111.48 134.98 52.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.38 109.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.407 ' HG2' ' O ' ' A' ' 197' ' ' ALA . 6.5 Cg_exo -72.19 159.96 48.46 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.471 2.114 . . . . 0.0 112.417 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.3 tt0 -129.36 121.37 27.28 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m 69.55 130.68 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.03 -25.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.435 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -39.97 87.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.99 -39.91 87.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.27 -10.64 58.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.354 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.02 -12.32 61.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.72 0.295 . . . . 0.0 111.384 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -60.01 138.79 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.579 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 t -60.81 -40.08 91.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.457 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 21.8 m-20 -129.89 74.55 80.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 60.2 Cg_endo -73.4 -26.62 14.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.482 2.121 . . . . 0.0 111.92 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.03 -40.07 88.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.68 88.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.1 t -65.85 -40.34 87.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 127' ' ' LEU . 2.9 tm? -60.93 -43.04 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.521 ' HG3' ' OG1' ' A' ' 190' ' ' THR . 86.3 tt0 -59.94 -40.65 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.14 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.12 -40.06 92.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.632 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 162' ' ' ILE . 95.4 t -60.04 -41.16 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.367 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -60.08 -40.15 88.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -62.27 -39.97 94.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.844 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.12 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.05 117.25 33.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 0.0 111.205 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.649 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 67.4 m -63.11 -40.06 96.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.731 HG22 HD22 ' A' ' 68' ' ' LEU . 81.1 p -123.38 140.54 52.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.864 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 148' ' ' LEU . 88.9 mt -119.85 127.21 52.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.207 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 94.6 m -118.7 137.41 53.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.779 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.75 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.4 t -60.06 -41.11 85.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.382 0.611 . . . . 0.0 111.188 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 155' ' ' THR . 95.7 m-20 -70.83 -38.99 73.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.485 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.505 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.5 t0 -66.19 134.25 52.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.626 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 1.078 HG12 ' HG2' ' A' ' 172' ' ' LYS . 15.4 m -98.96 119.98 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.129 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 171' ' ' ILE . 48.3 pt -102.36 134.84 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.983 0.42 . . . . 0.0 111.351 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 98.1 mt-10 -120.09 139.97 51.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.149 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 147' ' ' VAL . 45.2 pt -126.22 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.683 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.9 t -103.95 118.32 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.7 t80 -121.98 119.13 30.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.158 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 53.02 40.05 30.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.251 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.0 75.82 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.198 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.4 mttt -119.93 137.93 53.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.885 0.343 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.8 p -107.99 130.86 55.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.407 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 87.4 m-85 -119.97 140.05 51.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.741 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 58.7 mttp -100.79 128.0 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.846 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.617 ' HB ' HG13 ' A' ' 160' ' ' ILE . 48.7 mm -119.97 120.36 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 1.078 ' HG2' HG12 ' A' ' 159' ' ' VAL . 99.0 mttt -114.58 131.15 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.75 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.6 OUTLIER -73.8 96.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.787 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.7 tt -59.82 -52.08 66.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.915 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -160.87 142.52 12.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 185' ' ' ILE . 11.5 m -142.1 161.36 20.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -118.5 102.78 49.78 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 77.6 Cg_endo -100.77 175.9 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.683 2.922 . . . . 0.0 112.638 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.7 mt-10 -97.42 -0.04 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.798 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.2 m -133.65 156.05 48.59 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.114 0.483 . . . . 0.0 111.458 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 55.5 m -70.7 -10.61 59.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.3 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -59.86 -23.87 63.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 111.291 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 60.41 40.03 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.428 . . . . 0.0 110.904 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 66.2 m -127.74 142.77 51.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 176' ' ' VAL . 13.9 mt -119.91 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' A' ' 68' ' ' LEU . 82.4 m -143.31 151.71 40.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.783 HG22 ' H ' ' A' ' 189' ' ' GLU . 7.3 p -178.16 -55.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 152' ' ' SER . 54.7 mt 68.66 -1.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 187' ' ' VAL . 99.9 mt-10 -99.71 9.83 42.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.986 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.521 ' OG1' ' HG3' ' A' ' 145' ' ' GLU . 7.1 t 48.27 41.38 16.0 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -108.76 20.03 18.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.635 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.595 ' CD1' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -106.73 139.73 40.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.465 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 124' ' ' PHE . 23.4 t -90.09 121.2 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.766 0.317 . . . . 0.0 110.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.891 HG22 ' CG1' ' A' ' 125' ' ' VAL . 16.4 p -113.19 140.58 47.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 111.73 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -120.6 145.21 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.401 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.26 134.55 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 111.603 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . -117.32 161.29 33.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.345 0.357 0 C-N-CA 122.38 2.053 . . . . 0.0 112.433 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.463 -0.271 0 CA-C-O 121.003 0.335 . . . . 0.0 111.846 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 117' ' ' THR . 62.6 tt0 -117.74 137.77 52.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 m -119.97 130.98 55.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 56.1 t80 -133.64 132.79 41.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.391 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.49 135.82 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.74 150.87 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.722 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.4 123.14 48.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 110.931 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 114' ' ' ILE . 83.5 m-85 -130.89 147.22 52.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.966 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 94' ' ' VAL . 94.8 mtt-85 -81.75 149.46 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 21.9 m -84.95 133.36 34.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.582 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 86.7 m-85 -133.69 149.96 73.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -87.73 100.56 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.049 2.499 . . . . 0.0 113.514 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.858 HG22 ' OD1' ' A' ' 43' ' ' ASN . 87.6 mt -62.67 -41.37 91.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 110.349 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.23 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.412 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 98.1 mtp -68.1 -29.2 68.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.4 ttt -60.07 152.64 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -58.83 139.28 56.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 111.342 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ARG . 96.0 m-20 -63.93 -40.15 95.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -60.21 -40.71 91.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.324 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.38 -48.66 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 35' ' ' ASP . 97.3 mtt180 -125.0 143.36 50.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.072 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.41 148.78 47.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -60.12 -26.7 66.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.99 -39.7 86.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.355 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.38 82.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.858 ' OD1' HG22 ' A' ' 30' ' ' ILE . 97.8 m-20 -59.99 -39.73 86.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.733 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.88 8.27 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.581 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.28 29.4 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.73 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.65 22.82 38.14 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 85' ' ' LEU . 72.1 tttt -98.33 124.44 42.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 0.0 111.15 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.592 ' CD1' HD11 ' A' ' 50' ' ' LEU . 44.2 pt -113.44 149.69 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.3 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 94' ' ' VAL . 95.7 m-85 -101.58 134.44 44.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 110.732 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 69' ' ' PHE . 5.3 mp -134.08 161.78 61.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.246 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 73.9 Cg_endo -75.13 158.73 41.55 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.65 2.234 . . . . 0.0 113.188 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.856 ' HA ' HD23 ' A' ' 55' ' ' LEU . 73.8 Cg_endo -74.87 -13.39 21.73 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.054 2.503 . . . . 0.0 113.125 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -59.99 -40.0 87.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 111.525 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.524 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 52' ' ' PRO . 3.2 mm? -59.97 -40.02 87.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.78 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -59.98 -39.95 87.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.958 0.408 . . . . 0.0 110.092 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 98.6 mttt -69.12 -40.04 78.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.321 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.729 HD12 HD13 ' A' ' 55' ' ' LEU . 92.3 mt -59.9 -40.0 87.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.134 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -40.03 88.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.3 mtp -59.93 -40.03 87.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.792 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.596 HD13 HE21 ' A' ' 19' ' ' GLN . 80.9 mt -82.32 -1.95 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.784 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.1 t30 59.87 40.1 19.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD11 ' NE2' ' A' ' 19' ' ' GLN . 58.6 mt -82.64 131.29 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.857 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -81.84 149.96 28.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.511 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 49.8 p90 -87.35 157.97 52.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.664 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 74.4 Cg_endo -75.13 161.55 94.54 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.608 -1.414 . . . . 0.0 112.771 0.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.503 ' HE1' HD22 ' A' ' 58' ' ' LEU . 66.4 mmm -87.27 139.04 30.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 117' ' ' THR . 75.5 mt -108.85 134.35 51.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.7 m-85 -120.05 140.65 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 112.301 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -114.92 128.17 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.783 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 91.0 mt -99.01 127.54 44.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.9 ' HA ' HG12 ' A' ' 79' ' ' VAL . 88.5 m -120.02 130.08 54.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.117 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 117.98 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.91 -39.87 75.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -39.95 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.044 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 28.0 m -105.09 -15.38 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.793 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 5.11 57.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.223 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.69 140.05 34.45 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.125 0.488 . . . . 0.0 110.279 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 72' ' ' THR . 24.6 m -120.05 117.53 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.873 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.614 ' OG1' HD21 ' A' ' 104' ' ' LEU . 82.2 p -102.75 144.63 30.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.566 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.689 ' CD2' HG23 ' A' ' 155' ' ' THR . 0.1 OUTLIER -85.97 114.4 22.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.32 144.93 17.35 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.082 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.29 130.52 10.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.977 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.6 p -119.88 130.79 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.32 . . . . 0.0 111.479 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 47' ' ' LYS . 88.8 mt -110.24 -33.41 6.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.133 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.13 154.42 40.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 112.325 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 55' ' ' LEU . 81.8 m-85 -107.89 118.91 37.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.625 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 38' ' ' ARG . 46.8 pt -125.41 -5.01 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.669 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -89.17 98.71 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 0.0 111.414 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -40.03 78.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.941 0.4 . . . . 0.0 111.187 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.77 -29.88 67.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.278 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.91 49.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.928 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.669 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 89.1 mtm180 -119.44 149.8 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.523 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 114' ' ' ILE . 9.9 p -124.97 142.24 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.393 0.616 . . . . 0.0 111.24 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.799 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.4 m-85 -120.04 139.92 51.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.185 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.733 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.74 152.8 79.48 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 32.5 Cg_exo -61.0 154.78 54.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.557 2.172 . . . . 0.0 111.77 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.69 -40.16 94.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.343 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.423 ' NE1' ' CB ' ' A' ' 97' ' ' PRO . 67.2 p-90 -64.02 -40.11 95.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 58.3 ttm -60.46 -43.25 97.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.973 0.416 . . . . 0.0 110.787 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 106' ' ' ILE . 57.4 ttm -60.76 -40.49 92.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.5 -39.99 94.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.4 m -63.72 -40.41 96.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.614 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.4 mt -71.13 -24.01 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.45 30.58 56.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.302 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 101' ' ' MET . 45.6 pt -120.01 157.83 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -96.51 160.38 29.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.68 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.75 -3.41 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.76 -15.99 13.79 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.215 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 54.8 m -74.23 150.84 40.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.714 0.293 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.49 153.06 37.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.903 0.383 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 58.0 tp -119.96 132.7 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.282 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.72 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -99.96 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.848 HG23 ' HB3' ' A' ' 69' ' ' PHE . 86.9 mt -116.37 122.7 70.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.762 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.9 m -120.01 128.46 53.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -84.87 106.81 16.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.307 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.3 t -134.23 145.8 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.115 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 68' ' ' LEU . 96.2 m-20 -107.75 120.28 41.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.467 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' SG ' ' A' ' 186' ' ' CYS . 31.9 m -112.65 150.43 42.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.16 0.505 . . . . 0.0 111.753 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.685 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 45.0 Cg_endo -68.38 160.11 50.49 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.641 2.227 . . . . 0.0 111.44 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -75.0 120.2 20.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.45 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 192' ' ' LEU . . . -64.24 151.21 50.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.138 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 94.7 mm-40 -101.73 -18.0 16.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.13 134.81 18.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.823 ' CG1' HG22 ' A' ' 194' ' ' THR . 3.6 p -137.43 130.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.335 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.743 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 67.4 mttm -92.9 121.41 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.714 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 171' ' ' ILE . 82.6 mt -117.67 130.92 56.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.051 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.29 110.01 51.1 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HG3' HD11 ' A' ' 135' ' ' LEU . 97.2 Cg_endo -83.07 -176.71 2.97 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.654 2.236 . . . . 0.0 112.256 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 131' ' ' SER . 92.7 mt-30 -130.46 124.62 32.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.384 0.612 . . . . 0.0 110.378 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 1.2 m 71.05 166.97 0.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.956 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.7 -14.98 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.95 -40.07 87.73 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 111.066 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.503 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.4 t80 -59.93 -40.12 87.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.756 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.503 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -81.78 -9.55 59.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.543 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.9 -19.58 63.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.487 0.184 . . . . 0.0 111.435 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -61.99 132.11 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.666 0.269 . . . . 0.0 110.483 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.3 p -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.359 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -124.51 77.97 62.62 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.407 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.702 ' O ' HD23 ' A' ' 144' ' ' LEU . 52.2 Cg_endo -69.47 -33.91 16.67 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.52 2.147 . . . . 0.0 112.266 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.09 -40.34 89.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.271 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.93 95.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 147' ' ' VAL . 97.5 t -61.94 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -59.98 -40.1 87.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.401 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -42.32 93.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -63.29 -39.94 95.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.459 . . . . 0.0 110.295 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 162' ' ' ILE . 83.3 t -62.47 -41.96 93.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.945 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 95.3 mt -60.02 -40.03 87.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 188' ' ' ILE . 69.9 ttp85 -63.02 -39.96 96.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.62 -39.96 93.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.47 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.4 m-85 -99.35 120.29 39.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.235 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.534 ' HA ' HD11 ' A' ' 188' ' ' ILE . 15.9 t -69.97 -39.97 75.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.511 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.53 ' CB ' ' HB3' ' A' ' 81' ' ' HIS . 71.6 p -121.63 140.02 52.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 151' ' ' PHE . 95.1 mt -135.25 141.22 45.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 111.813 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.689 HG23 ' CD2' ' A' ' 81' ' ' HIS . 37.3 p -138.88 154.32 48.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.679 ' CG2' HG22 ' A' ' 176' ' ' VAL . 94.2 t -60.06 -39.95 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.324 0.583 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.1 -38.89 75.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.3 t0 -69.37 129.97 41.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.1 p -102.41 120.01 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.549 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.1 pt -105.12 140.01 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.942 0.401 . . . . 0.0 112.055 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.696 ' HG2' ' CB ' ' A' ' 170' ' ' LYS . 99.8 mt-10 -120.0 141.23 49.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.763 HD13 HG21 ' A' ' 147' ' ' VAL . 46.0 pt -129.87 140.13 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.383 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.7 t -112.17 120.03 40.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -123.79 129.56 51.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.999 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 53.75 39.95 30.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.565 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.2 9.71 86.76 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.135 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.3 mttm -108.85 137.15 47.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.724 0.262 . . . . 0.0 110.383 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -105.56 120.54 41.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 111.021 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.02 140.06 51.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.696 ' CB ' ' HG2' ' A' ' 161' ' ' GLU . 53.0 pttt -124.19 130.57 52.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.635 HD12 HD22 ' A' ' 127' ' ' LEU . 45.6 pt -132.06 140.81 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -119.73 137.4 53.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.972 0.415 . . . . 0.0 110.61 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.574 HG13 HD23 ' A' ' 127' ' ' LEU . 5.2 mp -81.47 112.85 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -57.26 7.14 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.743 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.4 tt0 -155.93 144.1 19.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.356 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' CG2' ' A' ' 156' ' ' VAL . 8.3 m -138.3 151.2 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.369 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -98.73 104.76 26.55 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 94.5 Cg_endo -100.23 177.16 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.437 2.758 . . . . 0.0 112.676 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.685 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 68.6 mm-40 -99.96 5.01 45.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 85.2 p -139.83 159.67 41.65 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.081 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.4 p -70.04 -18.54 63.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.892 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.9 p -59.98 -20.63 58.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.446 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 60.03 39.82 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 111.07 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 m -130.02 139.93 50.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.78 140.27 47.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' LEU . 75.3 m -129.48 100.31 5.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.802 HG11 HD22 ' A' ' 192' ' ' LEU . 5.7 p -126.87 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.631 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 149' ' ' ARG . 82.0 mt -105.62 -26.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.621 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.4 tt0 -89.97 -79.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.382 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 13.5 t -169.84 -158.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 0.0 111.102 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.9 m-20 75.74 25.09 1.2 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.892 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.802 HD22 HG11 ' A' ' 187' ' ' VAL . 28.4 tp -119.51 131.46 55.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 125' ' ' VAL . 20.8 t -92.84 129.0 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.76 0.314 . . . . 0.0 110.627 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.823 HG22 ' CG1' ' A' ' 125' ' ' VAL . 75.3 p -118.53 142.08 47.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -119.78 142.54 48.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.81 139.98 41.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 111.416 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -118.2 165.08 17.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.771 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 19.9 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 88.0 Cg_exo . . . . . 0 N--CA 1.465 -0.2 0 CA-C-O 120.579 0.158 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.405 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 78.2 mt-30 -100.08 120.01 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.716 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 116' ' ' SER . 25.2 m -124.28 131.76 53.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 111.689 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 116' ' ' SER . 22.3 t80 -120.24 139.88 52.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.613 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.93 133.07 55.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 57' ' ' LYS . 72.1 mt-10 -152.71 160.02 43.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.67 132.64 56.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.507 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 49.7 m-85 -139.67 159.99 40.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -94.56 126.32 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.471 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 29.8 p -91.06 141.79 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.346 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.4 m-85 -130.42 153.16 81.28 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.675 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.65 104.53 1.89 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.695 2.264 . . . . 0.0 112.628 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.756 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 90.7 mt -60.0 -39.82 81.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.385 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.768 ' HA ' HH11 ' A' ' 38' ' ' ARG . . . -59.33 -29.29 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.583 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.8 ttp -67.09 -37.72 84.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.281 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.98 140.04 57.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.18 151.75 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.587 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -59.97 -36.66 77.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.209 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -60.0 -34.06 72.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.667 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 37' ' ' ILE . 25.2 mt -110.24 9.11 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.377 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.768 HH11 ' HA ' ' A' ' 31' ' ' ALA . 28.5 ttp180 -119.95 137.15 54.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HE2' ' HB3' ' A' ' 41' ' ' ASP . 86.0 tttt -100.47 127.11 46.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.03 -40.08 88.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.633 ' HB3' ' HE2' ' A' ' 39' ' ' LYS . 52.4 t0 -59.98 -41.45 92.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.06 91.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.11 -40.06 88.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.78 18.7 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.19 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.58 163.33 23.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.209 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.91 11.39 64.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.859 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.8 mttt -115.7 140.05 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.5 pt -110.33 152.58 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.473 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.826 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 87.4 m-85 -93.12 132.07 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.733 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -142.42 160.21 55.15 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.292 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.759 ' O ' HD12 ' A' ' 55' ' ' LEU . 45.9 Cg_endo -65.63 144.58 79.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.081 2.521 . . . . 0.0 113.525 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 89' ' ' ALA . 25.8 Cg_endo -62.63 -20.33 70.55 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.059 2.506 . . . . 0.0 113.315 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.4 p -60.0 -43.58 95.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.648 0.261 . . . . 0.0 111.322 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -70.64 -41.46 72.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 111.313 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 84' ' ' VAL . 1.1 mp -60.07 -39.9 87.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -59.71 -39.38 84.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HD2' ' OE2' ' A' ' 23' ' ' GLU . 59.5 mttp -59.98 -39.29 85.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.667 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 91.9 mt -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -59.98 -39.97 87.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.94 -37.39 82.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.454 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.68 0.61 29.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.651 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.07 43.8 13.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.0 111.54 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.501 HG13 HD22 ' A' ' 58' ' ' LEU . 43.5 mm -72.24 130.24 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.618 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -69.76 140.41 53.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.477 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.541 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 25.1 t80 -87.43 141.75 32.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 188' ' ' ILE . 3.7 Cg_exo -74.84 160.36 96.6 Favored 'Cis proline' 0 C--N 1.348 0.552 0 C-N-CA 124.217 -1.16 . . . . 0.0 112.822 0.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.714 ' CE ' HD23 ' A' ' 55' ' ' LEU . 75.4 mtm -75.18 140.12 43.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.924 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.844 HD22 HG23 ' A' ' 153' ' ' THR . 79.1 mt -112.12 136.76 51.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.081 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.667 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 33.6 m-85 -131.86 147.08 52.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.171 0.51 . . . . 0.0 112.008 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 40.0 ttpt -122.68 129.29 51.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.332 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 112' ' ' LEU . 86.6 mt -100.38 125.6 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 111.049 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 79' ' ' VAL . 97.5 m -119.96 130.02 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.965 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . -107.83 118.09 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.7 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.361 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.12 -39.9 87.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.32 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.413 HG21 ' HA3' ' A' ' 105' ' ' GLY . 73.8 p -108.51 -11.63 15.11 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 68.16 14.32 65.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.68 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -100.0 139.95 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.562 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 71' ' ' LEU . 52.7 t -121.32 127.23 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.016 0.436 . . . . 0.0 111.215 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.599 HG21 ' HE3' ' A' ' 100' ' ' MET . 8.4 t -118.39 129.68 55.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.742 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 17.8 m-70 -83.76 139.61 32.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.363 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.73 -139.53 3.66 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.138 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -166.79 -164.0 21.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.38 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 55' ' ' LEU . 6.5 p -124.85 129.96 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.145 0.498 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.826 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 34.4 tp -92.62 -77.39 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -140.19 168.19 20.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.76 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 2.5 m-85 -90.94 116.33 28.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 49' ' ' PHE . 31.6 pt -141.83 -5.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.808 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -97.94 97.1 8.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 111.676 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.95 -40.12 72.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.504 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -85.8 -23.34 27.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 51' ' ' PRO . . . 114.76 46.5 0.6 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.558 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.808 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 21.6 mtm180 -111.0 149.47 30.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 111.069 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.864 HG21 HD11 ' A' ' 114' ' ' ILE . 10.8 p -129.92 140.27 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.756 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.5 m-85 -119.94 139.95 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.6 pt? -122.65 149.87 56.85 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.627 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.603 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 47.7 Cg_exo -53.64 158.84 7.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.87 2.38 . . . . 0.0 112.618 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.75 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mt-30 -60.07 -43.85 95.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.605 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.476 ' HZ3' ' O ' ' A' ' 159' ' ' VAL . 33.0 p-90 -68.88 -35.71 77.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.615 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.603 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.5 mmm -60.05 -40.1 88.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.3 -40.09 92.88 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.061 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.64 -40.08 88.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.964 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -64.91 -40.03 94.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.756 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 80' ' ' THR . 86.9 mt -69.92 -25.08 63.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.2 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.413 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 67.8 30.06 74.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.402 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 110' ' ' SER . 45.8 pt -113.4 139.42 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 111.893 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 8.2 pt20 -97.01 165.76 15.18 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 98.1 Cg_exo -43.92 140.51 4.93 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.658 2.239 . . . . 0.0 112.607 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.0 -9.99 75.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 58.0 m -70.06 153.08 43.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.502 ' CD2' ' HG3' ' A' ' 113' ' ' GLN . 9.9 tt -93.5 136.74 33.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.116 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 71' ' ' LEU . 60.1 tp -121.55 130.09 53.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.043 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.502 ' HG3' ' CD2' ' A' ' 111' ' ' LEU . 96.6 mt-30 -111.77 133.28 54.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.667 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HG21 ' A' ' 94' ' ' VAL . 85.4 mt -110.07 125.53 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.7 t -120.77 129.54 53.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.663 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.9 t -70.22 122.98 20.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 95.5 m -121.96 128.93 52.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 96.5 m-20 -123.94 120.02 31.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 186' ' ' CYS . 34.6 m -117.55 154.36 50.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.796 0.331 . . . . 0.0 111.618 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 93.6 Cg_endo -78.18 19.36 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.679 2.253 . . . . 0.0 112.555 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.808 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.0 mp 67.96 100.39 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.16 164.07 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.3 -22.17 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.412 ' HE1' ' HE2' ' A' ' 126' ' ' LYS . 64.3 t80 -142.71 131.18 22.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.497 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 194' ' ' THR . 3.3 p -135.95 132.4 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.258 0.551 . . . . 0.0 111.511 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 34.6 mttm -95.42 122.15 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.27 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 173' ' ' ILE . 86.0 mt -118.05 132.86 56.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 4.2 tt0 -116.58 113.51 40.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.818 ' HG3' HD11 ' A' ' 135' ' ' LEU . 83.7 Cg_endo -78.39 174.44 12.38 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.722 2.281 . . . . 0.0 112.439 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.61 HE22 ' HE2' ' A' ' 170' ' ' LYS . 98.4 mt-30 -125.7 123.93 39.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER 70.17 133.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.421 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -60.04 -24.82 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.186 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -39.92 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.67 -39.98 90.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.775 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.818 HD11 ' HG3' ' A' ' 129' ' ' PRO . 95.6 mt -82.19 -10.19 59.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -10.14 57.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.627 0.251 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.98 140.71 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.4 m -59.92 -40.15 87.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.287 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -124.66 75.84 64.11 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.749 0.309 . . . . 0.0 110.775 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 144' ' ' LEU . 36.0 Cg_exo -60.05 -33.76 95.13 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.632 2.221 . . . . 0.0 111.858 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.92 -40.12 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 147' ' ' VAL . 85.8 t -61.4 -43.57 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.87 -40.08 91.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.2 -40.35 89.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -66.59 -40.07 88.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.131 0.491 . . . . 0.0 109.866 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 162' ' ' ILE . 56.3 t -62.56 -40.1 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.93 -40.85 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.205 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.34 -40.07 96.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 110.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 89.2 m-85 -105.72 120.75 42.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.448 . . . . 0.0 111.781 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.3 m -60.16 -40.01 88.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.151 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.844 HG23 HD22 ' A' ' 68' ' ' LEU . 67.0 p -135.74 151.91 50.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.324 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.6 mp -117.43 130.45 56.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 173' ' ' ILE . 17.3 m -119.6 142.3 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.614 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.958 HG22 HG13 ' A' ' 176' ' ' VAL . 92.0 t -60.08 -45.05 96.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.199 0.523 . . . . 0.0 110.764 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -39.19 76.14 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.693 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.499 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 53.2 t0 -67.96 132.48 47.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 14.3 m -100.35 123.79 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.053 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 ' CG1' ' A' ' 147' ' ' VAL . 48.3 pt -104.72 138.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 98.9 mt-10 -120.03 140.09 51.52 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.598 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 147' ' ' VAL . 44.9 pt -130.02 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.937 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.1 t -108.79 113.3 26.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -119.91 119.18 32.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.503 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.5 m-20 51.14 39.35 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.22 -7.13 82.44 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.545 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 163' ' ' SER . 57.8 mtpt -100.03 137.4 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.966 0.383 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 8.9 t -112.19 120.66 42.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.237 0.542 . . . . 0.0 111.59 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CZ ' ' HE2' ' A' ' 167' ' ' LYS . 86.8 m-85 -120.01 140.0 51.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.042 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.924 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 51.4 pttt -119.93 136.82 54.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.117 0.484 . . . . 0.0 111.035 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.98 120.07 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.094 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.56 127.3 49.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.889 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 mp -81.97 120.04 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.634 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 128' ' ' GLU . 10.6 mp -69.79 -57.34 5.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.834 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.789 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.9 mt-10 -155.01 148.02 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.958 HG13 HG22 ' A' ' 156' ' ' VAL . 5.3 m -140.33 147.63 23.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -92.26 104.45 10.97 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 63.9 Cg_endo -102.47 163.93 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.639 2.893 . . . . 0.0 112.551 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.5 mt-10 -100.12 6.21 44.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.9 m -139.85 159.23 42.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.0 111.231 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.8 m -70.05 -12.9 61.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.7 m -59.17 -25.88 64.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 111.11 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.02 39.58 19.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.661 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.1 p -127.47 146.57 50.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.901 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.899 HD12 HD21 ' A' ' 192' ' ' LEU . 46.2 pt -128.39 136.87 58.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.065 0.46 . . . . 0.0 111.5 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 42.7 t -141.15 114.06 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.239 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 192' ' ' LEU . 7.2 p -120.84 112.52 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.496 0.665 . . . . 0.0 110.385 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.659 HD12 ' HD3' ' A' ' 66' ' ' PRO . 18.4 tt -79.97 -49.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 188' ' ' ILE . 77.2 mm-40 -91.03 -79.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 t -168.97 30.78 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.606 0.241 . . . . 0.0 111.604 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.808 ' HB2' HD23 ' A' ' 121' ' ' LEU . 95.9 m-20 -82.46 2.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.545 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 185' ' ' ILE . 62.4 tp -111.93 130.71 55.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 125' ' ' VAL . 31.6 t -95.37 123.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.169 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 125' ' ' VAL . 74.8 p -101.91 144.94 29.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -129.53 137.69 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.387 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.32 136.28 44.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.87 163.25 25.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.6 Cg_exo . . . . . 0 N--CA 1.463 -0.315 0 C-N-CA 122.361 2.041 . . . . 0.0 112.126 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.464 -0.235 0 CA-C-O 120.858 0.274 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' THR . 95.1 mt-30 -101.27 123.15 44.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 117' ' ' THR . 73.9 p -119.99 130.38 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 111.646 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.776 ' HB3' ' OG ' ' A' ' 116' ' ' SER . 86.2 t80 -121.27 126.66 50.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.761 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.18 130.87 54.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.208 0.528 . . . . 0.0 112.332 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.45 156.07 42.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.199 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.64 126.17 49.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.076 0.465 . . . . 0.0 111.773 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 97.5 m-85 -130.07 150.24 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.583 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 70.6 mtp85 -81.59 132.29 35.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.394 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 31.7 p -106.5 142.39 36.24 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.566 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 63.6 m-85 -140.37 152.75 67.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.547 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.56 ' HG2' ' SD ' ' A' ' 32' ' ' MET . 36.1 Cg_endo -65.66 119.76 6.84 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.232 1.955 . . . . 0.0 111.964 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.795 HG12 ' HB3' ' A' ' 95' ' ' TYR . 88.6 mt -59.93 -38.52 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -50.03 -20.54 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 29' ' ' PRO . 94.5 mtp -68.75 -32.65 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.98 143.19 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.99 151.04 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.143 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.78 -34.66 73.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.01 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 37' ' ' ILE . 69.7 mt -107.08 -0.17 9.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.116 0.484 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 51.8 ttt-85 -105.01 129.96 53.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.287 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -105.08 133.37 49.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.1 -40.07 88.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.381 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.68 -39.91 95.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.12 91.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.276 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.402 HD21 ' HE ' ' A' ' 38' ' ' ARG . 25.8 m120 -60.24 -40.0 88.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.659 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -100.14 1.7 42.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.181 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 180.0 35.69 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.61 29.97 9.75 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.845 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.01 122.47 42.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 83' ' ' GLY . 47.5 pt -115.33 149.9 17.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.499 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 97.5 m-85 -102.9 133.62 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.565 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 114' ' ' ILE . 1.6 mp -131.34 165.6 34.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.208 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.672 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 56.6 Cg_endo -71.59 157.38 56.09 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.163 1.908 . . . . 0.0 112.662 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.88 -23.08 30.66 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.737 2.291 . . . . 0.0 112.785 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -60.08 -40.09 88.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.229 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . . . -70.22 -42.55 72.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.785 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.4 tp -61.91 -41.02 97.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.382 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -59.86 -43.35 94.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 85.3 tttt -60.33 -40.08 89.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.798 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 ' CD1' ' A' ' 63' ' ' ILE . 87.3 mt -59.93 -40.08 87.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -59.67 -38.23 80.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.265 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.0 -39.18 84.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.04 -2.52 40.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.425 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.4 t30 60.02 40.26 18.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.588 0.233 . . . . 0.0 111.587 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CD1' HD22 ' A' ' 58' ' ' LEU . 86.3 mt -70.2 130.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.47 142.75 38.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 16.0 p90 -87.68 158.29 51.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.49 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 9.5 Cg_exo -72.82 146.84 88.01 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.758 -1.351 . . . . 0.0 112.708 0.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.18 140.01 48.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.474 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' SER . 21.5 mt -115.84 132.09 56.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 114' ' ' ILE . 11.6 m-85 -120.53 140.28 51.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.095 0.474 . . . . 0.0 111.638 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 115' ' ' SER . 87.3 tttt -115.65 129.96 56.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.779 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 96.8 mt -98.38 131.12 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.368 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.796 ' HA ' HG12 ' A' ' 79' ' ' VAL . 87.0 m -120.01 129.61 54.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.986 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.2 115.62 27.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -68.39 -40.02 81.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.49 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -40.02 87.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.4 m -100.62 -17.38 17.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.742 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.34 1.14 41.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.685 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -100.22 141.18 33.41 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.717 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 72' ' ' THR . 20.2 m -119.97 119.87 61.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.469 ' H ' HD21 ' A' ' 104' ' ' LEU . 36.2 p -110.34 139.46 45.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.37 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 77.7 m80 -84.8 114.39 22.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 0.0 110.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.33 158.49 20.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.34 165.26 27.5 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.73 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -128.69 133.1 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 117.361 0.581 . . . . 0.0 112.336 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.845 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.6 tp -92.22 -79.05 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.535 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -149.55 160.45 43.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CE1' HD13 ' A' ' 55' ' ' LEU . 80.3 m-85 -97.37 116.76 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.292 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.25 -4.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.601 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.33 97.83 11.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.378 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -39.92 76.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.459 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.97 -20.13 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.345 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 97.18 54.16 1.3 Allowed Glycine 0 C--O 1.23 -0.107 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.154 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.601 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 87.3 mtt180 -121.2 145.09 48.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.132 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 114' ' ' ILE . 93.6 t -120.4 131.72 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.311 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.795 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.8 138.91 53.79 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 101' ' ' MET . 1.8 pt? -134.56 159.04 73.74 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.63 0.252 . . . . 0.0 110.475 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 65.1 Cg_endo -70.52 158.25 56.5 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.659 2.239 . . . . 0.0 112.824 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.478 ' HA ' ' CE ' ' A' ' 101' ' ' MET . 78.0 mt-30 -61.71 -40.0 93.5 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.586 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 48.9 p-90 -62.83 -39.93 95.86 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.518 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.586 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 96.7 mtp -68.22 -40.0 82.2 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.332 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.739 ' HG2' HD11 ' A' ' 96' ' ' LEU . 76.4 mtm -61.01 -39.98 91.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.48 -40.1 92.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.7 m -63.21 -40.03 96.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.469 HD21 ' H ' ' A' ' 80' ' ' THR . 83.9 mt -86.24 -10.06 55.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.692 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.22 41.6 99.72 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.046 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.95 133.53 54.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.137 0.494 . . . . 0.0 110.749 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 5.7 mt-30 -96.43 160.0 30.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 18.3 Cg_endo -59.93 -1.97 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.299 2.0 . . . . 0.0 112.964 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.83 -12.54 24.04 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 m -94.46 151.52 19.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.313 . . . . 0.0 111.154 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.583 ' CD2' ' HG2' ' A' ' 26' ' ' ARG . 89.9 mt -79.98 158.11 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.597 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.2 tp -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.9 mt-30 -101.73 120.34 40.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.346 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 50' ' ' LEU . 87.8 mt -110.27 126.21 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.4 t -119.78 120.3 36.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.776 ' OG ' ' HB3' ' A' ' 21' ' ' PHE . 48.5 p -88.76 111.16 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.585 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 5.3 t -133.95 150.43 51.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.286 0.565 . . . . 0.0 112.251 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' OD2' HG23 ' A' ' 63' ' ' ILE . 97.7 m-20 -104.74 119.16 38.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.711 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 ' SG ' ' A' ' 186' ' ' CYS . 15.9 m -115.5 152.51 47.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 180' ' ' SER . 51.5 Cg_exo -57.84 166.25 5.49 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.917 1.744 . . . . 0.0 111.257 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 122' ' ' GLY . 8.0 tt -93.98 120.12 33.79 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.63 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.8 ' HA3' HG23 ' A' ' 185' ' ' ILE . . . -68.86 146.11 44.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.228 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.23 -19.85 16.9 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 195' ' ' ASP . 64.7 t80 -145.78 131.49 18.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.665 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 176' ' ' VAL . 7.5 p -131.0 129.44 63.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.671 0.748 . . . . 0.0 111.785 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 63.5 tttp -97.01 120.31 37.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.686 ' CD1' HD21 ' A' ' 144' ' ' LEU . 77.0 mt -113.94 135.3 54.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.65 ' CD ' HD11 ' A' ' 174' ' ' LEU . 2.6 tt0 -100.22 127.81 32.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.403 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 128' ' ' GLU . 86.5 Cg_endo -79.78 172.83 13.66 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.322 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.649 ' HG3' ' HG3' ' A' ' 170' ' ' LYS . 29.9 mm100 -135.62 121.16 19.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.88 24.89 13.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.513 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 m 41.95 24.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.86 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.43 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 95.5 m-20 -70.0 -40.01 75.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.412 . . . . 0.0 110.188 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.543 ' CE1' ' CE2' ' A' ' 196' ' ' PHE . 64.8 t80 -60.71 -40.06 90.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.763 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.16 -24.28 67.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.146 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.02 -19.61 63.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.16 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.9 mt -66.6 137.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.566 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.6 m -60.12 -39.92 87.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.518 ' H ' HG22 ' A' ' 137' ' ' ILE . 67.6 m-20 -129.7 71.87 82.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 134' ' ' PHE . 21.3 Cg_exo -64.68 -30.51 59.9 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.94 -41.0 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.14 98.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 147' ' ' VAL . 72.8 t -64.6 -41.04 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 1.087 HD11 HG21 ' A' ' 194' ' ' THR . 1.8 tm? -60.0 -43.19 95.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.12 -40.27 89.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 0.0 110.75 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -61.97 -40.08 94.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.965 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 162' ' ' ILE . 59.4 t -59.89 -40.48 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.516 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 188' ' ' ILE . 86.4 mt -60.23 -40.09 88.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.47 -40.02 77.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.183 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.97 -40.01 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.747 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.649 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 91.3 m-85 -102.71 118.02 35.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.101 0.476 . . . . 0.0 111.374 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.525 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 69.2 m -63.2 -39.94 96.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.032 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 68' ' ' LEU . 34.4 p -123.13 140.66 52.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.012 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 185' ' ' ILE . 86.5 mt -120.87 127.19 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.79 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 157' ' ' ASP . 25.0 m -126.46 142.9 51.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 173' ' ' ILE . 59.6 t -60.03 -42.08 88.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.357 0.598 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 155' ' ' THR . 96.0 m-20 -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.413 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.0 m-20 -75.35 140.09 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 121.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.467 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.649 ' HB ' ' CZ ' ' A' ' 151' ' ' PHE . 46.2 pt -104.12 138.69 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.702 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 47.9 mt-10 -121.06 140.62 51.7 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.756 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 147' ' ' VAL . 43.4 pt -127.55 142.85 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.211 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 31.6 t -111.54 115.94 30.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 54.6 t80 -121.14 122.93 41.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.955 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.36 39.99 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.535 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.85 89.91 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.932 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 163' ' ' SER . 97.5 mttt -104.48 136.97 43.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.8 p -108.67 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 111.413 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.43 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.2 m-85 -119.94 139.98 51.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.444 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 61.5 pttt -121.33 135.49 55.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.264 0.554 . . . . 0.0 111.245 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.638 HD11 HD11 ' A' ' 160' ' ' ILE . 45.9 pt -128.4 139.52 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.11 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -116.36 129.21 56.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.723 ' O ' HG13 ' A' ' 156' ' ' VAL . 3.4 mp -77.92 80.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.09 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.65 HD11 ' CD ' ' A' ' 128' ' ' GLU . 88.0 mt -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.5 mt-10 -146.27 139.4 25.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.791 0.329 . . . . 0.0 111.459 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 125' ' ' VAL . 32.5 m -144.6 160.03 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.631 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 104.0 54.15 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.453 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 66.9 Cg_endo -99.26 167.34 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.252 2.635 . . . . 0.0 113.053 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.91 9.9 42.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.757 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 43.6 t -139.85 162.02 36.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.1 m -70.67 -15.12 62.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.132 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.4 p -61.38 -21.07 63.73 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.729 0.3 . . . . 0.0 111.032 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.4 mmtt 60.08 40.21 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.625 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.523 ' C ' HD13 ' A' ' 185' ' ' ILE . 80.4 p -129.76 150.69 50.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.8 HG23 ' HA3' ' A' ' 122' ' ' GLY . 7.3 mm -117.94 118.36 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.519 ' SG ' HG21 ' A' ' 119' ' ' VAL . 10.9 m -143.2 160.59 40.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.833 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 186' ' ' CYS . 17.2 t 77.06 121.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.427 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 148' ' ' LEU . 14.8 mt -120.64 84.04 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.479 ' H ' HD11 ' A' ' 121' ' ' LEU . 99.4 mt-10 -126.33 -20.42 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -110.63 20.04 18.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.7 m-20 70.47 94.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 122' ' ' GLY . 4.1 tp -75.61 142.02 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.453 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 125' ' ' VAL . 26.3 t -99.99 128.36 51.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.018 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 1.087 HG21 HD11 ' A' ' 144' ' ' LEU . 70.1 p -117.87 144.57 45.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 124' ' ' PHE . 55.6 t0 -126.41 139.97 52.85 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.907 0.384 . . . . 0.0 110.973 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.543 ' CE2' ' CE1' ' A' ' 134' ' ' PHE . 96.6 m-85 -108.75 140.38 42.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.63 129.65 25.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.524 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 122.682 2.254 . . . . 0.0 112.653 179.605 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo . . . . . 0 N--CA 1.463 -0.275 0 CA-C-O 120.714 0.214 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.5 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.5 mt-30 -113.03 126.28 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.0 m -120.13 130.54 54.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.308 0.575 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 58.2 t80 -133.24 130.04 38.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.621 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.65 135.93 49.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -142.07 159.9 41.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.282 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CZ ' HD13 ' A' ' 111' ' ' LEU . 64.6 t80 -119.85 128.94 54.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.719 ' HD2' HG22 ' A' ' 114' ' ' ILE . 84.6 m-85 -139.08 153.15 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.587 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -81.07 140.7 34.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.547 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 49.8 t -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 111.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 18.5 m-85 -120.43 150.71 52.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.594 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' PRO . 6.2 Cg_exo -80.31 113.92 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.76 2.307 . . . . 0.0 112.232 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.837 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 95.8 mt -61.14 -39.91 84.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HA ' ' CZ ' ' A' ' 38' ' ' ARG . . . -59.79 -29.22 68.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 96.8 mmm -68.3 -36.66 79.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 110.214 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -61.04 140.05 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.36 143.59 52.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 112.044 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.9 m-20 -59.87 -26.27 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.103 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -60.05 -38.75 83.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.91 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.7 pt -108.05 -9.76 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.245 0.545 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.725 ' CZ ' ' HA ' ' A' ' 31' ' ' ALA . 66.4 ttt180 -89.23 139.77 30.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 86.0 tttt -101.16 125.51 47.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.376 . . . . 0.0 110.512 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.14 -40.82 91.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.659 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.763 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.0 m-20 -61.49 -39.99 92.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.1 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.14 90.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.98 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.79 -40.1 87.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.335 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 163' ' ' SER . 90.0 m-85 -102.7 6.04 39.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.56 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.41 160.72 22.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.105 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.15 10.75 73.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.336 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 22.2 mttm -104.45 143.18 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 96' ' ' LEU . 32.6 pt -121.5 169.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.725 ' O ' HG23 ' A' ' 94' ' ' VAL . 96.3 m-85 -100.45 131.48 46.35 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.512 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 48' ' ' ILE . 3.9 mp -140.6 163.37 43.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.613 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.552 ' HB3' ' O ' ' A' ' 89' ' ' ALA . 60.6 Cg_endo -72.22 133.78 21.78 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.14 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 34.6 Cg_exo -57.9 -11.9 10.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.691 2.261 . . . . 0.0 112.89 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.3 p -60.11 -39.05 84.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.54 75.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.382 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 58' ' ' LEU . 85.4 mt -60.03 -40.61 89.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.356 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -60.11 -40.03 88.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 33.6 mttm -67.5 -39.91 85.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.596 HD22 HG13 ' A' ' 63' ' ' ILE . 89.7 mt -60.18 -39.35 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.595 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -60.09 -39.79 87.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.17 -39.85 87.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 21' ' ' PHE . 89.6 mt -81.28 -0.36 40.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.712 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.89 43.32 15.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.245 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.596 HG13 HD22 ' A' ' 58' ' ' LEU . 47.8 mm -64.34 129.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.434 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -70.54 140.01 51.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -88.17 143.59 33.08 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.856 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 188' ' ' ILE . 7.6 Cg_exo -73.89 163.83 89.0 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.397 0.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.472 ' SD ' HD13 ' A' ' 58' ' ' LEU . 55.2 mtt -83.86 133.9 34.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.791 HD13 ' CB ' ' A' ' 186' ' ' CYS . 0.2 OUTLIER -122.12 137.98 54.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.566 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CB ' HD11 ' A' ' 114' ' ' ILE . 97.5 m-85 -123.69 140.49 52.94 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.152 0.501 . . . . 0.0 111.712 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 39.6 ttpt -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.099 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CE ' ' A' ' 100' ' ' MET . 88.6 mt -89.97 122.57 33.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.542 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 79' ' ' VAL . 60.2 m -99.42 122.25 42.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.454 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -117.36 133.89 55.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.352 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 62.27 139.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.103 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -40.0 87.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 p -129.81 17.72 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.489 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.15 -102.95 0.51 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.783 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -139.98 146.34 38.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.876 0.369 . . . . 0.0 111.267 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 72' ' ' THR . 62.5 t -120.77 119.21 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.901 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 103' ' ' THR . 30.8 p -102.11 163.47 12.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.886 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.459 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 79.1 m80 -103.96 114.83 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.84 159.86 17.27 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.981 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' A' ' 152' ' ' SER . . . -94.18 170.33 30.1 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.245 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.57 125.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 111.595 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.3 tp -92.75 -79.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.34 152.38 35.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.515 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 74.8 m-85 -99.33 115.7 29.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.591 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.04 -5.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.78 98.89 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.18 -39.86 82.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.04 0.447 . . . . 0.0 110.714 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.32 -30.64 70.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.047 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.43 50.47 0.71 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.444 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.562 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 50.4 ttp180 -117.65 140.04 50.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 49' ' ' PHE . 10.2 p -127.74 143.83 39.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.009 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.837 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.5 m-85 -119.97 140.45 50.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.257 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 48' ' ' ILE . 19.2 mt -114.92 137.9 23.1 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.707 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG22 ' A' ' 48' ' ' ILE . 42.3 Cg_exo -53.83 161.03 5.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.7 2.266 . . . . 0.0 112.325 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.02 -44.13 94.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.685 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CH2' ' SD ' ' A' ' 100' ' ' MET . 23.5 p-90 -69.66 -37.85 76.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.1 mmm -60.17 -39.98 88.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.1 mmm -60.16 -40.57 90.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -40.7 78.83 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.546 HG22 HG21 ' A' ' 80' ' ' THR . 94.2 m -60.26 -39.95 88.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 0.0 110.02 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.969 HD22 ' HB2' ' A' ' 73' ' ' ALA . 45.0 mt -80.9 -16.59 53.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.312 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.37 73.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.059 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.3 pt -111.41 143.99 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 pt20 -100.58 161.14 24.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.802 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.678 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.3 Cg_endo -48.9 134.76 28.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.675 2.25 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.44 -9.98 75.87 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.964 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.655 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 52.1 m -70.87 150.85 45.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.813 0.307 . . . . 0.0 110.61 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.518 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 74.2 mt -71.51 141.21 50.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 63.3 tp -123.87 130.02 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.692 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -113.37 120.0 39.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.993 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.719 HG22 ' HD2' ' A' ' 25' ' ' PHE . 21.0 tt -117.06 127.57 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.6 p -120.11 138.82 53.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.927 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -80.76 110.19 16.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 94.5 m -119.94 129.98 54.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.424 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -105.73 119.98 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.599 ' H ' HD11 ' A' ' 68' ' ' LEU . 32.7 m -115.92 149.41 43.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.964 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 7.5 Cg_exo -70.81 161.79 44.85 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.335 2.023 . . . . 0.0 110.508 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 190' ' ' THR . 1.3 mt -90.85 120.13 31.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.442 0.639 . . . . 0.0 112.277 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.74 165.79 47.45 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.7 -28.03 9.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.404 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 65.5 t80 -136.98 132.55 34.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 176' ' ' VAL . 2.9 p -133.67 131.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.748 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 61.9 mttp -94.97 124.86 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 194' ' ' THR . 82.5 mt -105.61 131.06 53.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.74 0.305 . . . . 0.0 110.778 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -106.71 109.69 63.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.47 164.92 32.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.61 2.206 . . . . 0.0 112.062 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.65 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.1 tt0 -124.52 120.98 33.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.938 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.98 146.76 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.002 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.39 -22.12 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.432 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.99 -39.61 86.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.797 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.641 ' CE1' HD11 ' A' ' 171' ' ' ILE . 65.6 t80 -59.9 -40.1 87.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 0.0 110.755 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.31 -8.22 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.965 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.02 -34.84 73.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.659 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.5 mt -55.68 137.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -60.01 -40.09 88.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.743 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 137' ' ' ILE . 42.5 t0 -129.95 79.76 72.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.931 0.396 . . . . 0.0 111.311 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.02 -25.53 16.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.57 2.18 . . . . 0.0 111.937 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.07 -41.4 92.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.441 ' HB2' ' OD2' ' A' ' 139' ' ' ASP . . . -64.73 -42.1 95.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.456 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.94 -40.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.679 HD13 ' O ' ' A' ' 144' ' ' LEU . 3.4 tm? -61.72 -39.99 93.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.862 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.16 -40.06 93.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -64.66 -42.18 95.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.75 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 162' ' ' ILE . 22.4 m -67.35 -36.44 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.512 HD11 ' CD1' ' A' ' 144' ' ' LEU . 86.6 mt -59.98 -40.09 87.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.2 -40.04 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.6 -39.86 89.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.44 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.15 119.6 34.94 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.711 ' HA ' HG12 ' A' ' 188' ' ' ILE . 50.1 m -62.11 -40.02 94.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.497 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 71.2 p -127.39 143.01 51.28 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.176 0.512 . . . . 0.0 111.33 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.831 HD21 HG12 ' A' ' 173' ' ' ILE . 8.2 tt -121.69 124.03 43.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.157 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 93.1 m -119.51 135.69 54.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.894 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.896 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 58.1 t -59.9 -41.76 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.161 0.505 . . . . 0.0 111.53 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.798 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.1 m-20 -74.31 146.04 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.339 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 119.99 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.339 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.406 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.3 pt -97.89 140.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.713 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -119.64 140.59 50.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.194 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.719 HD13 HG11 ' A' ' 147' ' ' VAL . 43.3 pt -136.09 145.81 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 29.0 t -115.39 119.4 36.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.701 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.437 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 53.2 t80 -125.84 120.49 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.437 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 59.96 31.45 20.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.443 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.75 -9.85 75.74 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.075 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -101.78 140.05 36.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.496 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 163' ' ' SER . 68.3 p -108.8 130.14 55.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.037 0.446 . . . . 0.0 111.505 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 139.97 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.184 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.713 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.7 mttt -103.33 133.28 48.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.961 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.641 HD11 ' CE1' ' A' ' 134' ' ' PHE . 48.5 mm -119.91 119.89 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.05 130.5 54.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.896 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.5 mp -83.88 132.26 31.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.325 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.04 -70.46 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.978 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 50.4 tp10 -140.3 139.86 35.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.945 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 156' ' ' VAL . 3.8 m -139.18 149.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.038 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -99.91 104.23 27.24 Favored Pre-proline 0 C--O 1.232 0.158 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 68.6 Cg_endo -102.9 177.97 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.691 2.928 . . . . 0.0 112.732 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.4 mt-10 -99.95 -0.01 40.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.82 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.3 m -138.29 151.65 47.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.028 0.442 . . . . 0.0 111.462 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 79.6 p -70.03 -10.03 57.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.706 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 46.9 t -55.68 -28.84 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.32 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 69.8 23.24 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.6 p -124.59 139.94 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.854 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.526 HD11 HD22 ' A' ' 154' ' ' LEU . 15.0 pt -132.2 140.05 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.791 ' CB ' HD13 ' A' ' 68' ' ' LEU . 11.2 t -119.76 109.75 15.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.816 HG11 HD22 ' A' ' 192' ' ' LEU . 12.0 p -141.09 99.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.603 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.711 HG12 ' HA ' ' A' ' 152' ' ' SER . 74.8 mt -97.18 -67.81 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.278 0.561 . . . . 0.0 111.566 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 189' ' ' GLU . 86.4 tt0 -94.1 -6.25 45.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.257 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -80.29 174.58 11.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -103.21 119.97 39.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.932 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.816 HD22 HG11 ' A' ' 187' ' ' VAL . 18.1 tp -120.26 140.09 51.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.254 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -89.27 120.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.522 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.595 HG22 HG13 ' A' ' 125' ' ' VAL . 76.2 p -113.85 146.47 39.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 196' ' ' PHE . 49.4 t0 -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 195' ' ' ASP . 11.2 m-85 -93.31 139.98 30.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 111.408 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -119.83 166.46 14.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.2 Cg_exo . . . . . 0 C--N 1.342 0.233 0 C-N-CA 122.446 2.097 . . . . 0.0 112.13 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 73.1 Cg_exo . . . . . 0 N--CA 1.464 -0.254 0 CA-C-O 120.77 0.237 . . . . 0.0 112.123 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.9 mt-30 -101.0 130.21 46.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.8 p -121.67 130.11 53.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 50.7 t80 -131.55 130.28 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -113.97 136.8 52.5 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mm-40 -149.99 160.03 43.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 120.04 38.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.71 ' CD2' HD12 ' A' ' 114' ' ' ILE . 86.2 m-85 -126.47 149.47 49.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -81.32 133.44 35.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.601 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.974 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 53.2 t -99.95 121.95 42.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 111.357 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.655 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 88.9 m-85 -120.42 150.06 51.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.992 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 108' ' ' PRO . 7.2 Cg_exo -75.68 107.02 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.848 2.366 . . . . 0.0 112.699 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.2 mt -61.09 -40.84 87.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.62 77.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.866 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.469 ' CG ' ' HB2' ' A' ' 29' ' ' PRO . 98.9 mmm -68.25 -30.29 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 96.5 mmm -59.94 142.24 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.26 154.49 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.673 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -55.16 -29.17 57.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.404 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -60.01 -39.9 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.2 mt -111.48 8.88 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.648 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 74.8 ttt180 -104.65 123.18 47.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.049 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.07 129.29 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.896 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.21 -40.09 88.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.269 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.88 -39.97 95.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.91 95.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.763 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.08 -40.1 88.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.351 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.38 14.53 22.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.273 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.57 164.0 24.06 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.119 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.52 11.78 63.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.472 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 67.9 mttm -109.86 145.12 37.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.567 HG21 ' CD2' ' A' ' 96' ' ' LEU . 48.0 pt -121.55 162.99 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.909 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.3 m-85 -96.58 133.24 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -134.25 165.47 36.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.239 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 84.6 Cg_endo -79.53 152.73 23.25 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.21 1.94 . . . . 0.0 112.67 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.973 ' HA ' HD13 ' A' ' 55' ' ' LEU . 19.1 Cg_exo -66.88 -21.74 49.96 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.961 2.441 . . . . 0.0 112.829 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 m -60.08 -40.07 88.28 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.37 80.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.226 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.96 -40.04 87.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.391 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -59.97 -42.76 94.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.59 -39.97 92.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.378 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 116' ' ' SER . 84.6 mt -63.34 -38.56 91.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.375 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.6 m -59.76 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.97 -39.48 85.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.489 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -81.76 -0.05 41.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.681 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.4 m120 59.98 42.43 16.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.704 0.288 . . . . 0.0 111.422 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.499 HG13 HD22 ' A' ' 58' ' ' LEU . 42.7 mm -70.02 130.02 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.744 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -72.05 139.59 48.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.781 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.743 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 28.9 t80 -88.42 146.52 37.86 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.863 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 1.0 ' HD2' HD13 ' A' ' 188' ' ' ILE . 59.9 Cg_endo -71.62 160.38 93.04 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.228 -1.155 . . . . 0.0 113.551 0.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.545 ' HB2' HG11 ' A' ' 84' ' ' VAL . 63.6 mtt -71.86 139.98 49.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' HB ' ' A' ' 153' ' ' THR . 95.4 mt -110.04 123.03 48.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.9 m-85 -119.99 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 28.4 ttpp -114.66 130.0 56.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.723 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 80' ' ' THR . 71.6 mt -94.17 121.72 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.581 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 29.8 m -106.76 119.93 40.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 78' ' ' ARG . . . -112.51 132.46 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.094 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 61.77 148.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 0.0 110.074 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.04 -40.06 88.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.56 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 72.0 p -135.48 13.71 3.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.356 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 -106.85 0.14 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.073 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.747 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 83.0 mtt85 -128.53 147.54 50.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 0.0 111.68 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 72' ' ' THR . 35.9 m -130.06 130.8 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.966 HG22 HD21 ' A' ' 104' ' ' LEU . 7.2 t -112.77 132.43 55.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 111.531 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.435 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 78.3 m80 -84.42 161.56 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.35 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.24 169.74 42.78 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.94 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.1 -177.26 29.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.985 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 67' ' ' MET . 9.0 p -130.2 131.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.333 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.1 tp -89.99 -79.21 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.056 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -139.66 155.18 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.705 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CG ' HD11 ' A' ' 55' ' ' LEU . 86.1 m-85 -99.9 116.53 32.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.931 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.5 pt -124.79 -5.47 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -91.88 100.11 12.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.01 0.433 . . . . 0.0 111.263 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.52 -39.97 77.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -66.54 -30.5 70.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 111.8 49.24 0.64 Allowed Glycine 0 C--N 1.319 -0.39 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.051 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.584 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 92.9 mtt180 -118.45 149.22 41.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.986 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.773 HG21 HD11 ' A' ' 114' ' ' ILE . 10.0 p -129.37 142.32 44.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.019 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.774 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.26 139.95 50.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.704 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -120.39 148.18 46.95 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.583 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.52 157.98 29.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.655 2.237 . . . . 0.0 112.016 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -60.79 -40.56 93.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CZ2' ' HE3' ' A' ' 100' ' ' MET . 44.6 p-90 -70.05 -40.03 75.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.201 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.509 ' HE3' ' CZ2' ' A' ' 99' ' ' TRP . 52.5 mtt -65.32 -39.92 93.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.09 -40.32 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.6 -40.03 95.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.978 0.418 . . . . 0.0 110.379 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.6 -40.08 95.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.966 HD21 HG22 ' A' ' 80' ' ' THR . 96.5 mt -83.72 -12.15 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.594 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.65 42.23 99.21 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.96 132.52 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.136 0.493 . . . . 0.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -100.11 159.22 30.39 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 38.9 Cg_exo -52.44 131.03 38.77 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.501 2.134 . . . . 0.0 112.01 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.27 77.9 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.668 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t -76.82 153.3 35.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 111' ' ' LEU . 10.4 tt -70.59 140.78 51.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.461 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.974 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.2 tp -126.9 139.95 52.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.645 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 95.6 mt-30 -113.91 127.15 55.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 50' ' ' LEU . 85.3 mt -119.98 124.46 72.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.9 t -119.13 121.06 38.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.66 108.07 17.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 9.2 t -131.37 140.93 49.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.933 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.567 ' HA ' HD12 ' A' ' 68' ' ' LEU . 58.0 t0 -99.66 120.01 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.652 HG23 ' N ' ' A' ' 186' ' ' CYS . 27.3 m -103.97 155.71 36.69 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.432 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.625 ' O ' ' HA ' ' A' ' 185' ' ' ILE . 12.3 Cg_exo -70.05 149.72 65.42 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.322 2.015 . . . . 0.0 111.333 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 190' ' ' THR . 8.3 tt -70.19 127.42 32.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.85 152.19 29.8 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.283 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -108.48 -29.97 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.454 ' HE2' ' CG ' ' A' ' 126' ' ' LYS . 70.2 t80 -140.85 134.24 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.832 HG23 ' CG1' ' A' ' 176' ' ' VAL . 5.7 p -130.1 130.85 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.111 0.481 . . . . 0.0 112.148 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD3' HD11 ' A' ' 174' ' ' LEU . 99.5 mttt -99.18 122.02 41.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.323 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' OG1' ' A' ' 194' ' ' THR . 86.4 mt -111.71 131.09 55.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.0 0.429 . . . . 0.0 111.292 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.06 110.42 62.36 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.354 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 95.9 Cg_endo -84.26 162.15 13.21 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.676 2.25 . . . . 0.0 112.651 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.633 ' OE1' ' HE3' ' A' ' 170' ' ' LYS . 61.5 tt0 -129.31 122.88 30.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.755 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.5 OUTLIER 75.9 131.05 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.66 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.21 -17.5 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.728 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HA ' ' OD2' ' A' ' 136' ' ' ASP . 96.0 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.628 0.251 . . . . 0.0 110.842 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 59.5 t80 -59.94 -40.13 87.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 0.0 111.059 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 196' ' ' PHE . 95.7 mt -85.57 -4.77 59.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 133' ' ' ASP . 94.1 m-20 -70.05 -16.83 63.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.39 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 139' ' ' ASP . 86.0 mt -61.18 139.26 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.419 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.3 p -61.41 -39.94 92.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.508 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.0 OUTLIER -129.43 73.98 81.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.783 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 74.5 Cg_endo -76.0 -29.77 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.479 2.119 . . . . 0.0 112.117 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.06 -40.13 88.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.112 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.4 89.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 147' ' ' VAL . 87.1 t -62.87 -41.98 94.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.553 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.01 -42.81 95.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -41.36 92.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -61.92 -40.26 94.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 162' ' ' ILE . 57.5 t -60.96 -42.61 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.021 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.12 -40.06 88.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.783 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.66 -39.93 90.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.486 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.484 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 93.9 m-85 -96.18 121.46 37.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.402 ' OG ' HD23 ' A' ' 68' ' ' LEU . 89.4 p -61.19 -39.94 92.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.51 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.689 ' HB ' HD22 ' A' ' 68' ' ' LEU . 7.3 t -128.32 141.23 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 0.0 111.075 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -113.4 120.13 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.2 p -119.94 145.87 46.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.184 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.789 ' CG2' HG22 ' A' ' 176' ' ' VAL . 72.1 t -60.07 -39.94 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 111.73 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.18 -38.68 78.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.595 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -67.14 131.69 46.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.249 0.547 . . . . 0.0 112.325 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.406 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 60.0 t -104.01 120.12 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.846 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 ' CG1' ' A' ' 147' ' ' VAL . 49.1 pt -106.27 134.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 111.998 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 49.0 mt-10 -120.58 140.03 52.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.462 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 147' ' ' VAL . 44.3 pt -131.08 140.83 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 65.2 m -105.92 120.99 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.495 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 60.1 t80 -119.97 120.0 35.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.495 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 55.36 40.0 31.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.432 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.99 8.7 87.42 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.027 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.4 mttp -106.19 132.62 52.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -101.13 119.96 39.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.391 . . . . 0.0 111.223 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 98.3 m-85 -120.82 140.07 52.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 55.3 pttt -117.83 131.91 56.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.639 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 127' ' ' LEU . 85.4 mt -120.01 120.12 62.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.249 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -107.29 130.01 54.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.368 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 5.3 mp -80.52 113.37 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 126' ' ' LYS . 1.5 pp -73.64 -56.51 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.729 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.53 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 99.0 mt-10 -155.57 136.42 13.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.832 ' CG1' HG23 ' A' ' 125' ' ' VAL . 21.4 m -130.57 159.96 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -105.08 104.11 45.29 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.78 0.324 . . . . 0.0 110.219 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.426 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 68.7 Cg_endo -100.19 179.17 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.733 2.956 . . . . 0.0 112.509 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.0 mt-10 -95.41 0.03 52.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 120' ' ' PRO . 88.2 p -140.31 159.88 41.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.031 0.443 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.05 -11.53 60.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.668 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.9 t -59.95 -18.58 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.415 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 66.77 26.41 9.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 110.702 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.8 m -125.9 139.98 53.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.104 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' PRO . 45.7 pt -127.52 143.87 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.652 ' N ' HG23 ' A' ' 119' ' ' VAL . 40.5 t -92.04 100.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.078 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.755 HG21 HD22 ' A' ' 192' ' ' LEU . 97.6 t -109.96 93.83 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.093 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 1.0 HD13 ' HD2' ' A' ' 66' ' ' PRO . 84.2 mt -110.59 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.836 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 188' ' ' ILE . 99.0 mt-10 -117.78 10.78 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.67 ' CB ' HD11 ' A' ' 121' ' ' LEU . 5.8 t -84.98 171.71 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.207 0.527 . . . . 0.0 111.992 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.49 119.45 37.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.79 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.755 HD22 HG21 ' A' ' 187' ' ' VAL . 31.4 tp -120.37 131.29 54.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 36.3 t -89.35 126.91 42.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.167 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.593 ' OG1' HD12 ' A' ' 127' ' ' LEU . 3.9 t -116.96 140.3 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.575 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -120.07 131.74 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.544 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.427 ' CD1' HD21 ' A' ' 135' ' ' LEU . 87.4 m-85 -100.14 122.34 42.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.38 . . . . 0.0 111.532 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -121.16 108.39 36.32 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 112.468 -179.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.463 -0.306 0 CA-C-O 120.885 0.285 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' A' ' 117' ' ' THR . 57.2 tt0 -101.49 119.99 39.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.473 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 116' ' ' SER . 82.6 p -119.6 137.56 53.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.942 0.401 . . . . 0.0 111.637 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 57' ' ' LYS . 75.2 t80 -125.74 130.52 51.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.618 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.15 136.7 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 112.052 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 98.6 mt-10 -140.53 153.6 46.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.067 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -120.14 122.57 41.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 92.3 m-85 -139.91 160.37 40.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.819 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -84.1 139.66 32.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.934 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 36.2 t -100.0 123.78 44.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 111.458 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.618 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 82.8 m-85 -121.67 149.92 54.11 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.237 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 32' ' ' MET . 65.0 Cg_endo -79.45 111.17 2.79 Favored 'Trans proline' 0 N--CA 1.467 -0.081 0 C-N-CA 123.194 2.596 . . . . 0.0 112.647 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.691 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mt -60.77 -40.03 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 110.682 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.52 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.321 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.651 ' HB3' ' HG2' ' A' ' 29' ' ' PRO . 57.7 ttm -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.462 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 98.3 mtp -58.98 155.69 12.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.737 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.584 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.1 139.99 57.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.041 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -59.97 -37.09 78.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.05 -39.75 87.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.584 HG12 ' HB2' ' A' ' 34' ' ' ASN . 47.7 pt -90.3 -0.66 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 18.5 mtp-105 -99.39 139.94 34.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.857 0.361 . . . . 0.0 110.905 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -96.13 139.71 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.731 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.6 p-10 -60.01 -40.03 87.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.8 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.71 92.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 40' ' ' ASP . 27.3 p30 -62.53 -40.01 95.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 37.8 m-85 -110.0 18.23 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.587 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.09 173.35 28.96 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.14 24.22 19.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 71.5 mmtt -111.52 142.29 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 111.231 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.698 ' CG1' HG12 ' A' ' 84' ' ' VAL . 47.3 pt -121.24 155.96 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.56 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.4 m-85 -100.82 133.96 44.51 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 114' ' ' ILE . 4.1 mp -140.18 164.54 36.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 69.3 Cg_endo -73.29 156.26 50.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.268 1.978 . . . . 0.0 112.715 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.978 ' HA ' HD13 ' A' ' 55' ' ' LEU . 74.3 Cg_endo -75.26 -15.6 20.11 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.906 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -60.0 -40.3 88.73 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -61.35 -37.59 83.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.978 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.6 mp -60.13 -39.79 87.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.576 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.4 p -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 110.474 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 21' ' ' PHE . 23.6 tptm -69.45 -40.04 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.258 0.551 . . . . 0.0 110.167 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 55' ' ' LEU . 90.8 mt -59.95 -39.6 86.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.112 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -57.84 -39.27 77.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -59.88 -37.26 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 98.2 mt -80.46 -0.05 35.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.597 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.03 40.44 18.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.659 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.423 HG12 ' OE1' ' A' ' 19' ' ' GLN . 85.8 mt -86.63 120.01 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.789 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -91.73 149.13 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.305 0.574 . . . . 0.0 111.854 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.521 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.2 p90 -87.39 157.79 52.66 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.529 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 30.3 Cg_endo -63.74 147.61 64.42 Favored 'Cis proline' 0 C--N 1.352 0.759 0 C-N-CA 123.771 -1.346 . . . . 0.0 112.742 0.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 59.0 mtt -93.59 139.59 30.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.677 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 186' ' ' CYS . 6.6 mp -101.49 120.9 41.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.025 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.682 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.0 m-85 -128.35 142.3 51.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.607 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 60.7 pttt -120.74 140.11 52.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -99.32 115.46 29.23 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.394 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.4 m -99.26 121.44 41.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.941 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.39 117.64 35.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.281 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -68.99 -39.99 79.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.433 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.906 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.434 HG21 ' HA3' ' A' ' 105' ' ' GLY . 77.8 p -105.4 -7.7 18.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.12 40.53 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.644 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -104.79 140.09 38.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.668 0.27 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 3.1 p -124.01 130.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.636 ' OG1' HD23 ' A' ' 71' ' ' LEU . 67.4 p -97.54 154.88 17.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.146 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 81.0 m80 -119.47 131.18 55.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.153 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.85 -173.72 36.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.538 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 152' ' ' SER . . . -107.62 -170.72 21.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.937 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.698 HG12 ' CG1' ' A' ' 48' ' ' ILE . 32.6 m -130.05 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 121.279 -0.168 . . . . 0.0 110.815 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 58.2 tp -89.99 -78.1 0.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.39 . . . . 0.0 110.544 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -147.72 159.8 43.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.886 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.865 ' CD2' HD11 ' A' ' 55' ' ' LEU . 88.3 m-85 -99.87 116.15 31.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.276 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.16 -4.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.077 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -87.45 100.41 12.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.38 -39.98 77.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.92 -30.85 71.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.095 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.57 50.32 0.71 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.386 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.549 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 98.8 mtt180 -117.64 148.23 42.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.948 0.404 . . . . 0.0 111.501 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 8.0 p -129.81 140.81 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.02 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.691 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.72 139.96 50.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.927 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.564 HD23 HG21 ' A' ' 48' ' ' ILE . 21.3 mt -114.81 139.58 24.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 48' ' ' ILE . 57.5 Cg_exo -55.01 155.59 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.699 2.266 . . . . 0.0 112.3 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.19 91.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.638 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.698 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 55.2 p-90 -69.95 -37.87 75.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.732 0.301 . . . . 0.0 111.356 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.655 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 98.1 mtp -69.94 -39.98 75.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.1 mtp -60.01 -40.94 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.037 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 21.3 pt-20 -64.12 -40.02 95.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.48 -40.06 95.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HG23 ' A' ' 80' ' ' THR . 82.9 mt -70.04 -24.13 63.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.369 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 74.66 29.97 60.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.8 pt -114.35 139.92 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 111.713 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.7 pt20 -95.25 160.01 31.63 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.415 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.5 Cg_endo -49.15 137.79 29.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.754 2.302 . . . . 0.0 112.48 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.09 -8.13 80.37 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.987 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 89.8 p -71.04 160.36 33.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.753 0.276 . . . . 0.0 110.605 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.65 145.2 30.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.473 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.934 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.1 tp -130.24 130.33 44.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 94.2 mt-30 -110.52 127.59 55.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.682 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 19.0 tt -118.44 127.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.407 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 47.0 t -120.02 130.03 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 23.4 t -89.9 116.03 27.66 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.857 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.752 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.6 t -129.98 138.83 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.74 121.07 44.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.537 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 120' ' ' PRO . 32.7 m -119.16 154.45 53.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.634 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.608 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 59.6 Cg_endo -72.5 153.31 55.11 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.791 2.327 . . . . 0.0 111.325 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.85 HD23 HG23 ' A' ' 187' ' ' VAL . 4.7 mp -64.29 130.05 42.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.954 0.407 . . . . 0.0 111.137 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.95 151.4 49.01 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.53 -20.05 15.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.516 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' OD2' ' A' ' 195' ' ' ASP . 60.4 t80 -145.79 131.16 18.6 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.681 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.699 HG23 ' CG1' ' A' ' 176' ' ' VAL . 11.5 p -134.0 134.44 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.267 0.556 . . . . 0.0 111.529 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.834 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 64.3 mttp -99.43 122.37 42.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.359 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 194' ' ' THR . 86.0 mt -113.25 128.59 56.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.417 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -111.7 112.22 53.81 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.105 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.509 ' CB ' HD11 ' A' ' 135' ' ' LEU . 84.2 Cg_endo -82.08 167.78 15.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.67 2.247 . . . . 0.0 112.462 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -126.07 121.22 32.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.6 142.15 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.03 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.09 -20.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.412 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.0 -39.56 86.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.138 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.3 t80 -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.9 mp -81.95 -11.21 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.543 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.08 -19.99 63.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.743 0.306 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.15 130.2 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.5 p -69.54 150.75 46.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.26 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 2.5 m-20 53.66 53.37 10.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 144' ' ' LEU . 31.0 Cg_endo -63.83 -34.65 60.17 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.351 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.08 -40.04 88.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.071 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.88 95.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 147' ' ' VAL . 81.6 t -60.1 -43.19 92.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.9 mm? -60.0 -40.57 89.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.57 -41.17 94.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.45 -39.94 89.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.176 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 143' ' ' VAL . 60.4 t -60.33 -42.07 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.86 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -41.27 91.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 188' ' ' ILE . 16.8 tpt180 -61.71 -40.0 93.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.222 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.483 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 98.6 m-20 -62.05 -39.99 94.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.822 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.01 122.67 43.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.318 . . . . 0.0 111.4 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.639 ' HA ' HD11 ' A' ' 188' ' ' ILE . 51.8 m -60.03 -40.02 87.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.527 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 10.0 t -136.06 149.97 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.613 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 173' ' ' ILE . 64.8 tp -120.04 128.2 53.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.3 m -119.05 140.19 50.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 176' ' ' VAL . 63.5 t -59.96 -42.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.398 0.618 . . . . 0.0 111.343 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.98 -39.71 75.77 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.678 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 81' ' ' HIS . 96.0 m-20 -65.53 140.39 58.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 112.449 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.403 HG22 ' CE ' ' A' ' 172' ' ' LYS . 53.1 t -105.77 120.02 55.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.654 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 171' ' ' ILE . 48.0 pt -106.94 141.4 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.798 0.332 . . . . 0.0 111.377 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.688 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 99.9 mt-10 -118.99 140.69 49.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 147' ' ' VAL . 46.7 pt -130.31 139.98 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.425 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 58.6 m -107.55 118.46 36.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -119.95 121.77 39.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.6 t30 55.07 40.03 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.421 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.88 9.9 86.23 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.891 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.6 mttt -110.38 138.05 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.807 0.303 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.1 m -106.63 121.16 43.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.545 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 90.3 m-85 -120.03 140.03 51.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.688 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 58.9 mtpt -106.07 123.99 48.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.354 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 160' ' ' ILE . 46.0 pt -122.42 131.13 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 110.639 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.403 ' CE ' HG22 ' A' ' 159' ' ' VAL . 35.0 ttmt -119.64 135.88 54.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.778 HD11 HD11 ' A' ' 154' ' ' LEU . 4.6 mp -84.62 120.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.083 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 126' ' ' LYS . 89.1 mt -68.79 -59.32 3.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.429 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.834 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.28 146.66 18.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.76 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 156' ' ' VAL . 4.3 m -139.02 145.15 28.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -88.94 104.7 8.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.327 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.1 Cg_endo -104.07 174.36 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.861 3.041 . . . . 0.0 112.351 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.6 mt-10 -100.03 0.73 41.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.1 m -132.81 150.03 52.2 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 111.184 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.5 m -70.98 -12.2 61.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.928 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -62.9 -10.39 13.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.0 mttm 59.93 24.58 13.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 111.425 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 64.2 m -121.08 135.76 55.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 46.7 pt -129.97 159.14 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.399 0.618 . . . . 0.0 112.355 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HD21 ' A' ' 68' ' ' LEU . 53.0 t -140.53 104.57 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.932 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.85 HG23 HD23 ' A' ' 121' ' ' LEU . 7.5 p -139.79 87.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.69 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 152' ' ' SER . 72.0 mt -99.49 -3.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.796 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 190' ' ' THR . 99.6 mt-10 -90.0 -80.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.291 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 13.1 t 177.38 36.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -109.64 16.77 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.436 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.825 ' HB2' HG11 ' A' ' 187' ' ' VAL . 19.0 tp -116.38 132.45 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 0.0 111.185 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 125' ' ' VAL . 39.9 t -95.11 120.01 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.04 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.65 HG22 HG11 ' A' ' 125' ' ' VAL . 81.6 p -103.31 141.2 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.0 111.895 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.401 ' OD2' ' CE2' ' A' ' 124' ' ' PHE . 96.0 m-20 -129.21 144.7 51.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.071 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.68 139.98 48.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 111.415 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.61 166.26 13.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.374 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 28.9 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.184 1.923 . . . . 0.0 112.1 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.652 0.188 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.7 mt-30 -99.94 120.32 39.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.451 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 116' ' ' SER . 8.9 t -130.0 139.95 50.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.136 0.493 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 55.2 t80 -128.82 130.19 46.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.98 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.08 135.71 48.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.0 mt-10 -144.48 160.05 41.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -119.13 135.46 54.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.417 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -149.7 160.02 43.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.943 0.401 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.83 132.67 39.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.79 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 31.4 p -96.48 141.81 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.482 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.9 m-85 -127.07 153.92 76.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.693 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HG3' ' CG ' ' A' ' 108' ' ' PRO . 5.7 Cg_exo -78.27 107.09 2.25 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.733 2.288 . . . . 0.0 113.016 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 87.2 mt -64.29 -40.03 87.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.87 80.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.276 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.488 ' CB ' ' HB2' ' A' ' 29' ' ' PRO . 57.6 ttm -67.6 -32.54 73.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.946 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.0 159.54 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.01 144.49 49.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.44 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.18 -38.96 81.11 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.99 -39.9 87.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 37' ' ' ILE . 83.2 mt -88.72 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.258 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 30' ' ' ILE . 62.4 mtm180 -99.68 138.97 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.261 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -103.67 132.47 49.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.455 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 111.242 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 96.1 m-20 -66.28 -40.06 89.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.95 95.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.14 -39.89 87.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 99' ' ' TRP . 86.4 m-85 -105.52 6.44 32.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.768 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -96.07 173.4 30.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.714 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.8 24.33 21.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.261 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.73 ' HD3' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.35 136.03 41.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 50' ' ' LEU . 45.6 pt -121.08 158.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 94' ' ' VAL . 65.6 m-85 -100.08 131.6 45.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.577 HD13 ' CE2' ' A' ' 69' ' ' PHE . 1.9 mp -131.78 162.65 55.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.042 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.59 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.5 Cg_endo -77.78 144.17 21.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.148 1.898 . . . . 0.0 112.155 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.1 Cg_exo -59.68 -23.93 73.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.603 2.202 . . . . 0.0 112.782 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -60.03 -39.93 87.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.116 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.82 85.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.156 0.503 . . . . 0.0 110.753 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.644 HD13 ' HE1' ' A' ' 67' ' ' MET . 34.7 tp -61.5 -39.94 92.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.771 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.3 p -60.06 -39.04 84.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.143 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HA ' ' CE ' ' A' ' 60' ' ' MET . 98.8 mttt -64.37 -40.06 95.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.96 0.41 . . . . 0.0 110.5 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 63' ' ' ILE . 96.1 mt -61.08 -35.45 77.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.11 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.7 m -60.01 -38.64 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.442 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.436 ' CE ' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -60.03 -36.43 77.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.304 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.94 -1.31 38.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.317 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.05 39.99 19.14 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 58' ' ' LEU . 85.4 mt -79.48 126.59 39.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -85.35 142.77 29.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 0.0 111.897 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.516 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 47.4 p90 -87.34 157.82 52.8 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.993 ' HG2' HG21 ' A' ' 188' ' ' ILE . 25.2 Cg_exo -65.24 157.77 75.89 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.542 0.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.644 ' HE1' HD13 ' A' ' 55' ' ' LEU . 65.6 mtm -100.14 145.77 27.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.189 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 186' ' ' CYS . 1.3 pt? -116.16 133.7 55.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.88 ' HB3' HG23 ' A' ' 114' ' ' ILE . 15.7 m-85 -120.03 140.02 51.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HE2' HG21 ' A' ' 79' ' ' VAL . 81.1 tttt -115.08 120.02 38.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.274 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.823 HD22 ' SD ' ' A' ' 100' ' ' MET . 6.5 mp -97.99 127.36 43.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -115.03 130.23 56.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.831 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.09 110.72 22.04 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.23 -40.07 88.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.687 HG21 ' O ' ' A' ' 104' ' ' LEU . 74.4 p -101.6 -10.41 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.61 6.56 16.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.615 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -104.1 141.31 36.45 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 71' ' ' LEU . 7.2 p -121.18 124.42 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.355 0.598 . . . . 0.0 111.626 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.569 HG23 HD21 ' A' ' 104' ' ' LEU . 68.9 p -104.3 151.12 23.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.34 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.414 ' ND1' HG21 ' A' ' 155' ' ' THR . 77.4 m80 -100.91 115.06 29.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 0.0 110.814 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CE ' ' A' ' 100' ' ' MET . . . -114.74 139.55 15.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.182 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -84.24 163.97 39.84 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.564 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.7 p -126.01 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.73 HD22 ' HD3' ' A' ' 47' ' ' LYS . 64.9 tp -90.33 -74.1 0.5 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.16 160.65 41.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.291 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.608 ' CD1' HD22 ' A' ' 55' ' ' LEU . 89.3 m-85 -95.72 116.76 29.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.2 -5.38 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.063 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -90.23 97.77 11.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.023 0.44 . . . . 0.0 111.412 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.95 -39.94 75.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.11 0.481 . . . . 0.0 110.796 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.08 -30.03 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.902 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.03 50.15 0.69 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.167 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.704 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 mtt180 -118.45 151.28 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.848 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 114' ' ' ILE . 12.4 p -130.03 142.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 28' ' ' TYR . 88.6 m-85 -119.08 140.02 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -123.56 147.96 54.46 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.894 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.21 -173.08 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.405 2.07 . . . . 0.0 112.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.91 -20.85 63.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.615 ' HE1' ' HA ' ' A' ' 44' ' ' PHE . 14.4 m95 -60.01 -49.91 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.575 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.823 ' SD ' HD22 ' A' ' 71' ' ' LEU . 67.6 mtt -70.01 -39.97 75.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.495 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 29' ' ' PRO . 67.8 mtt -63.89 -47.8 79.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.568 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.98 -40.12 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.235 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.938 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.687 ' O ' HG21 ' A' ' 76' ' ' THR . 92.9 mt -95.16 -19.05 20.4 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 101' ' ' MET . . . 58.89 47.76 88.97 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -113.49 150.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.031 0.443 . . . . 0.0 111.439 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.35 161.69 30.13 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.595 ' CG ' ' HG3' ' A' ' 29' ' ' PRO . 40.0 Cg_exo -59.62 -5.89 3.84 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.886 2.391 . . . . 0.0 113.421 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.13 -6.82 56.69 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.773 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.4 m -85.02 143.77 28.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.736 0.303 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.97 145.0 52.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.629 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 96' ' ' LEU . 54.1 tp -124.83 125.16 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.969 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -111.33 132.08 54.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.954 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 94' ' ' VAL . 88.9 mt -111.56 130.01 65.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.417 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 82.3 p -126.33 134.43 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.287 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' THR . 67.2 m -83.8 120.84 26.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.592 ' O ' HD21 ' A' ' 68' ' ' LEU . 70.8 p -126.34 139.95 52.89 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -112.69 110.8 21.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 186' ' ' CYS . 35.1 m -115.58 151.06 45.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.34 133.3 15.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.427 2.084 . . . . 0.0 110.958 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 190' ' ' THR . 5.0 mt -62.21 130.91 47.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.213 0.53 . . . . 0.0 112.091 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 159.2 50.31 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.058 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -105.66 -22.7 12.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -136.51 134.56 37.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 111.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.725 HG21 HD21 ' A' ' 154' ' ' LEU . 3.2 p -133.52 130.34 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.133 0.492 . . . . 0.0 111.54 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.813 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 99.4 mttt -96.86 123.12 40.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD22 ' CG2' ' A' ' 171' ' ' ILE . 90.9 mt -116.74 136.6 52.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.06 114.7 64.21 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.458 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.87 158.98 21.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.101 . . . . 0.0 112.83 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 131' ' ' SER . 96.9 mt-30 -122.72 121.6 36.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 130' ' ' GLN . 47.3 t 69.13 133.98 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.564 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.57 -23.05 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.94 -40.03 87.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.239 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 67.2 t80 -59.98 -40.13 88.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.97 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.36 -9.95 59.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.63 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.48 -10.18 58.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.573 0.225 . . . . 0.0 111.356 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.81 138.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 110.492 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.0 t -60.04 -40.04 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.531 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -129.75 71.24 82.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.927 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.686 ' O ' HD23 ' A' ' 144' ' ' LEU . 21.2 Cg_exo -65.11 -32.73 52.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.729 2.286 . . . . 0.0 111.909 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.01 -40.03 87.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.285 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.38 98.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 147' ' ' VAL . 64.2 t -62.33 -41.33 91.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -63.43 -40.1 96.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -45.8 91.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -60.28 -41.36 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.051 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 143' ' ' VAL . 62.6 t -60.29 -44.21 95.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.226 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.06 -40.05 88.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.4 mtp85 -65.1 -40.02 93.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.094 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.15 -40.08 88.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.539 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 147' ' ' VAL . 90.6 m-85 -97.74 120.15 37.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.177 0.513 . . . . 0.0 111.439 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.4 m -60.16 -39.91 88.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.022 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 41.9 p -126.87 145.23 50.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.866 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.725 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -119.88 119.4 33.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.999 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 184' ' ' SER . 73.6 p -124.28 141.37 52.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 176' ' ' VAL . 97.9 t -59.99 -40.18 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 111.841 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.77 -39.78 87.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.869 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 97.0 m-20 -74.5 140.11 44.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 112.325 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 ' CG ' ' A' ' 172' ' ' LYS . 7.2 p -106.04 121.93 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.492 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 46.0 pt -107.97 131.07 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 19.6 pt-20 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.727 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -121.15 148.97 24.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 82.3 p -109.01 117.55 34.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.206 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 64.6 t80 -119.99 120.06 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 10.9 m120 54.07 40.13 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.28 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.15 10.19 85.77 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.14 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 163' ' ' SER . 63.2 mttp -109.72 133.45 53.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.751 0.275 . . . . 0.0 110.368 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -107.38 123.9 49.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.3 m-85 -119.99 140.04 51.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 56.4 mttm -103.6 129.74 50.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.612 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 120.16 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.488 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.479 ' CG ' HG23 ' A' ' 159' ' ' VAL . 61.2 mttp -111.15 127.14 55.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.709 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -81.6 110.0 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.449 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.5 tt -63.58 -58.8 5.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.838 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.832 ' HG3' HD23 ' A' ' 174' ' ' LEU . 99.4 mt-10 -158.38 143.03 16.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.739 HG22 ' CG2' ' A' ' 156' ' ' VAL . 7.2 m -137.55 142.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.042 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.47 104.71 11.87 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.679 ' HB3' HG23 ' A' ' 185' ' ' ILE . 57.1 Cg_endo -102.99 -0.88 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.882 3.054 . . . . 0.0 112.966 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.48 21.54 12.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.9 p -141.09 155.56 46.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.7 p -70.01 -23.08 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.334 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 22.5 t -59.93 -36.63 77.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.577 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 29.8 mmtm 69.68 19.96 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 155' ' ' THR . 52.9 m -130.03 140.01 50.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.094 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 178' ' ' PRO . 44.6 pt -130.36 157.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 112.412 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.611 ' HB2' HD13 ' A' ' 68' ' ' LEU . 34.0 t -120.81 99.8 6.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.226 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.737 HG11 HD22 ' A' ' 192' ' ' LEU . 14.7 p -119.91 107.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.237 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.993 HG21 ' HG2' ' A' ' 66' ' ' PRO . 24.0 mt -95.54 -80.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.102 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.87 3.69 49.75 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.829 HG21 HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -78.92 171.1 15.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.085 0.469 . . . . 0.0 111.248 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -100.11 123.25 44.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.354 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.737 HD22 HG11 ' A' ' 187' ' ' VAL . 13.6 tp -120.29 131.49 54.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.53 120.08 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.8 t -118.15 148.14 42.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.109 0.481 . . . . 0.0 111.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -120.15 139.74 52.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -99.72 122.43 42.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.29 110.67 34.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo . . . . . 0 C--N 1.347 0.48 0 C-N-CA 122.394 2.063 . . . . 0.0 112.269 -179.579 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.464 -0.219 0 CA-C-O 120.722 0.218 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 117' ' ' THR . 72.0 tp60 -100.02 119.86 38.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.033 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 116' ' ' SER . 73.0 p -120.01 133.08 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 57.4 t80 -120.0 124.96 47.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -105.68 135.06 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' OE2' ' HG3' ' A' ' 91' ' ' GLU . 85.3 tt0 -145.05 155.28 43.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.706 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.62 120.03 41.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.17 0.51 . . . . 0.0 111.995 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' HE2' ' HG3' ' A' ' 51' ' ' PRO . 87.1 m-85 -121.06 140.01 52.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.628 ' O ' HG12 ' A' ' 94' ' ' VAL . 36.8 ptt180 -80.02 153.34 28.89 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 69.3 m -83.69 132.79 34.84 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 112.337 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.668 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 3.0 m-85 -130.53 126.29 21.95 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.078 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' MET . 16.0 Cg_exo -70.02 113.29 3.37 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.553 2.169 . . . . 0.0 112.016 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 95' ' ' TYR . 91.4 mt -66.21 -36.79 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 110.818 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.17 83.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.261 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.0 ptm -68.43 -20.07 64.62 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.134 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 96.9 mmm -64.69 156.92 28.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 28.2 m120 -60.06 141.36 55.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -39.66 86.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -59.93 -39.83 86.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.5 mt -87.26 -7.76 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.232 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 22.4 mtp-105 -98.96 140.04 33.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.086 0.469 . . . . 0.0 111.917 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.94 130.82 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.93 -40.11 87.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.28 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -64.0 -39.96 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.85 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.95 96.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.009 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.08 -40.02 88.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.58 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -105.14 2.01 28.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.626 0.25 . . . . 0.0 111.565 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.48 173.9 30.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -100.39 14.88 59.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.403 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.6 mttt -95.32 133.36 39.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.597 HD11 ' CD1' ' A' ' 114' ' ' ILE . 45.9 pt -118.85 164.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.811 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.445 ' CD1' HG12 ' A' ' 88' ' ' ILE . 98.7 m-85 -100.5 131.54 46.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -129.74 166.77 23.64 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.767 -179.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.862 ' HG3' ' HA ' ' A' ' 91' ' ' GLU . 31.6 Cg_endo -83.13 147.72 13.07 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.821 2.347 . . . . 0.0 113.4 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 55' ' ' LEU . 37.1 Cg_exo -61.93 -21.27 71.97 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.5 p -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.0 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.545 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.967 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.97 -40.25 88.44 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.544 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -40.0 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 60.9 mttp -69.24 -40.01 78.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.383 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.524 HD21 ' CB ' ' A' ' 116' ' ' SER . 88.2 mt -60.24 -39.81 88.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.033 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.4 m -59.99 -39.73 86.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.487 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.0 -38.89 83.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.355 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.06 0.01 33.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.517 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 59.97 42.77 15.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.811 0.339 . . . . 0.0 111.511 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.407 HD11 ' HG2' ' A' ' 19' ' ' GLN . 43.9 mm -76.33 129.99 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -83.88 146.71 27.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.432 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.3 m-85 -87.58 153.53 53.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.65 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.559 ' CG ' HD11 ' A' ' 188' ' ' ILE . 12.3 Cg_exo -71.07 163.09 86.27 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.659 0.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.432 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 76.0 mtm -84.09 137.0 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.358 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.766 ' HB2' ' O ' ' A' ' 117' ' ' THR . 76.7 mt -115.3 131.91 56.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.498 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE1' HG11 ' A' ' 84' ' ' VAL . 95.4 m-85 -129.6 144.1 51.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.53 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 28.3 ttpp -119.53 130.46 55.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 112' ' ' LEU . 7.5 mp -100.02 121.82 41.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 79' ' ' VAL . 98.6 m -114.17 130.04 56.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.983 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.19 30.95 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.487 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -68.42 -39.63 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.766 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.721 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 29.8 m -103.58 -15.97 15.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.57 7.92 62.07 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.536 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -99.4 140.17 33.97 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.85 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 72' ' ' THR . 59.3 t -119.95 120.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.5 p -109.28 138.35 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.273 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.596 ' CE1' ' HD3' ' A' ' 70' ' ' LYS . 3.1 m-70 -84.12 114.14 21.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.08 146.16 16.03 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.177 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' A' ' 152' ' ' SER . . . -96.51 162.62 22.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.771 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.617 HG11 ' HE1' ' A' ' 69' ' ' PHE . 8.1 p -120.73 126.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 48.6 tp -91.63 -74.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.9 159.96 41.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.245 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 55' ' ' LEU . 70.8 m-85 -100.79 116.21 32.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.826 0.346 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 HG12 ' CD1' ' A' ' 49' ' ' PHE . 48.3 pt -137.99 -4.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.827 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -104.29 158.02 16.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 110.889 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 93' ' ' ARG . 97.9 mt-10 -76.67 158.17 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.333 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.862 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 85.8 tt0 -59.99 -30.35 69.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.598 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -81.81 1.24 86.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.308 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 46.6 ptt85 -144.23 145.88 32.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 26' ' ' ARG . 7.7 p -142.89 150.41 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.664 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.776 ' HB3' HG12 ' A' ' 30' ' ' ILE . 85.3 m-85 -118.63 139.99 50.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -134.34 159.05 73.76 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 48' ' ' ILE . 22.9 Cg_exo -64.66 147.97 90.14 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.792 2.328 . . . . 0.0 112.13 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -60.01 -42.29 94.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.163 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -68.72 -40.04 80.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.5 ttm -60.03 -40.28 88.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' HG13 ' A' ' 106' ' ' ILE . 67.4 ttp -60.62 -41.27 94.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.46 -39.99 95.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.0 m -62.55 -40.01 95.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 -23.82 63.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.564 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.32 35.0 43.97 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.739 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.538 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.5 pt -118.11 147.43 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.969 0.414 . . . . 0.0 111.3 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.1 pt20 -98.18 161.63 24.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 8.5 Cg_endo -49.34 136.44 31.83 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.74 2.293 . . . . 0.0 112.162 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 -9.9 75.75 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.612 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.538 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 70.4 p -70.11 161.08 30.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.682 0.277 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.25 140.65 29.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 60.2 tp -120.07 127.99 53.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.93 119.95 40.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.18 0.514 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.836 HD13 HD21 ' A' ' 50' ' ' LEU . 18.9 tt -120.97 128.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 79.8 p -120.69 138.83 53.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 20' ' ' THR . 44.9 t -80.17 110.72 15.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 92.9 m -119.51 129.4 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -101.5 119.23 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 186' ' ' CYS . 22.1 m -120.12 152.6 54.65 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 49.4 Cg_endo -67.78 175.29 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.423 2.082 . . . . 0.0 110.684 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 122' ' ' GLY . 7.7 tt -94.41 120.04 34.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.938 0.399 . . . . 0.0 111.257 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.692 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -62.35 151.25 46.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.919 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -101.33 -17.02 16.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.065 0.433 . . . . 0.0 111.767 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.523 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 69.0 t80 -150.27 134.78 17.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.766 ' CG1' HG22 ' A' ' 194' ' ' THR . 7.7 p -139.21 130.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.344 0.592 . . . . 0.0 111.419 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.843 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 83.8 mttt -94.98 126.3 40.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.487 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.3 133.28 56.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.88 0.372 . . . . 0.0 110.954 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -109.19 110.59 60.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.762 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.52 175.59 10.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.579 2.186 . . . . 0.0 112.395 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -124.02 121.35 35.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.304 0.573 . . . . 0.0 110.089 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.431 ' HB3' ' OD1' ' A' ' 133' ' ' ASP . 6.3 t 59.83 168.78 0.07 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.086 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.26 -19.99 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.702 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' PHE . 47.7 p-10 -60.03 -39.93 87.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.01 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 66.9 t80 -59.96 -40.04 87.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.348 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.1 -7.71 59.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.717 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.94 -12.78 61.87 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 143' ' ' VAL . 85.4 mt -60.33 138.82 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.4 m -60.07 -39.99 87.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 111.314 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 137' ' ' ILE . 36.4 m-20 -125.9 75.73 71.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 25.2 Cg_endo -62.17 -40.61 40.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.5 2.133 . . . . 0.0 112.203 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.29 -40.02 88.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.36 96.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 137' ' ' ILE . 84.6 t -60.66 -41.96 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.247 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -59.98 -41.69 92.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.23 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.01 -40.47 89.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 111.043 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.97 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.8 HG22 HG21 ' A' ' 162' ' ' ILE . 77.2 t -61.89 -43.49 97.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.054 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.98 -40.95 90.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.02 0.438 . . . . 0.0 110.557 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -64.28 -40.15 95.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 96.7 m-20 -61.28 -40.05 92.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.478 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 97.7 m-85 -101.16 120.02 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.496 . . . . 0.0 110.911 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.524 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t -68.63 -39.99 80.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.864 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 74.1 p -124.41 140.06 53.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.219 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 151' ' ' PHE . 86.9 mt -131.18 136.89 48.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.962 0.411 . . . . 0.0 111.819 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 157' ' ' ASP . 21.7 m -118.77 145.49 45.56 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.704 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.5 t -60.02 -41.6 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.42 0.629 . . . . 0.0 110.646 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 155' ' ' THR . 95.9 m-20 -72.98 -40.01 65.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.675 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 54.0 t0 -61.01 135.21 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.999 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.27 120.03 53.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.31 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.9 pt -103.92 140.61 21.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.337 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.543 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.1 mt-10 -118.26 141.36 48.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 111.495 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.826 HD12 ' CE1' ' A' ' 164' ' ' TYR . 48.2 pt -125.63 139.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 33.2 p -105.81 108.16 19.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.919 0.39 . . . . 0.0 111.654 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.826 ' CE1' HD12 ' A' ' 162' ' ' ILE . 39.6 m-85 -120.49 123.75 43.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.707 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 59.29 34.34 22.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.39 83.4 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.062 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.5 mttt -119.45 138.43 53.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.791 0.295 . . . . 0.0 111.09 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 9.6 t -108.6 131.79 54.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.115 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.4 m-85 -120.01 140.03 51.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 96.8 mttt -97.2 127.25 43.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.12 134.5 54.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -79.49 122.26 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.522 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 84.6 mt -73.03 -57.9 3.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.083 0.468 . . . . 0.0 111.195 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.843 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.1 mt-10 -159.92 145.84 15.67 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.852 ' CB ' HD11 ' A' ' 185' ' ' ILE . 5.4 m -140.24 160.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -110.93 103.66 55.06 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 81.0 Cg_endo -100.25 171.18 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.605 2.87 . . . . 0.0 113.041 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 70.5 mm-40 -99.97 3.74 44.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.038 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.4 m -136.25 160.52 38.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.09 -13.11 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.341 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.8 p -67.9 -13.1 61.88 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.652 0.263 . . . . 0.0 111.428 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.681 ' HE3' HG22 ' A' ' 176' ' ' VAL . 4.8 tptm 49.99 41.84 23.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.322 0.582 . . . . 0.0 110.843 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.1 m -123.71 144.73 49.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.471 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 176' ' ' VAL . 20.2 mt -119.3 134.08 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.385 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 119' ' ' VAL . 64.2 m -142.21 100.09 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.011 0.434 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -149.42 113.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.856 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 66' ' ' PRO . 44.1 pt -103.21 -10.13 9.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.3 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -89.96 -79.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 14.6 t -172.52 -161.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.439 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' THR . 96.5 m-20 71.75 24.7 3.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.033 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 187' ' ' VAL . 21.1 tp -117.98 132.41 56.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 125' ' ' VAL . 47.1 t -94.59 124.84 47.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.766 HG22 ' CG1' ' A' ' 125' ' ' VAL . 76.3 p -115.93 149.77 38.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.28 135.82 52.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.76 138.85 39.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.157 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.7 162.49 28.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 53.0 Cg_endo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 121.966 1.777 . . . . 0.0 112.03 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 35.6 Cg_exo . . . . . 0 N--CA 1.472 0.233 0 CA-C-O 120.722 0.218 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.643 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.8 mt-30 -105.77 118.53 36.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.48 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.716 ' HA ' ' O ' ' A' ' 116' ' ' SER . 58.5 p -121.07 126.55 50.11 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 115' ' ' SER . 72.6 t80 -121.09 120.42 35.27 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 98.9 mt-10 -98.29 140.99 31.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 71.3 mt-10 -149.96 159.99 43.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.615 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 55.2 p90 -100.2 120.21 39.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.162 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.957 ' HB3' HG21 ' A' ' 94' ' ' VAL . 94.4 m-85 -120.19 140.36 51.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 76.4 mtp85 -82.31 142.66 31.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.393 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 50.6 m -84.48 135.4 34.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.899 0.38 . . . . 0.0 111.796 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 21.5 m-85 -129.71 137.21 30.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.249 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 33' ' ' MET . 95.4 Cg_endo -79.26 92.24 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.684 2.256 . . . . 0.0 112.965 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.797 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 85.0 mt -59.96 -40.02 81.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.983 0.421 . . . . 0.0 110.601 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.87 87.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.729 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.42 -31.07 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.71 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.575 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 94.4 mmm -59.21 145.01 44.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.546 ' HB3' HG12 ' A' ' 37' ' ' ILE . 19.6 t-20 -59.88 139.87 57.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.372 0.606 . . . . 0.0 112.359 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.91 -38.89 83.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.023 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 92.7 mtt-85 -59.87 -40.0 87.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.366 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 34' ' ' ASN . 47.6 pt -95.49 -1.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.575 ' HG3' ' HB2' ' A' ' 33' ' ' MET . 79.2 mmt-85 -125.43 155.75 39.93 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.033 0.444 . . . . 0.0 111.793 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -101.01 133.25 45.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.555 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -39.92 88.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.218 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -39.86 87.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.08 84.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 30' ' ' ILE . 27.2 m120 -60.01 -40.27 88.65 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 111.308 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.45 4.12 40.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.642 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.11 -174.49 28.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.232 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.35 32.46 6.8 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.695 ' HD2' HD13 ' A' ' 85' ' ' LEU . 36.6 ttpt -102.55 129.5 49.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.208 -0.496 . . . . 0.0 112.096 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 50' ' ' LEU . 41.7 pt -131.73 161.07 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.818 ' C ' HD22 ' A' ' 50' ' ' LEU . 93.0 m-85 -104.06 133.39 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.062 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.3 mm? -133.08 157.58 77.96 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.391 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.1 Cg_endo -75.24 132.55 15.22 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.21 2.607 . . . . 0.0 112.753 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.497 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 52.2 Cg_exo -53.59 -15.23 6.03 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 113.32 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 m -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.146 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.69 87.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.049 0.452 . . . . 0.0 111.088 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.881 HD21 ' CE1' ' A' ' 87' ' ' PHE . 68.7 mt -59.92 -39.75 86.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 109.974 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 73.3 mmtt -66.67 -39.94 88.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.294 0.569 . . . . 0.0 109.976 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.863 HD13 ' SD ' ' A' ' 67' ' ' MET . 90.8 mt -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -56.69 -38.19 71.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.037 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.666 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -59.98 -38.27 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.77 1.34 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.04 39.96 19.22 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.784 0.326 . . . . 0.0 111.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.592 HG22 ' HG2' ' A' ' 67' ' ' MET . 82.1 mt -88.5 120.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.186 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -95.77 140.21 30.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.619 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.553 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 51.8 p90 -87.17 159.67 50.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 34.9 Cg_exo -60.53 134.41 12.05 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.522 0.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.863 ' SD ' HD13 ' A' ' 58' ' ' LEU . 74.3 mtm -98.82 140.4 33.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.208 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 153' ' ' THR . 1.9 mp -97.42 127.46 43.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.215 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 116' ' ' SER . 89.3 m-85 -119.95 140.08 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.506 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.02 129.98 55.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.151 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 114' ' ' ILE . 1.4 mp -97.14 123.22 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.686 0.279 . . . . 0.0 111.078 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.701 ' HA ' HG12 ' A' ' 79' ' ' VAL . 90.8 m -114.02 121.28 43.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.398 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . . . -117.23 139.18 51.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 98.6 m-20 62.27 147.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.344 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.96 -40.67 89.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -133.13 8.41 4.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.404 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . -67.92 -105.73 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.849 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.41 157.41 46.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.924 0.392 . . . . 0.0 111.287 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 72' ' ' THR . 33.3 m -129.77 136.69 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.553 ' OG1' ' HG ' ' A' ' 104' ' ' LEU . 41.9 m -99.04 148.79 23.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -119.74 131.12 55.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.759 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.16 175.24 44.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.716 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.64 -175.06 25.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.478 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.97 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 0.0 111.559 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.695 HD13 ' HD2' ' A' ' 47' ' ' LYS . 65.0 tp -93.4 -79.98 0.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.341 0.591 . . . . 0.0 110.863 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -152.44 159.21 43.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.587 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.881 ' CE1' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -100.97 118.0 36.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.16 -4.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.96 99.68 12.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.391 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.09 -39.93 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.1 -30.26 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.633 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.688 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 104.34 68.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.421 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 84.8 mtt85 -119.98 141.05 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.918 0.39 . . . . 0.0 110.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.957 HG21 ' HB3' ' A' ' 25' ' ' PHE . 88.9 t -129.24 133.41 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 112.173 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.797 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 85.5 m-85 -117.23 139.12 51.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -132.86 147.11 64.17 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' HD2' ' SD ' ' A' ' 100' ' ' MET . 93.3 Cg_endo -83.97 -170.44 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 112.626 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.5 -27.1 68.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.036 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.492 ' CH2' ' HZ ' ' A' ' 151' ' ' PHE . 19.6 m95 -59.95 -49.49 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.916 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.551 ' HA ' HG21 ' A' ' 80' ' ' THR . 65.1 mtt -68.57 -40.04 80.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.315 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 57.8 ttm -62.37 -49.87 73.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.794 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.26 -39.92 78.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.423 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -67.47 -40.07 85.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.223 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.79 HD22 ' CB ' ' A' ' 73' ' ' ALA . 86.0 mt -88.57 -20.59 24.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.502 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.57 76.39 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.454 HD12 ' OG ' ' A' ' 110' ' ' SER . 45.1 pt -112.97 140.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 111.738 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.9 pm0 -95.91 162.33 24.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 99.5 Cg_exo -43.32 146.17 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.581 2.187 . . . . 0.0 112.694 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.97 75.51 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.105 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 106' ' ' ILE . 89.4 p -77.31 163.14 26.74 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.769 -0.253 . . . . 0.0 110.718 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.49 139.85 30.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.726 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 67.8 tp -126.5 124.86 41.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -111.97 120.1 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.857 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 ' CD2' ' A' ' 25' ' ' PHE . 47.2 pt -118.18 134.58 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.126 0.489 . . . . 0.0 111.047 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 30.7 t -119.99 128.72 53.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.956 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.2 t -65.6 117.66 8.38 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 90.6 m -119.27 129.87 55.13 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.433 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.1 t0 -100.39 117.67 35.05 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 186' ' ' CYS . 26.4 m -113.09 151.6 44.32 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.982 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 88.8 Cg_endo -78.87 159.32 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.572 2.181 . . . . 0.0 111.539 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 121' ' ' LEU . 6.5 mp -74.94 126.42 30.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.09 157.15 46.44 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.503 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.43 -28.97 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.739 0.27 . . . . 0.0 111.69 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.54 ' HE2' ' HE3' ' A' ' 126' ' ' LYS . 65.0 t80 -142.23 130.18 21.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.869 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 176' ' ' VAL . 13.2 p -132.89 131.85 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.905 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 96.1 mttt -102.04 125.81 48.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.455 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 171' ' ' ILE . 89.8 mt -110.02 136.06 49.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.523 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -99.54 111.3 61.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.58 160.37 31.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.736 2.29 . . . . 0.0 112.615 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.495 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 95.1 mt-30 -128.83 122.13 29.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.191 0.519 . . . . 0.0 110.289 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 69.09 134.28 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.524 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.3 -21.39 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.94 -40.54 89.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 75.6 t80 -59.93 -40.55 89.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.31 -9.06 59.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.712 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.99 -12.82 61.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.565 0.222 . . . . 0.0 111.395 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -59.98 139.59 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.3 p -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.506 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 137' ' ' ILE . 13.1 m-20 -129.26 74.34 81.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.514 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.704 ' O ' HD23 ' A' ' 144' ' ' LEU . 56.9 Cg_endo -71.94 -35.51 7.19 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.569 2.179 . . . . 0.0 112.239 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.91 97.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.846 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.629 HG13 ' CZ ' ' A' ' 164' ' ' TYR . 97.4 t -60.43 -42.2 90.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 140' ' ' PRO . 4.1 mm? -59.91 -40.11 87.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.94 -42.93 95.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.666 0.269 . . . . 0.0 110.636 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -62.28 -41.0 98.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.595 HG21 HD12 ' A' ' 162' ' ' ILE . 84.4 t -63.35 -40.2 88.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.385 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.52 ' CD2' HD11 ' A' ' 154' ' ' LEU . 94.3 mt -60.07 -40.45 89.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -63.14 -39.93 96.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.117 0.484 . . . . 0.0 110.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.96 -39.93 91.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.708 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.608 ' O ' HG13 ' A' ' 187' ' ' VAL . 42.1 m-85 -94.68 122.25 37.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 111.174 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.542 ' HB2' HG12 ' A' ' 188' ' ' ILE . 90.0 p -71.5 -33.68 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.657 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.783 ' HB ' HD23 ' A' ' 68' ' ' LEU . 7.8 t -136.26 141.21 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 111.907 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.725 ' HG ' HG11 ' A' ' 187' ' ' VAL . 83.6 mt -119.92 127.23 52.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.466 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 38.2 p -121.5 145.27 48.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.5 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.747 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.7 t -60.07 -39.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 0.0 111.309 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.74 -37.02 83.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.845 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.0 t0 -68.72 129.99 41.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.9 p -98.58 119.98 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 171' ' ' ILE . 45.8 pt -99.89 134.82 38.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 112.061 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 50.4 mt-10 -113.97 141.13 47.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.593 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.761 HD11 ' CE1' ' A' ' 164' ' ' TYR . 16.7 tt -121.26 129.98 75.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.355 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 23.3 p -108.7 110.07 21.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 111.753 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.761 ' CE1' HD11 ' A' ' 162' ' ' ILE . 5.5 m-85 -126.24 126.71 44.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.33 34.22 23.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.239 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.0 16.01 77.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.6 mttm -117.75 138.49 52.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.782 0.291 . . . . 0.0 110.57 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.2 p -110.93 131.08 55.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.058 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 93.7 m-85 -119.98 139.9 51.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.495 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 61.7 mtpt -103.81 127.19 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 160' ' ' ILE . 49.0 mm -119.96 129.21 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -114.92 133.32 56.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.633 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.747 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.9 OUTLIER -70.0 98.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.119 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.487 HD22 ' HD3' ' A' ' 126' ' ' LYS . 8.8 tt -60.02 -52.25 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.709 0.29 . . . . 0.0 111.742 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.905 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 83.4 tt0 -162.7 139.02 7.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.347 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -141.26 152.88 19.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.201 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 103.87 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 71.8 Cg_endo -100.68 175.15 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.72 2.946 . . . . 0.0 112.435 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.8 mt-10 -94.05 0.04 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.976 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -136.64 154.33 50.68 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.956 0.408 . . . . 0.0 111.34 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.03 -11.84 61.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.523 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.1 m -69.96 -9.42 55.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.498 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 59.95 38.67 20.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.224 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 56.2 m -130.05 135.79 48.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.612 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.3 pt -129.96 160.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 111.768 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HG23 ' A' ' 119' ' ' VAL . 46.4 t -99.94 120.46 39.83 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.725 HG11 ' HG ' ' A' ' 154' ' ' LEU . 9.7 p -110.66 14.59 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.412 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.748 HD11 ' HG ' ' A' ' 68' ' ' LEU . 91.0 mt -59.96 -46.28 94.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.481 ' HG3' HG22 ' A' ' 188' ' ' ILE . 98.9 mt-10 -155.88 81.59 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.229 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 187' ' ' VAL . 12.7 t -150.05 157.36 43.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.899 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -87.93 103.78 16.0 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.509 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.8 tp -119.94 134.17 55.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.2 t -97.3 122.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.484 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 70.2 p -102.5 142.46 33.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.568 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -129.55 146.54 51.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.68 139.91 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.319 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -108.92 165.95 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 77.4 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.621 2.214 . . . . 0.0 112.461 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 13.8 Cg_endo . . . . . 0 N--CA 1.463 -0.291 0 CA-C-O 120.716 0.215 . . . . 0.0 111.779 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.1 mt-30 -99.83 126.69 45.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.6 p -119.8 126.28 50.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.1 0.476 . . . . 0.0 111.76 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 115' ' ' SER . 65.9 t80 -120.17 124.35 45.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.618 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.51 129.94 55.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CD ' ' CZ ' ' A' ' 25' ' ' PHE . 81.7 tt0 -148.05 154.93 40.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.128 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -105.25 127.19 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.712 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.676 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.6 m-85 -133.47 159.98 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.719 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -96.06 127.88 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.512 ' HB3' HD22 ' A' ' 112' ' ' LEU . 28.7 p -91.37 143.62 26.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.517 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 93' ' ' ARG . 20.1 m-85 -129.95 153.34 80.97 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.502 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HB2' ' HG2' ' A' ' 32' ' ' MET . 89.6 Cg_endo -78.28 103.67 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.798 2.332 . . . . 0.0 112.968 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.766 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.5 mt -60.75 -40.07 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.113 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.625 ' HB2' HE21 ' A' ' 98' ' ' GLN . . . -59.83 -29.7 68.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.389 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.615 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 97.2 mmm -67.71 -38.68 83.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 91.2 mtp -64.89 148.66 51.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -59.53 140.94 55.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.057 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.51 -21.02 63.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.056 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.973 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 pt -99.99 1.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.094 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -127.03 159.33 34.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.151 0.501 . . . . 0.0 111.691 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -99.96 129.71 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.969 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.12 88.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.23 -39.95 88.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.262 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.21 76.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.652 HD21 ' HG3' ' A' ' 98' ' ' GLN . 20.5 t-20 -60.07 -40.61 90.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.033 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.83 1.52 40.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.242 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.29 -170.63 34.86 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.99 31.48 7.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.817 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' HD11 ' A' ' 85' ' ' LEU . 62.0 mttp -99.71 121.96 42.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.98 0.419 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.715 HD12 HD11 ' A' ' 50' ' ' LEU . 48.4 pt -119.42 149.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.745 ' CE1' ' HB2' ' A' ' 89' ' ' ALA . 65.3 t80 -104.77 127.84 52.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.632 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 114' ' ' ILE . 2.0 mp -133.39 160.02 70.26 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.646 0.26 . . . . 0.0 111.512 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.674 ' CA ' ' HB3' ' A' ' 89' ' ' ALA . 62.8 Cg_endo -72.32 147.76 47.87 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.766 2.31 . . . . 0.0 112.595 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 89' ' ' ALA . 27.3 Cg_exo -62.55 -19.0 66.48 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.866 2.377 . . . . 0.0 112.878 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.676 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -65.51 -43.42 90.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.092 0.473 . . . . 0.0 110.961 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 57.9 tp -60.28 -42.23 94.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.233 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -60.11 -40.1 88.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.065 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -40.09 90.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 69' ' ' PHE . 96.7 mt -63.63 -38.39 90.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.7 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.4 m -60.01 -37.96 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.11 -36.55 77.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.28 -1.77 42.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.296 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.96 40.59 18.75 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.595 ' CD1' HD22 ' A' ' 58' ' ' LEU . 85.4 mt -73.17 130.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.404 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -66.08 140.08 58.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.654 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.717 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 16.3 t80 -96.53 147.17 32.54 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.717 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 24.4 Cg_exo -66.96 155.45 84.14 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.149 -1.188 . . . . 0.0 113.062 0.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.441 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 66.6 mtt -90.86 140.29 29.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 117' ' ' THR . 35.7 mt -105.75 141.0 37.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.079 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.711 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 60.5 m-85 -133.41 147.0 51.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.431 . . . . 0.0 112.108 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 97.7 mttt -121.39 137.91 54.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.19 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.671 ' C ' HG23 ' A' ' 79' ' ' VAL . 86.5 mt -99.2 119.99 38.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.29 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -108.05 125.52 51.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.751 0.31 . . . . 0.0 111.665 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . . . -100.49 119.97 39.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.921 0.391 . . . . 0.0 110.676 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.15 -39.87 82.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.04 -39.84 87.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -106.16 -13.81 15.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 70.08 8.17 61.04 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -100.18 140.0 35.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 71' ' ' LEU . 9.7 p -123.64 122.76 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.628 HG23 ' CG ' ' A' ' 158' ' ' ASP . 60.5 m -106.06 134.84 48.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.323 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.64 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 3.4 t-80 -84.41 114.72 22.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.02 172.72 20.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.281 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -100.09 162.29 19.18 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.443 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.674 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 9.7 p -130.01 136.59 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 0.0 111.78 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.702 HD11 ' HD3' ' A' ' 47' ' ' LYS . 94.3 mt -91.01 -77.21 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.529 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -148.69 160.08 43.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.057 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 55' ' ' LEU . 96.7 m-85 -106.22 116.63 32.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.602 HG13 ' C ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -140.78 11.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.784 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . . . -85.14 99.9 11.37 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.82 -40.0 72.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.01 0.433 . . . . 0.0 110.649 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.14 -30.29 67.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.385 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 100.07 64.59 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.07 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . 35.6 ptt-85 -123.41 143.42 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HG ' ' A' ' 50' ' ' LEU . 97.5 t -123.28 132.78 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.542 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.766 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.0 m-85 -120.41 139.88 52.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 96' ' ' LEU . 1.7 pt? -134.49 159.49 72.05 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.297 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.634 ' HG2' ' CG ' ' A' ' 100' ' ' MET . 58.7 Cg_endo -68.91 159.21 54.82 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.655 2.236 . . . . 0.0 112.744 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.652 ' HG3' HD21 ' A' ' 43' ' ' ASN . 77.9 mt-30 -60.07 -43.02 95.76 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 29.4 p-90 -64.52 -40.0 94.81 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.634 ' CG ' ' HG2' ' A' ' 97' ' ' PRO . 93.9 mmm -63.49 -40.15 96.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.751 0.31 . . . . 0.0 111.307 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.3 ttp -61.8 -42.42 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.57 -39.98 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -65.61 -40.35 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 93.1 mt -69.97 -23.73 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.49 72.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.901 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.9 pt -120.4 151.58 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.49 160.45 32.99 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.05 -2.82 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.589 2.192 . . . . 0.0 113.323 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.51 -14.06 22.76 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.626 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.532 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 90.8 p -81.48 161.29 23.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.991 0.424 . . . . 0.0 111.132 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.42 140.02 51.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.37 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 27' ' ' CYS . 60.5 tp -118.94 129.38 55.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 64.0 tt0 -106.75 125.85 51.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 50' ' ' LEU . 14.9 tt -117.97 126.63 75.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.62 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 44.8 t -120.13 131.77 55.16 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 1.2 m -83.46 114.9 21.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.488 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 34.3 p -122.07 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 112.203 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 57.4 t0 -115.19 113.11 23.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.933 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 186' ' ' CYS . 34.4 m -119.36 150.38 49.41 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.929 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 -175.6 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.484 2.123 . . . . 0.0 111.407 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 187' ' ' VAL . 3.8 mp -95.27 119.47 33.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 0.0 110.709 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -60.0 159.14 23.92 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.732 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.29 -29.03 9.54 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.613 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 126' ' ' LYS . 69.2 t80 -145.28 130.25 18.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.69 0.281 . . . . 0.0 111.395 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.784 HG23 ' CG1' ' A' ' 176' ' ' VAL . 4.2 p -133.78 130.08 55.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.093 0.473 . . . . 0.0 112.187 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD2' ' HG2' ' A' ' 175' ' ' GLU . 85.4 mttt -99.73 121.62 41.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 144' ' ' LEU . 85.6 mt -105.31 131.35 52.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 172' ' ' LYS . 37.8 tt0 -114.63 109.52 47.93 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.68 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HG3' HD11 ' A' ' 135' ' ' LEU . 88.2 Cg_endo -83.94 -168.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.648 2.232 . . . . 0.0 112.601 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -121.84 121.19 36.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.293 0.568 . . . . 0.0 109.982 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t 59.52 178.0 0.08 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.96 -11.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.695 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.08 -40.39 89.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.539 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HD2' HD12 ' A' ' 135' ' ' LEU . 64.9 t80 -60.35 -40.27 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.647 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 129' ' ' PRO . 9.6 mp -80.47 -10.03 59.75 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.776 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.89 -19.31 63.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.601 0.239 . . . . 0.0 111.277 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.46 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.6 mt -60.43 133.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.2 m -60.1 -39.98 88.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.417 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.1 m-20 -126.04 76.5 71.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 144' ' ' LEU . 40.8 Cg_endo -68.79 -30.13 27.69 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.426 2.084 . . . . 0.0 112.071 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.12 99.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 147' ' ' VAL . 98.1 t -61.73 -49.67 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.588 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.2 -39.99 88.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.659 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.01 -46.35 89.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -60.57 -40.39 91.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 0.0 110.247 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 162' ' ' ILE . 62.4 t -63.12 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.169 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 154' ' ' LEU . 86.9 mt -60.04 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -66.5 -40.01 88.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.11 -40.04 92.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.676 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 96.7 m-85 -101.6 118.74 37.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.6 m -62.65 -39.92 95.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.361 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.537 ' CG2' HD22 ' A' ' 68' ' ' LEU . 33.7 p -125.56 149.84 47.99 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 111.737 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 192' ' ' LEU . 86.1 mt -116.02 121.72 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.428 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 94.3 m -119.95 130.07 54.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.002 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.8 t -59.95 -40.03 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 111.684 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.92 -38.61 76.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.304 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.628 ' CG ' HG23 ' A' ' 80' ' ' THR . 87.9 m-20 -69.54 134.85 49.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.552 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.49 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 6.1 m -102.53 119.93 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.465 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 171' ' ' ILE . 46.7 pt -104.29 140.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 111.52 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -120.01 140.55 50.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 147' ' ' VAL . 46.2 pt -128.01 140.4 49.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.993 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 50.8 m -105.36 119.97 40.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.422 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -122.59 119.97 32.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.423 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.497 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.03 40.14 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 13.6 81.86 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.252 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -116.72 139.28 50.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.808 0.304 . . . . 0.0 110.393 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.5 m -113.38 129.73 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.81 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.0 139.98 51.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.8 mttt -103.5 123.49 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.072 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 160' ' ' ILE . 45.6 pt -124.51 131.82 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.947 0.403 . . . . 0.0 110.787 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 62.9 tttp -119.58 134.6 55.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.959 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -77.55 118.39 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.436 HD22 ' HG2' ' A' ' 175' ' ' GLU . 9.1 tt -62.62 -60.04 4.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.653 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.746 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 22.0 pt-20 -163.02 159.3 23.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.784 ' CG1' HG23 ' A' ' 125' ' ' VAL . 13.6 m -147.77 159.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.896 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.71 102.89 51.76 Favored Pre-proline 0 C--O 1.233 0.226 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.451 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 57.4 Cg_endo -104.71 0.24 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.166 3.244 . . . . 0.0 113.009 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.3 21.33 11.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -143.82 156.56 44.52 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.198 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 80.3 p -71.25 -20.15 62.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.485 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 60.8 m -59.99 -39.89 87.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.602 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 68.34 20.0 8.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.2 t -128.06 131.09 49.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.835 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.732 ' H ' HD13 ' A' ' 185' ' ' ILE . 0.2 OUTLIER -131.04 159.83 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.304 0.574 . . . . 0.0 112.514 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.501 ' HB2' HG22 ' A' ' 153' ' ' THR . 35.2 t -129.56 126.05 37.65 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.26 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -148.63 83.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.814 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 85.3 mt -69.83 -40.06 78.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.5 tt0 -66.02 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.794 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 189' ' ' GLU . 10.4 t -179.98 41.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.5 ' H ' ' CG2' ' A' ' 187' ' ' VAL . 91.2 m-20 -98.38 7.75 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.872 ' HB2' HG11 ' A' ' 187' ' ' VAL . 12.5 tp -107.38 129.57 54.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 110.782 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -96.79 120.4 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.285 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' THR . . . . . 0.649 ' HA ' HG13 ' A' ' 125' ' ' VAL . 59.6 p -99.99 145.57 27.72 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -130.01 140.05 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.961 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 144' ' ' LEU . 97.3 m-85 -101.15 120.29 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.468 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.42 118.51 12.72 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.346 0.424 0 C-N-CA 122.315 2.01 . . . . 0.0 112.139 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.809 0.337 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -119.96 139.96 51.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.683 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.5 t -120.37 130.0 54.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.142 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.97 76.78 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.353 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 64.69 28.83 13.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 0.0 110.966 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.4 p -130.04 140.0 50.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.718 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t -120.05 129.71 54.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -119.74 124.7 46.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 56.65 -129.86 49.42 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.74 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.0 -10.03 75.33 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.679 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.17 -40.43 71.41 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.394 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.06 -39.8 87.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.829 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 3.1 31.13 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.213 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' HE1' ' OD1' ' A' ' 16' ' ' ASN . 64.5 t80 -99.03 130.55 45.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.962 0.381 . . . . 0.0 110.198 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.91 125.11 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.012 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.423 ' OD1' ' HE1' ' A' ' 14' ' ' PHE . 98.4 m-20 -79.16 139.59 37.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -100.21 116.79 64.15 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.719 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -57.01 162.09 9.69 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.455 2.103 . . . . 0.0 112.149 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 117' ' ' THR . 92.3 mm-40 -100.09 123.6 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -119.59 128.08 53.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.181 0.515 . . . . 0.0 111.927 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 50.5 t80 -133.7 138.49 45.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.96 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -116.75 136.71 52.75 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.979 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE2' ' HB1' ' A' ' 54' ' ' ALA . 99.2 mt-10 -140.05 148.96 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.461 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -121.84 126.81 49.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.537 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.621 ' HB2' HG21 ' A' ' 94' ' ' VAL . 89.6 m-85 -149.94 161.72 41.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.869 0.366 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' HD23 ' A' ' 111' ' ' LEU . 90.0 mtt180 -92.85 130.82 38.33 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.055 0.455 . . . . 0.0 110.562 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.879 ' HB2' HD11 ' A' ' 96' ' ' LEU . 17.5 p -101.19 147.81 25.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.95 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -130.11 148.74 70.94 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.192 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.709 ' O ' ' HG2' ' A' ' 32' ' ' MET . 55.4 Cg_endo -70.68 109.81 2.58 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.25 1.967 . . . . 0.0 112.44 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' A' ' 95' ' ' TYR . 84.1 mt -60.01 -26.7 36.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.476 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' HA ' HH12 ' A' ' 38' ' ' ARG . . . -58.24 -38.62 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.123 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.709 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.1 ptm -68.99 -23.64 64.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.742 0.306 . . . . 0.0 111.07 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.438 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 98.9 mtp -61.9 139.81 58.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 111.235 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.709 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.08 141.58 55.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.645 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.587 ' HA ' ' HG2' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.95 -39.91 87.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.386 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -60.0 -39.7 86.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.527 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.709 HG12 ' HB2' ' A' ' 34' ' ' ASN . 49.4 pt -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.587 ' HG2' ' HA ' ' A' ' 35' ' ' ASP . 22.0 ptt180 -128.29 160.1 33.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.978 0.418 . . . . 0.0 111.072 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.579 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 88.1 tttt -100.46 134.56 43.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -60.07 -40.02 88.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.21 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 96.0 m-20 -61.5 -39.97 92.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.99 0.424 . . . . 0.0 110.878 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.14 92.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.09 -40.05 88.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.08 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -101.84 5.4 41.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.524 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.83 179.08 35.35 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.327 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -109.97 25.57 16.18 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.305 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.751 ' HD3' HD13 ' A' ' 85' ' ' LEU . 61.0 mttm -101.24 135.25 43.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.67 0.272 . . . . 0.0 111.358 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.732 HG12 ' O ' ' A' ' 83' ' ' GLY . 48.3 pt -120.24 156.54 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.256 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.5 ' O ' HD22 ' A' ' 50' ' ' LEU . 90.4 m-85 -100.25 130.48 46.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.569 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 HD12 ' A' ' 114' ' ' ILE . 4.0 mm? -129.8 163.31 47.91 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.831 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 60.4 Cg_endo -77.1 149.45 28.52 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.244 1.963 . . . . 0.0 112.82 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.82 -23.8 62.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.576 2.184 . . . . 0.0 112.42 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -59.97 -39.99 87.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.075 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -68.07 -41.28 82.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.996 0.426 . . . . 0.0 110.998 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD22 ' CD1' ' A' ' 87' ' ' PHE . 58.8 tp -60.95 -43.25 98.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.5 m -60.2 -40.27 89.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.54 -40.01 94.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.2 0.524 . . . . 0.0 110.102 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 21' ' ' PHE . 88.2 mt -60.05 -39.98 87.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.046 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.2 m -59.83 -40.01 87.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.943 0.401 . . . . 0.0 110.123 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -59.97 -36.27 76.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.254 0.549 . . . . 0.0 110.092 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' A' ' 63' ' ' ILE . 12.4 tp -79.98 1.11 28.75 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.202 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.51 47.99 8.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 61' ' ' LEU . 49.2 mm -86.46 121.55 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -70.21 140.0 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.557 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.746 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 40.3 t80 -88.25 147.14 39.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.716 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.746 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 15.0 Cg_exo -71.09 158.91 94.52 Favored 'Cis proline' 0 C--N 1.352 0.752 0 C-N-CA 124.567 -1.014 . . . . 0.0 113.138 0.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.53 ' SD ' HD13 ' A' ' 58' ' ' LEU . 68.0 mtt -95.52 139.45 31.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.476 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.721 HD22 HG23 ' A' ' 153' ' ' THR . 82.4 mt -107.16 138.33 43.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.716 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.799 ' HB3' HG23 ' A' ' 114' ' ' ILE . 12.3 m-30 -120.09 140.02 51.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.044 0.449 . . . . 0.0 112.027 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' HB3' ' OG ' ' A' ' 115' ' ' SER . 62.6 tttp -119.02 130.18 55.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.744 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.651 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -94.25 133.21 38.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.955 ' HA ' HG12 ' A' ' 79' ' ' VAL . 94.2 m -120.01 129.94 54.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.318 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.13 110.82 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.981 0.419 . . . . 0.0 111.193 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -67.65 -40.0 84.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.531 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -39.92 87.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.804 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.502 HG21 ' HA3' ' A' ' 105' ' ' GLY . 67.1 p -101.29 -13.48 18.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.487 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 0.25 26.11 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.795 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -100.4 139.95 35.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 120.939 0.4 . . . . 0.0 110.459 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 72' ' ' THR . 13.1 m -121.7 117.42 52.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.021 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.411 HG22 ' OD1' ' A' ' 158' ' ' ASP . 72.0 p -100.97 155.87 17.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' CE1' ' HZ2' ' A' ' 70' ' ' LYS . 63.3 m80 -100.4 114.84 28.71 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 120.73 0.3 . . . . 0.0 110.621 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -104.74 160.01 15.66 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.923 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.732 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.99 164.3 22.56 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.027 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -127.83 133.52 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 117.26 0.53 . . . . 0.0 112.266 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.751 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.5 tp -92.03 -78.83 0.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.911 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -150.78 160.02 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.595 ' CD1' HD22 ' A' ' 55' ' ' LEU . 76.1 m-85 -94.93 116.63 28.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.7 pt -125.89 -8.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -99.55 103.68 15.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.897 0.379 . . . . 0.0 111.786 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.56 -39.98 92.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.293 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.65 -30.33 69.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.179 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.66 74.38 0.79 Allowed Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.522 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -119.9 140.72 50.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.777 0.323 . . . . 0.0 110.775 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.698 HG22 HD13 ' A' ' 50' ' ' LEU . 57.3 t -119.8 130.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.631 ' HB3' HG12 ' A' ' 30' ' ' ILE . 87.1 m-85 -119.99 139.95 51.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.545 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.879 HD11 ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -137.6 156.85 74.58 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.917 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.728 ' HG2' ' HB2' ' A' ' 100' ' ' MET . 37.8 Cg_endo -68.8 158.54 57.43 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.045 1.83 . . . . 0.0 111.459 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.25 -41.13 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 48.1 p-90 -65.76 -38.55 89.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.613 0.244 . . . . 0.0 111.179 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.728 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . 58.2 ttm -60.04 -40.12 88.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.358 . . . . 0.0 111.078 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.615 ' HG3' HD23 ' A' ' 96' ' ' LEU . 97.8 mtp -59.89 -40.01 87.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.92 -40.06 94.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.667 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -66.89 -40.23 87.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.357 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.2 mt -70.58 -24.31 62.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.329 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.502 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 72.53 28.85 66.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.629 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.5 pt -117.75 142.87 30.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 111.409 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.9 pt20 -96.39 159.96 30.74 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.746 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 85.5 Cg_exo -44.7 138.42 8.18 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.564 2.176 . . . . 0.0 112.537 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.03 -9.98 75.53 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.765 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.5 m -71.58 150.04 45.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.74 0.305 . . . . 0.0 110.725 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.463 HD23 ' HG2' ' A' ' 26' ' ' ARG . 87.3 mt -75.68 144.65 41.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.756 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.684 HD23 HG11 ' A' ' 94' ' ' VAL . 59.0 tp -127.05 130.98 51.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.079 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 97.4 mt-30 -104.3 128.95 52.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.01 HD12 HD11 ' A' ' 50' ' ' LEU . 91.9 mt -119.4 122.69 69.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.524 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 74.7 p -121.6 139.28 53.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.53 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.785 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 32.4 m -85.29 122.39 29.39 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.276 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.644 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 10.0 t -130.02 138.44 50.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.078 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -119.47 128.8 54.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.385 . . . . 0.0 110.344 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 121' ' ' LEU . 33.2 m -115.52 152.25 46.92 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.731 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.454 ' HB2' ' OE1' ' A' ' 179' ' ' GLU . 67.4 Cg_endo -73.84 16.46 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.187 1.925 . . . . 0.0 112.537 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.929 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.8 mp 64.57 108.32 0.03 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.369 . . . . 0.0 111.454 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -53.93 167.94 1.6 Allowed Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -107.55 -28.2 9.92 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.675 0.238 . . . . 0.0 111.585 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -142.46 132.1 23.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.369 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.802 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.7 p -131.33 130.17 62.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 111.327 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.43 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 88.3 tttt -99.7 120.09 39.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.66 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.876 HD22 HG22 ' A' ' 171' ' ' ILE . 85.5 mt -111.44 140.49 45.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 111.421 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.946 ' HG3' ' HG3' ' A' ' 199' ' ' PRO . 45.0 tt0 -91.71 117.2 67.64 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' A' ' 199' ' ' PRO . 71.9 Cg_endo -75.03 159.79 40.84 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.516 2.144 . . . . 0.0 112.167 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -136.19 121.51 19.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.2 m 66.79 135.14 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.29 -21.13 24.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.87 -40.06 87.38 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.783 0.325 . . . . 0.0 110.776 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.488 ' HD1' HD12 ' A' ' 135' ' ' LEU . 60.9 t80 -60.03 -40.06 88.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.756 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.488 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -80.72 -10.53 59.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -76.5 -10.22 59.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.281 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.0 mt -64.18 139.81 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.745 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.1 p -59.96 -40.05 87.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.349 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.503 ' H ' HG22 ' A' ' 137' ' ' ILE . 6.6 m-20 -127.12 71.92 76.29 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.788 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.92 -32.99 93.12 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.631 2.221 . . . . 0.0 111.879 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -60.19 -40.2 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.11 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.12 97.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.3 t -60.06 -41.15 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 HG21 ' A' ' 194' ' ' THR . 3.1 tm? -60.3 -44.01 95.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.194 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.1 -39.93 87.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.6 -40.03 95.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.606 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.514 HG22 HD12 ' A' ' 162' ' ' ILE . 75.7 t -61.78 -42.95 96.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.013 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HD11 ' A' ' 154' ' ' LEU . 89.6 mt -60.01 -40.05 87.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.821 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -65.04 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -62.86 -40.02 96.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.518 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.448 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 96.9 m-85 -105.56 119.69 39.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.768 0.318 . . . . 0.0 111.179 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.465 ' OG ' ' HA2' ' A' ' 83' ' ' GLY . 42.7 p -69.83 -35.79 75.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.721 HG23 HD22 ' A' ' 68' ' ' LEU . 34.3 p -124.56 140.32 53.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.107 0.48 . . . . 0.0 111.607 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.683 ' HB2' HG13 ' A' ' 185' ' ' ILE . 90.5 mt -122.1 130.17 53.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.6 m -119.78 140.12 51.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.015 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.613 ' CG2' HG22 ' A' ' 176' ' ' VAL . 98.3 t -60.05 -40.47 83.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.175 0.512 . . . . 0.0 110.652 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.404 ' H ' HG22 ' A' ' 155' ' ' THR . 11.0 t70 -74.74 -29.43 61.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.875 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 93.9 m-20 -78.45 140.14 38.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.988 0.423 . . . . 0.0 111.93 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -105.68 120.07 55.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.921 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.454 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.7 pt -103.38 137.93 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.927 0.394 . . . . 0.0 111.379 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 170' ' ' LYS . 99.0 mt-10 -119.98 140.05 51.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.205 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 147' ' ' VAL . 6.0 tt -116.21 135.61 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.729 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.0 t -109.76 115.19 29.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -123.56 127.35 48.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 45.5 t30 51.73 40.05 26.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.687 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.56 9.8 86.51 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.975 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 59.5 mttm -111.1 144.1 40.77 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.8 m -114.75 130.79 56.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 110.913 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -119.79 140.07 51.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.67 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.436 ' HA ' ' HG2' ' A' ' 161' ' ' GLU . 62.4 mttp -100.32 121.62 41.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.552 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.876 HG22 HD22 ' A' ' 127' ' ' LEU . 85.3 mt -120.02 120.01 61.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.711 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.536 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 38.5 ttpt -116.2 125.55 52.43 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 111.705 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 156' ' ' VAL . 4.9 mp -78.45 83.28 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.429 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.418 HD21 ' HE3' ' A' ' 172' ' ' LYS . 76.3 mt -59.99 -49.97 75.6 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 98.9 mt-10 -152.39 138.99 18.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.024 0.44 . . . . 0.0 111.735 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.848 HG11 HD13 ' A' ' 185' ' ' ILE . 16.7 m -140.33 151.57 21.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.686 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -96.18 104.77 18.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 65.0 Cg_endo -100.3 167.42 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.286 2.657 . . . . 0.0 112.706 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.454 ' OE1' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.92 -0.08 40.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.974 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.4 p -139.83 159.79 41.38 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.007 0.432 . . . . 0.0 111.376 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.2 m -70.08 -10.3 58.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.688 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.2 t -57.76 -25.75 60.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.685 0.278 . . . . 0.0 111.286 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 181' ' ' SER . 34.2 mmtp 60.02 39.97 19.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.069 0.461 . . . . 0.0 110.756 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -128.29 139.69 52.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.64 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.848 HD13 HG11 ' A' ' 176' ' ' VAL . 39.9 pt -127.32 131.53 70.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 153' ' ' THR . 23.3 m -139.97 119.95 13.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.08 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 187' ' ' VAL . 9.1 p -118.15 112.63 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.749 0.785 . . . . 0.0 111.171 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.619 HD13 ' HD2' ' A' ' 66' ' ' PRO . 55.5 mt -71.59 -60.72 2.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.547 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -90.08 -79.94 0.33 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 15.1 t -168.05 41.41 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.548 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.929 ' HB2' HD23 ' A' ' 121' ' ' LEU . 94.7 m-20 -88.76 2.09 54.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.548 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.425 ' H ' HG21 ' A' ' 187' ' ' VAL . 56.1 tp -111.6 130.32 55.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 110.828 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 125' ' ' VAL . 25.6 t -97.35 129.07 47.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.348 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.754 HG21 HD11 ' A' ' 144' ' ' LEU . 69.7 p -112.95 139.82 48.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.36 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -130.03 140.88 50.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.491 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.417 ' CE1' ' HE1' ' A' ' 134' ' ' PHE . 98.3 m-85 -100.02 121.11 40.87 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.847 0.356 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -124.48 110.48 28.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -62.52 110.3 1.05 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.256 1.97 . . . . 0.0 112.26 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.946 ' HG3' ' HG3' ' A' ' 128' ' ' GLU . 82.3 Cg_endo -99.32 -2.07 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.775 2.984 . . . . 0.0 112.555 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 202' ' ' TYR . 14.8 t -97.37 127.62 49.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.619 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -96.74 10.06 66.38 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.82 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.651 ' H ' HG12 ' A' ' 200' ' ' VAL . 94.7 m-85 -94.27 139.68 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.749 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 9.5 p -120.48 130.41 74.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.089 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -95.27 130.04 33.5 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.67 153.67 70.5 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.5 2.133 . . . . 0.0 112.309 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -83.91 132.86 34.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.062 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 207' ' ' TYR . 53.2 p90 -99.97 120.45 39.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.811 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.031 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.828 0.346 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -70.02 -40.0 75.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.97 130.03 54.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.026 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.07 -8.03 24.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.758 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.03 139.97 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.85 0.357 . . . . 0.0 110.991 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.5 m -106.8 139.86 40.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.7 m -89.99 140.05 30.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -60.04 -39.98 87.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.09 -19.93 9.29 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.653 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.88 151.14 42.2 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.251 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.63 -74.19 0.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -143.77 160.08 41.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 111.008 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.43 -179.7 17.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.48 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.95 140.01 51.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -114.7 127.18 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.992 0.425 . . . . 0.0 111.025 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.03 137.05 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.14 120.05 52.22 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 65.0 Cg_exo -50.85 120.46 6.63 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.345 2.03 . . . . 0.0 111.879 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.582 ' OE1' HD13 ' A' ' 63' ' ' ILE . 78.1 mt-30 -112.11 127.15 55.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.088 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.0 m -120.02 131.12 55.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.024 0.44 . . . . 0.0 111.755 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 27.7 t80 -124.11 141.06 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.301 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -113.04 130.58 56.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.16 0.505 . . . . 0.0 112.045 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -141.83 156.54 45.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.438 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -116.06 124.36 50.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.747 0.308 . . . . 0.0 110.692 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.562 ' CD2' HD12 ' A' ' 114' ' ' ILE . 90.8 m-85 -136.03 150.92 49.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' HD2' ' HG2' ' A' ' 93' ' ' ARG . 7.4 ptp180 -82.24 143.76 31.12 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.705 0.288 . . . . 0.0 110.842 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.785 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 46.5 t -98.99 123.14 43.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.041 0.448 . . . . 0.0 112.175 -178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.463 ' CB ' ' CE1' ' A' ' 95' ' ' TYR . 2.8 m-85 -117.85 146.24 38.47 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.325 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 32' ' ' MET . 71.8 Cg_endo -77.72 105.27 2.0 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.717 2.278 . . . . 0.0 112.953 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.852 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.4 mt -61.39 -40.02 84.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.847 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.02 75.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.814 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.425 ' HB2' ' HG2' ' A' ' 29' ' ' PRO . 97.7 mmm -68.34 -30.98 70.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.529 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 99.7 mmm -60.34 148.54 36.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.123 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -59.94 150.24 29.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.98 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.6 m-20 -59.93 -40.05 87.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.1 ptt-85 -64.4 -40.19 95.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.77 -40.91 77.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.592 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 35' ' ' ASP . 84.5 mmt-85 -122.58 140.08 53.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.798 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 9.8 mtpm? -80.58 149.35 29.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.1 -40.03 88.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.04 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.08 -39.99 87.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.412 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.88 80.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.071 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.659 ' OD1' HG22 ' A' ' 30' ' ' ILE . 98.5 m-20 -60.03 -39.89 87.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.964 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -107.65 16.76 23.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.212 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.98 168.6 26.14 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.329 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.15 16.36 58.27 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.118 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.719 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.1 mttt -100.72 135.57 41.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.798 0.332 . . . . 0.0 111.129 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 83' ' ' GLY . 46.5 pt -118.75 150.77 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.201 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.753 ' O ' HG23 ' A' ' 94' ' ' VAL . 90.1 m-85 -100.51 131.91 46.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.986 0.422 . . . . 0.0 111.018 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.761 HD21 HD13 ' A' ' 114' ' ' ILE . 5.4 mp -132.67 162.0 59.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.273 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.63 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 80.3 Cg_endo -77.28 153.05 31.22 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.166 1.91 . . . . 0.0 112.904 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 18.9 Cg_exo -66.27 -18.31 55.47 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.145 2.563 . . . . 0.0 112.545 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.8 t -60.01 -40.0 87.77 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.915 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.16 -38.18 82.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.16 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.684 HD21 ' CE1' ' A' ' 87' ' ' PHE . 81.5 mt -60.09 -41.37 92.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.695 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.1 m -60.02 -40.12 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.417 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -68.23 -39.99 82.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 HG13 ' A' ' 63' ' ' ILE . 95.7 mt -60.1 -39.88 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.158 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -59.97 -40.05 87.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.954 0.407 . . . . 0.0 110.261 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 97.9 mmm -60.01 -39.96 87.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.508 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 21' ' ' PHE . 88.6 mt -81.24 -0.07 39.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.821 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 60.02 39.96 19.29 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.675 0.274 . . . . 0.0 111.48 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD13 ' OE1' ' A' ' 19' ' ' GLN . 41.4 mm -68.13 136.79 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.897 0.379 . . . . 0.0 110.682 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -92.42 140.2 29.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.421 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.486 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 43.7 p90 -87.29 155.74 54.4 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.788 ' CD ' HD11 ' A' ' 188' ' ' ILE . 18.0 Cg_exo -66.88 162.49 74.09 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.758 0.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 62.2 mtt -95.0 130.35 41.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.821 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.874 HD11 ' SG ' ' A' ' 186' ' ' CYS . 65.0 mt -114.67 140.1 49.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.824 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.653 ' HB3' HG23 ' A' ' 114' ' ' ILE . 35.7 m-85 -120.01 140.08 51.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.734 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.754 ' HG2' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -117.03 130.38 56.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.978 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 112' ' ' LEU . 50.9 mt -96.0 120.98 37.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.74 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.82 HG23 HG22 ' A' ' 79' ' ' VAL . 97.3 m -104.03 120.06 40.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.28 115.38 30.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.605 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -67.83 -39.96 83.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.183 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -40.02 87.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.957 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 m -97.16 -14.96 21.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.34 -6.08 4.69 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.682 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.632 HH21 ' HB3' ' A' ' 157' ' ' ASP . 78.8 ttt180 -100.68 139.97 35.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.82 HG22 HG23 ' A' ' 72' ' ' THR . 47.3 t -118.08 119.99 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.3 p -99.93 159.62 14.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.621 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 74.5 m80 -101.74 115.14 29.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.65 0.262 . . . . 0.0 110.655 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.21 158.26 18.93 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.939 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -91.68 157.07 24.28 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.705 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 8.4 p -127.97 134.07 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 117.294 0.547 . . . . 0.0 112.341 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 ' HD3' ' A' ' 47' ' ' LYS . 44.4 tp -91.84 -79.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.558 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -142.65 159.71 41.7 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.719 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.684 ' CE1' HD21 ' A' ' 55' ' ' LEU . 72.5 m-85 -97.72 116.39 29.83 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.401 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 pt -127.61 -4.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -84.58 98.17 10.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 111.417 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.87 -39.88 76.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.164 0.507 . . . . 0.0 110.519 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -66.51 -30.67 71.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.363 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.63 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.0 42.97 1.14 Allowed Glycine 0 C--N 1.32 -0.323 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.684 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.671 ' HG2' ' HD2' ' A' ' 26' ' ' ARG . 29.4 mtm105 -117.15 150.9 37.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 112.151 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.769 HG21 HD11 ' A' ' 114' ' ' ILE . 14.8 p -128.78 145.03 36.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.219 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.852 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.1 m-85 -120.54 141.93 49.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.44 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 30' ' ' ILE . 69.8 mt -120.21 142.49 33.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.925 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' MET . 51.3 Cg_exo -57.95 156.97 26.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.511 2.141 . . . . 0.0 111.836 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.03 -41.97 93.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.789 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.645 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 49.3 p-90 -70.0 -40.11 75.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.281 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.645 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 97.4 mtp -66.57 -40.01 88.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.647 0.26 . . . . 0.0 111.037 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.2 mtp -60.06 -40.03 88.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.052 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 -40.01 94.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.077 0.465 . . . . 0.0 110.496 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.966 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 71' ' ' LEU . 85.8 mt -69.09 -24.25 64.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.856 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.29 29.96 65.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.589 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.593 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 45.6 pt -116.29 144.8 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 111.333 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.479 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -97.4 160.2 29.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.605 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 7.8 Cg_endo -49.2 135.22 31.04 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.591 2.194 . . . . 0.0 112.136 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 -6.51 82.64 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.699 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.593 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 93.1 p -74.61 157.39 35.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 110.659 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.5 mt -72.85 140.03 47.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.981 0.42 . . . . 0.0 111.02 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.907 HD11 HD22 ' A' ' 71' ' ' LEU . 61.6 tp -127.05 130.13 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.417 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.685 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 64.0 tt0 -107.7 120.24 41.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.769 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -111.37 129.98 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.442 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.637 ' OG ' ' HB3' ' A' ' 70' ' ' LYS . 80.6 p -126.38 139.85 52.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.068 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HA ' ' A' ' 20' ' ' THR . 20.7 t -77.52 120.61 22.73 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.732 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.2 m -119.99 130.0 54.54 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.039 0.447 . . . . 0.0 111.899 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 96.5 m-20 -121.41 119.96 33.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.611 HG11 ' CB ' ' A' ' 184' ' ' SER . 16.7 m -120.93 150.02 52.2 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 2.1 Cg_endo -79.78 142.92 16.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.907 2.405 . . . . 0.0 109.917 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 191' ' ' ASP . 9.8 mt -60.91 120.3 9.93 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.211 0.529 . . . . 0.0 111.455 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -72.42 160.36 54.02 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.129 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 96.6 mt-30 -99.98 -19.94 16.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.154 -0.219 . . . . 0.0 111.392 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.13 134.96 23.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 111.729 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.79 HG13 ' HA ' ' A' ' 194' ' ' THR . 2.4 p -136.4 129.74 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.612 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 84.7 tttt -97.06 119.97 36.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.022 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.53 HD23 HG13 ' A' ' 173' ' ' ILE . 88.0 mt -113.55 130.44 56.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.223 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.412 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 10.2 tt0 -104.28 110.03 63.54 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.906 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 199' ' ' PRO . 89.7 Cg_endo -80.45 170.29 16.13 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.596 2.197 . . . . 0.0 112.437 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 94.1 mt-30 -132.67 122.86 25.29 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.981 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 199' ' ' PRO . 52.0 m 67.87 137.21 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.755 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.27 -18.26 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.685 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.01 87.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.701 0.286 . . . . 0.0 111.011 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.533 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 66.4 t80 -60.04 -39.99 87.85 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.828 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.7 mt -88.68 -2.0 58.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.099 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.06 -30.88 69.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.551 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.7 mt -58.08 138.99 18.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.2 p -59.96 -37.65 80.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.555 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.551 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.4 m-20 -118.75 80.45 17.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.8 -32.01 30.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.623 2.216 . . . . 0.0 112.271 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -60.06 -40.84 90.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.09 98.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.74 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 147' ' ' VAL . 94.1 t -64.0 -42.55 96.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.332 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -59.91 -42.33 93.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.272 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.04 -42.11 93.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -59.97 -40.06 87.81 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.088 0.47 . . . . 0.0 110.59 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.788 HG22 HD13 ' A' ' 162' ' ' ILE . 57.7 t -61.46 -43.78 97.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.249 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.96 -40.24 92.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.803 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -63.32 -40.01 96.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.655 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -59.98 -39.97 87.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.313 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.595 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 88.5 m-85 -102.34 122.07 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.046 0.45 . . . . 0.0 111.676 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.4 ' HB3' ' CD2' ' A' ' 68' ' ' LEU . 66.2 m -61.1 -39.98 91.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.218 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.684 ' HB ' HD22 ' A' ' 68' ' ' LEU . 8.2 t -128.05 140.76 51.77 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.983 0.421 . . . . 0.0 111.187 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.732 HD11 HD11 ' A' ' 173' ' ' ILE . 49.8 tp -114.8 121.5 43.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.449 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 157' ' ' ASP . 53.4 m -119.38 140.29 50.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 176' ' ' VAL . 90.0 t -59.98 -41.51 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.48 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.632 ' HB3' HH21 ' A' ' 78' ' ' ARG . 95.9 m-20 -70.05 -34.92 73.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.89 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 95.7 m-20 -73.58 139.34 45.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.252 0.549 . . . . 0.0 112.412 -178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.9 p -107.31 120.0 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.57 178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.595 ' HB ' ' CE2' ' A' ' 151' ' ' PHE . 45.2 pt -106.96 138.42 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.043 0.449 . . . . 0.0 112.109 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -121.02 140.17 52.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.788 HD13 HG22 ' A' ' 147' ' ' VAL . 44.6 pt -127.34 141.37 46.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.238 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.2 t -110.73 117.86 34.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.179 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.459 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 54.0 t80 -120.45 120.28 35.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 56.21 40.05 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.577 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.96 9.89 86.2 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.089 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.678 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.9 mttt -112.74 137.42 51.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.785 0.293 . . . . 0.0 110.381 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.7 p -109.99 129.08 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.982 0.42 . . . . 0.0 111.486 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.533 ' CD1' ' HD1' ' A' ' 134' ' ' PHE . 89.2 m-85 -120.06 140.0 51.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.592 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 97.7 mttt -101.12 124.57 47.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.5 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.247 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -119.27 128.95 54.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.006 0.432 . . . . 0.0 110.684 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.768 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.3 mp -83.63 109.75 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.011 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.429 HD12 ' HE2' ' A' ' 126' ' ' LYS . 84.4 mt -67.89 -54.07 21.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.612 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 49.8 mt-10 -157.65 140.36 14.86 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.834 0.349 . . . . 0.0 111.212 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.777 ' CG1' HG23 ' A' ' 125' ' ' VAL . 4.5 m -140.05 154.56 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -110.18 102.59 51.59 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.494 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.503 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 63.6 Cg_endo -104.04 -2.69 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.144 3.229 . . . . 0.0 113.201 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 61.67 27.87 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.73 0.3 . . . . 0.0 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.4 p -140.16 147.37 40.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.985 0.422 . . . . 0.0 111.186 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.7 m -61.66 -40.03 93.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.0 p -60.01 -20.18 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.817 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 50.5 mttt 57.23 39.8 28.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.0 111.432 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.611 ' CB ' HG11 ' A' ' 119' ' ' VAL . 41.4 t -121.62 140.81 51.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.153 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 192' ' ' LEU . 17.7 pt -125.24 148.5 29.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.968 0.414 . . . . 0.0 111.475 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.874 ' SG ' HD11 ' A' ' 68' ' ' LEU . 53.0 t -139.27 99.38 3.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.574 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.76 ' HA ' HD21 ' A' ' 121' ' ' LEU . 11.7 p -117.45 113.27 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 121.783 0.801 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.788 HD11 ' CD ' ' A' ' 66' ' ' PRO . 20.6 mt -77.26 -62.37 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.29 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -90.02 -79.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.4 t -161.18 42.87 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.739 0.304 . . . . 0.0 111.662 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.786 ' HB2' HD22 ' A' ' 121' ' ' LEU . 92.7 m-20 -89.74 6.13 42.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.022 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.676 ' CD2' HD12 ' A' ' 185' ' ' ILE . 31.8 tp -120.45 130.09 54.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.869 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 125' ' ' VAL . 33.0 t -90.45 121.89 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.656 0.265 . . . . 0.0 110.907 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.79 ' HA ' HG13 ' A' ' 125' ' ' VAL . 52.6 p -100.99 151.98 21.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.463 0.649 . . . . 0.0 112.411 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -129.65 139.1 51.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.541 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.84 137.02 46.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.756 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -121.18 165.88 17.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.365 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 13.7 Cg_endo -56.05 124.67 16.84 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.143 1.895 . . . . 0.0 111.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.518 ' HB2' ' N ' ' A' ' 131' ' ' SER . 92.3 Cg_endo -80.66 129.46 7.29 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.597 2.198 . . . . 0.0 112.916 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.24 140.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.73 -118.68 1.87 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.247 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -100.77 130.04 46.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.882 0.372 . . . . 0.0 111.241 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.67 120.31 64.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.646 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -100.32 120.09 57.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.069 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.3 119.95 6.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.431 2.087 . . . . 0.0 112.296 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -97.14 133.25 42.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -100.03 120.08 39.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.825 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.769 0.318 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -119.93 140.03 51.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.7 t -120.16 130.1 54.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.77 167.5 34.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.248 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -120.02 135.3 54.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.3 m -60.13 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.758 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.07 34.33 23.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.897 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -63.13 -39.99 96.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.047 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.51 159.77 33.78 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.174 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.58 -11.55 74.34 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.562 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 -15.91 6.87 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.296 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -120.48 130.02 54.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.915 0.358 . . . . 0.0 110.95 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.87 142.17 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.83 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -120.03 139.93 51.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.613 0.244 . . . . 0.0 110.676 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.774 0.321 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -100.68 119.99 39.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -105.63 119.78 51.48 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.273 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 46.3 Cg_exo -57.51 152.83 45.12 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.329 2.019 . . . . 0.0 112.092 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.519 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 96.5 mt-30 -105.45 120.44 41.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 116' ' ' SER . 72.6 p -121.17 129.79 53.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.821 0.343 . . . . 0.0 111.689 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.647 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 78.6 t80 -119.85 139.43 52.38 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -106.26 134.86 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.137 0.494 . . . . 0.0 111.976 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 99.0 mt-10 -141.1 151.37 43.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.92 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -120.53 136.78 54.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.992 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.667 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.3 m-85 -152.57 159.97 43.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.848 0.356 . . . . 0.0 111.082 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -84.35 140.31 31.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 17.3 t -97.66 125.75 42.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.571 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.45 149.79 44.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.298 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.93 100.47 1.2 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.923 2.416 . . . . 0.0 112.326 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.591 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 83.6 mt -60.5 -40.1 83.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.946 0.403 . . . . 0.0 110.406 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 98' ' ' GLN . . . -60.01 -32.54 70.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.294 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 58.2 ttm -66.98 -39.02 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.888 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 94.8 mtp -60.9 151.72 29.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.092 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HB2' HD12 ' A' ' 37' ' ' ILE . 98.6 m-20 -59.45 143.8 48.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.184 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 38' ' ' ARG . 95.8 m-20 -60.03 -40.05 88.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.072 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -60.81 -40.04 91.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.879 0.371 . . . . 0.0 110.918 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 HD12 ' HB2' ' A' ' 34' ' ' ASN . 85.8 mt -68.18 -40.06 82.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.4 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 35' ' ' ASP . 39.6 mmt180 -116.34 140.18 49.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.136 0.493 . . . . 0.0 111.965 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.83 139.99 55.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.104 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -60.11 -39.08 84.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.078 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.96 -39.95 87.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.821 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.09 -39.93 87.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 30' ' ' ILE . 28.0 m120 -60.03 -41.4 92.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.415 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.14 6.92 38.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.714 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.61 171.9 29.54 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.534 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -99.45 18.29 56.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.211 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.852 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.24 131.41 46.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.415 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.759 HG22 ' HD3' ' A' ' 97' ' ' PRO . 46.2 pt -119.8 151.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.934 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.4 m-85 -101.81 131.38 48.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.145 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD11 ' CD1' ' A' ' 48' ' ' ILE . 5.0 mp -135.86 160.95 65.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.053 0.454 . . . . 0.0 111.814 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.591 ' CG ' ' HA2' ' A' ' 92' ' ' GLY . 32.3 Cg_exo -63.78 135.68 49.65 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.91 2.406 . . . . 0.0 112.364 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 37.0 Cg_exo -60.4 -20.12 61.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.697 2.265 . . . . 0.0 112.916 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 61.3 m -60.01 -40.52 89.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.872 0.368 . . . . 0.0 110.781 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.667 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -61.75 -39.9 93.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.269 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.535 ' HB2' ' CE1' ' A' ' 87' ' ' PHE . 59.1 tp -59.97 -40.21 88.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.113 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.8 m -59.98 -39.98 87.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.674 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -60.76 -39.95 90.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.378 0.609 . . . . 0.0 110.376 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 55' ' ' LEU . 87.7 mt -60.04 -39.5 86.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.067 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.8 t -57.76 -38.31 75.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.231 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.3 mtt -60.0 -37.06 78.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.403 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.618 HD11 ' CD1' ' A' ' 21' ' ' PHE . 87.6 mt -80.08 -0.06 34.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.41 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 59.95 40.06 19.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.697 0.284 . . . . 0.0 111.588 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 85.4 mt -86.72 120.07 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.97 0.414 . . . . 0.0 110.436 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -83.56 151.2 25.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.733 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.507 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 32.6 p90 -87.1 159.85 50.31 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.31 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 23.4 Cg_exo -65.65 147.53 73.14 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.192 -1.17 . . . . 0.0 112.866 0.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.6 mtt -95.58 138.92 32.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.775 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.855 HD22 ' HB ' ' A' ' 153' ' ' THR . 32.3 mt -114.05 139.34 49.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.667 ' HB3' HD11 ' A' ' 114' ' ' ILE . 94.6 m-85 -131.55 145.42 51.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.235 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HB3' ' ND1' ' A' ' 81' ' ' HIS . 22.4 pttp -122.21 140.32 52.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD13 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -98.58 128.09 44.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 113' ' ' GLN . 23.0 p -105.17 136.4 44.74 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.07 113.79 22.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.724 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -65.92 -39.07 90.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.814 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.89 -40.09 87.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.924 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 74.3 p -102.96 -14.49 16.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.94 41.49 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.744 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -101.22 140.16 35.89 Favored 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 120.779 0.323 . . . . 0.0 111.022 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.553 ' CG1' HG22 ' A' ' 72' ' ' THR . 41.6 t -119.99 121.41 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.685 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 80.1 p -102.45 156.34 17.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.914 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.644 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 93.0 m-70 -101.76 114.85 29.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.37 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.24 167.1 17.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.756 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.649 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.99 162.91 26.49 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.539 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.0 p -129.67 131.99 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 111.709 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.852 HD13 ' HD3' ' A' ' 47' ' ' LYS . 61.2 tp -93.38 -80.03 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.115 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.9 161.04 43.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 89.1 m-85 -95.3 116.48 28.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.217 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 pt -125.57 -4.62 5.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.661 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.84 98.12 11.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.136 0.493 . . . . 0.0 111.557 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.98 -40.07 75.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.96 -30.35 69.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.887 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.591 ' HA2' ' CG ' ' A' ' 51' ' ' PRO . . . 112.35 49.3 0.61 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.611 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.661 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 99.6 mtt180 -121.1 149.48 42.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.84 0.353 . . . . 0.0 111.558 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 49' ' ' PHE . 7.4 p -128.93 142.82 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.002 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 97.5 m-85 -114.02 137.6 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.928 HD12 ' HD2' ' A' ' 97' ' ' PRO . 1.8 tp -119.57 137.57 25.65 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.655 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.928 ' HD2' HD12 ' A' ' 96' ' ' LEU . 52.6 Cg_exo -53.25 145.55 43.71 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.45 2.1 . . . . 0.0 112.372 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 59.0 tt0 -60.05 -43.66 95.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.829 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 100' ' ' MET . 59.1 p-90 -69.98 -41.18 74.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 111.214 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.558 ' CG ' HD11 ' A' ' 96' ' ' LEU . 43.8 tpp -61.18 -40.32 93.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.555 ' HA ' HD21 ' A' ' 96' ' ' LEU . 57.1 ttm -60.06 -41.23 91.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.124 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.1 -40.07 94.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.519 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.02 -40.07 96.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.715 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.5 mt -69.44 -23.63 63.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.216 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.76 34.85 29.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.998 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 101' ' ' MET . 45.1 pt -119.77 146.99 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -95.8 157.15 36.43 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.428 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -49.39 138.07 30.83 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.399 2.066 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.98 -9.9 75.74 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.15 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 53.6 m -71.03 149.98 46.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.096 0.448 . . . . 0.0 110.669 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 112' ' ' LEU . 10.4 tt -71.04 140.15 50.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 71' ' ' LEU . 59.3 tp -126.76 130.46 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.639 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 93.7 mt-30 -109.19 130.31 55.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 69' ' ' PHE . 18.7 tt -118.29 128.38 75.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.226 0.536 . . . . 0.0 111.443 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 42.3 t -120.46 131.26 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.859 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 21' ' ' PHE . 61.4 m -70.11 130.24 41.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.704 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.7 m -120.08 130.03 54.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.831 0.348 . . . . 0.0 111.086 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 19' ' ' GLN . 98.0 m-20 -119.33 120.04 35.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.815 0.34 . . . . 0.0 110.227 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.15 153.62 44.6 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.911 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.28 17.69 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.823 2.348 . . . . 0.0 112.292 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.603 HD21 ' OG1' ' A' ' 190' ' ' THR . 0.2 OUTLIER 70.11 100.77 0.06 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.974 0.416 . . . . 0.0 111.968 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -57.02 156.82 12.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.244 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.24 -27.22 10.67 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -139.56 130.92 26.83 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.971 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 1.043 HG13 HG22 ' A' ' 194' ' ' THR . 2.6 p -130.02 130.19 65.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.211 0.529 . . . . 0.0 111.548 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.557 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 87.9 tttt -99.42 120.73 40.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.503 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.72 HD22 ' CG2' ' A' ' 171' ' ' ILE . 83.6 mt -108.76 135.51 49.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.408 . . . . 0.0 111.57 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.89 ' HB2' ' HG ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -107.39 119.92 49.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.905 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.538 ' HG2' ' HA ' ' A' ' 198' ' ' PRO . 91.2 Cg_endo -81.46 169.1 15.86 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.16 1.907 . . . . 0.0 111.573 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -138.25 121.62 17.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.989 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 133' ' ' ASP . 0.5 OUTLIER 63.32 26.74 15.18 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m 36.84 27.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.372 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.496 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 96.2 m-20 -68.54 -39.95 80.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.408 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 140' ' ' PRO . 64.0 t80 -62.29 -39.98 94.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.718 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.61 -24.13 63.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.938 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -59.97 -40.0 87.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.4 mt -57.5 139.01 17.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.83 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -60.28 -40.04 88.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.57 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.523 ' H ' HG22 ' A' ' 137' ' ' ILE . 79.7 m-20 -121.68 75.16 35.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.879 0.371 . . . . 0.0 110.772 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.476 ' HB2' ' CE2' ' A' ' 134' ' ' PHE . 42.3 Cg_endo -69.07 -34.93 15.73 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.786 2.324 . . . . 0.0 112.232 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -60.64 -40.65 92.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.49 98.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.401 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 147' ' ' VAL . 70.8 t -61.14 -42.58 93.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.548 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.09 -42.48 94.73 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.131 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.28 -42.27 95.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.675 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -63.56 -40.04 95.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 143' ' ' VAL . 95.5 t -62.01 -40.32 86.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.004 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.774 HD23 HD11 ' A' ' 154' ' ' LEU . 90.3 mt -60.31 -40.48 90.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.03 -39.96 87.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.531 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.79 -40.03 93.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.106 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.6 m-85 -103.0 121.42 42.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.895 0.379 . . . . 0.0 111.518 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.496 ' HA ' ' CD1' ' A' ' 188' ' ' ILE . 74.0 m -61.15 -40.02 92.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.0 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.855 ' HB ' HD22 ' A' ' 68' ' ' LEU . 4.8 t -136.35 147.8 47.56 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.355 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.774 HD11 HD23 ' A' ' 148' ' ' LEU . 84.9 mt -121.39 138.47 54.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.364 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 81' ' ' HIS . 54.6 m -116.08 136.08 53.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.701 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 7.2 p -59.81 -39.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -83.06 -21.16 33.85 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.609 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.7 t0 -78.95 136.28 37.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.515 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.407 ' N ' ' OD1' ' A' ' 158' ' ' ASP . 15.7 m -100.34 120.66 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.167 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 pt -107.15 138.93 30.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.284 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 96.5 mt-10 -120.05 139.99 51.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.067 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -129.31 140.04 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.762 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.3 t -110.13 114.5 28.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.378 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -120.13 122.3 40.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.595 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 51.2 t30 56.41 39.99 29.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.479 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.11 12.31 84.19 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.126 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 163' ' ' SER . 58.3 mttm -118.19 139.07 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.903 0.352 . . . . 0.0 110.664 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.5 p -109.53 133.62 52.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.1 m-85 -119.99 138.65 53.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.78 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 99.6 mttt -104.76 122.66 46.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.693 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.72 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 119.97 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.393 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -115.39 130.03 56.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.293 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -81.71 104.79 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.947 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' ' 128' ' ' GLU . 80.7 mt -60.53 -48.96 79.47 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.557 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.1 mt-10 -158.89 139.91 12.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.683 HG22 ' HB ' ' A' ' 156' ' ' VAL . 11.1 m -143.23 151.62 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.957 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -116.93 103.16 52.51 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.395 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.505 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 97.3 Cg_endo -100.08 12.32 0.57 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.734 2.956 . . . . 0.0 112.278 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 80.7 tt0 60.75 20.01 10.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.451 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 79.3 p -146.78 152.82 39.4 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.7 m -70.0 -18.56 63.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.548 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.7 t -59.9 -25.52 65.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.476 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 60.18 40.04 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.977 0.418 . . . . 0.0 110.89 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 p -122.38 142.65 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.224 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 44.9 pt -130.18 140.03 49.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 68' ' ' LEU . 44.1 t -134.65 138.11 44.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.042 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.721 HG23 ' CB ' ' A' ' 190' ' ' THR . 8.2 p -170.11 67.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.3 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.496 ' CD1' ' HA ' ' A' ' 152' ' ' SER . 84.8 mt -70.0 -40.02 78.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.845 0.355 . . . . 0.0 111.576 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -122.53 -10.08 8.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.686 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.721 ' CB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -78.95 174.49 11.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.783 0.325 . . . . 0.0 110.852 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.42 118.35 36.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.399 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 187' ' ' VAL . 25.2 tp -120.4 138.01 54.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.134 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 26.4 t -92.43 119.99 40.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.77 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 1.043 HG22 HG13 ' A' ' 125' ' ' VAL . 65.9 p -120.87 140.61 51.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.339 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -121.15 139.44 53.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.326 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -105.41 120.0 40.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.931 0.396 . . . . 0.0 111.291 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -132.64 107.65 13.05 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.538 ' HA ' ' HG2' ' A' ' 129' ' ' PRO . 71.0 Cg_endo -73.71 120.34 6.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.321 2.014 . . . . 0.0 113.149 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.595 ' HG3' ' CG ' ' A' ' 128' ' ' GLU . 45.0 Cg_endo -93.59 6.75 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.303 2.668 . . . . 0.0 112.412 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 200' ' ' VAL . 29.6 m -89.32 119.93 37.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.043 0.449 . . . . 0.0 110.843 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -167.55 -107.28 0.2 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.382 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -99.02 131.84 44.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.4 t -118.26 129.96 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 205' ' ' PRO . 11.2 tt0 -82.78 129.67 61.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 204' ' ' GLU . 27.2 Cg_endo -61.86 82.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.46 2.107 . . . . 0.0 112.341 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -96.9 132.84 42.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -69.87 139.96 53.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.02 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.3 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.93 179.898 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.722 0.296 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -100.2 130.01 46.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.543 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.2 m -128.44 143.03 50.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.919 0.39 . . . . 0.0 111.099 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.91 96.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.412 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -119.88 140.01 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 110.556 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.6 p -87.2 146.25 26.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.029 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.4 m -60.1 -39.97 88.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.9 -39.97 87.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.712 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.86 -166.08 42.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.523 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.93 -119.24 14.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.657 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.15 -9.93 75.78 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.672 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -100.06 10.6 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.287 . . . . 0.0 111.167 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.4 168.4 54.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.658 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 181' ' ' SER . 87.3 m-85 -120.03 140.7 50.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 0.0 110.588 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.6 t -59.96 -40.04 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.645 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.422 ' ND2' ' HB3' ' A' ' 179' ' ' GLU . 97.0 m-20 -100.48 119.93 39.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.9 mmt -108.15 120.0 48.13 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.253 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.78 154.94 49.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.301 2.001 . . . . 0.0 111.809 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 118' ' ' ASP . 97.0 mt-30 -103.27 123.25 46.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.722 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 116' ' ' SER . 9.0 t -129.98 139.93 50.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.204 0.526 . . . . 0.0 111.985 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 115' ' ' SER . 69.2 t80 -121.58 139.99 52.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.558 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -104.67 130.41 52.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.84 147.62 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.84 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.0 120.11 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.727 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 47.2 m-85 -140.69 151.77 44.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.997 0.427 . . . . 0.0 111.221 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.06 131.78 35.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.476 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 19.3 p -90.17 143.4 26.81 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.286 0.565 . . . . 0.0 111.304 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.567 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 43.6 m-85 -138.37 157.22 72.86 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.203 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.91 109.11 2.78 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.585 2.19 . . . . 0.0 112.507 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.836 HG12 ' HB3' ' A' ' 95' ' ' TYR . 85.6 mt -60.15 -40.03 82.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.109 0.48 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -59.69 -23.79 63.41 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.268 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.3 ttp -68.2 -36.62 79.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.213 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.493 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 97.0 mtp -59.91 141.8 54.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.146 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.11 151.9 25.65 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.702 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.582 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -54.03 -29.96 45.83 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.282 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 ttt-85 -60.05 -39.9 87.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.531 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' O ' ' A' ' 37' ' ' ILE . 13.0 mt -113.06 10.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.143 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.64 ' NE ' ' HA ' ' A' ' 31' ' ' ALA . 41.7 ttt180 -113.59 129.99 56.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.008 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.25 129.21 54.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.36 -40.21 89.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.161 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -64.24 -40.0 95.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.014 0.435 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.89 91.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.73 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.468 HD21 ' NE ' ' A' ' 38' ' ' ARG . 92.5 m-20 -59.97 -40.18 88.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.36 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -102.92 2.22 34.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.676 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.94 175.3 32.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.148 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.53 10.49 61.11 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.392 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HD3' HD13 ' A' ' 85' ' ' LEU . 63.7 mttp -80.54 129.78 34.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.747 HG12 ' O ' ' A' ' 83' ' ' GLY . 44.7 pt -120.06 154.15 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.789 ' C ' HD22 ' A' ' 50' ' ' LEU . 96.0 m-85 -99.33 134.46 42.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.629 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.4 mm? -131.16 160.08 68.65 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.218 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.651 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 97.6 Cg_endo -83.51 149.44 12.97 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.002 1.801 . . . . 0.0 112.735 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.2 Cg_exo -61.15 -29.1 86.4 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.116 2.544 . . . . 0.0 112.861 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.94 87.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.919 0.39 . . . . 0.0 110.391 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -67.29 -40.26 86.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.094 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.5 tp -60.03 -39.99 87.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.109 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -60.03 -40.08 88.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 98.8 mttt -63.53 -40.09 96.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.031 0.443 . . . . 0.0 110.302 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 69' ' ' PHE . 87.1 mt -61.68 -39.87 92.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.612 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -59.75 -37.54 79.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.039 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.84 -35.94 75.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.448 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.413 HD11 ' HD1' ' A' ' 21' ' ' PHE . 93.1 mt -79.98 -3.88 50.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.238 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 60.0 40.13 19.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.794 0.33 . . . . 0.0 111.538 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.433 HD12 HD22 ' A' ' 58' ' ' LEU . 85.2 mt -76.23 129.94 36.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.999 0.428 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -73.3 141.93 47.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.376 0.608 . . . . 0.0 111.892 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.515 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.1 p90 -87.63 153.62 52.94 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.521 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 56.5 Cg_endo -70.78 152.18 94.68 Favored 'Cis proline' 0 C--N 1.35 0.611 0 C-N-CA 123.486 -1.464 . . . . 0.0 112.912 0.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 58' ' ' LEU . 67.5 mtt -84.69 140.49 31.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.81 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.866 HD13 HG22 ' A' ' 153' ' ' THR . 67.1 mt -111.2 137.33 49.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.081 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.665 ' CE1' HD11 ' A' ' 58' ' ' LEU . 50.6 m-85 -130.59 143.74 50.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.069 0.461 . . . . 0.0 111.54 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 4.5 ttpm? -120.03 137.44 54.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.64 131.19 43.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.314 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.5 ' OG1' HG12 ' A' ' 79' ' ' VAL . 63.9 m -119.71 130.01 54.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.28 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.73 114.26 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -60.53 -39.98 89.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -60.4 -40.04 89.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.211 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.7 p -102.67 -9.09 20.36 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.717 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 58.95 12.85 16.69 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.85 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -103.65 140.34 37.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.698 0.285 . . . . 0.0 110.564 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.5 HG12 ' OG1' ' A' ' 72' ' ' THR . 27.1 m -119.88 119.79 61.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.063 0.459 . . . . 0.0 111.727 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.472 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 76.4 p -105.99 143.4 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.51 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.696 ' HE2' HG21 ' A' ' 117' ' ' THR . 80.0 m80 -93.76 114.55 26.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.752 0.311 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.13 159.98 13.78 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.817 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.747 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -92.91 162.84 26.55 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.386 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.676 HG23 HD23 ' A' ' 50' ' ' LEU . 10.8 p -124.74 130.61 73.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.0 112.19 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.541 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.1 tp -90.14 -79.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.22 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.01 160.13 42.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 86.1 m-85 -92.78 116.46 29.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.915 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.2 pt -122.99 -6.24 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB1' ' HG2' ' A' ' 93' ' ' ARG . . . -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.854 0.359 . . . . 0.0 111.723 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.69 -39.99 76.61 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.887 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -67.22 -30.77 70.78 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.651 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.99 67.81 0.55 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.848 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.746 ' HG2' ' HB1' ' A' ' 89' ' ' ALA . 22.5 ptt-85 -135.05 154.92 51.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.076 0.465 . . . . 0.0 111.158 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.494 ' CG1' HD23 ' A' ' 112' ' ' LEU . 11.9 p -129.19 140.17 49.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.836 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.07 139.96 51.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.262 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.684 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -131.17 156.28 80.35 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.685 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 57.9 Cg_endo -68.12 160.01 50.62 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.712 2.275 . . . . 0.0 112.094 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.22 -40.25 89.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.488 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 50.5 p-90 -65.19 -40.06 93.71 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.886 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.428 ' HG3' ' HG2' ' A' ' 97' ' ' PRO . 61.0 mtt -63.44 -40.18 96.46 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.462 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.9 ttp -60.06 -40.49 89.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.892 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.75 -40.07 94.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.582 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.8 m -68.39 -39.96 81.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.697 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.97 -24.01 63.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.998 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 70.25 30.18 69.69 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.125 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.18 149.95 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.943 0.401 . . . . 0.0 111.491 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 36.1 mt-30 -95.86 159.85 31.45 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.608 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 26.6 Cg_endo -62.61 0.09 1.66 Allowed 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.424 2.083 . . . . 0.0 113.147 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.94 -20.38 9.93 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.401 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.3 p -80.8 160.13 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.856 0.36 . . . . 0.0 111.09 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.2 151.74 36.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.062 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 27' ' ' CYS . 59.5 tp -120.13 130.88 54.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.573 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.9 123.31 47.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.871 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 23' ' ' GLU . 20.5 tt -119.5 121.65 66.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 46.6 t -120.04 126.53 51.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.686 ' O ' ' HA ' ' A' ' 20' ' ' THR . 34.9 t -63.69 131.0 46.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 94.6 m -120.0 130.01 54.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.797 0.332 . . . . 0.0 111.676 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.492 ' HB2' ' HB2' ' A' ' 19' ' ' GLN . 96.1 m-20 -118.55 125.44 49.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.139 0.495 . . . . 0.0 110.438 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 186' ' ' CYS . 33.6 m -114.2 150.9 44.43 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.605 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 73.0 Cg_endo -73.89 18.55 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.834 2.356 . . . . 0.0 112.531 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.649 HD11 HG21 ' A' ' 190' ' ' THR . 6.1 tt 61.23 92.68 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.865 0.364 . . . . 0.0 111.874 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -58.89 151.41 34.01 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.615 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -100.02 -16.8 17.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -140.0 142.18 36.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.816 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.878 ' CG1' HG22 ' A' ' 194' ' ' THR . 8.4 p -137.71 136.09 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.823 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 29.2 mmtm -98.91 124.7 44.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.431 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.687 HD12 ' HB ' ' A' ' 194' ' ' THR . 83.7 mt -113.73 131.0 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.013 0.435 . . . . 0.0 111.598 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -104.49 119.33 54.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 94.9 Cg_endo -77.83 160.39 30.86 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -125.93 121.4 33.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.983 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.2 t 56.77 160.61 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.155 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 m -71.89 -21.59 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -59.98 -40.09 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.702 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -60.75 -40.22 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.046 0.451 . . . . 0.0 110.496 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 86.2 mt -90.06 -0.41 57.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.298 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -60.01 -40.04 87.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.987 0.422 . . . . 0.0 110.672 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' H ' ' A' ' 139' ' ' ASP . 84.8 mt -55.21 139.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.938 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.9 p -60.18 -40.66 90.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.514 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -120.94 76.68 29.95 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.33 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.94 -28.69 16.05 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.425 2.084 . . . . 0.0 111.927 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.71 -40.05 93.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.93 98.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.019 0.438 . . . . 0.0 110.717 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.9 t -63.18 -40.29 88.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.484 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.466 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -60.36 -41.26 93.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.03 -40.28 88.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.274 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -63.72 -39.96 95.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 110.367 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.819 HG21 HD13 ' A' ' 162' ' ' ILE . 84.5 t -61.75 -40.02 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.547 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -59.98 -40.17 88.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.761 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.7 ttt85 -62.77 -40.01 95.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.89 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.99 93.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.934 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.18 121.84 42.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 111.071 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 188' ' ' ILE . 36.1 p -70.07 -39.93 75.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.494 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.866 HG22 HD13 ' A' ' 68' ' ' LEU . 11.1 p -119.37 138.59 52.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.547 HD11 HD22 ' A' ' 148' ' ' LEU . 87.0 mt -124.0 124.87 43.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 22.8 m -121.36 139.17 53.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.56 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.91 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 31.1 m -60.19 -39.96 82.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.325 0.583 . . . . 0.0 111.336 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -68.23 -40.06 82.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.621 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.91 140.24 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.126 0.488 . . . . 0.0 112.026 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 159' ' ' VAL . 8.3 p -105.18 121.88 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.286 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.3 pt -105.96 138.03 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.819 0.342 . . . . 0.0 111.277 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.472 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.0 mt-10 -120.07 140.12 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.504 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.819 HD13 HG21 ' A' ' 147' ' ' VAL . 45.9 pt -129.72 141.6 46.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.099 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.696 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 17.8 m -107.5 120.87 43.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.998 0.428 . . . . 0.0 111.569 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.496 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 65.0 t80 -120.67 119.56 33.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.223 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.496 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 12.4 m120 54.44 40.11 31.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.657 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.56 11.75 83.73 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -114.37 139.25 49.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.756 0.278 . . . . 0.0 110.473 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.526 HG22 ' OG ' ' A' ' 163' ' ' SER . 68.1 p -108.89 127.64 54.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.331 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.02 139.98 51.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.483 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 98.2 mttt -99.99 123.37 44.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.875 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.98 119.99 61.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.833 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -120.11 126.65 51.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.769 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.91 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -80.95 111.11 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 174' ' ' LEU . 8.0 tt -59.02 -58.26 9.45 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.823 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.3 tt0 -158.89 141.47 14.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.263 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.839 HG13 ' CG1' ' A' ' 156' ' ' VAL . 18.6 m -130.05 160.02 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.94 103.94 22.56 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.0 Cg_endo -103.48 166.81 0.23 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.768 2.978 . . . . 0.0 112.125 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.9 mt-10 -99.96 3.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.4 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 159.88 41.18 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.145 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.489 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 69.6 p -70.11 -10.14 57.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.07 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -59.84 -19.94 54.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 111.114 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 56.65 39.82 29.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.029 0.442 . . . . 0.0 111.281 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 68.5 m -129.94 141.91 50.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.908 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.55 HD12 HD21 ' A' ' 192' ' ' LEU . 45.3 pt -128.51 141.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.108 0.48 . . . . 0.0 112.033 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.637 ' SG ' HD11 ' A' ' 68' ' ' LEU . 41.8 t -129.22 125.73 37.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.093 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.779 HG23 ' OG1' ' A' ' 190' ' ' THR . 11.0 p -155.05 64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.049 0.452 . . . . 0.0 111.395 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' A' ' 152' ' ' SER . 85.0 mt -68.65 -39.98 81.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.137 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.13 -10.12 9.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.107 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.779 ' OG1' HG23 ' A' ' 187' ' ' VAL . 0.1 OUTLIER -81.38 176.34 9.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.248 0.547 . . . . 0.0 111.404 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -99.56 117.2 33.42 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.316 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.766 ' HG ' HG12 ' A' ' 125' ' ' VAL . 30.9 tp -120.49 137.25 54.46 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.754 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.97 121.16 39.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.368 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.878 HG22 ' CG1' ' A' ' 125' ' ' VAL . 62.6 p -115.69 144.27 44.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.02 0.438 . . . . 0.0 111.799 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -126.5 140.07 52.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.631 179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -103.33 126.56 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.416 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.499 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -127.75 105.25 20.86 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.518 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.2 119.41 6.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.419 2.08 . . . . 0.0 112.464 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -93.16 -5.1 3.04 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.872 2.381 . . . . 0.0 112.435 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.69 139.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 122.33 19.98 3.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.84 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -99.92 130.32 46.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.2 m -122.34 140.07 47.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.295 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -91.97 128.45 45.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.624 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.98 112.11 3.03 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -86.16 132.88 33.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.848 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.0 127.83 46.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.814 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.88 -179.882 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.86 0.362 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.03 139.99 51.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.794 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -121.86 139.98 52.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.853 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.56 -139.8 11.24 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.57 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -66.5 140.23 57.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.834 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.1 t -119.75 138.5 53.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.143 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.0 p -60.09 -39.1 84.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -118.06 140.0 50.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.99 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.96 6.61 58.75 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.042 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.85 16.24 63.8 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.518 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.49 19.94 70.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.395 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -113.94 129.59 56.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 179.59 52.96 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.471 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.98 140.01 51.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.737 0.303 . . . . 0.0 111.065 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.9 m -109.6 121.25 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.054 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -107.65 119.98 40.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.077 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.2 ttp -100.56 119.86 57.59 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.826 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.5 141.7 97.78 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.252 1.968 . . . . 0.0 112.075 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -108.69 128.87 55.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.532 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.5 m -120.03 129.91 54.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.128 0.49 . . . . 0.0 110.7 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 20.1 t80 -133.65 130.26 38.0 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -118.42 134.26 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.201 0.524 . . . . 0.0 112.04 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.4 mt-10 -139.26 159.12 42.91 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.894 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -121.26 136.88 54.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.439 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 94.7 m-85 -147.13 160.08 42.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.811 0.338 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.427 ' O ' HG12 ' A' ' 94' ' ' VAL . 98.2 mtt180 -89.13 121.95 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.989 0.423 . . . . 0.0 110.408 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.843 ' HB2' HD22 ' A' ' 96' ' ' LEU . 32.0 p -95.44 141.76 28.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.886 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.591 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 53.8 m-85 -123.98 148.35 56.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.508 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD2' ' CE ' ' A' ' 32' ' ' MET . 16.4 Cg_exo -68.87 108.74 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.788 2.325 . . . . 0.0 112.305 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.621 ' CG2' ' HD2' ' A' ' 38' ' ' ARG . 91.2 mt -59.97 -38.77 77.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.206 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.02 30.69 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.445 ' CE ' ' HD2' ' A' ' 29' ' ' PRO . 70.6 mtm -67.88 -39.58 83.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.867 0.365 . . . . 0.0 110.898 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.871 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . 93.1 mtp -60.19 144.78 49.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.904 0.383 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.0 m-20 -60.05 145.56 46.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.799 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.429 ' OD1' ' NH2' ' A' ' 38' ' ' ARG . 96.0 m-20 -60.05 -39.89 87.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.103 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -59.95 -40.04 87.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.7 mt -83.72 -1.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.871 ' HD3' ' HB2' ' A' ' 33' ' ' MET . 44.4 mtm180 -119.48 155.51 31.95 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.982 0.42 . . . . 0.0 111.882 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 87.6 tttt -100.56 131.49 46.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.332 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.634 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.637 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.2 m-20 -62.58 -39.96 95.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.603 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -39.95 95.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.22 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.03 -39.99 87.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.284 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.4 -0.0 30.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.563 0.221 . . . . 0.0 111.403 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -99.78 -179.6 30.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.62 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.11 23.39 34.65 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.134 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.4 mttt -81.1 126.97 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.968 0.413 . . . . 0.0 111.752 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.89 HD12 HD13 ' A' ' 114' ' ' ILE . 49.3 pt -119.99 150.04 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.86 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 94' ' ' VAL . 91.3 m-85 -102.71 133.92 46.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.555 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 48' ' ' ILE . 3.9 mp -138.13 161.69 58.07 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.265 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 59.7 Cg_endo -71.98 149.16 52.54 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.114 1.876 . . . . 0.0 112.238 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -63.98 -23.66 67.71 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.589 2.192 . . . . 0.0 112.591 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.6 p -60.14 -39.9 87.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.71 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.07 94.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.521 ' HA ' HD12 ' A' ' 58' ' ' LEU . 58.6 tp -63.9 -40.12 95.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.835 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.0 m -60.02 -41.33 91.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.936 0.398 . . . . 0.0 111.049 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 88.1 tttt -61.95 -39.87 93.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.321 0.581 . . . . 0.0 110.382 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.762 HD13 ' HE2' ' A' ' 67' ' ' MET . 88.3 mt -59.99 -39.41 85.62 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.638 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.1 m -59.96 -39.06 84.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.316 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 ttm -59.98 -38.45 82.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.772 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.86 -3.87 43.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.643 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.06 40.03 19.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 111.467 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.707 HG21 ' HE1' ' A' ' 67' ' ' MET . 11.0 tt -77.59 137.21 22.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.712 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -70.08 140.01 52.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.014 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 30.7 p90 -95.25 157.35 36.52 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.359 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' A' ' 188' ' ' ILE . 15.6 Cg_exo -69.55 171.34 53.25 Favored 'Cis proline' 0 C--N 1.347 0.46 0 C-N-CA 123.746 -1.356 . . . . 0.0 112.77 0.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.762 ' HE2' HD13 ' A' ' 58' ' ' LEU . 81.7 mmm -85.92 139.87 30.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.092 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.731 HD22 HG22 ' A' ' 153' ' ' THR . 64.4 mt -108.34 128.42 54.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.231 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.664 ' HB3' HG23 ' A' ' 114' ' ' ILE . 13.5 m-85 -121.95 140.04 52.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.662 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 50.2 pttt -126.38 138.22 53.53 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.247 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.654 ' CD2' HD21 ' A' ' 112' ' ' LEU . 8.1 mp -99.0 120.31 39.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.42 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.737 ' CB ' HG22 ' A' ' 79' ' ' VAL . 7.6 t -109.62 122.97 48.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 111.264 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.82 114.25 28.16 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.041 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -60.38 -39.99 89.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.894 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 m -103.27 -10.66 18.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.87 12.19 41.08 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.302 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -103.47 133.06 49.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.672 0.272 . . . . 0.0 110.308 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' CB ' ' A' ' 72' ' ' THR . 39.8 t -119.96 119.71 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.204 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.4 p -103.12 160.03 15.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.192 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 80.6 m80 -100.65 114.28 27.85 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.119 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.31 169.72 19.86 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.833 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.694 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -96.06 163.64 23.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.179 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.505 HG21 ' CE2' ' A' ' 69' ' ' PHE . 12.2 p -127.88 130.02 69.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.189 0.494 . . . . 0.0 112.084 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 ' HD3' ' A' ' 47' ' ' LYS . 60.6 tp -91.33 -78.16 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.191 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 87' ' ' PHE . 86.4 tt0 -154.63 160.53 41.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.003 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 91.3 m-85 -95.03 116.48 28.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -130.9 -4.82 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.71 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -86.91 97.85 10.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.07 0.462 . . . . 0.0 111.232 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -39.95 75.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.749 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.67 -30.5 68.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.663 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.9 49.77 0.72 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.113 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.71 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 84.3 mtm180 -116.27 148.44 40.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.921 0.391 . . . . 0.0 110.881 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 114' ' ' ILE . 11.2 p -130.08 142.4 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.152 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 28' ' ' TYR . 87.0 m-85 -119.93 139.96 51.62 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.843 HD22 ' HB2' ' A' ' 27' ' ' CYS . 2.3 pt? -122.81 148.7 54.42 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-O 120.703 0.287 . . . . 0.0 111.388 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.66 149.22 69.19 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.69 2.26 . . . . 0.0 112.084 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -60.03 -41.08 91.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.479 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -70.0 -40.02 75.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.406 ' SD ' HD22 ' A' ' 71' ' ' LEU . 57.6 ttm -61.41 -40.07 93.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.667 ' HE2' HD21 ' A' ' 96' ' ' LEU . 58.4 ttm -60.37 -40.75 91.91 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.218 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.77 -39.99 94.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.977 0.417 . . . . 0.0 110.496 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.1 m -63.2 -40.05 96.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.536 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.46 -24.02 63.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.093 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.25 31.84 53.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.684 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -111.98 140.0 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.419 . . . . 0.0 111.407 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 30.0 pt20 -96.93 160.24 29.61 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.671 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 96.1 Cg_exo -43.44 136.09 6.22 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.655 2.236 . . . . 0.0 112.417 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.04 -8.76 79.23 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.466 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.6 t -70.02 153.15 43.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.39 141.22 28.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.654 HD21 ' CD2' ' A' ' 71' ' ' LEU . 59.4 tp -125.53 129.91 50.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.61 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 95.8 mt-30 -111.32 130.93 55.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.409 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 94' ' ' VAL . 86.1 mt -109.97 129.74 64.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.896 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.662 ' HB2' ' HG2' ' A' ' 70' ' ' LYS . 20.2 m -121.96 132.54 54.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 29.4 t -88.67 116.16 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.237 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 81.8 p -125.77 139.84 53.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.507 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -111.11 114.74 28.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.6 m -119.09 148.52 45.06 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.29 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 34.7 Cg_exo -62.04 175.26 1.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.342 2.028 . . . . 0.0 112.301 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD11 HG23 ' A' ' 187' ' ' VAL . 0.3 OUTLIER -94.97 120.88 35.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.718 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 178' ' ' PRO . . . -69.87 133.63 25.03 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.85 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.402 ' HG2' ' CD2' ' A' ' 124' ' ' PHE . 58.4 tt0 -60.39 -44.01 96.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.633 0.254 . . . . 0.0 111.521 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.5 ' CE1' HG11 ' A' ' 193' ' ' VAL . 12.2 m-85 -138.67 145.31 40.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.126 0.489 . . . . 0.0 112.223 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.891 ' CG1' HG22 ' A' ' 194' ' ' THR . 6.5 p -131.81 130.38 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.928 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.915 ' HD2' ' HB2' ' A' ' 175' ' ' GLU . 30.4 mttm -97.61 126.42 42.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.306 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 144' ' ' LEU . 85.1 mt -111.48 134.98 52.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.38 109.97 48.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 199' ' ' PRO . 6.5 Cg_exo -72.19 159.96 48.46 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.471 2.114 . . . . 0.0 112.417 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.3 tt0 -129.36 121.37 27.28 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.715 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.0 m 69.55 130.68 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.485 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.0 m -60.03 -25.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.435 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -39.97 87.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.07 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -59.99 -39.91 87.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.7 mt -83.27 -10.64 58.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.354 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -71.02 -12.32 61.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.72 0.295 . . . . 0.0 111.384 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -60.01 138.79 20.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.579 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 t -60.81 -40.08 91.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.457 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 21.8 m-20 -129.89 74.55 80.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.664 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 60.2 Cg_endo -73.4 -26.62 14.14 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.482 2.121 . . . . 0.0 111.92 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.03 -40.07 88.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.68 88.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.815 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 147' ' ' VAL . 99.1 t -65.85 -40.34 87.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.401 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.637 HD21 HD13 ' A' ' 127' ' ' LEU . 2.9 tm? -60.93 -43.04 99.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.521 ' HG3' ' OG1' ' A' ' 190' ' ' THR . 86.3 tt0 -59.94 -40.65 89.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.14 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -61.12 -40.06 92.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.632 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.627 ' CG2' HD13 ' A' ' 162' ' ' ILE . 95.4 t -60.04 -41.16 85.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.367 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 154' ' ' LEU . 88.7 mt -60.08 -40.15 88.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -62.27 -39.97 94.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.844 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.12 -40.02 88.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.768 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.05 117.25 33.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 0.0 111.205 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.649 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 67.4 m -63.11 -40.06 96.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.105 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.731 HG22 HD22 ' A' ' 68' ' ' LEU . 81.1 p -123.38 140.54 52.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.864 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 148' ' ' LEU . 88.9 mt -119.85 127.21 52.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.207 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.505 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 94.6 m -118.7 137.41 53.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.779 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.75 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.4 t -60.06 -41.11 85.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.382 0.611 . . . . 0.0 111.188 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 155' ' ' THR . 95.7 m-20 -70.83 -38.99 73.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.485 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.505 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 52.5 t0 -66.19 134.25 52.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.626 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 1.078 HG12 ' HG2' ' A' ' 172' ' ' LYS . 15.4 m -98.96 119.98 47.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.129 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 171' ' ' ILE . 48.3 pt -102.36 134.84 41.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.983 0.42 . . . . 0.0 111.351 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 98.1 mt-10 -120.09 139.97 51.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.149 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.627 HD13 ' CG2' ' A' ' 147' ' ' VAL . 45.2 pt -126.22 141.96 44.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.713 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.683 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 47.9 t -103.95 118.32 36.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.7 t80 -121.98 119.13 30.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.158 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 53.02 40.05 30.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.251 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.0 75.82 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.198 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.683 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.4 mttt -119.93 137.93 53.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.885 0.343 . . . . 0.0 110.694 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.8 p -107.99 130.86 55.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.407 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 87.4 m-85 -119.97 140.05 51.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.741 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 58.7 mttp -100.79 128.0 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.79 0.329 . . . . 0.0 110.846 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.617 ' HB ' HG13 ' A' ' 160' ' ' ILE . 48.7 mm -119.97 120.36 62.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.01 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 1.078 ' HG2' HG12 ' A' ' 159' ' ' VAL . 99.0 mttt -114.58 131.15 56.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.75 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.6 OUTLIER -73.8 96.29 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.787 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.7 tt -59.82 -52.08 66.98 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.915 ' HB2' ' HD2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -160.87 142.52 12.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 185' ' ' ILE . 11.5 m -142.1 161.36 20.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -118.5 102.78 49.78 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.501 ' HA ' ' HA2' ' A' ' 122' ' ' GLY . 77.6 Cg_endo -100.77 175.9 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.683 2.922 . . . . 0.0 112.638 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.7 mt-10 -97.42 -0.04 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.798 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.2 m -133.65 156.05 48.59 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.114 0.483 . . . . 0.0 111.458 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 55.5 m -70.7 -10.61 59.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.3 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.3 m -59.86 -23.87 63.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.799 0.333 . . . . 0.0 111.291 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 60.41 40.03 17.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.0 0.428 . . . . 0.0 110.904 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 66.2 m -127.74 142.77 51.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.96 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 176' ' ' VAL . 13.9 mt -119.91 127.33 75.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 0.0 110.878 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' A' ' 68' ' ' LEU . 82.4 m -143.31 151.71 40.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.527 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.783 HG22 ' H ' ' A' ' 189' ' ' GLU . 7.3 p -178.16 -55.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.616 HG12 ' HA ' ' A' ' 152' ' ' SER . 54.7 mt 68.66 -1.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.971 0.415 . . . . 0.0 111.363 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.783 ' H ' HG22 ' A' ' 187' ' ' VAL . 99.9 mt-10 -99.71 9.83 42.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.986 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.521 ' OG1' ' HG3' ' A' ' 145' ' ' GLU . 7.1 t 48.27 41.38 16.0 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -108.76 20.03 18.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.635 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.595 ' CD1' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -106.73 139.73 40.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.465 -179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 124' ' ' PHE . 23.4 t -90.09 121.2 40.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.766 0.317 . . . . 0.0 110.98 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.891 HG22 ' CG1' ' A' ' 125' ' ' VAL . 16.4 p -113.19 140.58 47.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.068 0.461 . . . . 0.0 111.73 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -120.6 145.21 47.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.401 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -100.26 134.55 43.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 111.603 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 129' ' ' PRO . . . -117.32 161.29 33.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.461 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.75 129.95 25.31 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.38 2.053 . . . . 0.0 112.433 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 98.9 Cg_endo -80.04 168.37 18.97 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.784 2.323 . . . . 0.0 112.838 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 39.3 t -81.84 134.69 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.594 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -135.13 -137.27 3.71 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.633 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -70.01 139.97 52.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 110.667 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 60.9 t -117.09 130.02 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 205' ' ' PRO . 1.3 mp0 -91.96 125.86 55.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.042 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 204' ' ' GLU . 35.7 Cg_exo -57.28 157.25 22.28 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.43 2.087 . . . . 0.0 112.284 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -80.13 137.59 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -100.13 125.52 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.999 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.708 179.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.737 0.304 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.08 -39.93 87.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.4 t -69.95 134.27 48.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.687 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.79 24.15 0.41 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.135 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -107.51 138.39 43.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.857 0.36 . . . . 0.0 110.635 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.3 p -72.15 157.95 36.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -120.02 134.89 55.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.604 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -99.9 129.52 45.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.34 117.59 2.68 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.298 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.93 175.87 48.8 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.456 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.92 3.63 89.37 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.801 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -126.24 140.06 52.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.0 -2.22 81.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.78 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -100.06 120.61 40.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.617 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 m -109.18 131.21 60.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -100.05 119.95 39.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.709 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.5 mtt -99.97 120.02 58.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.84 128.57 15.22 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.375 2.05 . . . . 0.0 111.846 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.604 ' O ' ' HA ' ' A' ' 117' ' ' THR . 62.6 tt0 -117.74 137.77 52.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.632 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.0 m -119.97 130.98 55.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.045 0.45 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 56.1 t80 -133.64 132.79 41.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.391 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -107.49 135.82 48.32 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 114' ' ' ILE . 99.6 mt-10 -140.74 150.87 43.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.722 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -114.4 123.14 48.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.812 0.339 . . . . 0.0 110.931 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.768 ' CD2' HD12 ' A' ' 114' ' ' ILE . 83.5 m-85 -130.89 147.22 52.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.966 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.614 ' O ' HG12 ' A' ' 94' ' ' VAL . 94.8 mtt-85 -81.75 149.46 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.287 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.715 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 21.9 m -84.95 133.36 34.28 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.582 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 86.7 m-85 -133.69 149.96 73.44 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.552 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -87.73 100.56 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.049 2.499 . . . . 0.0 113.514 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.858 HG22 ' OD1' ' A' ' 43' ' ' ASN . 87.6 mt -62.67 -41.37 91.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.038 0.447 . . . . 0.0 110.349 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.23 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.412 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 98.1 mtp -68.1 -29.2 68.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.861 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.4 ttt -60.07 152.64 23.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -58.83 139.28 56.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 111.342 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' ARG . 96.0 m-20 -63.93 -40.15 95.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.444 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -60.21 -40.71 91.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.324 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 85.5 mt -64.38 -48.66 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 35' ' ' ASP . 97.3 mtt180 -125.0 143.36 50.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.072 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.41 148.78 47.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -60.12 -26.7 66.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.209 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.99 -39.7 86.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.355 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.38 82.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.858 ' OD1' HG22 ' A' ' 30' ' ' ILE . 97.8 m-20 -59.99 -39.73 86.76 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.733 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -102.88 8.27 39.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.581 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.97 172.28 29.4 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.73 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA3' ' CE1' ' A' ' 151' ' ' PHE . . . -100.65 22.82 38.14 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.66 ' HD2' HD12 ' A' ' 85' ' ' LEU . 72.1 tttt -98.33 124.44 42.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 0.0 111.15 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.592 ' CD1' HD11 ' A' ' 50' ' ' LEU . 44.2 pt -113.44 149.69 15.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.3 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 94' ' ' VAL . 95.7 m-85 -101.58 134.44 44.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.847 0.356 . . . . 0.0 110.732 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.739 HD22 ' CE2' ' A' ' 69' ' ' PHE . 5.3 mp -134.08 161.78 61.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.246 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 73.9 Cg_endo -75.13 158.73 41.55 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.65 2.234 . . . . 0.0 113.188 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.856 ' HA ' HD23 ' A' ' 55' ' ' LEU . 73.8 Cg_endo -74.87 -13.39 21.73 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.054 2.503 . . . . 0.0 113.125 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 m -59.99 -40.0 87.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.854 0.359 . . . . 0.0 111.525 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -60.04 -37.29 79.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.524 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 52' ' ' PRO . 3.2 mm? -59.97 -40.02 87.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.78 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -59.98 -39.95 87.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.958 0.408 . . . . 0.0 110.092 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 98.6 mttt -69.12 -40.04 78.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.321 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.729 HD12 HD13 ' A' ' 55' ' ' LEU . 92.3 mt -59.9 -40.0 87.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.134 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.8 m -60.17 -40.03 88.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.193 0.521 . . . . 0.0 110.617 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.3 mtp -59.93 -40.03 87.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.792 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.596 HD13 HE21 ' A' ' 19' ' ' GLN . 80.9 mt -82.32 -1.95 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.784 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.1 t30 59.87 40.1 19.64 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD11 ' NE2' ' A' ' 19' ' ' GLN . 58.6 mt -82.64 131.29 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.857 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.5 mtm105 -81.84 149.96 28.06 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.511 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 49.8 p90 -87.35 157.97 52.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.664 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 74.4 Cg_endo -75.13 161.55 94.54 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.608 -1.414 . . . . 0.0 112.771 0.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.503 ' HE1' HD22 ' A' ' 58' ' ' LEU . 66.4 mmm -87.27 139.04 30.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.507 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.676 ' HB2' ' O ' ' A' ' 117' ' ' THR . 75.5 mt -108.85 134.35 51.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.147 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.848 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.7 m-85 -120.05 140.65 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.128 0.489 . . . . 0.0 112.301 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -114.92 128.17 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.783 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.72 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 91.0 mt -99.01 127.54 44.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.9 ' HA ' HG12 ' A' ' 79' ' ' VAL . 88.5 m -120.02 130.08 54.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.117 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.62 117.98 32.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.91 -39.87 75.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -39.95 87.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.044 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.429 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 28.0 m -105.09 -15.38 15.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.934 -0.307 . . . . 0.0 111.793 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.1 5.11 57.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.223 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.69 140.05 34.45 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.125 0.488 . . . . 0.0 110.279 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.9 HG12 ' HA ' ' A' ' 72' ' ' THR . 24.6 m -120.05 117.53 53.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.873 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.614 ' OG1' HD21 ' A' ' 104' ' ' LEU . 82.2 p -102.75 144.63 30.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.566 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.689 ' CD2' HG23 ' A' ' 155' ' ' THR . 0.1 OUTLIER -85.97 114.4 22.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.32 144.93 17.35 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.082 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.491 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -107.29 130.52 10.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.977 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.798 HG11 ' CE2' ' A' ' 69' ' ' PHE . 8.6 p -119.88 130.79 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.773 0.32 . . . . 0.0 111.479 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.66 HD12 ' HD2' ' A' ' 47' ' ' LYS . 88.8 mt -110.24 -33.41 6.66 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.133 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.13 154.42 40.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 112.325 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.577 ' CG ' HD21 ' A' ' 55' ' ' LEU . 81.8 m-85 -107.89 118.91 37.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.625 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD11 ' NH2' ' A' ' 38' ' ' ARG . 46.8 pt -125.41 -5.01 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.669 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -89.17 98.71 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.835 0.35 . . . . 0.0 111.414 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.21 -40.03 78.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.941 0.4 . . . . 0.0 111.187 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.77 -29.88 67.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.278 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.91 49.99 0.66 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.928 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.669 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 89.1 mtm180 -119.44 149.8 41.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 111.523 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 114' ' ' ILE . 9.9 p -124.97 142.24 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-O 121.393 0.616 . . . . 0.0 111.24 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.799 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.4 m-85 -120.04 139.92 51.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.185 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.733 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -133.74 152.8 79.48 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.897 0.38 . . . . 0.0 111.551 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 32.5 Cg_exo -61.0 154.78 54.38 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.557 2.172 . . . . 0.0 111.77 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -61.69 -40.16 94.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.343 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.423 ' NE1' ' CB ' ' A' ' 97' ' ' PRO . 67.2 p-90 -64.02 -40.11 95.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.914 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 58.3 ttm -60.46 -43.25 97.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.973 0.416 . . . . 0.0 110.787 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' A' ' 106' ' ' ILE . 57.4 ttm -60.76 -40.49 92.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.214 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.5 -39.99 94.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.4 m -63.72 -40.41 96.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.614 HD21 ' OG1' ' A' ' 80' ' ' THR . 85.4 mt -71.13 -24.01 62.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.963 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.429 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.45 30.58 56.43 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.302 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 101' ' ' MET . 45.6 pt -120.01 157.83 22.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -96.51 160.38 29.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.68 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -57.75 -3.41 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.599 2.199 . . . . 0.0 113.187 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.76 -15.99 13.79 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.215 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 54.8 m -74.23 150.84 40.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.714 0.293 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.6 mt -75.49 153.06 37.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.903 0.383 . . . . 0.0 110.978 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.715 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 58.0 tp -119.96 132.7 55.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.282 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.72 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -99.96 120.02 39.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.848 HG23 ' HB3' ' A' ' 69' ' ' PHE . 86.9 mt -116.37 122.7 70.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.762 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.9 m -120.01 128.46 53.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.78 0.324 . . . . 0.0 110.839 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -84.87 106.81 16.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.307 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.3 t -134.23 145.8 49.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.115 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.55 ' HA ' HD12 ' A' ' 68' ' ' LEU . 96.2 m-20 -107.75 120.28 41.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.467 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG22 ' SG ' ' A' ' 186' ' ' CYS . 31.9 m -112.65 150.43 42.69 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.16 0.505 . . . . 0.0 111.753 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.685 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 45.0 Cg_endo -68.38 160.11 50.49 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.641 2.227 . . . . 0.0 111.44 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -75.0 120.2 20.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.45 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 192' ' ' LEU . . . -64.24 151.21 50.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.138 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.463 ' O ' ' HB ' ' A' ' 193' ' ' VAL . 94.7 mm-40 -101.73 -18.0 16.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.13 134.81 18.72 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.823 ' CG1' HG22 ' A' ' 194' ' ' THR . 3.6 p -137.43 130.33 43.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.133 0.492 . . . . 0.0 111.335 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.743 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 67.4 mttm -92.9 121.41 34.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.714 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.635 HD22 HD12 ' A' ' 171' ' ' ILE . 82.6 mt -117.67 130.92 56.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.051 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.29 110.01 51.1 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.843 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HG3' HD11 ' A' ' 135' ' ' LEU . 97.2 Cg_endo -83.07 -176.71 2.97 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.654 2.236 . . . . 0.0 112.256 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 131' ' ' SER . 92.7 mt-30 -130.46 124.62 32.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.384 0.612 . . . . 0.0 110.378 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 1.2 m 71.05 166.97 0.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.956 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.7 -14.98 13.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.95 -40.07 87.73 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.865 0.364 . . . . 0.0 111.066 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.503 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.4 t80 -59.93 -40.12 87.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.756 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.503 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.8 mp -81.78 -9.55 59.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.543 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.9 -19.58 63.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.487 0.184 . . . . 0.0 111.435 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -61.99 132.11 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.666 0.269 . . . . 0.0 110.483 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.3 p -59.87 -40.13 87.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.359 . . . . 0.0 111.415 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -124.51 77.97 62.62 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.407 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.702 ' O ' HD23 ' A' ' 144' ' ' LEU . 52.2 Cg_endo -69.47 -33.91 16.67 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.52 2.147 . . . . 0.0 112.266 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.09 -40.34 89.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.271 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.93 95.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.923 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 147' ' ' VAL . 97.5 t -61.94 -44.88 99.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.062 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -59.98 -40.1 87.97 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.401 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.99 -42.32 93.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.926 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -63.29 -39.94 95.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.065 0.459 . . . . 0.0 110.295 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.763 HG21 HD13 ' A' ' 162' ' ' ILE . 83.3 t -62.47 -41.96 93.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.945 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 95.3 mt -60.02 -40.03 87.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.565 ' HA ' HG23 ' A' ' 188' ' ' ILE . 69.9 ttp85 -63.02 -39.96 96.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.795 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -61.62 -39.96 93.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.847 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.47 ' CE1' ' HA3' ' A' ' 46' ' ' GLY . 97.4 m-85 -99.35 120.29 39.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.071 0.462 . . . . 0.0 111.235 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.534 ' HA ' HD11 ' A' ' 188' ' ' ILE . 15.9 t -69.97 -39.97 75.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.511 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.53 ' CB ' ' HB3' ' A' ' 81' ' ' HIS . 71.6 p -121.63 140.02 52.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.314 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 151' ' ' PHE . 95.1 mt -135.25 141.22 45.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.048 0.451 . . . . 0.0 111.813 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.689 HG23 ' CD2' ' A' ' 81' ' ' HIS . 37.3 p -138.88 154.32 48.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.697 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.679 ' CG2' HG22 ' A' ' 176' ' ' VAL . 94.2 t -60.06 -39.95 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.324 0.583 . . . . 0.0 110.947 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.1 -38.89 75.76 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.3 t0 -69.37 129.97 41.26 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.1 p -102.41 120.01 51.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.549 178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.1 pt -105.12 140.01 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.942 0.401 . . . . 0.0 112.055 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.696 ' HG2' ' CB ' ' A' ' 170' ' ' LYS . 99.8 mt-10 -120.0 141.23 49.89 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.763 HD13 HG21 ' A' ' 147' ' ' VAL . 46.0 pt -129.87 140.13 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.383 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 46.7 t -112.17 120.03 40.42 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -123.79 129.56 51.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.999 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 44.6 t30 53.75 39.95 30.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.565 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.2 9.71 86.76 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.135 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.681 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.3 mttm -108.85 137.15 47.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.724 0.262 . . . . 0.0 110.383 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -105.56 120.54 41.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 111.021 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.02 140.06 51.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.696 ' CB ' ' HG2' ' A' ' 161' ' ' GLU . 53.0 pttt -124.19 130.57 52.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.984 0.421 . . . . 0.0 111.38 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.635 HD12 HD22 ' A' ' 127' ' ' LEU . 45.6 pt -132.06 140.81 47.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.721 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.0 pttm -119.73 137.4 53.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.972 0.415 . . . . 0.0 110.61 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.574 HG13 HD23 ' A' ' 127' ' ' LEU . 5.2 mp -81.47 112.85 19.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.105 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.09 -57.26 7.14 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.743 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 86.4 tt0 -155.93 144.1 19.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.356 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.679 HG22 ' CG2' ' A' ' 156' ' ' VAL . 8.3 m -138.3 151.2 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.369 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -98.73 104.76 26.55 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.497 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 94.5 Cg_endo -100.23 177.16 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.437 2.758 . . . . 0.0 112.676 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.685 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 68.6 mm-40 -99.96 5.01 45.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 85.2 p -139.83 159.67 41.65 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.913 0.387 . . . . 0.0 111.081 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 87.4 p -70.04 -18.54 63.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.892 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 78.9 p -59.98 -20.63 58.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 111.446 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 60.03 39.82 19.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 111.07 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 m -130.02 139.93 50.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.007 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.6 pt -132.78 140.27 47.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.833 0.349 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' LEU . 75.3 m -129.48 100.31 5.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 0.0 110.856 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.802 HG11 HD22 ' A' ' 192' ' ' LEU . 5.7 p -126.87 114.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.631 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 149' ' ' ARG . 82.0 mt -105.62 -26.99 3.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.621 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.4 tt0 -89.97 -79.79 0.33 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.382 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 13.5 t -169.84 -158.7 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 0.0 111.102 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.9 m-20 75.74 25.09 1.2 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.892 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.802 HD22 HG11 ' A' ' 187' ' ' VAL . 28.4 tp -119.51 131.46 55.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.751 ' O ' HG12 ' A' ' 125' ' ' VAL . 20.8 t -92.84 129.0 44.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.76 0.314 . . . . 0.0 110.627 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.823 HG22 ' CG1' ' A' ' 125' ' ' VAL . 75.3 p -118.53 142.08 47.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 111.619 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -119.78 142.54 48.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.81 139.98 41.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 111.416 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -118.2 165.08 17.28 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.771 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 19.9 Cg_endo -59.56 144.86 99.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.08 155.53 38.02 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.575 2.183 . . . . 0.0 112.57 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 26.7 m -80.04 140.0 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 135.32 140.35 4.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.388 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.4 132.85 45.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.803 0.335 . . . . 0.0 110.808 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.06 130.05 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -95.2 130.47 32.36 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.7 95.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.246 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -99.87 121.15 40.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -100.05 122.19 42.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.849 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.777 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.913 0.387 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.47 ' HB3' ' HD2' ' A' ' 5' ' ' PHE . 87.3 m-85 -119.99 140.03 51.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.027 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -129.99 145.54 51.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.09 77.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.076 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.47 ' HD2' ' HB3' ' A' ' 2' ' ' PHE . 52.8 m-85 -109.97 134.01 52.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.88 0.371 . . . . 0.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.7 m -128.24 140.03 52.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -128.81 140.93 51.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -139.96 153.64 46.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.29 117.44 0.76 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.675 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.88 14.53 80.72 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.009 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.08 -79.06 0.88 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.712 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.8 m120 59.69 30.08 19.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.89 0.376 . . . . 0.0 110.887 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.04 75.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.906 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -125.92 127.34 45.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.33 119.99 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.766 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.76 -15.61 18.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.3 mtm -101.09 143.5 26.73 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.822 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 88.0 Cg_exo -48.15 160.79 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.431 2.088 . . . . 0.0 112.071 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.405 ' H ' ' HB2' ' A' ' 118' ' ' ASP . 78.2 mt-30 -100.08 120.01 39.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.716 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 116' ' ' SER . 25.2 m -124.28 131.76 53.54 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.034 0.445 . . . . 0.0 111.689 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CB ' ' HB3' ' A' ' 116' ' ' SER . 22.3 t80 -120.24 139.88 52.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.613 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.93 133.07 55.28 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 57' ' ' LYS . 72.1 mt-10 -152.71 160.02 43.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -116.67 132.64 56.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.717 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 49.7 m-85 -139.67 159.99 40.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -94.56 126.32 39.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.471 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 29.8 p -91.06 141.79 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.346 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.4 m-85 -130.42 153.16 81.28 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.675 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.65 104.53 1.89 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.695 2.264 . . . . 0.0 112.628 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.756 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 90.7 mt -60.0 -39.82 81.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.385 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.768 ' HA ' HH11 ' A' ' 38' ' ' ARG . . . -59.33 -29.29 67.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.583 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 61.8 ttp -67.09 -37.72 84.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.281 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.98 140.04 57.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.18 151.75 26.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.587 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -59.97 -36.66 77.6 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.209 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.5 mtp85 -60.0 -34.06 72.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.667 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 37' ' ' ILE . 25.2 mt -110.24 9.11 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 110.377 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.768 HH11 ' HA ' ' A' ' 31' ' ' ALA . 28.5 ttp180 -119.95 137.15 54.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.957 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.633 ' HE2' ' HB3' ' A' ' 41' ' ' ASP . 86.0 tttt -100.47 127.11 46.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.03 -40.08 88.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.633 ' HB3' ' HE2' ' A' ' 39' ' ' LYS . 52.4 t0 -59.98 -41.45 92.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.849 0.357 . . . . 0.0 110.579 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.06 91.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.11 -40.06 88.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.069 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -107.78 18.7 21.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.19 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.58 163.33 23.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.209 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.91 11.39 64.25 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.859 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 98.8 mttt -115.7 140.05 49.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 0.0 110.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 83' ' ' GLY . 45.5 pt -110.33 152.58 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.473 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.826 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 87.4 m-85 -93.12 132.07 37.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.733 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -142.42 160.21 55.15 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.292 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.759 ' O ' HD12 ' A' ' 55' ' ' LEU . 45.9 Cg_endo -65.63 144.58 79.08 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.081 2.521 . . . . 0.0 113.525 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 89' ' ' ALA . 25.8 Cg_endo -62.63 -20.33 70.55 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.059 2.506 . . . . 0.0 113.315 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.4 p -60.0 -43.58 95.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.648 0.261 . . . . 0.0 111.322 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -70.64 -41.46 72.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.395 0.617 . . . . 0.0 111.313 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.95 HD21 HG21 ' A' ' 84' ' ' VAL . 1.1 mp -60.07 -39.9 87.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.537 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 t -59.71 -39.38 84.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.57 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' HD2' ' OE2' ' A' ' 23' ' ' GLU . 59.5 mttp -59.98 -39.29 85.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.014 0.435 . . . . 0.0 110.387 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.667 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 91.9 mt -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.177 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -59.98 -39.97 87.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.94 -37.39 82.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.454 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.7 mt -79.68 0.61 29.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.651 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.07 43.8 13.93 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.866 0.365 . . . . 0.0 111.54 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.501 HG13 HD22 ' A' ' 58' ' ' LEU . 43.5 mm -72.24 130.24 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.618 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -69.76 140.41 53.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.477 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.541 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 25.1 t80 -87.43 141.75 32.65 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.551 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.659 ' HD3' HD12 ' A' ' 188' ' ' ILE . 3.7 Cg_exo -74.84 160.36 96.6 Favored 'Cis proline' 0 C--N 1.348 0.552 0 C-N-CA 124.217 -1.16 . . . . 0.0 112.822 0.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.714 ' CE ' HD23 ' A' ' 55' ' ' LEU . 75.4 mtm -75.18 140.12 43.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.924 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.844 HD22 HG23 ' A' ' 153' ' ' THR . 79.1 mt -112.12 136.76 51.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.081 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.667 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 33.6 m-85 -131.86 147.08 52.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.171 0.51 . . . . 0.0 112.008 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 40.0 ttpt -122.68 129.29 51.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.332 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 112' ' ' LEU . 86.6 mt -100.38 125.6 46.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 111.049 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 79' ' ' VAL . 97.5 m -119.96 130.02 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.965 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 77' ' ' GLY . . . -107.83 118.09 35.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.7 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -69.97 -39.98 75.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.361 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.12 -39.9 87.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.32 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.413 HG21 ' HA3' ' A' ' 105' ' ' GLY . 73.8 p -108.51 -11.63 15.11 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 68.16 14.32 65.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.68 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -100.0 139.95 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.765 0.317 . . . . 0.0 110.562 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 71' ' ' LEU . 52.7 t -121.32 127.23 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.016 0.436 . . . . 0.0 111.215 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.599 HG21 ' HE3' ' A' ' 100' ' ' MET . 8.4 t -118.39 129.68 55.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.95 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.742 ' HB3' ' OG1' ' A' ' 153' ' ' THR . 17.8 m-70 -83.76 139.61 32.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.363 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.73 -139.53 3.66 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.138 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -166.79 -164.0 21.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.38 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.95 HG21 HD21 ' A' ' 55' ' ' LEU . 6.5 p -124.85 129.96 73.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.145 0.498 . . . . 0.0 111.521 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.826 HD23 ' CZ ' ' A' ' 49' ' ' PHE . 34.4 tp -92.62 -77.39 0.44 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -140.19 168.19 20.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.76 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.751 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 2.5 m-85 -90.94 116.33 28.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 49' ' ' PHE . 31.6 pt -141.83 -5.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.808 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -97.94 97.1 8.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.972 0.415 . . . . 0.0 111.676 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.95 -40.12 72.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.504 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -85.8 -23.34 27.25 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.561 ' HA2' ' HG3' ' A' ' 51' ' ' PRO . . . 114.76 46.5 0.6 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.558 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.808 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 21.6 mtm180 -111.0 149.47 30.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.083 0.468 . . . . 0.0 111.069 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.864 HG21 HD11 ' A' ' 114' ' ' ILE . 10.8 p -129.92 140.27 49.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.756 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 86.5 m-85 -119.94 139.95 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.997 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.6 pt? -122.65 149.87 56.85 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.627 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.603 ' HD2' ' HG3' ' A' ' 100' ' ' MET . 47.7 Cg_exo -53.64 158.84 7.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.87 2.38 . . . . 0.0 112.618 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.75 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mt-30 -60.07 -43.85 95.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.605 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.476 ' HZ3' ' O ' ' A' ' 159' ' ' VAL . 33.0 p-90 -68.88 -35.71 77.21 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.615 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.603 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.5 mmm -60.05 -40.1 88.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.794 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.3 -40.09 92.88 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.061 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.64 -40.08 88.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.964 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -64.91 -40.03 94.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.756 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.585 HD21 HG22 ' A' ' 80' ' ' THR . 86.9 mt -69.92 -25.08 63.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.2 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.413 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 67.8 30.06 74.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.402 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 110' ' ' SER . 45.8 pt -113.4 139.42 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.083 0.468 . . . . 0.0 111.893 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 8.2 pt20 -97.01 165.76 15.18 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 98.1 Cg_exo -43.92 140.51 4.93 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.658 2.239 . . . . 0.0 112.607 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.0 -9.99 75.47 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 58.0 m -70.06 153.08 43.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.968 0.413 . . . . 0.0 111.095 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.502 ' CD2' ' HG3' ' A' ' 113' ' ' GLN . 9.9 tt -93.5 136.74 33.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.116 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 71' ' ' LEU . 60.1 tp -121.55 130.09 53.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.043 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.502 ' HG3' ' CD2' ' A' ' 111' ' ' LEU . 96.6 mt-30 -111.77 133.28 54.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.667 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HG21 ' A' ' 94' ' ' VAL . 85.4 mt -110.07 125.53 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.696 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.7 t -120.77 129.54 53.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.188 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.663 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.9 t -70.22 122.98 20.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 95.5 m -121.96 128.93 52.06 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 96.5 m-20 -123.94 120.02 31.3 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.407 ' CG2' ' HB3' ' A' ' 186' ' ' CYS . 34.6 m -117.55 154.36 50.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.796 0.331 . . . . 0.0 111.618 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 93.6 Cg_endo -78.18 19.36 0.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.679 2.253 . . . . 0.0 112.555 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.808 HD23 ' HB2' ' A' ' 191' ' ' ASP . 10.0 mp 67.96 100.39 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.761 0.315 . . . . 0.0 111.232 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.16 164.07 0.17 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.3 -22.17 12.45 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.412 ' HE1' ' HE2' ' A' ' 126' ' ' LYS . 64.3 t80 -142.71 131.18 22.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.497 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 194' ' ' THR . 3.3 p -135.95 132.4 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.258 0.551 . . . . 0.0 111.511 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 34.6 mttm -95.42 122.15 37.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.27 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 173' ' ' ILE . 86.0 mt -118.05 132.86 56.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 174' ' ' LEU . 4.2 tt0 -116.58 113.51 40.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.818 ' HG3' HD11 ' A' ' 135' ' ' LEU . 83.7 Cg_endo -78.39 174.44 12.38 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.722 2.281 . . . . 0.0 112.439 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.61 HE22 ' HE2' ' A' ' 170' ' ' LYS . 98.4 mt-30 -125.7 123.93 39.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.283 0.563 . . . . 0.0 110.281 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.4 OUTLIER 70.17 133.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.421 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.743 HG12 ' HG3' ' A' ' 199' ' ' PRO . 27.8 m -60.04 -24.82 31.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.186 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.01 -39.92 87.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -60.67 -39.98 90.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.775 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.818 HD11 ' HG3' ' A' ' 129' ' ' PRO . 95.6 mt -82.19 -10.19 59.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -70.05 -10.14 57.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.627 0.251 . . . . 0.0 111.317 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.98 140.71 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.0 110.302 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.4 m -59.92 -40.15 87.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.287 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.496 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.2 m-20 -124.66 75.84 64.11 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.749 0.309 . . . . 0.0 110.775 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 144' ' ' LEU . 36.0 Cg_exo -60.05 -33.76 95.13 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.632 2.221 . . . . 0.0 111.858 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -59.92 -40.12 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.96 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.111 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 147' ' ' VAL . 85.8 t -61.4 -43.57 96.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.87 -40.08 91.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.2 -40.35 89.75 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.176 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -66.59 -40.07 88.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.131 0.491 . . . . 0.0 109.866 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 162' ' ' ILE . 56.3 t -62.56 -40.1 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.07 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.93 -40.85 90.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.205 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -63.34 -40.07 96.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.976 0.417 . . . . 0.0 110.811 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.02 -40.0 94.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.451 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 89.2 m-85 -105.72 120.75 42.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.04 0.448 . . . . 0.0 111.781 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.3 m -60.16 -40.01 88.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.151 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.844 HG23 HD22 ' A' ' 68' ' ' LEU . 67.0 p -135.74 151.91 50.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.324 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.6 mp -117.43 130.45 56.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.526 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.519 ' O ' HD13 ' A' ' 173' ' ' ILE . 17.3 m -119.6 142.3 48.52 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.614 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.958 HG22 HG13 ' A' ' 176' ' ' VAL . 92.0 t -60.08 -45.05 96.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.199 0.523 . . . . 0.0 110.764 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.97 -39.19 76.14 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.693 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.499 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 53.2 t0 -67.96 132.48 47.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.476 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 14.3 m -100.35 123.79 53.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.053 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.564 HD12 ' CG1' ' A' ' 147' ' ' VAL . 48.3 pt -104.72 138.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 98.9 mt-10 -120.03 140.09 51.52 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.598 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 147' ' ' VAL . 44.9 pt -130.02 144.32 38.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.937 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 48.1 t -108.79 113.3 26.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.473 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -119.91 119.18 32.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.503 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.473 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.5 m-20 51.14 39.35 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.714 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 88.22 -7.13 82.44 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.545 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 163' ' ' SER . 57.8 mtpt -100.03 137.4 38.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.966 0.383 . . . . 0.0 110.902 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 8.9 t -112.19 120.66 42.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.237 0.542 . . . . 0.0 111.59 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CZ ' ' HE2' ' A' ' 167' ' ' LYS . 86.8 m-85 -120.01 140.0 51.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.042 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.924 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 51.4 pttt -119.93 136.82 54.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.117 0.484 . . . . 0.0 111.035 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.98 120.07 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.094 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -102.56 127.3 49.7 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.723 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.889 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 3.3 mp -81.97 120.04 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.634 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.566 ' CD1' ' HB2' ' A' ' 128' ' ' GLU . 10.6 mp -69.79 -57.34 5.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.834 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.789 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.9 mt-10 -155.01 148.02 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.607 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.958 HG13 HG22 ' A' ' 156' ' ' VAL . 5.3 m -140.33 147.63 23.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -92.26 104.45 10.97 Favored Pre-proline 0 C--N 1.331 -0.221 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 63.9 Cg_endo -102.47 163.93 0.3 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.639 2.893 . . . . 0.0 112.551 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.5 mt-10 -100.12 6.21 44.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 52.9 m -139.85 159.23 42.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.0 111.231 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 54.8 m -70.05 -12.9 61.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.7 m -59.17 -25.88 64.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 111.11 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt 60.02 39.58 19.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.661 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.1 p -127.47 146.57 50.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.901 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.899 HD12 HD21 ' A' ' 192' ' ' LEU . 46.2 pt -128.39 136.87 58.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.065 0.46 . . . . 0.0 111.5 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 42.7 t -141.15 114.06 8.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.239 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 192' ' ' LEU . 7.2 p -120.84 112.52 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.496 0.665 . . . . 0.0 110.385 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.659 HD12 ' HD3' ' A' ' 66' ' ' PRO . 18.4 tt -79.97 -49.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 188' ' ' ILE . 77.2 mm-40 -91.03 -79.96 0.35 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 t -168.97 30.78 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.606 0.241 . . . . 0.0 111.604 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.808 ' HB2' HD23 ' A' ' 121' ' ' LEU . 95.9 m-20 -82.46 2.19 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.545 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.899 HD21 HD12 ' A' ' 185' ' ' ILE . 62.4 tp -111.93 130.71 55.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.786 0.327 . . . . 0.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 125' ' ' VAL . 31.6 t -95.37 123.07 47.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.169 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 125' ' ' VAL . 74.8 p -101.91 144.94 29.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -129.53 137.69 50.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.387 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -104.32 136.28 44.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.87 163.25 25.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.6 Cg_exo -50.69 140.06 37.95 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.361 2.041 . . . . 0.0 112.126 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.743 ' HG3' HG12 ' A' ' 132' ' ' VAL . 14.5 Cg_endo -56.96 159.92 13.61 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.741 2.294 . . . . 0.0 112.249 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.95 131.17 35.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.206 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 149.07 130.01 1.84 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.506 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -99.96 133.19 44.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.757 0.313 . . . . 0.0 110.766 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.13 130.05 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.955 0.407 . . . . 0.0 111.304 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -100.14 121.41 53.85 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.735 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.04 153.31 74.52 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.308 2.006 . . . . 0.0 112.298 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -99.79 122.97 43.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -99.53 123.5 43.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.867 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 22.6 pttm . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -121.14 139.92 52.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.086 0.47 . . . . 0.0 111.216 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.7 t -131.4 144.83 51.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.14 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -60.03 -40.82 97.54 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.32 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' HB2' ' HD1' ' A' ' 8' ' ' PHE . 85.4 m-85 -122.45 140.32 52.85 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.632 0.253 . . . . 0.0 110.833 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.4 p -69.04 -39.91 78.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.744 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.2 p -60.09 -40.85 91.06 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.511 ' HD1' ' HB2' ' A' ' 5' ' ' PHE . 44.5 m-85 -60.24 -40.07 88.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.042 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 58.34 -121.41 26.16 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.333 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.55 81.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.862 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.01 -163.52 11.19 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.2 t30 60.05 39.91 19.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.93 0.395 . . . . 0.0 110.835 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.04 -13.78 24.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.634 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 140.05 51.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 t -100.85 120.0 49.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.707 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -97.98 -0.03 45.5 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.677 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.1 tpp -82.88 124.19 77.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.03 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.7 159.94 38.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.541 2.16 . . . . 0.0 112.259 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' THR . 95.1 mt-30 -101.27 123.15 44.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.233 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.492 HG22 ' OG1' ' A' ' 117' ' ' THR . 73.9 p -119.99 130.38 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 111.646 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.776 ' HB3' ' OG ' ' A' ' 116' ' ' SER . 86.2 t80 -121.27 126.66 50.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.761 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.18 130.87 54.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.208 0.528 . . . . 0.0 112.332 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.45 156.07 42.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.199 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -102.64 126.17 49.63 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.076 0.465 . . . . 0.0 111.773 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 54' ' ' ALA . 97.5 m-85 -130.07 150.24 51.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.583 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 70.6 mtp85 -81.59 132.29 35.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.841 0.353 . . . . 0.0 110.394 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 31.7 p -106.5 142.39 36.24 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.566 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 63.6 m-85 -140.37 152.75 67.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.547 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.56 ' HG2' ' SD ' ' A' ' 32' ' ' MET . 36.1 Cg_endo -65.66 119.76 6.84 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.232 1.955 . . . . 0.0 111.964 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.795 HG12 ' HB3' ' A' ' 95' ' ' TYR . 88.6 mt -59.93 -38.52 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . . . -50.03 -20.54 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 29' ' ' PRO . 94.5 mtp -68.75 -32.65 72.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 110.711 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.98 143.19 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.99 151.04 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.143 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.535 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.1 m-20 -59.78 -34.66 73.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.01 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.97 -36.23 76.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 37' ' ' ILE . 69.7 mt -107.08 -0.17 9.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.116 0.484 . . . . 0.0 110.628 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.535 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 51.8 ttt-85 -105.01 129.96 53.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.287 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -105.08 133.37 49.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.1 -40.07 88.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.381 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.68 -39.91 95.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.12 91.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.276 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.402 HD21 ' HE ' ' A' ' 38' ' ' ARG . 25.8 m120 -60.24 -40.0 88.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.659 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -100.14 1.7 42.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.181 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.91 180.0 35.69 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.61 29.97 9.75 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.845 ' HD3' HD13 ' A' ' 85' ' ' LEU . 98.3 mttt -100.01 122.47 42.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.689 HG12 ' O ' ' A' ' 83' ' ' GLY . 47.5 pt -115.33 149.9 17.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.271 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.499 ' CZ ' HD23 ' A' ' 85' ' ' LEU . 97.5 m-85 -102.9 133.62 47.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.565 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 114' ' ' ILE . 1.6 mp -131.34 165.6 34.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.208 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.672 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 56.6 Cg_endo -71.59 157.38 56.09 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.163 1.908 . . . . 0.0 112.662 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.88 -23.08 30.66 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 122.737 2.291 . . . . 0.0 112.785 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -60.08 -40.09 88.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.229 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . . . -70.22 -42.55 72.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.415 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.785 HD13 ' CE1' ' A' ' 87' ' ' PHE . 58.4 tp -61.91 -41.02 97.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.382 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.4 t -59.86 -43.35 94.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 111.27 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 85.3 tttt -60.33 -40.08 89.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.798 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.577 HD22 ' CD1' ' A' ' 63' ' ' ILE . 87.3 mt -59.93 -40.08 87.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.074 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.6 t -59.67 -38.23 80.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.265 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.8 ttp -60.0 -39.18 84.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.685 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.1 mt -79.04 -2.52 40.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.425 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.4 t30 60.02 40.26 18.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.588 0.233 . . . . 0.0 111.587 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CD1' HD22 ' A' ' 58' ' ' LEU . 86.3 mt -70.2 130.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 110.833 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -77.47 142.75 38.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.709 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' PRO . 16.0 p90 -87.68 158.29 51.21 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.49 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 65' ' ' TYR . 9.5 Cg_exo -72.82 146.84 88.01 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.758 -1.351 . . . . 0.0 112.708 0.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 63.3 mtt -72.18 140.01 48.54 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.474 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 116' ' ' SER . 21.5 mt -115.84 132.09 56.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.856 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.803 ' HB3' HG23 ' A' ' 114' ' ' ILE . 11.6 m-85 -120.53 140.28 51.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.095 0.474 . . . . 0.0 111.638 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 115' ' ' SER . 87.3 tttt -115.65 129.96 56.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.779 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 113' ' ' GLN . 96.8 mt -98.38 131.12 44.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.368 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.796 ' HA ' HG12 ' A' ' 79' ' ' VAL . 87.0 m -120.01 129.61 54.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.986 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.2 115.62 27.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -68.39 -40.02 81.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.49 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -40.02 87.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.873 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.4 m -100.62 -17.38 17.07 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.742 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 71.34 1.14 41.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.685 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -100.22 141.18 33.41 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.83 0.348 . . . . 0.0 110.717 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 72' ' ' THR . 20.2 m -119.97 119.87 61.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.996 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.469 ' H ' HD21 ' A' ' 104' ' ' LEU . 36.2 p -110.34 139.46 45.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.37 179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 77.7 m80 -84.8 114.39 22.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.963 0.411 . . . . 0.0 110.673 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.33 158.49 20.5 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -93.34 165.26 27.5 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.73 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.1 p -128.69 133.1 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 117.361 0.581 . . . . 0.0 112.336 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.845 HD13 ' HD3' ' A' ' 47' ' ' LYS . 62.6 tp -92.22 -79.05 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.535 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -149.55 160.45 43.47 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.785 ' CE1' HD13 ' A' ' 55' ' ' LEU . 80.3 m-85 -97.37 116.76 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.292 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -129.25 -4.08 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.601 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.33 97.83 11.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 111.378 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.72 -39.92 76.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.459 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -69.97 -20.13 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.345 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.672 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 97.18 54.16 1.3 Allowed Glycine 0 C--O 1.23 -0.107 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.154 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.601 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 87.3 mtt180 -121.2 145.09 48.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.132 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 114' ' ' ILE . 93.6 t -120.4 131.72 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.311 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.795 ' HB3' HG12 ' A' ' 30' ' ' ILE . 86.9 m-85 -120.8 138.91 53.79 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.222 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 101' ' ' MET . 1.8 pt? -134.56 159.04 73.74 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.63 0.252 . . . . 0.0 110.475 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.551 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 65.1 Cg_endo -70.52 158.25 56.5 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.659 2.239 . . . . 0.0 112.824 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.478 ' HA ' ' CE ' ' A' ' 101' ' ' MET . 78.0 mt-30 -61.71 -40.0 93.5 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.586 ' CE2' ' HG3' ' A' ' 100' ' ' MET . 48.9 p-90 -62.83 -39.93 95.86 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.518 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.586 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 96.7 mtp -68.22 -40.0 82.2 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.332 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.739 ' HG2' HD11 ' A' ' 96' ' ' LEU . 76.4 mtm -61.01 -39.98 91.77 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.48 -40.1 92.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.667 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.7 m -63.21 -40.03 96.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.734 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.469 HD21 ' H ' ' A' ' 80' ' ' THR . 83.9 mt -86.24 -10.06 55.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.692 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.22 41.6 99.72 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.046 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.95 133.53 54.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.137 0.494 . . . . 0.0 110.749 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 5.7 mt-30 -96.43 160.0 30.62 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.439 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 107' ' ' GLN . 18.3 Cg_endo -59.93 -1.97 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.299 2.0 . . . . 0.0 112.964 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.83 -12.54 24.04 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.413 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.1 m -94.46 151.52 19.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.313 . . . . 0.0 111.154 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.583 ' CD2' ' HG2' ' A' ' 26' ' ' ARG . 89.9 mt -79.98 158.11 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.597 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 59.2 tp -120.23 131.56 55.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.832 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.9 mt-30 -101.73 120.34 40.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.346 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 50' ' ' LEU . 87.8 mt -110.27 126.21 67.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.833 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 37.4 t -119.78 120.3 36.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.776 ' OG ' ' HB3' ' A' ' 21' ' ' PHE . 48.5 p -88.76 111.16 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.585 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 5.3 t -133.95 150.43 51.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.286 0.565 . . . . 0.0 112.251 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' OD2' HG23 ' A' ' 63' ' ' ILE . 97.7 m-20 -104.74 119.16 38.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.711 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 ' SG ' ' A' ' 186' ' ' CYS . 15.9 m -115.5 152.51 47.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 180' ' ' SER . 51.5 Cg_exo -57.84 166.25 5.49 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.917 1.744 . . . . 0.0 111.257 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 122' ' ' GLY . 8.0 tt -93.98 120.12 33.79 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.63 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.8 ' HA3' HG23 ' A' ' 185' ' ' ILE . . . -68.86 146.11 44.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.228 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -99.23 -19.85 16.9 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 195' ' ' ASP . 64.7 t80 -145.78 131.49 18.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.665 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 176' ' ' VAL . 7.5 p -131.0 129.44 63.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.671 0.748 . . . . 0.0 111.785 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HB3' ' H ' ' A' ' 175' ' ' GLU . 63.5 tttp -97.01 120.31 37.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.686 ' CD1' HD21 ' A' ' 144' ' ' LEU . 77.0 mt -113.94 135.3 54.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.65 ' CD ' HD11 ' A' ' 174' ' ' LEU . 2.6 tt0 -100.22 127.81 32.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.403 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.455 ' HD2' ' HG3' ' A' ' 128' ' ' GLU . 86.5 Cg_endo -79.78 172.83 13.66 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.543 2.162 . . . . 0.0 112.322 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.649 ' HG3' ' HG3' ' A' ' 170' ' ' LYS . 29.9 mm100 -135.62 121.16 19.39 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.531 ' H ' ' HE1' ' A' ' 202' ' ' TYR . 0.5 OUTLIER 59.88 24.89 13.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.513 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 m 41.95 24.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.86 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.43 ' HB3' ' HE2' ' A' ' 169' ' ' PHE . 95.5 m-20 -70.0 -40.01 75.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.964 0.412 . . . . 0.0 110.188 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.543 ' CE1' ' CE2' ' A' ' 196' ' ' PHE . 64.8 t80 -60.71 -40.06 90.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.763 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.16 -24.28 67.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.146 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.02 -19.61 63.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.16 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.9 mt -66.6 137.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.566 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.6 m -60.12 -39.92 87.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.576 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.518 ' H ' HG22 ' A' ' 137' ' ' ILE . 67.6 m-20 -129.7 71.87 82.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.088 0.47 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.521 ' HB3' ' CE1' ' A' ' 134' ' ' PHE . 21.3 Cg_exo -64.68 -30.51 59.9 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.643 2.229 . . . . 0.0 112.314 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -59.94 -41.0 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.313 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.14 98.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.974 0.416 . . . . 0.0 110.96 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 147' ' ' VAL . 72.8 t -64.6 -41.04 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 1.087 HD11 HG21 ' A' ' 194' ' ' THR . 1.8 tm? -60.0 -43.19 95.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.12 -40.27 89.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 0.0 110.75 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -61.97 -40.08 94.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.965 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.892 HG22 HD13 ' A' ' 162' ' ' ILE . 59.4 t -59.89 -40.48 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.516 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 188' ' ' ILE . 86.4 mt -60.23 -40.09 88.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.615 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -69.47 -40.02 77.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.183 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.97 -40.01 87.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.747 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.649 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 91.3 m-85 -102.71 118.02 35.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.101 0.476 . . . . 0.0 111.374 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.525 ' HB2' ' HA2' ' A' ' 83' ' ' GLY . 69.2 m -63.2 -39.94 96.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.032 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 68' ' ' LEU . 34.4 p -123.13 140.66 52.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.012 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 185' ' ' ILE . 86.5 mt -120.87 127.19 51.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.79 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 157' ' ' ASP . 25.0 m -126.46 142.9 51.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 173' ' ' ILE . 59.6 t -60.03 -42.08 88.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.357 0.598 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 155' ' ' THR . 96.0 m-20 -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.413 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.41 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.0 m-20 -75.35 140.09 42.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.89 121.98 61.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.467 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.649 ' HB ' ' CZ ' ' A' ' 151' ' ' PHE . 46.2 pt -104.12 138.69 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.702 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 47.9 mt-10 -121.06 140.62 51.7 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.756 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.892 HD13 HG22 ' A' ' 147' ' ' VAL . 43.4 pt -127.55 142.85 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.211 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 31.6 t -111.54 115.94 30.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.626 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.469 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 54.6 t80 -121.14 122.93 41.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.955 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.469 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.36 39.99 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.535 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.85 89.91 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.932 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 163' ' ' SER . 97.5 mttt -104.48 136.97 43.05 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.8 p -108.67 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 111.413 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.43 ' HE2' ' HB3' ' A' ' 133' ' ' ASP . 87.2 m-85 -119.94 139.98 51.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.444 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 61.5 pttt -121.33 135.49 55.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.264 0.554 . . . . 0.0 111.245 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.638 HD11 HD11 ' A' ' 160' ' ' ILE . 45.9 pt -128.4 139.52 51.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.11 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -116.36 129.21 56.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.939 0.4 . . . . 0.0 111.573 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.723 ' O ' HG13 ' A' ' 156' ' ' VAL . 3.4 mp -77.92 80.99 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.09 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.65 HD11 ' CD ' ' A' ' 128' ' ' GLU . 88.0 mt -60.04 -50.02 75.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 99.5 mt-10 -146.27 139.4 25.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.791 0.329 . . . . 0.0 111.459 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 125' ' ' VAL . 32.5 m -144.6 160.03 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.631 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.43 104.0 54.15 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.453 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 66.9 Cg_endo -99.26 167.34 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.252 2.635 . . . . 0.0 113.053 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 98.9 mt-10 -99.91 9.9 42.2 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.791 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.757 ' HB2' ' HG2' ' A' ' 120' ' ' PRO . 43.6 t -139.85 162.02 36.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 111.257 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 53.1 m -70.67 -15.12 62.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.132 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 82.4 p -61.38 -21.07 63.73 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.729 0.3 . . . . 0.0 111.032 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.4 mmtt 60.08 40.21 18.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.625 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.523 ' C ' HD13 ' A' ' 185' ' ' ILE . 80.4 p -129.76 150.69 50.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.125 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.8 HG23 ' HA3' ' A' ' 122' ' ' GLY . 7.3 mm -117.94 118.36 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.519 ' SG ' HG21 ' A' ' 119' ' ' VAL . 10.9 m -143.2 160.59 40.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.833 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 186' ' ' CYS . 17.2 t 77.06 121.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.427 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 148' ' ' LEU . 14.8 mt -120.64 84.04 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.479 ' H ' HD11 ' A' ' 121' ' ' LEU . 99.4 mt-10 -126.33 -20.42 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -110.63 20.04 18.06 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 190' ' ' THR . 95.7 m-20 70.47 94.57 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 110.407 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 122' ' ' GLY . 4.1 tp -75.61 142.02 42.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.453 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.645 ' O ' HG12 ' A' ' 125' ' ' VAL . 26.3 t -99.99 128.36 51.96 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.018 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 1.087 HG21 HD11 ' A' ' 144' ' ' LEU . 70.1 p -117.87 144.57 45.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.049 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 124' ' ' PHE . 55.6 t0 -126.41 139.97 52.85 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.907 0.384 . . . . 0.0 110.973 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.543 ' CE2' ' CE1' ' A' ' 134' ' ' PHE . 96.6 m-85 -108.75 140.38 42.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -116.63 129.65 25.12 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.524 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.604 ' N ' ' HD2' ' A' ' 199' ' ' PRO . 74.0 Cg_exo -49.53 -49.26 16.18 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.682 2.254 . . . . 0.0 112.653 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 198' ' ' PRO . 11.5 Cg_endo -54.84 141.79 76.31 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.785 1.657 . . . . 0.0 112.094 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.543 ' HB ' ' HD1' ' A' ' 202' ' ' TYR . 27.8 m -82.54 142.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.118 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.604 ' HA3' ' HG2' ' A' ' 128' ' ' GLU . . . -82.66 44.1 3.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.057 -0.592 . . . . 0.0 113.771 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.543 ' HD1' ' HB ' ' A' ' 200' ' ' VAL . 89.6 m-85 -98.93 131.95 44.62 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 117.247 0.523 . . . . 0.0 110.154 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 61.7 t -117.77 129.78 73.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.294 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -96.64 120.18 62.49 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.595 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.44 105.92 2.05 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.372 2.048 . . . . 0.0 112.389 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -100.07 122.22 42.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -98.62 125.94 44.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.828 -179.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -68.67 -38.67 80.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -120.01 140.08 51.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.785 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.19 157.75 1.46 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.377 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -120.03 139.95 51.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.964 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.7 t -60.92 -40.11 91.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.068 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.6 t -116.71 131.18 57.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.762 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -68.12 140.0 56.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.052 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.71 179.59 53.33 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.273 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.95 174.72 46.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.647 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.55 10.01 75.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.764 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -100.1 129.68 46.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.23 168.08 42.44 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.348 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -120.01 139.92 51.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.53 123.92 67.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.519 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -100.07 118.18 35.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.016 0.436 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.6 mmt -104.4 130.66 22.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.96 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.15 159.67 7.41 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.246 1.964 . . . . 0.0 111.589 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.5 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.5 mt-30 -113.03 126.28 55.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.0 m -120.13 130.54 54.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.308 0.575 . . . . 0.0 111.692 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 58.2 t80 -133.24 130.04 38.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.621 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -109.65 135.93 49.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 48.6 mt-10 -142.07 159.9 41.31 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.282 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CZ ' HD13 ' A' ' 111' ' ' LEU . 64.6 t80 -119.85 128.94 54.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.291 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.719 ' HD2' HG22 ' A' ' 114' ' ' ILE . 84.6 m-85 -139.08 153.15 48.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.587 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -81.07 140.7 34.95 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.547 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 49.8 t -99.29 124.68 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 111.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.552 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 18.5 m-85 -120.43 150.71 52.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.594 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.678 ' HG3' ' HB3' ' A' ' 108' ' ' PRO . 6.2 Cg_exo -80.31 113.92 2.98 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.76 2.307 . . . . 0.0 112.232 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.837 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 95.8 mt -61.14 -39.91 84.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.176 0.512 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HA ' ' CZ ' ' A' ' 38' ' ' ARG . . . -59.79 -29.22 68.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.937 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 96.8 mmm -68.3 -36.66 79.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 110.214 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -61.04 140.05 57.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.586 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.36 143.59 52.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 112.044 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.69 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.9 m-20 -59.87 -26.27 65.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.103 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -60.05 -38.75 83.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.91 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.7 pt -108.05 -9.76 10.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.245 0.545 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.725 ' CZ ' ' HA ' ' A' ' 31' ' ' ALA . 66.4 ttt180 -89.23 139.77 30.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.065 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.763 ' HE2' ' HB2' ' A' ' 41' ' ' ASP . 86.0 tttt -101.16 125.51 47.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.891 0.376 . . . . 0.0 110.512 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.14 -40.82 91.14 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.659 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.763 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 95.0 m-20 -61.49 -39.99 92.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.1 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -40.14 90.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.98 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.79 -40.1 87.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.335 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 163' ' ' SER . 90.0 m-85 -102.7 6.04 39.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.56 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.41 160.72 22.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.105 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.15 10.75 73.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.336 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.744 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 22.2 mttm -104.45 143.18 33.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.738 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.909 HG21 HD23 ' A' ' 96' ' ' LEU . 32.6 pt -121.5 169.29 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.725 ' O ' HG23 ' A' ' 94' ' ' VAL . 96.3 m-85 -100.45 131.48 46.35 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.512 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD11 ' CD1' ' A' ' 48' ' ' ILE . 3.9 mp -140.6 163.37 43.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.613 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.552 ' HB3' ' O ' ' A' ' 89' ' ' ALA . 60.6 Cg_endo -72.22 133.78 21.78 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.351 2.034 . . . . 0.0 112.14 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 34.6 Cg_exo -57.9 -11.9 10.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.691 2.261 . . . . 0.0 112.89 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.3 p -60.11 -39.05 84.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.01 -35.54 75.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.382 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 58' ' ' LEU . 85.4 mt -60.03 -40.61 89.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.356 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.3 m -60.11 -40.03 88.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.006 0.431 . . . . 0.0 110.995 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.635 ' HD3' ' HZ ' ' A' ' 21' ' ' PHE . 33.6 mttm -67.5 -39.91 85.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.758 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.596 HD22 HG13 ' A' ' 63' ' ' ILE . 89.7 mt -60.18 -39.35 86.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.595 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.3 m -60.09 -39.79 87.34 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.17 -39.85 87.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.75 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD11 ' CD1' ' A' ' 21' ' ' PHE . 89.6 mt -81.28 -0.36 40.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.712 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.89 43.32 15.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.245 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.596 HG13 HD22 ' A' ' 58' ' ' LEU . 47.8 mm -64.34 129.28 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.434 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -70.54 140.01 51.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.777 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -88.17 143.59 33.08 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.856 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 188' ' ' ILE . 7.6 Cg_exo -73.89 163.83 89.0 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.397 0.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.472 ' SD ' HD13 ' A' ' 58' ' ' LEU . 55.2 mtt -83.86 133.9 34.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.921 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.791 HD13 ' CB ' ' A' ' 186' ' ' CYS . 0.2 OUTLIER -122.12 137.98 54.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.566 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CB ' HD11 ' A' ' 114' ' ' ILE . 97.5 m-85 -123.69 140.49 52.94 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 121.152 0.501 . . . . 0.0 111.712 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 39.6 ttpt -103.81 126.32 50.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.099 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CE ' ' A' ' 100' ' ' MET . 88.6 mt -89.97 122.57 33.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.542 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.687 ' HA ' HG13 ' A' ' 79' ' ' VAL . 60.2 m -99.42 122.25 42.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.454 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.969 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -117.36 133.89 55.45 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.352 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 62.27 139.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.103 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -40.0 87.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.048 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.7 p -129.81 17.72 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.489 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.15 -102.95 0.51 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.783 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.3 mtp-105 -139.98 146.34 38.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.876 0.369 . . . . 0.0 111.267 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG13 ' HA ' ' A' ' 72' ' ' THR . 62.5 t -120.77 119.21 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.901 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.546 HG21 HG22 ' A' ' 103' ' ' THR . 30.8 p -102.11 163.47 12.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.756 0.312 . . . . 0.0 110.886 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.459 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 79.1 m80 -103.96 114.83 29.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.84 159.86 17.27 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.981 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' A' ' 152' ' ' SER . . . -94.18 170.33 30.1 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.245 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -123.57 125.64 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.211 0.529 . . . . 0.0 111.595 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 61.3 tp -92.75 -79.58 0.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -149.34 152.38 35.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.515 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 74.8 m-85 -99.33 115.7 29.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.591 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.0 pt -130.04 -5.05 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.562 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -88.78 98.89 11.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.18 -39.86 82.41 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.04 0.447 . . . . 0.0 110.714 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.32 -30.64 70.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.047 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.43 50.47 0.71 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.444 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.562 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 50.4 ttp180 -117.65 140.04 50.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 111.367 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 49' ' ' PHE . 10.2 p -127.74 143.83 39.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.009 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.837 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.5 m-85 -119.97 140.45 50.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.257 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.909 HD23 HG21 ' A' ' 48' ' ' ILE . 19.2 mt -114.92 137.9 23.1 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.707 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.581 ' HD3' HG22 ' A' ' 48' ' ' ILE . 42.3 Cg_exo -53.83 161.03 5.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.7 2.266 . . . . 0.0 112.325 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -60.02 -44.13 94.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 111.685 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CH2' ' SD ' ' A' ' 100' ' ' MET . 23.5 p-90 -69.66 -37.85 76.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 97' ' ' PRO . 97.1 mmm -60.17 -39.98 88.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.211 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 99.1 mmm -60.16 -40.57 90.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.833 0.349 . . . . 0.0 110.983 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -68.94 -40.7 78.83 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.546 HG22 HG21 ' A' ' 80' ' ' THR . 94.2 m -60.26 -39.95 88.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.407 0.622 . . . . 0.0 110.02 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.969 HD22 ' HB2' ' A' ' 73' ' ' ALA . 45.0 mt -80.9 -16.59 53.17 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.312 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.02 27.37 73.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.059 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.3 pt -111.41 143.99 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.076 0.465 . . . . 0.0 111.097 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.3 pt20 -100.58 161.14 24.9 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.802 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.678 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.3 Cg_endo -48.9 134.76 28.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.675 2.25 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.44 -9.98 75.87 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.964 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.655 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 52.1 m -70.87 150.85 45.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.813 0.307 . . . . 0.0 110.61 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.518 HD13 ' CZ ' ' A' ' 24' ' ' PHE . 74.2 mt -71.51 141.21 50.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 63.3 tp -123.87 130.02 51.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.692 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -113.37 120.0 39.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.993 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.719 HG22 ' HD2' ' A' ' 25' ' ' PHE . 21.0 tt -117.06 127.57 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.346 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 73.6 p -120.11 138.82 53.34 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.927 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 28.0 t -80.76 110.19 16.03 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 94.5 m -119.94 129.98 54.58 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.424 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -105.73 119.98 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.599 ' H ' HD11 ' A' ' 68' ' ' LEU . 32.7 m -115.92 149.41 43.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.964 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.523 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 7.5 Cg_exo -70.81 161.79 44.85 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.335 2.023 . . . . 0.0 110.508 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.605 HD13 HG21 ' A' ' 190' ' ' THR . 1.3 mt -90.85 120.13 31.62 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.442 0.639 . . . . 0.0 112.277 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.74 165.79 47.45 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -107.7 -28.03 9.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.404 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 65.5 t80 -136.98 132.55 34.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.64 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 176' ' ' VAL . 2.9 p -133.67 131.0 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.748 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 61.9 mttp -94.97 124.86 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD12 ' HB ' ' A' ' 194' ' ' THR . 82.5 mt -105.61 131.06 53.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.74 0.305 . . . . 0.0 110.778 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -106.71 109.69 63.27 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.47 164.92 32.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.61 2.206 . . . . 0.0 112.062 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.65 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 64.1 tt0 -124.52 120.98 33.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.938 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.98 146.76 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.002 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.2 t -60.39 -22.12 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.432 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -59.99 -39.61 86.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.797 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.641 ' CE1' HD11 ' A' ' 171' ' ' ILE . 65.6 t80 -59.9 -40.1 87.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.943 0.401 . . . . 0.0 110.755 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -80.31 -8.22 59.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.965 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -60.02 -34.84 73.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.659 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.5 mt -55.68 137.03 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.702 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -60.01 -40.09 88.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.743 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 137' ' ' ILE . 42.5 t0 -129.95 79.76 72.51 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.931 0.396 . . . . 0.0 111.311 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.02 -25.53 16.11 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.57 2.18 . . . . 0.0 111.937 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.07 -41.4 92.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.441 ' HB2' ' OD2' ' A' ' 139' ' ' ASP . . . -64.73 -42.1 95.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.456 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.94 -40.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.477 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.679 HD13 ' O ' ' A' ' 144' ' ' LEU . 3.4 tm? -61.72 -39.99 93.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.862 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -65.16 -40.06 93.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.904 0.383 . . . . 0.0 111.073 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -64.66 -42.18 95.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.75 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 162' ' ' ILE . 22.4 m -67.35 -36.44 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.512 HD11 ' CD1' ' A' ' 144' ' ' LEU . 86.6 mt -59.98 -40.09 87.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.041 0.448 . . . . 0.0 109.792 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -62.2 -40.04 94.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.411 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -60.6 -39.86 89.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.44 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.15 119.6 34.94 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.066 0.46 . . . . 0.0 111.244 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.711 ' HA ' HG12 ' A' ' 188' ' ' ILE . 50.1 m -62.11 -40.02 94.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.497 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 71.2 p -127.39 143.01 51.28 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.176 0.512 . . . . 0.0 111.33 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.831 HD21 HG12 ' A' ' 173' ' ' ILE . 8.2 tt -121.69 124.03 43.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.157 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 93.1 m -119.51 135.69 54.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.894 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.896 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 58.1 t -59.9 -41.76 86.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.161 0.505 . . . . 0.0 111.53 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.798 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 155' ' ' THR . 96.1 m-20 -74.31 146.04 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.339 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.0 t -109.99 119.99 60.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.339 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.406 HG13 ' HB ' ' A' ' 171' ' ' ILE . 46.3 pt -97.89 140.24 18.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.997 0.427 . . . . 0.0 111.86 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.713 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -119.64 140.59 50.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.194 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.719 HD13 HG11 ' A' ' 147' ' ' VAL . 43.3 pt -136.09 145.81 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.98 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.535 ' HB2' ' CD1' ' A' ' 44' ' ' PHE . 29.0 t -115.39 119.4 36.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 0.0 110.701 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.437 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 53.2 t80 -125.84 120.49 30.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.729 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.437 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 59.96 31.45 20.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.443 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.75 -9.85 75.74 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.075 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -101.78 140.05 36.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.702 0.287 . . . . 0.0 110.496 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 163' ' ' SER . 68.3 p -108.8 130.14 55.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.037 0.446 . . . . 0.0 111.505 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -120.04 139.97 51.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.184 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.713 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.7 mttt -103.33 133.28 48.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.961 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.641 HD11 ' CE1' ' A' ' 134' ' ' PHE . 48.5 mm -119.91 119.89 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.05 130.5 54.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.896 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.5 mp -83.88 132.26 31.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.325 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.04 -70.46 0.57 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.978 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.748 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 50.4 tp10 -140.3 139.86 35.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.945 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 156' ' ' VAL . 3.8 m -139.18 149.69 23.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.038 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -99.91 104.23 27.24 Favored Pre-proline 0 C--O 1.232 0.158 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 68.6 Cg_endo -102.9 177.97 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.691 2.928 . . . . 0.0 112.732 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.4 mt-10 -99.95 -0.01 40.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.82 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.3 m -138.29 151.65 47.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.028 0.442 . . . . 0.0 111.462 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.454 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 79.6 p -70.03 -10.03 57.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.706 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 46.9 t -55.68 -28.84 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.726 0.298 . . . . 0.0 111.32 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 181' ' ' SER . 74.3 mmtt 69.8 23.24 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.939 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.6 p -124.59 139.94 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.854 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.526 HD11 HD22 ' A' ' 154' ' ' LEU . 15.0 pt -132.2 140.05 48.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.791 ' CB ' HD13 ' A' ' 68' ' ' LEU . 11.2 t -119.76 109.75 15.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.816 HG11 HD22 ' A' ' 192' ' ' LEU . 12.0 p -141.09 99.96 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.603 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.711 HG12 ' HA ' ' A' ' 152' ' ' SER . 74.8 mt -97.18 -67.81 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.278 0.561 . . . . 0.0 111.566 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 189' ' ' GLU . 86.4 tt0 -94.1 -6.25 45.48 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.257 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 187' ' ' VAL . 0.0 OUTLIER -80.29 174.58 11.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.248 0.547 . . . . 0.0 111.469 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -103.21 119.97 39.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.932 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.816 HD22 HG11 ' A' ' 187' ' ' VAL . 18.1 tp -120.26 140.09 51.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.254 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -89.27 120.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.522 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.595 HG22 HG13 ' A' ' 125' ' ' VAL . 76.2 p -113.85 146.47 39.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.149 0.5 . . . . 0.0 111.776 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 196' ' ' PHE . 49.4 t0 -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.625 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 195' ' ' ASP . 11.2 m-85 -93.31 139.98 30.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.933 0.397 . . . . 0.0 111.408 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -119.83 166.46 14.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 75.2 Cg_exo -51.68 142.31 41.08 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.446 2.097 . . . . 0.0 112.13 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.1 160.1 48.97 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.569 2.18 . . . . 0.0 112.409 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.48 133.94 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 139.99 59.93 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.491 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -100.07 138.48 37.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.773 0.32 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.78 125.13 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.738 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -100.16 119.83 58.24 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.977 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.9 107.5 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.518 2.145 . . . . 0.0 112.278 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -99.93 120.86 40.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.801 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.56 124.01 44.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.806 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.74 0.305 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -70.01 -40.02 75.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.3 t -126.42 135.45 51.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.41 170.1 51.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.535 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.1 139.98 51.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.577 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 55.7 m -127.62 135.52 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.856 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.5 p -82.68 159.08 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.984 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.01 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.637 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.73 137.92 20.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.551 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.12 143.53 20.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.491 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.49 -173.0 49.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.731 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -103.11 120.18 40.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.0 111.057 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.28 164.36 54.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.431 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.95 140.0 51.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.5 m -104.31 130.07 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.343 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.58 -0.03 52.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.449 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -95.43 137.62 22.01 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.665 0.269 . . . . 0.0 110.662 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 73.1 Cg_exo -49.6 167.45 0.18 Allowed 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.369 2.046 . . . . 0.0 112.123 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.9 mt-30 -101.0 130.21 46.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.697 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.8 p -121.67 130.11 53.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HE2' ' HG3' ' A' ' 23' ' ' GLU . 50.7 t80 -131.55 130.28 42.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -113.97 136.8 52.5 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mm-40 -149.99 160.03 43.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.76 120.04 38.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.445 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.71 ' CD2' HD12 ' A' ' 114' ' ' ILE . 86.2 m-85 -126.47 149.47 49.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -81.32 133.44 35.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.601 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.974 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 53.2 t -99.95 121.95 42.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 111.357 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.655 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 88.9 m-85 -120.42 150.06 51.16 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.992 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 108' ' ' PRO . 7.2 Cg_exo -75.68 107.02 2.38 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.848 2.366 . . . . 0.0 112.699 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.774 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 86.2 mt -61.09 -40.84 87.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.02 -36.62 77.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.866 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.469 ' CG ' ' HB2' ' A' ' 29' ' ' PRO . 98.9 mmm -68.25 -30.29 69.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 96.5 mmm -59.94 142.24 54.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.26 154.49 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.673 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 38' ' ' ARG . 96.0 m-20 -55.16 -29.17 57.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.404 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -60.01 -39.9 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.55 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 37' ' ' ILE . 24.2 mt -111.48 8.88 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 0.0 110.648 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.664 ' HB3' ' HA ' ' A' ' 35' ' ' ASP . 74.8 ttt180 -104.65 123.18 47.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.049 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -104.07 129.29 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.896 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.21 -40.09 88.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.269 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.88 -39.97 95.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.99 0.424 . . . . 0.0 111.226 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.95 -39.91 95.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.763 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -60.08 -40.1 88.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.351 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -110.38 14.53 22.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.273 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.57 164.0 24.06 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.119 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.52 11.78 63.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.472 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.623 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 67.9 mttm -109.86 145.12 37.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 111.242 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.567 HG21 ' CD2' ' A' ' 96' ' ' LEU . 48.0 pt -121.55 162.99 20.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.909 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 94' ' ' VAL . 94.3 m-85 -96.58 133.24 41.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.879 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -134.25 165.47 36.47 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.239 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 84.6 Cg_endo -79.53 152.73 23.25 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.21 1.94 . . . . 0.0 112.67 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.973 ' HA ' HD13 ' A' ' 55' ' ' LEU . 19.1 Cg_exo -66.88 -21.74 49.96 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.961 2.441 . . . . 0.0 112.829 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 m -60.08 -40.07 88.28 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.925 0.342 . . . . 0.0 111.925 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.37 80.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.226 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.973 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.96 -40.04 87.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.391 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.7 t -59.97 -42.76 94.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.59 -39.97 92.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.031 0.443 . . . . 0.0 110.378 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.501 HD21 ' OG ' ' A' ' 116' ' ' SER . 84.6 mt -63.34 -38.56 91.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.375 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.6 m -59.76 -39.47 84.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.2 mtp -59.97 -39.48 85.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.489 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -81.76 -0.05 41.33 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.681 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.4 m120 59.98 42.43 16.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.704 0.288 . . . . 0.0 111.422 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.499 HG13 HD22 ' A' ' 58' ' ' LEU . 42.7 mm -70.02 130.02 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.744 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -72.05 139.59 48.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.781 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.743 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 28.9 t80 -88.42 146.52 37.86 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.863 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 1.0 ' HD2' HD13 ' A' ' 188' ' ' ILE . 59.9 Cg_endo -71.62 160.38 93.04 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.228 -1.155 . . . . 0.0 113.551 0.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.545 ' HB2' HG11 ' A' ' 84' ' ' VAL . 63.6 mtt -71.86 139.98 49.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD22 ' HB ' ' A' ' 153' ' ' THR . 95.4 mt -110.04 123.03 48.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.457 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 114' ' ' ILE . 14.9 m-85 -119.99 140.0 51.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HD3' ' NE2' ' A' ' 81' ' ' HIS . 28.4 ttpp -114.66 130.0 56.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.723 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 80' ' ' THR . 71.6 mt -94.17 121.72 35.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.846 0.355 . . . . 0.0 110.581 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 113' ' ' GLN . 29.8 m -106.76 119.93 40.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 78' ' ' ARG . . . -112.51 132.46 55.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.094 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 61.77 148.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.833 0.349 . . . . 0.0 110.074 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -60.04 -40.06 88.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.56 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 72.0 p -135.48 13.71 3.48 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.356 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.64 -106.85 0.14 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.073 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.747 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 83.0 mtt85 -128.53 147.54 50.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.012 0.434 . . . . 0.0 111.68 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 72' ' ' THR . 35.9 m -130.06 130.8 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.417 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.966 HG22 HD21 ' A' ' 104' ' ' LEU . 7.2 t -112.77 132.43 55.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 0.0 111.531 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.435 ' NE2' ' HD3' ' A' ' 70' ' ' LYS . 78.3 m80 -84.42 161.56 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.35 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.24 169.74 42.78 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.94 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -101.1 -177.26 29.12 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.985 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 67' ' ' MET . 9.0 p -130.2 131.45 65.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.728 0.299 . . . . 0.0 111.333 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 62.1 tp -89.99 -79.21 0.35 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.056 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -139.66 155.18 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.705 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.854 ' CG ' HD11 ' A' ' 55' ' ' LEU . 86.1 m-85 -99.9 116.53 32.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.931 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.5 pt -124.79 -5.47 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -91.88 100.11 12.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.01 0.433 . . . . 0.0 111.263 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.52 -39.97 77.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.041 0.448 . . . . 0.0 111.032 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -66.54 -30.5 70.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 111.8 49.24 0.64 Allowed Glycine 0 C--N 1.319 -0.39 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.051 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.584 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 92.9 mtt180 -118.45 149.22 41.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.984 0.421 . . . . 0.0 110.986 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.773 HG21 HD11 ' A' ' 114' ' ' ILE . 10.0 p -129.37 142.32 44.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.019 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.774 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.26 139.95 50.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.704 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 112' ' ' LEU . 80.0 mt -120.39 148.18 46.95 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.7 0.286 . . . . 0.0 111.583 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.52 157.98 29.47 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.655 2.237 . . . . 0.0 112.016 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -60.79 -40.56 93.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.509 ' CZ2' ' HE3' ' A' ' 100' ' ' MET . 44.6 p-90 -70.05 -40.03 75.34 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.201 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.509 ' HE3' ' CZ2' ' A' ' 99' ' ' TRP . 52.5 mtt -65.32 -39.92 93.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 57.6 ttm -60.09 -40.32 89.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.161 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -63.6 -40.03 95.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.978 0.418 . . . . 0.0 110.379 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.6 -40.08 95.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.983 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.966 HD21 HG22 ' A' ' 80' ' ' THR . 96.5 mt -83.72 -12.15 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.594 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.65 42.23 99.21 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.905 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 76.3 mt -109.96 132.52 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.136 0.493 . . . . 0.0 110.819 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -100.11 159.22 30.39 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.953 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.581 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 38.9 Cg_exo -52.44 131.03 38.77 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.501 2.134 . . . . 0.0 112.01 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.27 77.9 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.668 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t -76.82 153.3 35.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 111' ' ' LEU . 10.4 tt -70.59 140.78 51.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.461 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.974 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.2 tp -126.9 139.95 52.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.491 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.645 ' HB2' ' HB ' ' A' ' 72' ' ' THR . 95.6 mt-30 -113.91 127.15 55.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.553 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 50' ' ' LEU . 85.3 mt -119.98 124.46 72.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.511 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 29.9 t -119.13 121.06 38.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.83 0.348 . . . . 0.0 110.889 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.66 108.07 17.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 9.2 t -131.37 140.93 49.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.933 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.567 ' HA ' HD12 ' A' ' 68' ' ' LEU . 58.0 t0 -99.66 120.01 39.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.652 HG23 ' N ' ' A' ' 186' ' ' CYS . 27.3 m -103.97 155.71 36.69 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.432 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.625 ' O ' ' HA ' ' A' ' 185' ' ' ILE . 12.3 Cg_exo -70.05 149.72 65.42 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.322 2.015 . . . . 0.0 111.333 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.67 HD11 ' CB ' ' A' ' 190' ' ' THR . 8.3 tt -70.19 127.42 32.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.85 152.19 29.8 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.283 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -108.48 -29.97 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.454 ' HE2' ' CG ' ' A' ' 126' ' ' LYS . 70.2 t80 -140.85 134.24 29.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.728 0.299 . . . . 0.0 111.497 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.832 HG23 ' CG1' ' A' ' 176' ' ' VAL . 5.7 p -130.1 130.85 66.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-O 121.111 0.481 . . . . 0.0 112.148 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD3' HD11 ' A' ' 174' ' ' LEU . 99.5 mttt -99.18 122.02 41.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.323 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.593 HD12 ' OG1' ' A' ' 194' ' ' THR . 86.4 mt -111.71 131.09 55.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.0 0.429 . . . . 0.0 111.292 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -102.06 110.42 62.36 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.354 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 197' ' ' ALA . 95.9 Cg_endo -84.26 162.15 13.21 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.676 2.25 . . . . 0.0 112.651 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.633 ' OE1' ' HE3' ' A' ' 170' ' ' LYS . 61.5 tt0 -129.31 122.88 30.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.755 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' GLN . 0.5 OUTLIER 75.9 131.05 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.66 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.21 -17.5 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.728 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.444 ' HA ' ' OD2' ' A' ' 136' ' ' ASP . 96.0 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.628 0.251 . . . . 0.0 110.842 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HD2' ' CD1' ' A' ' 169' ' ' PHE . 59.5 t80 -59.94 -40.13 87.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.874 0.368 . . . . 0.0 111.059 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.427 HD21 ' CD1' ' A' ' 196' ' ' PHE . 95.7 mt -85.57 -4.77 59.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.858 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' ' HA ' ' A' ' 133' ' ' ASP . 94.1 m-20 -70.05 -16.83 63.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.587 0.232 . . . . 0.0 111.39 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 139' ' ' ASP . 86.0 mt -61.18 139.26 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.698 0.285 . . . . 0.0 110.419 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 70.3 p -61.41 -39.94 92.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.32 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.508 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.0 OUTLIER -129.43 73.98 81.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.783 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 74.5 Cg_endo -76.0 -29.77 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.479 2.119 . . . . 0.0 112.117 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.06 -40.13 88.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.112 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.46 -40.4 89.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 147' ' ' VAL . 87.1 t -62.87 -41.98 94.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.553 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.1 tm? -60.01 -42.81 95.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.042 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -41.36 92.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -61.92 -40.26 94.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.934 HG22 HG21 ' A' ' 162' ' ' ILE . 57.5 t -60.96 -42.61 93.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.021 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 97.9 mt -60.12 -40.06 88.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.783 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -60.66 -39.93 90.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.486 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.12 -39.94 88.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.484 ' CE2' ' HB ' ' A' ' 160' ' ' ILE . 93.9 m-85 -96.18 121.46 37.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.402 ' OG ' HD23 ' A' ' 68' ' ' LEU . 89.4 p -61.19 -39.94 92.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.51 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.689 ' HB ' HD22 ' A' ' 68' ' ' LEU . 7.3 t -128.32 141.23 51.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 0.0 111.075 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -113.4 120.13 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.94 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.2 p -119.94 145.87 46.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.184 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.789 ' CG2' HG22 ' A' ' 176' ' ' VAL . 72.1 t -60.07 -39.94 81.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 111.73 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.18 -38.68 78.82 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.595 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -67.14 131.69 46.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.249 0.547 . . . . 0.0 112.325 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.406 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 60.0 t -104.01 120.12 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.846 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.797 HD12 ' CG1' ' A' ' 147' ' ' VAL . 49.1 pt -106.27 134.6 47.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 111.998 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.639 ' HG2' ' HB3' ' A' ' 170' ' ' LYS . 49.0 mt-10 -120.58 140.03 52.1 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.462 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.934 HG21 HG22 ' A' ' 147' ' ' VAL . 44.3 pt -131.08 140.83 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.231 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 65.2 m -105.92 120.99 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.213 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.495 ' CE1' ' ND2' ' A' ' 165' ' ' ASN . 60.1 t80 -119.97 120.0 35.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.655 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.495 ' ND2' ' CE1' ' A' ' 164' ' ' TYR . 98.6 m-20 55.36 40.0 31.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.432 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.99 8.7 87.42 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.027 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.4 mttp -106.19 132.62 52.03 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -101.13 119.96 39.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.92 0.391 . . . . 0.0 111.223 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.461 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 98.3 m-85 -120.82 140.07 52.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.719 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.639 ' HB3' ' HG2' ' A' ' 161' ' ' GLU . 55.3 pttt -117.83 131.91 56.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.151 0.501 . . . . 0.0 111.639 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 127' ' ' LEU . 85.4 mt -120.01 120.12 62.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.249 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -107.29 130.01 54.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.368 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 5.3 mp -80.52 113.37 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.642 HD11 ' HD3' ' A' ' 126' ' ' LYS . 1.5 pp -73.64 -56.51 4.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.729 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.53 ' H ' ' HG ' ' A' ' 174' ' ' LEU . 99.0 mt-10 -155.57 136.42 13.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.331 . . . . 0.0 110.388 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.832 ' CG1' HG23 ' A' ' 125' ' ' VAL . 21.4 m -130.57 159.96 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -105.08 104.11 45.29 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.78 0.324 . . . . 0.0 110.219 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.426 ' HB3' ' CG2' ' A' ' 185' ' ' ILE . 68.7 Cg_endo -100.19 179.17 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.733 2.956 . . . . 0.0 112.509 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 120' ' ' PRO . 99.0 mt-10 -95.41 0.03 52.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.825 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 120' ' ' PRO . 88.2 p -140.31 159.88 41.21 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.031 0.443 . . . . 0.0 111.213 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -70.05 -11.53 60.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.668 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.9 t -59.95 -18.58 46.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.415 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 66.77 26.41 9.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.958 0.408 . . . . 0.0 110.702 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.8 m -125.9 139.98 53.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.104 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' PRO . 45.7 pt -127.52 143.87 39.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.4 . . . . 0.0 111.811 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.652 ' N ' HG23 ' A' ' 119' ' ' VAL . 40.5 t -92.04 100.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.078 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.755 HG21 HD22 ' A' ' 192' ' ' LEU . 97.6 t -109.96 93.83 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.093 -179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 1.0 HD13 ' HD2' ' A' ' 66' ' ' PRO . 84.2 mt -110.59 -75.03 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.836 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.588 ' HG3' HG22 ' A' ' 188' ' ' ILE . 99.0 mt-10 -117.78 10.78 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.221 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.67 ' CB ' HD11 ' A' ' 121' ' ' LEU . 5.8 t -84.98 171.71 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.207 0.527 . . . . 0.0 111.992 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.49 119.45 37.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.79 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.755 HD22 HG21 ' A' ' 187' ' ' VAL . 31.4 tp -120.37 131.29 54.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 36.3 t -89.35 126.91 42.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.167 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.593 ' OG1' HD12 ' A' ' 127' ' ' LEU . 3.9 t -116.96 140.3 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.575 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -120.07 131.74 55.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.544 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.427 ' CD1' HD21 ' A' ' 135' ' ' LEU . 87.4 m-85 -100.14 122.34 42.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.897 0.38 . . . . 0.0 111.532 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 129' ' ' PRO . . . -121.16 108.39 36.32 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.67 109.96 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.381 2.054 . . . . 0.0 112.468 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -92.96 3.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.011 2.474 . . . . 0.0 112.641 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.95 139.0 18.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.031 0.443 . . . . 0.0 111.546 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -137.57 25.95 2.94 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.223 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.2 136.65 38.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.087 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.93 139.71 46.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -96.68 124.34 50.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.7 116.5 3.27 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.397 2.064 . . . . 0.0 112.272 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -84.66 140.03 31.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -96.46 125.91 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.782 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.8 -179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.2 mmm . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.859 0.362 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.95 -40.43 88.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.8 m -125.71 136.66 53.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.69 170.59 3.17 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.427 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -70.04 -39.92 75.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.925 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.3 m -130.01 140.02 50.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.3 m -79.41 150.27 31.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.89 130.01 55.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.612 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.49 -166.71 54.73 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.237 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.44 177.79 43.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.62 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.95 167.74 51.55 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.582 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.13 120.03 39.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.864 0.364 . . . . 0.0 110.742 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.98 -139.86 29.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.47 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -104.91 132.54 51.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -109.75 135.46 48.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -80.07 139.96 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.3 mtp -101.09 119.97 56.5 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.981 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.18 156.28 59.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.275 1.983 . . . . 0.0 111.773 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' A' ' 117' ' ' THR . 57.2 tt0 -101.49 119.99 39.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.473 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 116' ' ' SER . 82.6 p -119.6 137.56 53.78 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.942 0.401 . . . . 0.0 111.637 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 57' ' ' LYS . 75.2 t80 -125.74 130.52 51.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.618 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.15 136.7 39.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.989 0.423 . . . . 0.0 112.052 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 98.6 mt-10 -140.53 153.6 46.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.067 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -120.14 122.57 41.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 92.3 m-85 -139.91 160.37 40.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.819 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -84.1 139.66 32.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.934 ' HB2' ' HB2' ' A' ' 112' ' ' LEU . 36.2 t -100.0 123.78 44.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 111.458 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.618 ' HB2' ' CE2' ' A' ' 95' ' ' TYR . 82.8 m-85 -121.67 149.92 54.11 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.237 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.651 ' HG2' ' HB3' ' A' ' 32' ' ' MET . 65.0 Cg_endo -79.45 111.17 2.79 Favored 'Trans proline' 0 N--CA 1.467 -0.081 0 C-N-CA 123.194 2.596 . . . . 0.0 112.647 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.691 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.4 mt -60.77 -40.03 83.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 0.0 110.682 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.52 73.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.321 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.651 ' HB3' ' HG2' ' A' ' 29' ' ' PRO . 57.7 ttm -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.462 ' O ' ' HD2' ' A' ' 38' ' ' ARG . 98.3 mtp -58.98 155.69 12.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.737 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.584 ' HB2' HG12 ' A' ' 37' ' ' ILE . 98.6 m-20 -60.1 139.99 57.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.041 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -59.97 -37.09 78.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.452 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -60.05 -39.75 87.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.73 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.584 HG12 ' HB2' ' A' ' 34' ' ' ASN . 47.7 pt -90.3 -0.66 9.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.559 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 18.5 mtp-105 -99.39 139.94 34.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.857 0.361 . . . . 0.0 110.905 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -96.13 139.71 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.731 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HA ' HD21 ' A' ' 43' ' ' ASN . 33.6 p-10 -60.01 -40.03 87.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.232 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.76 -40.11 76.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.8 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.71 92.27 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.485 HD21 ' HA ' ' A' ' 40' ' ' ASP . 27.3 p30 -62.53 -40.01 95.41 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 37.8 m-85 -110.0 18.23 20.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.894 0.378 . . . . 0.0 110.587 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.09 173.35 28.96 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.169 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.14 24.22 19.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 85' ' ' LEU . 71.5 mmtt -111.52 142.29 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 111.231 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.698 ' CG1' HG12 ' A' ' 84' ' ' VAL . 47.3 pt -121.24 155.96 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.56 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.625 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 97.4 m-85 -100.82 133.96 44.51 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.447 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 114' ' ' ILE . 4.1 mp -140.18 164.54 36.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.32 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 69.3 Cg_endo -73.29 156.26 50.88 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.268 1.978 . . . . 0.0 112.715 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.978 ' HA ' HD13 ' A' ' 55' ' ' LEU . 74.3 Cg_endo -75.26 -15.6 20.11 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.906 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.9 t -60.0 -40.3 88.73 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB1' ' OE2' ' A' ' 23' ' ' GLU . . . -61.35 -37.59 83.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.152 0.501 . . . . 0.0 111.383 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.978 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.6 mp -60.13 -39.79 87.52 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.576 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.4 p -60.01 -40.03 87.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 110.474 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 21' ' ' PHE . 23.6 tptm -69.45 -40.04 77.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.258 0.551 . . . . 0.0 110.167 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD12 ' HA ' ' A' ' 55' ' ' LEU . 90.8 mt -59.95 -39.6 86.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.112 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.9 t -57.84 -39.27 77.29 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.523 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.4 mtt -59.88 -37.26 78.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 98.2 mt -80.46 -0.05 35.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.597 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 60.03 40.44 18.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.807 0.337 . . . . 0.0 111.659 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.423 HG12 ' OE1' ' A' ' 19' ' ' GLN . 85.8 mt -86.63 120.01 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.789 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -91.73 149.13 21.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.305 0.574 . . . . 0.0 111.854 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.521 ' H ' ' HD1' ' A' ' 65' ' ' TYR . 3.2 p90 -87.39 157.79 52.66 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.529 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 30.3 Cg_endo -63.74 147.61 64.42 Favored 'Cis proline' 0 C--N 1.352 0.759 0 C-N-CA 123.771 -1.346 . . . . 0.0 112.742 0.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.453 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 59.0 mtt -93.59 139.59 30.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.677 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 ' HB2' ' A' ' 186' ' ' CYS . 6.6 mp -101.49 120.9 41.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.025 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.682 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 94.0 m-85 -128.35 142.3 51.17 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.607 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 60.7 pttt -120.74 140.11 52.13 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -99.32 115.46 29.23 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.394 -178.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.4 m -99.26 121.44 41.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.841 0.353 . . . . 0.0 111.941 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.39 117.64 35.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.281 178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -68.99 -39.99 79.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.433 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -40.02 87.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.906 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.434 HG21 ' HA3' ' A' ' 105' ' ' GLY . 77.8 p -105.4 -7.7 18.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 62.84 12.12 40.53 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.644 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -104.79 140.09 38.6 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.668 0.27 . . . . 0.0 110.962 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 3.1 p -124.01 130.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.636 ' OG1' HD23 ' A' ' 71' ' ' LEU . 67.4 p -97.54 154.88 17.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.146 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 158' ' ' ASP . 81.0 m80 -119.47 131.18 55.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.812 0.339 . . . . 0.0 110.153 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.85 -173.72 36.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.538 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 152' ' ' SER . . . -107.62 -170.72 21.91 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.937 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.698 HG12 ' CG1' ' A' ' 48' ' ' ILE . 32.6 m -130.05 159.71 41.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 121.279 -0.168 . . . . 0.0 110.815 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 47' ' ' LYS . 58.2 tp -89.99 -78.1 0.38 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.918 0.39 . . . . 0.0 110.544 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -147.72 159.8 43.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.886 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.865 ' CD2' HD11 ' A' ' 55' ' ' LEU . 88.3 m-85 -99.87 116.15 31.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.276 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -131.16 -4.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.077 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -87.45 100.41 12.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.005 0.431 . . . . 0.0 111.176 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.38 -39.98 77.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.746 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.92 -30.85 71.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.095 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 109.57 50.32 0.71 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.386 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.549 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 98.8 mtt180 -117.64 148.23 42.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.948 0.404 . . . . 0.0 111.501 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 49' ' ' PHE . 8.0 p -129.81 140.81 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.02 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.691 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.3 m-85 -118.72 139.96 50.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.927 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.564 HD23 HG21 ' A' ' 48' ' ' ILE . 21.3 mt -114.81 139.58 24.35 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 48' ' ' ILE . 57.5 Cg_exo -55.01 155.59 18.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.699 2.266 . . . . 0.0 112.3 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.19 91.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.638 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.698 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 55.2 p-90 -69.95 -37.87 75.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.732 0.301 . . . . 0.0 111.356 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.655 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 98.1 mtp -69.94 -39.98 75.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.724 0.297 . . . . 0.0 111.078 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' PRO . 98.1 mtp -60.01 -40.94 90.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.037 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 21.3 pt-20 -64.12 -40.02 95.29 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.2 m -62.48 -40.06 95.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HG23 ' A' ' 80' ' ' THR . 82.9 mt -70.04 -24.13 63.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.369 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.434 ' HA3' HG21 ' A' ' 76' ' ' THR . . . 74.66 29.97 60.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.357 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.448 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.8 pt -114.35 139.92 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.138 0.494 . . . . 0.0 111.713 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.7 pt20 -95.25 160.01 31.63 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.415 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.544 ' HB3' ' HG3' ' A' ' 29' ' ' PRO . 9.5 Cg_endo -49.15 137.79 29.25 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.754 2.302 . . . . 0.0 112.48 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.09 -8.13 80.37 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.987 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 27' ' ' CYS . 89.8 p -71.04 160.36 33.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.753 0.276 . . . . 0.0 110.605 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.65 145.2 30.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.685 0.279 . . . . 0.0 110.473 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.934 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 62.1 tp -130.24 130.33 44.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.056 0.455 . . . . 0.0 111.364 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 94.2 mt-30 -110.52 127.59 55.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.366 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.682 ' CG1' ' HB3' ' A' ' 69' ' ' PHE . 19.0 tt -118.44 127.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.407 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 47.0 t -120.02 130.03 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.311 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 23.4 t -89.9 116.03 27.66 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.857 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.752 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 9.6 t -129.98 138.83 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -109.74 121.07 44.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.537 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 120' ' ' PRO . 32.7 m -119.16 154.45 53.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.634 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.608 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 59.6 Cg_endo -72.5 153.31 55.11 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.791 2.327 . . . . 0.0 111.325 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.85 HD23 HG23 ' A' ' 187' ' ' VAL . 4.7 mp -64.29 130.05 42.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.954 0.407 . . . . 0.0 111.137 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.95 151.4 49.01 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.53 -20.05 15.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.516 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' CE2' ' OD2' ' A' ' 195' ' ' ASP . 60.4 t80 -145.79 131.16 18.6 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.681 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.699 HG23 ' CG1' ' A' ' 176' ' ' VAL . 11.5 p -134.0 134.44 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 CA-C-O 121.267 0.556 . . . . 0.0 111.529 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.834 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 64.3 mttp -99.43 122.37 42.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.359 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD12 ' HB ' ' A' ' 194' ' ' THR . 86.0 mt -113.25 128.59 56.52 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.417 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -111.7 112.22 53.81 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.105 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.509 ' CB ' HD11 ' A' ' 135' ' ' LEU . 84.2 Cg_endo -82.08 167.78 15.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.67 2.247 . . . . 0.0 112.462 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -126.07 121.22 32.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.851 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.455 ' N ' ' HB2' ' A' ' 199' ' ' PRO . 0.4 OUTLIER 67.6 142.15 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.03 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -60.09 -20.71 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.412 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.0 -39.56 86.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.138 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.571 ' HD1' HD12 ' A' ' 135' ' ' LEU . 64.3 t80 -59.98 -40.02 87.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.571 HD12 ' HD1' ' A' ' 134' ' ' PHE . 9.9 mp -81.95 -11.21 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.543 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.08 -19.99 63.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.743 0.306 . . . . 0.0 111.141 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.4 mt -69.15 130.2 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.774 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 79.5 p -69.54 150.75 46.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.26 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 140' ' ' PRO . 2.5 m-20 53.66 53.37 10.97 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.644 ' O ' HD23 ' A' ' 144' ' ' LEU . 31.0 Cg_endo -63.83 -34.65 60.17 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.531 2.154 . . . . 0.0 112.351 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.08 -40.04 88.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.071 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.88 95.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 147' ' ' VAL . 81.6 t -60.1 -43.19 92.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.9 mm? -60.0 -40.57 89.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.57 -41.17 94.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.826 0.346 . . . . 0.0 110.989 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.45 -39.94 89.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.075 0.464 . . . . 0.0 110.176 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 143' ' ' VAL . 60.4 t -60.33 -42.07 89.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.86 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 90.6 mt -60.05 -41.27 91.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 188' ' ' ILE . 16.8 tpt180 -61.71 -40.0 93.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.222 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.483 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 98.6 m-20 -62.05 -39.99 94.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.822 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -100.01 122.67 43.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.767 0.318 . . . . 0.0 111.4 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.639 ' HA ' HD11 ' A' ' 188' ' ' ILE . 51.8 m -60.03 -40.02 87.88 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.527 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 10.0 t -136.06 149.97 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.613 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 173' ' ' ILE . 64.8 tp -120.04 128.2 53.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 25.3 m -119.05 140.19 50.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.374 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 176' ' ' VAL . 63.5 t -59.96 -42.48 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.398 0.618 . . . . 0.0 111.343 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.98 -39.71 75.77 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.678 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.51 ' OD2' ' HB2' ' A' ' 81' ' ' HIS . 96.0 m-20 -65.53 140.39 58.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.294 0.569 . . . . 0.0 112.449 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG22 ' CE ' ' A' ' 172' ' ' LYS . 53.1 t -105.77 120.02 55.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.654 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 171' ' ' ILE . 48.0 pt -106.94 141.4 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.798 0.332 . . . . 0.0 111.377 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.688 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 99.9 mt-10 -118.99 140.69 49.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 147' ' ' VAL . 46.7 pt -130.31 139.98 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.425 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 58.6 m -107.55 118.46 36.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -119.95 121.77 39.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 39.6 t30 55.07 40.03 31.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.421 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.88 9.9 86.23 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.891 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.6 mttt -110.38 138.05 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.807 0.303 . . . . 0.0 110.491 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.1 m -106.63 121.16 43.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.545 ' CD1' ' HD2' ' A' ' 134' ' ' PHE . 90.3 m-85 -120.03 140.03 51.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.688 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 58.9 mtpt -106.07 123.99 48.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.354 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.704 HD11 HD11 ' A' ' 160' ' ' ILE . 46.0 pt -122.42 131.13 73.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.976 0.417 . . . . 0.0 110.639 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.403 ' CE ' HG22 ' A' ' 159' ' ' VAL . 35.0 ttmt -119.64 135.88 54.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.778 HD11 HD11 ' A' ' 154' ' ' LEU . 4.6 mp -84.62 120.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.083 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.463 ' HB2' ' CB ' ' A' ' 126' ' ' LYS . 89.1 mt -68.79 -59.32 3.17 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.942 0.401 . . . . 0.0 111.429 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.834 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.4 mt-10 -158.28 146.66 18.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.76 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 156' ' ' VAL . 4.3 m -139.02 145.15 28.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.263 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -88.94 104.7 8.11 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.327 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 66.1 Cg_endo -104.07 174.36 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 123.861 3.041 . . . . 0.0 112.351 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.608 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 99.6 mt-10 -100.03 0.73 41.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.697 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 53.1 m -132.81 150.03 52.2 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 111.184 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.5 m -70.98 -12.2 61.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.928 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.5 p -62.9 -10.39 13.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.0 mttm 59.93 24.58 13.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 111.425 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 64.2 m -121.08 135.76 55.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.479 ' CG2' ' HB3' ' A' ' 178' ' ' PRO . 46.7 pt -129.97 159.14 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.399 0.618 . . . . 0.0 112.355 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HD21 ' A' ' 68' ' ' LEU . 53.0 t -140.53 104.57 4.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.932 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.85 HG23 HD23 ' A' ' 121' ' ' LEU . 7.5 p -139.79 87.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.69 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.639 HD11 ' HA ' ' A' ' 152' ' ' SER . 72.0 mt -99.49 -3.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.796 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 190' ' ' THR . 99.6 mt-10 -90.0 -80.04 0.33 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.291 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 189' ' ' GLU . 13.1 t 177.38 36.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -109.64 16.77 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.436 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.825 ' HB2' HG11 ' A' ' 187' ' ' VAL . 19.0 tp -116.38 132.45 56.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.044 0.45 . . . . 0.0 111.185 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 125' ' ' VAL . 39.9 t -95.11 120.01 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.04 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.65 HG22 HG11 ' A' ' 125' ' ' VAL . 81.6 p -103.31 141.2 36.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.0 111.895 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.401 ' OD2' ' CE2' ' A' ' 124' ' ' PHE . 96.0 m-20 -129.21 144.7 51.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.071 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -113.68 139.98 48.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 111.415 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.61 166.26 13.81 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.374 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 28.9 Cg_endo -62.94 129.88 27.39 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.184 1.923 . . . . 0.0 112.1 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.455 ' HB2' ' N ' ' A' ' 131' ' ' SER . 73.2 Cg_endo -76.09 162.2 34.62 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.643 2.229 . . . . 0.0 112.477 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 16.8 t -86.19 128.68 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.169 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -107.33 -5.02 34.96 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.715 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -100.05 136.65 39.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.795 0.331 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 10.5 p -119.95 129.9 74.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -98.76 125.64 41.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.74 125.83 13.8 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.415 2.076 . . . . 0.0 112.276 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -99.98 119.98 39.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -100.0 123.17 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.818 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 63.3 tttm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.871 -179.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.907 0.384 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 59.96 38.21 21.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.102 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.1 t -99.91 120.06 39.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.21 -164.17 32.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.411 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 60.03 40.67 18.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.817 0.341 . . . . 0.0 111.047 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.5 m -114.18 138.42 50.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -60.04 -39.94 87.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.453 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -109.35 122.68 47.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.889 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.77 138.42 15.17 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.498 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.4 120.02 6.12 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.647 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.12 -23.89 1.54 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.91 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -125.08 140.04 53.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.803 0.335 . . . . 0.0 111.047 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.82 -147.56 18.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.659 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.96 140.02 51.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.0 m -80.66 -5.56 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.722 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -79.91 138.8 37.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.743 0.306 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 36.9 mtt -110.23 110.45 58.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.255 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.37 169.36 4.05 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.311 2.008 . . . . 0.0 111.678 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 117' ' ' THR . 93.7 mt-30 -99.94 120.32 39.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.451 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 116' ' ' SER . 8.9 t -130.0 139.95 50.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.136 0.493 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.617 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 55.2 t80 -128.82 130.19 46.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.98 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.08 135.71 48.98 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 50.0 mt-10 -144.48 160.05 41.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.47 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -119.13 135.46 54.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.417 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 23' ' ' GLU . 95.3 m-85 -149.7 160.02 43.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.943 0.401 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -94.83 132.67 39.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.43 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.79 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 31.4 p -96.48 141.81 29.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.482 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.559 ' HB2' ' CE1' ' A' ' 95' ' ' TYR . 90.9 m-85 -127.07 153.92 76.61 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.693 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.595 ' HG3' ' CG ' ' A' ' 108' ' ' PRO . 5.7 Cg_exo -78.27 107.09 2.25 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.733 2.288 . . . . 0.0 113.016 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HD3' ' A' ' 38' ' ' ARG . 87.2 mt -64.29 -40.03 87.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.87 80.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.276 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.488 ' CB ' ' HB2' ' A' ' 29' ' ' PRO . 57.6 ttm -67.6 -32.54 73.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.946 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.0 159.54 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 98.6 m-20 -60.01 144.49 49.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.44 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -59.18 -38.96 81.11 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 110.799 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.99 -39.9 87.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.344 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 37' ' ' ILE . 83.2 mt -88.72 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.258 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.569 ' HD3' ' O ' ' A' ' 30' ' ' ILE . 62.4 mtm180 -99.68 138.97 36.02 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.261 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -103.67 132.47 49.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.455 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.0 -40.03 87.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.3 . . . . 0.0 111.242 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 96.1 m-20 -66.28 -40.06 89.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.074 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.95 95.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.733 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.14 -39.89 87.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.615 ' HA ' ' HE1' ' A' ' 99' ' ' TRP . 86.4 m-85 -105.52 6.44 32.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.768 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 41' ' ' ASP . . . -96.07 173.4 30.34 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.714 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.8 24.33 21.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.261 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.73 ' HD3' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -101.35 136.03 41.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.937 0.399 . . . . 0.0 111.107 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 50' ' ' LEU . 45.6 pt -121.08 158.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.623 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.596 ' O ' HG23 ' A' ' 94' ' ' VAL . 65.6 m-85 -100.08 131.6 45.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.577 HD13 ' CE2' ' A' ' 69' ' ' PHE . 1.9 mp -131.78 162.65 55.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.042 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.59 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.5 Cg_endo -77.78 144.17 21.7 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.148 1.898 . . . . 0.0 112.155 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 51' ' ' PRO . 33.1 Cg_exo -59.68 -23.93 73.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.603 2.202 . . . . 0.0 112.782 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.0 m -60.03 -39.93 87.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.116 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -38.82 85.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.156 0.503 . . . . 0.0 110.753 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.644 HD13 ' HE1' ' A' ' 67' ' ' MET . 34.7 tp -61.5 -39.94 92.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.771 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.3 p -60.06 -39.04 84.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.143 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HA ' ' CE ' ' A' ' 60' ' ' MET . 98.8 mttt -64.37 -40.06 95.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.96 0.41 . . . . 0.0 110.5 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 63' ' ' ILE . 96.1 mt -61.08 -35.45 77.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.11 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.7 m -60.01 -38.64 83.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.442 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.436 ' CE ' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -60.03 -36.43 77.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.304 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.5 mt -79.94 -1.31 38.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.317 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 60.05 39.99 19.14 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 58' ' ' LEU . 85.4 mt -79.48 126.59 39.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -85.35 142.77 29.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.285 0.564 . . . . 0.0 111.897 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.516 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 47.4 p90 -87.34 157.82 52.8 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.993 ' HG2' HG21 ' A' ' 188' ' ' ILE . 25.2 Cg_exo -65.24 157.77 75.89 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.646 -1.398 . . . . 0.0 112.542 0.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.644 ' HE1' HD13 ' A' ' 55' ' ' LEU . 65.6 mtm -100.14 145.77 27.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.189 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 186' ' ' CYS . 1.3 pt? -116.16 133.7 55.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.503 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.88 ' HB3' HG23 ' A' ' 114' ' ' ILE . 15.7 m-85 -120.03 140.02 51.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.934 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.529 ' HE2' HG21 ' A' ' 79' ' ' VAL . 81.1 tttt -115.08 120.02 38.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.274 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.823 HD22 ' SD ' ' A' ' 100' ' ' MET . 6.5 mp -97.99 127.36 43.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.9 m -115.03 130.23 56.89 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.831 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.09 110.72 22.04 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.641 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.23 -40.07 88.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.03 -39.98 87.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.687 HG21 ' O ' ' A' ' 104' ' ' LEU . 74.4 p -101.6 -10.41 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.61 6.56 16.87 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.615 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -104.1 141.31 36.45 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 120.787 0.327 . . . . 0.0 110.239 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 71' ' ' LEU . 7.2 p -121.18 124.42 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.355 0.598 . . . . 0.0 111.626 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.569 HG23 HD21 ' A' ' 104' ' ' LEU . 68.9 p -104.3 151.12 23.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.34 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.414 ' ND1' HG21 ' A' ' 155' ' ' THR . 77.4 m80 -100.91 115.06 29.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.859 0.361 . . . . 0.0 110.814 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.521 ' HA3' ' CE ' ' A' ' 100' ' ' MET . . . -114.74 139.55 15.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.182 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.492 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -84.24 163.97 39.84 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.564 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.561 ' HB ' ' CD2' ' A' ' 69' ' ' PHE . 7.7 p -126.01 132.58 70.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.064 0.459 . . . . 0.0 111.906 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.73 HD22 ' HD3' ' A' ' 47' ' ' LYS . 64.9 tp -90.33 -74.1 0.5 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.056 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -145.16 160.65 41.11 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.291 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.608 ' CD1' HD22 ' A' ' 55' ' ' LEU . 89.3 m-85 -95.72 116.76 29.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.2 -5.38 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.063 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.704 ' HB1' ' H ' ' A' ' 93' ' ' ARG . . . -90.23 97.77 11.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.023 0.44 . . . . 0.0 111.412 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.95 -39.94 75.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.11 0.481 . . . . 0.0 110.796 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.08 -30.03 68.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.902 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 110.03 50.15 0.69 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.167 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.704 ' H ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 mtt180 -118.45 151.28 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 110.848 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 114' ' ' ILE . 12.4 p -130.03 142.52 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 28' ' ' TYR . 88.6 m-85 -119.08 140.02 50.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -123.56 147.96 54.46 Favored Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.894 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.21 -173.08 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.405 2.07 . . . . 0.0 112.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.91 -20.85 63.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.615 ' HE1' ' HA ' ' A' ' 44' ' ' PHE . 14.4 m95 -60.01 -49.91 75.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.575 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.823 ' SD ' HD22 ' A' ' 71' ' ' LEU . 67.6 mtt -70.01 -39.97 75.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.495 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 29' ' ' PRO . 67.8 mtt -63.89 -47.8 79.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.568 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.98 -40.12 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.235 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.3 m -69.99 -40.04 75.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.938 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.687 ' O ' HG21 ' A' ' 76' ' ' THR . 92.9 mt -95.16 -19.05 20.4 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 101' ' ' MET . . . 58.89 47.76 88.97 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.124 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.6 pt -113.49 150.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.031 0.443 . . . . 0.0 111.439 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -93.35 161.69 30.13 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.595 ' CG ' ' HG3' ' A' ' 29' ' ' PRO . 40.0 Cg_exo -59.62 -5.89 3.84 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.886 2.391 . . . . 0.0 113.421 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.13 -6.82 56.69 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.773 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.4 m -85.02 143.77 28.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.736 0.303 . . . . 0.0 110.988 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.97 145.0 52.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.629 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.851 HD22 HD22 ' A' ' 96' ' ' LEU . 54.1 tp -124.83 125.16 43.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.969 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 93.8 mt-30 -111.33 132.08 54.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.954 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 94' ' ' VAL . 88.9 mt -111.56 130.01 65.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.417 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 82.3 p -126.33 134.43 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.287 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' THR . 67.2 m -83.8 120.84 26.53 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.592 ' O ' HD21 ' A' ' 68' ' ' LEU . 70.8 p -126.34 139.95 52.89 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -112.69 110.8 21.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG23 ' H ' ' A' ' 186' ' ' CYS . 35.1 m -115.58 151.06 45.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.34 133.3 15.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.427 2.084 . . . . 0.0 110.958 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.829 HD13 HG21 ' A' ' 190' ' ' THR . 5.0 mt -62.21 130.91 47.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.213 0.53 . . . . 0.0 112.091 -178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -76.09 159.2 50.31 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.058 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -105.66 -22.7 12.91 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -136.51 134.56 37.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.673 0.273 . . . . 0.0 111.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.725 HG21 HD21 ' A' ' 154' ' ' LEU . 3.2 p -133.52 130.34 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-O 121.133 0.492 . . . . 0.0 111.54 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.813 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 99.4 mttt -96.86 123.12 40.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD22 ' CG2' ' A' ' 171' ' ' ILE . 90.9 mt -116.74 136.6 52.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 0.0 110.761 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' CD ' ' HB3' ' A' ' 199' ' ' PRO . 0.6 OUTLIER -104.06 114.7 64.21 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.458 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.87 158.98 21.25 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.451 2.101 . . . . 0.0 112.83 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 131' ' ' SER . 96.9 mt-30 -122.72 121.6 36.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.649 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 130' ' ' GLN . 47.3 t 69.13 133.98 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.564 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.57 -23.05 29.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.153 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.94 -40.03 87.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.239 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.438 ' HD1' ' CD1' ' A' ' 169' ' ' PHE . 67.2 t80 -59.98 -40.13 88.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.367 . . . . 0.0 110.97 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.36 -9.95 59.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.63 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.48 -10.18 58.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.573 0.225 . . . . 0.0 111.356 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 139' ' ' ASP . 85.6 mt -59.81 138.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.82 0.343 . . . . 0.0 110.492 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 43.0 t -60.04 -40.04 88.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.531 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -129.75 71.24 82.17 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.927 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.686 ' O ' HD23 ' A' ' 144' ' ' LEU . 21.2 Cg_exo -65.11 -32.73 52.31 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.729 2.286 . . . . 0.0 111.909 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.01 -40.03 87.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.285 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.06 -42.38 98.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 147' ' ' VAL . 64.2 t -62.33 -41.33 91.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.7 mm? -63.43 -40.1 96.27 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -45.8 91.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.901 0.382 . . . . 0.0 110.569 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -60.28 -41.36 93.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.051 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 143' ' ' VAL . 62.6 t -60.29 -44.21 95.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.226 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.06 -40.05 88.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.755 0.312 . . . . 0.0 110.825 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 47.4 mtp85 -65.1 -40.02 93.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.094 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.15 -40.08 88.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.539 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 147' ' ' VAL . 90.6 m-85 -97.74 120.15 37.61 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.177 0.513 . . . . 0.0 111.439 -179.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 75.4 m -60.16 -39.91 88.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.022 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 41.9 p -126.87 145.23 50.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.056 0.455 . . . . 0.0 111.866 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.725 HD21 HG21 ' A' ' 125' ' ' VAL . 62.3 tp -119.88 119.4 33.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.999 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.582 HG22 ' HB3' ' A' ' 184' ' ' SER . 73.6 p -124.28 141.37 52.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.739 ' CG2' HG22 ' A' ' 176' ' ' VAL . 97.9 t -59.99 -40.18 82.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.163 0.506 . . . . 0.0 111.841 -179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -66.77 -39.78 87.97 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.869 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 97.0 m-20 -74.5 140.11 44.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.159 0.504 . . . . 0.0 112.325 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.479 HG23 ' CG ' ' A' ' 172' ' ' LYS . 7.2 p -106.04 121.93 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.612 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.492 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 46.0 pt -107.97 131.07 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 19.6 pt-20 -120.03 140.05 51.59 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.682 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.727 HG21 HG22 ' A' ' 147' ' ' VAL . 45.6 pt -121.15 148.97 24.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.121 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 82.3 p -109.01 117.55 34.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.206 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.492 ' CE2' ' OD1' ' A' ' 165' ' ' ASN . 64.6 t80 -119.99 120.06 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 164' ' ' TYR . 10.9 m120 54.07 40.13 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.28 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.15 10.19 85.77 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.14 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.648 ' O ' ' HA ' ' A' ' 163' ' ' SER . 63.2 mttp -109.72 133.45 53.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.751 0.275 . . . . 0.0 110.368 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.1 p -107.38 123.9 49.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.3 m-85 -119.99 140.04 51.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.692 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.416 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 56.4 mttm -103.6 129.74 50.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.612 ' CG2' HD22 ' A' ' 127' ' ' LEU . 85.8 mt -120.02 120.16 62.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.488 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.479 ' CG ' HG23 ' A' ' 159' ' ' VAL . 61.2 mttp -111.15 127.14 55.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.077 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.709 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 4.6 mp -81.6 110.0 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.449 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 175' ' ' GLU . 8.5 tt -63.58 -58.8 5.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.838 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.832 ' HG3' HD23 ' A' ' 174' ' ' LEU . 99.4 mt-10 -158.38 143.03 16.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.099 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.739 HG22 ' CG2' ' A' ' 156' ' ' VAL . 7.2 m -137.55 142.48 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.042 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -92.47 104.71 11.87 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.679 ' HB3' HG23 ' A' ' 185' ' ' ILE . 57.1 Cg_endo -102.99 -0.88 0.34 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.882 3.054 . . . . 0.0 112.966 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.48 21.54 12.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.924 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 91.9 p -141.09 155.56 46.12 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.021 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 84.7 p -70.01 -23.08 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.334 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 22.5 t -59.93 -36.63 77.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.018 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.577 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 29.8 mmtm 69.68 19.96 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.049 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 155' ' ' THR . 52.9 m -130.03 140.01 50.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.094 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 178' ' ' PRO . 44.6 pt -130.36 157.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 112.412 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.611 ' HB2' HD13 ' A' ' 68' ' ' LEU . 34.0 t -120.81 99.8 6.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.226 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.737 HG11 HD22 ' A' ' 192' ' ' LEU . 14.7 p -119.91 107.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.237 -179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.993 HG21 ' HG2' ' A' ' 66' ' ' PRO . 24.0 mt -95.54 -80.0 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.102 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -97.87 3.69 49.75 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.218 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.829 HG21 HD13 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -78.92 171.1 15.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.085 0.469 . . . . 0.0 111.248 -179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -100.11 123.25 44.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.354 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.737 HD22 HG11 ' A' ' 187' ' ' VAL . 13.6 tp -120.29 131.49 54.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.788 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 39.4 t -90.53 120.08 38.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.875 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 8.8 t -118.15 148.14 42.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.109 0.481 . . . . 0.0 111.942 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -120.15 139.74 52.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -99.72 122.43 42.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 0.0 111.18 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -121.29 110.67 34.11 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.8 117.48 4.32 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.394 2.063 . . . . 0.0 112.269 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.462 ' HB3' ' CD ' ' A' ' 128' ' ' GLU . 81.1 Cg_endo -93.99 -3.21 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.934 2.423 . . . . 0.0 112.803 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.6 p -90.54 139.61 17.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.319 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.61 -65.33 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.054 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -100.01 128.96 46.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.751 0.31 . . . . 0.0 110.507 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.82 129.99 74.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.007 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 206' ' ' ASP . 8.2 tt0 -106.11 110.19 63.79 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.053 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.85 10.02 1.8 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.672 2.248 . . . . 0.0 112.711 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.439 ' HB2' ' HG2' ' A' ' 204' ' ' GLU . 96.0 m-20 -82.35 134.56 35.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.735 0.302 . . . . 0.0 110.912 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -100.04 126.87 46.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.958 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.672 0.272 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.98 -44.03 94.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.937 0.398 . . . . 0.0 110.619 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.9 m -59.96 -40.03 87.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.922 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.47 7.76 75.35 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.686 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -119.98 140.02 51.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.779 0.323 . . . . 0.0 110.793 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 t -118.46 124.36 47.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.853 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.6 t -120.06 130.67 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -120.07 139.97 51.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.17 -9.38 76.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.943 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.28 -10.04 74.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.824 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 74.99 21.4 78.49 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.345 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -100.06 120.02 39.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.068 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.52 -148.1 0.13 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.738 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -119.91 140.04 51.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 110.895 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.34 10.03 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.54 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -99.12 -0.01 42.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.303 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 mmt -82.39 139.98 44.98 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.681 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.33 159.73 51.97 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.382 2.055 . . . . 0.0 112.001 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 117' ' ' THR . 72.0 tp60 -100.02 119.86 38.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.033 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 116' ' ' SER . 73.0 p -120.01 133.08 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 116' ' ' SER . 57.4 t80 -120.0 124.96 47.2 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -105.68 135.06 47.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' OE2' ' HG3' ' A' ' 91' ' ' GLU . 85.3 tt0 -145.05 155.28 43.26 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.706 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.62 120.03 41.26 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.17 0.51 . . . . 0.0 111.995 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' HE2' ' HG3' ' A' ' 51' ' ' PRO . 87.1 m-85 -121.06 140.01 52.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.628 ' O ' HG12 ' A' ' 94' ' ' VAL . 36.8 ptt180 -80.02 153.34 28.89 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 69.3 m -83.69 132.79 34.84 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 112.337 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.668 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 3.0 m-85 -130.53 126.29 21.95 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.078 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.713 ' O ' ' HG2' ' A' ' 32' ' ' MET . 16.0 Cg_exo -70.02 113.29 3.37 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.553 2.169 . . . . 0.0 112.016 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.776 HG12 ' HB3' ' A' ' 95' ' ' TYR . 91.4 mt -66.21 -36.79 78.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 110.818 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.71 -39.17 83.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.261 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.713 ' HG2' ' O ' ' A' ' 29' ' ' PRO . 28.0 ptm -68.43 -20.07 64.62 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.134 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' ARG . 96.9 mmm -64.69 156.92 28.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 111.138 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 28.2 m120 -60.06 141.36 55.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.01 -39.66 86.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -59.93 -39.83 86.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.729 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 37' ' ' ILE . 85.5 mt -87.26 -7.76 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.232 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 34' ' ' ASN . 22.4 mtp-105 -98.96 140.04 33.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.086 0.469 . . . . 0.0 111.917 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.94 130.82 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.233 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.93 -40.11 87.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.721 0.296 . . . . 0.0 111.28 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -64.0 -39.96 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.973 0.416 . . . . 0.0 110.85 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.95 96.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.009 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -60.08 -40.02 88.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.58 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -105.14 2.01 28.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.626 0.25 . . . . 0.0 111.565 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.48 173.9 30.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 151' ' ' PHE . . . -100.39 14.88 59.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.403 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.584 ' HD3' ' HB2' ' A' ' 85' ' ' LEU . 98.6 mttt -95.32 133.36 39.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.81 0.338 . . . . 0.0 110.286 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.597 HD11 ' CD1' ' A' ' 114' ' ' ILE . 45.9 pt -118.85 164.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.811 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.445 ' CD1' HG12 ' A' ' 88' ' ' ILE . 98.7 m-85 -100.5 131.54 46.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 110.933 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -129.74 166.77 23.64 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.767 -179.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.862 ' HG3' ' HA ' ' A' ' 91' ' ' GLU . 31.6 Cg_endo -83.13 147.72 13.07 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.821 2.347 . . . . 0.0 113.4 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.967 ' HA ' HD13 ' A' ' 55' ' ' LEU . 37.1 Cg_exo -61.93 -21.27 71.97 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.654 2.236 . . . . 0.0 112.473 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.5 p -60.11 -40.02 88.22 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.0 78.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.545 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.967 HD13 ' HA ' ' A' ' 52' ' ' PRO . 6.5 mp -59.97 -40.25 88.44 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.544 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -40.0 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.548 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 21' ' ' PHE . 60.9 mttp -69.24 -40.01 78.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.383 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.524 HD21 ' CB ' ' A' ' 116' ' ' SER . 88.2 mt -60.24 -39.81 88.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.033 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.4 m -59.99 -39.73 86.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.487 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.2 mtt -60.0 -38.89 83.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.355 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.06 0.01 33.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.517 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 59.97 42.77 15.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 120.811 0.339 . . . . 0.0 111.511 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.407 HD11 ' HG2' ' A' ' 19' ' ' GLN . 43.9 mm -76.33 129.99 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 mtp-105 -83.88 146.71 27.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.37 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.432 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.3 m-85 -87.58 153.53 53.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.65 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.559 ' CG ' HD11 ' A' ' 188' ' ' ILE . 12.3 Cg_exo -71.07 163.09 86.27 Favored 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.659 0.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.432 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 76.0 mtm -84.09 137.0 33.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.358 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.766 ' HB2' ' O ' ' A' ' 117' ' ' THR . 76.7 mt -115.3 131.91 56.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.498 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.617 ' HE1' HG11 ' A' ' 84' ' ' VAL . 95.4 m-85 -129.6 144.1 51.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.97 0.414 . . . . 0.0 111.53 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.596 ' HD3' ' CE1' ' A' ' 81' ' ' HIS . 28.3 ttpp -119.53 130.46 55.2 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.668 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 112' ' ' LEU . 7.5 mp -100.02 121.82 41.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.631 HG23 HG22 ' A' ' 79' ' ' VAL . 98.6 m -114.17 130.04 56.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.983 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.19 30.95 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.487 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -68.42 -39.63 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.766 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -39.95 87.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.721 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 105' ' ' GLY . 29.8 m -103.58 -15.97 15.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.57 7.92 62.07 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.536 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -99.4 140.17 33.97 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.85 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 72' ' ' THR . 59.3 t -119.95 120.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.988 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.5 p -109.28 138.35 45.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.273 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.596 ' CE1' ' HD3' ' A' ' 70' ' ' LYS . 3.1 m-70 -84.12 114.14 21.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.104 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.08 146.16 16.03 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.928 -0.654 . . . . 0.0 113.177 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.524 ' HA2' ' HB3' ' A' ' 152' ' ' SER . . . -96.51 162.62 22.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.771 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.617 HG11 ' HE1' ' A' ' 69' ' ' PHE . 8.1 p -120.73 126.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . 48.6 tp -91.63 -74.71 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.473 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -139.9 159.96 41.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.245 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CE2' HD11 ' A' ' 55' ' ' LEU . 70.8 m-85 -100.79 116.21 32.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.826 0.346 . . . . 0.0 111.538 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 HG12 ' CD1' ' A' ' 49' ' ' PHE . 48.3 pt -137.99 -4.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.827 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -104.29 158.02 16.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.851 0.358 . . . . 0.0 110.889 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 93' ' ' ARG . 97.9 mt-10 -76.67 158.17 31.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.333 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.862 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 85.8 tt0 -59.99 -30.35 69.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.598 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 26' ' ' ARG . . . -81.81 1.24 86.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.308 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.545 ' HA ' ' HG2' ' A' ' 26' ' ' ARG . 46.6 ptt85 -144.23 145.88 32.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 26' ' ' ARG . 7.7 p -142.89 150.41 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.664 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.776 ' HB3' HG12 ' A' ' 30' ' ' ILE . 85.3 m-85 -118.63 139.99 50.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.914 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.7 pt? -134.34 159.05 73.76 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.433 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 48' ' ' ILE . 22.9 Cg_exo -64.66 147.97 90.14 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.792 2.328 . . . . 0.0 112.13 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -60.01 -42.29 94.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.163 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -68.72 -40.04 80.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.5 ttm -60.03 -40.28 88.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.12 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.461 ' HG3' HG13 ' A' ' 106' ' ' ILE . 67.4 ttp -60.62 -41.27 94.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.46 -39.99 95.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.731 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.0 m -62.55 -40.01 95.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.471 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.32 -23.82 63.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.564 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 76' ' ' THR . . . 76.32 35.0 43.97 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.739 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.538 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.5 pt -118.11 147.43 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.969 0.414 . . . . 0.0 111.3 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 1.1 pt20 -98.18 161.63 24.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 8.5 Cg_endo -49.34 136.44 31.83 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.74 2.293 . . . . 0.0 112.162 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.99 -9.9 75.75 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.612 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.538 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 70.4 p -70.11 161.08 30.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.682 0.277 . . . . 0.0 110.747 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.0 mt -87.25 140.65 29.33 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.898 0.38 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 60.2 tp -120.07 127.99 53.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -106.93 119.95 40.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.18 0.514 . . . . 0.0 110.902 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.836 HD13 HD21 ' A' ' 50' ' ' LEU . 18.9 tt -120.97 128.05 76.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.339 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 79.8 p -120.69 138.83 53.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.852 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 20' ' ' THR . 44.9 t -80.17 110.72 15.85 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.766 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 92.9 m -119.51 129.4 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -101.5 119.23 38.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.034 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.424 HG21 ' SG ' ' A' ' 186' ' ' CYS . 22.1 m -120.12 152.6 54.65 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.8 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.523 ' CG ' ' HB2' ' A' ' 179' ' ' GLU . 49.4 Cg_endo -67.78 175.29 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.423 2.082 . . . . 0.0 110.684 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 122' ' ' GLY . 7.7 tt -94.41 120.04 34.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.938 0.399 . . . . 0.0 111.257 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.692 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -62.35 151.25 46.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.919 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -101.33 -17.02 16.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 117.065 0.433 . . . . 0.0 111.767 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.523 ' HE2' ' HG3' ' A' ' 126' ' ' LYS . 69.0 t80 -150.27 134.78 17.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.806 0.336 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.766 ' CG1' HG22 ' A' ' 194' ' ' THR . 7.7 p -139.21 130.05 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.344 0.592 . . . . 0.0 111.419 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.843 ' HB2' ' H ' ' A' ' 175' ' ' GLU . 83.8 mttt -94.98 126.3 40.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.487 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.1 mt -115.3 133.28 56.18 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.88 0.372 . . . . 0.0 110.954 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -109.19 110.59 60.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.762 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.52 175.59 10.87 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.579 2.186 . . . . 0.0 112.395 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -124.02 121.35 35.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.304 0.573 . . . . 0.0 110.089 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.496 ' CA ' ' HB3' ' A' ' 199' ' ' PRO . 6.3 t 59.83 168.78 0.07 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.086 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.794 HG22 ' HG2' ' A' ' 199' ' ' PRO . 16.4 t -77.26 -19.99 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.702 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 134' ' ' PHE . 47.7 p-10 -60.03 -39.93 87.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.01 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.503 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 66.9 t80 -59.96 -40.04 87.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.348 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.1 mt -81.1 -7.71 59.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.717 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.94 -12.78 61.87 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.359 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 143' ' ' VAL . 85.4 mt -60.33 138.82 20.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.4 m -60.07 -39.99 87.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.853 0.358 . . . . 0.0 111.314 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.487 ' H ' HG22 ' A' ' 137' ' ' ILE . 36.4 m-20 -125.9 75.73 71.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.416 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 25.2 Cg_endo -62.17 -40.61 40.52 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.5 2.133 . . . . 0.0 112.203 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -60.29 -40.02 88.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.171 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.36 96.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.941 0.401 . . . . 0.0 110.767 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 137' ' ' ILE . 84.6 t -60.66 -41.96 90.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.247 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.652 HD13 ' C ' ' A' ' 144' ' ' LEU . 3.0 tm? -59.98 -41.69 92.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.23 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -60.01 -40.47 89.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 0.0 111.043 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.97 -39.99 96.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.17 0.509 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.8 HG22 HG21 ' A' ' 162' ' ' ILE . 77.2 t -61.89 -43.49 97.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.054 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.1 mt -59.98 -40.95 90.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.02 0.438 . . . . 0.0 110.557 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -64.28 -40.15 95.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 96.7 m-20 -61.28 -40.05 92.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.478 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 46' ' ' GLY . 97.7 m-85 -101.16 120.02 39.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.496 . . . . 0.0 110.911 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.524 ' HB3' ' HA2' ' A' ' 83' ' ' GLY . 10.0 t -68.63 -39.99 80.51 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.864 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 81' ' ' HIS . 74.1 p -124.41 140.06 53.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.219 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 151' ' ' PHE . 86.9 mt -131.18 136.89 48.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.962 0.411 . . . . 0.0 111.819 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 157' ' ' ASP . 21.7 m -118.77 145.49 45.56 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.704 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 95.5 t -60.02 -41.6 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.42 0.629 . . . . 0.0 110.646 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 155' ' ' THR . 95.9 m-20 -72.98 -40.01 65.61 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.675 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' A' ' 155' ' ' THR . 54.0 t0 -61.01 135.21 57.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.999 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -104.27 120.03 53.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.31 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.9 pt -103.92 140.61 21.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.337 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.543 ' OE2' ' HE2' ' A' ' 170' ' ' LYS . 99.1 mt-10 -118.26 141.36 48.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.019 0.438 . . . . 0.0 111.495 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.826 HD12 ' CE1' ' A' ' 164' ' ' TYR . 48.2 pt -125.63 139.87 50.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.598 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 33.2 p -105.81 108.16 19.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.919 0.39 . . . . 0.0 111.654 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.826 ' CE1' HD12 ' A' ' 162' ' ' ILE . 39.6 m-85 -120.49 123.75 43.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.707 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 59.29 34.34 22.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 12.39 83.4 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.062 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 163' ' ' SER . 98.5 mttt -119.45 138.43 53.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.791 0.295 . . . . 0.0 111.09 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 162' ' ' ILE . 9.6 t -108.6 131.79 54.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.115 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 88.4 m-85 -120.01 140.03 51.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.543 ' HE2' ' OE2' ' A' ' 161' ' ' GLU . 96.8 mttt -97.2 127.25 43.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.873 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -119.94 120.03 61.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.957 0.408 . . . . 0.0 110.841 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -113.12 134.5 54.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.285 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.704 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -79.49 122.26 34.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.522 179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 126' ' ' LYS . 84.6 mt -73.03 -57.9 3.7 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.083 0.468 . . . . 0.0 111.195 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.843 ' H ' ' HB2' ' A' ' 126' ' ' LYS . 99.1 mt-10 -159.92 145.84 15.67 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.852 ' CB ' HD11 ' A' ' 185' ' ' ILE . 5.4 m -140.24 160.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -110.93 103.66 55.06 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 81.0 Cg_endo -100.25 171.18 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.605 2.87 . . . . 0.0 113.041 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.523 ' HB2' ' CG ' ' A' ' 120' ' ' PRO . 70.5 mm-40 -99.97 3.74 44.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.038 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.4 m -136.25 160.52 38.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 111.399 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.09 -13.11 62.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.341 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 79.8 p -67.9 -13.1 61.88 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.652 0.263 . . . . 0.0 111.428 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.681 ' HE3' HG22 ' A' ' 176' ' ' VAL . 4.8 tptm 49.99 41.84 23.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.322 0.582 . . . . 0.0 110.843 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.1 m -123.71 144.73 49.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.471 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.852 HD11 ' CB ' ' A' ' 176' ' ' VAL . 20.2 mt -119.3 134.08 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.385 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.424 ' SG ' HG21 ' A' ' 119' ' ' VAL . 64.2 m -142.21 100.09 3.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.011 0.434 . . . . 0.0 111.027 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.676 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -149.42 113.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.856 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 66' ' ' PRO . 44.1 pt -103.21 -10.13 9.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.3 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -89.96 -79.98 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.472 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 191' ' ' ASP . 14.6 t -172.52 -161.23 0.16 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 111.439 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 190' ' ' THR . 96.5 m-20 71.75 24.7 3.37 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.033 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.676 ' HB2' HG11 ' A' ' 187' ' ' VAL . 21.1 tp -117.98 132.41 56.39 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.569 ' O ' HG12 ' A' ' 125' ' ' VAL . 47.1 t -94.59 124.84 47.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.766 HG22 ' CG1' ' A' ' 125' ' ' VAL . 76.3 p -115.93 149.77 38.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -125.28 135.82 52.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.869 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.76 138.85 39.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.157 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -117.7 162.49 28.66 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.701 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 53.0 Cg_endo -68.24 153.61 74.11 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.966 1.777 . . . . 0.0 112.03 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.794 ' HG2' HG22 ' A' ' 132' ' ' VAL . 75.8 Cg_exo -51.09 169.2 0.19 Allowed 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.793 2.329 . . . . 0.0 112.626 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 200' ' ' VAL . 17.1 m -90.31 119.98 38.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.098 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -108.22 25.44 20.1 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.239 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -98.95 129.74 45.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.894 0.378 . . . . 0.0 110.972 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.28 139.99 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.956 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -93.58 120.81 65.94 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.92 16.41 1.48 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.543 2.162 . . . . 0.0 112.798 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.84 140.03 36.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.77 0.319 . . . . 0.0 110.852 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -97.66 122.55 40.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.797 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.859 0.362 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.465 ' CE2' ' HA2' ' A' ' 4' ' ' GLY . 47.1 p90 -148.02 160.35 42.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -59.9 -38.95 83.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.328 . . . . 0.0 110.993 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' HA2' ' CE2' ' A' ' 2' ' ' PHE . . . 100.8 16.93 24.8 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.337 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.517 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 64.9 t80 -73.8 133.46 43.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.831 0.348 . . . . 0.0 110.509 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.1 m -59.88 139.76 57.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.426 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -60.27 -39.92 88.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.686 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -104.84 139.7 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.231 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.66 -172.58 40.97 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.715 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 5' ' ' PHE . . . 179.97 179.04 48.8 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.75 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.28 -1.0 87.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.849 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -100.03 120.01 39.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.889 0.376 . . . . 0.0 110.536 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.23 -162.39 33.71 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.391 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.01 140.04 51.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 0.0 110.759 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 17' ' ' MET . 60.8 t -109.23 122.56 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.757 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.15 7.55 46.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.625 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.539 ' H ' HG12 ' A' ' 15' ' ' VAL . 3.9 ttt -95.45 119.79 64.76 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.621 0.248 . . . . 0.0 111.167 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' MET . 35.6 Cg_exo -61.27 157.67 39.15 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.73 2.287 . . . . 0.0 112.442 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.643 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.8 mt-30 -105.77 118.53 36.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.48 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.716 ' HA ' ' O ' ' A' ' 116' ' ' SER . 58.5 p -121.07 126.55 50.11 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 115' ' ' SER . 72.6 t80 -121.09 120.42 35.27 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 115' ' ' SER . 98.9 mt-10 -98.29 140.99 31.74 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -176.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 71.3 mt-10 -149.96 159.99 43.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.615 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' O ' ' CD2' ' A' ' 24' ' ' PHE . 55.2 p90 -100.2 120.21 39.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.162 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.957 ' HB3' HG21 ' A' ' 94' ' ' VAL . 94.4 m-85 -120.19 140.36 51.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.028 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.643 ' O ' ' HB ' ' A' ' 94' ' ' VAL . 76.4 mtp85 -82.31 142.66 31.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.393 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 112' ' ' LEU . 50.6 m -84.48 135.4 34.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.899 0.38 . . . . 0.0 111.796 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' HB3' ' CE2' ' A' ' 95' ' ' TYR . 21.5 m-85 -129.71 137.21 30.43 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.249 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 33' ' ' MET . 95.4 Cg_endo -79.26 92.24 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.684 2.256 . . . . 0.0 112.965 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.797 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 85.0 mt -59.96 -40.02 81.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.983 0.421 . . . . 0.0 110.601 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.87 87.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.729 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.42 -31.07 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.71 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.575 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 94.4 mmm -59.21 145.01 44.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.572 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.546 ' HB3' HG12 ' A' ' 37' ' ' ILE . 19.6 t-20 -59.88 139.87 57.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.372 0.606 . . . . 0.0 112.359 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.91 -38.89 83.6 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.023 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 92.7 mtt-85 -59.87 -40.0 87.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.366 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 34' ' ' ASN . 47.6 pt -95.49 -1.45 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.575 ' HG3' ' HB2' ' A' ' 33' ' ' MET . 79.2 mmt-85 -125.43 155.75 39.93 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.033 0.444 . . . . 0.0 111.793 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -101.01 133.25 45.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.555 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.18 -39.92 88.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.218 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -39.86 87.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.837 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.08 84.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.506 HD21 HG22 ' A' ' 30' ' ' ILE . 27.2 m120 -60.01 -40.27 88.65 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.76 0.314 . . . . 0.0 111.308 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -101.45 4.12 40.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.642 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.11 -174.49 28.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.232 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.35 32.46 6.8 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.695 ' HD2' HD13 ' A' ' 85' ' ' LEU . 36.6 ttpt -102.55 129.5 49.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.208 -0.496 . . . . 0.0 112.096 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 50' ' ' LEU . 41.7 pt -131.73 161.07 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.818 ' C ' HD22 ' A' ' 50' ' ' LEU . 93.0 m-85 -104.06 133.39 49.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.062 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.818 HD22 ' C ' ' A' ' 49' ' ' PHE . 3.3 mm? -133.08 157.58 77.96 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 121.001 0.429 . . . . 0.0 111.391 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.688 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 72.1 Cg_endo -75.24 132.55 15.22 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.21 2.607 . . . . 0.0 112.753 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' N ' ' HB3' ' A' ' 87' ' ' PHE . 52.2 Cg_exo -53.59 -15.23 6.03 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 113.32 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.0 m -59.92 -40.1 87.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.146 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.69 87.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.049 0.452 . . . . 0.0 111.088 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.881 HD21 ' CE1' ' A' ' 87' ' ' PHE . 68.7 mt -59.92 -39.75 86.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.215 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.2 m -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 0.0 109.974 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HA ' ' HE2' ' A' ' 60' ' ' MET . 73.3 mmtt -66.67 -39.94 88.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.294 0.569 . . . . 0.0 109.976 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.863 HD13 ' SD ' ' A' ' 67' ' ' MET . 90.8 mt -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.584 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -56.69 -38.19 71.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.037 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.666 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 77.4 mtm -59.98 -38.27 82.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.8 mt -80.77 1.34 30.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 60.04 39.96 19.22 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.784 0.326 . . . . 0.0 111.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.592 HG22 ' HG2' ' A' ' 67' ' ' MET . 82.1 mt -88.5 120.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.186 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -95.77 140.21 30.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.619 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.553 ' HA ' ' C ' ' A' ' 66' ' ' PRO . 51.8 p90 -87.17 159.67 50.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 65' ' ' TYR . 34.9 Cg_exo -60.53 134.41 12.05 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.522 0.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.863 ' SD ' HD13 ' A' ' 58' ' ' LEU . 74.3 mtm -98.82 140.4 33.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.208 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 153' ' ' THR . 1.9 mp -97.42 127.46 43.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.215 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 116' ' ' SER . 89.3 m-85 -119.95 140.08 51.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.506 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.02 129.98 55.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.151 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 114' ' ' ILE . 1.4 mp -97.14 123.22 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.686 0.279 . . . . 0.0 111.078 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.701 ' HA ' HG12 ' A' ' 79' ' ' VAL . 90.8 m -114.02 121.28 43.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.398 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . . . -117.23 139.18 51.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.244 178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.406 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . 98.6 m-20 62.27 147.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.851 0.358 . . . . 0.0 110.344 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.96 -40.67 89.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.1 p -133.13 8.41 4.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.404 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 74' ' ' ASN . . . -67.92 -105.73 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.849 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -138.41 157.41 46.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.924 0.392 . . . . 0.0 111.287 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 72' ' ' THR . 33.3 m -129.77 136.69 58.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.553 ' OG1' ' HG ' ' A' ' 104' ' ' LEU . 41.9 m -99.04 148.79 23.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.937 0.398 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -119.74 131.12 55.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.759 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.16 175.24 44.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.716 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -103.64 -175.06 25.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.478 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.96 159.97 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.805 0.336 . . . . 0.0 111.559 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.695 HD13 ' HD2' ' A' ' 47' ' ' LYS . 65.0 tp -93.4 -79.98 0.39 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.341 0.591 . . . . 0.0 110.863 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -152.44 159.21 43.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.587 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.881 ' CE1' HD21 ' A' ' 55' ' ' LEU . 7.2 m-85 -100.97 118.0 36.12 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.449 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.6 pt -134.16 -4.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.96 99.68 12.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.994 0.426 . . . . 0.0 111.391 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.09 -39.93 78.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.536 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.1 -30.26 70.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.633 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.688 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 104.34 68.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.421 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HG2' ' OH ' ' A' ' 28' ' ' TYR . 84.8 mtt85 -119.98 141.05 50.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.918 0.39 . . . . 0.0 110.767 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.957 HG21 ' HB3' ' A' ' 25' ' ' PHE . 88.9 t -129.24 133.41 65.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.583 0.706 . . . . 0.0 112.173 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.797 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 85.5 m-85 -117.23 139.12 51.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.688 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -132.86 147.11 64.17 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.283 -179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' HD2' ' SD ' ' A' ' 100' ' ' MET . 93.3 Cg_endo -83.97 -170.44 0.85 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.768 2.312 . . . . 0.0 112.626 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.5 -27.1 68.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.036 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.492 ' CH2' ' HZ ' ' A' ' 151' ' ' PHE . 19.6 m95 -59.95 -49.49 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.916 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.551 ' HA ' HG21 ' A' ' 80' ' ' THR . 65.1 mtt -68.57 -40.04 80.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.315 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 57.8 ttm -62.37 -49.87 73.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.794 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.26 -39.92 78.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.423 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 93.9 m -67.47 -40.07 85.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.223 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.79 HD22 ' CB ' ' A' ' 73' ' ' ALA . 86.0 mt -88.57 -20.59 24.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.502 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.57 76.39 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.464 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.454 HD12 ' OG ' ' A' ' 110' ' ' SER . 45.1 pt -112.97 140.22 34.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 111.738 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 11.9 pm0 -95.91 162.33 24.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.471 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 99.5 Cg_exo -43.32 146.17 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.581 2.187 . . . . 0.0 112.694 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.96 -9.97 75.51 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.105 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 106' ' ' ILE . 89.4 p -77.31 163.14 26.74 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 122.769 -0.253 . . . . 0.0 110.718 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.49 139.85 30.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.784 0.326 . . . . 0.0 110.726 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.595 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 67.8 tp -126.5 124.86 41.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.981 0.419 . . . . 0.0 111.06 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -111.97 120.1 40.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.857 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.794 HG12 ' CD2' ' A' ' 25' ' ' PHE . 47.2 pt -118.18 134.58 61.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.126 0.489 . . . . 0.0 111.047 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 30.7 t -119.99 128.72 53.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.956 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 20' ' ' THR . 22.2 t -65.6 117.66 8.38 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 19' ' ' GLN . 90.6 m -119.27 129.87 55.13 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.433 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 58.1 t0 -100.39 117.67 35.05 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 186' ' ' CYS . 26.4 m -113.09 151.6 44.32 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.982 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 179' ' ' GLU . 88.8 Cg_endo -78.87 159.32 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.572 2.181 . . . . 0.0 111.539 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 121' ' ' LEU . 6.5 mp -74.94 126.42 30.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.09 157.15 46.44 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.503 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.43 -28.97 8.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.739 0.27 . . . . 0.0 111.69 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.54 ' HE2' ' HE3' ' A' ' 126' ' ' LYS . 65.0 t80 -142.23 130.18 21.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.869 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.801 ' HA ' HG12 ' A' ' 176' ' ' VAL . 13.2 p -132.89 131.85 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.905 ' HD2' ' HB3' ' A' ' 175' ' ' GLU . 96.1 mttt -102.04 125.81 48.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.455 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 171' ' ' ILE . 89.8 mt -110.02 136.06 49.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.523 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -99.54 111.3 61.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.017 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.58 160.37 31.68 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.736 2.29 . . . . 0.0 112.615 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.495 ' OE1' ' HB2' ' A' ' 170' ' ' LYS . 95.1 mt-30 -128.83 122.13 29.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.191 0.519 . . . . 0.0 110.289 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 69.09 134.28 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.524 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.3 -21.39 26.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.264 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -59.94 -40.54 89.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.718 0.294 . . . . 0.0 110.773 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 75.6 t80 -59.93 -40.55 89.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.007 0.432 . . . . 0.0 110.813 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.8 mt -81.31 -9.06 59.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.712 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -69.99 -12.82 61.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.565 0.222 . . . . 0.0 111.395 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.5 mt -59.98 139.59 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.3 p -61.08 -39.97 91.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.339 . . . . 0.0 111.506 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 137' ' ' ILE . 13.1 m-20 -129.26 74.34 81.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.953 0.406 . . . . 0.0 110.514 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.704 ' O ' HD23 ' A' ' 144' ' ' LEU . 56.9 Cg_endo -71.94 -35.51 7.19 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.569 2.179 . . . . 0.0 112.239 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.207 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.91 97.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.846 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.629 HG13 ' CZ ' ' A' ' 164' ' ' TYR . 97.4 t -60.43 -42.2 90.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.99 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 140' ' ' PRO . 4.1 mm? -59.91 -40.11 87.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.559 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.94 -42.93 95.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.666 0.269 . . . . 0.0 110.636 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -62.28 -41.0 98.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.056 0.455 . . . . 0.0 110.487 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.595 HG21 HD12 ' A' ' 162' ' ' ILE . 84.4 t -63.35 -40.2 88.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.385 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.52 ' CD2' HD11 ' A' ' 154' ' ' LEU . 94.3 mt -60.07 -40.45 89.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 60.8 ttt85 -63.14 -39.93 96.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.117 0.484 . . . . 0.0 110.591 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -60.96 -39.93 91.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.708 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.608 ' O ' HG13 ' A' ' 187' ' ' VAL . 42.1 m-85 -94.68 122.25 37.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.052 0.453 . . . . 0.0 111.174 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.542 ' HB2' HG12 ' A' ' 188' ' ' ILE . 90.0 p -71.5 -33.68 69.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.657 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.783 ' HB ' HD23 ' A' ' 68' ' ' LEU . 7.8 t -136.26 141.21 43.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.962 0.41 . . . . 0.0 111.907 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.725 ' HG ' HG11 ' A' ' 187' ' ' VAL . 83.6 mt -119.92 127.23 52.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.466 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 158' ' ' ASP . 38.2 p -121.5 145.27 48.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.5 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.747 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.7 t -60.07 -39.92 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.263 0.554 . . . . 0.0 111.309 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.74 -37.02 83.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.845 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.505 ' HB2' ' OG1' ' A' ' 155' ' ' THR . 55.0 t0 -68.72 129.99 41.54 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 159' ' ' VAL . 7.9 p -98.58 119.98 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.184 177.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 171' ' ' ILE . 45.8 pt -99.89 134.82 38.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 112.061 -178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 50.4 mt-10 -113.97 141.13 47.79 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.593 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.761 HD11 ' CE1' ' A' ' 164' ' ' TYR . 16.7 tt -121.26 129.98 75.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.355 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 23.3 p -108.7 110.07 21.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.788 0.328 . . . . 0.0 111.753 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.761 ' CE1' HD11 ' A' ' 162' ' ' ILE . 5.5 m-85 -126.24 126.71 44.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 58.33 34.22 23.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.239 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.0 16.01 77.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.993 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 163' ' ' SER . 68.6 mttm -117.75 138.49 52.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.782 0.291 . . . . 0.0 110.57 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 74.2 p -110.93 131.08 55.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.058 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.65 ' O ' ' HA ' ' A' ' 161' ' ' GLU . 93.7 m-85 -119.98 139.9 51.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.321 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' HB2' ' OE1' ' A' ' 130' ' ' GLN . 61.7 mtpt -103.81 127.19 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 160' ' ' ILE . 49.0 mm -119.96 129.21 75.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.456 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -114.92 133.32 56.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.633 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.747 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.9 OUTLIER -70.0 98.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.119 179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.487 HD22 ' HD3' ' A' ' 126' ' ' LYS . 8.8 tt -60.02 -52.25 66.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.709 0.29 . . . . 0.0 111.742 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.905 ' HB3' ' HD2' ' A' ' 126' ' ' LYS . 83.4 tt0 -162.7 139.02 7.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.347 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 125' ' ' VAL . 11.5 m -141.26 152.88 19.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.201 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.9 103.87 43.41 Favored Pre-proline 0 C--N 1.33 -0.239 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 176' ' ' VAL . 71.8 Cg_endo -100.68 175.15 0.3 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.72 2.946 . . . . 0.0 112.435 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 120' ' ' PRO . 99.8 mt-10 -94.05 0.04 55.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.976 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.7 m -136.64 154.33 50.68 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-O 120.956 0.408 . . . . 0.0 111.34 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.9 m -70.03 -11.84 61.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.523 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.1 m -69.96 -9.42 55.03 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.498 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 41.4 mttt 59.95 38.67 20.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.089 0.471 . . . . 0.0 111.224 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 56.2 m -130.05 135.79 48.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.612 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 45.3 pt -129.96 160.02 41.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.936 0.398 . . . . 0.0 111.768 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.814 ' HB2' HG23 ' A' ' 119' ' ' VAL . 46.4 t -99.94 120.46 39.83 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.886 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.725 HG11 ' HG ' ' A' ' 154' ' ' LEU . 9.7 p -110.66 14.59 8.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.412 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.748 HD11 ' HG ' ' A' ' 68' ' ' LEU . 91.0 mt -59.96 -46.28 94.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.481 ' HG3' HG22 ' A' ' 188' ' ' ILE . 98.9 mt-10 -155.88 81.59 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.229 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 187' ' ' VAL . 12.7 t -150.05 157.36 43.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.899 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -87.93 103.78 16.0 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.509 ' HG ' HG12 ' A' ' 125' ' ' VAL . 56.8 tp -119.94 134.17 55.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.451 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 34.2 t -97.3 122.27 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.484 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 125' ' ' VAL . 70.2 p -102.5 142.46 33.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.568 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -129.55 146.54 51.35 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.659 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -105.68 139.91 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.319 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.523 ' HB1' ' HD2' ' A' ' 198' ' ' PRO . . . -108.92 165.95 11.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.999 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.523 ' HD2' ' HB1' ' A' ' 197' ' ' ALA . 77.4 Cg_exo -51.24 149.79 15.74 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.621 2.214 . . . . 0.0 112.461 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.95 164.16 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.685 2.256 . . . . 0.0 112.469 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.94 135.1 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.222 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 110.14 -28.64 10.12 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.572 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -101.53 127.09 48.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.97 130.84 73.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.406 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.96 119.99 58.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.25 140.9 73.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.42 2.08 . . . . 0.0 112.291 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -98.28 129.04 45.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.755 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -99.01 127.05 44.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.871 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.901 0.381 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -120.08 139.82 51.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.565 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 29.0 t -130.83 138.75 50.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.639 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.0 -38.39 74.29 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.214 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 3' ' ' SER . 98.8 m-85 61.56 19.99 10.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.706 0.289 . . . . 0.0 111.099 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.5 t -130.58 139.71 50.44 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.697 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.5 m -120.31 124.05 44.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.831 0.348 . . . . 0.0 111.193 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.592 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 71.9 t80 -60.31 -40.0 88.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.59 -7.27 82.23 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.078 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.592 ' H ' ' HD2' ' A' ' 8' ' ' PHE . . . -119.94 -14.04 5.77 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.489 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.3 -153.21 51.67 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.983 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.16 -39.94 88.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.875 0.369 . . . . 0.0 110.791 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.9 -178.9 46.51 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.216 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -99.72 113.34 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.097 0.475 . . . . 0.0 109.972 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.14 11.37 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.439 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 55.5 t30 59.97 36.32 21.59 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.09 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.1 mtt -104.41 132.26 21.12 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.009 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 13.8 Cg_endo -55.6 158.4 13.26 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.608 2.205 . . . . 0.0 111.779 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' A' ' 117' ' ' THR . 97.1 mt-30 -99.83 126.69 45.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 116' ' ' SER . 33.6 p -119.8 126.28 50.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.1 0.476 . . . . 0.0 111.76 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 115' ' ' SER . 65.9 t80 -120.17 124.35 45.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.618 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.51 129.94 55.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' CD ' ' CZ ' ' A' ' 25' ' ' PHE . 81.7 tt0 -148.05 154.93 40.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.128 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -105.25 127.19 52.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.712 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.676 ' HZ ' ' HB2' ' A' ' 54' ' ' ALA . 95.6 m-85 -133.47 159.98 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.719 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -96.06 127.88 42.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.916 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.512 ' HB3' HD22 ' A' ' 112' ' ' LEU . 28.7 p -91.37 143.62 26.43 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.517 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 93' ' ' ARG . 20.1 m-85 -129.95 153.34 80.97 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.502 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HB2' ' HG2' ' A' ' 32' ' ' MET . 89.6 Cg_endo -78.28 103.67 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.798 2.332 . . . . 0.0 112.968 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.766 ' CG1' ' HB3' ' A' ' 95' ' ' TYR . 88.5 mt -60.75 -40.07 83.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.113 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.625 ' HB2' HE21 ' A' ' 98' ' ' GLN . . . -59.83 -29.7 68.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.389 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.615 ' HG2' ' HB2' ' A' ' 29' ' ' PRO . 97.2 mmm -67.71 -38.68 83.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.939 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 91.2 mtp -64.89 148.66 51.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.013 0.435 . . . . 0.0 111.074 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -59.53 140.94 55.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.057 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.51 -21.02 63.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.056 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.973 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 pt -99.99 1.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.094 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -127.03 159.33 34.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.151 0.501 . . . . 0.0 111.691 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -99.96 129.71 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.969 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.03 -40.12 88.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.858 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.23 -39.95 88.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.262 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.21 76.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.652 HD21 ' HG3' ' A' ' 98' ' ' GLN . 20.5 t-20 -60.07 -40.61 90.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.033 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -100.83 1.52 40.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.242 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.29 -170.63 34.86 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -108.99 31.48 7.68 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.817 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.702 ' HD3' HD11 ' A' ' 85' ' ' LEU . 62.0 mttp -99.71 121.96 42.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.98 0.419 . . . . 0.0 111.378 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.715 HD12 HD11 ' A' ' 50' ' ' LEU . 48.4 pt -119.42 149.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.502 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.745 ' CE1' ' HB2' ' A' ' 89' ' ' ALA . 65.3 t80 -104.77 127.84 52.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.632 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.72 HD21 HD13 ' A' ' 114' ' ' ILE . 2.0 mp -133.39 160.02 70.26 Favored Pre-proline 0 N--CA 1.463 0.205 0 CA-C-O 120.646 0.26 . . . . 0.0 111.512 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.674 ' CA ' ' HB3' ' A' ' 89' ' ' ALA . 62.8 Cg_endo -72.32 147.76 47.87 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.766 2.31 . . . . 0.0 112.595 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 89' ' ' ALA . 27.3 Cg_exo -62.55 -19.0 66.48 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.866 2.377 . . . . 0.0 112.878 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.676 ' HB2' ' HZ ' ' A' ' 25' ' ' PHE . . . -65.51 -43.42 90.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.092 0.473 . . . . 0.0 110.961 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 87' ' ' PHE . 57.9 tp -60.28 -42.23 94.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.233 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.7 m -60.11 -40.1 88.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.065 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.03 -40.09 90.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 69' ' ' PHE . 96.7 mt -63.63 -38.39 90.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.7 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.4 m -60.01 -37.96 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.11 -36.55 77.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.255 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -80.28 -1.77 42.31 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.296 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 59.96 40.59 18.75 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.595 ' CD1' HD22 ' A' ' 58' ' ' LEU . 85.4 mt -73.17 130.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.404 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -66.08 140.08 58.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.654 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.717 ' CG ' ' HA ' ' A' ' 66' ' ' PRO . 16.3 t80 -96.53 147.17 32.54 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.445 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.717 ' HA ' ' CG ' ' A' ' 65' ' ' TYR . 24.4 Cg_exo -66.96 155.45 84.14 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.149 -1.188 . . . . 0.0 113.062 0.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.441 ' HG3' ' HD1' ' A' ' 65' ' ' TYR . 66.6 mtt -90.86 140.29 29.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.38 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 117' ' ' THR . 35.7 mt -105.75 141.0 37.93 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.079 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.711 ' HB3' ' CG1' ' A' ' 114' ' ' ILE . 60.5 m-85 -133.41 147.0 51.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.431 . . . . 0.0 112.108 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.643 ' O ' ' HA ' ' A' ' 114' ' ' ILE . 97.7 mttt -121.39 137.91 54.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.19 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.671 ' C ' HG23 ' A' ' 79' ' ' VAL . 86.5 mt -99.2 119.99 38.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.29 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -108.05 125.52 51.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.751 0.31 . . . . 0.0 111.665 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB2' ' HB3' ' A' ' 104' ' ' LEU . . . -100.49 119.97 39.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.921 0.391 . . . . 0.0 110.676 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -68.15 -39.87 82.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.538 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.04 -39.84 87.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -106.16 -13.81 15.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 73' ' ' ALA . . . 70.08 8.17 61.04 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -100.18 140.0 35.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.298 . . . . 0.0 110.588 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.671 HG23 ' C ' ' A' ' 71' ' ' LEU . 9.7 p -123.64 122.76 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.197 0.522 . . . . 0.0 111.464 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.628 HG23 ' CG ' ' A' ' 158' ' ' ASP . 60.5 m -106.06 134.84 48.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.323 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.64 ' CE1' ' HB3' ' A' ' 68' ' ' LEU . 3.4 t-80 -84.41 114.72 22.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.94 0.4 . . . . 0.0 111.758 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.02 172.72 20.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.281 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' HG12 ' A' ' 48' ' ' ILE . . . -100.09 162.29 19.18 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.443 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.674 ' HB ' ' HD2' ' A' ' 69' ' ' PHE . 9.7 p -130.01 136.59 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.053 0.454 . . . . 0.0 111.78 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.702 HD11 ' HD3' ' A' ' 47' ' ' LYS . 94.3 mt -91.01 -77.21 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.529 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -148.69 160.08 43.5 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.057 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD1' ' HB2' ' A' ' 55' ' ' LEU . 96.7 m-85 -106.22 116.63 32.26 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.225 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.602 HG13 ' C ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -140.78 11.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.784 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.745 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . . . -85.14 99.9 11.37 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.82 -40.0 72.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.01 0.433 . . . . 0.0 110.649 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.14 -30.29 67.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.385 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 51' ' ' PRO . . . 100.07 64.59 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.07 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' CD2' ' A' ' 28' ' ' TYR . 35.6 ptt-85 -123.41 143.42 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.217 0.532 . . . . 0.0 111.928 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HG ' ' A' ' 50' ' ' LEU . 97.5 t -123.28 132.78 70.78 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.542 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.766 ' HB3' ' CG1' ' A' ' 30' ' ' ILE . 87.0 m-85 -120.41 139.88 52.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 96' ' ' LEU . 1.7 pt? -134.49 159.49 72.05 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.297 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.634 ' HG2' ' CG ' ' A' ' 100' ' ' MET . 58.7 Cg_endo -68.91 159.21 54.82 Favored 'Trans proline' 0 CA--C 1.533 0.452 0 C-N-CA 122.655 2.236 . . . . 0.0 112.744 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.652 ' HG3' HD21 ' A' ' 43' ' ' ASN . 77.9 mt-30 -60.07 -43.02 95.76 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.541 ' CD1' ' HB2' ' A' ' 97' ' ' PRO . 29.4 p-90 -64.52 -40.0 94.81 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.826 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.634 ' CG ' ' HG2' ' A' ' 97' ' ' PRO . 93.9 mmm -63.49 -40.15 96.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.751 0.31 . . . . 0.0 111.307 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 63.3 ttp -61.8 -42.42 98.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.57 -39.98 92.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 94.6 m -65.61 -40.35 92.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 93.1 mt -69.97 -23.73 63.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.786 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.44 25.49 72.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.901 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' HB ' ' OG ' ' A' ' 110' ' ' SER . 44.9 pt -120.4 151.58 23.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.892 0.377 . . . . 0.0 111.565 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.49 160.45 32.99 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.581 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.05 -2.82 2.47 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.589 2.192 . . . . 0.0 113.323 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.51 -14.06 22.76 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.626 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.532 ' OG ' ' HB ' ' A' ' 106' ' ' ILE . 90.8 p -81.48 161.29 23.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.991 0.424 . . . . 0.0 111.132 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -70.42 140.02 51.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.37 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 27' ' ' CYS . 60.5 tp -118.94 129.38 55.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.019 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 64.0 tt0 -106.75 125.85 51.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.72 HD13 HD21 ' A' ' 50' ' ' LEU . 14.9 tt -117.97 126.63 75.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.62 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 44.8 t -120.13 131.77 55.16 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.998 0.369 . . . . 0.0 111.998 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.669 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 1.2 m -83.46 114.9 21.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.488 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.686 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 34.3 p -122.07 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.036 0.446 . . . . 0.0 112.203 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 18' ' ' PRO . 57.4 t0 -115.19 113.11 23.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.933 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 186' ' ' CYS . 34.4 m -119.36 150.38 49.41 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.929 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.67 -175.6 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.484 2.123 . . . . 0.0 111.407 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.833 HD23 HG23 ' A' ' 187' ' ' VAL . 3.8 mp -95.27 119.47 33.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.062 0.458 . . . . 0.0 110.709 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 192' ' ' LEU . . . -60.0 159.14 23.92 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.732 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -107.29 -29.03 9.54 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.613 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.47 ' CE2' ' HG3' ' A' ' 126' ' ' LYS . 69.2 t80 -145.28 130.25 18.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.69 0.281 . . . . 0.0 111.395 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.784 HG23 ' CG1' ' A' ' 176' ' ' VAL . 4.2 p -133.78 130.08 55.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.093 0.473 . . . . 0.0 112.187 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD2' ' HG2' ' A' ' 175' ' ' GLU . 85.4 mttt -99.73 121.62 41.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.971 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 144' ' ' LEU . 85.6 mt -105.31 131.35 52.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.083 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 199' ' ' PRO . 37.8 tt0 -114.63 109.52 47.93 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.68 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HG3' HD11 ' A' ' 135' ' ' LEU . 88.2 Cg_endo -83.94 -168.01 0.51 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.648 2.232 . . . . 0.0 112.601 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -121.84 121.19 36.61 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.293 0.568 . . . . 0.0 109.982 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.0 t 59.52 178.0 0.08 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.96 -11.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.695 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.08 -40.39 89.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.539 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HD2' HD12 ' A' ' 135' ' ' LEU . 64.9 t80 -60.35 -40.27 90.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.014 0.435 . . . . 0.0 110.647 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.542 HD11 ' HG3' ' A' ' 129' ' ' PRO . 9.6 mp -80.47 -10.03 59.75 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.776 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -69.89 -19.31 63.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.601 0.239 . . . . 0.0 111.277 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.46 ' O ' ' HD3' ' A' ' 140' ' ' PRO . 85.6 mt -60.43 133.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.677 0.275 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.2 m -60.1 -39.98 88.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.417 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 137' ' ' ILE . 1.1 m-20 -126.04 76.5 71.69 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 144' ' ' LEU . 40.8 Cg_endo -68.79 -30.13 27.69 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.426 2.084 . . . . 0.0 112.071 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -59.92 -40.23 88.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.926 0.393 . . . . 0.0 110.881 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.12 99.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 147' ' ' VAL . 98.1 t -61.73 -49.67 83.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.588 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 140' ' ' PRO . 3.5 mm? -60.2 -39.99 88.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.659 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.01 -46.35 89.78 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.31 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -60.57 -40.39 91.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.153 0.501 . . . . 0.0 110.247 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.845 HG22 HG21 ' A' ' 162' ' ' ILE . 62.4 t -63.12 -40.63 89.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.169 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 154' ' ' LEU . 86.9 mt -60.04 -40.0 87.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.69 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -66.5 -40.01 88.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -61.11 -40.04 92.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.676 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.532 ' CZ ' ' HB ' ' A' ' 160' ' ' ILE . 96.7 m-85 -101.6 118.74 37.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.6 m -62.65 -39.92 95.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.361 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.537 ' CG2' HD22 ' A' ' 68' ' ' LEU . 33.7 p -125.56 149.84 47.99 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 111.737 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 192' ' ' LEU . 86.1 mt -116.02 121.72 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.428 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 158' ' ' ASP . 94.3 m -119.95 130.07 54.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.002 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 173' ' ' ILE . 89.8 t -59.95 -40.03 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 111.684 -178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -69.92 -38.61 76.27 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.304 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.628 ' CG ' HG23 ' A' ' 80' ' ' THR . 87.9 m-20 -69.54 134.85 49.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.552 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.49 ' O ' ' HZ3' ' A' ' 99' ' ' TRP . 6.1 m -102.53 119.93 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.465 178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 171' ' ' ILE . 46.7 pt -104.29 140.03 23.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.007 0.432 . . . . 0.0 111.52 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 170' ' ' LYS . 97.1 mt-10 -120.01 140.55 50.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.221 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.845 HG21 HG22 ' A' ' 147' ' ' VAL . 46.2 pt -128.01 140.4 49.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.993 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 167' ' ' LYS . 50.8 m -105.36 119.97 40.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.422 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' ND2' ' A' ' 165' ' ' ASN . 64.8 t80 -122.59 119.97 32.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.423 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.497 ' ND2' ' CE2' ' A' ' 164' ' ' TYR . 98.6 m-20 54.03 40.14 31.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.516 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.03 13.6 81.86 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.252 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.69 ' O ' ' HA ' ' A' ' 163' ' ' SER . 61.6 mttp -116.72 139.28 50.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.808 0.304 . . . . 0.0 110.393 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 92.5 m -113.38 129.73 56.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.977 0.418 . . . . 0.0 110.81 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -120.0 139.98 51.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.973 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HG2' ' HG2' ' A' ' 161' ' ' GLU . 96.8 mttt -103.5 123.49 47.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.072 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.746 HD11 HD11 ' A' ' 160' ' ' ILE . 45.6 pt -124.51 131.82 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.947 0.403 . . . . 0.0 110.787 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 128' ' ' GLU . 62.9 tttp -119.58 134.6 55.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.959 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.722 ' HB ' ' HA ' ' A' ' 156' ' ' VAL . 0.0 OUTLIER -77.55 118.39 24.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.436 HD22 ' HG2' ' A' ' 175' ' ' GLU . 9.1 tt -62.62 -60.04 4.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.911 0.386 . . . . 0.0 110.653 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.746 ' HG2' ' HD2' ' A' ' 126' ' ' LYS . 22.0 pt-20 -163.02 159.3 23.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.692 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.784 ' CG1' HG23 ' A' ' 125' ' ' VAL . 13.6 m -147.77 159.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.896 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.71 102.89 51.76 Favored Pre-proline 0 C--O 1.233 0.226 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.451 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 183' ' ' LYS . 57.4 Cg_endo -104.71 0.24 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 124.166 3.244 . . . . 0.0 113.009 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 61.3 21.33 11.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.735 0.302 . . . . 0.0 110.539 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -143.82 156.56 44.52 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.198 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 80.3 p -71.25 -20.15 62.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.485 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 60.8 m -59.99 -39.89 87.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.602 ' HA ' ' HG3' ' A' ' 178' ' ' PRO . 74.3 mmtt 68.34 20.0 8.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.039 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.2 t -128.06 131.09 49.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.835 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.732 ' H ' HD13 ' A' ' 185' ' ' ILE . 0.2 OUTLIER -131.04 159.83 42.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.304 0.574 . . . . 0.0 112.514 -179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.501 ' HB2' HG22 ' A' ' 153' ' ' THR . 35.2 t -129.56 126.05 37.65 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.26 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.872 HG11 ' HB2' ' A' ' 192' ' ' LEU . 7.6 p -148.63 83.26 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.814 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 66' ' ' PRO . 85.3 mt -69.83 -40.06 78.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 190' ' ' THR . 86.5 tt0 -66.02 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.794 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 189' ' ' GLU . 10.4 t -179.98 41.31 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.5 ' H ' ' CG2' ' A' ' 187' ' ' VAL . 91.2 m-20 -98.38 7.75 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.558 0.218 . . . . 0.0 111.504 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.872 ' HB2' HG11 ' A' ' 187' ' ' VAL . 12.5 tp -107.38 129.57 54.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 110.782 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 125' ' ' VAL . 38.3 t -96.79 120.4 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.285 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' THR . . . . . 0.649 ' HA ' HG13 ' A' ' 125' ' ' VAL . 59.6 p -99.99 145.57 27.72 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.208 0.528 . . . . 0.0 111.84 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -130.01 140.05 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.961 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 144' ' ' LEU . 97.3 m-85 -101.15 120.29 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.948 0.404 . . . . 0.0 111.468 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -135.42 118.51 12.72 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 199' ' ' PRO . 56.5 Cg_endo -69.99 130.24 18.72 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.315 2.01 . . . . 0.0 112.139 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.506 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 23.8 Cg_endo -94.48 -3.28 2.63 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.116 2.544 . . . . 0.0 112.693 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.2 136.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 111.217 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.22 84.72 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.579 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -98.7 123.5 42.95 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.4 m -119.93 139.1 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.942 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.05 110.7 60.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.001 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.79 27.02 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.803 2.335 . . . . 0.0 112.653 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -100.01 122.13 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.735 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.59 123.67 44.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.776 -179.922 . . . . . . . . 0 0 . 1 stop_ save_